Citrus Sinensis ID: 002953
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.337 | 0.138 | 0.485 | 3e-82 | |
| O15021 | 2626 | Microtubule-associated se | yes | no | 0.317 | 0.104 | 0.465 | 2e-76 | |
| Q811L6 | 2618 | Microtubule-associated se | yes | no | 0.317 | 0.104 | 0.462 | 4e-76 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.317 | 0.184 | 0.468 | 3e-75 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | no | no | 0.317 | 0.152 | 0.458 | 2e-74 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.327 | 0.180 | 0.458 | 9e-74 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.327 | 0.180 | 0.455 | 3e-73 | |
| Q810W7 | 1570 | Microtubule-associated se | no | no | 0.327 | 0.180 | 0.455 | 4e-73 | |
| Q60592 | 1734 | Microtubule-associated se | no | no | 0.317 | 0.158 | 0.451 | 5e-73 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.317 | 0.207 | 0.455 | 1e-72 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 307 bits (786), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 162/334 (48%), Positives = 208/334 (62%), Gaps = 43/334 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKK D IRKN V ++ ER+IL V+N FVV+ FY+F + LYLVMEYL GGD SL
Sbjct: 1556 KVLKKLDTIRKNMVNHVIVERNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASL 1615
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LR LGC +E +A+ YIAE VL LEYLH +VHRDLKPDN+LI GHIKLTDFGLSK+G
Sbjct: 1616 LRALGCFEEHMAKHYIAETVLCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIG 1675
Query: 600 LINS--------------------------TDDLS---GPAVSGTTLLGDEEPQLTASEH 630
+I+ DD S P +G T L + + +
Sbjct: 1676 IIDDKKMEDSGNTNTNTHFNFSTSPTNTSMMDDSSTTGNPNGNGNTSLNSSQTNILSPYP 1735
Query: 631 QQE-------RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683
Q++ ++ + VGTPDYL+PEILLGTGHG T DWW++GIIL+E + G PPFN +
Sbjct: 1736 QRKNTLKTPLKKPVKKVVGTPDYLSPEILLGTGHGQTVDWWALGIILYEFLTGSPPFNDD 1795
Query: 684 HPQQIFDNIL--NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
P+ IF +IL +R++ W PEE+S EA DLI + L DP++RLG+ GA EVK H FF
Sbjct: 1796 TPELIFQHILHRDREMEW---PEEISSEAKDLILKLLNPDPYKRLGANGAYEVKTHPFFA 1852
Query: 742 DINWDTLARQKA--AFVPTSESALDTSYFTSRYS 773
++NWDTL Q+ F+P E+ DT YF R S
Sbjct: 1853 NVNWDTLIDQEMDNIFLPKPENNYDTDYFWDRQS 1886
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 288 bits (736), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 135/290 (46%), Positives = 188/290 (64%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV + SF R +L +VMEY+ GGD +L++
Sbjct: 604 INKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMK 663
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHIKLTDFGLSKVGL+
Sbjct: 664 NMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLM 723
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 724 SMTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 767
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP E P+A DLI L ++
Sbjct: 768 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQDLITLLLRQN 827
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF +R
Sbjct: 828 PLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 134/290 (46%), Positives = 188/290 (64%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV + SF R +L +VMEY+ GGD +L++
Sbjct: 599 INKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMK 658
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHIKLTDFGLSKVGL+
Sbjct: 659 NMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLM 718
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 719 SMTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 762
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP E P+A +LI L ++
Sbjct: 763 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQN 822
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF +R
Sbjct: 823 PLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 136/290 (46%), Positives = 185/290 (63%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N + + ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+
Sbjct: 430 INKQNLILRNQIHQVFVERDILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLK 489
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D++R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSKVGL+
Sbjct: 490 NMGPLPVDMSRMYFAETVLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKVGLM 549
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
N T +L + E + GTP+Y+APE++L G+G
Sbjct: 550 NMTTNLYEGHI----------------EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV 593
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ I WP E + ++ DLI R L ++
Sbjct: 594 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIIWPGGEEALPADSQDLITRLLRQN 653
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
+RLG+GGA EVKQH FF ++W+ L RQKA FVP E+ DTSYF +R
Sbjct: 654 SLERLGTGGAQEVKQHTFFLSLDWNGLLRQKAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 133/290 (45%), Positives = 184/290 (63%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 543 INKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLK 602
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 603 NIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 662
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 663 SLTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 706
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP E + P+A DL + L ++
Sbjct: 707 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQN 766
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+G A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 767 PLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 9e-74, Method: Compositional matrix adjust.
Identities = 139/303 (45%), Positives = 189/303 (62%), Gaps = 20/303 (6%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+
Sbjct: 405 INKQNLILRNQIQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLK 464
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L ++AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 465 NIGALPVEMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLM 524
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 525 SLTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 568
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ I WP E + EA LI L +
Sbjct: 569 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTN 628
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR----YSWNTT 777
P RLG+GGA EVKQH FF+D++W L RQKA F+P ES DTSYF +R + N+
Sbjct: 629 PLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSY 688
Query: 778 DEN 780
DE+
Sbjct: 689 DED 691
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 277 bits (708), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 138/303 (45%), Positives = 189/303 (62%), Gaps = 20/303 (6%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+
Sbjct: 407 INKQNLILRNQIQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLK 466
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L ++AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 467 NIGALPVEMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLM 526
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 527 SLTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 570
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ I WP E + +A LI L +
Sbjct: 571 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDILWPEGDEALPTDAQLLISSLLQTN 630
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR----YSWNTT 777
P RLG+GGA EVKQH FF+D++W L RQKA F+P ES DTSYF +R + N+
Sbjct: 631 PLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSY 690
Query: 778 DEN 780
DE+
Sbjct: 691 DED 693
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q810W7|MAST1_RAT Microtubule-associated serine/threonine-protein kinase 1 OS=Rattus norvegicus GN=Mast1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 138/303 (45%), Positives = 189/303 (62%), Gaps = 20/303 (6%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+
Sbjct: 407 INKQNLILRNQIQQAFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLK 466
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L ++AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 467 NIGALPVEMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLM 526
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 527 SLTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 570
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ I WP E + +A LI L +
Sbjct: 571 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDILWPEGDEALPTDAQLLISSLLQTN 630
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR----YSWNTT 777
P RLG+GGA EVKQH FF+D++W L RQKA F+P ES DTSYF +R + N+
Sbjct: 631 PLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRYHHVNSY 690
Query: 778 DEN 780
DE+
Sbjct: 691 DED 693
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Isoform 2 may play a role in neuronal transcriptional regulation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 131/290 (45%), Positives = 183/290 (63%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 484 INKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 543
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 544 NIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 603
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + E + GTP+Y+APE++L G+G
Sbjct: 604 SLTTNLYEGHI----------------EKDAREFLDKQVCGTPEYIAPEVILRQGYGKPV 647
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++
Sbjct: 648 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQN 707
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+ A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 708 PLERLGTSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 275 bits (703), Expect = 1e-72, Method: Compositional matrix adjust.
Identities = 132/290 (45%), Positives = 181/290 (62%), Gaps = 16/290 (5%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ + ERDIL NPFVV F SF R +L +VMEY+ GGD +LL+
Sbjct: 420 INKQNLILRNQIQQVFVERDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLK 479
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 480 NMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLM 539
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ +L + E + GTP+Y+APE++ G+G
Sbjct: 540 SMATNLYEGHI----------------EKDAREFVDKQVCGTPEYIAPEVIFRQGYGKPV 583
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++G+IL+E +VG PF + P+++F +++ +I WP E + +A DLI R L +
Sbjct: 584 DWWAMGVILYEFLVGCVPFFGDTPEELFGQVVSDEIMWPEGDEALPLDAQDLITRLLRQS 643
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P RLG+GG EVKQH FF ++W L R KA FVP E+ DTSYF +R
Sbjct: 644 PMDRLGTGGTHEVKQHPFFLALDWAGLLRHKAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | ||||||
| 449439583 | 1189 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.701 | 0.677 | 0.0 | |
| 255585466 | 1289 | kinase, putative [Ricinus communis] gi|2 | 0.443 | 0.297 | 0.934 | 0.0 | |
| 224121136 | 1322 | predicted protein [Populus trichocarpa] | 0.399 | 0.260 | 0.936 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.543 | 0.336 | 0.746 | 0.0 | |
| 359491046 | 1304 | PREDICTED: uncharacterized protein LOC10 | 0.548 | 0.362 | 0.758 | 0.0 | |
| 224133272 | 1319 | predicted protein [Populus trichocarpa] | 0.573 | 0.375 | 0.700 | 0.0 | |
| 356520647 | 1296 | PREDICTED: uncharacterized protein LOC10 | 0.542 | 0.361 | 0.739 | 0.0 | |
| 30684702 | 1296 | protein kinase family protein [Arabidops | 0.443 | 0.295 | 0.843 | 0.0 | |
| 6729348 | 1023 | IRE homolog 1 [Arabidopsis thaliana] | 0.443 | 0.374 | 0.843 | 0.0 | |
| 26449548 | 1296 | putative protein kinase [Arabidopsis tha | 0.443 | 0.295 | 0.841 | 0.0 |
| >gi|449439583|ref|XP_004137565.1| PREDICTED: uncharacterized protein LOC101214945 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1131 bits (2925), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/874 (67%), Positives = 681/874 (77%), Gaps = 40/874 (4%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILV+IR KFDKAKEEVNSDLA+FA DLVG+LEKN ++HPEWQETIEDLLVLARSCAM+
Sbjct: 319 EEILVMIRAKFDKAKEEVNSDLAIFAADLVGVLEKNVDTHPEWQETIEDLLVLARSCAMS 378
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCE IVQELDDRRQELPPG LKQL+TR+LFILTRCTRLLQFHKES LAEDE++
Sbjct: 379 SPGEFWLQCESIVQELDDRRQELPPGMLKQLHTRILFILTRCTRLLQFHKESGLAEDENV 438
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
FQ RQSR LHSADKR R+ K S+ AKASK SSRKSYSQEQ GLDW R+H + G
Sbjct: 439 FQLRQSRNLHSADKRTAPAMGREMKSSSAAKASKGTSSRKSYSQEQRGLDWSREHDILPG 498
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N +S DD +K+L S RDRM+SWK+LPSP +KES + ++ K + L S IR
Sbjct: 499 NNVSTSPDDTSKNLVSPTGRDRMASWKRLPSPAKSSVKESTLKVQGDNKKFKSLNMSKIR 558
Query: 258 RGLSEIDL-TAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
+SE D AK SE P ++ + +KHQHK SWG WGDQ +SD+ SSIICRICEEE+
Sbjct: 559 MSVSETDFAAAKVSELPLPRDSHDQPTKHQHKPSWG-WGDQPTVSDE-SSIICRICEEEI 616
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PT++VEDHS+ICA+ADRCDQKG+SVNERLLRI+ETLEKM+ES QKD + VGSPDVAK
Sbjct: 617 PTANVEDHSRICAVADRCDQKGISVNERLLRIAETLEKMIESFTQKDSQH--VGSPDVAK 674
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSS+TEESD+ SPK SDWSRRGSEDMLD E D+SVFMDDLKGLPSM+CKTRFGPKS
Sbjct: 675 VSNSSMTEESDI-SPKHSDWSRRGSEDMLDCFHETDSSVFMDDLKGLPSMSCKTRFGPKS 733
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNA---- 492
DQGMTTSSAGSMTPRSPLLTPRTSQ DL LAGKGA EHDD Q+ AD+ R +A
Sbjct: 734 DQGMTTSSAGSMTPRSPLLTPRTSQFDLFLAGKGAYYEHDDLTQISDLADIARCSANTPL 793
Query: 493 --------VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY------- 537
+ + L + ++I+ R F +F R + +YL +L
Sbjct: 794 GDDCSMQYLLTCLEDLRVVIN-RRKFNALTVDTFGTRIEKLIREKYLQLCELVDDEKIDI 852
Query: 538 --SLLRNLGCLDEDVAR------VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG--- 586
+++ L++D+ R ++ ++ +++ ++ + R L
Sbjct: 853 ASTVIDEDTPLEDDIVRSLRTSPIHSSKDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGD 912
Query: 587 --HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644
IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG +EP ++ASEHQQERRKKRSAVGTP
Sbjct: 913 LFAIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGYDEPTMSASEHQQERRKKRSAVGTP 972
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE 704
DYLAPEILLGTGHG TADWWSVGIILFELIVGIPPFNAEHPQ IFDNILNRKIPWP++PE
Sbjct: 973 DYLAPEILLGTGHGATADWWSVGIILFELIVGIPPFNAEHPQTIFDNILNRKIPWPQIPE 1032
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALD 764
EMS +A DLIDR LTEDPHQRLG+ GASEVKQH+FFKDINWDTLARQKAAFVPTSESALD
Sbjct: 1033 EMSHDAQDLIDRLLTEDPHQRLGAIGASEVKQHMFFKDINWDTLARQKAAFVPTSESALD 1092
Query: 765 TSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGS 824
TSYFTSRYSWN +D+++YP S+ EDSSDADSLSG SCLSNRQ+EVGDECGGL +FE G+
Sbjct: 1093 TSYFTSRYSWNHSDDHVYPHSELEDSSDADSLSG-DSCLSNRQDEVGDECGGLTDFEPGA 1151
Query: 825 SVNYSFSNFSFKNLSQLASINYDLLSKGWKDDPP 858
SVNYSFSNFSFKNLSQLASINYDLLSKG KDDPP
Sbjct: 1152 SVNYSFSNFSFKNLSQLASINYDLLSKGLKDDPP 1185
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585466|ref|XP_002533426.1| kinase, putative [Ricinus communis] gi|223526726|gb|EEF28957.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/384 (93%), Positives = 374/384 (97%), Gaps = 1/384 (0%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL
Sbjct: 907 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 966
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCLDE+VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 967 LRNLGCLDEEVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 1026
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDLSGPAVSGT++L D+EPQL+ASEHQ+ERRKKRSAVGTPDYLAPEILLGTGHGT
Sbjct: 1027 LINSTDDLSGPAVSGTSMLEDDEPQLSASEHQRERRKKRSAVGTPDYLAPEILLGTGHGT 1086
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVG+ILFELIVGIPPFNAEHPQ IFDNILNRKIPWPRVPEEMSPEA DLIDR LT
Sbjct: 1087 TADWWSVGVILFELIVGIPPFNAEHPQIIFDNILNRKIPWPRVPEEMSPEAQDLIDRLLT 1146
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDP RLG+GGASEVKQHVFFKDINWDTLARQKAAFVP+SESALDTSYFTSRYSWNT+D+
Sbjct: 1147 EDPEVRLGAGGASEVKQHVFFKDINWDTLARQKAAFVPSSESALDTSYFTSRYSWNTSDQ 1206
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFKNLS 839
+YP SDFEDSSDADSLSGSSSCLSNRQ+EVGDECGGLAEFESGSSVNYSFSNFSFKNLS
Sbjct: 1207 -VYPTSDFEDSSDADSLSGSSSCLSNRQDEVGDECGGLAEFESGSSVNYSFSNFSFKNLS 1265
Query: 840 QLASINYDLLSKGWKDDPPRNPNA 863
QLASINYDLLSKGWKDDP NPN+
Sbjct: 1266 QLASINYDLLSKGWKDDPSTNPNS 1289
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121136|ref|XP_002318507.1| predicted protein [Populus trichocarpa] gi|222859180|gb|EEE96727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/379 (93%), Positives = 369/379 (97%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL
Sbjct: 940 KVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 999
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 1000 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 1059
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDLSGPAVSGT++L D+EPQL+ SEHQ+ERRKKRSAVGTPDYLAPEILLGTGHGT
Sbjct: 1060 LINSTDDLSGPAVSGTSMLVDDEPQLSTSEHQRERRKKRSAVGTPDYLAPEILLGTGHGT 1119
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVG+ILFELIVGIPPFNAEHPQ IFDNILN KIPWPRVPEEMSPEA DLIDR LT
Sbjct: 1120 TADWWSVGVILFELIVGIPPFNAEHPQTIFDNILNCKIPWPRVPEEMSPEAQDLIDRLLT 1179
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDP+QRLG+GGASEVKQHVFFKDINWDTLARQKAAFVP+SESALDTSYFTSRYSWNT+D+
Sbjct: 1180 EDPYQRLGAGGASEVKQHVFFKDINWDTLARQKAAFVPSSESALDTSYFTSRYSWNTSDD 1239
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSNFSFKNLS 839
IYPASDFEDSSDADSLSGSSSCLSNR +EVGDEC GLAEFESGS VNYSFSNFSFKNLS
Sbjct: 1240 AIYPASDFEDSSDADSLSGSSSCLSNRHDEVGDECQGLAEFESGSGVNYSFSNFSFKNLS 1299
Query: 840 QLASINYDLLSKGWKDDPP 858
QLASINYD+LSKGWKDDPP
Sbjct: 1300 QLASINYDILSKGWKDDPP 1318
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/473 (74%), Positives = 400/473 (84%), Gaps = 4/473 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HP+WQETIEDLLVLARSCAMT
Sbjct: 322 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPDWQETIEDLLVLARSCAMT 381
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 382 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 441
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ AKA K SS+K++SQEQ + WK+D ++
Sbjct: 442 FNLRQSRVLHSAGKFIPPSVGRDTKSSSAAKALK-PSSKKAFSQEQSMMGWKKD-VMQPE 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK +SS+ R+RM+SWKK PSP G+ KE+ K+QN G+VE K+SN +
Sbjct: 500 NLSIPADDDNAKLFDSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRVESSKASNNK 559
Query: 258 RGLSEIDL-TAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEV 316
R S++DL TAKPSE P ++L+H+SKHQHKVSWGYWGDQQN + + +SIICRICEE+V
Sbjct: 560 RFTSDVDLSTAKPSELLPVKDSLDHASKHQHKVSWGYWGDQQNNNSEENSIICRICEEDV 619
Query: 317 PTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAK 376
PTSHVEDHS+ICA+ADRCDQKGLSVNERL+RIS+TLEKMMES QKD +VGSPDVAK
Sbjct: 620 PTSHVEDHSRICAVADRCDQKGLSVNERLVRISDTLEKMMESCTQKDTQQ-MVGSPDVAK 678
Query: 377 VSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKS 436
VSNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKS
Sbjct: 679 VSNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKS 738
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIR 489
DQGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQ+ + AD+ R
Sbjct: 739 DQGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIAR 791
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491046|ref|XP_003634211.1| PREDICTED: uncharacterized protein LOC100259538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/484 (75%), Positives = 404/484 (83%), Gaps = 11/484 (2%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EE+L VIR KFDKAKEEVNSDLA+FA DLVGILEKNAESHPEWQETIEDLLVLAR CA+T
Sbjct: 321 EEVLAVIRVKFDKAKEEVNSDLAIFAADLVGILEKNAESHPEWQETIEDLLVLARRCAVT 380
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S G+FWLQCEGIVQELDDRRQELP G LKQL+TRMLFILTRCTRLLQFHKES LAEDEH+
Sbjct: 381 SSGQFWLQCEGIVQELDDRRQELPMGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEHV 440
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
Q RQSR+LHSADKR+P G RDGK S+ A + A++RKSYSQEQHGLDWK DHA++ G
Sbjct: 441 LQLRQSRILHSADKRVPSGVGRDGK-SSSAAKASRAATRKSYSQEQHGLDWKSDHAIQPG 499
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N LSP + K+L+S RDRM+SWKKLPSP GK +KES KEQ D KVE K N
Sbjct: 500 NFLSPTS-ETTKTLDSPVGRDRMASWKKLPSPAGKTVKESVPMKEQTDIKVESSKMLN-N 557
Query: 258 RGLSEIDL-TAKPSEFPPAAETLEH---SSKHQHKVSWGYWGDQQNISDDSSSIICRICE 313
+ + ++DL TAKP + PPA + H SSKHQHK SWGYWGDQ NIS+D SSIICRICE
Sbjct: 558 QAIPDVDLTTAKPPDIPPAKDFHGHSSISSKHQHKASWGYWGDQPNISED-SSIICRICE 616
Query: 314 EEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPD 373
EEVPTSHVEDHS+ICAIADRCDQKG+SVNERL+RI+ETLEKMMES QKD + VGSPD
Sbjct: 617 EEVPTSHVEDHSRICAIADRCDQKGISVNERLIRIAETLEKMMESLSQKDFQH--VGSPD 674
Query: 374 -VAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRF 432
VAKVSNSSVTEESDVLSPK SD SRRGSEDMLD PEADN VF+DDLKG PSM+CKTRF
Sbjct: 675 VVAKVSNSSVTEESDVLSPKLSDCSRRGSEDMLDCFPEADNYVFVDDLKGFPSMSCKTRF 734
Query: 433 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNA 492
GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGA SEHDD PQ+ + AD+ R A
Sbjct: 735 GPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGAYSEHDDLPQMNELADISRCAA 794
Query: 493 VESI 496
S+
Sbjct: 795 NASL 798
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133272|ref|XP_002321526.1| predicted protein [Populus trichocarpa] gi|222868522|gb|EEF05653.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/524 (70%), Positives = 409/524 (78%), Gaps = 29/524 (5%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKEEVNSDLAVFA DLVGILEKNA+SHPEWQETIEDLLVLARSCAMT
Sbjct: 328 EEILVVIRAKFDKAKEEVNSDLAVFAADLVGILEKNADSHPEWQETIEDLLVLARSCAMT 387
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
SPGEFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE++
Sbjct: 388 SPGEFWLQCEGIVQDLDDRRQELPPGILKQLHTRMLFILTRCTRLLQFHKESGLAEDENI 447
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGK-----------GSTIAKASKAASSRKSYSQEQHGL 186
FQ Q R+L SADK IP G RDGK + ++ KAAS RKSYSQEQ
Sbjct: 448 FQLHQLRLLQSADKHIPPGVGRDGKISSAPKKAASAKKSYSQEQKAASVRKSYSQEQCA- 506
Query: 187 DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDG 246
W R+ V G LS P D+ KS ES R+R+SSWK LPSP KI KE + QND
Sbjct: 507 -WGREQDVLPGKFLS-PADNTPKSDESPTGRNRISSWKPLPSPPVKITKEVVPPRGQNDD 564
Query: 247 KVEPLKSSNIRRGLSEIDL-TAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSS 305
K EPLK+SN R+G S++ L AK SE P + EHS+KHQHK+SWG WGDQQNI+D+ S
Sbjct: 565 KNEPLKTSNDRKGASDVLLAAAKASELPLVKDLHEHSTKHQHKISWGNWGDQQNIADE-S 623
Query: 306 SIICRICEEEVPTSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIH 365
SIICRICEEEVPT +VEDHS+ICAI DRCDQ LSVNERL+RISETLEKM+ES QKDI
Sbjct: 624 SIICRICEEEVPTLYVEDHSRICAITDRCDQMCLSVNERLIRISETLEKMIESFAQKDIQ 683
Query: 366 NVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPS 425
+ VGSPD+AKVSNSSVTEESDVLSPK SDWSRRGSEDMLD+ PEADNS+FMDD+KGLPS
Sbjct: 684 H-AVGSPDIAKVSNSSVTEESDVLSPKLSDWSRRGSEDMLDFFPEADNSIFMDDMKGLPS 742
Query: 426 MACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKA 485
M+CKTRFGPKSDQGM TSSAGSMTPRSPLLTPR SQIDLLLAGK A SEHDD PQ+ + A
Sbjct: 743 MSCKTRFGPKSDQGMATSSAGSMTPRSPLLTPRNSQIDLLLAGKSAFSEHDDLPQLNELA 802
Query: 486 DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529
D+ R V ++ E D IS Y TC E+L +V++
Sbjct: 803 DIAR--CVATMPLEDDRAIS----------YLLTCLEDLRVVID 834
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520647|ref|XP_003528972.1| PREDICTED: uncharacterized protein LOC100816852 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1805), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/472 (73%), Positives = 395/472 (83%), Gaps = 4/472 (0%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
EEILVVIR KFDKAKE+VNSDLA+FA DLVGILEKNA++HPEWQETIEDLLVLARSCAMT
Sbjct: 319 EEILVVIRAKFDKAKEDVNSDLAIFAADLVGILEKNADTHPEWQETIEDLLVLARSCAMT 378
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
S GEFWLQCE IVQELDDRRQE PPG LKQL+TRMLFILTRCTRLLQFHKES LAEDE +
Sbjct: 379 SSGEFWLQCESIVQELDDRRQEHPPGMLKQLHTRMLFILTRCTRLLQFHKESGLAEDEPV 438
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDHAVKQG 197
F RQSRVLHSA K IP RD K S+ K K SS+K++SQEQ + WK+D ++
Sbjct: 439 FNLRQSRVLHSAGKCIPPSVGRDTKSSSATKVLK-PSSKKAFSQEQSMMGWKKD-VMQPE 496
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
N+ P DDNAK SS+ R+RM+SWKK PSP G+ KE+ K+QN G++E K+SN +
Sbjct: 497 NLSIPADDDNAKHFNSSSGRNRMASWKKFPSPTGRSPKEAVQLKDQNYGRIESSKASNNK 556
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNISDDSSSIICRICEEEVP 317
R S++D TAKPSE P ++L+H+SKHQHKVSWG+WGDQQN + + +SIICRICEE+VP
Sbjct: 557 RFSSDVD-TAKPSELHPVKDSLDHASKHQHKVSWGHWGDQQNNNSEENSIICRICEEDVP 615
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
TSHVEDHS+ICA+ADRCDQKGLSVNERL RI+ETLEKMMES QKD +VGSPDVAKV
Sbjct: 616 TSHVEDHSRICALADRCDQKGLSVNERLGRIAETLEKMMESCTQKDTQQ-MVGSPDVAKV 674
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SNSS+TEESDV SPK SDWSRRGSEDMLD PEADNSVFMDDLKGLP M+CKTRFGPKSD
Sbjct: 675 SNSSMTEESDVPSPKLSDWSRRGSEDMLDCFPEADNSVFMDDLKGLPLMSCKTRFGPKSD 734
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIR 489
QGMTTSSAGSMTPRSPL+TPRTSQIDLLLAGKGA SEHDD PQ+ + AD+ R
Sbjct: 735 QGMTTSSAGSMTPRSPLMTPRTSQIDLLLAGKGAYSEHDDLPQMNELADIAR 786
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684702|ref|NP_188412.2| protein kinase family protein [Arabidopsis thaliana] gi|332642494|gb|AEE76015.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/384 (84%), Positives = 350/384 (91%), Gaps = 1/384 (0%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSL
Sbjct: 911 KVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 970
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 971 LRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 1030
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGHG
Sbjct: 1031 LINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGHGA 1090
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRFLT
Sbjct: 1091 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRFLT 1150
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+DE
Sbjct: 1151 EDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTSDE 1210
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFKNL 838
+P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFKNL
Sbjct: 1211 QFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFKNL 1270
Query: 839 SQLASINYDLLSKGWKDDPPRNPN 862
SQLASINYDLLSKGWKD+P + P+
Sbjct: 1271 SQLASINYDLLSKGWKDEPQQIPH 1294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|6729348|dbj|BAA89784.1| IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/384 (84%), Positives = 350/384 (91%), Gaps = 1/384 (0%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSL
Sbjct: 638 KVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 697
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 698 LRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 757
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGHG
Sbjct: 758 LINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGHGA 817
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRFLT
Sbjct: 818 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRFLT 877
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+DE
Sbjct: 878 EDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTSDE 937
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFKNL 838
+P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFKNL
Sbjct: 938 QFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFKNL 997
Query: 839 SQLASINYDLLSKGWKDDPPRNPN 862
SQLASINYDLLSKGWKD+P + P+
Sbjct: 998 SQLASINYDLLSKGWKDEPQQIPH 1021
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|26449548|dbj|BAC41900.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1709), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/384 (84%), Positives = 349/384 (90%), Gaps = 1/384 (0%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSL
Sbjct: 911 KVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 970
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 971 LRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 1030
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGHG
Sbjct: 1031 LINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGHGA 1090
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW VPEEMS EAHD+IDRFLT
Sbjct: 1091 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWHHVPEEMSAEAHDIIDRFLT 1150
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+DE
Sbjct: 1151 EDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTSDE 1210
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSN-RQEEVGDECGGLAEFESGSSVNYSFSNFSFKNL 838
+P+ + D SDADS++ SS C SN +E +EC G AEFESG V+YSFSNFSFKNL
Sbjct: 1211 QFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFKNL 1270
Query: 839 SQLASINYDLLSKGWKDDPPRNPN 862
SQLASINYDLLSKGWKD+P + P+
Sbjct: 1271 SQLASINYDLLSKGWKDEPQQIPH 1294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 863 | ||||||
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.443 | 0.295 | 0.776 | 2.6e-310 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.546 | 0.382 | 0.581 | 1.3e-275 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.428 | 0.316 | 0.677 | 7.5e-191 | |
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.331 | 0.268 | 0.687 | 3e-150 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.391 | 0.349 | 0.421 | 2e-73 | |
| UNIPROTKB|F1NAH4 | 1370 | MAST2 "Uncharacterized protein | 0.317 | 0.2 | 0.468 | 1.2e-71 | |
| UNIPROTKB|Q6P0Q8 | 1798 | MAST2 "Microtubule-associated | 0.317 | 0.152 | 0.468 | 1.9e-71 | |
| UNIPROTKB|E1B754 | 1710 | LOC535643 "Uncharacterized pro | 0.317 | 0.160 | 0.465 | 9.6e-71 | |
| UNIPROTKB|F1Q4I0 | 1909 | MAST4 "Uncharacterized protein | 0.391 | 0.177 | 0.424 | 9.8e-71 | |
| UNIPROTKB|G5E6T0 | 1339 | G5E6T0 "Uncharacterized protei | 0.391 | 0.252 | 0.424 | 1.5e-70 |
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1543 (548.2 bits), Expect = 2.6e-310, Sum P(2) = 2.6e-310
Identities = 298/384 (77%), Positives = 319/384 (83%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAERDILI+VRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSL
Sbjct: 911 KVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 970
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCL+ED+ RVYIAEVVLALEYLHS VVHRDLKPDNLLIAHDGHIKLTDFGLSKVG
Sbjct: 971 LRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 1030
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDL+GPAVSGT+LL +EE +L ASE Q ERRKKRSAVGTPDYLAPEILLGTGHG
Sbjct: 1031 LINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGHGA 1090
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP VPEEMS EAHD+IDRFLT
Sbjct: 1091 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRFLT 1150
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
EDPHQRLG+ GA+EVKQH+FFKDINWDTLARQKAAFVP SESA+DTSYF SRYSWNT+DE
Sbjct: 1151 EDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTSDE 1210
Query: 780 NIYPAXXXXXXXXXXXXXXXXXXXXNRQEE-VGDECGGLAEXXXXXXXXXXXXXXXXXXX 838
+P+ N EE +EC G AE
Sbjct: 1211 QFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFKNL 1270
Query: 839 XQLASINYDLLSKGWKDDPPRNPN 862
QLASINYDLLSKGWKD+P + P+
Sbjct: 1271 SQLASINYDLLSKGWKDEPQQIPH 1294
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1361 (484.2 bits), Expect = 1.3e-275, Sum P(2) = 1.3e-275
Identities = 278/478 (58%), Positives = 336/478 (70%)
Query: 18 EEILVVIRTKFDKAKEEVNSDLAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMT 77
E+IL +IRTKFDKAKEEVNSDL F GDL+ I +KN ESHPE TIEDLLVLA++CA T
Sbjct: 264 EDILNLIRTKFDKAKEEVNSDLFAFGGDLLDIYDKNKESHPELLVTIEDLLVLAKTCAKT 323
Query: 78 SPGEFWLQCEGIVQELDDRRQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHM 137
+ EFWLQCEGIVQ+LDDRRQELPPG LKQL+TRMLFILTRCTRLLQFHKES ++E
Sbjct: 324 TSKEFWLQCEGIVQDLDDRRQELPPGVLKQLHTRMLFILTRCTRLLQFHKES-WGQEEDA 382
Query: 138 FQFRQSRVLHSADKRIPQGTLRDGXXXXXXXXXXXXXXXXXXXQEQHGLDWKRDHAVKQG 197
Q RQS VLHSADKR P G +RDG QEQ GL+W V+
Sbjct: 383 VQLRQSGVLHSADKRDPTGEVRDGKGSSTANALKVPSTKKAYSQEQRGLNWIEGFFVRPA 442
Query: 198 NILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKEQNDGKVEPLKSSNIR 257
LS P ++ +K ES A D+MSSWK+LPSP K ++E+ SKEQND KVEP +
Sbjct: 443 P-LSSPYNETSKDSESPANIDKMSSWKRLPSPASKGVQEAAVSKEQNDRKVEPPQVVKKL 501
Query: 258 RGLSEIDLTAKPSEFPPAAETLEHSSKHQHKVSWGYWGDQQNXXXXXXXXXXXXXEEEVP 317
+S+ AK E A + EH SK++H +SWGYWG Q+ EEE+P
Sbjct: 502 VAISDDMAVAKLPEVSSAKASQEHMSKNRHNISWGYWG-HQSCISEESSIICRICEEEIP 560
Query: 318 TSHVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKV 377
T+HVEDHS+ICA+AD+ DQKG+ V+ERL+ ++ TLEK+ ++ +QKD V SP+ K+
Sbjct: 561 TTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKD-SLAAVESPEGMKI 619
Query: 378 SNSSVTEESDVLSPKFSDWSRRGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSD 437
SN+S+TEE DVLSPK SDWSRRGSEDMLD PE DNSVFMDD+ LPSM+C+TRFGPKSD
Sbjct: 620 SNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRFGPKSD 679
Query: 438 QGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIR--KNAV 493
QGM TSSAGSMTPRSP+ TPR I+LLL GKG + DDFPQ+ + AD+ R NA+
Sbjct: 680 QGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAANAI 737
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1283 (456.7 bits), Expect = 7.5e-191, Sum P(3) = 7.5e-191
Identities = 256/378 (67%), Positives = 286/378 (75%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKADMIRKNAVESILAER+ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL+SL
Sbjct: 783 KVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLFSL 842
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRNLGCLDED+AR+YIAEVVLALEYLHS+ ++HRDLKPDNLLI DGHIKLTDFGLSKVG
Sbjct: 843 LRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDFGLSKVG 902
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LINSTDDLSG + G + E+ ++ RKK + VGTPDYLAPEILLG GHG
Sbjct: 903 LINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILLGMGHGK 962
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
TADWWSVG+ILFE++VGIPPFNAE PQQIF+NI+NR IPWP VPEE+S EAHDLI++ LT
Sbjct: 963 TADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDLINKLLT 1022
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
E+P QRLG+ GA EVKQH FFKDINWDTLARQKA FVP++E DTSYF SRY WN DE
Sbjct: 1023 ENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEPQ-DTSYFMSRYIWNPEDE 1081
Query: 780 NIYPAXXXXXXXXXXXXXXXXXXXXNRQEEVGDECGGLAEXXXX--XXXXXXXXXXXXXX 837
N++ N QEE GDECG LAE
Sbjct: 1082 NVHGGSDFDDLTDTCSSSSF-----NTQEEDGDECGSLAEFGNGPNLAVKYSFSNFSFKN 1136
Query: 838 XXQLASINYDLLSKGWKD 855
QLASINYDL+ K K+
Sbjct: 1137 LSQLASINYDLVLKNAKE 1154
|
|
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 3.0e-150, Sum P(3) = 3.0e-150
Identities = 205/298 (68%), Positives = 241/298 (80%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKK DMIRKN +E IL ER+ILI+VR PF+VRFFYSFTCR+NLYLVMEYLNGGDLYSL
Sbjct: 699 KVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSL 758
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L+ +GCLDE++AR+YIAE+VLALEYLHSL++VHRDLKPDNLLIA++GHIKLTDFGLSK+G
Sbjct: 759 LQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIG 818
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEH----QQERRKKRSAVGTPDYLAPEILLGT 655
LIN+T DLSG D P+ T S H Q+E R + SAVGTPDYLAPEILLGT
Sbjct: 819 LINNTIDLSGHE-------SDVSPR-TNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGT 870
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
HG ADWWS GI+LFEL+ GIPPF A P++IFDNILN K+PWP VP EMS EA DLI+
Sbjct: 871 EHGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLIN 930
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYS 773
R L +P +RLG+ GA+EVK H FF+ ++W+ LA QKAAFVP ES DTSYF SR+S
Sbjct: 931 RLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFS 988
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 700 (251.5 bits), Expect = 2.0e-73, Sum P(2) = 2.0e-73
Identities = 153/363 (42%), Positives = 224/363 (61%)
Query: 417 MDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGK-GALS-- 473
++++ L + +T P++D+ +++S+ R P + + I L+ G GA+
Sbjct: 280 LEEMAQLGNYDSRTAETPETDESVSSSNTSLRLRRKPRESDFET-IKLISNGAYGAVYFV 338
Query: 474 EHDDFPQ--VLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528
H + Q +KK + +I +N ++ ERDIL NPFVV + SF R +L +VM
Sbjct: 339 RHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVM 398
Query: 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 588
EY+ GGD +L++N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHI
Sbjct: 399 EYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHI 458
Query: 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648
KLTDFGLSKVGL+ S TT L + + A E ++ GTP+Y+A
Sbjct: 459 KLTDFGLSKVGLM-----------SMTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIA 502
Query: 649 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSP 708
PE++L G+G DWW++GIIL+E +VG PF + P+++F +++ +I WP E P
Sbjct: 503 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPP 562
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
+A DLI L ++P +RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF
Sbjct: 563 DAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYF 622
Query: 769 TSR 771
+R
Sbjct: 623 DTR 625
|
|
| UNIPROTKB|F1NAH4 MAST2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 698 (250.8 bits), Expect = 1.2e-71, Sum P(2) = 1.2e-71
Identities = 136/290 (46%), Positives = 192/290 (66%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 378 INKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 437
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 438 NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 497
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ T +L + T +E K+ GTP+Y+APE++L G+G
Sbjct: 498 SLTTNLYEGHIEKDT---------------REFLDKQ-VCGTPEYIAPEVILRQGYGKPV 541
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++G+IL+E +VG PF + P+++F +++ +I WP + + P+A DLI + L ++
Sbjct: 542 DWWAMGVILYEFLVGCVPFFGDTPEELFGQVISDEIAWPEGDDALPPDAQDLISKLLRQN 601
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +R+G+G A EVKQH FFKD++W+ L RQKA F+P ES DTSYF +R
Sbjct: 602 PLERMGTGSAFEVKQHRFFKDLDWNGLLRQKAEFIPQLESEDDTSYFDTR 651
|
|
| UNIPROTKB|Q6P0Q8 MAST2 "Microtubule-associated serine/threonine-protein kinase 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 1.9e-71, Sum P(3) = 1.9e-71
Identities = 136/290 (46%), Positives = 187/290 (64%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 543 INKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLK 602
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 603 NIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 662
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
S TT L + + A E ++ GTP+Y+APE++L G+G
Sbjct: 663 -----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPV 706
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP E + P+A DL + L ++
Sbjct: 707 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQN 766
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+G A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 767 PLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
|
| UNIPROTKB|E1B754 LOC535643 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 9.6e-71, Sum P(3) = 9.6e-71
Identities = 135/290 (46%), Positives = 187/290 (64%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 457 INKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 516
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+ R+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 517 NIGALPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 576
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
S TT L + + A E ++ GTP+Y+APE++L G+G
Sbjct: 577 -----------SLTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIAPEVILRQGYGKPV 620
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
DWW++GIIL+E +VG PF + P+++F +++ +I WP + + P+A DL + L ++
Sbjct: 621 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQN 680
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
P +RLG+G A EVKQH FF ++W L RQKA F+P ES DTSYF +R
Sbjct: 681 PLERLGTGSAYEVKQHPFFTGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 730
|
|
| UNIPROTKB|F1Q4I0 MAST4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 9.8e-71, Sum P(2) = 9.8e-71
Identities = 154/363 (42%), Positives = 224/363 (61%)
Query: 417 MDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGK-GALS-- 473
++++ L + T P++D+ +++S+A R P + + I L+ G GA+
Sbjct: 359 LEEMAQLGNYDSGTAETPETDESVSSSTASLKLQRKPRESDFET-IKLISNGAYGAVYFV 417
Query: 474 EHDDFPQ--VLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528
H + Q +KK + +I +N ++ ERDIL NPFVV + SF R +L +VM
Sbjct: 418 RHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVM 477
Query: 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 588
EY+ GGD +L++N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHI
Sbjct: 478 EYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHI 537
Query: 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648
KLTDFGLSKVGL+ S TT L + + A E ++ GTP+Y+A
Sbjct: 538 KLTDFGLSKVGLM-----------SMTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIA 581
Query: 649 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSP 708
PE++L G+G DWW++GIIL+E +VG PF + P+++F +++ +I WP E P
Sbjct: 582 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPP 641
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
+A DLI L ++P +RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF
Sbjct: 642 DAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYF 701
Query: 769 TSR 771
+R
Sbjct: 702 DTR 704
|
|
| UNIPROTKB|G5E6T0 G5E6T0 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 697 (250.4 bits), Expect = 1.5e-70, Sum P(2) = 1.5e-70
Identities = 154/363 (42%), Positives = 224/363 (61%)
Query: 417 MDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGK-GALS-- 473
++++ L + T P++D+ +++S+A R P + + I L+ G GA+
Sbjct: 276 LEEMAQLGNYDSGTAETPETDESVSSSNASLKLRRKPRESDFET-IKLISNGAYGAVYFV 334
Query: 474 EHDDFPQ--VLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528
H + Q +KK + +I +N ++ ERDIL NPFVV + SF R +L +VM
Sbjct: 335 RHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVM 394
Query: 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 588
EY+ GGD +L++N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLL+ GHI
Sbjct: 395 EYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHI 454
Query: 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648
KLTDFGLSKVGL+ S TT L + + A E ++ GTP+Y+A
Sbjct: 455 KLTDFGLSKVGLM-----------SMTTNLYEGHIEKDAREFLDKQ-----VCGTPEYIA 498
Query: 649 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSP 708
PE++L G+G DWW++GIIL+E +VG PF + P+++F +++ +I WP E P
Sbjct: 499 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPP 558
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
+A DLI L ++P +RLG+GGA EVKQH FF+ ++W++L RQKA F+P ES DTSYF
Sbjct: 559 DAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRCLDWNSLLRQKAEFIPQLESEDDTSYF 618
Query: 769 TSR 771
+R
Sbjct: 619 DTR 621
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 863 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-133 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-106 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-105 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-104 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-101 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-99 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-97 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-86 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-85 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-83 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-81 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-80 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-80 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-76 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-75 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-73 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-72 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-71 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-70 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-70 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-69 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-68 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-68 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-68 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-67 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-66 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-66 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-65 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-64 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-64 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-63 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-62 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-62 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-61 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-61 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-60 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-60 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-59 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-58 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-58 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-57 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-57 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-56 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-56 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-56 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-56 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-55 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-53 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-52 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-52 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-52 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-52 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-51 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-50 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-50 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-50 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-50 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-45 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-44 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-43 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-43 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-42 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-42 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-42 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-41 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-39 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-39 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-39 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-38 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-38 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-37 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-37 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-36 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-36 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-35 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-34 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-34 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-33 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-31 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-30 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-30 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-27 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-26 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-25 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-25 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-21 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-20 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-20 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-19 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-04 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 3e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 0.003 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 398 bits (1024), Expect = e-133
Identities = 147/265 (55%), Positives = 185/265 (69%), Gaps = 24/265 (9%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+KKADMIRKN V+ +L ERDIL ++P+VV+ +YSF ++NLYLVMEYL GGDL SLL
Sbjct: 25 VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLL 84
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
N+G LDEDVAR+YIAE+VLALEYLHS ++HRDLKPDN+LI +GH+KLTDFGLSKVGL
Sbjct: 85 ENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ +L+ + + VGTPDY+APE++LG GH T
Sbjct: 145 VRRQINLNDDEK-----------------------EDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWWS+G IL+E +VGIPPF+ E P++IF NILN KI WP E+S EA DLI + L
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV-EVSDEAIDLISKLLVP 240
Query: 721 DPHQRLGSGGASEVKQHVFFKDINW 745
DP +RLG+ E+K H FFK I+W
Sbjct: 241 DPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 330 bits (848), Expect = e-106
Identities = 137/289 (47%), Positives = 183/289 (63%), Gaps = 6/289 (2%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL+K+DMI++N + + AERDIL +P++V+ +YSF E+LYLVMEY+ GGDL +LL
Sbjct: 33 VLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL 92
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
E+ AR YIAE+VLAL+ +H L +HRD+KPDN+LI DGHIKL DFGL K
Sbjct: 93 IRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK-- 150
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+N D LL + + +H+Q R + S VGTPDY+APE+L GT +G
Sbjct: 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLT 719
DWWS+G+IL+E++ G PPF ++ Q+ ++ I+N K P+ +SPEA DLI R L
Sbjct: 211 CDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC 270
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DP RLGS E+K H FFK I+W+ L K FVP S LDTS F
Sbjct: 271 -DPEDRLGS--FEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 325 bits (835), Expect = e-105
Identities = 121/260 (46%), Positives = 161/260 (61%), Gaps = 34/260 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLKK +I++ VE L ER+IL + +PF+V+ Y+F E LYLV+EY GG+L+S L
Sbjct: 25 VLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHL 84
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
G E+ AR Y AE+VLALEYLHSL +++RDLKP+N+L+ DGHIKLTDFGL+K
Sbjct: 85 SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKE-- 142
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
E T + GTP+YLAPE+LLG G+G
Sbjct: 143 ------------------LSSEGSRT-----------NTFCGTPEYLAPEVLLGKGYGKA 173
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWWS+G++L+E++ G PPF AE ++I++ IL + R PE +SPEA DLI L +
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL---RFPEFLSPEARDLISGLLQK 230
Query: 721 DPHQRLGSGGASEVKQHVFF 740
DP +RLGSGGA E+K H FF
Sbjct: 231 DPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 324 bits (831), Expect = e-104
Identities = 136/291 (46%), Positives = 187/291 (64%), Gaps = 24/291 (8%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ K ++I +N ++ + ERDIL NPFVV F SF + +L +VMEY+ GGD +LL+
Sbjct: 34 INKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 93
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N+G L D+AR+Y AE VLALEYLH+ +VHRDLKPDNLLI GHIKLTDFGLSK+GL+
Sbjct: 94 NIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKK----RSAVGTPDYLAPEILLGTGH 657
+ T +L E E+ + + GTP+Y+APE++L G+
Sbjct: 154 SLTTNL--------------------YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
G DWW++GIIL+E +VG PF + P+++F +++ I WP E + +A DLI R
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRL 253
Query: 718 LTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
L ++P +RLG+GGA EVKQH FF ++W+ L RQKA F+P ES DTSYF
Sbjct: 254 LRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 314 bits (808), Expect = e-101
Identities = 125/292 (42%), Positives = 174/292 (59%), Gaps = 41/292 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L KA +++ VE +L E+ IL S+R+PF+V + SF NLYLVMEY+ GG+L+S L
Sbjct: 33 ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL 92
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R G E VAR Y A+VVLALEYLHSL +V+RDLKP+NLL+ DG+IK+TDFG +K
Sbjct: 93 RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-- 150
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
V G T + GTP+YLAPEI+L G+G
Sbjct: 151 -----------VKGRTY---------------------TLCGTPEYLAPEIILSKGYGKA 178
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWW++GI+++E++ G PPF ++P QI++ IL K+ R P SP+A DLI L
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---RFPSFFSPDAKDLIRNLLQV 235
Query: 721 DPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
D +RLG+ G +++K H +F I+W L ++K A F+P + DTS F
Sbjct: 236 DLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = 8e-99
Identities = 134/269 (49%), Positives = 171/269 (63%), Gaps = 37/269 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VLKK+DMI KN V ++ AER I++ +P+V + +YSF ++ LYLVMEYLNGGD S
Sbjct: 27 KVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS 86
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L++ LG L ED A+ YIAEVVL +E LH ++HRD+KP+NLLI GH+KLTDFGLS+
Sbjct: 87 LIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
GL N + VGTPDYLAPE +LG G
Sbjct: 147 GLEN-----------------------------------KKFVGTPDYLAPETILGVGDD 171
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRF 717
+DWWS+G ++FE + G PPF+AE P +FDNIL+R+I WP V E SPEA DLI+R
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 718 LTEDPHQRLGSGGASEVKQHVFFKDINWD 746
L DP +RLG+ G E+K H FFK INWD
Sbjct: 232 LCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 307 bits (789), Expect = 4e-97
Identities = 119/298 (39%), Positives = 176/298 (59%), Gaps = 11/298 (3%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ L+K++M+ K V + AERDIL NP+VV+ +YSF LYL+MEYL GGD+ +L
Sbjct: 32 KKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L E+ R YIAE +LA++ +H L +HRD+KPDNLL+ GHIKL+DFGL G
Sbjct: 92 LMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-G 150
Query: 600 L---INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR-----SAVGTPDYLAPEI 651
L + + L +++ + ++ R S VGTPDY+APE+
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 652 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE-EMSPEA 710
L TG+ DWWS+G+I++E++VG PPF +++PQ+ + I+N K E +SPEA
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEA 270
Query: 711 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DLI R + +RLG+ G +E+K H FFK ++W+ + + A +P +S DTS F
Sbjct: 271 KDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 4e-86
Identities = 107/261 (40%), Positives = 147/261 (56%), Gaps = 38/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+KK + + E IL E IL +++P +VR + F + LYLVMEY GGDL+ LL
Sbjct: 31 VIKKKKIKKD--RERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ G L ED AR Y+ +++ ALEYLHS +VHRDLKP+N+L+ DGH+KL DFGL++
Sbjct: 89 KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR--- 145
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
K + VGTP+Y+APE+LLG G+G
Sbjct: 146 -----------------------------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 661 ADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS+G+IL+EL+ G PPF + ++F I K P+P ++SPEA DLI + L
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 720 EDPHQRLGSGGASEVKQHVFF 740
+DP +RL A E QH FF
Sbjct: 237 KDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 275 bits (705), Expect = 8e-85
Identities = 134/346 (38%), Positives = 193/346 (55%), Gaps = 33/346 (9%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ L+KAD++ +N + AERDIL N +VV+ +YSF ++NLY VM+Y+ GGD+ SL
Sbjct: 32 KTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL---- 595
L LG +ED+AR YIAE+ A+E +H + +HRD+KPDN+LI DGHIKLTDFGL
Sbjct: 92 LIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
Query: 596 -----SKVGLINSTDDLSGPAVSGTTLLGDEEP-QLTASE----HQQERRKKRSAVGTPD 645
SK D ++ + + + +L E Q +R S VGTP+
Sbjct: 152 RWTHDSK--YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN 209
Query: 646 YLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP---RV 702
Y+APE+LL TG+ DWWSVG+IL+E++VG PPF A+ P + ++N W +
Sbjct: 210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN----WETTLHI 265
Query: 703 PE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR-QKAAFVPTS 759
P ++S EA DLI R RLG GA E+K H FFK I++ +L R QKA ++P
Sbjct: 266 PSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKI 324
Query: 760 ESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSN 805
DTS F + D + D +SS ++ ++ +
Sbjct: 325 THPTDTSNF------DPVDPEKLRSDDSGESSPDRNVKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 270 bits (691), Expect = 8e-83
Identities = 134/354 (37%), Positives = 193/354 (54%), Gaps = 45/354 (12%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
L K++M +K+ + + AERD+L +P+VV +YSF + LYL+ME+L GGDL ++L
Sbjct: 34 LLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI 93
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
EDV R Y+AE VLA+E +H L +HRD+KPDN+LI GHIKL+DFGLS G
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFH 152
Query: 602 NSTD----------DLSGPAVSGTTLLGDEEPQLTASEHQQ---ERRKKR----SAVGTP 644
D + + + + LT S Q ++ +R S VGTP
Sbjct: 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP 212
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV-- 702
DY+APEI L G+G DWWS+G I+FE ++G PPF +E+ + + I+N W
Sbjct: 213 DYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLY 268
Query: 703 -PEE--MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTS 759
P++ +S EA DLI R +T + RLG GGA E+K H FF+ ++WDT+ + +A F+P
Sbjct: 269 FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327
Query: 760 ESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDE 813
+S DTSYF P + E +A +L +QEE +
Sbjct: 328 KSITDTSYF--------------PTDELEQVPEAPAL---KQAAPAQQEESVEL 364
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 8e-81
Identities = 118/289 (40%), Positives = 174/289 (60%), Gaps = 10/289 (3%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL K +MI++N V+ +L E++IL ++ +PF+ + SF L LVM+Y GG+L+ LL
Sbjct: 33 VLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL 92
Query: 541 --RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ CL E+VAR Y AEV+LALEYLH L +V+RDLKP+N+L+ GHI L+DF LSK
Sbjct: 93 QRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK- 151
Query: 599 GLINSTDDLSGPAVS--GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
+ A+ + P T SE R S VGT +Y+APE++ G G
Sbjct: 152 -QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR--SNSFVGTEEYIAPEVISGDG 208
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
HG+ DWW++GI+L+E++ G PF + + F NIL +++ +P P +S A DLI +
Sbjct: 209 HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSP-PVSSSARDLIRK 267
Query: 717 FLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQKAAFVPTSESALD 764
L +DP +RLGS GA+E+KQH FF+ +NW + +P + +D
Sbjct: 268 LLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 3e-80
Identities = 116/306 (37%), Positives = 169/306 (55%), Gaps = 47/306 (15%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ +KK+ + + N V +L ERDIL + ++ ++V+ Y+F E LYL MEY+ GGD +L
Sbjct: 32 KRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L NLG L ED AR Y+AE+ A++ LH L +HRDLKP+N LI GHIKLTDFGLSK G
Sbjct: 92 LNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK-G 150
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
++ S VG+PDY+APE+L G G+
Sbjct: 151 IVT---------------------------------YANSVVGSPDYMAPEVLRGKGYDF 177
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPE---EMSPEAHDLI 714
T D+WS+G +L+E + G PPF+ P + ++N+ K + P + +S EA DLI
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237
Query: 715 DRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSW 774
+ + + R GS ++K H FFK+++W+ L K FVP ES +DT YF
Sbjct: 238 TKLINDPSR-RFGS--LEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFD----- 289
Query: 775 NTTDEN 780
+ +E+
Sbjct: 290 DFENED 295
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 4e-80
Identities = 95/262 (36%), Positives = 150/262 (57%), Gaps = 16/262 (6%)
Query: 481 VLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+L K +I++ V+ + E+++L + +P +++ +Y+F ENLY V+EY G+L
Sbjct: 33 ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQY 92
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+R G LDE R Y AE++LALEYLHS ++HRDLKP+N+L+ D HIK+TDFG +KV
Sbjct: 93 IRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKV- 151
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L + + + S+ ++ RR+ S VGT +Y++PE+L G
Sbjct: 152 -------LDPNSSPESN---KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK 201
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
++D W++G I+++++ G PPF + F IL + +P P+A DLI++ L
Sbjct: 202 SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPN---FPPDAKDLIEKLLV 258
Query: 720 EDPHQRLGSG-GASEVKQHVFF 740
DP RLG G E+K H FF
Sbjct: 259 LDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 1e-76
Identities = 98/271 (36%), Positives = 157/271 (57%), Gaps = 41/271 (15%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+KK ++ E I +E++IL +PF+V+ + +F ++ +Y++MEY GG+L+++LR
Sbjct: 26 VKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR 85
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+ G DE AR YIA VVLA EYLH+ +++RDLKP+NLL+ +G++KL DFG +K
Sbjct: 86 DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK--- 142
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
L +K + GTP+Y+APEI+L G+ +
Sbjct: 143 ----------------LKS-------------GQKTWTFCGTPEYVAPEIILNKGYDFSV 173
Query: 662 DWWSVGIILFELIVGIPPFNA--EHPQQIFDNIL--NRKIPWPRVPEEMSPEAHDLIDRF 717
D+WS+GI+L+EL+ G PPF E P +I+++IL N K+ +P + A DLI +
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY---IDKAAKDLIKQL 230
Query: 718 LTEDPHQRLG--SGGASEVKQHVFFKDINWD 746
L +P +RLG GG ++K+H +F +W+
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 4e-75
Identities = 101/294 (34%), Positives = 160/294 (54%), Gaps = 39/294 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VLKK +++ + VE + E+ +L PF+ + F ++ L+ VMEY+NGGDL
Sbjct: 26 KVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ G DE AR Y AE+VL L++LH +++RDLK DN+L+ +GHIK+ DFG+ K
Sbjct: 86 HIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G++ + GTPDY+APEIL +G
Sbjct: 146 GILG-------------------------------GVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
DWW++G++L+E++ G PF + ++F +IL ++ +PR +S EA ++ FL
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR---WLSKEAKSILKSFL 231
Query: 719 TEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYF 768
T++P +RLG G ++K H FF++I+WD L R+ K F P + D S F
Sbjct: 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNF 285
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 2e-73
Identities = 107/293 (36%), Positives = 161/293 (54%), Gaps = 41/293 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+V+ ++IR + + E+ +L V +PF++R F++ + LY++MEY+ GG+L+S
Sbjct: 32 KVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LRN G Y +E+V ALEYLHS +V+RDLKP+N+L+ +GHIKLTDFG +K
Sbjct: 92 LRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK-K 150
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L + T L GTP+YLAPE++ GH
Sbjct: 151 LRDRTWTL---------------------------------CGTPEYLAPEVIQSKGHNK 177
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW++GI+++E++VG PPF ++P I++ IL K+ +PR + A DLI + L
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR---HLDLYAKDLIKKLLV 234
Query: 720 EDPHQRLGS--GGASEVKQHVFFKDINWDT--LARQKAAFVPTSESALDTSYF 768
D +RLG+ GA +VK H +FK ++WD + K VP DTS F
Sbjct: 235 VDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 5e-72
Identities = 124/328 (37%), Positives = 187/328 (57%), Gaps = 51/328 (15%)
Query: 480 QVLKKADMIRKNAVES--ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+VLKKA ++R N ++ AER+IL +V++PF+V Y+F LYL++EYL+GG+L+
Sbjct: 30 KVLKKATIVR-NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 88
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L G ED A Y++E+ LALE+LH +++RDLKP+N+L+ GH+KLTDFGL K
Sbjct: 89 MHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
E E + GT +Y+APEIL+ +GH
Sbjct: 149 -------------------------------ESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
G DWWS+G ++++++ G PPF AE+ ++ D IL K+ +P ++PEA DL+ +
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---NLPPYLTPEARDLLKKL 234
Query: 718 LTEDPHQRLGSG--GASEVKQHVFFKDINW-DTLARQ-KAAFVPTSESALDTSYFTSRYS 773
L +P RLG+G A+EV+ H FF+ +NW D LAR+ + F P +S D S F S+++
Sbjct: 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFT 294
Query: 774 WNTTDENIYPASDFEDSSDADSLSGSSS 801
T P DS D +LS S++
Sbjct: 295 RQT------PV----DSPDDSTLSESAN 312
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 6e-71
Identities = 107/296 (36%), Positives = 163/296 (55%), Gaps = 36/296 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ ++KA ++ ++ V LAER +L V PF+V +SF E LYLV+ ++NGG+L+
Sbjct: 24 KTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHH 83
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L+ G D AR Y AE++ ALE LH V++RDLKP+N+L+ + GHI L DFGL K+
Sbjct: 84 LQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + K + GTP+YLAPE+LLG G+
Sbjct: 144 MKDDD-------------------------------KTNTFCGTPEYLAPELLLGHGYTK 172
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW++G++L+E++ G+PPF E+ +++ IL + R P+ +A DL+ L+
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL---RFPDGFDRDAKDLLIGLLS 229
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYS 773
DP +RLG GA E+K H FF ++W L + F P SA+DTS F ++
Sbjct: 230 RDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFT 285
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 1e-70
Identities = 134/337 (39%), Positives = 194/337 (57%), Gaps = 25/337 (7%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ L+K D++ +N V + AERDIL N +VVR +YSF ++NLY VM+Y+ GGD+ SL
Sbjct: 32 KTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK-- 597
L +G ED+AR YIAE+ A+E +H + +HRD+KPDN+LI DGHIKLTDFGL
Sbjct: 92 LIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
Query: 598 -----VGLINSTDDLSGPAVSGTTLLGDEE---------PQLTASEHQQERRKKRSAVGT 643
S D + ++ + GD P + Q +R S VGT
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP 703
P+Y+APE+LL TG+ DWWSVG+IL+E++VG PPF A+ P + ++N + P
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271
Query: 704 E-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT-LARQKAAFVPTSES 761
+ ++SPEA DLI + L P RLG GA E+K H FFK I++ + L +Q A ++P
Sbjct: 272 QAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITH 330
Query: 762 ALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSG 798
DTS F + D + + D ++ + D+L+G
Sbjct: 331 PTDTSNF------DPVDPDKLWSDDDKEGNVNDTLNG 361
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 9e-70
Identities = 111/288 (38%), Positives = 159/288 (55%), Gaps = 43/288 (14%)
Query: 480 QVLKKADMIRK-NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+VLKKA +++K E ER +L +VR PF+V Y+F L+L+++Y+NGG+L+
Sbjct: 34 KVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELF 93
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ L E RVYIAE+VLAL++LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 94 THLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--T 655
L + + S GT +Y+APE++ G
Sbjct: 154 EFLAEEEE------------------------------RAYSFCGTIEYMAPEVIRGGSG 183
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQ----QIFDNILNRKIPWPRVPEEMSPEAH 711
GH DWWS+G++ FEL+ G PF + Q +I IL K P P+ MS EA
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP---FPKTMSAEAR 240
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA--RQKAAFVP 757
D I + L +DP +RLG+ GA E+K H FF+ I+WD LA R A F P
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-69
Identities = 94/265 (35%), Positives = 139/265 (52%), Gaps = 40/265 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+LKK + ++ E IL + +P +VR +F +++LYLVMEY GGDL+ L
Sbjct: 31 ILKKRS-EKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL 89
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
G L ED A+ +++ LEYLHS ++HRDLKP+N+L+ +G +K+ DFGL+K L
Sbjct: 90 SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL 149
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGT 659
+S+ + VGTP Y+APE+LL G G+G
Sbjct: 150 KSSS-------------------------------SLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 660 TADWWSVGIILFELIVGIPPFNAEH---PQQIFDNILNRKIPWPR-VPEEMSPEAHDLID 715
D WS+G+IL+EL+ G PPF+ E+ Q+ IL + + S EA DLI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFF 740
+ L +DP +R A E+ QH +F
Sbjct: 239 KCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 2e-68
Identities = 105/297 (35%), Positives = 164/297 (55%), Gaps = 42/297 (14%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ LKK ++++ V+ + E+ IL+ + +PF+V SF +Y ++E++ GG+L++
Sbjct: 49 KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTH 108
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LR G DVA+ Y AE+VLA EYLHS +++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 109 LRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-- 166
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + + GTP+YLAPE++ GHG
Sbjct: 167 --------------------------------KVPDRTFTLCGTPEYLAPEVIQSKGHGK 194
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW++G++L+E I G PPF + P +I++ IL ++ +P + A DL+ L
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG---RARDLVKGLLQ 251
Query: 720 EDPHQRLGS--GGASEVKQHVFFKDINWDTL-ARQKAAFVPTS-ESALDTSYFTSRY 772
D +RLG+ GG ++VK H +F NWD L AR A +P +S DTS F +Y
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNF-EKY 307
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 4e-68
Identities = 111/324 (34%), Positives = 174/324 (53%), Gaps = 42/324 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VL+K +++K + I+AER++L+ +V++PF+V YSF + LY V++Y+NGG+L+
Sbjct: 26 KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L+ E AR Y AE+ AL YLHSL +++RDLKP+N+L+ GH+ LTDFGL K
Sbjct: 86 HLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ S TT + GTP+YLAPE+L +
Sbjct: 146 GI----------EHSKTT---------------------STFCGTPEYLAPEVLRKQPYD 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
T DWW +G +L+E++ G+PPF + +++DNILN+ + R+ +S A L++ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---RLKPNISVSARHLLEGLL 231
Query: 719 TEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWN 775
+D +RLG+ E+K HVFF INWD L +K F P +D +F ++
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEE 291
Query: 776 TTDENIYPASDF----EDSSDADS 795
++ + D +AD
Sbjct: 292 PVPNSVGKSPDSVLVSASVKEADD 315
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 5e-68
Identities = 122/297 (41%), Positives = 177/297 (59%), Gaps = 12/297 (4%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L+KADM+ K V I AERDIL+ +VV+ FYSF + NLYL+ME+L GGD+ +L
Sbjct: 32 KILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF----GL 595
L L E+ + YIAE VLA++ +H L +HRD+KPDNLL+ GH+KL+DF GL
Sbjct: 92 LMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
K +L+ S + + + + R+ S VGTPDY+APE+ + T
Sbjct: 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 211
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK----IPWPRVPEEMSPEAH 711
G+ DWWS+G+I++E+++G PPF +E PQ+ + ++N K P P VP +S +A
Sbjct: 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFP-PEVP--ISEKAK 268
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DLI RF T D R+GS G E+K H FF+ ++W + + AA +S DTS F
Sbjct: 269 DLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-67
Identities = 130/346 (37%), Positives = 187/346 (54%), Gaps = 36/346 (10%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ L+K D++ +N V + AERDIL N +VV+ +YSF ++NLY VM+Y+ GGD+ SL
Sbjct: 32 KTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L + E +AR YIAE+ LA+E +H + +HRD+KPDN+LI DGHIKLTDFGL G
Sbjct: 92 LIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC-TG 150
Query: 600 LI---NSTDDLSGPAVSGTTL-------------LGDEEPQLTASEHQQERR-KKRSAVG 642
NS G + ++ GD L +Q +R S VG
Sbjct: 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210
Query: 643 TPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP-- 700
TP+Y+APE+LL G+ DWWSVG+ILFE++VG PPF A P + ++N W
Sbjct: 211 TPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN----WENT 266
Query: 701 -RVPEE--MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT-LARQKAAFV 756
+P + +SPEA DLI + RLG GA ++K H FF ++++ + + Q A +V
Sbjct: 267 LHIPPQVKLSPEAVDLITKLCCSAEE-RLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYV 325
Query: 757 PTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDA-DSLSGSSS 801
P +DTS F + +E DS+ D+L +
Sbjct: 326 PKISHPMDTSNF------DPVEEESPWNDASGDSTRTWDTLCSPNG 365
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 2e-66
Identities = 113/318 (35%), Positives = 170/318 (53%), Gaps = 47/318 (14%)
Query: 468 GKGALSEHDDFPQ-----VLKKADMIRKNAVESILAERDILI---SVRNPFVVRFFYSFT 519
GK L+E+ + LKK D+I ++ VES++ E+ I S R+PF+V F F
Sbjct: 13 GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ 72
Query: 520 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
+++ VMEY GGDL + E A Y A VVL L+YLH ++V+RDLK DN
Sbjct: 73 TEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
LL+ +G +K+ DFGL K G+ G +T
Sbjct: 132 LLLDTEGFVKIADFGLCKEGM--------GFGDRTSTF---------------------- 161
Query: 640 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW 699
GTP++LAPE+L T + DWW +G++++E++VG PF + +++FD+I+N ++ +
Sbjct: 162 -CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY 220
Query: 700 PRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTL--ARQKAAF 755
PR +S EA ++ R L +P +RLGSG A +VK+ FF+DINWD L + K F
Sbjct: 221 PRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPF 277
Query: 756 VPTSESALDTSYFTSRYS 773
VPT + D S F ++
Sbjct: 278 VPTIKGPEDVSNFDEEFT 295
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 3e-66
Identities = 121/296 (40%), Positives = 179/296 (60%), Gaps = 10/296 (3%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L+KADM+ K V I AERDIL+ + +VV+ FYSF + NLYL+ME+L GGD+ +L
Sbjct: 32 KILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTL 91
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF----GL 595
L L E+ + YIAE VLA++ +H L +HRD+KPDNLL+ GH+KL+DF GL
Sbjct: 92 LMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
K +L+ S T + + + R+ S VGTPDY+APE+ + T
Sbjct: 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT 211
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK---IPWPRVPEEMSPEAHD 712
G+ DWWS+G+I++E+++G PPF +E PQ+ + ++N K I P VP +S +A D
Sbjct: 212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP--ISEKAKD 269
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
LI RF E H R+G+ G E+K + FF+ ++W+ + + AA +S DTS F
Sbjct: 270 LILRFCCEWEH-RIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 7e-65
Identities = 113/311 (36%), Positives = 170/311 (54%), Gaps = 40/311 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+VLKKA + ++ V + + ERDIL V +PF+V+ Y+F LYL++++L GGDL++
Sbjct: 30 KVLKKATLKVRDRVRTKM-ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR 88
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L E+ + Y+AE+ LAL++LHSL +++RDLKP+N+L+ +GHIKLTDFGLSK
Sbjct: 89 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK-- 146
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
E +K S GT +Y+APE++ GH
Sbjct: 147 -----------------------------ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ADWWS G+++FE++ G PF + ++ IL K+ +P+ +SPEA L+
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRALFK 234
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSRYSWN 775
+P RLG+G G E+K+H FF I+W+ L R+ K F P DT YF ++
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSR 294
Query: 776 T-TDENIYPAS 785
T D P S
Sbjct: 295 TPKDSPGIPPS 305
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-64
Identities = 116/321 (36%), Positives = 165/321 (51%), Gaps = 51/321 (15%)
Query: 466 LAGKGALSE-----HDDFPQV-----LKKADMIRKNAVESILAERDILISVRNPFVVRFF 515
+ G+GA E H QV L K +MI+++ ERDI+ + ++V+
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109
Query: 516 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 575
Y+F + LY+VMEY+ GGDL +L+ N + E AR Y AEVVLAL+ +HS+ +HRD+
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 576 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635
KPDN+L+ GH+KL DF GT + D +
Sbjct: 169 KPDNMLLDKSGHLKLADF--------------------GTCMKMDANGMVRCD------- 201
Query: 636 KKRSAVGTPDYLAPEILLGTGH----GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691
+AVGTPDY++PE+L G G DWWSVG+ L+E++VG PF A+ +
Sbjct: 202 ---TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 692 ILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK--DINWDT 747
I++ K + +P E+S +A DLI FLT+ RLG G E+K H FFK +D
Sbjct: 259 IMDHKNSLTFPDDI-EISKQAKDLICAFLTDREV-RLGRNGVDEIKSHPFFKNDQWTFDN 316
Query: 748 LARQKAAFVPTSESALDTSYF 768
+ A VP S +DTS F
Sbjct: 317 IRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 7e-64
Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 39/290 (13%)
Query: 482 LKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LKK ++ + VE + ER +L + +PF+ F +F +E+L+ VMEYLNGGDL +
Sbjct: 28 LKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI 87
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
++ G DE AR Y AE++ L++LH +++RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 88 QSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--- 144
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ G+ K + GTPDY+APEIL G + +
Sbjct: 145 --------------ENMNGE--------------GKASTFCGTPDYIAPEILKGQKYNES 176
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWWS G++L+E+++G PF+ E ++FD+ILN P P +S EA D + +
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DRPH--FPRWISKEAKDCLSKLFER 233
Query: 721 DPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
DP +RLG G +++QH FF+ I+W+ L +++ F P +S D S F
Sbjct: 234 DPTKRLGVDG--DIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 9e-63
Identities = 112/320 (35%), Positives = 175/320 (54%), Gaps = 38/320 (11%)
Query: 480 QVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VL+K +++K I+AER++L+ ++++PF+V YSF E LY V++Y+NGG+L+
Sbjct: 26 KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L+ C E AR Y AEV A+ YLHSL +++RDLKP+N+L+ GH+ LTDFGL K
Sbjct: 86 HLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ EP+ T S + GTP+YLAPE+L +
Sbjct: 146 GV---------------------EPEETTS----------TFCGTPEYLAPEVLRKEPYD 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
T DWW +G +L+E++ G+PPF + Q++DNIL++ + ++P + A DL+ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL---QLPGGKTVAACDLLVGLL 231
Query: 719 TEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYFTSRYSWN 775
+D +RLG+ E+K HVFF INWD L ++ + P D +F ++
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQE 291
Query: 776 TTDENIYPASDFEDSSDADS 795
++ D SS + S
Sbjct: 292 AVSSSVGQTPDLTASSSSAS 311
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 214 bits (545), Expect = 1e-62
Identities = 111/302 (36%), Positives = 171/302 (56%), Gaps = 38/302 (12%)
Query: 480 QVLKKADMIRK-NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+VL+KA +++K VE ER++L VR +PF+V Y+F L+L+++Y++GG+++
Sbjct: 34 KVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMF 93
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ L ED R Y E++LALE+LH L +V+RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 94 THLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TG 656
L +E+ + S GT +Y+APEI+ G G
Sbjct: 154 EFL------------------------------SEEKERTYSFCGTIEYMAPEIIRGKGG 183
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW-PRVPEEMSPEAHDLID 715
HG DWWS+GI++FEL+ G PF E + + R + P P + PEA DL+
Sbjct: 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLH 243
Query: 716 RFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSR 771
+ L +DP +RLG+G GASE+K+H FFK ++W+ LA +K F P+ + LD F
Sbjct: 244 KLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEE 303
Query: 772 YS 773
++
Sbjct: 304 FT 305
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 4e-62
Identities = 114/320 (35%), Positives = 165/320 (51%), Gaps = 40/320 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++LKK +I K+ V L E +L + R+PF+ YSF + L VMEY NGG+L+
Sbjct: 26 KILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 85
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L ED AR Y AE+V AL YLHS VV+RDLK +NL++ DGHIK+TDFGL K G
Sbjct: 86 LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + ++ GTP+YLAPE+L +G
Sbjct: 146 ISDG-------------------------------ATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW +G++++E++ G PF + +++F+ IL +I +PR +SPEA L+ L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR---TLSPEAKSLLAGLLK 231
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWN 775
+DP QRLG G A E+ +H FF INW + ++K F P S DT YF ++
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQ 291
Query: 776 TTDENIYPASDFEDSSDADS 795
+ I P ++
Sbjct: 292 SIT--ITPPDRYDSLGLLQL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 208 bits (531), Expect = 2e-61
Identities = 94/285 (32%), Positives = 142/285 (49%), Gaps = 47/285 (16%)
Query: 468 GKGALS-----EHDDFPQV--LK---KADMIRKNAVESILAERDILISVRNPFVVRFFYS 517
GKGA + D ++ +K K + K +V ++L ER IL + +PF+V +YS
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 518 FTCRENLYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 576
F EN+YLV++ L GGDL Y L + E+ + +I E+VLALEYLHS ++HRD+K
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIK 127
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
PDN+L+ GH+ +TDF ++ ++T
Sbjct: 128 PDNILLDEQGHVHITDFNIAT--------------------------KVTPDTLTTST-- 159
Query: 637 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-R 695
GTP Y+APE+L G+ DWWS+G+ +E + G P+ H + I D I +
Sbjct: 160 ----SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG-HSRTIRDQIRAKQ 214
Query: 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ P S EA D I++ L DP +RLG ++K H +F
Sbjct: 215 ETADVLYPATWSTEAIDAINKLLERDPQKRLG-DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 4e-61
Identities = 112/297 (37%), Positives = 157/297 (52%), Gaps = 39/297 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L K +M+++ ERD+L++ ++ Y+F NLYLVM+Y GGDL +L
Sbjct: 32 KILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTL 91
Query: 540 LRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L L ED+AR Y+AE+VLA++ +H L VHRD+KPDN+L+ +GHI+L DFG
Sbjct: 92 LSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG---- 147
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL----G 654
S LL D Q AVGTPDY++PEIL G
Sbjct: 148 --------------SCLRLLADGTVQSNV------------AVGTPDYISPEILQAMEDG 181
Query: 655 TGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAH 711
G G DWWS+G+ ++E++ G PF AE + + I+N K +P ++S EA
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DLI R + P RLG G + K H FF+ I+WD + A +VP S DTS F
Sbjct: 242 DLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 2e-60
Identities = 120/336 (35%), Positives = 179/336 (53%), Gaps = 41/336 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536
+VL K +++ K V + ER+IL+ +PF+V +SF +LYLV +Y++GG+L
Sbjct: 24 KVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL 83
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
+ L+ G ED A+ YIAE+VLALE+LH +V+RDLKP+N+L+ GHI L DFGLS
Sbjct: 84 FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLS 143
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-T 655
K L TD+ + GTT +YLAPE+LL
Sbjct: 144 KANL---TDNKTTNTFCGTT----------------------------EYLAPEVLLDEK 172
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
G+ D+WS+G+++FE+ G PF AE QQ++ NI K+ +P+ +S E +
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFVK 230
Query: 716 RFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYFTSRY 772
L +P RLG+ A E+K+H FF DI+WD L++++ F P +S D S F +
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEF 290
Query: 773 S-WNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQ 807
+ + + I P D A+S SSS N +
Sbjct: 291 TNSSLLNAGIVPWEDVPGLPGANSTPLSSSVQENFR 326
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 113/318 (35%), Positives = 170/318 (53%), Gaps = 41/318 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L+K +I K+ V + E +L + R+PF+ Y+F + L VMEY NGG+L+
Sbjct: 26 KILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH 85
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L E+ AR Y AE+V ALEYLHS VV+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 86 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + G T+ ++ GTP+YLAPE+L +G
Sbjct: 146 ISD-----------GATM--------------------KTFCGTPEYLAPEVLEDNDYGR 174
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW +G++++E++ G PF + +++F+ IL +I R P +SPEA L+ L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---RFPRTLSPEAKSLLAGLLK 231
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWN 775
+DP QRLG G A EV +H FF INW + ++K F P S +DT YF ++
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 291
Query: 776 T---TDENIYPASDFEDS 790
+ T + Y + +
Sbjct: 292 SITITPPDRYDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 5e-59
Identities = 105/301 (34%), Positives = 171/301 (56%), Gaps = 41/301 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VLKK +++ + V+ + E+ IL ++ ++PF+ F ++ L+ VMEY+NGGDL
Sbjct: 26 KVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ DE +R Y AEV LAL +LH V++RDLK DN+L+ +GH KL DFG+ K
Sbjct: 86 QIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G++N V+ TT GTPDY+APEIL +G
Sbjct: 146 GILNG--------VTTTTF-----------------------CGTPDYIAPEILQELEYG 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWW++G++++E++ G PPF A++ +F++IL+ + + P +S EA ++ F+
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY---PVWLSKEAVSILKAFM 231
Query: 719 TEDPHQRLG----SGGASEVKQHVFFKDINWDTL-ARQ-KAAFVPTSESALDTSYFTSRY 772
T++P++RLG GG +KQH FFK+I+W L R+ K F P ++ D + F +
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDF 291
Query: 773 S 773
+
Sbjct: 292 T 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 3e-58
Identities = 110/302 (36%), Positives = 159/302 (52%), Gaps = 52/302 (17%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+V+KK+ ++ + V ERDIL +P++ + Y+F ++NLYLVMEY GGDL SL
Sbjct: 32 KVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSL 91
Query: 540 L-RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG---- 594
L R DED+A+ Y+AE+VLA+ +H + VHRD+KP+N+LI GHIKL DFG
Sbjct: 92 LNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR 151
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL- 653
L+ ++NS VGTPDY+APE+L
Sbjct: 152 LTANKMVNSK----------------------------------LPVGTPDYIAPEVLTT 177
Query: 654 -----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN--RKIPWPRVPEEM 706
+G DWWS+G+I +E+I G PF+ + ++NI+N R + +P P ++
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP-KV 236
Query: 707 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTS 766
S + DLI L +RLG G + H FF I+W+ + FVPT +S DTS
Sbjct: 237 SSDFLDLIQSLLC-GQKERLGYEG---LCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTS 292
Query: 767 YF 768
F
Sbjct: 293 NF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 5e-58
Identities = 107/290 (36%), Positives = 162/290 (55%), Gaps = 45/290 (15%)
Query: 480 QVLKKADMIRK-NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+VLKKA +++K E ER +L +R +PF+V Y+F L+L+++Y+NGG+L+
Sbjct: 34 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELF 93
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ L E ++Y E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 94 THLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--T 655
H+ E + S GT +Y+AP+I+ G
Sbjct: 154 ------------------------------EFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQ----QIFDNILNRKIPWPRVPEEMSPEAH 711
GH DWWS+G++++EL+ G PF + + +I IL + P+P +EMS A
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP---QEMSALAK 240
Query: 712 DLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVP 757
D+I R L +DP +RLG G A E+K+H FF+ INWD LA +K A F P
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 93/294 (31%), Positives = 157/294 (53%), Gaps = 39/294 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
++LKK +I+ + VE + E+ +L + + PF+ + F + LY VMEY+NGGDL
Sbjct: 31 KILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ +G E A Y AE+ + L +LHS +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 91 HIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK- 149
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
E+ + R+ GTPDY+APEI+ +G
Sbjct: 150 ------------------------------ENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWW+ G++L+E++ G PPF+ E ++F +I+ + +P+ +S EA + L
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---SLSKEAVSICKGLL 236
Query: 719 TEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYF 768
T+ P +RLG G G ++++H FF+ I+W+ L R+ + F P + F
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENF 290
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 3e-57
Identities = 105/295 (35%), Positives = 165/295 (55%), Gaps = 40/295 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VLKK +++ + VE + E+ IL RN PF+ + + F + L+ VME++NGGDL
Sbjct: 26 KVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ DE AR Y AE+ AL +LH +++RDLK DN+L+ H+GH KL DFG+ K
Sbjct: 86 HIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ N T+ + GTPDY+APEIL +G
Sbjct: 146 GIFNGK--------------------TTS-----------TFCGTPDYIAPEILQEMLYG 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWW++G++L+E++ G PF AE+ +F+ ILN ++ + P +S +A D++ F+
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLSQDAVDILKAFM 231
Query: 719 TEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
T++P RLGS GG + +H FFK+++W+ L R++ F P +S D S F
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNF 286
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 3e-57
Identities = 107/319 (33%), Positives = 173/319 (54%), Gaps = 52/319 (16%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+ LKK ++ + VE + E+ +L ++ +PF+ + +F +ENL+ VMEYLNGGDL
Sbjct: 26 KALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+++ D A Y AE++ L++LHS +V+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 86 HIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK- 144
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+LGD K + GTPDY+APEILLG +
Sbjct: 145 ----------------ENMLGDA--------------KTCTFCGTPDYIAPEILLGQKYN 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
T+ DWWS G++L+E+++G PF+ +++F +I ++ P P ++ EA D++ +
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI---RMDNPCYPRWLTREAKDILVKLF 231
Query: 719 TEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF-------- 768
+P +RLG G +++QH FF++I+W L ++ F P +SA D S F
Sbjct: 232 VREPERRLGVKG--DIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEK 289
Query: 769 -----TSRYSWNTTDENIY 782
T R N+ D+N++
Sbjct: 290 PRLSVTDRMLINSMDQNMF 308
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 1e-56
Identities = 83/263 (31%), Positives = 128/263 (48%), Gaps = 38/263 (14%)
Query: 483 KKADMIRKNA--VESILAERDILISVRNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYS 538
K ++ + +E++ E IL S+++P +VR++ S E L + +EY++GG L S
Sbjct: 31 KSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSS 90
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
LL+ G L E V R Y +++ L YLHS +VHRD+K N+L+ DG +KL DFG +K
Sbjct: 91 LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ + G S GTP ++APE++ G +G
Sbjct: 151 --LGDIETGEG---------------------------TGSVRGTPYWMAPEVIRGEEYG 181
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDN-ILNRKIPWPRVPEEMSPEAHDLIDRF 717
AD WS+G + E+ G PP++ I + P P +PE +S EA D + +
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-PEIPEHLSEEAKDFLRKC 240
Query: 718 LTEDPHQRLGSGGASEVKQHVFF 740
L DP +R A E+ QH F
Sbjct: 241 LRRDPKKR---PTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 196 bits (498), Expect = 4e-56
Identities = 109/314 (34%), Positives = 168/314 (53%), Gaps = 40/314 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++LKK +I K+ V L E +L + R+PF+ YSF ++ L VMEY+NGG+L+
Sbjct: 26 KILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH 85
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L ED R Y AE+V AL+YLHS ++V+RDLK +NL++ DGHIK+TDFGL K G
Sbjct: 86 LSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ ++ ++ GTP+YLAPE+L +G
Sbjct: 146 ITDAA-------------------------------TMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW +G++++E++ G PF + +++F+ IL I +PR +S +A L+ L
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT---LSADAKSLLSGLLI 231
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWN 775
+DP++RLG G A E+ +H FF +NW + +K F P S DT YF ++
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQ 291
Query: 776 TTDENIYPASDFED 789
T I P +++
Sbjct: 292 TI--TITPPEKYDE 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 196 bits (498), Expect = 4e-56
Identities = 113/302 (37%), Positives = 163/302 (53%), Gaps = 39/302 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++LKK ++ K+ V L E +L + R+PF+ YSF + L VMEY NGG+L+
Sbjct: 26 KILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH 85
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L ED AR Y AE+V AL+YLHS + VV+RDLK +NL++ DGHIK+TDFGL K
Sbjct: 86 LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ + G T+ ++ GTP+YLAPE+L +G
Sbjct: 146 GIKD-----------GATM--------------------KTFCGTPEYLAPEVLEDNDYG 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
DWW +G++++E++ G PF + +++F+ IL +I +PR +SPEA L+ L
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT---LSPEAKSLLSGLL 231
Query: 719 TEDPHQRLGSGG--ASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYFTSRYSW 774
+DP QRLG G A E+ QH FF I W + +K F P S DT YF ++
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTA 291
Query: 775 NT 776
Sbjct: 292 QM 293
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 6e-56
Identities = 107/311 (34%), Positives = 171/311 (54%), Gaps = 38/311 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VL+K +++K + I++ER++L+ +V++PF+V +SF + LY V++Y+NGG+L+
Sbjct: 26 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L+ C E AR Y AE+ AL YLHSL +V+RDLKP+N+L+ GHI LTDFGL K
Sbjct: 86 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ E T S + GTP+YLAPE+L +
Sbjct: 146 NI---------------------EHNGTTS----------TFCGTPEYLAPEVLHKQPYD 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
T DWW +G +L+E++ G+PPF + + +++DNILN+ + ++ ++ A L++ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSARHLLEGLL 231
Query: 719 TEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYFTSRYSWN 775
+D +RLG+ E+K H+FF INWD L +K F P D +F ++
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEE 291
Query: 776 TTDENIYPASD 786
+I + D
Sbjct: 292 PVPNSIGQSPD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-55
Identities = 106/306 (34%), Positives = 164/306 (53%), Gaps = 45/306 (14%)
Query: 471 ALSEHDDFPQV----LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526
A +++DFP V +K+ +I++ V+ + +ER IL + +PF V + SF LYL
Sbjct: 49 ATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108
Query: 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586
V+E++ GG+ ++ LR DV Y A++VL EYL SL +V+RDLKP+NLL+ DG
Sbjct: 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
Query: 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
IK+TDFG +KV + + GTP+Y
Sbjct: 169 FIKMTDFGFAKV----------------------------------VDTRTYTLCGTPEY 194
Query: 647 LAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEM 706
+APEILL GHG ADWW++GI ++E++VG PPF A P I+ IL I +P+ +
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF---L 251
Query: 707 SPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762
L+ + L+ D +R G+ GA VK+H +F +I+W +L + + + P ++
Sbjct: 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311
Query: 763 LDTSYF 768
D+S F
Sbjct: 312 FDSSNF 317
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 3e-53
Identities = 104/312 (33%), Positives = 173/312 (55%), Gaps = 38/312 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VL+K ++ + + I+AER++L+ +V++PF+V YSF E LY V++++NGG+L+
Sbjct: 26 KVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L+ E AR Y AE+ AL YLHS+ +V+RDLKP+N+L+ GH+ LTDFGL K
Sbjct: 86 HLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ A S TT + GTP+YLAPE++ +
Sbjct: 146 GI----------AQSDTT---------------------TTFCGTPEYLAPEVIRKQPYD 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
T DWW +G +L+E++ G+PPF +++DNIL++ + + S A +++ L
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---VLRPGASLTAWSILEELL 231
Query: 719 TEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWN 775
+D +RLG+ E+++H FF+ ++W L ++K F P E D S F + ++
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEE 291
Query: 776 TTDENIYPASDF 787
T ++ +SD+
Sbjct: 292 TVPYSVCFSSDY 303
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 115/297 (38%), Positives = 163/297 (54%), Gaps = 41/297 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L K +MI+++ ERDI+ +P+VV+ F +F + LY+VMEY+ GGDL +L
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+ N + E A+ Y AEVVLAL+ +HS+ ++HRD+KPDN+L+ GH+KL DFG
Sbjct: 134 MSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG----- 187
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--- 656
T + DE + +AVGTPDY++PE+L G
Sbjct: 188 ---------------TCMKMDETGMVRCD----------TAVGTPDYISPEVLKSQGGDG 222
Query: 657 -HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE--EMSPEAHDL 713
+G DWWSVG+ LFE++VG PF A+ + I++ K PE E+S A +L
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-NFPEDVEISKHAKNL 281
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD--INWDTLARQKAAFVPTSESALDTSYF 768
I FLT D RLG G E+KQH FFK+ NWD + A VP S +D+S F
Sbjct: 282 ICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 2e-52
Identities = 103/324 (31%), Positives = 172/324 (53%), Gaps = 40/324 (12%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+ LKK ++ + VE + E+ +L ++ NPF+ + +F +E+L+ VME+LNGGDL
Sbjct: 26 KALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+++ G D A Y AE+V L++LHS +++RDLK DN+++ DGHIK+ DFG+ K
Sbjct: 86 HIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK- 144
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ GD + + GTPDY+APEIL G +
Sbjct: 145 ----------------ENVFGDN--------------RASTFCGTPDYIAPEILQGLKYT 174
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWWS G++L+E+++G PF+ + ++F++I ++ P P ++ E+ D++++
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRWITKESKDILEKLF 231
Query: 719 TEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWNT 776
DP +RLG G ++ H FFK INW L +++ F P +S D S F + +
Sbjct: 232 ERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREF-LSE 288
Query: 777 TDENIYPASDFEDSSDADSLSGSS 800
Y + DS D + +G S
Sbjct: 289 KPRLSYSDKNLIDSMDQSAFAGFS 312
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 110/297 (37%), Positives = 161/297 (54%), Gaps = 39/297 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L K +M+++ ERD+L++ N ++ Y+F NLYLVM+Y GGDL +L
Sbjct: 32 KILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTL 91
Query: 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L L ED+AR Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG
Sbjct: 92 LSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG---- 147
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL----G 654
S L+ D Q + AVGTPDY++PEIL G
Sbjct: 148 --------------SCLKLMEDGTVQSSV------------AVGTPDYISPEILQAMEDG 181
Query: 655 TG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAH 711
G +G DWWS+G+ ++E++ G PF AE + + I+N K +P ++S +A
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAK 241
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DLI R + H RLG G + KQH FF I+WD + +A ++P S DTS F
Sbjct: 242 DLIRRLICSREH-RLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 4e-52
Identities = 115/301 (38%), Positives = 166/301 (55%), Gaps = 49/301 (16%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L K +MI+++ ERDI+ +P+VV+ FY+F LY+VMEY+ GGDL +L
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 133
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG----L 595
+ N + E AR Y AEVVLAL+ +HS+ +HRD+KPDN+L+ GH+KL DFG +
Sbjct: 134 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
+K G++ +AVGTPDY++PE+L
Sbjct: 193 NKEGMVRCD----------------------------------TAVGTPDYISPEVLKSQ 218
Query: 656 G----HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPE 709
G +G DWWSVG+ L+E++VG PF A+ + I+N K + +P ++S E
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKE 277
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN--WDTLARQKAAFVPTSESALDTSY 767
A +LI FLT D RLG G E+K+H+FFK+ W+TL A VP S +DTS
Sbjct: 278 AKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 336
Query: 768 F 768
F
Sbjct: 337 F 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-52
Identities = 82/271 (30%), Positives = 133/271 (49%), Gaps = 46/271 (16%)
Query: 468 GKGA-------LSEHDDFPQVLKKADMIRKNA--VESILAERDILISVRNPFVVRFFYSF 518
GKG+ + D VLK+ D+ + E L E IL + +P +++++ SF
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF 68
Query: 519 TCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRD 574
+ L +VMEY +GGDL ++ E+ + ++ LAL+YLHS +++HRD
Sbjct: 69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRD 128
Query: 575 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 634
+KP N+ + +G +KL DFG+SKV ++ST DL T+
Sbjct: 129 IKPQNIFLTSNGLVKLGDFGISKV--LSSTVDL------AKTV----------------- 163
Query: 635 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694
VGTP YL+PE+ + +D WS+G +L+EL PF E+ ++ IL
Sbjct: 164 ------VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
Query: 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ P +P + S E +L+ L +DP +R
Sbjct: 218 GQY--PPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 9e-51
Identities = 105/297 (35%), Positives = 158/297 (53%), Gaps = 39/297 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++L K +M+++ ER++L++ ++ Y+F LYLVM+Y GGDL +L
Sbjct: 32 KILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTL 91
Query: 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L L ED+AR YIAE+VLA+ +H L VHRD+KPDN+L+ +GHI+L DFG
Sbjct: 92 LSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG---- 147
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL----G 654
+ D GT + AVGTPDY++PEIL G
Sbjct: 148 SCLKMNQD-------GTV-------------------QSSVAVGTPDYISPEILQAMEDG 181
Query: 655 TG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN--RKIPWPRVPEEMSPEAH 711
G +G DWWS+G+ ++E++ G PF AE + + I+N + +P ++S EA
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAK 241
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
DLI R + +RLG G + K+H FF+ I+W+ + +A ++P S DTS F
Sbjct: 242 DLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 93/284 (32%), Positives = 146/284 (51%), Gaps = 41/284 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
L K + ++ + L E+ IL V + F+V Y+F +++L LVM +NGGDL +
Sbjct: 26 LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY 85
Query: 542 NLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
N+G E A Y A+++ LE+LH R+V+RDLKP+N+L+ G+++++D GL
Sbjct: 86 NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL---- 141
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
AV + +K + GTP Y+APE+L G +
Sbjct: 142 -----------AV-----------------ELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRF 717
+ DW+++G L+E+I G PF +++ L R+ V P++ SPEA DL +
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 718 LTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVP 757
L +DP +RLG G A EV++H FKD+NW L F+P
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 3e-50
Identities = 103/325 (31%), Positives = 170/325 (52%), Gaps = 53/325 (16%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+V+KK + ++ + E+ + + N PF+V F L+ V+E+++GGDL
Sbjct: 26 KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ L E+ AR Y AE+ LAL +LH +++RDLK DN+L+ +GHIKLTD+G+ K
Sbjct: 86 HMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
G+ P + +T GTP+Y+APEIL G +G
Sbjct: 146 GI--------RPGDTTSTF-----------------------CGTPNYIAPEILRGEDYG 174
Query: 659 TTADWWSVGIILFELIVGIPPF----NAEHPQQ-----IFDNILNRKIPWPRVPEEMSPE 709
+ DWW++G+++FE++ G PF +++P Q +F IL ++I R+P +S +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---RIPRSLSVK 231
Query: 710 AHDLIDRFLTEDPHQRLG---SGGASEVKQHVFFKDINWDTLARQKAA--FVPTSESALD 764
A ++ FL +DP +RLG G ++K H FF++I+WD L +++ + P ES D
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRD 291
Query: 765 TSYFTSRYSWNTTDENIYPASDFED 789
F ++ TDE + D D
Sbjct: 292 LDNFDPQF----TDEPVQLTPDDPD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 79/259 (30%), Positives = 127/259 (49%), Gaps = 36/259 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K + K E I+ E IL ++P +V+++ S+ ++ L++VME+ +GG L LL+
Sbjct: 30 IKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLK 89
Query: 542 NL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L E E++ LEYLHS ++HRD+K N+L+ DG +KL DFGLS
Sbjct: 90 STNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA--- 146
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
QL+ ++ + VGTP ++APE++ G +
Sbjct: 147 -----------------------QLSDTKARNTM------VGTPYWMAPEVINGKPYDYK 177
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
AD WS+GI EL G PP++ P + I P R PE+ S E D + + L +
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237
Query: 721 DPHQRLGSGGASEVKQHVF 739
+P +R A ++ +H F
Sbjct: 238 NPEKR---PTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 8e-50
Identities = 89/276 (32%), Positives = 151/276 (54%), Gaps = 37/276 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
++LKK +I+ + VE + E+ +L + + PF+ + F + LY VMEY+NGGDL
Sbjct: 31 KILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY 90
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ +G E A Y AE+ + L +LH +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 91 HIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK- 149
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
EH + R+ GTPDY+APEI+ +G
Sbjct: 150 ------------------------------EHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWW+ G++L+E++ G PPF+ E ++F +I+ + +P+ +S EA + +
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK---SLSKEAVSICKGLM 236
Query: 719 TEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 752
T+ P +RLG G G ++++H FF+ I+WD L ++
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENRE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 91/276 (32%), Positives = 153/276 (55%), Gaps = 37/276 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
++LKK +I+ + VE + E+ +L +S + PF+ + F + LY VMEY+NGGDL
Sbjct: 31 KILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ +G E A Y AE+ + L +LHS +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 91 QIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ + G T ++ GTPDY+APEI+ +G
Sbjct: 151 NMWD-----------GVT--------------------TKTFCGTPDYIAPEIIAYQPYG 179
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+ DWW+ G++L+E++ G PF E ++F +I+ + +P+ MS EA + +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLM 236
Query: 719 TEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 752
T+ P +RLG G G ++K+H FF+ I+W+ L R++
Sbjct: 237 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 7e-48
Identities = 101/292 (34%), Positives = 154/292 (52%), Gaps = 46/292 (15%)
Query: 508 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 567
NPF+V F L+LV+EY+NGGDL ++ L E+ AR Y AE+ +AL +LH
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 627
+++RDLK DN+L+ DGHIKLTD+G+ K GL GP + +T
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL--------GPGDTTSTF---------- 156
Query: 628 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN--AEHP 685
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ ++P
Sbjct: 157 -------------CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP 203
Query: 686 -----QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG---SGGASEVKQH 737
+F IL + I R+P +S +A ++ FL +DP +RLG G S++K H
Sbjct: 204 DMNTEDYLFQVILEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260
Query: 738 VFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFED 789
FF+ I+WD L +++ P + + Y + T E + D ED
Sbjct: 261 TFFRSIDWDLLEKKQV--TPPFKPQITDDYGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-46
Identities = 81/252 (32%), Positives = 117/252 (46%), Gaps = 71/252 (28%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLD 547
+ +E +L E +IL + +P +V+ + F +LYLVMEY GG L LL N G L
Sbjct: 31 SSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLS 90
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDD 606
ED + +++ LEYLHS ++HRDLKP+N+L+ D G +KL DFGLSK
Sbjct: 91 EDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSK--------- 141
Query: 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWS 665
++ ++ VGTP Y+APE+LLG G+ +D WS
Sbjct: 142 ----------------------LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 666 VGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+G+IL+EL PE DLI + L +DP +R
Sbjct: 180 LGVILYEL----------------------------------PELKDLIRKMLQKDPEKR 205
Query: 726 LGSGGASEVKQH 737
A E+ +H
Sbjct: 206 P---SAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 8e-46
Identities = 102/325 (31%), Positives = 169/325 (52%), Gaps = 53/325 (16%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+V+KK + ++ + E+ + N PF+V F L+ V+EY+NGGDL
Sbjct: 26 KVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 85
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ L E+ AR Y AE+ LAL YLH +++RDLK DN+L+ +GHIKLTD+G+ K
Sbjct: 86 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
GL P T S GTP+Y+APEIL G +G
Sbjct: 146 GL---------------------RPGDTTSTF----------CGTPNYIAPEILRGEDYG 174
Query: 659 TTADWWSVGIILFELIVGIPPFN----AEHPQQ-----IFDNILNRKIPWPRVPEEMSPE 709
+ DWW++G+++FE++ G PF+ +++P Q +F IL ++I R+P +S +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIPRSLSVK 231
Query: 710 AHDLIDRFLTEDPHQRLG---SGGASEVKQHVFFKDINWDTLARQKAA--FVPTSESALD 764
A ++ FL +DP +RLG G ++++ H FF++++WD + +++ F P
Sbjct: 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFG 291
Query: 765 TSYFTSRYSWNTTDENIYPASDFED 789
F +++ T+E + D +D
Sbjct: 292 LDNFDAQF----TNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 94/278 (33%), Positives = 144/278 (51%), Gaps = 44/278 (15%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+KK +RK E I+ E I+ ++P +V ++ S+ + L++VMEY++GG L ++
Sbjct: 49 IKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT 107
Query: 542 -NLGCLDED-VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
N ++E +A V EV+ LEYLHS V+HRD+K DN+L++ DG +KL DFG +
Sbjct: 108 QNFVRMNEPQIAYV-CREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA-- 164
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
QLT +E+ K+ S VGTP ++APE++ +G
Sbjct: 165 ------------------------QLT-----KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS+GI+ E+ G PP+ E P + I + IP + PE+ SPE D +++ L
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757
+DP +R A E+ QH F K A K F P
Sbjct: 256 KDPEKR---PSAEELLQHPFLK------KACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 87/255 (34%), Positives = 130/255 (50%), Gaps = 34/255 (13%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 548
++ I E +L +++P +V+++ RE +Y+ MEY +GG L LL + LDE
Sbjct: 39 DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE 98
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
V RVY +++ L YLHS +VHRD+KP N+ + H+G IKL DFG +
Sbjct: 99 HVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK---------- 148
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWS 665
+ TT +G E Q S GTP Y+APE++ G GHG AD WS
Sbjct: 149 --LKNNTTTMG---------EEVQ------SLAGTPAYMAPEVITGGKGKGHGRAADIWS 191
Query: 666 VGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 724
+G ++ E+ G P++ ++ QI ++ P ++SPE D +DR L DP +
Sbjct: 192 LGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKK 251
Query: 725 RLGSGGASEVKQHVF 739
R ASE+ QH F
Sbjct: 252 RP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 2e-43
Identities = 76/135 (56%), Positives = 98/135 (72%), Gaps = 3/135 (2%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+V+KKADMI KN V + AERD L ++PF+V +YS N+YLVMEYL GGD+ SL
Sbjct: 35 KVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSL 94
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L G DE++A YI+EV LAL+YLH ++HRDLKPDN+LI+++GHIKLTDFGLSKV
Sbjct: 95 LHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
Query: 600 L---INSTDDLSGPA 611
L +N D L+ P+
Sbjct: 155 LNRELNMMDILTTPS 169
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 73/238 (30%), Positives = 122/238 (51%), Gaps = 33/238 (13%)
Query: 488 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
I++ A++SI+ E D+L ++++P +V++ S ++LY+++EY G L +++ G
Sbjct: 38 IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP 97
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
E + VY+ +V+ L YLH V+HRD+K N+L DG +KL DFG++
Sbjct: 98 ESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA----------- 146
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667
T L D S VGTP ++APE++ +G T +D WS+G
Sbjct: 147 --------TKLNDVSKDDA------------SVVGTPYWMAPEVIEMSGASTASDIWSLG 186
Query: 668 IILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ EL+ G PP+ +P I+ P +PE +SPE D + + +DP+ R
Sbjct: 187 CTVIELLTGNPPYYDLNPMAALFRIVQD--DHPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 160 bits (404), Expect = 9e-43
Identities = 104/351 (29%), Positives = 152/351 (43%), Gaps = 47/351 (13%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+VL K + VE L E IL S+ P +V+ + F +LYLVMEY++GG L
Sbjct: 28 KVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED 87
Query: 539 LLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFG 594
LL+ +G L E A +A+++ ALEYLHS ++HRD+KP+N+L+ DG +KL DFG
Sbjct: 88 LLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFG 147
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
L+K LL D ++VGTP Y+APE+LLG
Sbjct: 148 LAK-------------------LLPDP------GSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 655 TGH---GTTADWWSVGIILFELIVGIPPFNAEH----PQQIFDNILNRKIPW------PR 701
+++D WS+GI L+EL+ G+PPF E Q IL P P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW-DTLARQKAAFVPTSE 760
PE +S A DL+ + L +DP RL S S H + ++ ++
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS---SSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299
Query: 761 SALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVG 811
L + I + D S+ + S+
Sbjct: 300 LRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSS 350
|
Length = 384 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-42
Identities = 67/131 (51%), Positives = 86/131 (65%), Gaps = 3/131 (2%)
Query: 641 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP 700
+GTPDYLAPE+LLG HG DWW++G+ LFE + GIPPFN E PQQ+F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 701 RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 760
E++S A + I+ LT DP +R G E+KQH F ++W+ L Q F+P +
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 761 SALDTSYFTSR 771
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 88/267 (32%), Positives = 130/267 (48%), Gaps = 38/267 (14%)
Query: 488 IRKNAVESI-LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-- 544
I+K E++ L E+ IL V + FVV Y++ ++ L LV+ +NGGDL + N+G
Sbjct: 38 IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP 97
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
DE+ A Y AE+ LE LH R+V+RDLKP+N+L+ GHI+++D GL
Sbjct: 98 GFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL--------- 148
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
AV E R VGT Y+APE++ + + DWW
Sbjct: 149 ------AV-----------------EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWW 185
Query: 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPH 723
+G +++E+I G PF + + + R E+ S A + + LT+DP
Sbjct: 186 GLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245
Query: 724 QRLG--SGGASEVKQHVFFKDINWDTL 748
RLG GA EVK H FF+ N+ L
Sbjct: 246 FRLGCRGEGAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 81/250 (32%), Positives = 121/250 (48%), Gaps = 38/250 (15%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
+E I E L R+P++ +++ SF L+++MEY GG LL+ G LDE
Sbjct: 43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIA 101
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ EV+L LEYLH +HRD+K N+L++ +G +KL DFG V
Sbjct: 102 FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG-----------------V 144
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
SG QLT++ K+ + VGTP ++APE++ +G+ AD WS+GI E
Sbjct: 145 SG---------QLTST-----MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIE 190
Query: 673 LIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGA 731
L G PP + HP ++ I P + S D + L +DP +R A
Sbjct: 191 LAKGEPPLSDLHPMRVLFLIPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERP---SA 245
Query: 732 SEVKQHVFFK 741
E+ +H F K
Sbjct: 246 KELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 80/253 (31%), Positives = 123/253 (48%), Gaps = 41/253 (16%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
+ +L E L S +P+VV+ + +F + +V+EY++GG L LL+ +G + E V
Sbjct: 44 KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY 103
Query: 554 YIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+++ L+YLH+ ++HRD+KP NLLI G +K+ DFG+SKV + +T D
Sbjct: 104 IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD------ 155
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
+ + VGT Y++PE + G + AD WS+G+ L E
Sbjct: 156 -----------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
Query: 673 LIVGIPPFNAEHPQQIFD---NILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728
+G PF F+ I + P P EE SPE D I L +DP +R
Sbjct: 193 CALGKFPFLPPGQPSFFELMQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP-- 248
Query: 729 GGASEVKQHVFFK 741
A+E+ QH F K
Sbjct: 249 -SAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 35/252 (13%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDE 548
+ ++ I+ E IL +P++V+++ S+ +L++VMEY G + +++ L E
Sbjct: 39 EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE 98
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ + + + LEYLHS + +HRD+K N+L+ +G KL DFG
Sbjct: 99 EEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG-------------- 144
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668
VSG QLT K+ + +GTP ++APE++ G+ AD WS+GI
Sbjct: 145 ---VSG---------QLT-----DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187
Query: 669 ILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728
E+ G PP++ HP + I N+ P PE+ SPE +D + + L +DP +R
Sbjct: 188 TAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER--- 244
Query: 729 GGASEVKQHVFF 740
A ++ QH F
Sbjct: 245 PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-39
Identities = 80/277 (28%), Positives = 139/277 (50%), Gaps = 44/277 (15%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL----Y 537
L K + ++ E + E+ IL V + F+V Y+F + +L LVM +NGGDL Y
Sbjct: 26 LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIY 85
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
++ E A Y A+++ LE+LH R+++RDLKP+N+L+ +DG+++++D GL
Sbjct: 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL-- 143
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
A E + + K + GTP ++APE+L G +
Sbjct: 144 -----------------------------AVELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 658 GTTADWWSVGIILFELIVGIPPFNAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
+ D++++G+ L+E+I PF A +++ ILN + + P++ SP +
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY---PDKFSPASKSF 231
Query: 714 IDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWDTL 748
+ L +DP +RLG G ++ H F+D+NW L
Sbjct: 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 93/282 (32%), Positives = 142/282 (50%), Gaps = 45/282 (15%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDL 536
+ L K + K L ER +L V PF+V Y+F + L +++ +NGGDL
Sbjct: 25 KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL 84
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
+ L G E R Y E++L LE++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 85 HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GT 655
D S ++K ++VGT Y+APE+L GT
Sbjct: 145 C--------DFS-------------------------KKKPHASVGTHGYMAPEVLQKGT 171
Query: 656 GHGTTADWWSVGIILFELIVGIPPF---NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
+ ++ADW+S+G +LF+L+ G PF + +I L + +P+ SPE
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV---ELPDSFSPELKS 228
Query: 713 LIDRFLTEDPHQRLG--SGGASEVKQHVFFKDINWDTLARQK 752
L++ L D +RLG GA EVK+HVFFK I+W + QK
Sbjct: 229 LLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 45/265 (16%)
Query: 497 LAERDILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
L ER +L V PF+V Y+F + L +++ +NGGDL+ L G E R
Sbjct: 42 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF 101
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
Y AE++L LE++H+ VV+RDLKP N+L+ GH++++D GL+ D S
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--------DFS----- 148
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFE 672
++K ++VGT Y+APE+L G + ++ADW+S+G +LF+
Sbjct: 149 --------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 673 LIVGIPPF---NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG-- 727
L+ G PF + +I L + P + SPE L++ L D ++RLG
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCL 245
Query: 728 SGGASEVKQHVFFKDINWDTLARQK 752
GA EVK+H FF+ ++W + QK
Sbjct: 246 GRGAQEVKEHPFFRSLDWQMVFLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-39
Identities = 75/251 (29%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
+ AV+ + E +L +++P +V++ + +NLY+ +E + GG L LL+ G E
Sbjct: 43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP 102
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
V R+Y +++L LEYLH VHRD+K N+L+ +G +KL DFG++K
Sbjct: 103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK------------ 150
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGI 668
E +S G+P ++APE++ G +G AD WS+G
Sbjct: 151 --------------------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190
Query: 669 ILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728
+ E+ G PP++ I K P +P+ +S EA D I + L DP R
Sbjct: 191 TVLEMATGKPPWSQLEGVAAVFKIGRSKE-LPPIPDHLSDEAKDFILKCLQRDPSLRP-- 247
Query: 729 GGASEVKQHVF 739
A+E+ +H F
Sbjct: 248 -TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 6e-39
Identities = 79/260 (30%), Positives = 134/260 (51%), Gaps = 35/260 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+KK D+ ++ E + E I+ ++P +V + S+ + L++VME+L GG L ++
Sbjct: 49 VKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT 108
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+ +E +A V +A V+ AL +LH+ V+HRD+K D++L+ DG +KL+DFG
Sbjct: 109 HTRMNEEQIATVCLA-VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA---- 163
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
Q++ +E +++S VGTP ++APE++ +GT
Sbjct: 164 ----------------------QVS-----KEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI++ E++ G PP+ E P Q I + P + ++SP +DR L D
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256
Query: 722 PHQRLGSGGASEVKQHVFFK 741
P QR A+E+ H F
Sbjct: 257 PAQR---ATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 1e-38
Identities = 92/271 (33%), Positives = 138/271 (50%), Gaps = 44/271 (16%)
Query: 488 IRKNAVESI-LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-- 544
I+K ES+ L E+ IL V + FVV Y++ ++ L LV+ +NGGDL + ++G
Sbjct: 38 IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA 97
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
+E A Y AE+ LE LH R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV------- 150
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
H E + + VGT Y+APE++ + + DWW
Sbjct: 151 -------------------------HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 185
Query: 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEE----MSPEAHDLIDRFLTE 720
++G +L+E+I G PF + ++I + R + V EE SP+A L L +
Sbjct: 186 ALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLV--KEVQEEYSEKFSPDARSLCKMLLCK 242
Query: 721 DPHQRLG--SGGASEVKQHVFFKDINWDTLA 749
DP +RLG GGA EVK+H FK IN+ L
Sbjct: 243 DPKERLGCQGGGAREVKEHPLFKQINFKRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 42/269 (15%)
Query: 482 LKKADMIRKNA-VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+K+ D+ + V+ + E + +P VV+++ SF + L+LVM YL+GG L ++
Sbjct: 31 IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM 90
Query: 541 R---NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ G LDE + + EV+ LEYLHS +HRD+K N+L+ DG +K+ DFG+S
Sbjct: 91 KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS- 149
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTG 656
L + D R+ +++ VGTP ++APE++ G
Sbjct: 150 ASLADGGDR--------------------------TRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAH----- 711
+ AD WS GI EL G P++ P ++ L P + + +
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPSLETGADYKKYSKSFR 241
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+I L +DP +R A E+ +H FF
Sbjct: 242 KMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 1e-37
Identities = 86/268 (32%), Positives = 137/268 (51%), Gaps = 40/268 (14%)
Query: 488 IRKNAVESI-LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-- 544
I+K E++ L E+ IL V + FVV Y++ ++ L LV+ +NGGDL + N+G
Sbjct: 38 IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP 97
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
DE A Y AE+ LE L R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 98 GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV------- 150
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
+ P E R VGT Y+APE++ + + DWW
Sbjct: 151 ----------------QIP---------EGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185
Query: 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDP 722
+G +++E+I G PF + +++ ++R++ E+ S +A + LT++P
Sbjct: 186 GLGCLIYEMIQGQSPFR-KRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNP 244
Query: 723 HQRLG--SGGASEVKQHVFFKDINWDTL 748
+RLG GA+ VKQH FK+IN+ L
Sbjct: 245 KERLGCRGNGAAGVKQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-37
Identities = 91/278 (32%), Positives = 138/278 (49%), Gaps = 40/278 (14%)
Query: 488 IRKNAVESI-LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-- 544
I+K ES+ L E+ IL V + FVV Y++ ++ L LV+ +NGGDL + N+G
Sbjct: 38 IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP 97
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
+E+ A Y AE++ LE LH V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 98 GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-------- 149
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
+ P E R VGT Y+APE+L + + D+W
Sbjct: 150 --VKIP----------------------EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYW 185
Query: 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPH 723
+G +++E+I G PF + + + R + V + S EA + LT+DP
Sbjct: 186 GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPK 245
Query: 724 QRLG--SGGASEVKQHVFFKDINWDTL--ARQKAAFVP 757
QRLG GA EVK+H FF+++N+ L FVP
Sbjct: 246 QRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 32/251 (12%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
K V ++ E +L ++++ +V+++ E L + MEY+ GG + L+ G L E
Sbjct: 45 KKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET 104
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
V R Y +++ +EYLHS +VHRD+K N+L G++KL DFG SK L
Sbjct: 105 VTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RLQT 156
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
SGT + +S GTP +++PE++ G G+G AD WSVG
Sbjct: 157 ICSSGTGM--------------------KSVTGTPYWMSPEVISGEGYGRKADVWSVGCT 196
Query: 670 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729
+ E++ PP+ I + P++P +SP+A + + R E+ +R
Sbjct: 197 VVEMLTEKPPWAEFEAMAAIFKIATQP-TNPQLPSHVSPDARNFLRRTFVENAKKR---P 252
Query: 730 GASEVKQHVFF 740
A E+ +H F
Sbjct: 253 SAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 71/246 (28%), Positives = 117/246 (47%), Gaps = 50/246 (20%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLD 547
+ +++E +IL +++P +VR++ R N LY+VMEY GGDL L++ ++
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 548 EDVARVYIAEVVLALEYLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
E+ + +++LAL H V+HRDLKP N+ + + ++KL DFGL+K ++
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILG 161
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
A + VGTP Y++PE L + +D
Sbjct: 162 HDSSF-------------------AKTY----------VGTPYYMSPEQLNHMSYDEKSD 192
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI---PWPRVPEEMSPEAHDLIDRFLT 719
WS+G +++EL PPF A + Q L KI + R+P S E +++I L
Sbjct: 193 IWSLGCLIYELCALSPPFTARNQLQ-----LASKIKEGKFRRIPYRYSSELNEVIKSMLN 247
Query: 720 EDPHQR 725
DP +R
Sbjct: 248 VDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 4e-36
Identities = 84/276 (30%), Positives = 139/276 (50%), Gaps = 41/276 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K+ ++ ++ E I+ E ++ ++P +V + S+ + L++VMEYL GG L ++
Sbjct: 49 IKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 109 ET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---- 163
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 164 ----------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI+ E++ G PP+ E+P + I P + PE++S D ++R L D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757
+R G A E+ QH F K +A+ ++ P
Sbjct: 257 VEKR---GSAKELLQHPFLK------IAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 41/276 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K+ ++ ++ E I+ E ++ ++NP +V F SF + L++VMEYL GG L ++
Sbjct: 49 IKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT 108
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
C+DE E + ALE+LH+ +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 109 ET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA---- 163
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 164 ----------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI+ E++ G PP+ E+P + I P + PE++SP D ++R L D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757
+R G A E+ QH F K LA+ ++ P
Sbjct: 257 VEKR---GSAKELLQHPFLK------LAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 82/288 (28%), Positives = 124/288 (43%), Gaps = 69/288 (23%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+ I A+ I A L + ++P+VV+ F LVMEY+ DL +LR+
Sbjct: 37 RLEGGIPNQALREIKA----LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD 91
Query: 543 L-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
L E + Y+ ++ + Y+H+ ++HRDLKP NLLI+ DG +K+ DFGL+++
Sbjct: 92 EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL--- 148
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTT 660
+E + HQ V T Y APE+L G
Sbjct: 149 ---------------FSEEEPRLYS---HQ---------VATRWYRAPELLYGARKYDPG 181
Query: 661 ADWWSVGIILFELIVGIPPFNAEHP-QQ---IFDNIL----------------------- 693
D W+VG I EL+ G P F E+ +Q +F L
Sbjct: 182 VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR-TLGTPNEETWPGLTSLPDYNKITFP 240
Query: 694 -NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
++ IP + + SPEA DL+ L DP +RL A+E +H +F
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 85/262 (32%), Positives = 123/262 (46%), Gaps = 52/262 (19%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG---DLYSLLRNLGCL 546
+ E I E +L R+P +V +F S+ R+ L++VMEY GG D+Y + R G L
Sbjct: 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPL 98
Query: 547 DEDVARVYIA----EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
E IA E + L YLH +HRD+K N+L+ DG +KL DFG+S
Sbjct: 99 SELQ----IAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA----- 149
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGT 659
QLTA+ K++S +GTP ++APE+ G+
Sbjct: 150 ---------------------QLTAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRF 717
D W++GI EL PP HP + I P P++ E+ SP HD I +
Sbjct: 184 KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKC 243
Query: 718 LTEDPHQRLGSGGASEVKQHVF 739
LT+DP +R A+++ QH F
Sbjct: 244 LTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 83/260 (31%), Positives = 133/260 (51%), Gaps = 35/260 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+++ ++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 110 ET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---- 164
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 165 ----------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI+ E+I G PP+ E+P + I P + PE++S D ++R L D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 722 PHQRLGSGGASEVKQHVFFK 741
+R G A E+ QH F K
Sbjct: 258 VEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 5e-34
Identities = 88/290 (30%), Positives = 144/290 (49%), Gaps = 41/290 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K+ ++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 49 IKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 108
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
C+DE E + AL++LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 109 ET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---- 163
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 164 ----------------------QITP-----EQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI+ E++ G PP+ E+P + I P + PE +S D ++R L D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
+R G A E+ QH F K LA+ ++ P +A + +SR
Sbjct: 257 VDRR---GSAKELLQHPFLK------LAKPLSSLTPLIIAAKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 70/241 (29%), Positives = 120/241 (49%), Gaps = 39/241 (16%)
Query: 493 VESILAERDILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
V I E +L +R P + +++ S+ L+++MEY GG + +L++ G + E
Sbjct: 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEK 101
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
V I EV++AL+Y+H + V+HRD+K N+L+ + G++KL DFG+
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGV-------------- 147
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGI 668
A+ Q K+ + VGTP ++APE++ G + T AD WS+GI
Sbjct: 148 -----------------AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 669 ILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLG 727
++E+ G PP++ + I K P PR+ + S + + L E+P +RL
Sbjct: 191 TIYEMATGNPPYSDVDAFRAMMLIPKSK-P-PRLEDNGYSKLLREFVAACLDEEPKERLS 248
Query: 728 S 728
+
Sbjct: 249 A 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 82/291 (28%), Positives = 142/291 (48%), Gaps = 42/291 (14%)
Query: 457 PRTSQIDLLLAGKG-------ALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNP 509
PR+ + + G+G A +H +K D+ ++ E + E I+ ++
Sbjct: 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQ 78
Query: 510 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 569
VV + S+ E L+++ME+L GG L ++ +E +A V V+ AL YLHS
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV-CESVLQALCYLHSQG 137
Query: 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 629
V+HRD+K D++L+ DG +KL+DFG ++
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGF-------------------------------CAQ 166
Query: 630 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689
++ K++S VGTP ++APE++ T +GT D WS+GI++ E++ G PP+ ++ P Q
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226
Query: 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ + P + ++SP D ++R LT +P +R A E+ H F
Sbjct: 227 KRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 2e-33
Identities = 83/273 (30%), Positives = 139/273 (50%), Gaps = 39/273 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
L K + +K+ + L E++IL V +PF+V Y+F + +L LVM +NGGDL +
Sbjct: 26 LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIY 85
Query: 542 NLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
N+G ++ RV Y A++ + +LHS+ +V+RD+KP+N+L+ G+ +L+D GL
Sbjct: 86 NVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL---- 141
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
AV +L + +R GT Y+APEIL +
Sbjct: 142 -----------AV-----------ELKDGKTITQR------AGTNGYMAPEILKEEPYSY 173
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEE---MSPEAHDLIDR 716
DW+++G ++E++ G PF +H +++ L R+ V E + E+ D+
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232
Query: 717 FLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTL 748
FL + P RLGS + + ++H FFK IN+ L
Sbjct: 233 FLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 50/256 (19%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDV-ARV 553
IL E DIL +P++V F+ +F ++ + MEY++GG L +L+ + G + E + ++
Sbjct: 46 ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI 105
Query: 554 YIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+A V+ L YLH +++HRD+KP N+L+ G IKL DFG+S L+NS
Sbjct: 106 AVA-VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNS--------- 154
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
++ VGT Y+APE + G + +D WS+G+ L E
Sbjct: 155 -----------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
Query: 673 LIVG---IPPFNAEHPQQIFD---NILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQR 725
L G PP N P IF+ I+N P PR+P SP+ D ++ L +DP +R
Sbjct: 192 LATGRFPYPPENDP-PDGIFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRER 248
Query: 726 LGSGGASEVKQHVFFK 741
E+ +H F K
Sbjct: 249 ---PSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/252 (25%), Positives = 107/252 (42%), Gaps = 41/252 (16%)
Query: 482 LKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
LK+ D+ + + E + E IL SV +P ++ + +F L +VMEY GDL
Sbjct: 30 LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKA 89
Query: 540 LRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
+ + E +++ L+ LH +++HRDLK N+L+ + +K+ D G+
Sbjct: 90 ISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGI 149
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
SKV N ++ +GTP Y+APE+ G
Sbjct: 150 SKVLKKNMA---------------------------------KTQIGTPHYMAPEVWKGR 176
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+ +D WS+G +L+E+ PPF A Q + + K +P +P S + + I
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--YPPIPPIYSQDLQNFIR 234
Query: 716 RFLTEDPHQRLG 727
L P R
Sbjct: 235 SMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 78/270 (28%), Positives = 115/270 (42%), Gaps = 69/270 (25%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVL 560
+L +++P +V+ LYLV EY + DL L G L ++ + + +++
Sbjct: 51 LLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK---VGLINSTDDLSGPAVSGTTL 617
L Y HS R++HRDLKP N+LI DG +KL DFGL++ + L T +
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE----------- 158
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVG 676
V T Y APEILLG+ H T D WSVG I E+I G
Sbjct: 159 -----------------------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
Query: 677 IPPF--NAEHPQ--QIFD-----------------NILNRKIPWPRVPEE-----MSPEA 710
P F ++E Q +IF + +P E + PE
Sbjct: 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255
Query: 711 HDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
DL+ + L +P +R+ A E +H +F
Sbjct: 256 IDLLSKMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 77/246 (31%), Positives = 111/246 (45%), Gaps = 68/246 (27%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
L LV E+++ DL + L C L + + + +++ +++LHS R+VHRDLKP N
Sbjct: 81 LTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
+L+ DG +K+ DFGL+++ E LT S
Sbjct: 138 ILVTSDGQVKIADFGLARI--------------------YSFEMALT------------S 165
Query: 640 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF----NAEHPQQIFDNI-LN 694
V T Y APE+LL + + T D WSVG I EL P F A+ +IFD I L
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225
Query: 695 RKIPWPR--------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734
+ WPR VP E+ E DL+ + LT +PH+R+ A E
Sbjct: 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVP-EICEEGLDLLKKMLTFNPHKRI---SAFEA 281
Query: 735 KQHVFF 740
QH +F
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 40/268 (14%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
K + + +E + E DIL ++P +V + ++ L++++E+ +GG L S++
Sbjct: 35 AKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIML 94
Query: 542 NLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
L L E R +++ AL +LHS +V+HRDLK N+L+ DG +KL DFG+S
Sbjct: 95 ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GT 655
+K+ + +GTP ++APE++
Sbjct: 155 -------------------------------STLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+ AD WS+GI L EL PP + +P ++ IL + P P + S +D +
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKDI 743
L +DP R A+E+ +H F D
Sbjct: 244 SCLVKDPDDRP---TAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 77/259 (29%), Positives = 132/259 (50%), Gaps = 35/259 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+KK D+ ++ E + E I+ ++ VV + S+ + L++VME+L GG L ++
Sbjct: 50 VKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 109
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+ +E +A V +A V+ AL LH+ V+HRD+K D++L+ HDG +KL+DFG
Sbjct: 110 HTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF------ 162
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
++ +E +++S VGTP ++APE++ +G
Sbjct: 163 -------------------------CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI++ E++ G PP+ E P + I + P + ++SP +DR L D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 722 PHQRLGSGGASEVKQHVFF 740
P QR A+E+ +H F
Sbjct: 258 PAQR---ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 90/308 (29%), Positives = 144/308 (46%), Gaps = 48/308 (15%)
Query: 457 PRTSQIDLLLAGKG-------ALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNP 509
PR + G+G A +H +KK D+ ++ E + E I+ +
Sbjct: 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE 79
Query: 510 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 569
VV + S+ + L++VME+L GG L ++ + +E +A V ++ V+ AL YLH+
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQG 138
Query: 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 629
V+HRD+K D++L+ DG IKL+DFG ++
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGF-------------------------------CAQ 167
Query: 630 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689
+E K++S VGTP ++APE++ +GT D WS+GI++ E+I G PP+ E P Q
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227
Query: 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749
I + P + ++S +D L +P QR A E+ QH F K LA
Sbjct: 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR---ATAQELLQHPFLK------LA 278
Query: 750 RQKAAFVP 757
+ VP
Sbjct: 279 GPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 69/250 (27%), Positives = 123/250 (49%), Gaps = 39/250 (15%)
Query: 481 VLKKADMIRKNAVE--SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+K+ D+ + N E + E +L + + +++R++ SF + L +VMEY GDL+
Sbjct: 29 AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHK 88
Query: 539 LL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
LL R ++ V R +I +++L L +LHS +++HRD+K NL + ++K+ D G+
Sbjct: 89 LLKMQRGRPLPEDQVWRFFI-QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGV 147
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
+K+ +S T + VGTP YL+PE+
Sbjct: 148 AKL-------------LSDNTNFA------------------NTIVGTPYYLSPELCEDK 176
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+ +D W++G++L+E G PF+A + + I+ +P V + S + LID
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FPPVSQMYSQQLAQLID 234
Query: 716 RFLTEDPHQR 725
+ LT+D QR
Sbjct: 235 QCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 73/255 (28%), Positives = 119/255 (46%), Gaps = 39/255 (15%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLY-LVMEYLNGGDLYSLLRNLGCLDEDVA 551
VE++ E ++ + +P ++R TC ++ + L +E++ GG + LL G E V
Sbjct: 47 VEALRKEIRLMARLNHPHIIRM-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI 105
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGP 610
Y +++ L YLH +++HRD+K NLLI G +++ DFG + +G
Sbjct: 106 INYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA----ARLAAKGTG- 160
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670
A E Q + +GT ++APE+L G +G + D WSVG ++
Sbjct: 161 ----------------AGEFQGQ------LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198
Query: 671 FELIVGIPPFNAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 726
E+ PP+NAE H IF I + P +PE +SP D+ R L P R
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIF-KIASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR- 255
Query: 727 GSGGASEVKQHVFFK 741
+ E+ +H F+
Sbjct: 256 --PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 66/290 (22%)
Query: 482 LKKADMIRKNAVESILAERDI--LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+KK + ++ A R+I L + +P +++ F + +LYLV E+++ DLY L
Sbjct: 29 IKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKL 87
Query: 540 LR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ L E + + Y+ +++ L + HS ++HRDLKP+NLLI +G +KL DFGL++
Sbjct: 88 IKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARS 147
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGH 657
P T H V T Y APE+LLG G+
Sbjct: 148 --------FGSPVRPYT--------------HY---------VVTRWYRAPELLLGDKGY 176
Query: 658 GTTADWWSVGIILFELIVGIPPF-------------------NAEHPQQIFDNILNRK-- 696
T D WSVG I EL+ P F + E + N K
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 697 ------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+P P++ SP+A DL+ + L DPH+R+ A + H +F
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 88/293 (30%), Positives = 130/293 (44%), Gaps = 68/293 (23%)
Query: 482 LKKADMIRKNAVESILAERDILI--SVRNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLY 537
LKK M + I A R+I + +R+P +VR T + ++Y+V EY++ DL
Sbjct: 29 LKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLT 87
Query: 538 SLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
LL + E + Y+ +++ L+YLHS ++HRD+K N+LI +DG +KL DFGL+
Sbjct: 88 GLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA 147
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-T 655
+ T + V T Y PE+LLG T
Sbjct: 148 R------------------PYTKRNSADYT------------NRVITLWYRPPELLLGAT 177
Query: 656 GHGTTADWWSVGIILFELIVGIPPFN----AEHPQQIFD-------------------NI 692
+G D WSVG IL EL +G P F E ++IF+
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237
Query: 693 LNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
L K P+ R E + P A DL+D+ LT DP +R+ A + QH +F
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 74/243 (30%), Positives = 113/243 (46%), Gaps = 48/243 (19%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 555
IL E I+ R+P++V F+ +F N+ + ME+++ G L + + G + ++
Sbjct: 50 ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIA 109
Query: 556 AEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
VV L YL++ R++HRD+KP N+L+ G IKL DFG+S LINS D
Sbjct: 110 VAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD-------- 160
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
+ VGT Y++PE + G + +D WS+GI + EL
Sbjct: 161 ------------------------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196
Query: 675 VGIPPFNA--------EHPQQIFD---NILNRKIPWPRVPEEMSPE-AHDLIDRFLTEDP 722
+G PF + P I D I+ P PR+P PE D +D L +DP
Sbjct: 197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDP 254
Query: 723 HQR 725
+R
Sbjct: 255 TER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 66/282 (23%)
Query: 496 ILAERDILISVRNPFVVR---FFY--SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV 550
IL E +L +R+ ++ S ++Y+V E + DL+ ++++ L +D
Sbjct: 46 ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDH 104
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
+ ++ +++ L+YLHS V+HRDLKP N+L+ + +K+ DFGL++
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR------------- 151
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGII 669
G DE+ LT E+ V T Y APE+LL + T A D WSVG I
Sbjct: 152 ---GVDPDEDEKGFLT--EY----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCI 196
Query: 670 LFELIVGIPPFNAEH---------------PQQIFDNILN-------------RKIPWPR 701
EL+ P F ++ I + K P +
Sbjct: 197 FAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSK 256
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+ SPEA DL+++ L DP +R+ A E H + +
Sbjct: 257 LFPGASPEAIDLLEKMLVFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 73/252 (28%), Positives = 124/252 (49%), Gaps = 40/252 (15%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVA 551
E + E D+L S+++ +V+ Y TC ++ + + ME++ GG + S+L G L E V
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQ--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF 104
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK----VGLINSTDDL 607
Y +++ + YLH+ VVHRD+K +N+++ +G IKL DFG ++ VGL + ++
Sbjct: 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667
+S GTP ++APE++ +G+G +D WS+G
Sbjct: 165 L-----------------------------KSMHGTPYWMAPEVINESGYGRKSDIWSIG 195
Query: 668 IILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727
+FE+ G PP + I + PR+P+ S A D + LT D H+R
Sbjct: 196 CTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER-- 253
Query: 728 SGGASEVKQHVF 739
A ++ +H F
Sbjct: 254 -PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 59/247 (23%), Positives = 106/247 (42%), Gaps = 41/247 (16%)
Query: 487 MIRKNA----VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
++++A +E L E I+ + +P +V+ T E L +VMEY+ GGDL LR
Sbjct: 35 TLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK 94
Query: 543 LGCLDEDVARV--YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ ++ + + ++ +EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 95 NRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ + G + + ++APE L G T+
Sbjct: 155 DDDYYKVKG---------------------------GKLPI---RWMAPESLK-EGKFTS 183
Query: 661 A-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
D WS G++L+E+ +G P+ ++ + + P PE + L+ +
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--PPNCPPELYKLMLQCW 241
Query: 719 TEDPHQR 725
EDP R
Sbjct: 242 AEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 79/250 (31%), Positives = 124/250 (49%), Gaps = 37/250 (14%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
++ +E I E +L +P+V +++ S+ L+++MEYL GG LLR G DE
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEF 101
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
+ E++ L+YLHS + +HRD+K N+L++ G +KL DFG
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFG--------------- 146
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
V+G QLT ++ K+ + VGTP ++APE++ + + + AD WS+GI
Sbjct: 147 --VAG---------QLTDTQ-----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGIT 190
Query: 670 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729
EL G PP + HP ++ I K P + E S + ID L +DP R
Sbjct: 191 AIELAKGEPPNSDMHPMRVLFLI--PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---P 245
Query: 730 GASEVKQHVF 739
A E+ +H F
Sbjct: 246 TAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 74/262 (28%), Positives = 112/262 (42%), Gaps = 50/262 (19%)
Query: 494 ESILAERDILISVRN-PFVVRFFYSF------TCRENLYLVMEYLNGG---DLYSLLRNL 543
E I E +IL N P + F+ +F + L+LVME GG DL LR
Sbjct: 47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 544 G-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
G L E+ + E + L YLH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 107 GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----- 161
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGH 657
QL ++ ++ + +GTP ++APE++ +
Sbjct: 162 ---------------------QLDSTLG-----RRNTFIGTPYWMAPEVIACDEQPDASY 195
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
+D WS+GI EL G PP HP + I P + PE S + +D I
Sbjct: 196 DARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISEC 255
Query: 718 LTEDPHQRLGSGGASEVKQHVF 739
L ++ QR E+ +H F
Sbjct: 256 LIKNYEQRPFM---EELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 67/239 (28%), Positives = 114/239 (47%), Gaps = 45/239 (18%)
Query: 508 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 567
NP ++ +YS T + L+M+Y+ GDL+ LL+ G L E + I ++V AL LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 568 LRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 626
++H D+K +N+L I L D+GL K + GT D
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------------IIGTPSCYD------ 167
Query: 627 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686
GT DY +PE + G + + DWW+VG++ +EL+ G PF + +
Sbjct: 168 ---------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212
Query: 687 QI-FDNILNR---KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
++ +++L R K+P+ + +S A+D + L + + RL + +E+ +H F K
Sbjct: 213 ELDLESLLKRQQKKLPFIKN---VSKNANDFVQSMLKYNINYRLTNY--NEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 37/250 (14%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
++ +E I E +L +P++ R++ S+ L+++MEYL GG LL+ G L+E
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEET 101
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
+ E++ L+YLHS R +HRD+K N+L++ G +KL DFG++
Sbjct: 102 YIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG------------ 149
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
QLT ++ K+ + VGTP ++APE++ + + AD WS+GI
Sbjct: 150 --------------QLTDTQ-----IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGIT 190
Query: 670 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729
EL G PP + HP ++ L K P + + S + ++ L +DP R
Sbjct: 191 AIELAKGEPPNSDLHPMRVL--FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR---P 245
Query: 730 GASEVKQHVF 739
A E+ +H F
Sbjct: 246 TAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 44/269 (16%)
Query: 468 GKGALSE-------HDDFPQVLKKADMIRKNAVESILA--ERDILISVRNPFVVRFFYSF 518
GKGA E DD V K+ ++ R + E A E IL +++P ++ ++ F
Sbjct: 9 GKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF 68
Query: 519 TCRENLYLVMEYLNGGDLYS-LLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLK 576
L + MEY NGG LY ++R G L +E++ Y+ ++V A+ Y+H ++HRD+K
Sbjct: 69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK 128
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
N+ + G IKL DFG+SK+ LG E
Sbjct: 129 TLNIFLTKAGLIKLGDFGISKI-------------------LGSEYSM------------ 157
Query: 637 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696
+ VGTP Y++PE+ G + +D W++G +L+EL+ F+A +P + I+
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217
Query: 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ V S E L+ L +DP +R
Sbjct: 218 --YTPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/254 (26%), Positives = 108/254 (42%), Gaps = 56/254 (22%)
Query: 487 MIRKNA----VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
++++A +E L E I+ + +P VV+ T E LY+VMEY+ GGDL S LR
Sbjct: 35 TLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK 94
Query: 543 LG---CLDE------DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593
L + +AR +EYL S +HRDL N L+ + +K++DF
Sbjct: 95 NRPKLSLSDLLSFALQIAR--------GMEYLESKNFIHRDLAARNCLVGENLVVKISDF 146
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
GLS+ + G + + ++APE L
Sbjct: 147 GLSRDLYDDDYYRKRG---------------------------GKLPI---RWMAPESLK 176
Query: 654 GTGHGTTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAH 711
G T+ D WS G++L+E+ +G P+ +++ + + N P PE +
Sbjct: 177 -EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--PPNCPPELY 233
Query: 712 DLIDRFLTEDPHQR 725
DL+ + EDP R
Sbjct: 234 DLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 72/264 (27%), Positives = 133/264 (50%), Gaps = 39/264 (14%)
Query: 468 GKGALSEH-DDFPQ-VLKKADMIRKNAVESILAERDILI--SVRNPFVVRFFYSFTCREN 523
GK L + +D Q V+K+ ++ + + E + +++ + ++++P +V++ SF N
Sbjct: 14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73
Query: 524 LYLVMEYLNGGDLYSLLRNL-GCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
LY+VM+Y GGDLY + G L ED + ++ LAL+++H +++HRD+K N+
Sbjct: 74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 133
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ DG IKL DFG+++V +NST +L+ R+ +
Sbjct: 134 LTKDGTIKLGDFGIARV--LNSTVELA-----------------------------RTCI 162
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR 701
GTP YL+PEI + +D W++G +L+E+ F A + + + I+ +P
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--YPP 220
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQR 725
V S + +L+ + +P R
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 70/245 (28%), Positives = 119/245 (48%), Gaps = 43/245 (17%)
Query: 489 RKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNG---GDLYSLLRNLG 544
R ++ I++E I+ +R+P +VR++ +F + LY+VM+ + G G+ ++ L+
Sbjct: 48 RDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK 107
Query: 545 --CLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+E + +++ ++VLAL YLH R+VHRDL P+N+++ D + +TDFGL+K
Sbjct: 108 QRFTEERIWNIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---- 162
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+Q K S VGT Y PEI+ +G A
Sbjct: 163 ----------------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKA 194
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTE 720
D W+ G IL+++ PPF + + + I+ + +PE M S + D+I LT
Sbjct: 195 DVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTP 252
Query: 721 DPHQR 725
D R
Sbjct: 253 DAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 80/276 (28%), Positives = 119/276 (43%), Gaps = 70/276 (25%)
Query: 498 AERDI--LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARV 553
A R+I L + +P +VR LYLV E+L+ DL + + LD + +
Sbjct: 45 AIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKS 103
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK-VGLINSTDDLSGPAV 612
Y+ +++ + Y HS RV+HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV---------P-- 152
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 671
+ H+ V T Y APEILLG+ +T D WS+G I
Sbjct: 153 ------------VRTYTHE---------VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFA 191
Query: 672 ELIVGIPPF--NAEHPQ--QIFDNILN----------RKIP--------WPRVPE----- 704
E++ P F ++E Q +IF L +P W R
Sbjct: 192 EMVNRRPLFPGDSEIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVP 250
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ + DL+ + L DP +R+ A QH +F
Sbjct: 251 NLDEDGLDLLSKMLVYDPAKRI---SAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 78/276 (28%), Positives = 123/276 (44%), Gaps = 50/276 (18%)
Query: 468 GKGALSE-------HDDFPQVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYS 517
GKG S D LKK +M+ A + L E D+L + +P V+++ S
Sbjct: 11 GKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLAS 70
Query: 518 FTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHR 573
F L +V+E + GDL ++++ + E Y ++ ALE++HS R++HR
Sbjct: 71 FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR 130
Query: 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 633
D+KP N+ I G +KL D GL G S+ T + H
Sbjct: 131 DIKPANVFITATGVVKLGDLGL---GRFFSSK--------------------TTAAH--- 164
Query: 634 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ--QIFDN 691
S VGTP Y++PE + G+ +D WS+G +L+E+ PF + +
Sbjct: 165 -----SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
Query: 692 ILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRL 726
I K +P +P + S E DL+ R + DP +R
Sbjct: 220 I--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 35/247 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK+ E L E I+ + +P +VR T E LY+V EY+ GGDL L
Sbjct: 35 TLKEGASEE--EREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R + L ++ +EYL S VHRDL N L+ + +K++DFGLS+
Sbjct: 93 RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR-- 150
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
I D RK+ ++APE L +
Sbjct: 151 DIYEDDYY---------------------------RKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 660 TADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D WS G++L+E+ +G P+ +++ + + + PR PE E ++L+ +
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRL-PR-PENCPDELYELMLQCW 241
Query: 719 TEDPHQR 725
DP R
Sbjct: 242 AYDPEDR 248
|
Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 70/268 (26%), Positives = 131/268 (48%), Gaps = 40/268 (14%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDVA 551
+E + E +IL + +P++V+ +F L++++E+ GG + +++ L L E
Sbjct: 53 LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 112
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+V +++ AL+YLHS++++HRDLK N+L+ DG IKL DFG+S
Sbjct: 113 QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS--------------- 157
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSV 666
+++ + +++ S +GTP ++APE+++ T + AD WS+
Sbjct: 158 ----------------AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201
Query: 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 726
GI L E+ PP + +P ++ I + P P + S E D + L + P R
Sbjct: 202 GITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR- 260
Query: 727 GSGGASEVKQHVFFKDINWDTLARQKAA 754
A+++ +H F + + R+ A
Sbjct: 261 --PSAAQLLEHPFVSSVTSNRPLRELVA 286
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 45/253 (17%)
Query: 487 MIRKNAVES----ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
++++A E L E ++ + +P VVR T E LYLV+EY+ GGDL LR
Sbjct: 30 TLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRK 89
Query: 543 ---------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593
L + ++ +EYL S + VHRDL N L+ D +K++DF
Sbjct: 90 SRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDF 149
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
GLS+ + ++ +++ + + ++APE L
Sbjct: 150 GLSR--------------------------DVYDDDYYRKKTGGKLPI---RWMAPESLK 180
Query: 654 GTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
+ +D WS G++L+E+ G P+ +++ + + P+ PE E ++
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-PK-PEYCPDELYE 238
Query: 713 LIDRFLTEDPHQR 725
L+ DP R
Sbjct: 239 LMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 75/252 (29%), Positives = 119/252 (47%), Gaps = 68/252 (26%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLI 582
+YLV EY+ DL++++R L EDV + YI +++ AL+Y+HS V+HRDLKP N+L+
Sbjct: 84 IYLVFEYMET-DLHAVIRA-NIL-EDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140
Query: 583 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642
D +KL DFGL++ ++ ++ E P LT ++ V
Sbjct: 141 NSDCRVKLADFGLAR--SLSELEE------------NPENPVLT--DY----------VA 174
Query: 643 TPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--------------------- 680
T Y APEILLG+ T D WSVG IL E+++G P F
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 681 ------NAEHPQQIFDNILNRKIPWPRVPEEM----SPEAHDLIDRFLTEDPHQRLGSGG 730
+ + D++ +R + +E+ S +A DL+ + L +P++RL
Sbjct: 235 EDIESIKSPFAATMLDSLPSRP---RKPLDELLPKASDDALDLLKKLLVFNPNKRL---T 288
Query: 731 ASEVKQHVFFKD 742
A E +H +
Sbjct: 289 AEEALEHPYVAQ 300
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 70/265 (26%), Positives = 132/265 (49%), Gaps = 38/265 (14%)
Query: 479 PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
P V + +++ ++++ E +L +++ +V++ S ++L + +EY+ GG + +
Sbjct: 36 PSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA 95
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
LL N G +E + R ++ +++ L YLH+ ++HRD+K N+L+ + G IK++DFG+SK
Sbjct: 96 LLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
NS +T P L S ++APE++ T +
Sbjct: 156 LEANSL----------STKTNGARPSLQGSVF---------------WMAPEVVKQTSYT 190
Query: 659 TTADWWSVGIILFELIVGIPPF-NAEHPQQIF---DNILNRKIPWPRVPEEMSPEAHDLI 714
AD WS+G ++ E++ G PF + Q IF +N P +P +S EA D +
Sbjct: 191 RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS------PEIPSNISSEAIDFL 244
Query: 715 DRFLTEDPHQRLGSGGASEVKQHVF 739
++ D ++R A+E+ +H F
Sbjct: 245 EKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 85/312 (27%), Positives = 128/312 (41%), Gaps = 78/312 (25%)
Query: 459 TSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF 518
T +I +A K DD + ++K + L E +L +R+ +V +F
Sbjct: 25 TGEI---VAIKKFKESEDD--------EDVKK----TALREVKVLRQLRHENIVNLKEAF 69
Query: 519 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 578
+ LYLV EY+ L L + G L D R YI +++ A+ Y HS ++HRD+KP+
Sbjct: 70 RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPE 129
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
N+L++ G +KL DFG ++ L LT
Sbjct: 130 NILVSESGVLKLCDFGFARA--------LRARP----------ASPLT------------ 159
Query: 639 SAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH------------- 684
V T Y APE+L+G T +G D W++G I+ EL+ G P F +
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219
Query: 685 ---PQQ--IFD-NILNR--KIPWPRVPE--------EMSPEAHDLIDRFLTEDPHQRLGS 728
P +F N P P PE ++S A D + L DP +RL
Sbjct: 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL-- 277
Query: 729 GGASEVKQHVFF 740
E+ QH +F
Sbjct: 278 -TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 2e-25
Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 49/261 (18%)
Query: 494 ESILAERDILISVRN-PFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNLGCLD 547
E I AE +IL ++ + P VV+F+ + ++ L+LV+E NGG + L++
Sbjct: 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG 118
Query: 548 EDVARVYIA----EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
E + IA E ++ L++LH + +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------ 172
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHG 658
QLT++ ++ ++VGTP ++APE++ L + +
Sbjct: 173 --------------------QLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYD 207
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
D WS+GI EL G PP HP + I P PE S E +D I + L
Sbjct: 208 ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCL 267
Query: 719 TEDPHQRLGSGGASEVKQHVF 739
T+D +R S++ QHVF
Sbjct: 268 TKDYEKR---PTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 75/246 (30%), Positives = 113/246 (45%), Gaps = 47/246 (19%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 558
ER +I P +V ++++LV+++ GG L+S + + E+ + + AE+
Sbjct: 35 ERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEM 94
Query: 559 VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTL 617
V+AL+ LH +V RDL P+N+L+ GHI+LT F S+V D G AV
Sbjct: 95 VVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENM-- 147
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677
Y APE+ + DWWS+G ILFEL+ G
Sbjct: 148 ----------------------------YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
Query: 678 PPFNAEHPQQIFDNI-LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA--SEV 734
HP I + LN +PE +S EA L+ + L +P +RLG+G A ++
Sbjct: 180 TLVEC-HPSGINTHTTLN-------IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231
Query: 735 KQHVFF 740
K H FF
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 70/286 (24%)
Query: 489 RKNAVESI----LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 544
RK A + I L E +L +++P ++ F + N+ LV E++ DL ++++
Sbjct: 38 RKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD-K 95
Query: 545 CLDEDVARV--YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
+ A + Y+ + LEYLHS ++HRDLKP+NLLIA DG +KL DFGL++
Sbjct: 96 SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS---- 151
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTA 661
G ++T HQ V T Y APE+L G H G
Sbjct: 152 ---------------FGSPNRKMT---HQ---------VVTRWYRAPELLFGARHYGVGV 184
Query: 662 DWWSVGIILFELIVGIP--PFNAEHPQ--QIFDNILNRKIP--WPRVPEEMSP------- 708
D WSVG I EL++ +P P +++ Q +IF L WP V
Sbjct: 185 DMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF-EALGTPTEENWPGVTSLPDYVEFKPFP 243
Query: 709 -------------EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+A DL+ R LT +P++R+ A + +H +F
Sbjct: 244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 73/250 (29%), Positives = 122/250 (48%), Gaps = 37/250 (14%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
++ +E I E +L +P+V +++ S+ L+++MEYL GG LL G LDE
Sbjct: 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDET 101
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
+ E++ L+YLHS + +HRD+K N+L++ G +KL DFG++
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------------ 149
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
QLT ++ K+ + VGTP ++APE++ + + + AD WS+GI
Sbjct: 150 --------------QLTDTQ-----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 190
Query: 670 LFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729
EL G PP + HP ++ L K P + S + ++ L ++P R
Sbjct: 191 AIELAKGEPPHSELHPMKVL--FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR---P 245
Query: 730 GASEVKQHVF 739
A E+ +H F
Sbjct: 246 TAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 78/285 (27%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVY 554
I+ E +L +P++V F+ +F + + ME+++GG L +L+ G + E++ ++
Sbjct: 46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS 105
Query: 555 IAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
IA V+ L YL +++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 106 IA-VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN------- 156
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
S VGT Y++PE L GT + +D WS+G+ L E+
Sbjct: 157 -------------------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
Query: 674 IVG---IPPFNAEH------------------------------PQQIF---DNILNRKI 697
+G IPP +A+ P IF D I+N
Sbjct: 192 AIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE-- 249
Query: 698 PWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
P P++P S E D +D+ L ++P +R E+ +H F K
Sbjct: 250 PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK---ELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 57/265 (21%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNL----GCLDED 549
IL E +I S ++P++V+++ +F ++ + MEY GG L S+ + + G + E
Sbjct: 46 ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105
Query: 550 VARVYIAEVVL-ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
V IAE VL L YLHS +++HRD+KP N+L+ G +KL DFG+S L+NS
Sbjct: 106 VL-GKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVNS----- 158
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668
++GT GT Y+APE + G + T+D WS+G+
Sbjct: 159 ---LAGTF------------------------TGTSFYMAPERIQGKPYSITSDVWSLGL 191
Query: 669 ILFELIVGIPPFNAEHPQ-----QIFDNILNRKIPWPRVPEEM------SPEAHDLIDRF 717
L E+ PF E ++ I+N +P P + +E S E D I +
Sbjct: 192 TLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--MPNPELKDEPGNGIKWSEEFKDFIKQC 249
Query: 718 LTEDPHQRLGSGGASEVKQHVFFKD 742
L +DP +R ++ +H + K
Sbjct: 250 LEKDPTRRPTP---WDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 52/245 (21%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD---LYSLLRNLGCLDEDVAR 552
I+ E DIL +P++V F+ +F +Y+ MEY++ G LY+ + EDV R
Sbjct: 46 IIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR 105
Query: 553 VYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
VV L++L ++HRD+KP N+L+ +G +KL DFG
Sbjct: 106 RITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG----------------- 148
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGT---TADWWS 665
VSG L AS ++ +G Y+APE + + T +D WS
Sbjct: 149 VSG---------NLVAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 666 VGIILFELIVGIPPFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTE 720
+G+ + E+ +G P+ P + + NI + P +P S +A D + + L +
Sbjct: 193 LGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNK 248
Query: 721 DPHQR 725
P++R
Sbjct: 249 IPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/249 (28%), Positives = 120/249 (48%), Gaps = 35/249 (14%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDV 550
V ++ E +L ++++ +V+++ R + L + MEY+ GG + L+ G L E V
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
R Y +++ + YLHS +VHRD+K N+L G++KL DFG SK L
Sbjct: 108 TRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RLQTI 159
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670
+SGT + RS GTP +++PE++ G G+G AD WS+G +
Sbjct: 160 CMSGTGI--------------------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199
Query: 671 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 730
E++ PP+ AE+ + + P++P +S A D + E H+
Sbjct: 200 VEMLTEKPPW-AEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRP----S 254
Query: 731 ASEVKQHVF 739
A E+ +H F
Sbjct: 255 AEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 41/261 (15%)
Query: 486 DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
D +K+ V+++ +E + L + + +V++ T E L + +EY+ GG + S LR G
Sbjct: 45 DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
+E + R + +V+ L YLHS ++HRDLK DNLL+ DG K++DFG+SK +D
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-----KSD 159
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA--DW 663
D+ ++ G+ ++APE++ G +A D
Sbjct: 160 DIYD-NDQNMSMQ-----------------------GSVFWMAPEVIHSYSQGYSAKVDI 195
Query: 664 WSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEE----MSPEAHDLIDRFL 718
WS+G ++ E+ G P+ + E +F L K P +P + +SP A D ++
Sbjct: 196 WSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACF 253
Query: 719 TEDPHQRLGSGGASEVKQHVF 739
T +P R A E+ QH F
Sbjct: 254 TINPDNR---PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 70/260 (26%), Positives = 116/260 (44%), Gaps = 56/260 (21%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDV-AR 552
I++E +IL +P+++ F+ +F + + E+++GG D+Y + E V R
Sbjct: 46 IMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGR 99
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ +A VV L YL SL+++HRD+KP N+L+ G +KL DFG+S L+NS
Sbjct: 100 IAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSI-------- 149
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
++ VGT Y+APE + G +G +D WS+GI E
Sbjct: 150 ------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185
Query: 673 LIVG---IPPFNAEH----PQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQ 724
L +G P P Q+ I++ P +P + S + I + + + P +
Sbjct: 186 LALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKE 243
Query: 725 RLGSGGASEVKQHVFFKDIN 744
R + H F N
Sbjct: 244 RP---APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 71/277 (25%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
++I+A RDIL F +++Y+VM+ L DL+ ++ + L E+ R
Sbjct: 64 DNIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRY 111
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
++ +++ L+Y+HS V+HRDLKP NLL+ D +++ DFG+++ GL +S
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSP--------- 161
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 672
E + +E+ V T Y APE+LL TTA D WSVG I E
Sbjct: 162 -------TEHKYFMTEY----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
Query: 673 LI---------------------VGIPPFN------AEHPQQIFDNILNRK-IPWPRVPE 704
++ +G P ++ ++ N+ ++ +PW ++
Sbjct: 205 MLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFP 264
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+ SPEA DL+ + L DP +R+ + QH F
Sbjct: 265 KASPEALDLLSQMLQFDPEERI---TVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 78/263 (29%), Positives = 123/263 (46%), Gaps = 49/263 (18%)
Query: 494 ESILAERDILISVRN-PFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNL-GC- 545
E I AE +IL S+ N P VV+F+ F + L+LV+E NGG + L++ L C
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 546 --LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
LDE + + +L L++LH+ R++HRD+K +N+L+ +G +KL DFG+S
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------ 176
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHG 658
QLT++ R ++ ++VGTP ++APE++ +
Sbjct: 177 --------------------QLTST-----RLRRNTSVGTPFWMAPEVIACEQQYDYSYD 211
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
D WS+GI EL G PP HP + I P PE+ + I + L
Sbjct: 212 ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCL 271
Query: 719 TEDPHQRLGSGGASEVKQHVFFK 741
+D R + + +H F K
Sbjct: 272 IKDFEAR---PSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 74/265 (27%), Positives = 107/265 (40%), Gaps = 68/265 (25%)
Query: 507 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALEY 564
+P +V+ F + LY V EY+ G +LY L+ R E V R I +++ L +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
+H HRDLKP+NLL++ +K+ DFGL++ I S P
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE--IRS------------------RPP 154
Query: 625 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN-- 681
T V T Y APEILL + ++ D W++G I+ EL P F
Sbjct: 155 YTDY------------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202
Query: 682 --AEHPQQIFD-----------------NILNRKIPWPRVPEEM-------SPEAHDLID 715
+ +I + L + P P + SPEA DLI
Sbjct: 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIK 261
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFF 740
L DP +R AS+ QH +F
Sbjct: 262 DMLRWDPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 37/234 (15%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDVAR 552
+ E +L + +P ++ ++ +F + L +VMEY GG L ++ LDED
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+ +++LAL ++H+ ++HRDLK N+L+ H +K+ DFG+SK+ LS
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LS--- 153
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
+ K + VGTP Y++PE+ G + +D W++G +L+
Sbjct: 154 ---------------------SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLY 192
Query: 672 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
EL F A + + I++ + + + SP+ LI L DP +R
Sbjct: 193 ELASLKRAFEAANLPALVLKIMSGT--FAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 71/263 (26%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K D + +E + E DIL S +P +V+ +F NL++++E+ GG + +++
Sbjct: 36 KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 95
Query: 543 LG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
L L E RV + + AL YLH +++HRDLK N+L DG IKL DFG+S
Sbjct: 96 LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS----- 150
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTG 656
+++ + +++ S +GTP ++APE+++
Sbjct: 151 --------------------------AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+ AD WS+GI L E+ PP + +P ++ I + P P S E D + +
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKK 244
Query: 717 FLTEDPHQRLGSGGASEVKQHVF 739
L ++ R +++ QH F
Sbjct: 245 CLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-23
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 52/276 (18%)
Query: 468 GKGALSE-------HDDFPQVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYS 517
G+G SE D P LKK D++ A + E D+L + +P V++++ S
Sbjct: 11 GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 518 FTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHR 573
F L +V+E + GDL ++++ + E Y ++ ALE++HS RV+HR
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130
Query: 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 633
D+KP N+ I G +KL D GL + +S T + H
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGR--FFSSK---------------------TTAAH--- 164
Query: 634 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693
S VGTP Y++PE + G+ +D WS+G +L+E+ PF + ++ L
Sbjct: 165 -----SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYS--L 216
Query: 694 NRKIP---WPRVP-EEMSPEAHDLIDRFLTEDPHQR 725
+KI +P +P + S E L++ + DP +R
Sbjct: 217 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 468 GKGALSEHDDFPQ--VLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524
G+ L +H + Q +K+ + +AVE E +L +++P +V F SF +L
Sbjct: 14 GRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73
Query: 525 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 582
Y+VMEY +GGDL ++ ED + ++ L ++++H RV+HRD+K N+ +
Sbjct: 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL 133
Query: 583 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642
+G +KL DFG +++ L+ P T VG
Sbjct: 134 TQNGKVKLGDFGSARL--------LTSPGAYACTY-----------------------VG 162
Query: 643 TPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV 702
TP Y+ PEI + +D WS+G IL+EL PF A + + + + + +
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC--QGSYKPL 220
Query: 703 PEEMSPEAHDLIDRFLTEDPHQR 725
P S E LI + +P R
Sbjct: 221 PSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 52/276 (18%)
Query: 468 GKGALSE-------HDDFPQVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYS 517
G+G SE D P LKK +M+ A + + E D+L + +P V+++ S
Sbjct: 11 GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDS 70
Query: 518 FTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHR 573
F L +V+E + GDL +++ + E Y ++ A+E++HS RV+HR
Sbjct: 71 FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130
Query: 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 633
D+KP N+ I G +KL D GL G S+ T + H
Sbjct: 131 DIKPANVFITATGVVKLGDLGL---GRFFSSK--------------------TTAAH--- 164
Query: 634 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693
S VGTP Y++PE + G+ +D WS+G +L+E+ PF + +F L
Sbjct: 165 -----SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFS--L 216
Query: 694 NRKIP---WPRVP-EEMSPEAHDLIDRFLTEDPHQR 725
+KI +P +P E S + +L+ + DP QR
Sbjct: 217 CQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 67/250 (26%), Positives = 118/250 (47%), Gaps = 38/250 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILI--SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
V+K+ D+ + E +++++++ +++P +V FF SF L++VMEY +GGDL
Sbjct: 29 VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMK 88
Query: 539 LL-RNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLTDFGL 595
+ R G L ED + ++ L L+++H +++HRD+K N+ ++ +G + KL DFG+
Sbjct: 89 RINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
++ +N + +L+ + VGTP YL+PEI
Sbjct: 149 ARQ--LNDSMELA-----------------------------YTCVGTPYYLSPEICQNR 177
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+ D WS+G +L+EL PF + Q+ I P P S + LI
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISP-NFSRDLRSLIS 235
Query: 716 RFLTEDPHQR 725
+ P R
Sbjct: 236 QLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 69/262 (26%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
E+I+ DI+ F SF ++Y+V E + DLY L++ L D +
Sbjct: 63 ENIIGILDIIRP-------PSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQY 110
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
++ +++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL+++
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--------------- 155
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 672
D LT E+ V T Y APEI+L + T A D WSVG IL E
Sbjct: 156 -ADPEHDHTGFLT--EY----------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAE 202
Query: 673 LIVGIPPFNAEH--------------PQQI-FDNILNRK-------------IPWPRVPE 704
++ P F + P Q + I++ + +PW ++
Sbjct: 203 MLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP 262
Query: 705 EMSPEAHDLIDRFLTEDPHQRL 726
P+A DL+D+ LT +PH+R+
Sbjct: 263 NADPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
L + ME++ GG + L++ G L E+V R Y +++ + YLHS +VHRD+K N+L
Sbjct: 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
G++KL DFG SK L +SGT + +S GT
Sbjct: 141 SVGNVKLGDFGASK--------RLQTICLSGTGM--------------------KSVTGT 172
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRV 702
P +++PE++ G G+G AD WSVG + E++ PP+ E IF + + P +
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPVL 230
Query: 703 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
P +S D + R E + A E+ +H F
Sbjct: 231 PPHVSDHCRDFLKRIFVEAKLRP----SADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 43/224 (19%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCL--DEDVARVYIAEVVLALEYLHS 567
+V++ S + + ME + GG L +LLR+ G L +E Y +++ L+YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 568 LRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSG--PAVSGTTLLGDEEPQ 624
++VHRD+K DN+L+ + G +K++DFG SK L+G P T
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--------RLAGINPCTETFT-------- 170
Query: 625 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF-N 681
GT Y+APE++ G+G AD WS+G + E+ G PPF
Sbjct: 171 -----------------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213
Query: 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
PQ + KI P +PE +S EA + I R DP +R
Sbjct: 214 LGEPQAAMFKVGMFKIH-PEIPESLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 84/301 (27%), Positives = 126/301 (41%), Gaps = 82/301 (27%)
Query: 482 LKKADMIR-KNAVE-SILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLY 537
LKK M ++ + S L E +L+++R+P +V + ++++LVMEY DL
Sbjct: 37 LKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLA 95
Query: 538 SLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
SLL N+ E + + +++ L+YLH ++HRDLK NLL+ G +K+ DFGL+
Sbjct: 96 SLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
+ PA T P+ V T Y APE+LLG
Sbjct: 156 RT--------YGLPAKPMT-------PK----------------VVTLWYRAPELLLGCT 184
Query: 657 HGTTA-DWWSVGIILFELIVGIPPFNA------------------EH------------- 684
TTA D W+VG IL EL+ P E
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 685 ---PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
P+Q ++N L K PW +S L++ L DP +R A E + +FK
Sbjct: 245 FTLPKQPYNN-LKHKFPW------LSEAGLRLLNFLLMYDPKKR---ATAEEALESSYFK 294
Query: 742 D 742
+
Sbjct: 295 E 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 78/291 (26%), Positives = 117/291 (40%), Gaps = 96/291 (32%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRE--------NLYLVMEYLNGGDLYSLLRNLGCLDE 548
L E +IL+ +++P +V T +E +Y+VMEY+ DL SL+ + +
Sbjct: 52 LREINILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM---KQ 101
Query: 549 DVARVYIAEV-------VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+EV + + +LH ++HRDLK NLL+ + G +K+ DFGL
Sbjct: 102 PFL---QSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL------ 152
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
A E+ + V T Y APE+LLG +TA
Sbjct: 153 -------------------------AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187
Query: 662 -DWWSVGIILFELIVGIPPFNAEHP----QQIFDNIL---NRKIPWPRVPE--------- 704
D WSVG I EL+ P F + +IF +L KI WP E
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF-KLLGTPTEKI-WPGFSELPGAKKKTF 245
Query: 705 ---------------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+S DL++R LT DP +R+ A + +H +F
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI---SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 71/286 (24%)
Query: 486 DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
M++K A+ I +L +R+ +V F ++ LYLV E+++ L L +
Sbjct: 41 KMVKKIAMREI----RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG 96
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
LDE R Y+ +++ +E+ HS ++HRD+KP+N+L++ G +KL DFG ++
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART------- 149
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWW 664
L+ P T V T Y APE+L+G T +G D W
Sbjct: 150 -LAAPGEVYT-----------------------DYVATRWYRAPELLVGDTKYGRAVDIW 185
Query: 665 SVGIILFELIVGIPPFNA------------------EHPQQIFDNILNRKIPWPRVPE-- 704
+VG ++ E++ G P F Q+IF N R+PE
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK--NPLFAGMRLPEVK 243
Query: 705 ----------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
++S DL + L DP R S S++ H FF
Sbjct: 244 EIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS---SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 35/208 (16%)
Query: 526 LVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
LV++Y N GDL +++ E A + +V+LA+ ++HS ++HRD+K N+L
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ +G +KL DFG SK+ +DD+ R+
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVG-----------------------------RTFC 206
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR 701
GTP Y+APEI + AD +S+G++L+EL+ PF+ E+ +++ L + +
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR--YDP 264
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSG 729
+P +SPE +++ L+ DP +R S
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 39/238 (16%)
Query: 507 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 566
++ +V +F S+ R+ L++ ME+ GG L + G L E E + L YLH
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 626
S +HRD+K N+L+ +GH+KL DFG+S Q+T
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSA--------------------------QIT 157
Query: 627 ASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAE 683
A+ K++S +GTP ++APE+ G+ D W+VGI EL PP
Sbjct: 158 AT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212
Query: 684 HPQQIFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
HP + + P++ ++M S H + LT++P +R A ++ QH F
Sbjct: 213 HPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR---PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDV 550
V ++ E +L ++R+ +V+++ E L + +EY+ GG + L+ G L E+V
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
R Y +++ + YLHS +VHRD+K N+L G++KL DFG SK +
Sbjct: 108 TRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RIQTI 159
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670
+SGT + +S GTP +++PE++ G G+G AD WSV +
Sbjct: 160 CMSGTGI--------------------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 671 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
E++ PP+ I + P +P+ +S D + + E+
Sbjct: 200 VEMLTEKPPWAEYEAMAAIFKIATQPTK-PMLPDGVSDACRDFLKQIFVEE 249
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 45/270 (16%)
Query: 468 GKGALSE-------HDDFPQVLKKADMIRKNAVESILAERD--ILISVRNPFVVRFFYSF 518
GKG+ E D V+KK ++ + E AE++ +L +++P +V + S+
Sbjct: 9 GKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW 68
Query: 519 TCREN-LYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDL 575
+ LY+VM + GGDLY L+ L E+ + ++ +AL+YLH ++HRDL
Sbjct: 69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDL 128
Query: 576 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635
K N+ + IK+ D G+++V L N D S
Sbjct: 129 KTQNVFLTRTNIIKVGDLGIARV-LENQCDMAS--------------------------- 160
Query: 636 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695
+ +GTP Y++PE+ + +D W++G ++E+ FNA+ + I+
Sbjct: 161 ---TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217
Query: 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
K+ P +P++ SPE +LI L++ P +R
Sbjct: 218 KL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRV 570
+V +F S+ RE L++ MEY GG L + G L E E + L YLHS
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 571 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 630
+HRD+K N+L+ +G +KL DFG++ ++TA+
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--------------------------KITAT-- 159
Query: 631 QQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687
K++S +GTP ++APE+ G+ D W+VGI EL PP HP +
Sbjct: 160 ---IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216
Query: 688 IFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLTEDPHQR 725
+ P++ ++ S H+ + LT++P +R
Sbjct: 217 ALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 82/277 (29%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
E+I++ DI IS P E++Y V E L G DL+ LL + L++ +
Sbjct: 69 ENIISLSDIFIS---P-----------LEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQY 112
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
++ +++ L+Y+HS VVHRDLKP N+LI + +K+ DFGL+++
Sbjct: 113 FLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--------------- 157
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 672
++PQ+T V T Y APEI+L + D WS G I E
Sbjct: 158 -------QDPQMTGY------------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198
Query: 673 LIVGIPPFNAEHPQQIF-----------DNILNR-----------------KIPWPRVPE 704
++ G P F + F D+++N +P+ +
Sbjct: 199 MLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFK 258
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
P A DL+++ L DP +R+ A+E H +
Sbjct: 259 NADPSAIDLLEKMLVFDPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 68/233 (29%), Positives = 101/233 (43%), Gaps = 57/233 (24%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
LYL E L DL+ ++R+ L + + +I +++ L+Y+HS V+HRDLKP NLL+
Sbjct: 81 LYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN 139
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
D +K+ DFGL++ N G+ +T V T
Sbjct: 140 ADCELKICDFGLARGFSENP---------------GENAGFMT------------EYVAT 172
Query: 644 PDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNA----EHPQQIF-------DN 691
Y APEI+L T A D WSVG IL EL+ P F + QI +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 692 ILNR-----------------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727
L+R K P+ + +P A DL+++ L DP +R+
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 70/250 (28%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+++YLV L G DL ++++ L +D + + +++ L+Y+HS ++HRDLKP N+
Sbjct: 93 QDVYLVTH-LMGADLNNIVK-CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIA 150
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ TDD ++T V
Sbjct: 151 VNEDCELKILDFGLAR-----HTDD-----------------EMTGY------------V 176
Query: 642 GTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILN----- 694
T Y APEI+L H T D WSVG I+ EL+ G F ++H Q+ I+N
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL-KRIMNLVGTP 235
Query: 695 -----RKIP----------WPRVPEE--------MSPEAHDLIDRFLTEDPHQRLGSGGA 731
+KI P++P++ +P A DL+++ L DP +R+ A
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI---TA 292
Query: 732 SEVKQHVFFK 741
+E H +
Sbjct: 293 AEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-20
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 45/219 (20%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVY 554
I+ E +L +P++V F+ +F + + ME+++GG L +L+ G + E + +V
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 109
Query: 555 IAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
IA V+ L YL +++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 110 IA-VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN------- 160
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
S VGT Y++PE L GT + +D WS+G+ L E+
Sbjct: 161 -------------------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
Query: 674 IVG---IPPFNAEHPQQIF------DNILNRKIPWPRVP 703
+G IPP +A+ + +F D + P PR P
Sbjct: 196 AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 70/263 (26%), Positives = 115/263 (43%), Gaps = 73/263 (27%)
Query: 494 ESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
E+++A +DI+ R F ++Y+V E L DL+ ++R+ L +D +
Sbjct: 64 ENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQ 111
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
++ +++ L+Y+HS V+HRDLKP NLL+ + +K+ DFGL++ + D
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDF----- 164
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILF 671
+E+ V T Y APE+LL + + T D WSVG I
Sbjct: 165 --------------MTEY----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200
Query: 672 ELIVGIPPF-NAEHPQQI--------------FDNILN-------RKIP-WPRVP----- 703
EL+ P F ++ Q+ I N R +P PR
Sbjct: 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLF 260
Query: 704 EEMSPEAHDLIDRFLTEDPHQRL 726
+P A DL+++ L DP +R+
Sbjct: 261 PHANPLAIDLLEKMLVFDPSKRI 283
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 40/256 (15%)
Query: 480 QVLKKADMIRKNAVESILA--ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+VLK+ + N E++ A E +L + +P +V+F SF R+ ++ EY G DL
Sbjct: 31 KVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLD 90
Query: 538 SLLRNLGCLDEDVARVYIAE----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593
L L + ++ + E ++L + Y+H R++HRDLK N+ + ++ +K+ DF
Sbjct: 91 CKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDF 149
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G+S++ L+ S D TT GTP Y++PE L
Sbjct: 150 GVSRL-LMGSCD-------LATTF-----------------------TGTPYYMSPEALK 178
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
G+ + +D WS+G IL+E+ F ++ + I+ P P +PE S + + +
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTPSLPETYSRQLNSI 236
Query: 714 IDRFLTEDPHQRLGSG 729
+ L +DP R +
Sbjct: 237 MQSMLNKDPSLRPSAA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVA 551
E+ L E +L +++ +V +F R LYLV EY+ ++ LL + G E V
Sbjct: 45 ETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV- 102
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
R YI +++ A+ + H +VHRD+KP+NLLI+H+ +KL DFG ++ +LS
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS--- 151
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
E +E+ V T Y +PE+LLG +G D WSVG IL
Sbjct: 152 ---------EGSNANYTEY----------VATRWYRSPELLLGAPYGKAVDMWSVGCILG 192
Query: 672 ELIVGIPPFNAEHP-QQIFDNILNRKIPWPRVPEEM 706
EL G P F E Q+F +K+ P E+M
Sbjct: 193 ELSDGQPLFPGESEIDQLFT---IQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 66/272 (24%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL--YSLLRNLGCLDEDVARVYIA 556
E +L + +P +V+ LYLV E+L+ DL + L + + + Y+
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107
Query: 557 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV-GLINSTDDLSGPAVSGT 615
+++ L + HS RV+HRDLKP NLLI +G IKL DFGL++ G+ P + T
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV---------PVRTYT 158
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 674
H+ V T Y APEILLG + +TA D WS+G I E++
Sbjct: 159 --------------HE---------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 675 V--GIPPFNAEHPQ--QIFDNI-LNRKIPWPRV--------------PEEMS-------P 708
+ P ++E Q +IF + ++ WP V ++ S
Sbjct: 196 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDE 255
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ DL+ + L DP++R+ + A H FF
Sbjct: 256 DGRDLLSQMLHYDPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 67/273 (24%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYI 555
E ++ +++ +VR L LV EY++ DL + G LD + + +
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+++ + + H RV+HRDLKP NLLI G +KL DFGL++ I
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI-------------- 152
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELI 674
P T S + V T Y AP++LLG+ + T+ D WSVG I+ E+I
Sbjct: 153 -------PVNTFS----------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
Query: 675 VGIPPF----NAEHPQQIFDNILN--RKIPWPRV---PE--------------EMSPEAH 711
G P F N + +IF I+ + WP + PE ++ P A
Sbjct: 196 TGRPLFPGTNNEDQLLKIF-RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHAD 254
Query: 712 ----DLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
DL+ R L +P R+ A + QH +F
Sbjct: 255 PLGIDLLHRLLQLNPELRI---SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-19
Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDVARVYIAEVVLALEYLH 566
+V+ F F + L L+MEY +GGDL L+ E + ++VLAL+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 626
S +++HRDLK N+ + G IKL DFG SK +D +S S
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSLDVAS------------- 229
Query: 627 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686
S GTP YLAPE+ + AD WS+G+IL+EL+ PF +
Sbjct: 230 ------------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277
Query: 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+I +L K + P +S L+D L+++P R
Sbjct: 278 EIMQQVLYGK--YDPFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 42/202 (20%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
+++L+ DIL P + F E +Y+V E + DL+ ++ + L D +V
Sbjct: 59 DNVLSALDIL----QPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKV 107
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
++ +++ L+YLHS ++HRD+KP NLL+ + +K+ DFGL++V
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV--------------- 152
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFE 672
EEP E + V T Y APEIL+G+ H T+A D WSVG I E
Sbjct: 153 -------EEP--------DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197
Query: 673 LIVGIPPFNAEHPQQIFDNILN 694
L+ F A+ P Q D I +
Sbjct: 198 LLGRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 52/260 (20%)
Query: 495 SILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL----GCLDED 549
+L + DI + SV P+ V F+ + ++++ ME ++ L + + + ED
Sbjct: 45 RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPED 103
Query: 550 VARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V ALEYLHS L V+HRD+KP N+LI +G +KL DFG+S D ++
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG----YLVDSVA 159
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWW 664
K G Y+APE + G+ +D W
Sbjct: 160 ----------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVW 191
Query: 665 SVGIILFELIVGIPPFNAEHP--QQIFDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTED 721
S+GI + EL G P+++ QQ+ + + P P++P E SPE D +++ L ++
Sbjct: 192 SLGITMIELATGRFPYDSWKTPFQQLKQVV---EEPSPQLPAEKFSPEFQDFVNKCLKKN 248
Query: 722 PHQRLGSGGASEVKQHVFFK 741
+R E+ QH FF+
Sbjct: 249 YKER---PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 71/284 (25%)
Query: 488 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
I+K A L E +L +++P +V F + L+LV EY + L L +N +
Sbjct: 43 IKKIA----LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP 98
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
E + + I + + A+ + H +HRD+KP+N+LI G IKL DFG +++ L
Sbjct: 99 EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--------L 150
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSV 666
+GP T V T Y APE+L+G T +G D W++
Sbjct: 151 TGPGDDYT-----------------------DYVATRWYRAPELLVGDTQYGPPVDVWAI 187
Query: 667 GIILFELIVGIP--PFNAEHPQ----------------QIFDNILNR-----KIPWP--R 701
G + EL+ G P P ++ Q QIF N+ IP P R
Sbjct: 188 GCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST--NQFFKGLSIPEPETR 245
Query: 702 VPEEM-----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
P E S A + L DP +RL E+ +H +F
Sbjct: 246 EPLESKFPNISSPALSFLKGCLQMDPTERLSC---EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 67/305 (21%)
Query: 469 KGALSEHDDFPQVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRENLYL 526
K L++ L++ +IR+ ++I+ ++L V ++Y+
Sbjct: 37 KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL---NSVYI 93
Query: 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHD 585
V EY+ DL ++L G L E+ AR+++ +++ L+Y+HS V+HRDLKP N+ I D
Sbjct: 94 VQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED 151
Query: 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPD 645
+K+ DFGL+++ +P + + E + T
Sbjct: 152 LVLKIGDFGLARI----------------------VDPHYSHKGYLSE------GLVTKW 183
Query: 646 YLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAEHP----QQIFDNI-------- 692
Y +P +LL + T A D W+ G I E++ G P F H Q I +++
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 693 --LNRKIPW--------PRVP-----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
L IP PR P ++PEA D +++ LT +P RL A E H
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL---TAEEALMH 300
Query: 738 VFFKD 742
+
Sbjct: 301 PYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-18
Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 39/199 (19%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV-ARVY 554
I+ E +L +P++V F+ +F + + ME+++GG L +L+ + E++ +V
Sbjct: 50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS 109
Query: 555 IAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
IA V+ L YL +++HRD+KP N+L+ G IKL DFG+S LI+S +
Sbjct: 110 IA-VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMAN------- 160
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
S VGT Y++PE L GT + +D WS+G+ L EL
Sbjct: 161 -------------------------SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 674 IVG---IPPFNAEHPQQIF 689
+G IPP +A+ + IF
Sbjct: 196 AIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 69/275 (25%), Positives = 110/275 (40%), Gaps = 64/275 (23%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARV 553
S L E +L +++ +VR + + L LV EY + DL + G +D ++ +
Sbjct: 45 SALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKS 103
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
++ +++ L + HS V+HRDLKP NLLI +G +KL DFGL++ I P
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PV-- 153
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFE 672
R + V T Y P++L G + T+ D WS G I E
Sbjct: 154 ---------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 192
Query: 673 L----------------------IVGIP-----PFNAEHPQQIFDNILNRKIPWPRVPEE 705
L ++G P P ++ P + V +
Sbjct: 193 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK 252
Query: 706 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
++ DL+ L +P QR+ A E QH +F
Sbjct: 253 LNSTGRDLLQNLLVCNPVQRI---SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 70/253 (27%), Positives = 106/253 (41%), Gaps = 69/253 (27%)
Query: 521 RENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
++ L LV EYL+ DL + + G L R+++ +++ L Y H RV+HRDLKP N
Sbjct: 75 KKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
LLI+ G +KL DFGL++ + P T S +
Sbjct: 134 LLISERGELKLADFGLARAKSV---------------------PSKTYS----------N 162
Query: 640 AVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA-----EHPQQIFDNIL 693
V T Y P++LLG T + T+ D W VG I +E+ G P F + +IF +L
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF-RVL 221
Query: 694 NRKIP--WPRVPE------------------------EMSPEAHDLIDRFLTEDPHQRLG 727
WP V + P +L +FL +P +R+
Sbjct: 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI- 280
Query: 728 SGGASEVKQHVFF 740
A+E +H +F
Sbjct: 281 --SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 79/299 (26%), Positives = 123/299 (41%), Gaps = 75/299 (25%)
Query: 482 LKKA--DMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN-----LYLVMEYLNG 533
LKK +M + + L E +L + + ++VR E LYLV EYL+
Sbjct: 31 LKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS 90
Query: 534 GDLYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GH 587
DL + + G L + ++ +++ + + H V+HRDLKP NLL+ G
Sbjct: 91 -DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149
Query: 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL 647
+K+ D GL + S P S T H+ + T Y
Sbjct: 150 LKIADLGLGRA--------FSIPVKSYT--------------HE---------IVTLWYR 178
Query: 648 APEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--NAEHPQ-------------QIFDN 691
APE+LLG+ H +T D WSVG I E+ P F ++E Q Q++
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 692 ILNRK----IP-WP-----RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ + P W R ++SPE DL+ + L DP +R+ + A H +F
Sbjct: 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL---THPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 525 YLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
Y+V Y++ DL LL N L E + Y+ +++ + YLH ++HRD+K N+LI
Sbjct: 91 YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID 149
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
+ G +K+ DFGL++ + G RK + V T
Sbjct: 150 NQGILKIADFGLARPYDGPPPNPKGGGGGG--------------------TRKYTNLVVT 189
Query: 644 PDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF----NAEHPQQIFD-------- 690
Y PE+LLG TTA D W +G + E+ P + + IF
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE 249
Query: 691 -----------NILNRKIPWPRVPEE----MSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735
++ +PR EE + PE DL+ + L+ DP++RL AS+
Sbjct: 250 TWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL---TASDAL 306
Query: 736 QHVFF 740
+H +F
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 68/242 (28%), Positives = 99/242 (40%), Gaps = 47/242 (19%)
Query: 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
LVM+ + DL ++ L E + + +++ L LH +HRDL P N+ I
Sbjct: 97 LVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK 155
Query: 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPD 645
G K+ DFGL++ P S T L+ E Q R + S V T
Sbjct: 156 GICKIADFGLAR--------RYGYPPYSDT---------LSKDETMQRREEMTSKVVTLW 198
Query: 646 YLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-RKIP----W 699
Y APE+L+G + D WSVG I EL+ G P F E+ I P W
Sbjct: 199 YRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNW 258
Query: 700 PRVPE-----EMSP---------------EAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
P+ + E +P +A DL+ L +P +R+ A E +H +
Sbjct: 259 PQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI---SAKEALKHEY 315
Query: 740 FK 741
FK
Sbjct: 316 FK 317
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 65/246 (26%)
Query: 523 NLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
L LV E ++ +LY L++ L E + Y+ +++ +L+++H + HRD+KP+N+L
Sbjct: 74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL 132
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
I D +KL DFG + I S P T +
Sbjct: 133 I-KDDILKLADFGSCRG--IYSK------------------PPYTEY------------I 159
Query: 642 GTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFD------ 690
T Y APE LL G +G D W+VG + FE++ P F + +I D
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 691 -NILNRKIPW--------PRVPEE-------MSPEAHDLIDRFLTEDPHQRLGSGGASEV 734
+L + + S E DL+ + L DP +R+ A +
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI---TAKQA 276
Query: 735 KQHVFF 740
+H +F
Sbjct: 277 LRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 77/301 (25%), Positives = 113/301 (37%), Gaps = 74/301 (24%)
Query: 482 LKKADMIRKNAVESILAERDILI--SVRNPFVVRFF---------YSFTCRENLYLVMEY 530
LKK M + I A R+I I +++ VV Y+ + + YLV E+
Sbjct: 42 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN-RYKGSFYLVFEF 100
Query: 531 LNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIK 589
DL LL N + + ++ L Y+H +++HRD+K N+LI DG +K
Sbjct: 101 CEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK 159
Query: 590 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 649
L DFGL++ ++ + + V T Y P
Sbjct: 160 LADFGLARAFSLSKNSK---------------------------PNRYTNRVVTLWYRPP 192
Query: 650 EILLGTGH-GTTADWWSVGIILFELIVGIPPF--NAEHPQQIFDNILNRKIP---WP--- 700
E+LLG G D W G I+ E+ P N E Q + L I WP
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252
Query: 701 ----------------RVPEEMSP-----EAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
+V E + P A DLID+ L DP +R+ + A H F
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN---HDF 309
Query: 740 F 740
F
Sbjct: 310 F 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 79/275 (28%), Positives = 125/275 (45%), Gaps = 65/275 (23%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED--VARVYIA 556
E +L +++ +VR + LYLV EYL+ DL + + ++ + + Y+
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 557 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+++ + Y HS RV+HRDLKP NLLI + +KL DFGL++ I P + T
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--------PVRTFT 161
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELI 674
H+ V T Y APEILLG+ H T D WSVG I E++
Sbjct: 162 --------------HE---------VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
Query: 675 VGIP--PFNAEHPQ--QIF--------------DNILNRKIPWPRVPEE--------MSP 708
P P ++E + +IF ++ + K +P+ P + + P
Sbjct: 199 NQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEP 258
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
DL+ + L DP +R+ + A E H +FKD+
Sbjct: 259 AGVDLLSKMLRLDPSKRITARAALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 69/234 (29%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 521 RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
+ YLV EY++ DL LL + L ED + ++ +++ L Y H +HRD+K N
Sbjct: 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSN 146
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
+L+ + G IKL DFGL+++ + +E R +
Sbjct: 147 ILLNNKGQIKLADFGLARL------------------------------YNSEESRPYTN 176
Query: 640 AVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNA--EHPQ-QIFDNILNR 695
V T Y PE+LLG +G D WS G IL EL P F A E Q ++ +
Sbjct: 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236
Query: 696 KIP--WP-------------------RVPEEMS---PEAHDLIDRFLTEDPHQR 725
P WP R+ EE S A DL+D LT DP +R
Sbjct: 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 74/241 (30%), Positives = 111/241 (46%), Gaps = 47/241 (19%)
Query: 496 ILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARV 553
IL + D+ L S P++V+ + F ++++ ME L L LL+ + G + ED+
Sbjct: 60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGK 118
Query: 554 YIAEVVLALEYL---HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG-LINSTDDLSG 609
+V AL YL H V+HRD+KP N+L+ G++KL DFG+S G L++S
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDS------ 168
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGT---TADWWS 665
+ K RSA G Y+APE I + AD WS
Sbjct: 169 ------------------------KAKTRSA-GCAAYMAPERIDPPDPNPKYDIRADVWS 203
Query: 666 VGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 724
+GI L EL G P+ N + ++ IL + P E SP+ +D LT+D +
Sbjct: 204 LGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRK 263
Query: 725 R 725
R
Sbjct: 264 R 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 75/272 (27%), Positives = 116/272 (42%), Gaps = 65/272 (23%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDVARVYI 555
E +L +++P +V LYL+ E+L+ DL L +L +D ++ + Y+
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL 107
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+++ + + HS RV+HRDLKP NLLI + G IKL DFGL++ G V
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA---------FGIPVRVY 158
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELI 674
T H+ V T Y APE+LLG + T D WS+G I E+
Sbjct: 159 T-------------HE---------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196
Query: 675 VGIPPFNAEHP-QQIFDNILNRKIP----WPRV---PE------------------EMSP 708
P F+ + Q+F P WP V P+ +
Sbjct: 197 TKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDE 256
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
+ DL+++ L DP +R+ A + H +F
Sbjct: 257 DGLDLLEKMLIYDPAKRI---SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 65/251 (25%)
Query: 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
+E L V EY++ ++++ G L R+++ +++ L Y+H ++HRDLKP NL
Sbjct: 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
LI++ G +KL DFGL++ I P T S S
Sbjct: 135 LISYLGELKLADFGLARAKSI---------------------PSQTYS----------SE 163
Query: 641 VGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF--NAEHPQQIFDNILNRKI 697
V T Y P++LLG T + + D W G I E++ G P F ++ +Q+ +
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223
Query: 698 P----WPRV-------PE-----------------EMSPEAHDLIDRFLTEDPHQRLGSG 729
P WP V PE P+A DL + L P R+
Sbjct: 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI--- 280
Query: 730 GASEVKQHVFF 740
A + H +F
Sbjct: 281 SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 67/269 (24%), Positives = 121/269 (44%), Gaps = 62/269 (23%)
Query: 487 MIRKNAVES----ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR- 541
M+++NA S +L+E ++L V +P V++ + + + L L++EY G L S LR
Sbjct: 37 MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRE 96
Query: 542 ---------------NLGCLDEDVARVYIAEVVLA--------LEYLHSLRVVHRDLKPD 578
N LD R +++ ++YL +++VHRDL
Sbjct: 97 SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
N+L+A +K++DFGLS+ ++++ KR
Sbjct: 157 NVLVAEGRKMKISDFGLSR------------------------------DVYEEDSYVKR 186
Query: 639 SAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRK 696
S P ++A E L + T +D WS G++L+E++ +G P+ P+++F N+L
Sbjct: 187 SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLKTG 245
Query: 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
R PE S E ++L+ ++P +R
Sbjct: 246 YRMER-PENCSEEMYNLMLTCWKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 67/220 (30%), Positives = 94/220 (42%), Gaps = 61/220 (27%)
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
L + + + + + L++LH+ +VHRDLKP+N+L+ G +KL DFGL++ I S
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQ 161
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
P V TL Y APE+LL + + T D WS
Sbjct: 162 MALTPVV--VTLW---------------------------YRAPEVLLQSTYATPVDMWS 192
Query: 666 VGIILFELIVGIPPF--NAEHPQ--QIFDNI-LNRKIPWPR------------------- 701
VG I E+ P F N+E Q +IFD I L + WPR
Sbjct: 193 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQS 252
Query: 702 -VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
VP E+ L+ LT +PH+R+ A QH FF
Sbjct: 253 VVP-EIEESGAQLLLEMLTFNPHKRI---SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 73/287 (25%), Positives = 107/287 (37%), Gaps = 56/287 (19%)
Query: 482 LKKADMIRKNAVES---ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG--GDL 536
+KK K + E I+ E L +R+P + + + +LVMEY G D+
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDI 104
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
+ + L E + L YLHS +HRD+K N+L+ G +KL DFG
Sbjct: 105 LEVHKK--PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-- 160
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
+ L PA S VGTP ++APE++L
Sbjct: 161 -------SASLVSPA--------------------------NSFVGTPYWMAPEVILAMD 187
Query: 657 HGT---TADWWSVGIILFELIVGIPP-FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
G D WS+GI EL PP FN ++ N + S +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLSSNDWSDYFRN 245
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFK-----DINWDTLARQKAA 754
+D L + P R S E+ +H F + D + R K A
Sbjct: 246 FVDSCLQKIPQDRPSS---EELLKHRFVLRERPPTVIIDLIQRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 74/280 (26%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
E +L +++ V+ FT +L YLVM ++ G DL L+++ L ED +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQ 121
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ +++ L+Y+H+ ++HRDLKP NL + D +K+ DFGL++ + +++G V
Sbjct: 122 FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV 177
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT-TADWWSVGIILF 671
T Y APE++L H T T D WSVG I+
Sbjct: 178 ------------------------------TRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207
Query: 672 ELIVGIPPFNA-EH-------------PQQIF------DNILNRKIPWPRVPEE------ 705
E++ G P F +H P + F ++ N PR ++
Sbjct: 208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 706 --MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+P A +++++ L D R+ A+E H +F++
Sbjct: 268 PNANPLAVNVLEKMLVLDAESRI---TAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 69/262 (26%), Positives = 106/262 (40%), Gaps = 66/262 (25%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 554
I E +IL V +P VV+ F + +++E+++GG L DVAR
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-- 175
Query: 555 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
+++ + YLH +VHRD+KP NLLI ++K+ DFG+S++ + T D P
Sbjct: 176 --QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMD---PC--- 225
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSVGII 669
S+VGT Y++PE + G G D WS+G+
Sbjct: 226 -----------------------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 670 LFELIVGIPPFNAEHPQQIFDNILNRKIPW------------PRVPEEMSPEAHDLIDRF 717
+ E +G PF + R+ W P P S E I
Sbjct: 263 ILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASREFRHFISCC 311
Query: 718 LTEDPHQRLGSGGASEVKQHVF 739
L +P +R A ++ QH F
Sbjct: 312 LQREPAKRW---SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 45/214 (21%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
+ L+LVME+ G + L++N L ED E++ L +LH+ +V+HRD+K N
Sbjct: 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQN 151
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR--KK 637
+L+ + +KL DFG+S Q +R ++
Sbjct: 152 VLLTENAEVKLVDFGVSA---------------------------------QLDRTVGRR 178
Query: 638 RSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692
+ +GTP ++APE++ + +D WS+GI E+ G PP HP +
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--F 236
Query: 693 LNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQR 725
L + P P++ ++ S + D I+ L ++ R
Sbjct: 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 57/276 (20%)
Query: 482 LKKADMIRKNAVESILAERDILISVR------NPFVVRFFYSFTCRENLYLVMEYLNGGD 535
LKK IR++ E+ L ++ L + +P +V + + + +Y M Y+ G
Sbjct: 32 LKK---IREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 536 LYSLLRNL---GCLDEDVA---------RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
L SLL+++ L +++A ++ ++ +EY+HS V+HRDLKPDN+L+
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFH-KICATIEYVHSKGVLHRDLKPDNILLG 147
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
G + + D+G + ++ L D + + VGT
Sbjct: 148 LFGEVVILDWGAAI--FKKLEEED----------LLDIDVDERNICYS-SMTIPGKIVGT 194
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRV- 702
PDY+APE LLG + D +++G+IL++++ P+ + RKI + V
Sbjct: 195 PDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK---------GRKISYRDVI 245
Query: 703 --PEEMSPEAHDLIDRFLTE--------DPHQRLGS 728
P E++P + I FL++ DP +R S
Sbjct: 246 LSPIEVAP--YREIPPFLSQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 41/212 (19%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
+ L+LVME+ G + L++N L E+ E++ L +LH +V+HRD+K N
Sbjct: 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
+L+ + +KL DFG+S ++ + ++ +
Sbjct: 142 VLLTENAEVKLVDFGVS-------------------------------AQLDRTVGRRNT 170
Query: 640 AVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694
+GTP ++APE++ + +D WS+GI E+ G PP HP + L
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--FLI 228
Query: 695 RKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQR 725
+ P PR+ ++ S + I+ L ++ QR
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/159 (33%), Positives = 75/159 (47%), Gaps = 34/159 (21%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 582
L LV EYL+ DL L N G L ++++ +++ L Y H +++HRDLKP NLLI
Sbjct: 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136
Query: 583 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642
G +KL DFGL++ + P T S + V
Sbjct: 137 NEKGELKLADFGLARAKSV---------------------PTKTYS----------NEVV 165
Query: 643 TPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 680
T Y P++LLG T + T D W VG IL+E+ G P F
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 47/212 (22%)
Query: 503 LISVRNPFVVRFF----YSFTCREN-LYLVMEYLNGGDLYSLLRNL---GCLDEDVARVY 554
L + +P VVR F S T RE L LV E+++ DL + L + G E + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM- 115
Query: 555 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
+ +++ L++LHS RVVHRDLKP N+L+ G IKL DFGL+++ S
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------YSF 162
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
L S V T Y APE+LL + + T D WSVG I E+
Sbjct: 163 QMALT-------------------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
Query: 675 VGIPPF--NAEHPQ--QIFDNI-LNRKIPWPR 701
P F +++ Q +I D I L + WPR
Sbjct: 204 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-14
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 32/187 (17%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVY 554
+ + E +L +++ +V +E L LV EY++ + ++ G L + +++
Sbjct: 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLF 108
Query: 555 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
+ +++ L Y+H ++HRDLKP NLLI+ G +KL DFGL++ +
Sbjct: 109 LFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV------------- 155
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFEL 673
P T S + V T Y P++LLG T + T D W VG I E+
Sbjct: 156 --------PSHTYS----------NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
Query: 674 IVGIPPF 680
I G+ F
Sbjct: 198 IQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/162 (33%), Positives = 77/162 (47%), Gaps = 34/162 (20%)
Query: 521 RENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
++L LV EYL+ DL L + G ++ ++++ +++ L Y H +V+HRDLKP N
Sbjct: 76 EKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
LLI G +KL DFGL++ I P T S +
Sbjct: 135 LLINERGELKLADFGLARAKSI---------------------PTKTYS----------N 163
Query: 640 AVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 680
V T Y P+ILLG T + T D W VG I +E+ G P F
Sbjct: 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 61/278 (21%)
Query: 488 IRKNAVES----ILAERDILISVRN-PFVVRFFYSFTCRE-NLYLVMEYLNGG--DLYSL 539
IR E +L + D+++ + P++V+F Y RE + ++ ME ++ Y
Sbjct: 37 IRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF-YGALFREGDCWICMELMDISLDKFYKY 95
Query: 540 LRNL--GCLDEDV-ARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
+ + + E++ ++ +A V AL YL L+++HRD+KP N+L+ +G+IKL DFG+
Sbjct: 96 VYEVLKSVIPEEILGKIAVA-TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154
Query: 596 SKVG-LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL- 653
S G L++S K R A G Y+APE +
Sbjct: 155 S--GQLVDSI------------------------------AKTRDA-GCRPYMAPERIDP 181
Query: 654 --GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-RKIPWPRVP----EEM 706
G+ +D WS+GI L+E+ G P+ + +FD + K P + E
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEEREF 239
Query: 707 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
SP + I+ L +D +R E+ +H F KD
Sbjct: 240 SPSFVNFINLCLIKDESKRPKYK---ELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 72/249 (28%)
Query: 523 NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
++YLV +L G DL ++++ C L +D + I +++ L+Y+HS ++HRDLKP NL
Sbjct: 96 DVYLVT-HLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 151
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
+ D +K+ DFGL++ ++ D+++G
Sbjct: 152 AVNEDCELKILDFGLAR----HTDDEMTG------------------------------Y 177
Query: 641 VGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF-NAEHPQQIF--------- 689
V T Y APEI+L H T D WSVG I+ EL+ G F +H Q+
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 690 DNILNRKIP----------WPRVPEE--------MSPEAHDLIDRFLTEDPHQRLGSGGA 731
L +KI ++P+ +P A DL+++ L D +R+ A
Sbjct: 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TA 294
Query: 732 SEVKQHVFF 740
++ H +F
Sbjct: 295 AQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/181 (32%), Positives = 85/181 (46%), Gaps = 37/181 (20%)
Query: 499 ERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARV 553
E +IL S+++ +V+ Y C R NL LVMEYL G L L ++ LD +
Sbjct: 55 EIEILKSLQHDNIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
Y +++ +EYL S R VHRDL N+L+ + +K+ DFGL+KV
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV--------------- 157
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY-LAPEILLGTGHGTTADWWSVGIILFE 672
PQ +E K R +P + APE L + +D WS G++L+E
Sbjct: 158 --------LPQ------DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 673 L 673
L
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 69/248 (27%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
++ YLVM Y+ DL ++ + L ED + + +++ L+Y+HS ++HRDLKP NL
Sbjct: 93 QDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLA 149
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ ++ +++G V
Sbjct: 150 VNEDCELKILDFGLAR----HADAEMTGYVV----------------------------- 176
Query: 642 GTPDYLAPEILLGTGHGT-TADWWSVGIILFELIVGIPPFNAE--------------HPQ 686
T Y APE++L H T D WSVG I+ E++ G F + P
Sbjct: 177 -TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235
Query: 687 QIFDNILNRKI------PWPRVPEE--------MSPEAHDLIDRFLTEDPHQRLGSGGAS 732
F L K P+ P + SP+A DL+++ L D +RL A+
Sbjct: 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL---TAT 292
Query: 733 EVKQHVFF 740
E +H +F
Sbjct: 293 EALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 45/237 (18%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
L E IL +P +VR T ++ +Y+VME + GGD + LR G R+ +
Sbjct: 41 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVK 94
Query: 557 EVV-------LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
E++ +EYL S +HRDL N L+ +K++DFG+S+
Sbjct: 95 ELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR------------ 142
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
+EE + AS ++ + + APE L + + +D WS GI+
Sbjct: 143 ----------EEEDGVYASTGGMKQIPVK-------WTAPEALNYGRYSSESDVWSFGIL 185
Query: 670 LFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
L+E +G P+ QQ + I + + P PE + L++R DP QR
Sbjct: 186 LWEAFSLGAVPYANLSNQQTREAI-EQGVRLP-CPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 44/243 (18%)
Query: 499 ERDILISVRNPFVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYI 555
E +IL ++ + +V++ +L L+MEYL G L L+ + ++ ++
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+++ ++YL S R +HRDL N+L+ + +K++DFGL+KV D
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL---PEDK--------- 163
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675
++ + S + + APE L + + +D WS G+ L+EL
Sbjct: 164 -------------DYYYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
Query: 676 GIPPF-----------NAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDP 722
P Q I +L R+ P E +DL+ +P
Sbjct: 208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEP 267
Query: 723 HQR 725
R
Sbjct: 268 QDR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 56/216 (25%)
Query: 491 NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDE 548
A ++ LAE ++ ++R+P +V+ LY+V EY+ G L LR+ G +
Sbjct: 42 TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL 101
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V +EYL VHRDL N+L++ D K++DFGL+K
Sbjct: 102 AQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK----------- 150
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVG 667
+ Q+ K P + APE L T +D WS G
Sbjct: 151 ------------------EASQGQDSGK------LPVKWTAPEALREKKFSTKSDVWSFG 186
Query: 668 IILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP 703
I+L+E I F ++P+PR+P
Sbjct: 187 ILLWE----IYSFG--------------RVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 65/251 (25%), Positives = 106/251 (42%), Gaps = 64/251 (25%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
++L LV EYL+ DL + + G + ++++ +++ L Y H +V+HRDLKP NL
Sbjct: 77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
LI G +KL DFGL++ + P T S +
Sbjct: 136 LINERGELKLADFGLARAKSV---------------------PTKTYS----------NE 164
Query: 641 VGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF---NAEHPQQIFDNILN-- 694
V T Y P++LLG+ + T D W VG I FE+ G P F E + +L
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
Query: 695 RKIPWPRV---------------PE-------EMSPEAHDLIDRFLTEDPHQRLGSGGAS 732
+ WP + P+ + E +L+ +FL + +R+ A
Sbjct: 225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI---SAE 281
Query: 733 EVKQHVFFKDI 743
E +H +F+ +
Sbjct: 282 EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 72/302 (23%)
Query: 481 VLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+KK ++ + + L +++I+ S +++P ++ + SF LY+V + G
Sbjct: 29 AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88
Query: 539 LLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
LL+ L E + +V+ AL+Y+HS +HR +K ++L++ DG + L+
Sbjct: 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLR-Y 147
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK----KRSAVGTPDYLAPEIL 652
V +I +H + +R +S+V +L+PE+L
Sbjct: 148 SVSMI---------------------------KHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 653 LGTGHGTTA--DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP----RVPEEM 706
G D +SVGI EL G PF Q+ + +P P
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 707 ---------------------------SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
S H ++ L DP R AS++ H F
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR---PSASQLLNHSF 297
Query: 740 FK 741
FK
Sbjct: 298 FK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-13
Identities = 68/255 (26%), Positives = 109/255 (42%), Gaps = 72/255 (28%)
Query: 510 FVVRFFYSFTCREN-----LYLVMEYLNGG-----DLYSLLRNLGCLDEDVARVYIAEVV 559
F+ ++Y+ ++N L +VME++ Y+ RN L + ++Y ++
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKLYSYQLC 180
Query: 560 LALEYLHSLRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618
AL Y+HS + HRDLKP NLLI + H +KL DFG S LL
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG------------------SAKNLL 222
Query: 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGI 677
+ + S + + Y APE++LG T + T D WS+G I+ E+I+G
Sbjct: 223 AGQ--------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268
Query: 678 PPFNAEH--------------PQQIFDNILN---RKIPWPRV---------PEEMSPEAH 711
P F+ + P + +N I +P V P+ +A
Sbjct: 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAI 328
Query: 712 DLIDRFLTEDPHQRL 726
+ I +FL +P +RL
Sbjct: 329 NFISQFLKYEPLKRL 343
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 84/321 (26%), Positives = 131/321 (40%), Gaps = 79/321 (24%)
Query: 460 SQIDLLLAGKGALSE-HDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVV---RFF 515
S ID K A+ + +D F V +D R IL E +L +R+P +V
Sbjct: 18 SAIDTHTGEKVAIKKINDVFEHV---SDATR------ILREIKLLRLLRHPDIVEIKHIM 68
Query: 516 YSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 573
+ RE ++Y+V E L DL+ +++ L + + ++ +++ AL+Y+H+ V HR
Sbjct: 69 LPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127
Query: 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 633
DLKP N+L D +K+ DFGL++V + + A+ T
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWT------------------ 164
Query: 634 RRKKRSAVGTPDYLAPEILLGTGHG--TTA-DWWSVGIILFELIVGIPPF---NAEH--- 684
V T Y APE L G+ T A D WS+G I E++ G P F N H
Sbjct: 165 -----DYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218
Query: 685 ---------PQQIFDNILNRK-------------IPWPRVPEEMSPEAHDLIDRFLTEDP 722
+ + N K +P+ + P A L++R L DP
Sbjct: 219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP 278
Query: 723 HQRLGSGGASEVKQHVFFKDI 743
R A E +FK +
Sbjct: 279 KDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 46/215 (21%)
Query: 470 GALSEHDDFPQVLKKADMIRKNAVESI---------LAERDILISVRNPFVVRFFYSFTC 520
G + +F VL+ +K AV++I L E ++ + + +VR
Sbjct: 11 GEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL-GVIL 69
Query: 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRDLKPD 578
LY+VME ++ G+L + LR G V ++ + +V +EYL S ++VHRDL
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR 129
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
N+L++ DG K++DFGL++V G + L
Sbjct: 130 NILVSEDGVAKVSDFGLARV----------GSMGVDNSKL-------------------- 159
Query: 639 SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
+ APE L + +D WS G++L+E+
Sbjct: 160 ----PVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 82/253 (32%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
+YLV L G DL ++++ DE V + I +++ L+Y+HS ++HRDLKP N+ +
Sbjct: 95 VYLVTN-LMGADLNNIVKCQKLSDEHV-QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
D +++ DFGL++ + D+++G V T
Sbjct: 153 EDCELRILDFGLAR----QADDEMTG------------------------------YVAT 178
Query: 644 PDYLAPEILLGTGH-GTTADWWSVGIILFEL---------------------IVGIP--- 678
Y APEI+L H T D WSVG I+ EL +VG P
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238
Query: 679 ---PFNAEHPQQIFDNILNRKIPWPRVPEE--------MSPEAHDLIDRFLTEDPHQRLG 727
++EH ++ ++ P +P++ +P A DL+++ L D +R+
Sbjct: 239 VLKKISSEHARKYIQSL-------PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI- 290
Query: 728 SGGASEVKQHVFF 740
ASE H +F
Sbjct: 291 --SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 73/271 (26%), Positives = 114/271 (42%), Gaps = 49/271 (18%)
Query: 472 LSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531
L E D +K ++A + E ++L +++ +VRF+ T L +V EY+
Sbjct: 30 LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89
Query: 532 NGGDLYSLLRNLG----CLD--EDVA--------RVYIA-EVVLALEYLHSLRVVHRDLK 576
GDL LR+ G L EDVA + IA ++ + YL SL VHRDL
Sbjct: 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
N L+ +K+ DFG+S+ I STD V G T+L
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRD--IYSTDYYR---VGGRTMLPIR--------------- 189
Query: 637 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILN- 694
++ PE +L T +D WS G++L+E+ G P+ + + I
Sbjct: 190 ---------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240
Query: 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
R++ PR PE + ++ +P QR
Sbjct: 241 RELERPRT---CPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 47/159 (29%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGC------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 577
+YLVME ++ NL C LD + + +++ +++LHS ++HRDLKP
Sbjct: 96 VYLVMELMDA--------NL-CQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146
Query: 578 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKK 637
N+++ D +K+ DFGL++ T + P V
Sbjct: 147 SNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVV------------------------ 179
Query: 638 RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 676
T Y APE++LG G+ D WSVG I+ E+I G
Sbjct: 180 -----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 67/233 (28%), Positives = 96/233 (41%), Gaps = 63/233 (27%)
Query: 562 LEYLHSLRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617
+ YLHS V+HRDLKP N+L+ +G +K+ D GL++ L N+ P
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNA------PLKP---- 168
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVG 676
L D +P V T Y APE+LLG H T A D W++G I EL+
Sbjct: 169 LADLDP----------------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212
Query: 677 IP-------------PFNAEHPQQIFDNILNRKIP--WPRVPEEMSPEAHDLIDRFLTED 721
P PF + ++IF +L WP + ++M PE L+ F T+
Sbjct: 213 EPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDI-KKM-PEYDTLMKDFKTKT 269
Query: 722 -PHQRLGS-----GGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYF 768
P L + K + +D R T+E AL+ YF
Sbjct: 270 YPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR------ITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 36/195 (18%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+++Y+VME ++ +L +++ LD + + +++ +++LHS ++HRDLKP N++
Sbjct: 102 QDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 158
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ +GT+ + V
Sbjct: 159 VKSDCTLKILDFGLAR--------------TAGTSFMMTPY------------------V 186
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWP 700
T Y APE++LG G+ D WSVG I+ E+I G F +H Q I P P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 701 RVPEEMSPEAHDLID 715
+++ P ++
Sbjct: 247 EFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 58/249 (23%), Positives = 107/249 (42%), Gaps = 55/249 (22%)
Query: 479 PQVLKKADMIRKNAVESILAERDILI--SVRNPFVVRFFYSFTCR------ENLYLVMEY 530
+KK +N + A R++++ V + ++ FT + +++YLVME
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590
++ + L D + + +++ +++LHS ++HRDLKP N+++ D +K+
Sbjct: 108 MDANLCQVIHMEL---DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
DFGL++ T+ + P V T Y APE
Sbjct: 165 LDFGLARTA---CTNFMMTPYVV-----------------------------TRYYRAPE 192
Query: 651 ILLGTGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPE 709
++LG G+ D WSVG I+ EL+ G F +H Q W +V E++
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-----------WNKVIEQLGTP 241
Query: 710 AHDLIDRFL 718
+ + ++R
Sbjct: 242 SAEFMNRLQ 250
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 40/239 (16%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYLNGGDLYSLL-RNLGCLDEDVA 551
+ +L E +++ + NP++VR C E+ LVME G L L +N ++++
Sbjct: 41 DELLREANVMQQLDNPYIVRMIG--ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT 98
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+ + +V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 99 EL-VHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKA------------- 144
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
LG +E A H + K + APE + + +D WS G++++
Sbjct: 145 ------LGADENYYKAKTHGKWPVK---------WYAPECMNYYKFSSKSDVWSFGVLMW 189
Query: 672 ELI-VGIPPFNAEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLG 727
E G P+ ++ I + + R+ P+ PE +DL+ T +R G
Sbjct: 190 EAFSYGQKPYKGMKGNEVTQMIESGE----RMECPQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 42/248 (16%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
LK+ M + E+ LAE +++ +++P +VR Y+ +E +Y++ EY+ G L L+
Sbjct: 38 LKQGSM----SPEAFLAEANLMKQLQHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLK 92
Query: 542 NLGCLDEDVARV--YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+ + ++ A++ + ++ +HRDL+ N+L++ K+ DFGL++
Sbjct: 93 TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR-- 150
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHG 658
LI E+ + TA E + K + APE I GT
Sbjct: 151 LI-------------------EDNEYTAREGAKFPIK---------WTAPEAINYGT-FT 181
Query: 659 TTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
+D WS GI+L E++ G P+ ++ N L R PR P+ E ++L+
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPR-PDNCPEELYELMRLC 239
Query: 718 LTEDPHQR 725
E P +R
Sbjct: 240 WKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 43/234 (18%)
Query: 506 VRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 564
+ +P +V S L+ V EY+ G L +L G L + +V+ AL
Sbjct: 35 LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALAC 94
Query: 565 LHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 621
H+ +VHRDLKP N++++ G H K+ DFG+ + G D
Sbjct: 95 AHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-------------PGV---RDA 138
Query: 622 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681
+ + +GTP Y APE L G +D ++ G+I E + G
Sbjct: 139 DVATLTRTTE--------VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190
Query: 682 AEHPQQIFDNILNRKIPWPRVPEEMS-P---EAH---DLIDRFLTEDPHQRLGS 728
+I L+ P ++S P H ++ + L +DP QR S
Sbjct: 191 GASVAEILYQQLS--------PVDVSLPPWIAGHPLGQVLRKALNKDPRQRAAS 236
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-11
Identities = 65/247 (26%), Positives = 118/247 (47%), Gaps = 36/247 (14%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN----LGCLDED 549
++ E +++ +++ +VR+ F + N LY++ME+ + GDL ++ G ++E
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118
Query: 550 VARVYIAEVVLALEYLHSL-------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
+++ AL Y H+L RV+HRDLKP N+ ++ G+ +G I
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST---------GIRHIGKIT 169
Query: 603 S-TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGT 659
+ ++L+G ++ +GD S++ S VGTP Y +PE+LL +
Sbjct: 170 AQANNLNGRPIAK---IGD----FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFL 718
+D W++G I++EL G PF H F +++ P +P + S E + LI L
Sbjct: 223 KSDMWALGCIIYELCSGKTPF---HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLL 279
Query: 719 TEDPHQR 725
+R
Sbjct: 280 NLSAKER 286
|
Length = 1021 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 49/245 (20%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL------RNLGCLDEDVAR 552
E ++ + +P +V T + + ++ EYLN GDL+ L ++GC ++
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 553 V----------YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
V +IA ++ +EYL S VH+DL N+LI H+K++D GLS+ I
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--I 174
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
S D V +LL ++ PE ++ + +
Sbjct: 175 YSADYYR---VQPKSLLPIR------------------------WMPPEAIMYGKFSSDS 207
Query: 662 DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D WS G++L+E+ G+ P+ Q++ + + R++ P E+ P + L+ E
Sbjct: 208 DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-LP-CSEDCPPRMYSLMTECWQE 265
Query: 721 DPHQR 725
P +R
Sbjct: 266 GPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 42/199 (21%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYLNGGDLYS 538
+VLK + K+ + ++ E +I+ + NP++VR C E L LVME +GG L
Sbjct: 28 KVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIG--VCEAEALMLVMEMASGGPLNK 83
Query: 539 LLRNLGCLDEDVARVYIAE----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594
L +++ + E V + ++YL VHRDL N+L+ + + K++DFG
Sbjct: 84 FL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILL 653
LSK LG ++ A RSA P + APE +
Sbjct: 141 LSKA-------------------LGADDSYYKA----------RSAGKWPLKWYAPECIN 171
Query: 654 GTGHGTTADWWSVGIILFE 672
+ +D WS GI ++E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 58/277 (20%)
Query: 472 LSEHDDFPQVLKKA--DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529
L +D V K + +A + E ++L + ++ +V+F+ T + +V E
Sbjct: 29 LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88
Query: 530 YLNGGDLYSLLRN-------LGCLDEDVAR------VYIA-EVVLALEYLHSLRVVHRDL 575
Y+ GDL LR+ L D + + IA ++ + YL S VHRDL
Sbjct: 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDL 148
Query: 576 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635
N L+ +D +K+ DFG+S+ + +TD V G T+L
Sbjct: 149 ATRNCLVGYDLVVKIGDFGMSRD--VYTTDYYR---VGGHTML----------------- 186
Query: 636 KKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF----NAEHPQQIF 689
P ++ PE ++ T +D WS G++L+E+ G P+ N E + I
Sbjct: 187 --------PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238
Query: 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 726
L ++ P E +D++ DP QR+
Sbjct: 239 QGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 46/253 (18%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ LK+ + + L E ++ + +P +VR E L LVME G L
Sbjct: 29 KTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLLKY 85
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L+ + + +V + + YL S VHRDL N+L+ + K++DFG+S+
Sbjct: 86 LKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRA- 144
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHG 658
LG S++ + R + + APE I G
Sbjct: 145 ------------------LG------AGSDYYRATTAGRWPL---KWYAPECINYGK-FS 176
Query: 659 TTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNI-----LNRKIPWPRVPEEMSPEAHD 712
+ +D WS G+ L+E G P+ ++ + L R PEE E +
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-------PEECPQEIYS 229
Query: 713 LIDRFLTEDPHQR 725
++ P R
Sbjct: 230 IMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 59/246 (23%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDVARV 553
+ L E +L +V +P V+R + +V+ + + DLY+ L + L D A +
Sbjct: 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALI 161
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
+++ L YLH+ R++HRD+K +N+ I + + D G ++ + + L G A
Sbjct: 162 IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP-VVAPAFL-GLA-- 217
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
GT + APE+L + + AD WS GI+LFE+
Sbjct: 218 ----------------------------GTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
Query: 674 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT----------EDPH 723
+ +P IF++ P PEE H + + ++ DP
Sbjct: 250 LA--------YPSTIFEDP-------PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294
Query: 724 QRLGSG 729
RL G
Sbjct: 295 SRLVRG 300
|
Length = 357 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 59/227 (25%)
Query: 488 IRKNAV-ESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG 544
I+ +A ++ LAE ++ +R+ +V+ E LY+V EY+ G L LR+ G
Sbjct: 37 IKNDATAQAFLAEASVMTQLRHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 95
Query: 545 --CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
L D + +V A+EYL + VHRDL N+L++ D K++DFGL+K +
Sbjct: 96 RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--AS 153
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
ST D V T APE L T +D
Sbjct: 154 STQDTGKLPVKWT--------------------------------APEALREKKFSTKSD 181
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP-EEMSP 708
WS GI+L+E I F ++P+PR+P +++ P
Sbjct: 182 VWSFGILLWE----IYSFG--------------RVPYPRIPLKDVVP 210
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 35/153 (22%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+++YLVME ++ +L +++ LD + + +++ +++LHS ++HRDLKP N++
Sbjct: 95 QDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ +GT+ + V
Sbjct: 152 VKSDCTLKILDFGLAR--------------TAGTSFM------------------MTPYV 179
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
T Y APE++LG G+ D WSVG I+ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 51/255 (20%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ LK M + E+ L E I+ +R+ +V+ + + E +Y+V EY++ G L
Sbjct: 36 KTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91
Query: 540 LRN-------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI-KLT 591
L++ L L D+A A++ + YL S +HRDL N+L+ + + K+
Sbjct: 92 LKSGEGKKLRLPQL-VDMA----AQIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIA 145
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
DFGL++ L+ D+E TA E + K + APE
Sbjct: 146 DFGLAR-------------------LIEDDE--YTAREGAKFPIK---------WTAPEA 175
Query: 652 LLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEA 710
+D WS GI+L E++ G P+ +++ + + R PR P E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPR-PPNCPEEL 233
Query: 711 HDLIDRFLTEDPHQR 725
+DL+ + +DP +R
Sbjct: 234 YDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 44/239 (18%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-----RNLGCLD- 547
ES L E I+ +R+ +V+ Y+ E +Y+V EY++ G L L R L +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
D+A A+V + Y+ + +HRDL+ N+L+ K+ DFGL++ LI
Sbjct: 105 VDMA----AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LI------ 152
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667
E+ + TA ++ A + APE L +D WS G
Sbjct: 153 -------------EDNEYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 668 IILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
I+L EL+ G P+ + +++ + + R P P++ H+L+ + +DP +R
Sbjct: 191 ILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMP-CPQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 47/213 (22%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 487 MIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 544
MI++ ++ + + E +++ + + +V+ + T + +Y+V EY++ G L + LR G
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG 94
Query: 545 CLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+ + + +V + YL S + +HRDL N L+ G +K++DFGLS+
Sbjct: 95 KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY----- 149
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP---DYLAPEILLGTGHGTT 660
+L DE S+VG+ + PE+LL + +
Sbjct: 150 -------------VLDDE---------------YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 661 ADWWSVGIILFELI-VGIPPFNAEHPQQIFDNI 692
+D W+ G++++E+ +G P+ + + + +
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 7e-11
Identities = 63/249 (25%), Positives = 98/249 (39%), Gaps = 42/249 (16%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
+ I+ E L +++P + + + +LVMEY G L + L E
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 129
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
+ L YLHS ++HRD+K N+L+ G +KL DFG + ++ PA
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG---------SASIASPA-- 178
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIIL 670
S VGTP ++APE++L G D WS+GI
Sbjct: 179 ------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214
Query: 671 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 730
EL PP + +I + P + E S + +D L + P R S
Sbjct: 215 IELAERKPPLFNMNAMSALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQDRPTS-- 271
Query: 731 ASEVKQHVF 739
E+ +H+F
Sbjct: 272 -EELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 58/238 (24%), Positives = 89/238 (37%), Gaps = 33/238 (13%)
Query: 491 NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN--LGCLDE 548
+ ++ L E I+ S+ + ++R Y L +V E G L LR LG
Sbjct: 38 DIMDDFLKEAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLI 96
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
Y ++ + YL S R +HRDL N+L+A D +K+ DFGL +
Sbjct: 97 STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRA---------- 146
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668
L E EH K A + APE L +D W G+
Sbjct: 147 ---------LPQNEDHYVMEEH----LKVPFA-----WCAPESLRTRTFSHASDVWMFGV 188
Query: 669 ILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
L+E+ G P+ QI I R PE + ++++ + +P R
Sbjct: 189 TLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER-PEACPQDIYNVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 44/243 (18%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 555
L E ++ VVR + + +VME + GDL S LR+ + +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRP-EAENNPGLG 114
Query: 556 -----------AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
AE+ + YL + + VHRDL N ++A D +K+ DFG+++ I T
Sbjct: 115 PPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET 172
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
D RK + ++APE L T +D W
Sbjct: 173 D---------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVW 205
Query: 665 SVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 723
S G++L+E+ + P+ +++ +++ +PE + +L+ +P
Sbjct: 206 SFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH--LDLPENCPDKLLELMRMCWQYNPK 263
Query: 724 QRL 726
R
Sbjct: 264 MRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 51/198 (25%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDVA 551
+ I+ E L +++P + + + +LVMEY G DL + + + +
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK------KPLQ 119
Query: 552 RVYIAEV----VLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
V IA + + L YLHS ++HRD+K N+L+ G +KL DFG +
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK--------- 170
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWW 664
S PA S VGTP ++APE++L G D W
Sbjct: 171 SSPA--------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVW 204
Query: 665 SVGIILFELIVGIPP-FN 681
S+GI EL PP FN
Sbjct: 205 SLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 39/237 (16%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVAR 552
L E +IL +P +V+ ++ +Y+VME + GG L + LR L
Sbjct: 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL 96
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ +EYL S +HRDL N L+ + +K++DFG+S+
Sbjct: 97 QMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--------------- 141
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 671
+E T S+ ++ K + APE L G T+ D WS GI+L+
Sbjct: 142 ------EEEGGIYTVSDGLKQIPIK--------WTAPEA-LNYGRYTSESDVWSYGILLW 186
Query: 672 ELI-VGIPPFNAEHPQQIFDNI-LNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQR 725
E +G P+ QQ + I ++P P+ PEE+ + L+ + DP R
Sbjct: 187 ETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEI----YRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 58/294 (19%)
Query: 457 PRTSQIDLLLAGKG-----------ALSEHDDFPQVLKKADMIRK--NAVESILAERDIL 503
PR++ ++ G+G + E VL KA K N E D+
Sbjct: 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMF 62
Query: 504 ISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDV--------ARV 553
+ + VVR CRE Y+++EY + GDL LR DE + +V
Sbjct: 63 RKLSHKNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 554 YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ ++ L +++L + R VHRDL N L++ +K++ LSK
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--------------- 165
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
+ E K R+A+ +LAPE + T +D WS G++++E
Sbjct: 166 ---------------DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 673 LIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ G PF +++ + + K+ P VPE + L+ R +P R
Sbjct: 211 VFTQGELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 59/249 (23%), Positives = 109/249 (43%), Gaps = 39/249 (15%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ LK+ M VE L E ++ +++P +V+ T Y++ E++ G+L
Sbjct: 37 KTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 540 LRNLGCLDED-VARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
LR + + V +Y+A ++ A+EYL +HRDL N L+ + +K+ DFGLS+
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ + D + A G + P + APE L
Sbjct: 153 ---LMTGDTYTAHA-------GAKFP--------------------IKWTAPESLAYNKF 182
Query: 658 GTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+D W+ G++L+E+ G+ P+ Q+++ +L + R PE P+ ++L+
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMER-PEGCPPKVYELMRA 240
Query: 717 FLTEDPHQR 725
+P R
Sbjct: 241 CWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 39/182 (21%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYI 555
E IL ++ +P +++ +FT + L++ DLY L RN+ D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICD----ILAI 187
Query: 556 AEVVL-ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
VL A++YLH R++HRD+K +N+ I H G + L DFG + + + + G A
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA--- 244
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
GT APE+L +G D WS GI+LFE+
Sbjct: 245 ---------------------------GTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 675 VG 676
Sbjct: 278 TC 279
|
Length = 391 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 53/192 (27%), Positives = 78/192 (40%), Gaps = 39/192 (20%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
+ I+ E L +R+P +++ + +LVMEY G L + L E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
+ L YLHS ++HRD+K N+L++ G +KL DFG + + PA
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPA-- 168
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIIL 670
VGTP ++APE++L G D WS+GI
Sbjct: 169 ------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 671 FELIVGIPP-FN 681
EL PP FN
Sbjct: 205 IELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 48/217 (22%)
Query: 476 DDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535
+D PQ LK I+ L+E IL +P +V+ T R+ +Y+VME + GGD
Sbjct: 29 EDLPQELK----IK------FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78
Query: 536 LYSLLRNLGCLDEDVARVYIAEVVL----ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 591
S LR +++ + + L + YL S +HRDL N L+ + +K++
Sbjct: 79 FLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKIS 135
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
DFG+S+ E+ + +S ++ K + APE
Sbjct: 136 DFGMSR----------------------QEDDGIYSSSGLKQIPIK--------WTAPEA 165
Query: 652 LLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQ 687
L + + +D WS GI+L+E +G+ P+ QQ
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 41/237 (17%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLL-RNLGCLDEDVA 551
E L E I+ +P +V+ EN +++VME G+L S L N LD
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASL 109
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+Y ++ AL YL S R VHRD+ N+L++ +KL DFGLS+
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-------------- 155
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIIL 670
L DE K S P ++APE + + +D W G+ +
Sbjct: 156 -----YLEDES------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 198
Query: 671 FE-LIVGIPPFNAEHPQQIFDNILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+E L++G+ PF + I N ++P +P P + L+ + DP +R
Sbjct: 199 WEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 57/243 (23%), Positives = 109/243 (44%), Gaps = 36/243 (14%)
Query: 487 MIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NL 543
MIR+ A+ + + E +++ + +P +V+ + T + +++V EY+ G L + LR
Sbjct: 35 MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK 94
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
G L + ++V A+EYL S +HRDL N L+ D +K++DFGL++ L
Sbjct: 95 GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL--- 151
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 663
DD Q T+S+ + K + PE+ + + +D
Sbjct: 152 -DD-----------------QYTSSQGTKFPVK---------WAPPEVFDYSRFSSKSDV 184
Query: 664 WSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
WS G++++E+ G P+ ++ +++ R P+ E + ++ E P
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYR-PKLAPTEVYTIMYSCWHEKP 242
Query: 723 HQR 725
R
Sbjct: 243 EDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/254 (22%), Positives = 109/254 (42%), Gaps = 49/254 (19%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ LK M +V++ L E +++ ++++ +VR + T E +Y++ EY+ G L
Sbjct: 36 KTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 540 LRNLGCLDEDVARV-------YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 592
L++ ++ +V + A++ + Y+ +HRDL+ N+L++ K+ D
Sbjct: 92 LKS-----DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
FGL++V E+ + TA E + K + APE +
Sbjct: 147 FGLARV---------------------IEDNEYTAREGAKFPIK---------WTAPEAI 176
Query: 653 LGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAH 711
+D WS GI+L+E++ G P+ + + L R PR E E +
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYRMPR-MENCPDELY 234
Query: 712 DLIDRFLTEDPHQR 725
D++ E +R
Sbjct: 235 DIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 38/218 (17%)
Query: 480 QVLKKADMIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+V KA I + A+ E + E +++ + +P +V+ + T ++ LY+V E++ G L
Sbjct: 30 KVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87
Query: 538 SLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
+ LR G L +D+ +V +EYL +HRDL N L++ G +K++DFG++
Sbjct: 88 NYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGT 655
+ L DD + T+S S P + PE+ +
Sbjct: 148 RYVL----DD-----------------EYTSS----------SGAKFPVKWSPPEVFNFS 176
Query: 656 GHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692
+ + +D WS G++++E+ G PF + ++ + I
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/258 (22%), Positives = 112/258 (43%), Gaps = 52/258 (20%)
Query: 488 IRKNAVES----ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+RK A + L E ++ + +P +V+ E Y++ME + GGDL S LR+
Sbjct: 34 LRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA 93
Query: 544 GCLDEDVARVYIAEVV-LALE------YLHSLRVVHRDLKPDNLLIAHDGH-----IKLT 591
+ + E++ + L+ YL + +HRDL N L++ G+ +K+
Sbjct: 94 RVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
DFGL++ + S++ ++ + V ++APE
Sbjct: 154 DFGLAR--------------------------DIYKSDYYRKEGEGLLPV---RWMAPES 184
Query: 652 LLGTGHGTTADWWSVGIILFE-LIVGIPPFNAEHPQQIFDNILN--RKIPWPRVPEEMSP 708
LL T +D WS G++++E L +G P+ A + Q++ ++ R P+++
Sbjct: 185 LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKI-- 242
Query: 709 EAHDLIDRFLTEDPHQRL 726
+ L+ +DP +R
Sbjct: 243 --YQLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 49/196 (25%), Positives = 81/196 (41%), Gaps = 45/196 (22%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNL 543
N + + E +IL ++ + +V+ Y C E+ + L+ME+L G L L RN
Sbjct: 46 GGNHIADLKKEIEILRNLYHENIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK 103
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV----- 598
++ Y ++ ++YL S + VHRDL N+L+ + +K+ DFGL+K
Sbjct: 104 NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
DDL P + APE L+ +
Sbjct: 164 EYYTVKDDLDSPVF---------------------------------WYAPECLIQSKFY 190
Query: 659 TTADWWSVGIILFELI 674
+D WS G+ L+EL+
Sbjct: 191 IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 15/132 (11%)
Query: 481 VLKKADMIR----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536
VL M+R KNA L E I+ +++P ++R + L ++ EY+ GDL
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 537 YSLLRNL----GCLDEDVARV------YIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
L DV + ++A ++ ++YL SL VHRDL N L+ +
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166
Query: 586 GHIKLTDFGLSK 597
IK+ DFG+S+
Sbjct: 167 YTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 45/279 (16%)
Query: 474 EHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533
E D +K NA + E ++L ++++ +V+F+ + L +V EY+
Sbjct: 32 EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 91
Query: 534 GDLYSLLRNLGCLDEDVAR------------VYIAEVVLA-LEYLHSLRVVHRDLKPDNL 580
GDL LR G +A ++IA+ + A + YL S VHRDL N
Sbjct: 92 GDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
L+ + +K+ DFG+S+ + STD V G T+L
Sbjct: 152 LVGENLLVKIGDFGMSRD--VYSTDYYR---VGGHTMLPIR------------------- 187
Query: 641 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPW 699
++ PE ++ T +D WS+G++L+E+ G P+ ++ + I ++
Sbjct: 188 -----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-- 240
Query: 700 PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738
+ P E +DL+ +PH RL + Q++
Sbjct: 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 36/235 (15%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
E+ L E ++ +R+ +V+ Y+ E +Y+V EY++ G L L+ + ++
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 554 --YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
A++ + Y+ + VHRDL+ N+L+ + K+ DFGL++ LI
Sbjct: 105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LI---------- 152
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
E+ + TA ++ A + APE L +D WS GI+L
Sbjct: 153 ---------EDNEYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 672 ELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
EL G P+ +++ D + R P P E HDL+ + ++P +R
Sbjct: 195 ELTTKGRVPYPGMVNREVLDQV-ERGYRMP-CPPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 54/249 (21%), Positives = 103/249 (41%), Gaps = 39/249 (15%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
++LK D++++ + E L +R+ ++ F + E +Y++ E + G L +
Sbjct: 36 KILKSDDLLKQQDFQK---EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 540 LRNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
LR+ VA + +A +V + YL +HRDL N+L+ D K+ DFGL++
Sbjct: 93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ +E +S+ + + + APE
Sbjct: 153 L---------------------IKEDVYLSSDKKIPYK----------WTAPEAASHGTF 181
Query: 658 GTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
T +D WS GI+L+E+ G P+ + +++D I P P + E + ++
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-TAGYRMPC-PAKCPQEIYKIMLE 239
Query: 717 FLTEDPHQR 725
+P R
Sbjct: 240 CWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 52/247 (21%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDVAR-- 552
E ++L ++++ +V+F+ + L +V EY+ GDL LR G L + R
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 553 ---------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
++IA ++ + YL S VHRDL N L+ + +K+ DFG+S+ +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VY 174
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
STD V G T+L ++ PE ++ T +D
Sbjct: 175 STDYYR---VGGHTMLPIR------------------------WMPPESIMYRKFTTESD 207
Query: 663 WWSVGIILFELIV-GIPPFNAEHPQQIFDNILN-RKIPWPRV-PEEMSPEAHDLIDRFLT 719
WS G+IL+E+ G P+ ++ + I R + PRV P+E+ +D++
Sbjct: 208 VWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEV----YDIMLGCWQ 263
Query: 720 EDPHQRL 726
+P QRL
Sbjct: 264 REPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 50/238 (21%)
Query: 473 SEHDDFPQVLKKADMIR----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528
E D P VL M+R K A L E I+ ++NP ++R + L ++
Sbjct: 38 PEFDGQP-VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMIT 96
Query: 529 EYLNGGDLYSLL------------RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 576
EY+ GDL L N+ + ++ ++YL SL VHRDL
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
N L+ + IK+ DFG+S+ L + ++ R
Sbjct: 157 TRNCLVGNHYTIKIADFGMSR--------------------------NLYSGDYY---RI 187
Query: 637 KRSAVGTPDYLAPE-ILLGTGHGTTADWWSVGIILFELIVGIP--PFNAEHPQQIFDN 691
+ AV ++A E ILLG T +D W+ G+ L+E+ P++ +Q+ +N
Sbjct: 188 QGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 50/223 (22%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
KNA L E IL +++P ++R + L ++ EY+ GDL L + D++
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 550 V------------------ARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590
+ +++A ++ ++YL SL VHRDL N L+ + IK+
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
DFG+S+ L A ++ R + AV ++A E
Sbjct: 180 ADFGMSR--------------------------NLYAGDYY---RIQGRAVLPIRWMAWE 210
Query: 651 ILLGTGHGTTADWWSVGIILFELIV--GIPPFNAEHPQQIFDN 691
+L T +D W+ G+ L+E+++ P+ +Q+ +N
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 55/255 (21%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
LK M + LAE I+ +R+P +++ + T E +Y+V E + G L L+
Sbjct: 38 LKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ 93
Query: 542 NLGC----LDE--DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
L + D+A A+V + YL + +HRDL N+L+ + K+ DFGL
Sbjct: 94 GGAGRALKLPQLIDMA----AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGL 149
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
++V + ++ A E + K + APE L
Sbjct: 150 ARV-------------------IKEDI--YEAREGAKFPIK---------WTAPEAALYN 179
Query: 656 GHGTTADWWSVGIILFELIV-GIPPF----NAEHPQQIFDNILNRKIPWPRVPEEMSPEA 710
+D WS GI+L E++ G P+ NAE QQ+ ++P P E
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---RMP---CPPGCPKEL 233
Query: 711 HDLIDRFLTEDPHQR 725
+D++ EDP R
Sbjct: 234 YDIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 25/160 (15%)
Query: 547 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606
D +V + + +V+ L LH + +VHRD+KP+NLL+ DG +K+ DFG + D
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGA-------AVDM 359
Query: 607 LSGPAVSGTTLLGDEEPQLTASEH----QQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
+G ++ L G +P+ + E Q R A+ L+P L G D
Sbjct: 360 CTG--INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAA--LLSPFAWL-YGRPDLFD 414
Query: 663 WWSVGIILFELIV-------GIPPFNAEHPQQIFDNILNR 695
++ G++L ++ V I FN E Q +DN LNR
Sbjct: 415 SYTAGVLLMQMCVPELRPVANIRLFNTELRQ--YDNDLNR 452
|
Length = 507 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
E+ L E I+ +R+ +V Y+ E +Y+V E++ G L L+ + ++
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPL-YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL 104
Query: 554 --YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
A++ + Y+ + +HRDL+ N+L+ + K+ DFGL++ LI
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR--LI---------- 152
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
E+ + TA ++ A + APE L +D WS GI+L
Sbjct: 153 ---------EDNEYTA---------RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 194
Query: 672 ELIV-GIPPFNAEHPQQIFDNI-LNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQR 725
EL+ G P+ +++ + + ++P P+ PE + H+L+ +DP +R
Sbjct: 195 ELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL----HELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 37/187 (19%)
Query: 492 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----LGCLD 547
A + IL E ++ SV +P VVR + L+ + + G L +RN +G
Sbjct: 52 ANKEILDEAYVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
V IA+ + YL R+VHRDL N+L+ H+K+TDFGL+K
Sbjct: 111 LLNWCVQIAK---GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK---------- 157
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667
LL +E + A + + ++A E +L + +D WS G
Sbjct: 158 ---------LLDVDEKEYHAEGGKVPIK----------WMALESILHRIYTHKSDVWSYG 198
Query: 668 IILFELI 674
+ ++EL+
Sbjct: 199 VTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 45/229 (19%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ L++A + N + IL E ++ SV NP V R + L+ + + G L
Sbjct: 42 KELREATSPKAN--KEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDY 98
Query: 540 LRNLGCLDEDVARVYI----AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
+R +++ Y+ ++ + YL R+VHRDL N+L+ H+K+TDFGL
Sbjct: 99 VREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLG 654
+K LLG +E E+ E K P ++A E +L
Sbjct: 156 AK-------------------LLGADE-----KEYHAEGGK------VPIKWMALESILH 185
Query: 655 TGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR--KIPWP 700
+ +D WS G+ ++EL+ G P++ +I +IL + ++P P
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 33/189 (17%)
Query: 488 IRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLG 544
IR+ A+ E + E +++ + +P +V+ + T R + LV E++ G L LR G
Sbjct: 36 IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG 95
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
++ +V + YL S V+HRDL N L+ + +K++DFG+++ L
Sbjct: 96 KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL---- 151
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
DD Q T+S + K + +PE+ + + + +D W
Sbjct: 152 DD-----------------QYTSSTGTKFPVK---------WSSPEVFSFSKYSSKSDVW 185
Query: 665 SVGIILFEL 673
S G++++E+
Sbjct: 186 SFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 33/141 (23%)
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLI 601
L + + + +++ + YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LF 162
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
NS L D +P V T Y APE+LLG H T A
Sbjct: 163 NSP----------LKPLADLDP----------------VVVTFWYRAPELLLGARHYTKA 196
Query: 662 -DWWSVGIILFELIVGIPPFN 681
D W++G I EL+ P F+
Sbjct: 197 IDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 37/186 (19%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDE 548
E +IL ++ + +V+ Y C E L L+MEY+ G L L ++ L +
Sbjct: 51 SGWKKEINILKTLYHENIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ 108
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ ++ ++ + YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 109 LL--LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK----------- 155
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668
AV E+ + R S V + A E L +D WS G+
Sbjct: 156 --AVP------------EGHEYYRVREDGDSPVF---WYAVECLKENKFSYASDVWSFGV 198
Query: 669 ILFELI 674
L+EL+
Sbjct: 199 TLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/141 (30%), Positives = 65/141 (46%), Gaps = 33/141 (23%)
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLI 601
L + + + +++ + YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LF 162
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
NS L D +P V T Y APE+LLG H T A
Sbjct: 163 NSP----------LKPLADLDP----------------VVVTFWYRAPELLLGARHYTKA 196
Query: 662 -DWWSVGIILFELIVGIPPFN 681
D W++G I EL+ P F+
Sbjct: 197 IDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 46/216 (21%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRN-------LGCLDEDV 550
E +++ +++P +V T + ++ EYL GDL+ L+RN DE V
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 551 AR-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
++IA ++ +EYL S VHRDL N L+ +K++DFGLS+ I
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--DIY 175
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
S D R + ++ ++ PE +L T +D
Sbjct: 176 SAD---------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESD 208
Query: 663 WWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKI 697
WS G++L+E+ G+ P+ Q++ + I +R++
Sbjct: 209 IWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 56/263 (21%)
Query: 487 MIRKN----AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR- 541
++R+N A + IL E ++ V +P+V R + LV + + G L +R
Sbjct: 43 VLRENTSPKANKEILDEAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRE 101
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
N + + ++ + YL +R+VHRDL N+L+ H+K+TDFGL+++ I
Sbjct: 102 NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTT 660
+ T E+ + K P ++A E +L
Sbjct: 162 DET------------------------EYHADGGK------VPIKWMALESILHRRFTHQ 191
Query: 661 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI-LNRKIPWP---------------RVP 703
+D WS G+ ++EL+ G P++ ++I D + ++P P +
Sbjct: 192 SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMID 251
Query: 704 EEMSPEAHDLIDRF--LTEDPHQ 724
E P +L+D F + DP +
Sbjct: 252 SECRPRFRELVDEFSRMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 57/270 (21%), Positives = 100/270 (37%), Gaps = 73/270 (27%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-- 541
+AD R+ A ++AE D +P +V+ + + L+ EY+ GDL LR
Sbjct: 52 QADFQREAA---LMAEFD------HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR 102
Query: 542 ---NLGCLDEDVARVYI-----------------AEVVLALEYLHSLRVVHRDLKPDNLL 581
L + +V + YL + VHRDL N L
Sbjct: 103 SPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ + +K+ DFGLS+ I S D E +
Sbjct: 163 VGENMVVKIADFGLSRN--IYSADYYK----------ASENDAIPIR------------- 197
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPP-FNAEHPQQIF----DNILNR 695
++ PE + + T +D W+ G++L+E+ G+ P + H + I+ N+L+
Sbjct: 198 ----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS- 252
Query: 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
P+ E ++L+ ++ P R
Sbjct: 253 ------CPDNCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 51/169 (30%)
Query: 524 LYLVMEYLNGGDLYSLLR------------------NLGCLDEDVARVYIAEVVLALEYL 565
LY+++EY G+L LR + V+ Y +V +EYL
Sbjct: 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY--QVARGMEYL 150
Query: 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 625
S R +HRDL N+L+ D +K+ DFGL++
Sbjct: 151 ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR---------------------------- 182
Query: 626 TASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFEL 673
H + KK S P ++APE L + +D WS GI+++E+
Sbjct: 183 --GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 37/207 (17%)
Query: 524 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+ ++ EY GDL + LR L + + +V + +L S +HRDL N+L
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVL 173
Query: 582 IAHDGHI-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
+ H G I K+ DFGL++ ++N S V G L
Sbjct: 174 LTH-GKIVKICDFGLAR-DIMND----SNYVVKGNARL---------------------- 205
Query: 641 VGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIP 698
P ++APE + + +D WS GI+L+E+ +G P+ F ++
Sbjct: 206 ---PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR 262
Query: 699 WPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ PE E +D++ DP +R
Sbjct: 263 MAQ-PEHAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
NA E L E IL + +P + R T L ++MEY+ GDL L+
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG 119
Query: 550 VAR----------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+A +Y+A ++ + YL SL VHRDL N L+ + IK+ DFG+S+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-------VARVYI---AEVVL 560
VVR + + +VME + GDL S LR+L E+ + I AE+
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
+ YL++ + VHRDL N ++AHD +K+ DFG+++ I TD
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETD--------------- 173
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL-IVGIPP 679
RK + ++APE L T++D WS G++L+E+ + P
Sbjct: 174 ------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221
Query: 680 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ +Q+ +++ + P+ DL+ +P R
Sbjct: 222 YQGLSNEQVLKFVMDGG--YLDQPDNCPERVTDLMRMCWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-07
Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 39/186 (20%)
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
+ +V +E+L S VHRDL N+L+A +K+ DFGL++ +++ ++ +S
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVS----K 296
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
G+T L ++APE + + T +D WS GI+L+E+
Sbjct: 297 GSTFL------------------------PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
Query: 674 --IVGIPPFNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQRLGS 728
+ G P +P I D+ KI P+ + E +D++ + +P +R
Sbjct: 333 FSLGGTP-----YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF 387
Query: 729 GGASEV 734
S++
Sbjct: 388 LHLSDI 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 63/192 (32%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV--- 550
E+IL +IL S N +++ Y F DLYS + DE
Sbjct: 223 ENILKIEEILRSEANTYMITQKYDF----------------DLYSFM-----YDEAFDWK 261
Query: 551 -------ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
R + +++ A+EY+H +++HRD+K +N+ + DG I L DFG
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--------- 312
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTAD 662
TA ++ER VGT +PEIL G G+ D
Sbjct: 313 ----------------------TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 663 WWSVGIILFELI 674
WS G+IL +++
Sbjct: 351 IWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 59/226 (26%)
Query: 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV----------------YIAEVVLALEY 564
R LYL +EY G+L LR L+ D A + A+V ++Y
Sbjct: 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 139
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
L + +HRDL N+L+ + K+ DFGLS+
Sbjct: 140 LSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------------------------- 172
Query: 625 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 682
QE K++ P ++A E L + + T +D WS G++L+E++ +G P+
Sbjct: 173 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226
Query: 683 EHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQR 725
++++ K+P P E +DL+ + E P++R
Sbjct: 227 MTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 267
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/237 (21%), Positives = 107/237 (45%), Gaps = 36/237 (15%)
Query: 492 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVA 551
+VE+ LAE +++ ++++ +V+ ++ +E +Y++ E++ G L L++ + +
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 102
Query: 552 RV--YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
++ + A++ + ++ +HRDL+ N+L++ K+ DFGL++V
Sbjct: 103 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV----------- 151
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
E+ + TA E + K + APE + +D WS GI+
Sbjct: 152 ----------IEDNEYTAREGAKFPIK---------WTAPEAINFGSFTIKSDVWSFGIL 192
Query: 670 LFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
L E++ G P+ ++ L R PR E E ++++ R P +R
Sbjct: 193 LMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPRP-ENCPEELYNIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 52/244 (21%), Positives = 101/244 (41%), Gaps = 54/244 (22%)
Query: 505 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALE 563
S+ + ++VR +L LV + G L +R + LD + ++ +
Sbjct: 65 SLDHAYIVRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623
YL R+VHR+L N+L+ D +++ DFG++ LL ++
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD-------------------LLYPDDK 164
Query: 624 QLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 681
+ SEH+ TP ++A E +L + +D WS G+ ++E++ G P+
Sbjct: 165 KYFYSEHK-----------TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
Query: 682 AEHPQQIFDNILNR--KIPWPR---------------VPEEMSPEAHDLIDRF--LTEDP 722
P ++ D +L + ++ P+ + E + P +L + F + DP
Sbjct: 214 GMRPHEVPD-LLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
Query: 723 HQRL 726
+ L
Sbjct: 273 PRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 45/183 (24%), Positives = 72/183 (39%), Gaps = 38/183 (20%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
L E I+ +P ++R T + ++ EY+ G L LR D +
Sbjct: 53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLV 109
Query: 557 E----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ ++YL + VHRDL N+L+ + K++DFGLS+
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-------------- 155
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 671
L D E T + K T APE + T+A D WS GI+++
Sbjct: 156 -----LEDSEATYTT------KGGKIPIRWT----APEA-IAYRKFTSASDVWSFGIVMW 199
Query: 672 ELI 674
E++
Sbjct: 200 EVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 52/186 (27%)
Query: 524 LYLVMEYLNGGDLYSLLR-----------NLGCLDED-------VARVYIAEVVLALEYL 565
LY+++EY + G+L LR N + E+ V+ Y +V +EYL
Sbjct: 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY--QVARGMEYL 156
Query: 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQL 625
S + +HRDL N+L+ D +K+ DFGL++ D+
Sbjct: 157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DI------------------ 190
Query: 626 TASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAE 683
H + KK + P ++APE L + +D WS G++L+E+ +G P+
Sbjct: 191 ----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 684 HPQQIF 689
+++F
Sbjct: 247 PVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 41/178 (23%)
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 228
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
+ +K SA ++APE + + T +D WS G++L+E+
Sbjct: 229 -------------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
Query: 674 I-VGIPPF-----NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+G P+ N E Q++ D R PE +PE + ++ DP +R
Sbjct: 270 FSLGASPYPGVQINEEFCQRLKDGTRM------RAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 45/209 (21%)
Query: 473 SEHDDFPQ-VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531
S H D+PQ V+ KA + E+ L R +V VR TC LV+
Sbjct: 188 SSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTC-----LVLPKY 242
Query: 532 NGGDLYSLL----RNLGCLD-EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586
DLY+ L R LG VAR +++ A++Y+H ++HRD+K +N+L+
Sbjct: 243 RS-DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPE 297
Query: 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
I L DFG + + S P G GT D
Sbjct: 298 DICLGDFGAACF----ARGSWSTPFHYGIA-------------------------GTVDT 328
Query: 647 LAPEILLGTGHGTTADWWSVGIILFELIV 675
APE+L G + + D WS G+++FE V
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFEAAV 357
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 44/170 (25%)
Query: 530 YLNGGDLYSLLRNLGCLDEDVAR-------VYIA-EVVLALEYLHSLRVVHRDLKPDNLL 581
Y+N G+L L+ + + + V++A ++ + YLH V+H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
I + +K+TD LS+ DL P LGD E R K
Sbjct: 150 IDEELQVKITDNALSR--------DLF-P--MDYHCLGDNE----------NRPVK---- 184
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-------VGIPPFNAEH 684
++A E L+ + + +D WS G++L+EL+ V I PF
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 52/276 (18%)
Query: 469 KGALSEHDDFPQVLK----KADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCREN 523
+G LS+ D + K D+ + +E L+E + +P V++ F
Sbjct: 17 EGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL 76
Query: 524 LYL-----VMEYLNGGDLYSLL--RNLGCLDEDVAR----VYIAEVVLALEYLHSLRVVH 572
+ ++ ++ GDL+S L LG L E + ++ ++ L +EYL + +H
Sbjct: 77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIH 136
Query: 573 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQ 632
RDL N ++ D + + DFGLSK I S D
Sbjct: 137 RDLAARNCMLREDMTVCVADFGLSKK--IYSGD--------------------------- 167
Query: 633 ERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691
R+ R A ++A E L + + +D W+ G+ ++E+ G P+ +I+D
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227
Query: 692 ILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQR 725
+ + R+ PE+ E +DL+ DP R
Sbjct: 228 LRHGN----RLKQPEDCLDELYDLMYSCWRADPKDR 259
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 51/271 (18%)
Query: 473 SEHDDFPQV---LKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYL-- 526
SE F +V + KAD+ + +E L E + +P V++ S R L
Sbjct: 22 SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81
Query: 527 ---VMEYLNGGDLYS--LLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 577
++ ++ GDL++ L+ +G L ++ ++ +EYL S +HRDL
Sbjct: 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAA 141
Query: 578 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKK 637
N ++ + + + DFGLSK I S GD Q AS+ +
Sbjct: 142 RNCMLNENMTVCVADFGLSKK--IYS---------------GDYYRQGCASKLPVK---- 180
Query: 638 RSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL--N 694
+LA E L + T +D W+ G+ ++E++ G P+ +I++ ++ N
Sbjct: 181 --------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
Query: 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
R P E++ ++L+ + + +P R
Sbjct: 233 RLKQPPDCLEDV----YELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 53/171 (30%)
Query: 524 LYLVMEYLNGGDLYSLLR-------------------NLGCLDEDVARVYIAEVVLALEY 564
LY+V+EY G+L LR L D V+ Y +V +E+
Sbjct: 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL-VSFAY--QVARGMEF 147
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
L S + +HRDL N+L+ D +K+ DFGL++ D+
Sbjct: 148 LASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------DI----------------- 182
Query: 625 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI 674
H + +K + P ++APE L + +D WS G++L+E+
Sbjct: 183 -----HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 31/173 (17%)
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 233
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 234 -------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
Query: 674 I-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+G P+ + F L R P+ +PE + + +P QR
Sbjct: 275 FSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 49/226 (21%), Positives = 96/226 (42%), Gaps = 53/226 (23%)
Query: 487 MIRKNAVESILA----ERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ +A E L+ E +++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 54 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 113
Query: 542 NLGCLDE----DVARV------------YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
D+ARV +V +EYL S + +HRDL N+L+ +
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP- 644
+K+ DFGL++ + + KK + P
Sbjct: 174 NVMKIADFGLAR------------------------------DVNNIDYYKKTTNGRLPV 203
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIF 689
++APE L + +D WS G++++E+ +G P+ +++F
Sbjct: 204 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 41/185 (22%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
L+E I+ +P ++ T + + +V EY+ G L + LR + + +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR------KHDGQFTVI 106
Query: 557 EVV-------LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
++V ++YL + VHRDL N+L+ + K++DFGLS+V DD
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV----LEDD--- 159
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
P + TT G + TA E R+ + +D WS GI+
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRK---------------------FTSASDVWSYGIV 198
Query: 670 LFELI 674
++E++
Sbjct: 199 MWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 506 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 565
V P V EN +VMEY+ G L L+ + G + +++R E+ + L
Sbjct: 61 VNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EIGRLVGKL 111
Query: 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
HS ++H DL N+++ G I L DFGL++
Sbjct: 112 HSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 44/191 (23%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI----------AEVVL 560
VVR + + ++ME + GDL S LR+L E+ E+
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
+ YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD--------------- 173
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 680
RK + +++PE L T +D WS G++L+E+
Sbjct: 174 ------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 681 NAEHPQQIFDN 691
AE P Q N
Sbjct: 217 LAEQPYQGMSN 227
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 39/175 (22%), Positives = 62/175 (35%), Gaps = 49/175 (28%)
Query: 560 LALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLG 619
+ L+ L +LR +HR K N+L+ DG +KL G V P S
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKL--DGS--VAF-------KTPEQSR----- 65
Query: 620 DEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 679
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 680 FNAEHP-QQIFDNILNRKIPWPRVPE--------EMSPEAHDLIDRFLTEDPHQR 725
+N E I + +LN P + D + + P +R
Sbjct: 104 YNEERELSAILEILLNG--MPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRR 156
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 54/187 (28%)
Query: 524 LYLVMEYLNGGDLYSLLR-------------------NLGCLDEDVARVYIAEVVLALEY 564
LY+++EY + G+L LR L D V+ Y +V +EY
Sbjct: 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL-VSCAY--QVARGMEY 149
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
L S + +HRDL N+L+ D +K+ DFGL++
Sbjct: 150 LASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--------------------------- 182
Query: 625 LTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 682
H + KK + P ++APE L + +D WS G++L+E+ +G P+
Sbjct: 183 ---DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 683 EHPQQIF 689
+++F
Sbjct: 240 IPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 31/142 (21%)
Query: 554 YIAEVVL----ALEYLHS-LRVVHRDLKPDNLLI-AHDGHIK-LTDFGLSKVGLINSTDD 606
++A+++ AL+Y H+ L ++H DLKP+N+L+ D + +T+ L D
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666
L G ER + + V T Y +PE++LG G + D WS+
Sbjct: 292 LGGCC--------------------DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331
Query: 667 GIILFELIVGIPPF----NAEH 684
G I++EL G + N EH
Sbjct: 332 GCIIYELYTGKLLYDTHDNLEH 353
|
Length = 467 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 70/284 (24%)
Query: 477 DFPQVLK---KADMIRKNAVESILAE-------RD------ILISV-RNPFVVRFFYSFT 519
+F QVLK K D +R +A + E RD +L + +P ++ +
Sbjct: 7 NFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 66
Query: 520 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV----------------YIAEVVLALE 563
R LYL +EY G+L LR L+ D A + A+V ++
Sbjct: 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 126
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623
YL + +HRDL N+L+ + K+ DFGLS+ G V +G
Sbjct: 127 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----------GQEVYVKKTMG---- 171
Query: 624 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 682
R R ++A E L + + T +D WS G++L+E++ +G P+
Sbjct: 172 ----------RLPVR-------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214
Query: 683 EHPQQIFDNI-LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
++++ + ++ P ++ E +DL+ + E P++R
Sbjct: 215 MTCAELYEKLPQGYRLEKPLNCDD---EVYDLMRQCWREKPYER 255
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 64/286 (22%), Positives = 117/286 (40%), Gaps = 74/286 (25%)
Query: 477 DFPQVLK---KADMIRKNAVESILAE-------RD------ILISV-RNPFVVRFFYSFT 519
+F QV++ K D ++ NA +L E RD +L + +P ++ +
Sbjct: 14 NFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE 73
Query: 520 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV----------------YIAEVVLALE 563
R LY+ +EY G+L LR L+ D A + ++V ++
Sbjct: 74 NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQ 133
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623
YL + +HRDL N+L+ + K+ DFGLS+ G V +G
Sbjct: 134 YLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----------GEEVYVKKTMG---- 178
Query: 624 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNA 682
R R ++A E L + + T +D WS G++L+E++ +G P+
Sbjct: 179 ----------RLPVR-------WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221
Query: 683 EHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLIDRFLTEDPHQR 725
++++ K+P P E ++L+ + + P++R
Sbjct: 222 MTCAELYE-----KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYER 262
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 31/161 (19%)
Query: 557 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616
+V +E+L S VHRDL N+LI +K+ DFGL++ ++ ++ +S G+T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYIS----KGST 301
Query: 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-V 675
L ++APE + + T +D WS GI+L+E+ +
Sbjct: 302 FL------------------------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
Query: 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
G P+ + F N + R + P S E ++++ +
Sbjct: 338 GGTPYPELPMNEQFYNAIKRGYRMAK-PAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 25/81 (30%), Positives = 34/81 (41%), Gaps = 24/81 (29%)
Query: 526 LVMEYLNGGDL--------YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKP 577
+VMEY+ G L LLR +G V + LH +VH DL
Sbjct: 74 IVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK------------LHKAGIVHGDLTT 118
Query: 578 DNLLIAHDGHIKLTDFGLSKV 598
N+++ D + L DFGL K
Sbjct: 119 SNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 48/205 (23%)
Query: 508 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD-----EDVARVYIAEVVL-A 561
+P +V + +F L++V ++ Y ++L C ++A YI + VL A
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFM----AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 562 LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL-SKVGLINSTDDLSGPAVSGTTLLGD 620
L+Y+H + VHR +K ++LI+ DG + L+ GL S + +IN
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------ 153
Query: 621 EEPQLTASEHQQERR-----KKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFEL 673
H Q R K S P +L+PE+L G+ +D +SVGI EL
Sbjct: 154 ---------HGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
Query: 674 IVGIPPFNAEHPQQIFDNILNRKIP 698
G PF Q+ LN +P
Sbjct: 204 ANGHVPFKDMPATQMLLEKLNGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 469 KGALSEHDDFPQVLKKADMI---RKNAVESILAERDILISVRNPFVVRFF---YSFTCRE 522
+G L++ D +V K I ++ +E L+E + +P V+R E
Sbjct: 17 EGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE 76
Query: 523 NL---YLVMEYLNGGDLYSLL--RNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHR 573
+++ ++ GDL+S L LG L + ++ ++ +EYL S +HR
Sbjct: 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR 136
Query: 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQE 633
DL N ++ + ++ + DFGLSK ++ ++ ++
Sbjct: 137 DLAARNCMLNENMNVCVADFGLSK--------------------------KIYNGDYYRQ 170
Query: 634 RRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690
R + V ++A E L + T +D WS G+ ++E+ G P+ +I+D
Sbjct: 171 GRIAKMPV---KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 27/179 (15%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYI 555
L+E I+ +P ++ T + ++ E++ G L S LR N G +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+ ++YL + VHRDL N+L+ + K++DFGLS+ DD S P T
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF----LEDDTSDPTY--T 166
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
+ LG + P + APE + + +D WS GI+++E++
Sbjct: 167 SSLGGKIPI--------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 2e-04
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 14/93 (15%)
Query: 506 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 565
V P + Y E +VMEY+ G DL +L L V +A+ L
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVGE-IVAK-------L 444
Query: 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
H +VH DL N ++ D + L DFGL K
Sbjct: 445 HKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/183 (23%), Positives = 73/183 (39%), Gaps = 40/183 (21%)
Query: 526 LVMEYLNGGDLYSLLRNLGCLDEDVARV-----YIAEVVLALEYLHSLRVVHRDLKPDNL 580
+V+ Y+ GDL + +R+ + V + +V +EYL S + VHRDL N
Sbjct: 74 VVLPYMKHGDLRNFIRS----ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNC 129
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
++ +K+ DFGL++ + E+
Sbjct: 130 MLDESFTVKVADFGLAR--------------------------DIYDKEYYSVHNHT--G 161
Query: 641 VGTP-DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILN-RKI 697
P ++A E L T +D WS G++L+EL+ G PP+ I +L R++
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL 221
Query: 698 PWP 700
P
Sbjct: 222 LQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 42/178 (23%), Positives = 76/178 (42%), Gaps = 32/178 (17%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 558
E DIL ++ + ++ +++ + + +VM DL++ + G L + A + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRR 193
Query: 559 VL-ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617
+L AL YLH ++HRD+K +N+ + + L DFG +
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA--------------------- 232
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675
+L A + GT + +PE+L + D WS G++LFE+ V
Sbjct: 233 -----CKLDAHPDTP---QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282
|
Length = 392 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 38/147 (25%), Positives = 63/147 (42%), Gaps = 41/147 (27%)
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
+ ++ + YL R+VHRDL N+L+ H+K+TDFGL+++
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------------- 158
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
L GDE+ E+ + K ++A E + +D WS G+ ++EL
Sbjct: 159 ---LEGDEK------EYNADGGKM-----PIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204
Query: 674 IV--GIPPFNAEHPQQIFDNILNRKIP 698
+ G P +D I R+IP
Sbjct: 205 MTFGGKP----------YDGIPTREIP 221
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 9/73 (12%)
Query: 526 LVMEYLNGGDLYS-LLRNLGCLDEDVARVY---IAEVVLALEYLHSLRVVHRDLKPDNLL 581
LVME++ G + + L+++ L ED +Y + + +VH DL N+L
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147
Query: 582 IAHDGHIKLTDFG 594
+ DG + + D
Sbjct: 148 V-DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 35/182 (19%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
L+E I+ + ++R T + ++ EY+ G L LR+ D + + +
Sbjct: 54 LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLV 110
Query: 557 E----VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ ++YL + VHRDL N+L+ + K++DFGLS+V
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-------------- 156
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
L D E T S + R + APE + + +D WS GI+++E
Sbjct: 157 ----LEDDPEGTYTTSGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWE 202
Query: 673 LI 674
++
Sbjct: 203 VM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/213 (21%), Positives = 90/213 (42%), Gaps = 47/213 (22%)
Query: 506 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL------RNLGCLDEDVARV------ 553
+++P +V T + L ++ Y + DL+ L ++G D+D
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 554 ----YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609
+ ++ +E+L S VVH+DL N+L+ ++K++D GL + + + D
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE--VYAADYYK- 181
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
+ G +LL +++PE ++ +D WS G++
Sbjct: 182 --LMGNSLLPIR------------------------WMSPEAIMYGKFSIDSDIWSYGVV 215
Query: 670 LFELI-VGIPPFNAEHPQQIFDNILNRKI-PWP 700
L+E+ G+ P+ Q + + I NR++ P P
Sbjct: 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 62/220 (28%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA-------EVVLALEYLHSLRVVHRD 574
EN+ +V E++ G L LR ++ RV +A ++ AL YL +VH +
Sbjct: 90 ENI-MVEEFVEHGPLDVCLR------KEKGRVPVAWKITVAQQLASALSYLEDKNLVHGN 142
Query: 575 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTD---DLSGPAVSGTTLLGDEEPQLTASEHQ 631
+ N+L+A ++GL T LS P VS T L
Sbjct: 143 VCAKNILLA-------------RLGLAEGTSPFIKLSDPGVSFTAL-------------S 176
Query: 632 QERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF- 689
+E R +R ++APE + G T AD WS G L E+ F+ E P +
Sbjct: 177 REERVERIP-----WIAPECVPGGNSLSTAADKWSFGTTLLEIC-----FDGEVPLKERT 226
Query: 690 ----DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ +K R+PE E LI + LT +P QR
Sbjct: 227 PSEKERFYEKKH---RLPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 40/215 (18%)
Query: 524 LYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 578
LV+E+ GDL + LR+ +DV + EV L +LH +H DL
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129
Query: 579 NLLIAHDGHIKLTDFGLS----KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQER 634
N + D +K+ D+GL+ + D + P L P+L Q
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP-------LRWLAPELVEIRGQDLL 182
Query: 635 RKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNIL 693
K ++ + WS+G+ ++EL P+ +Q+ ++
Sbjct: 183 PKDQTKKS-------------------NIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223
Query: 694 ---NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ K+P P++ + S ++++ +F DP R
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVM-QFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 26/96 (27%), Positives = 37/96 (38%), Gaps = 28/96 (29%)
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDL--------YSLLRNLGCLDEDVARVYIAEVVLAL 562
+V N +VMEY+ G L LLR +G V +
Sbjct: 65 IVYDVDPD----NGLIVMEYIEGELLKDALEEARPDLLREVG---RLVGK---------- 107
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
LH +VH DL N++++ G I DFGL +
Sbjct: 108 --LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 50/210 (23%)
Query: 497 LAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN----------LGC 545
L E I+ + +VR SF R ++++E + GGDL S LR L
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 546 LDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLI 601
D ++ A +V +YL +HRD+ N L+ G K+ DFG+++
Sbjct: 116 KD----LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---- 167
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
D+ AS + RK A+ ++ PE L +
Sbjct: 168 ----DIYR-----------------ASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKT 202
Query: 662 DWWSVGIILFELI-VGIPPFNAEHPQQIFD 690
D WS G++L+E+ +G P+ Q++ +
Sbjct: 203 DVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 31/173 (17%)
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613
Y +V +E+L S + +HRDL N+L++ + +K+ DFGL++ D P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-------DIYKDP--- 227
Query: 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673
+ +K A ++APE + + T +D WS G++L+E+
Sbjct: 228 -------------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
Query: 674 I-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+G P+ + F L R PE +PE + ++ +P R
Sbjct: 269 FSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 18/90 (20%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 513 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 572
R +Y F E L + + + + C ++ + + + +++ LEY+H + H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 573 RDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 28/187 (14%)
Query: 507 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEY 564
R+P ++ + FT L+++ ++ G SLL+ + E + + + L Y
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNY 116
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
LH +HR++K ++LI+ DG + L+ GLS + + + + PQ
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY--------DFPQ 166
Query: 625 LTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNA 682
+ S +L+PE+L G+ +D +SVGI EL G PF
Sbjct: 167 FSTS--------------VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
Query: 683 EHPQQIF 689
Q+
Sbjct: 213 MLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 19/127 (14%)
Query: 477 DFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536
P K AD R+ A+ +LA + + + P V+ S YL+ME++ G L
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPV----PKVL---ASGESDGWSYLLMEWIEGETL 80
Query: 537 YSLLRNLGCLDEDVARVYIAEVVL-ALEYLHSLR---VVHRDLKPDNLLIAHDGHIKLTD 592
+ + + IAE + L LH L + H DL P N+L+ + + D
Sbjct: 81 DEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIID 132
Query: 593 FGLSKVG 599
+ + G
Sbjct: 133 WEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.003
Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 5/77 (6%)
Query: 520 CRENLYLVMEYL-NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKP 577
++N+ LVME++ + G L+++ +E+ +Y +VV + L +VH DL
Sbjct: 89 LKKNV-LVMEFIGDDGSPAPRLKDVPLEEEEAEELY-EQVVEQMRRLYQEAGLVHGDLSE 146
Query: 578 DNLLIAHDGHIKLTDFG 594
N+L HDG + D
Sbjct: 147 YNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.67 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.47 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.45 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.08 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.99 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.93 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.89 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.27 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.95 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.81 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.15 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.53 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.03 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.75 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 94.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.74 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.39 | |
| PLN02236 | 344 | choline kinase | 93.86 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.41 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 93.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.28 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 92.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 91.51 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 91.42 | |
| PTZ00384 | 383 | choline kinase; Provisional | 90.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 88.98 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.82 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 87.61 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 87.57 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 87.47 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 86.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.26 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 84.45 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 83.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 83.59 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 83.47 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-63 Score=551.87 Aligned_cols=365 Identities=43% Similarity=0.699 Sum_probs=285.8
Q ss_pred CcccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
...+|.++ +||+||||+|+.+ .|+++|..+..+.++++++.|.+||...++|+||+||+.|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45556655 9999999999665 378899999999999999999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||++||++.++|.+.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+-.......+
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999996422211111
Q ss_pred C------CCCCccCcccCCCCC----cc-------chhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHH
Q 002953 607 L------SGPAVSGTTLLGDEE----PQ-------LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669 (863)
Q Consensus 607 l------~~p~~~g~~l~g~~~----~~-------~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvI 669 (863)
. ....... ....+.. +. ..............+.+|||.|||||++.+.+|+..+||||||||
T Consensus 299 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSE-AKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhcc-CCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0 0000000 0000000 00 011111222344567899999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhH
Q 002953 670 LFELIVGIPPFNAEHPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 747 (863)
Q Consensus 670 LyELLTGk~PF~~~~~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~ 747 (863)
|||||.|.+||.++++.+++++|++.+. .+|. ...++++++|||.+||. ||++|+|.++++||++||||++|+|+.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999999999999999999999999874 4443 24588999999999999 999999999999999999999999999
Q ss_pred HhhccCCccCCCCCCCCCCCcccccccCCCCCCCCCCCCCCCCcccccCCCCCCCCcchhhhhhcccCCCccccCCCCcc
Q 002953 748 LARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVN 827 (863)
Q Consensus 748 l~~~~ppfvP~~~s~lDts~F~s~~s~~~tD~n~~p~~d~~~~~~~~~~s~s~s~~s~~~~e~~~~~~~~~~~~~~~~~~ 827 (863)
|....|||+|.+.+.+|++||+.. .+.+... .....+..+..+.........-.+..++|
T Consensus 456 l~~~~apfvP~v~~~~DT~yFddF-----~e~~~~~---------------~~~~~~~~~~k~~~~~~~~~~~~~~~Fvg 515 (550)
T KOG0605|consen 456 LREMPAPFVPQVNSELDTQYFDDF-----PEEDSMT---------------PTADKSGPSRKMLSMVDTNNSSKDINFVG 515 (550)
T ss_pred hhcCCCCCCCCCCCcccccccccC-----cccccCc---------------ccccccccchhhhhcccccCCcccccccc
Confidence 999999999999999999999841 1111000 00011111111111111112234446899
Q ss_pred eeeeCCcccCcccccccc
Q 002953 828 YSFSNFSFKNLSQLASIN 845 (863)
Q Consensus 828 ~~f~~f~~~~~~~~~~~~ 845 (863)
|+|.+|++.+.......|
T Consensus 516 fTyk~~~~~~~~~~~~~~ 533 (550)
T KOG0605|consen 516 FTYKNFDGLNKANSLLIN 533 (550)
T ss_pred eeeecccccccccccccc
Confidence 999999999887666544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-61 Score=518.95 Aligned_cols=290 Identities=46% Similarity=0.840 Sum_probs=263.8
Q ss_pred CCcccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 457 PRTSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 457 ~~~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
....+|.++ +||+|+||+|+.+ .|+++|..+..++.++++.+|..||.+++||+||++++.|++.+++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 345566665 9999999998654 36888999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||+||+.||+|+.+|++.+.|++..+++|+++|+.||.|||++|||||||||+|||++.+||++|+|||+|+....
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~---- 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK---- 177 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999995221
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.+..++++|||+.|||||++.+.+|+..+||||||+++|||++|.+||.+.+.
T Consensus 178 ---------------------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 178 ---------------------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred ---------------------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 12345679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
..++++|..++.. ..+..++.++++||+++|.+||++|+|. +++.+|.+||||+++||+.+... .|||.|.....
T Consensus 231 ~~~~~~I~~~k~~--~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 231 KKMYDKILKGKLP--LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred HHHHHHHhcCcCC--CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence 9999999998853 3356699999999999999999999974 68999999999999999999876 49999999999
Q ss_pred CCCCCcccccccCCCCC
Q 002953 763 LDTSYFTSRYSWNTTDE 779 (863)
Q Consensus 763 lDts~F~s~~s~~~tD~ 779 (863)
.++++|+.++.....+.
T Consensus 309 ~~~~~Fd~eft~~~~~~ 325 (357)
T KOG0598|consen 309 EDTSNFDNEFTSYTVDY 325 (357)
T ss_pred cccccccHHHHhccccC
Confidence 99999999887665443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-57 Score=515.87 Aligned_cols=281 Identities=38% Similarity=0.757 Sum_probs=255.7
Q ss_pred CcccceEE-Eeecccceeecc----------ccceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDD----------FPQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~----------~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ly 525 (863)
...+|.++ +||+|.||+|.. +.|++||..+...+.++.++.|.+|+.... ||++++++..|++++++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34456655 999999999833 358999999999999999999999998875 999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||+.||++. ++...+.|++..+++|+++|+.||.|||++||||||||.+|||+|.+|++||+|||+++.++.
T Consensus 446 fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~---- 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG---- 520 (694)
T ss_pred EEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC----
Confidence 999999999944 444458899999999999999999999999999999999999999999999999999995321
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.+..+.++||||.|||||++.+..|+.++|||||||+|||||.|..||.++++
T Consensus 521 ---------------------------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 521 ---------------------------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred ---------------------------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 12356789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 761 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s 761 (863)
++++..|+.....+ |..+|.++.++++++|.++|++|+|+ ..+++|++||||+.|+|+.|.++ +|||+|...+
T Consensus 574 ee~FdsI~~d~~~y---P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 574 EEVFDSIVNDEVRY---PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred HHHHHHHhcCCCCC---CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 99999999988654 57899999999999999999999997 57999999999999999999876 5999999999
Q ss_pred CCCCCCcccccc
Q 002953 762 ALDTSYFTSRYS 773 (863)
Q Consensus 762 ~lDts~F~s~~s 773 (863)
..|.+||+.+|.
T Consensus 651 ~~D~snFd~eFt 662 (694)
T KOG0694|consen 651 PEDVSNFDEEFT 662 (694)
T ss_pred hhhhcccchhhh
Confidence 999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-57 Score=475.26 Aligned_cols=274 Identities=39% Similarity=0.792 Sum_probs=253.7
Q ss_pred ccce-EEEeecccceeec----------cccceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQID-LLLAGKGALSEHD----------DFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~-l~vLGkG~FG~V~----------~~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|. +..||.|+||.|. -+.|+++|..+.+..+++++.+|..+|+.+.||++++|++.|.+.+++||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3344 4499999999983 3458999999999999999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++||.|+.++++.++|++..+++|++||+.||+|||+++|+||||||+|||||.+|++||+|||+|+..
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v--------- 194 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV--------- 194 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999841
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
...+.+.||||.|+|||++..++|+.++||||||+++|||+.|.+||...++..+
T Consensus 195 -------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i 249 (355)
T KOG0616|consen 195 -------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI 249 (355)
T ss_pred -------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH
Confidence 1235689999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccC-CCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVP-TSESAL 763 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP-~~~s~l 763 (863)
+++|+.++..+| ..++.++++||+++|+.|-.+|.|. ++..+|+.||||++++|..+..+ ++||+| ......
T Consensus 250 Y~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~g 326 (355)
T KOG0616|consen 250 YEKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPG 326 (355)
T ss_pred HHHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCc
Confidence 999999998775 5799999999999999999999886 58999999999999999999876 589888 777788
Q ss_pred CCCCccc
Q 002953 764 DTSYFTS 770 (863)
Q Consensus 764 Dts~F~s 770 (863)
|+++|+.
T Consensus 327 dtsnfd~ 333 (355)
T KOG0616|consen 327 DTSNFDD 333 (355)
T ss_pred ccccccc
Confidence 9999976
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-53 Score=497.28 Aligned_cols=790 Identities=39% Similarity=0.513 Sum_probs=544.2
Q ss_pred hhhhhhhhhhhhhhhhhccc-----hhhhhhhhhhhhhhccccCchhhHHHHHHHHHHhhhhccCCcceeeeehhhHhhh
Q 002953 19 EILVVIRTKFDKAKEEVNSD-----LAVFAGDLVGILEKNAESHPEWQETIEDLLVLARSCAMTSPGEFWLQCEGIVQEL 93 (863)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (863)
+.+|.|+++|...++=++.| +|+|++|.|-..|+.-+.-+|-|+.|++||+.+..|..|.+++||+-|++++|-|
T Consensus 242 wamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 242 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred HHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 88999999999999999999 9999999999999999999999999999999999999999999999999999999
Q ss_pred hhh---cccCCcchHHHHHHHHHHHHHhhHHHhhhhcccccccccccccccccccccccccCCCCcc---ccCCCcchHh
Q 002953 94 DDR---RQELPPGTLKQLYTRMLFILTRCTRLLQFHKESALAEDEHMFQFRQSRVLHSADKRIPQGT---LRDGKGSTIA 167 (863)
Q Consensus 94 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 167 (863)
|.- ||+++-+.+++.+.+|+||+|||+|.-||.+|.- ...|+...|||-- +.--|+++.. .+=-.-++++
T Consensus 322 Dw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~-~~ees~~~~~qFs---scs~r~~kv~ss~~~l~~~~t~~ 397 (1205)
T KOG0606|consen 322 DWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDT-GDEESSLEFRQFS---SCSPRFSKVYSSWESLAQLETAT 397 (1205)
T ss_pred ccchhhhhhccccccccccccchhhcccchheeeccccCC-ccccccccccccc---cccccccccccchhhhhcccccc
Confidence 999 9999999999999999999999999999999983 3344545667632 1112222211 1100012222
Q ss_pred hhhhhhcccccc---hhhhhcc--CccccccccCCcccCCCCCCCcccccchhhhhcccccccCCCCcccccccCCCccc
Q 002953 168 KASKAASSRKSY---SQEQHGL--DWKRDHAVKQGNILSPPGDDNAKSLESSAARDRMSSWKKLPSPVGKIMKESPTSKE 242 (863)
Q Consensus 168 ~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (863)
.+.+ +.-+++ ++--.+. +|++.- +.+..+-.+. +.+.-++. ++++.|+.++++--+.-+...+.+-
T Consensus 398 ~~~~--~~~~~~~~~~~~~~g~k~~~~~~s----p~~~kl~~st-~~ss~s~~--~~~s~~~~~~~~~s~~~~~~~~s~~ 468 (1205)
T KOG0606|consen 398 PREK--SSQSSQGEVSPSSAGQKDSWKSNS----PESSKLELST-ALSSVSPN--HPGSPSKSLTSAASTLRTALRTSSP 468 (1205)
T ss_pred cccc--ccccccccccCCccccccccccCC----hhhhhccccc-hhhhcccc--cCCCccccccchhhhhccccccCCC
Confidence 2222 222222 2211111 355432 2222222222 22222222 7999999999999999999999999
Q ss_pred cCCCccccccccccccCCcccccccCCCCCCchhhhhhccc---cccCcccccccCCccCcCCCCCcEEEeccCcCcccc
Q 002953 243 QNDGKVEPLKSSNIRRGLSEIDLTAKPSEFPPAAETLEHSS---KHQHKVSWGYWGDQQNISDDSSSIICRICEEEVPTS 319 (863)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~CriCe~~vp~~ 319 (863)
++|+++.|+...--| --.++-..+-|+.+...+-++ .--+.--|+.|++-+-+ ..+++.||||||..+|.-
T Consensus 469 ~~ds~~~~~~~~p~~-----~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v-~~~d~~i~~~~e~~~p~~ 542 (1205)
T KOG0606|consen 469 SEDSKIFPLRAPPPP-----SSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCV-GTSDSGICRICEAEGPRL 542 (1205)
T ss_pred CCCccccccCCCCCc-----cccccCCCCCCCcccccCCCCCCcccchhhhcccccccccc-ccCCcccccccccccccc
Confidence 999999998633222 122233333344333221111 11223348889876654 555899999999999999
Q ss_pred hHHHhHHHHHHhhhccccccchHHHHHHHHHHHHHhhcccc-ccccccccCCCCcceeeeccccCCcccccccccccccc
Q 002953 320 HVEDHSKICAIADRCDQKGLSVNERLLRISETLEKMMESSV-QKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKFSDWSR 398 (863)
Q Consensus 320 ~ie~H~~~C~~a~~~~~~~~~~de~~~~~~~~~~~~~~~~~-q~~~~n~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~ 398 (863)
+.+.|..+|..+.+|..+.+.++.+++++.+.+.++..+.. +...+- -+.+.--.++.++.. ++-.. +-+.|+|
T Consensus 543 ~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~--~~~~l~s~lS~~~~s--S~p~S-rdsspsr 617 (1205)
T KOG0606|consen 543 HSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTP--TGGPLCSPLSPRSLS--SNPSS-RDSSPSR 617 (1205)
T ss_pred cccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCC--cccccccccCCCCCC--CCccc-Ccccccc
Confidence 99999999999999999999999999999888888554321 110000 011211223332222 34444 6788999
Q ss_pred cccccccccccccCccccccCCCCCCcCccccccCCCCCCCCcccCCCCCCCCCCccCCCcccceEEEeecc--------
Q 002953 399 RGSEDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQIDLLLAGKG-------- 470 (863)
Q Consensus 399 ~~~e~v~~~~~~~~~~~~~~d~~~~~sm~~~~~~gp~s~~~~s~ss~g~~~p~sp~~~~~~~~~~l~vLGkG-------- 470 (863)
..+..+....+.-....+-...+ ...+.-..+.|... .-..-...+...+.+|...+.....++...++|
T Consensus 618 d~s~~~~~~~ppI~i~~~~~~yG-ft~~airVy~Gd~d-~ytvhh~v~sv~egsPA~~agls~~DlIthvnge~v~gl~H 695 (1205)
T KOG0606|consen 618 DSSAAMLSLRPPITIHFSGKKYG-FTLRAIRVYMGDKD-VYTVHHSVGSVEEGSPAFEAGLSAGDLITHVNGEPVHGLVH 695 (1205)
T ss_pred ccchhhcCcCCceeeeccccccC-ceeeeEEEecCCcc-cceeeeeeeeecCCCCccccCCCccceeEeccCcccchhhH
Confidence 99988887766544443222222 22222333334333 111112223333334433333333333322222
Q ss_pred --------------------------------------------------------------------------------
Q 002953 471 -------------------------------------------------------------------------------- 470 (863)
Q Consensus 471 -------------------------------------------------------------------------------- 470 (863)
T Consensus 696 ~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~~~s~~ 775 (1205)
T KOG0606|consen 696 TEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRKISKQDCELLHTSRSFL 775 (1205)
T ss_pred HHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHHHHhhhhhhhccccccc
Confidence
Q ss_pred ----------------------------------------cceeeccc----------cceehhhhhhchhHHHHHHHHH
Q 002953 471 ----------------------------------------ALSEHDDF----------PQVLKKADMIRKNAVESILAER 500 (863)
Q Consensus 471 ----------------------------------------~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei 500 (863)
+|+.+... .++.++...+.+...+....+.
T Consensus 776 ss~eS~pgdp~~sls~sP~sp~~yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s 855 (1205)
T KOG0606|consen 776 SSSESLPGDPTRSLSASPRSPTKYRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKS 855 (1205)
T ss_pred cccccCCCCcccccccCCCCcccccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCcc
Confidence 11111000 0112222222222233333333
Q ss_pred HHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcce
Q 002953 501 DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580 (863)
Q Consensus 501 ~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNI 580 (863)
.++-...+|.+++....|.....++|||+|+.|++|...|++.+..+++-++.++..+..+++|||...++|||++|.|+
T Consensus 856 ~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 856 NILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSL 935 (1205)
T ss_pred CccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccch
Confidence 33333445777766666666778999999999999999999989899999999999999999999999999999999999
Q ss_pred eecCCCcEEEeecC-CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCc
Q 002953 581 LIAHDGHIKLTDFG-LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659 (863)
Q Consensus 581 LLd~~g~VKLiDFG-LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ 659 (863)
|+..+|+.+++||| +.+.+..+...+..++...+.+..-......... ...+........||+.|.+||.+.+..++.
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQL-SADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCcccccccccccccc-ccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999 6666665555555444333222111110011111 111335566789999999999999999999
Q ss_pred cceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 660 ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+|||++|++++|.++|.+||....+++++++|.....+||..+...+.++++++.++|..+|.+|.++..+.++..|+|
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPF 1094 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999998888889999999
Q ss_pred CCCCChhHHhhccCCccCCCCCCCCCCCcccccccCCCCCCCCCCCCCCCCcccccCCCCCCCCcchhhhhhcccCCCcc
Q 002953 740 FKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAE 819 (863)
Q Consensus 740 Fk~IdW~~l~~~~ppfvP~~~s~lDts~F~s~~s~~~tD~n~~p~~d~~~~~~~~~~s~s~s~~s~~~~e~~~~~~~~~~ 819 (863)
|+.++|+.+..+...|+|...+..|+++|.++|.|...+++..-.+.+. .-.+...+..|... +...+.|+
T Consensus 1095 ~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~---~~~s~~~~~~~~~p--e~~~~~~~---- 1165 (1205)
T KOG0606|consen 1095 FQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGS---KLDSPDESPECTTP--ELKPAMCG---- 1165 (1205)
T ss_pred cCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCccc---CccCccccccccCc--cccCCcCc----
Confidence 9999999999999999999999999999999999887665543332211 11111122222211 11122333
Q ss_pred ccCCCCcceeeeCCcccCcccccccccccccC
Q 002953 820 FESGSSVNYSFSNFSFKNLSQLASINYDLLSK 851 (863)
Q Consensus 820 ~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~ 851 (863)
+..|.+|+|.|.++++|+|++.+-.
T Consensus 1166 -------~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1166 -------NLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred -------cccccccCccChhhccccChHhhcC
Confidence 3349999999999999999998865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-52 Score=463.17 Aligned_cols=273 Identities=36% Similarity=0.695 Sum_probs=240.2
Q ss_pred CcccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
+..+|.+. .||.|+|++|..+ .||+.|..+++.+.++.+..|..+|.+| .||+|++||..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34455554 8999999998544 3678888899999999999999999999 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+|+||+++|+|.++|++.|.|++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||.|+.+......
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999963221110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
...+. . .........+++||..|.+||+|.....++.+|||+||||||+|+.|.+||.+.++
T Consensus 231 -~~~~~----------~-------~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 231 -QENPV----------D-------PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred -ccCcc----------C-------cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 00000 0 00011224679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAA 754 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~pp 754 (863)
..++++|+...+.| |.++++.+.+||+++|..||.+|+ |+++|++||||.+|+|+.+.++.||
T Consensus 293 yliFqkI~~l~y~f---p~~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 293 YLIFQKIQALDYEF---PEGFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHHhcccC---CCCCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCChhhhhhcCCC
Confidence 99999999988876 468999999999999999999999 9999999999999999999988764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=454.44 Aligned_cols=303 Identities=37% Similarity=0.658 Sum_probs=251.9
Q ss_pred cccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...++++ .||+|..|+|+.+ .||+.|..+..++...++..|.+||+.++||+++.||..|+.++++|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3445544 8999999999654 3788888888889999999999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 528 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||+||+|..+++++ +.|++..+++|+++++.||+|||.+|||||||||+||||..+|||.|+||.|+.......+-
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999999876 56999999999999999999999999999999999999999999999999998753211000
Q ss_pred CC-CCCCccC----------c-----ccCCCCC---ccch------hhhhhhhhhccccccCCCCCCChhhhcCCCCCcc
Q 002953 606 DL-SGPAVSG----------T-----TLLGDEE---PQLT------ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660 (863)
Q Consensus 606 dl-~~p~~~g----------~-----~l~g~~~---~~~~------~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k 660 (863)
-. ..+...+ . ....... .... ..-......+.++++||-.|+|||++.|.+++.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 00 0000000 0 0000000 0000 0001223456789999999999999999999999
Q ss_pred ceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCC
Q 002953 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVF 739 (863)
Q Consensus 661 sDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPF 739 (863)
+|||+||+++||||+|..||.+.+..+++.+|+.....+|..+ .++..++|||+++|.+||.+|+|+ .+|.||++|||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 9999999999999999999999999999999999999998766 689999999999999999999986 58999999999
Q ss_pred CCCCChhHHhhccCCccCCCCCC
Q 002953 740 FKDINWDTLARQKAAFVPTSESA 762 (863)
Q Consensus 740 Fk~IdW~~l~~~~ppfvP~~~s~ 762 (863)
|++++|.-+....||++|.....
T Consensus 395 F~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 395 FEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred ccCCChhheeccCCCcCCCcccc
Confidence 99999998888899999986543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=496.40 Aligned_cols=279 Identities=39% Similarity=0.729 Sum_probs=249.7
Q ss_pred ccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.++ +||+|+||+|..+ .|.++|..+.+......|..|.+||..-+.++|+++++.|+++.++||||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 345544 9999999998443 35677777888888999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++||+|..++.+.+++|++.++||+++|+.||..||+.|+|||||||+|||||..|||||+|||.|-....+
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d------ 228 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD------ 228 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC------
Confidence 99999999999999999999999999999999999999999999999999999999999999999988632100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
..-.....+|||.|++||++.. ..|+..||||||||++|||++|..||+.+
T Consensus 229 ------------------------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 229 ------------------------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred ------------------------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 0123456799999999999963 45899999999999999999999999999
Q ss_pred ChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCC
Q 002953 684 HPQQIFDNILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSES 761 (863)
Q Consensus 684 ~~~el~~kIl~~--~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s 761 (863)
+..++|.+|++. .+.||. ...+|.++++||.++|. +|+.|+|.+++++|..||||.+++|+.|....|||+|.+.+
T Consensus 285 slveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 285 SLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred HHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 999999999987 455553 24599999999999998 89999999999999999999999999999999999999999
Q ss_pred CCCCCCccc
Q 002953 762 ALDTSYFTS 770 (863)
Q Consensus 762 ~lDts~F~s 770 (863)
..||++|+.
T Consensus 363 d~DTsnFd~ 371 (1317)
T KOG0612|consen 363 DDDTSNFDV 371 (1317)
T ss_pred CCccccccc
Confidence 999999953
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=445.44 Aligned_cols=285 Identities=39% Similarity=0.720 Sum_probs=261.5
Q ss_pred CcccceEE-Eeecccceee----------ccccceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 458 RTSQIDLL-LAGKGALSEH----------DDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V----------~~~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
....|+++ +||+|.||+| +.+.|++||..++.+..+.+.+.|-++|...+||++..|-+.|++.+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 44566665 9999999998 233578899999999999999999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+.||.|+.+|.+...|+++.+++|.++|+.||.|||+.+||+||||.+|+|++.+|||||+|||+++..+.
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~----- 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK----- 320 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999985221
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.+....++||||.|+|||++....|+.++|||.+||+||||++|++||+..+..
T Consensus 321 --------------------------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 321 --------------------------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred --------------------------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 134567899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
.++.-|+.....| |..++++++.|+..+|.+||.+|+|. ..|.||.+|+||.+++|+.+.+. .|||.|.+.+.
T Consensus 375 kLFeLIl~ed~kF---Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSe 451 (516)
T KOG0690|consen 375 KLFELILMEDLKF---PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSE 451 (516)
T ss_pred HHHHHHHhhhccC---CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccc
Confidence 9999999988866 46899999999999999999999987 48999999999999999998766 49999999999
Q ss_pred CCCCCcccccccCC
Q 002953 763 LDTSYFTSRYSWNT 776 (863)
Q Consensus 763 lDts~F~s~~s~~~ 776 (863)
.|++||+.+|+-.+
T Consensus 452 tDTryFD~EFT~q~ 465 (516)
T KOG0690|consen 452 TDTRYFDEEFTSQP 465 (516)
T ss_pred cchhhhhhhhhcce
Confidence 99999999876433
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=456.71 Aligned_cols=325 Identities=34% Similarity=0.598 Sum_probs=273.8
Q ss_pred CCccCCCcccceEEEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 002953 452 SPLLTPRTSQIDLLLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR 521 (863)
Q Consensus 452 sp~~~~~~~~~~l~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 521 (863)
.|+.......+ .+||+||||+|+.+. +.+.|+.+.++......++|..||.+++.++||.+-+.|++.
T Consensus 180 qpvt~n~F~~~--RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 180 QPVTKNTFRVY--RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred hhccccceeee--EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 34444444333 489999999997653 234455666667777899999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
+.+||||..|+||+|..+|.+.+ .|++..+++|+++|+.||++||+.+||+|||||+|||+|+.||++|+|+|||...
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999999998877 7999999999999999999999999999999999999999999999999999842
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
. .+......+||..|||||++.+..|+..+|||||||+||||+.|..|
T Consensus 338 ~--------------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sP 385 (591)
T KOG0986|consen 338 P--------------------------------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSP 385 (591)
T ss_pred C--------------------------------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCc
Confidence 1 12233456999999999999999999999999999999999999999
Q ss_pred CCCCC----hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--
Q 002953 680 FNAEH----PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ-- 751 (863)
Q Consensus 680 F~~~~----~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~-- 751 (863)
|.... .+++-++++.... .+++.+|+++++|++.+|++||.+|+|+ ++++++.+||||+++||..+...
T Consensus 386 Fr~~KeKvk~eEvdrr~~~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml 462 (591)
T KOG0986|consen 386 FRQRKEKVKREEVDRRTLEDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGML 462 (591)
T ss_pred hhhhhhhhhHHHHHHHHhcchh---hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCC
Confidence 96543 2355555655554 3468899999999999999999999997 69999999999999999999875
Q ss_pred cCCccCCCCC-----CCCCCCcccc--cccCCCCCCCCCCCCCCCCcccccCCCCCCCCc-chhhhhhc-ccCC-Ccccc
Q 002953 752 KAAFVPTSES-----ALDTSYFTSR--YSWNTTDENIYPASDFEDSSDADSLSGSSSCLS-NRQEEVGD-ECGG-LAEFE 821 (863)
Q Consensus 752 ~ppfvP~~~s-----~lDts~F~s~--~s~~~tD~n~~p~~d~~~~~~~~~~s~s~s~~s-~~~~e~~~-~~~~-~~~~~ 821 (863)
.|||+|.... .+|..+|+.. ..+..+|+++|.... ++|+| .||+|+++ +++. ++.|.
T Consensus 463 ~PPfiPdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~-------------tg~vsipWQnE~~ET~~f~elnv~~ 529 (591)
T KOG0986|consen 463 EPPFIPDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFA-------------TGSVSIPWQNEMIETECFEELNVFG 529 (591)
T ss_pred CCCCCCCccccchhhhhhhhhcccccceecccccHHHHHhcc-------------CCcccchHHHHHHHhhhHHHhhccc
Confidence 6999998754 6788899864 567788888887773 45666 89999988 5776 88887
Q ss_pred CCCCc
Q 002953 822 SGSSV 826 (863)
Q Consensus 822 ~~~~~ 826 (863)
+.++.
T Consensus 530 ~~~~~ 534 (591)
T KOG0986|consen 530 DDGAK 534 (591)
T ss_pred ccccc
Confidence 77644
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=450.27 Aligned_cols=286 Identities=35% Similarity=0.733 Sum_probs=259.1
Q ss_pred CcccceEE-Eeecccceeecc----------ccceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDD----------FPQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~----------~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
+..+|+++ +||+|+||+|-. +.+++||..++..+.++..+.|.++|... +-|++++++..|++-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 44556666 999999999832 25788999999999999999999999876 4689999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||+.||+|...|+..|+|.+..+.+|+++|+.||-+||++|||+||||.+|||++.+|||||+|||+++..+.
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~---- 502 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF---- 502 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
....++++||||.|+|||++..++|+.++||||+||+||||+.|++||.+.++
T Consensus 503 ---------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 503 ---------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ---------------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 12346789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCccCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 761 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s 761 (863)
.++++.|+.....+ |..+|.++.++++.+|.+.|.+|+|++ .-++|..||||+.|+|+.+.+. +|||.|..+.
T Consensus 556 ~elF~aI~ehnvsy---PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~ 632 (683)
T KOG0696|consen 556 DELFQAIMEHNVSY---PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKC 632 (683)
T ss_pred HHHHHHHHHccCcC---cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcccc
Confidence 99999999988765 578999999999999999999999974 5689999999999999999876 5999999999
Q ss_pred CCCCCCcccccccCCC
Q 002953 762 ALDTSYFTSRYSWNTT 777 (863)
Q Consensus 762 ~lDts~F~s~~s~~~t 777 (863)
.-+.++|+..|.-.++
T Consensus 633 ~r~~eNFD~~Ft~~~~ 648 (683)
T KOG0696|consen 633 GRDAENFDKFFTREPT 648 (683)
T ss_pred CCchhhhhHHHhcCCC
Confidence 9999999987764443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=450.61 Aligned_cols=305 Identities=42% Similarity=0.715 Sum_probs=253.6
Q ss_pred EEEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+.-||=|+||+|..+. |.+.|..++.++++.++..|.+||...+.++||+||+.|++++++|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 4479999999986553 567788888999999999999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC---CCCC
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD---LSGP 610 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d---l~~p 610 (863)
|++..+|-+.+.|+|+.+++|++++.+|+++.|+.|+|||||||+|||||.+|||||+|||||+- +.+..+. -.+.
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG-fRWTHdskYYq~gd 792 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG-FRWTHDSKYYQEGD 792 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc-ceeccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999973 2221110 0111
Q ss_pred CccCc-----ccCCCCCccchhhh----hhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 611 AVSGT-----TLLGDEEPQLTASE----HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 611 ~~~g~-----~l~g~~~~~~~~~~----~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
+..-. ...++..+-+...+ .....-.....+||+.|+|||++...+|+..|||||.|||||||+.|++||.
T Consensus 793 H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 793 HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCcc
Confidence 11111 11111111111111 1122334568899999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCC
Q 002953 682 AEHPQQIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTS 759 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~ 759 (863)
...+-++..++++.... ..+ -..++.++.+||.++.. +++.|+|...+++|+.||||++|||..+..+.+||+|..
T Consensus 873 ~~tp~~tq~kv~nw~~~-l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~I 950 (1034)
T KOG0608|consen 873 ADTPGETQYKVINWRNF-LHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRI 950 (1034)
T ss_pred CCCCCcceeeeeehhhc-cccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhccCCcCccc
Confidence 99988887777765432 122 35799999999999876 899999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccc
Q 002953 760 ESALDTSYFTSR 771 (863)
Q Consensus 760 ~s~lDts~F~s~ 771 (863)
.-..|+++|+..
T Consensus 951 tHptDTSNFdpv 962 (1034)
T KOG0608|consen 951 THPTDTSNFDPV 962 (1034)
T ss_pred cCCCccccCCcC
Confidence 999999999873
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=454.69 Aligned_cols=245 Identities=34% Similarity=0.617 Sum_probs=226.6
Q ss_pred ccceE-EEeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDL-LLAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.. .+||+|||+.+|.+ .|++-|..+.+..+.+.+.+|++|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 34443 49999999998654 36777888889999999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|+|..++|..++++.+.++|.+++.|+.||+.||.|||+++|||||||..|||++.+.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999998999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.+..+..+.||||.|+|||++...+++..+||||+||+||.||+|+|||...+..++
T Consensus 170 -----------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket 226 (592)
T KOG0575|consen 170 -----------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET 226 (592)
T ss_pred -----------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH
Confidence 112456789999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
+.+|......+| ..++.++++||.+||..||.+|| |+++||.|+||+
T Consensus 227 y~~Ik~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 227 YNKIKLNEYSMP---SHLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFK 273 (592)
T ss_pred HHHHHhcCcccc---cccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhh
Confidence 999999988765 58999999999999999999999 999999999994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=439.44 Aligned_cols=247 Identities=33% Similarity=0.567 Sum_probs=214.2
Q ss_pred EEEeecccceeeccc----------cceehhhhhhc----hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 464 LLLAGKGALSEHDDF----------PQVLKKADMIR----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 464 l~vLGkG~FG~V~~~----------~kvlKK~~i~~----k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
...||+|+||.|..+ .|++.|..... ......+.+|++||++|+|||||+++++|...++.|||||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 349999999998433 24555544443 2233457899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~d 606 (863)
|+.||+|++.+-..+.+.+...+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|++..
T Consensus 257 ~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g------ 330 (475)
T KOG0615|consen 257 YVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG------ 330 (475)
T ss_pred EecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc------
Confidence 99999999999999999999999999999999999999999999999999999877 679999999999521
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC---CccceeechhHHHHHHHhCCCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH---GTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y---s~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
+....+++||||.|.|||++.+.++ ..++|+|||||+||-+|+|.+||...
T Consensus 331 --------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 331 --------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred --------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 1234568999999999999988664 45889999999999999999999877
Q ss_pred ChHH-HHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 684 HPQQ-IFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 684 ~~~e-l~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.... +.++|..+.+.+- ..+..+++++.+||.+||..||++|| +++|+|+||||+.++-
T Consensus 385 ~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 385 YTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALNHPWFKDAPC 445 (475)
T ss_pred cCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhcChhhhcccc
Confidence 6555 8889999887764 45678999999999999999999999 9999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=432.26 Aligned_cols=272 Identities=35% Similarity=0.721 Sum_probs=254.2
Q ss_pred Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||-||||.|..+ .|++||.++.+..+.+++..|.+||..++.|+||+||..|.+..++||+||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 7999999998433 378899999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|...|+..+.|++..+++|+..++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+..
T Consensus 507 lWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki---------------- 570 (732)
T KOG0614|consen 507 LWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI---------------- 570 (732)
T ss_pred hhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh----------------
Confidence 9999999999999999999999999999999999999999999999999999999999999852
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
..+.++.++||||.|.|||++++++++.++|+||||+++||||+|.+||.+.++..+|..|+++
T Consensus 571 ----------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 571 ----------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred ----------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence 1235778999999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCccc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s 770 (863)
-.. ..+|..++..+.+||+++...+|.+|+|+ +++.+|.+|.||.++||+.+..+ .||++|.+.++.|++||+.
T Consensus 635 id~-i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~ 712 (732)
T KOG0614|consen 635 IDK-IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDN 712 (732)
T ss_pred hhh-hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccC
Confidence 533 34578899999999999999999999995 89999999999999999999865 5899999999999999987
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=404.47 Aligned_cols=273 Identities=41% Similarity=0.756 Sum_probs=235.0
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+||+|+||.|+.+. |++++...........+.+|+.+|++++||||++++++|...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 69999999996542 33333333445566778899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~------------- 148 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD------------- 148 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-------------
Confidence 9999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+...++..+...
T Consensus 149 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 149 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (323)
T ss_pred ------------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123467999999999999999999999999999999999999999998888888888766
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
... ++..+++++.+||.+||..||.+||+. .++.++++||||.+++|..+... .+|+.|......++.+|+..
T Consensus 211 ~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05571 211 EIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEE 287 (323)
T ss_pred CCC---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 654 356799999999999999999999964 37999999999999999988754 47888888888888888654
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 288 ~ 288 (323)
T cd05571 288 F 288 (323)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=400.63 Aligned_cols=273 Identities=41% Similarity=0.798 Sum_probs=235.1
Q ss_pred eecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||+|+||.|+.+. +++| +...........+.+|+.+|.+++||||+++++++...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999986542 2333 33333455667788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-------------- 146 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-------------- 146 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--------------
Confidence 999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+....
T Consensus 147 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 147 -----------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred -----------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 011234679999999999999999999999999999999999999999998888888887766
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccccc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSRYS 773 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~~s 773 (863)
.. ++..+++++.+||.+||..||.+||+..++.++++||||...+|..+... .+++.|...+..++++|+..+.
T Consensus 210 ~~---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (312)
T cd05585 210 LR---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFT 285 (312)
T ss_pred CC---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCcccc
Confidence 54 35678999999999999999999998888999999999999999877644 4788888888888888876554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=404.99 Aligned_cols=303 Identities=39% Similarity=0.720 Sum_probs=235.6
Q ss_pred EEEeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. +++| +...........+.+|+.+|..++||||++++++|.+.+.+||||||++|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 3489999999986442 2333 33333445567788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC---
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP--- 610 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p--- 610 (863)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.............
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 165 (364)
T cd05599 86 GDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165 (364)
T ss_pred cHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccc
Confidence 99999998888899999999999999999999999999999999999999999999999999874211100000000
Q ss_pred -Cc------cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 611 -AV------SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 611 -~~------~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.. ......... ................+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 166 ALPSNFLDFISKPMSSKR---KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred cccccccccccccccccc---cccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCC
Confidence 00 000000000 00000000011223568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCC
Q 002953 684 HPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESA 762 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~ 762 (863)
+..+.+..+......++. ....+++++.+||.+||. +|.+|++..++.++++||||++++|+.+....++++|...+.
T Consensus 243 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (364)
T cd05599 243 NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSI 321 (364)
T ss_pred CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCCCCc
Confidence 888888888765433221 122578999999999997 999999655699999999999999999988888999998888
Q ss_pred CCCCCccc
Q 002953 763 LDTSYFTS 770 (863)
Q Consensus 763 lDts~F~s 770 (863)
.|.++|+.
T Consensus 322 ~~~~~~~~ 329 (364)
T cd05599 322 TDTSNFDD 329 (364)
T ss_pred hhhhhccc
Confidence 88877754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=408.48 Aligned_cols=306 Identities=42% Similarity=0.713 Sum_probs=234.0
Q ss_pred EEEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. |++.+...........+.+|+++|+.++|||||++++.|.+.+.+|+|||||+|
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 4599999999996652 223333334455667899999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC--C
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP--A 611 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p--~ 611 (863)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.............. .
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~ 165 (382)
T cd05625 86 GDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165 (382)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211000000000 0
Q ss_pred c--cCcccC---CCC-----Cccchh----hhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 612 V--SGTTLL---GDE-----EPQLTA----SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 612 ~--~g~~l~---g~~-----~~~~~~----~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
. ...... +.. ...... ...........+.+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 245 (382)
T cd05625 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245 (382)
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCC
Confidence 0 000000 000 000000 00000111234568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh-hccCCc
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA-RQKAAF 755 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~-~~~ppf 755 (863)
+||...++.+...++.......+. ....+++++.+||.+|+ .+|.+|++..+++++++||||+.++|.... ...+|+
T Consensus 246 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~ 324 (382)
T cd05625 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPY 324 (382)
T ss_pred CCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcCCCCc
Confidence 999998888777777654332211 12468999999999987 599999976679999999999999998744 446899
Q ss_pred cCCCCCCCCCCCccc
Q 002953 756 VPTSESALDTSYFTS 770 (863)
Q Consensus 756 vP~~~s~lDts~F~s 770 (863)
.|......|+++|+.
T Consensus 325 ~~~~~~~~~~~~~~~ 339 (382)
T cd05625 325 IPKITHPTDTSNFDP 339 (382)
T ss_pred cCcCCCcchhhhcCC
Confidence 999988899888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=407.56 Aligned_cols=242 Identities=32% Similarity=0.566 Sum_probs=215.5
Q ss_pred EEEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-EEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~-lyLVmEy~~GG 534 (863)
+..||+|..|+|+.+. .++|..... +....+++.+|++||+.++|||||.+|+.|..++. ++|+||||+||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 3489999999997763 345544333 44556789999999999999999999999999995 99999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|..+++..++++|.....++.++++||.|||+ ++||||||||+||||+..|.|||||||.|+...
T Consensus 164 SLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv------------- 230 (364)
T KOG0581|consen 164 SLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV------------- 230 (364)
T ss_pred CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh-------------
Confidence 999999999999999999999999999999995 999999999999999999999999999988421
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-----ChHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-----HPQQI 688 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-----~~~el 688 (863)
....++++||..|||||.+.+..|+.++||||||++++||++|+.||... +..++
T Consensus 231 --------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L 290 (364)
T KOG0581|consen 231 --------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL 290 (364)
T ss_pred --------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH
Confidence 12456899999999999999999999999999999999999999999764 67888
Q ss_pred HHHHhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~-iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+..|+.+.. |.+|.. +|+++++||..||++||.+|+ ++.++++|||++..
T Consensus 291 l~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 291 LCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHHHhhc
Confidence 888987655 566776 999999999999999999999 99999999999854
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=407.70 Aligned_cols=304 Identities=42% Similarity=0.771 Sum_probs=233.8
Q ss_pred EEeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||+|+.+. +++| +...........+.+|+++|..++||||++++++|.+..++||||||++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 489999999996542 2333 333334455677899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+................+
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 166 (377)
T cd05629 87 DLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166 (377)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccc
Confidence 99999988888999999999999999999999999999999999999999999999999999632110000000000000
Q ss_pred c----ccCCC-----CCccchhhh-------hhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 615 T----TLLGD-----EEPQLTASE-------HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 615 ~----~l~g~-----~~~~~~~~~-------~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
. ...+. ......... ...........+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~ 246 (377)
T cd05629 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWP 246 (377)
T ss_pred cccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCC
Confidence 0 00000 000000000 0000011124689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCcc
Q 002953 679 PFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFV 756 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfv 756 (863)
||...+..+.+..+.... ..+|. ...++.++.+||.+||. +|.+|++..++.++++||||++++|+.+....+|++
T Consensus 247 Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~ 324 (377)
T cd05629 247 PFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFI 324 (377)
T ss_pred CCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHccCCCCcc
Confidence 999988888888777543 22222 12578999999999997 899887777999999999999999999988889999
Q ss_pred CCCCCCCCCCCccc
Q 002953 757 PTSESALDTSYFTS 770 (863)
Q Consensus 757 P~~~s~lDts~F~s 770 (863)
|......++.+|..
T Consensus 325 ~~~~~~~~~~~~~~ 338 (377)
T cd05629 325 PQLKSITDTSYFPT 338 (377)
T ss_pred cCCCCccccccCCc
Confidence 99888887777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=405.21 Aligned_cols=305 Identities=39% Similarity=0.701 Sum_probs=228.9
Q ss_pred EEEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. |++++...........+.+|+.+|..++||||+++++.+.+...+|||||||+|
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 3489999999996542 233333334445567788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC---
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP--- 610 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p--- 610 (863)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.............
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 165 (363)
T cd05628 86 GDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165 (363)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccc
Confidence 99999999888999999999999999999999999999999999999999999999999999874211000000000
Q ss_pred CccC-cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSG-TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g-~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.... ..........................+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~ 245 (363)
T cd05628 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245 (363)
T ss_pred cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0000 000000000000000000011224568999999999999999999999999999999999999999999998888
Q ss_pred HHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCC
Q 002953 690 DNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSY 767 (863)
Q Consensus 690 ~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~ 767 (863)
.++.... ..+|. ...+++++++||.+|+. +|.+|++..++++|++||||++++|+.+....++..+...+..++++
T Consensus 246 ~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (363)
T cd05628 246 KKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSN 323 (363)
T ss_pred HHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCCcchhhc
Confidence 8887643 22332 12478999999999886 67777655599999999999999999997765544444455556666
Q ss_pred ccc
Q 002953 768 FTS 770 (863)
Q Consensus 768 F~s 770 (863)
|+.
T Consensus 324 ~~~ 326 (363)
T cd05628 324 FDE 326 (363)
T ss_pred cCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=396.01 Aligned_cols=274 Identities=39% Similarity=0.747 Sum_probs=234.5
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+||+|+||.|+.+. |++++...........+.+|+.+|+.++||||+++++++...+.+|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 68999999996542 33333333445566788899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------------- 148 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------------- 148 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-------------
Confidence 9999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 149 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~ 210 (328)
T cd05593 149 ------------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (328)
T ss_pred ------------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC
Confidence 01122467999999999999999999999999999999999999999988888888777665
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
... ++..++.++.+||.+||.+||.+|++. .++.++++||||.+++|..+... .+|+.|...+..++.+|+..
T Consensus 211 ~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (328)
T cd05593 211 DIK---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEE 287 (328)
T ss_pred Ccc---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcc
Confidence 544 456789999999999999999999864 48999999999999999988654 47888888888888888765
Q ss_pred cc
Q 002953 772 YS 773 (863)
Q Consensus 772 ~s 773 (863)
++
T Consensus 288 ~~ 289 (328)
T cd05593 288 FT 289 (328)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=402.41 Aligned_cols=303 Identities=41% Similarity=0.703 Sum_probs=228.3
Q ss_pred EEEeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. +++| +...........+.+|+.+|..++||||+++++++.+.+++|+||||++|
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 4489999999996542 2333 33344455667899999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC--CCCC
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL--SGPA 611 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl--~~p~ 611 (863)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.......... .+..
T Consensus 86 g~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~ 165 (381)
T cd05626 86 GDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSH 165 (381)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccc
Confidence 99999998888899999999999999999999999999999999999999999999999999863211000000 0000
Q ss_pred ccCcc-----cC--------CCCCccchhh-hhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 612 VSGTT-----LL--------GDEEPQLTAS-EHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 612 ~~g~~-----l~--------g~~~~~~~~~-~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
..... +. +......... ..........+.+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~ 245 (381)
T cd05626 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245 (381)
T ss_pred ccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCC
Confidence 00000 00 0000000000 0000011224578999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccC--CcCCcCCCCCHHHHHcCCCCCCCChhHHhh-cc
Q 002953 678 PPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTE--DPHQRLGSGGASEVKQHVFFKDINWDTLAR-QK 752 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~--DP~kRpg~~SAeEILqHPFFk~IdW~~l~~-~~ 752 (863)
+||...+..+....+.... ..++. ...+++++.+||.+||.. +|..|+ ++.++++||||++++|..... ..
T Consensus 246 ~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~---~~~~~l~hp~f~~~~~~~~~~~~~ 321 (381)
T cd05626 246 PPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRN---GADDIKAHPFFSEVDFSSDIRTQP 321 (381)
T ss_pred CCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCC---CHHHHhcCcccCCCChhHHhhcCC
Confidence 9999888777766666432 22221 235899999999997654 444588 999999999999999987544 45
Q ss_pred CCccCCCCCCCCCCCccc
Q 002953 753 AAFVPTSESALDTSYFTS 770 (863)
Q Consensus 753 ppfvP~~~s~lDts~F~s 770 (863)
+|++|......++++|+.
T Consensus 322 ~~~~p~~~~~~~~~~~~~ 339 (381)
T cd05626 322 APYVPKISHPMDTSNFDP 339 (381)
T ss_pred CCccCcCCCcchhhhcCC
Confidence 789998888888888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=398.84 Aligned_cols=284 Identities=35% Similarity=0.688 Sum_probs=249.8
Q ss_pred CcccceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
...+|+++ +||+|+|++|-.+ .|++||..+......+-+..|..++.+. +||++|-++..|+++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 34567766 9999999997332 3677777777777888889999999875 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+|.||++||+|.-+++++.+++++.+++|..+|+.||.|||++|||+||||.+|+|++..|++||+|+|+++.++.
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~---- 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG---- 403 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999985321
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC---
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA--- 682 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~--- 682 (863)
.+..+.++||||.|+|||++.+..|+..+|||+||++|+||+.|+.||.-
T Consensus 404 ---------------------------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 404 ---------------------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred ---------------------------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 12455689999999999999999999999999999999999999999942
Q ss_pred -----CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--c
Q 002953 683 -----EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--K 752 (863)
Q Consensus 683 -----~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ 752 (863)
.....+++-|++..... |..+|-.+..+++..|.+||.+|+|+ -+..++..|+||+.++|+.+.+. .
T Consensus 457 ~n~d~ntedylfqvilekqiri---prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ 533 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQIRI---PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVL 533 (593)
T ss_pred CCcccchhHHHHHHHhhhcccc---cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccC
Confidence 23456777788777654 56789999999999999999999987 47899999999999999999875 4
Q ss_pred CCccCCCCCCCCCCCcccccccC
Q 002953 753 AAFVPTSESALDTSYFTSRYSWN 775 (863)
Q Consensus 753 ppfvP~~~s~lDts~F~s~~s~~ 775 (863)
|||.|...+..+..+|++.|+-.
T Consensus 534 ppf~p~i~~d~~l~~fd~qft~e 556 (593)
T KOG0695|consen 534 PPFQPQITDDYGLDNFDTQFTSE 556 (593)
T ss_pred CCCCCccccccCccccccccccC
Confidence 99999999999999998877533
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=392.67 Aligned_cols=271 Identities=38% Similarity=0.746 Sum_probs=229.5
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++++...........+..|.++|..+ +||||++++++|.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 68999999986542 233333333445566788899999876 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~------------ 149 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN------------ 149 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~ 210 (321)
T cd05591 150 -------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210 (321)
T ss_pred -------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 0112346799999999999999999999999999999999999999999999999998887
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC----CHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG----GASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYF 768 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~----SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F 768 (863)
....+ +..++.++.+||.+||+.||.+|++.. +++++++||||..++|..+... .++|.|......+..+|
T Consensus 211 ~~~~~---p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (321)
T cd05591 211 DDVLY---PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNF 287 (321)
T ss_pred CCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhc
Confidence 66543 456899999999999999999999752 8999999999999999988654 36777777666666666
Q ss_pred cc
Q 002953 769 TS 770 (863)
Q Consensus 769 ~s 770 (863)
++
T Consensus 288 ~~ 289 (321)
T cd05591 288 DQ 289 (321)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=391.27 Aligned_cols=269 Identities=39% Similarity=0.770 Sum_probs=232.3
Q ss_pred EEeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. +++|.. ........+.+.+|+.+|++++||||+++++++.+...+|+||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 489999999986542 233332 2223345567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------------- 152 (291)
T cd05612 87 ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------------- 152 (291)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------------
Confidence 999999988889999999999999999999999999999999999999999999999999987310
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 153 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~ 212 (291)
T cd05612 153 --------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212 (291)
T ss_pred --------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 011235799999999999999999999999999999999999999999999888988887
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s 770 (863)
+...+ +..++..+++||++||+.||.+|++. .+++++++||||..++|..+... .+++.|......++.+|++
T Consensus 213 ~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 289 (291)
T cd05612 213 GKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDD 289 (291)
T ss_pred CCcCC---CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccC
Confidence 76544 45679999999999999999999954 36999999999999999987754 4778888877788877754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=394.45 Aligned_cols=272 Identities=39% Similarity=0.757 Sum_probs=231.2
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++++.........+.+..|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 68999999996542 223333333445567788899999876 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------------ 149 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------------ 149 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 210 (320)
T cd05590 150 -------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210 (320)
T ss_pred -------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence 0112346799999999999999999999999999999999999999999999888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
....+ +..++.++.+||++||+.||.+|+++ .+.+++++||||.+++|+.+... .|||.|...+..|.++|+
T Consensus 211 ~~~~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (320)
T cd05590 211 DEVVY---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287 (320)
T ss_pred CCCCC---CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcC
Confidence 66543 45689999999999999999999954 23499999999999999988654 478999988888888876
Q ss_pred cc
Q 002953 770 SR 771 (863)
Q Consensus 770 s~ 771 (863)
..
T Consensus 288 ~~ 289 (320)
T cd05590 288 PD 289 (320)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=394.52 Aligned_cols=274 Identities=38% Similarity=0.757 Sum_probs=231.8
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. |++++.........+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3445554 89999999986542 233333334445567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~------- 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP------- 169 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+
T Consensus 170 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 170 ---------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred ---------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 01123579999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhcc--CCccCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESAL 763 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~~--ppfvP~~~s~l 763 (863)
.+..+..+...+ +..++..+++||.+||+.||.+|+++ .+++++++||||++++|+.+.... +|+.+......
T Consensus 223 ~~~~i~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (329)
T PTZ00263 223 IYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPG 299 (329)
T ss_pred HHHHHhcCCcCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 888888776543 45689999999999999999999964 468999999999999999887543 45555555555
Q ss_pred CCCCcc
Q 002953 764 DTSYFT 769 (863)
Q Consensus 764 Dts~F~ 769 (863)
++.+|.
T Consensus 300 ~~~~~~ 305 (329)
T PTZ00263 300 DTSNFE 305 (329)
T ss_pred cchhcc
Confidence 555554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=396.12 Aligned_cols=273 Identities=38% Similarity=0.762 Sum_probs=233.5
Q ss_pred ccceEE-Eeecccceeecccc--------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..|.+. .||+|+||.|+.+. +++| +.........+.+.+|+.+|..++||||+++++++.+.+.+|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 345544 89999999986542 2333 22333445567788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~------- 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------- 182 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
......+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+...
T Consensus 183 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 235 (340)
T PTZ00426 183 ---------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL 235 (340)
T ss_pred ---------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence 01124579999999999999999999999999999999999999999998888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESAL 763 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~l 763 (863)
++..+......+ +..+++.+.++|++||+.||.+|++. .+++++++||||.+++|..+... .+|++|......
T Consensus 236 ~~~~i~~~~~~~---p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~ 312 (340)
T PTZ00426 236 IYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVF 312 (340)
T ss_pred HHHHHhcCCCCC---CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCc
Confidence 888888766543 46689999999999999999999754 48999999999999999988754 478899887766
Q ss_pred CCCCcc
Q 002953 764 DTSYFT 769 (863)
Q Consensus 764 Dts~F~ 769 (863)
+.++|.
T Consensus 313 ~~~~~~ 318 (340)
T PTZ00426 313 DSSNFE 318 (340)
T ss_pred chhhcC
Confidence 666653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=390.11 Aligned_cols=273 Identities=34% Similarity=0.722 Sum_probs=229.9
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||.|+.+. |++++.........+.+..|+.++..++| ++|++++++|.+.+.+|+||||++|
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 489999999996542 23333333344566778899999999976 5688999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~----------- 154 (324)
T cd05587 86 GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG----------- 154 (324)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 155 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 155 --------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred --------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999999888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
..... ++..++.++.+||.+||..||.+|++. ...+++++||||+.++|..+... .+++.|......+.++|+
T Consensus 215 ~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (324)
T cd05587 215 EHNVS---YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFD 291 (324)
T ss_pred cCCCC---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcC
Confidence 76654 356789999999999999999999965 34589999999999999988654 467888777666777775
Q ss_pred cc
Q 002953 770 SR 771 (863)
Q Consensus 770 s~ 771 (863)
..
T Consensus 292 ~~ 293 (324)
T cd05587 292 KF 293 (324)
T ss_pred cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=390.67 Aligned_cols=272 Identities=36% Similarity=0.707 Sum_probs=224.3
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++++...........+.+|+.++.++ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 69999999986442 333333334445567788999999888 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 149 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------------ 149 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-------ChHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-------HPQQ 687 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-------~~~e 687 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... ....
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~ 210 (327)
T cd05617 150 -------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210 (327)
T ss_pred -------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH
Confidence 01123468999999999999999999999999999999999999999532 2233
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
.+..+..... .+|..++..+.++|.+||..||.+|++. .+++++++||||+.++|+.+... .++|.|.....
T Consensus 211 ~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 287 (327)
T cd05617 211 LFQVILEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287 (327)
T ss_pred HHHHHHhCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCC
Confidence 4444544433 3456789999999999999999999964 35789999999999999988755 46788887666
Q ss_pred CCCCCcccc
Q 002953 763 LDTSYFTSR 771 (863)
Q Consensus 763 lDts~F~s~ 771 (863)
.+.++|+..
T Consensus 288 ~~~~~~~~~ 296 (327)
T cd05617 288 YGLENFDTQ 296 (327)
T ss_pred cchhhcCCc
Confidence 666777554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=389.09 Aligned_cols=271 Identities=34% Similarity=0.720 Sum_probs=227.5
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||.|+.+. |++++...........+..|..++..+ +||+|+++++++.+.+.+|+||||++|
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 489999999996542 233333333344556678899998887 589999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 86 g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~----------- 154 (323)
T cd05616 86 GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----------- 154 (323)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...++..+.
T Consensus 155 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 155 --------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred --------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999999988988888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
.....+ +..++.++.+||.+||+.||.+|++. ....++++||||+.++|+.+... .+|+.|... ..|..+|+
T Consensus 215 ~~~~~~---p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 290 (323)
T cd05616 215 EHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENFD 290 (323)
T ss_pred hCCCCC---CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-CchhhhcC
Confidence 766543 46789999999999999999999975 35799999999999999998765 477887654 34555554
Q ss_pred c
Q 002953 770 S 770 (863)
Q Consensus 770 s 770 (863)
.
T Consensus 291 ~ 291 (323)
T cd05616 291 K 291 (323)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=395.49 Aligned_cols=305 Identities=42% Similarity=0.698 Sum_probs=231.8
Q ss_pred EEeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. +++| +...........+.+|+++|..++||||+++++.|.+++.+|+|||||+||
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 489999999996542 2232 333333445677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC-----
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG----- 609 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~----- 609 (863)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.............
T Consensus 87 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~ 166 (376)
T cd05598 87 DMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166 (376)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccc
Confidence 999999988889999999999999999999999999999999999999999999999999986321000000000
Q ss_pred --CCccCcccCCC-C---Cccchh-hhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 610 --PAVSGTTLLGD-E---EPQLTA-SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 610 --p~~~g~~l~g~-~---~~~~~~-~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
........... . ...... .............+||+.|||||++.+..++.++|||||||++|||++|++||.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred ccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 00000000000 0 000000 0000011122356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh-hccCCccCCCC
Q 002953 683 EHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA-RQKAAFVPTSE 760 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~-~~~ppfvP~~~ 760 (863)
.+..+....+......... ....+++++.+||.+|+ .+|.+|++..++.++++||||+.++|..+. ...++++|...
T Consensus 247 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~ 325 (376)
T cd05598 247 DTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKIT 325 (376)
T ss_pred CCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCCCCCcCC
Confidence 8887777766554332211 12468999999999987 599999987789999999999999999885 44578899887
Q ss_pred CCCCCCCccc
Q 002953 761 SALDTSYFTS 770 (863)
Q Consensus 761 s~lDts~F~s 770 (863)
...++++|+.
T Consensus 326 ~~~~~~~~~~ 335 (376)
T cd05598 326 HPTDTSNFDP 335 (376)
T ss_pred CcchhhhcCC
Confidence 7778777754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=400.57 Aligned_cols=242 Identities=32% Similarity=0.574 Sum_probs=218.3
Q ss_pred Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.||+|+||+||... +++|..... .++..+.+..|+.||+.++|||||++++++.+.+++|||||||+||+|
T Consensus 17 ~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 17 EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 59999999997652 455554444 566778899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC------CcEEEeecCCccccccCCCCCCCCC
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD------GHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~------g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
..||++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+...
T Consensus 97 s~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---------- 166 (429)
T KOG0595|consen 97 SDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---------- 166 (429)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC----------
Confidence 9999999999999999999999999999999999999999999999875 358999999999521
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
......+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+..+++.
T Consensus 167 ----------------------~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 167 ----------------------PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred ----------------------chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 1234457899999999999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+..+....|.++..++....+|+..+|..+|.+|. +..+.+.|+|...
T Consensus 225 ~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 225 YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLAA 273 (429)
T ss_pred HHhccccccCchhhhccCchhhhhhHHHhcCccccC---chHHhhhhhhccc
Confidence 998888777777888999999999999999999999 8999999988764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=390.93 Aligned_cols=299 Identities=45% Similarity=0.790 Sum_probs=234.3
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||+|+.+. |++++...........+.+|+.+|..++||||+++++++.+++++|+||||++|+
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 489999999996542 2333333334456677899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..................
T Consensus 87 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 166 (350)
T cd05573 87 DLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166 (350)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccc
Confidence 99999988888999999999999999999999999999999999999999999999999998742211100000000000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
..... ....................||+.|+|||++.+..++.++|||||||++|||++|..||...+....+.++..
T Consensus 167 ~~~~~--~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 167 LLFRD--NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244 (350)
T ss_pred ccccc--cccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhc
Confidence 00000 0000000000111223456799999999999999999999999999999999999999999888888888876
Q ss_pred --cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC-HHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCCccc
Q 002953 695 --RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG-ASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 695 --~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~S-AeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~F~s 770 (863)
....+|.. ..+++++.+||.+||. ||.+|+ + ++++++||||++++|+......+|++|......++.+|+.
T Consensus 245 ~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~---~s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (350)
T cd05573 245 WKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNFDD 318 (350)
T ss_pred cCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcC---CCHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhcCC
Confidence 33333332 2379999999999997 999999 7 9999999999999999998888999999888877777654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=395.74 Aligned_cols=305 Identities=40% Similarity=0.717 Sum_probs=231.5
Q ss_pred EEEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||.|+.+. |++++...........+.+|+.+|..++||||+++++.|.+.+++||||||++|
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 3489999999996542 233333344455667888999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC----C
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS----G 609 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~----~ 609 (863)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++........... .
T Consensus 86 g~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~ 165 (360)
T cd05627 86 GDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165 (360)
T ss_pred ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccccccc
Confidence 999999988888999999999999999999999999999999999999999999999999998742111000000 0
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+.......................+||+.|+|||++.+..++.++|||||||++|||++|.+||...+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~ 245 (360)
T cd05627 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245 (360)
T ss_pred CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH
Confidence 00000000000000000000000111223568999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCC
Q 002953 690 DNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSY 767 (863)
Q Consensus 690 ~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~ 767 (863)
.++..... .+|. ...++.++++||.+|+. ||.+|++..+++++++||||++++|..+....++..+...+..|.++
T Consensus 246 ~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (360)
T cd05627 246 RKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSN 323 (360)
T ss_pred HHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCcchhhh
Confidence 88876432 2222 12478999999999875 99999988889999999999999999997765544445556667777
Q ss_pred ccc
Q 002953 768 FTS 770 (863)
Q Consensus 768 F~s 770 (863)
|+.
T Consensus 324 ~~~ 326 (360)
T cd05627 324 FDE 326 (360)
T ss_pred cCC
Confidence 653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=393.30 Aligned_cols=273 Identities=41% Similarity=0.773 Sum_probs=228.0
Q ss_pred eecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 467 AGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV---RNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 467 LGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
||+|+||+|+.+. |++.+..............|..++..+ +||||+++++.|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999996542 223233333344455667788888765 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~----------- 149 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD----------- 149 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+++..+
T Consensus 150 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 150 --------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred --------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 0112346799999999999764 4899999999999999999999999999988888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
..+...++. ..+++++.+||++||..||.+||++ .++.++++||||.+++|+.+... .+++.|......+.++|+
T Consensus 210 ~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (330)
T cd05586 210 AFGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFD 287 (330)
T ss_pred HcCCCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcC
Confidence 777665542 3579999999999999999999975 48999999999999999988654 468888877777777776
Q ss_pred ccc
Q 002953 770 SRY 772 (863)
Q Consensus 770 s~~ 772 (863)
..+
T Consensus 288 ~~~ 290 (330)
T cd05586 288 PEF 290 (330)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=387.16 Aligned_cols=271 Identities=39% Similarity=0.765 Sum_probs=228.0
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. |++++.........+.+..|..++..+ +||||+++++++...+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 68999999996542 233333333344556677788888754 8999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~------------ 149 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG------------ 149 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 210 (316)
T cd05592 150 -------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210 (316)
T ss_pred -------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 0112346799999999999999999999999999999999999999999988888888765
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCccccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSRY 772 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~~ 772 (863)
... .++..++.++.+||.+||..||.+||+ ...++++||||..++|..+... .+++.|......+.++|+..+
T Consensus 211 ~~~---~~~~~~~~~~~~ll~~~l~~~P~~R~~--~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05592 211 DRP---HFPRWISKEAKDCLSKLFERDPTKRLG--VDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREF 285 (316)
T ss_pred CCC---CCCCCCCHHHHHHHHHHccCCHHHcCC--ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 443 345678999999999999999999993 2468999999999999988654 467888888888888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=389.95 Aligned_cols=273 Identities=41% Similarity=0.762 Sum_probs=233.7
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+||+|+||.|+.+. |++++...........+.+|+.+|+.++||||++++++|...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 68999999996542 23333333344556678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~------------- 148 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------------- 148 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-------------
Confidence 9999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+....+..+...
T Consensus 149 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05595 149 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210 (323)
T ss_pred ------------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 01112467999999999999999999999999999999999999999998888888887766
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhcc--CCccCCCCCCCCCCCcccc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~~--ppfvP~~~s~lDts~F~s~ 771 (863)
...+ +..+++++.+||.+||..||.+|++. .++.++++||||.+++|..+.... +|+.|...+..++.+|+..
T Consensus 211 ~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05595 211 EIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDE 287 (323)
T ss_pred CCCC---CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcc
Confidence 6543 56789999999999999999999864 489999999999999999887543 7888888888888887764
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 288 ~ 288 (323)
T cd05595 288 F 288 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=387.30 Aligned_cols=269 Identities=35% Similarity=0.710 Sum_probs=225.3
Q ss_pred Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. +++| +...........+..|..++..+ +||||+++++++.+.+++|+||||+.||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 69999999986542 2233 22222234556678888888764 8999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------------ 149 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------------ 149 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~ 210 (316)
T cd05620 150 -------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210 (316)
T ss_pred -------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 0112346799999999999999999999999999999999999999999888888887765
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH-HHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-SEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA-eEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
... .++..++.++.+||.+||..||.+|+ ++ +++++||||+.++|..+... .+|+.|......+.++|+.+
T Consensus 211 ~~~---~~~~~~~~~~~~li~~~l~~dP~~R~---~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd05620 211 DTP---HYPRWITKESKDILEKLFERDPTRRL---GVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDRE 284 (316)
T ss_pred CCC---CCCCCCCHHHHHHHHHHccCCHHHcC---CChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 543 34567899999999999999999999 65 68999999999999987654 36788887777777777553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=389.15 Aligned_cols=271 Identities=35% Similarity=0.712 Sum_probs=220.9
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++++...........+.+|+.++.++ +||||+++++++.+.+.+|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 69999999986542 333333333445566788999999876 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~------------ 149 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP------------ 149 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC---------CCh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA---------EHP 685 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~---------~~~ 685 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ...
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05618 150 -------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210 (329)
T ss_pred -------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence 0112346899999999999999999999999999999999999999952 112
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSE 760 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~ 760 (863)
..+...+..... .+|..++.++.+||++||..||.+|+++ .++.++++||||++++|+.+... .+++.|...
T Consensus 211 ~~~~~~i~~~~~---~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
T cd05618 211 DYLFQVILEKQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNIS 287 (329)
T ss_pred HHHHHHHhcCCC---CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCC
Confidence 234444544443 3456789999999999999999999954 24789999999999999988654 467777766
Q ss_pred CCCCCCCccc
Q 002953 761 SALDTSYFTS 770 (863)
Q Consensus 761 s~lDts~F~s 770 (863)
...+..+|.+
T Consensus 288 ~~~~~~~~~~ 297 (329)
T cd05618 288 GEFGLDNFDA 297 (329)
T ss_pred CcccchhcCc
Confidence 6555555544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=387.55 Aligned_cols=270 Identities=38% Similarity=0.774 Sum_probs=230.2
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++++...........+..|..++..+ +||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 68999999986542 233333334445566788999999888 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------------ 149 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG------------ 149 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+..+..
T Consensus 150 -------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~ 210 (318)
T cd05570 150 -------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210 (318)
T ss_pred -------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 0112245799999999999999999999999999999999999999999888888888876
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH-----HHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCC
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA-----SEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 767 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA-----eEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~ 767 (863)
.... ++..++.++.+||++||..||.+|| ++ .++++||||+.++|...... .+|+.|......+.++
T Consensus 211 ~~~~---~~~~~~~~~~~li~~~l~~dP~~R~---s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (318)
T cd05570 211 DEVR---YPRWLSKEAKSILKSFLTKNPEKRL---GCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSN 284 (318)
T ss_pred CCCC---CCCcCCHHHHHHHHHHccCCHHHcC---CCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhh
Confidence 6543 3567899999999999999999999 66 99999999999999877654 4788888887777777
Q ss_pred ccccc
Q 002953 768 FTSRY 772 (863)
Q Consensus 768 F~s~~ 772 (863)
|+..+
T Consensus 285 ~~~~~ 289 (318)
T cd05570 285 FDDEF 289 (318)
T ss_pred cCchh
Confidence 76544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=386.73 Aligned_cols=273 Identities=38% Similarity=0.760 Sum_probs=227.6
Q ss_pred Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. +++| +...........+..|..+ ++.++||||+++++.+...+.+|+||||++||
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 68999999986542 2333 2223333444556666664 57799999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------------ 149 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------------ 149 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 210 (323)
T cd05575 150 -------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210 (323)
T ss_pred -------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 0112345799999999999999999999999999999999999999999988888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
.... ++..++.++.+||.+||+.||.+||+. ..+.++++||||..++|..+... .+|+.|......+...|+..
T Consensus 211 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05575 211 KPLR---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPE 287 (323)
T ss_pred CCCC---CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCcc
Confidence 6543 345689999999999999999999965 35689999999999999988754 47888887777777777654
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 288 ~ 288 (323)
T cd05575 288 F 288 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=387.65 Aligned_cols=269 Identities=42% Similarity=0.748 Sum_probs=230.2
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. |++++...........+.+|+.+|..++||||+++++++...+++||||||++||
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 389999999996542 2233333333445667889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------------- 152 (333)
T cd05600 87 DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------------- 152 (333)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------------
Confidence 999999988889999999999999999999999999999999999999999999999999987310
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+.+..+..
T Consensus 153 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 153 --------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred --------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 012346799999999999999999999999999999999999999999988888777765
Q ss_pred cCCC--CCCCC---CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCCcc
Q 002953 695 RKIP--WPRVP---EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFT 769 (863)
Q Consensus 695 ~~~~--~p~~p---~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~F~ 769 (863)
.... .|... ..++.++.+||.+||..+|.+|+ ++.++++||||.+++|..+....+|++|......+..+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T cd05600 213 WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGYFD 289 (333)
T ss_pred ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhhcc
Confidence 3321 12211 25689999999999999999999 9999999999999999999888899999888777776664
Q ss_pred c
Q 002953 770 S 770 (863)
Q Consensus 770 s 770 (863)
.
T Consensus 290 ~ 290 (333)
T cd05600 290 D 290 (333)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=388.30 Aligned_cols=273 Identities=35% Similarity=0.709 Sum_probs=223.7
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. |++++...........+..|+.++..+ +||||++++++|.+.+.+||||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 68999999986542 333333333444566788999999998 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------------ 149 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------------ 149 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC------------
Confidence 99999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---------Ch
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE---------HP 685 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~---------~~ 685 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05588 150 -------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210 (329)
T ss_pred -------------------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccch
Confidence 01123468999999999999999999999999999999999999999531 12
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSE 760 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~ 760 (863)
...++.+..... .+|..++.++.+||.+||..||.+|+++ .+++++++||||..++|..+... .+++.|...
T Consensus 211 ~~~~~~~~~~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
T cd05588 211 DYLFQVILEKQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIE 287 (329)
T ss_pred HHHHHHHHcCCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCC
Confidence 234444544443 3456789999999999999999999964 35899999999999999988654 367777776
Q ss_pred CCCCCCCccccc
Q 002953 761 SALDTSYFTSRY 772 (863)
Q Consensus 761 s~lDts~F~s~~ 772 (863)
...+..+|...+
T Consensus 288 ~~~~~~~~~~~~ 299 (329)
T cd05588 288 SDRDLDNFDPQF 299 (329)
T ss_pred CcchhhhcCCcc
Confidence 666666665543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=386.31 Aligned_cols=272 Identities=39% Similarity=0.730 Sum_probs=228.3
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHH---hcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILI---SVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~---~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..||+|+||.|+.+. |++++.........+.+.+|++++. .++||||+++++++.+.+.+|+||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 489999999986542 2333333334455667888877764 567999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+||+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 154 (324)
T cd05589 85 AGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--------- 154 (324)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---------
Confidence 99999988865 57999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 155 ----------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred ----------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0112356899999999999999999999999999999999999999999998888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 767 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~ 767 (863)
+...... ++..++.++.+||.+||..||.+||+. .++.++++||||++++|..+... .+|+.|......|.++
T Consensus 213 i~~~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 289 (324)
T cd05589 213 IVNDEVR---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSN 289 (324)
T ss_pred HHhCCCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhh
Confidence 8776654 356789999999999999999999975 37999999999999999987644 4788888777777777
Q ss_pred cccc
Q 002953 768 FTSR 771 (863)
Q Consensus 768 F~s~ 771 (863)
|...
T Consensus 290 ~~~~ 293 (324)
T cd05589 290 FDEE 293 (324)
T ss_pred cCcc
Confidence 6554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=385.91 Aligned_cols=270 Identities=37% Similarity=0.721 Sum_probs=228.1
Q ss_pred Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+|+||+|+.+. +++| +..............|..++.. ++||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999996542 2333 2222223445667788888876 48999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~------------ 149 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG------------ 149 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC------------
Confidence 99999988788999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 210 (316)
T cd05619 150 -------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210 (316)
T ss_pred -------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 0112346799999999999999999999999999999999999999999888888877765
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH-HHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe-EILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
... .++..++.++.+||.+||..||.+|| ++. ++++||||+.++|..+... .+++.|......+.++|+..
T Consensus 211 ~~~---~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd05619 211 DNP---CYPRWLTREAKDILVKLFVREPERRL---GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKE 284 (316)
T ss_pred CCC---CCCccCCHHHHHHHHHHhccCHhhcC---CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChh
Confidence 543 34566899999999999999999999 775 9999999999999988654 58899999888888888765
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 285 ~ 285 (316)
T cd05619 285 F 285 (316)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=386.24 Aligned_cols=273 Identities=36% Similarity=0.718 Sum_probs=227.9
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. |++.+...........+..|..+ ++.++||||+++++++...+.+|+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 68999999996542 22223323333444556667664 67799999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~------------ 149 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ------------ 149 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~ 210 (325)
T cd05604 150 -------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210 (325)
T ss_pred -------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc
Confidence 0112346799999999999999999999999999999999999999999998888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
..... +...+..+.++|.+||..+|.+||+. .++.++++||||+.++|..+... .+|+.|......+.++|+..
T Consensus 211 ~~~~~---~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (325)
T cd05604 211 KPLVL---RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAV 287 (325)
T ss_pred CCccC---CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCc
Confidence 65433 34689999999999999999999975 46789999999999999988754 36788887777777777654
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 288 ~ 288 (325)
T cd05604 288 F 288 (325)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=385.12 Aligned_cols=274 Identities=41% Similarity=0.804 Sum_probs=229.2
Q ss_pred EEeecccceeecccc-------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..||+|+||.|+.+. |++++.... .......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 479999999997542 222222221 223345678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------- 153 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-------- 153 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--------
Confidence 999999999998888999999999999999999999999999999999999999999999999998731100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+....+.
T Consensus 154 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~ 210 (323)
T cd05584 154 -----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210 (323)
T ss_pred -----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 011234679999999999999989999999999999999999999999998888888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTS 766 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts 766 (863)
.+...... ++..+++++.+||.+||..+|++||+. .+++++++||||...+|..+... .+++.+...+..+.+
T Consensus 211 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05584 211 KILKGKLN---LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVS 287 (323)
T ss_pred HHHcCCCC---CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhh
Confidence 88776654 356789999999999999999999964 57999999999999999988654 366777666666666
Q ss_pred Cccccc
Q 002953 767 YFTSRY 772 (863)
Q Consensus 767 ~F~s~~ 772 (863)
.|+..+
T Consensus 288 ~~~~~~ 293 (323)
T cd05584 288 QFDSKF 293 (323)
T ss_pred hcCchh
Confidence 665543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.40 Aligned_cols=271 Identities=39% Similarity=0.754 Sum_probs=224.4
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~-IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. |++.+...........+..|.. +++.++||||+++++++.+.+.+|+||||++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999996542 2333333333344455666665 578899999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------------ 149 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------------ 149 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+...++..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 150 -------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred -------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 0112346799999999999998899999999999999999999999999988888888876
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s 770 (863)
.... ++...+.++.++|.+||+.||.+|++. .++.++++|+||..++|..+... .+++.|......+...|+.
T Consensus 211 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (321)
T cd05603 211 KPLQ---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDP 286 (321)
T ss_pred CCCC---CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCC
Confidence 6543 345788999999999999999999975 46789999999999999988654 3677776666655555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=385.04 Aligned_cols=273 Identities=41% Similarity=0.747 Sum_probs=232.5
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+||+|+||.|+.+. |++++...........+.+|++++..++||||+++++++...+.+|+||||++||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 68999999996542 33333333444556678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~------------ 149 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD------------ 149 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC------------
Confidence 99999888889999999999999999999997 79999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~ 210 (325)
T cd05594 150 -------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210 (325)
T ss_pred -------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc
Confidence 0112245799999999999999999999999999999999999999999888888887766
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s 770 (863)
.... ++..+++++.+||.+||+.||.+|++. .++.++++||||.++.|..+... .+|+.|...+..++.+|+.
T Consensus 211 ~~~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (325)
T cd05594 211 EEIR---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDE 287 (325)
T ss_pred CCCC---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCc
Confidence 6554 356789999999999999999999854 38999999999999999987654 3788888888888888876
Q ss_pred cc
Q 002953 771 RY 772 (863)
Q Consensus 771 ~~ 772 (863)
.+
T Consensus 288 ~~ 289 (325)
T cd05594 288 EF 289 (325)
T ss_pred hh
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=400.18 Aligned_cols=248 Identities=35% Similarity=0.652 Sum_probs=214.9
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhch--hHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRK--NAVESILAERDILISVR-NPFVVRFFYSFTCRENL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k--~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~l 524 (863)
...|.+. .||+|+||+|+.+. |++.+...... ...+.+.+|+.+|+.++ ||||+++++++.+...+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 3445544 89999999985542 22222211111 24456778999999999 99999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s 603 (863)
|+|||||.||+|++++.+.+++.+..++.++.||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--- 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--- 172 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC---
Confidence 9999999999999999999999999999999999999999999999999999999999999 999999999998420
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-C-CccceeechhHHHHHHHhCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-H-GTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-y-s~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.......+.|||+.|+|||++.+.. | +.++||||+|++||.|++|..||.
T Consensus 173 ----------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 173 ----------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred ----------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 0123456789999999999999987 8 589999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCC-CHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~i-S~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+...++.+|..+...+| ..+ +.++++||.+||..||.+|+ ++.+|++||||+..
T Consensus 225 d~~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPWFQKE 281 (370)
T ss_pred CccHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChhhccC
Confidence 9999999999998888665 456 99999999999999999999 99999999999863
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=383.08 Aligned_cols=273 Identities=38% Similarity=0.758 Sum_probs=224.9
Q ss_pred Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~-IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+|+||+|+.+. |++.+...........+..|.. +++.++||||+++++++...+.+|+||||++||
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 68999999996542 2222222222333345555555 467789999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~------------ 149 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH------------ 149 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC------------
Confidence 99999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+..
T Consensus 150 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 150 -------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred -------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 0112346799999999999999999999999999999999999999999998888888876
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
.... .+..++..+.++|.+||+.||.+|++. ....++++|+||..++|+.+... .+++.|......+...|+..
T Consensus 211 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (325)
T cd05602 211 KPLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPE 287 (325)
T ss_pred CCcC---CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCc
Confidence 5543 345789999999999999999999965 35679999999999999998754 36777777666666666554
Q ss_pred c
Q 002953 772 Y 772 (863)
Q Consensus 772 ~ 772 (863)
+
T Consensus 288 ~ 288 (325)
T cd05602 288 F 288 (325)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=382.00 Aligned_cols=272 Identities=33% Similarity=0.699 Sum_probs=227.0
Q ss_pred EEeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.+||+|+||.|+.+. +++| +.........+.+..|+.++..+. |++|+++++++.+.+.+|+||||++|
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 489999999996542 2333 333334455667888999998886 57888999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~----------- 154 (323)
T cd05615 86 GDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD----------- 154 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998731100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...++..+.
T Consensus 155 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 155 --------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred --------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234679999999999999999999999999999999999999999999888888888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
..... ++..++.++.+|+.+||.++|.+|++. ...+++++||||..++|..+... .+|+.|..... ...+|+
T Consensus 215 ~~~~~---~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 290 (323)
T cd05615 215 EHNVS---YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFD 290 (323)
T ss_pred hCCCC---CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcC
Confidence 76654 346789999999999999999999975 35789999999999999998765 47888765332 344554
Q ss_pred cc
Q 002953 770 SR 771 (863)
Q Consensus 770 s~ 771 (863)
..
T Consensus 291 ~~ 292 (323)
T cd05615 291 KF 292 (323)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=384.16 Aligned_cols=273 Identities=38% Similarity=0.728 Sum_probs=225.5
Q ss_pred EEeecccceeecccc----------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..||+|+||.|+.+. +++|.... ........+.+|+++|++++||||+++++++.+.+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 479999999987432 12222111 122234467789999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~---------- 151 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH---------- 151 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC----------
Confidence 9999999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 152 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 152 ---------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ---------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 01123467999999999999988999999999999999999999999998888888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC--HHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCc
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG--ASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYF 768 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~S--AeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F 768 (863)
...... ++..+++++.+||++||+.||.+||++.. ++++++||||..++|..+... .+++.|......+..++
T Consensus 211 ~~~~~~---~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (318)
T cd05582 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYF 287 (318)
T ss_pred HcCCCC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhc
Confidence 766654 35678999999999999999999996533 899999999999999987654 36677766555555445
Q ss_pred ccc
Q 002953 769 TSR 771 (863)
Q Consensus 769 ~s~ 771 (863)
++.
T Consensus 288 ~~~ 290 (318)
T cd05582 288 DPE 290 (318)
T ss_pred Ccc
Confidence 443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=375.07 Aligned_cols=263 Identities=34% Similarity=0.575 Sum_probs=214.1
Q ss_pred EEEeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. +++|. ...........+.+|+.+|..++|+||+++++++.+.+.+|+||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 4589999999986542 33332 2222333445678999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 85 g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---------- 154 (285)
T cd05631 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---------- 154 (285)
T ss_pred CcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC----------
Confidence 9999888653 3589999999999999999999999999999999999999999999999999874100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 0111245799999999999999999999999999999999999999987654322222
Q ss_pred Hhhc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCC
Q 002953 692 ILNR-KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 758 (863)
Q Consensus 692 Il~~-~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~ 758 (863)
+... ......++..++.++.+||++||+.||.+||+. .+++++++||||.+++|+.+... +|||.|.
T Consensus 213 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 2111 111123456789999999999999999999964 36999999999999999999876 6899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=380.73 Aligned_cols=271 Identities=40% Similarity=0.706 Sum_probs=227.0
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||+|+.+. |++++...........+..|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 389999999996542 2333333333445667889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---------- 156 (330)
T cd05601 87 DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK---------- 156 (330)
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC----------
Confidence 999999876 679999999999999999999999999999999999999999999999999987421000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc------CCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~------g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........||+.|+|||++. +..++.++|||||||++|+|++|..||...+...
T Consensus 157 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 216 (330)
T cd05601 157 --------------------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216 (330)
T ss_pred --------------------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH
Confidence 00112357999999999997 4567899999999999999999999999888888
Q ss_pred HHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCC
Q 002953 688 IFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 765 (863)
Q Consensus 688 l~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDt 765 (863)
.+.++..... .+|. ...++.++.+||++||. +|.+|| +++++++||||..++|..+....+++.|......+.
T Consensus 217 ~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~---t~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (330)
T cd05601 217 TYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERL---GYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDT 291 (330)
T ss_pred HHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCC---CHHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcchh
Confidence 8888766432 2222 23579999999999998 999999 999999999999999999988888999988777777
Q ss_pred CCccc
Q 002953 766 SYFTS 770 (863)
Q Consensus 766 s~F~s 770 (863)
++|..
T Consensus 292 ~~~~~ 296 (330)
T cd05601 292 SNFDE 296 (330)
T ss_pred hhcCC
Confidence 77654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=406.31 Aligned_cols=242 Identities=31% Similarity=0.576 Sum_probs=216.7
Q ss_pred Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+-|.|..+ .|++.|..-........+.+|+-||+-+.||||+++|++++++.++|+|+||++||.
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 7999999988433 244444433344455678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|++++...|+|++.++..++.||+.|+.|+|..+|+||||||+|+|++..++|||+|||+|..-.
T Consensus 99 LFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--------------- 163 (786)
T KOG0588|consen 99 LFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--------------- 163 (786)
T ss_pred hHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---------------
Confidence 99999999999999999999999999999999999999999999999999999999999998411
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
++....+.||+|.|.|||++.|.+| +.++||||-|||||.||+|++||.+++...++.++..
T Consensus 164 -----------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~ 226 (786)
T KOG0588|consen 164 -----------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR 226 (786)
T ss_pred -----------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 1234457899999999999999998 7899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
+.+.+ |..+|.++++||.+||..||++|+ |.++|++|||+.+..-
T Consensus 227 G~f~M---Ps~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 227 GVFEM---PSNISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred CcccC---CCcCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 98865 478999999999999999999999 9999999999987643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=385.88 Aligned_cols=278 Identities=41% Similarity=0.725 Sum_probs=223.3
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. |++++...........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 345544 89999999986442 2333333344445567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......
T Consensus 123 Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~------ 195 (370)
T cd05621 123 EYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET------ 195 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC------
Confidence 99999999999976 46899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
......+.+||+.|||||++.+.. ++.++|||||||++|+|++|.+||...+
T Consensus 196 ------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 196 ------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ------------------------CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 001123568999999999997643 7889999999999999999999999998
Q ss_pred hHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh--HHhhccCCccCCCC
Q 002953 685 PQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD--TLARQKAAFVPTSE 760 (863)
Q Consensus 685 ~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~--~l~~~~ppfvP~~~ 760 (863)
....+.++..... .+|. ...++..++++|.+||.. +.+|++..++.++++||||+...|. .+....+|+.|...
T Consensus 252 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~-~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~ 329 (370)
T cd05621 252 LVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTD-REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS 329 (370)
T ss_pred HHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccC-chhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCC
Confidence 8888888876543 2222 235799999999999984 4444433399999999999986654 44445678888888
Q ss_pred CCCCCCCccc
Q 002953 761 SALDTSYFTS 770 (863)
Q Consensus 761 s~lDts~F~s 770 (863)
...|.++|+.
T Consensus 330 ~~~~~~~~~~ 339 (370)
T cd05621 330 SDIDSSNFDD 339 (370)
T ss_pred CcchhhhcCC
Confidence 7777777753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.07 Aligned_cols=274 Identities=39% Similarity=0.736 Sum_probs=225.9
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. |++.+...........+..|+.++..++|+||+++++.+.+.+.+|+||||++||
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 489999999986542 2333333344445566889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.......
T Consensus 87 ~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---------- 156 (332)
T cd05623 87 DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---------- 156 (332)
T ss_pred cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----------
Confidence 99999977 4679999999999999999999999999999999999999999999999999987321000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.
T Consensus 157 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~ 216 (332)
T cd05623 157 --------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (332)
T ss_pred --------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH
Confidence 01122357999999999986 34578999999999999999999999999998888
Q ss_pred HHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCC
Q 002953 689 FDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTS 766 (863)
Q Consensus 689 ~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts 766 (863)
+.++..... .+|.....++.++.+||++||..+ .+|++..+++++++||||.+++|+.+....+|++|...+..+++
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~-~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (332)
T cd05623 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTS 295 (332)
T ss_pred HHHHhCCCccccCCCccccCCHHHHHHHHHHccCh-hhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCcccc
Confidence 888876543 334444568999999999999864 45544459999999999999999999888889998877766666
Q ss_pred Ccc
Q 002953 767 YFT 769 (863)
Q Consensus 767 ~F~ 769 (863)
++.
T Consensus 296 ~~~ 298 (332)
T cd05623 296 NFD 298 (332)
T ss_pred cCC
Confidence 553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=376.06 Aligned_cols=274 Identities=38% Similarity=0.721 Sum_probs=226.0
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||+|+.+. |++++...........+.+|+.++..++|+||+++++++.+.+++|+||||++||
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 389999999986442 2233333334445566888999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---------- 156 (331)
T cd05624 87 DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---------- 156 (331)
T ss_pred cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----------
Confidence 99999987 4679999999999999999999999999999999999999999999999999987411000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 157 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~ 216 (331)
T cd05624 157 --------------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (331)
T ss_pred --------------------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH
Confidence 001123579999999999976 4578899999999999999999999999888888
Q ss_pred HHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCC
Q 002953 689 FDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTS 766 (863)
Q Consensus 689 ~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts 766 (863)
+..+.... ..+|.....++.++.+||.+||..+ .+|++..+++++++||||++++|+.+....+|++|......+..
T Consensus 217 ~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~~~ 295 (331)
T cd05624 217 YGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTS 295 (331)
T ss_pred HHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcchhh
Confidence 88887644 2334444567999999999999864 46665569999999999999999999888899999877666666
Q ss_pred Ccc
Q 002953 767 YFT 769 (863)
Q Consensus 767 ~F~ 769 (863)
+|+
T Consensus 296 ~~~ 298 (331)
T cd05624 296 NFD 298 (331)
T ss_pred hcC
Confidence 554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=384.09 Aligned_cols=277 Identities=40% Similarity=0.687 Sum_probs=225.9
Q ss_pred cccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. .++| +...........+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 3445544 89999999986442 2333 33333444556688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~----- 195 (370)
T cd05596 122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN----- 195 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 999999999999876 46899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC----CCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----GHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.
T Consensus 196 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 196 -------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred -------------------------CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 00112346799999999999764 3789999999999999999999999999
Q ss_pred ChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCC--cCCCCCHHHHHcCCCCCCCChhHHh--hccCCccC
Q 002953 684 HPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQ--RLGSGGASEVKQHVFFKDINWDTLA--RQKAAFVP 757 (863)
Q Consensus 684 ~~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~k--Rpg~~SAeEILqHPFFk~IdW~~l~--~~~ppfvP 757 (863)
+....+.++..... .+|. ...++.++.+||.+||..+|.+ |+ +++++++||||++.+|.... ...+|++|
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~---s~~ell~h~~~~~~~~~~~~~~~~~~~~~p 326 (370)
T cd05596 251 SLVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRN---GVDEIKSHPFFKNDQWTFDNIRETVAPVVP 326 (370)
T ss_pred CHHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCC---CHHHHhcCcccCCCChhhHHhcCCCcCccC
Confidence 98888888876543 2222 1257999999999999988887 88 99999999999998886543 44578888
Q ss_pred CCCCCCCCCCccc
Q 002953 758 TSESALDTSYFTS 770 (863)
Q Consensus 758 ~~~s~lDts~F~s 770 (863)
......++.+|+.
T Consensus 327 ~~~~~~~~~~~~~ 339 (370)
T cd05596 327 ELSSDIDTSNFDD 339 (370)
T ss_pred cCCCcchhhhcCC
Confidence 8877777777654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=376.29 Aligned_cols=273 Identities=40% Similarity=0.766 Sum_probs=222.2
Q ss_pred EEeecccceeecccc-------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 465 LLAGKGALSEHDDFP-------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..||+|+||.|+.+. |++++.... .....+.+..|+.+|..+ +||||++++++|..++.+|+|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 489999999997432 222222222 223446788999999999 58999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~------ 159 (332)
T cd05614 86 YVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE------ 159 (332)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC------
Confidence 99999999999888889999999999999999999999999999999999999999999999999987421100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC----C
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE----H 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~----~ 684 (863)
.......+||+.|||||++.+. .++.++|||||||++|||++|..||... .
T Consensus 160 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 215 (332)
T cd05614 160 ------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215 (332)
T ss_pred ------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC
Confidence 0112346799999999999875 4789999999999999999999999643 2
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCccCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTSE 760 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~ 760 (863)
...+...+..... .++..++..+.+||.+||..||.+||+++ +++++++||||++++|..+... .+++.|...
T Consensus 216 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (332)
T cd05614 216 QSEVSRRILKCDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIR 292 (332)
T ss_pred HHHHHHHHhcCCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 3344444544333 34567899999999999999999999876 8999999999999999987654 467888877
Q ss_pred CCCCCCCccc
Q 002953 761 SALDTSYFTS 770 (863)
Q Consensus 761 s~lDts~F~s 770 (863)
...+...|..
T Consensus 293 ~~~~~~~~~~ 302 (332)
T cd05614 293 NELDVGNFAE 302 (332)
T ss_pred CcchhhhcCc
Confidence 7777666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=374.39 Aligned_cols=275 Identities=40% Similarity=0.746 Sum_probs=226.3
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. |++.+.........+.+.+|+.++..++||||++++++|.+++++|+||||++||
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 489999999986432 2333333444455667889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.......
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------- 156 (331)
T cd05597 87 DLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---------- 156 (331)
T ss_pred cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----------
Confidence 99999976 4579999999999999999999999999999999999999999999999999986321000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||...+..+.
T Consensus 157 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~ 216 (331)
T cd05597 157 --------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216 (331)
T ss_pred --------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH
Confidence 001123479999999999973 4478899999999999999999999999888888
Q ss_pred HHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCC
Q 002953 689 FDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTS 766 (863)
Q Consensus 689 ~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts 766 (863)
+..+.... ..++.....++.++++||++||.. |.+|++..+++++++||||.+++|..+....++++|...+..+++
T Consensus 217 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
T cd05597 217 YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTS 295 (331)
T ss_pred HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcchhh
Confidence 88876543 233333345899999999999975 555554459999999999999999999888888999888877777
Q ss_pred Cccc
Q 002953 767 YFTS 770 (863)
Q Consensus 767 ~F~s 770 (863)
+|+.
T Consensus 296 ~~~~ 299 (331)
T cd05597 296 NFDV 299 (331)
T ss_pred hcCC
Confidence 6653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=383.31 Aligned_cols=277 Identities=42% Similarity=0.751 Sum_probs=224.7
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. |++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 345444 89999999986442 2333333444445567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 123 Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~------ 195 (371)
T cd05622 123 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE------ 195 (371)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC------
Confidence 99999999999876 46899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........+||+.|||||++.+.. ++.++|||||||++|||++|.+||.+.+
T Consensus 196 ------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 196 ------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred ------------------------CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 001123568999999999997643 7899999999999999999999999999
Q ss_pred hHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh--hHHhhccCCccCCCC
Q 002953 685 PQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW--DTLARQKAAFVPTSE 760 (863)
Q Consensus 685 ~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW--~~l~~~~ppfvP~~~ 760 (863)
....+.++..... .+|. ...++.++++||.+||. +|..|++..+++++++|+||++..| ..+....+|++|...
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (371)
T cd05622 252 LVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 329 (371)
T ss_pred HHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCC
Confidence 8888888876542 3332 24689999999999998 6777665569999999999998655 455555678888877
Q ss_pred CCCCCCCcc
Q 002953 761 SALDTSYFT 769 (863)
Q Consensus 761 s~lDts~F~ 769 (863)
...++++|.
T Consensus 330 ~~~~~~~~~ 338 (371)
T cd05622 330 SDIDTSNFD 338 (371)
T ss_pred CcchhhhcC
Confidence 777666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=383.48 Aligned_cols=248 Identities=31% Similarity=0.535 Sum_probs=203.9
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--~lyLVmEy~~GG 534 (863)
...||+|+||.|+.+. .++|..........+.+.+|+.+|.+++|||||++++...... .++++|||++||
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 3489999999996553 2444444433333677899999999999999999999755555 699999999999
Q ss_pred ChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.+.+ .|++..++.|++||+.||+|||++|||||||||+|||++. ++.+||+|||+++.... .
T Consensus 102 sL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~--~-------- 171 (313)
T KOG0198|consen 102 SLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES--K-------- 171 (313)
T ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--c--------
Confidence 9999999887 7999999999999999999999999999999999999999 69999999999884211 0
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCC-CChHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFD 690 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~-~~~~el~~ 690 (863)
...........||+.|||||++.+. ...+++|||||||++.||+||++||.. ......+-
T Consensus 172 ------------------~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~ 233 (313)
T KOG0198|consen 172 ------------------GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL 233 (313)
T ss_pred ------------------cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH
Confidence 0001223457899999999999962 334599999999999999999999987 44444444
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+.... ..|.+|..+|.++++||.+||.++|++|| ||+++|+|||.+..
T Consensus 234 ~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 234 LIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQN 282 (313)
T ss_pred HHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhcc
Confidence 554444 44678899999999999999999999999 99999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=398.47 Aligned_cols=248 Identities=33% Similarity=0.563 Sum_probs=219.8
Q ss_pred cceEEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 461 QIDLLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 461 ~~~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.-++..||+|+-|.|+.+. +++|+..+......+.+++|+.+|+..+|+|||++++.|-..+.+|+|||||+|
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g 354 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG 354 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence 3345589999999997653 566666666666678899999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|.+.+.. -.++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..
T Consensus 355 gsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~------------ 421 (550)
T KOG0578|consen 355 GSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE------------ 421 (550)
T ss_pred Cchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc------------
Confidence 999999876 4599999999999999999999999999999999999999999999999999874211
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
...+..+.+|||+|||||++....|+.++||||||++++||+-|.+||...++-..+..|.
T Consensus 422 -------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa 482 (550)
T KOG0578|consen 422 -------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 482 (550)
T ss_pred -------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence 1124567899999999999999999999999999999999999999999888888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
....+-...++.+|+++++||.+||+.|+.+|+ +|.|+|+||||+..
T Consensus 483 ~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 483 TNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLKMA 529 (550)
T ss_pred hcCCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhhhc
Confidence 766655566788999999999999999999999 99999999999643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=361.42 Aligned_cols=257 Identities=33% Similarity=0.633 Sum_probs=208.6
Q ss_pred eecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||+|+||+|+.+. +++|+. ........+.+..|+++|+.++||||++++++|..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999996542 233332 222333446678899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 537 YSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 537 ~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 988743 346899999999999999999999999999999999999999999999999998731100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQI 688 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~----~el 688 (863)
........||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... ...
T Consensus 151 ---------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 209 (280)
T cd05608 151 ---------------------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209 (280)
T ss_pred ---------------------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH
Confidence 0112245799999999999999999999999999999999999999976543 223
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhcc--CCccC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVP 757 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~~--ppfvP 757 (863)
...+..... .++..++.++.+|+.+||+.||++||+. .+++++++||||++++|..+.... +||.|
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 210 KQRILNDSV---TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred HHhhcccCC---CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 333333222 3456789999999999999999999976 489999999999999999886543 46655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.90 Aligned_cols=243 Identities=32% Similarity=0.519 Sum_probs=213.4
Q ss_pred Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+||+|.|+.|+.+. .++|... .......+.+.+|++|.+.|+|||||+|++.+...+..|||+|+|.|++|
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl 97 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 97 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHH
Confidence 89999999986542 1222111 12233677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
..-|-..-.+++..+-.+++||+.||.|+|.+||||||+||+|+|+... .-+||+|||+|....
T Consensus 98 ~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~------------- 164 (355)
T KOG0033|consen 98 FEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN------------- 164 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-------------
Confidence 9877666778999999999999999999999999999999999999654 359999999998411
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.+.....++|||.|||||++...+|+..+|||+-|++||-||.|.+||++.+...+++.|+
T Consensus 165 -------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 165 -------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred -------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 1123346899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 694 NRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 694 ~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+...++. .+..+++++++||++||..||.+|+ |+.|.|+|||+.+-
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICNR 273 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcch
Confidence 99988876 6788999999999999999999999 99999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.44 Aligned_cols=289 Identities=48% Similarity=0.863 Sum_probs=236.0
Q ss_pred EEeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. +++|. ...........+.+|+++++.++||||+++++.+..++++|+||||++|+
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 489999999986432 23332 22222344567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..............
T Consensus 87 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~--- 163 (305)
T cd05609 87 DCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGH--- 163 (305)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccc---
Confidence 99999988888999999999999999999999999999999999999999999999999998742211110000000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.. ............|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+..
T Consensus 164 ----------~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 164 ----------IE---KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230 (305)
T ss_pred ----------cc---cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 00 00001112235689999999999998899999999999999999999999999888888888877
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCCcc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFT 769 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~F~ 769 (863)
....++.....++.++.+||.+||..+|++||++.++.++++||||...+|....+....++|.+....+.+||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 231 DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred cccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 766655555578999999999999999999998778999999999999999999888889999988777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=357.32 Aligned_cols=263 Identities=34% Similarity=0.568 Sum_probs=213.4
Q ss_pred EEEeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+.+||+|+||+|+.+. +++|+. ..........+.+|+.+|+.++||||+++++.+.+.+.+|+||||++|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 3489999999985542 333332 222233345678899999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---------- 154 (285)
T cd05605 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---------- 154 (285)
T ss_pred CcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC----------
Confidence 9999888654 4589999999999999999999999999999999999999999999999999874100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 0011245799999999999998899999999999999999999999987665433322
Q ss_pred HhhcC-CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCccCC
Q 002953 692 ILNRK-IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPT 758 (863)
Q Consensus 692 Il~~~-~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppfvP~ 758 (863)
+...- ...+.++..++..+.+||.+||..||.+||++. +++++++||||...+|+.+... .|||.|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 213 VERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred HHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 22111 111234566899999999999999999999875 8999999999999999998765 3688774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=387.66 Aligned_cols=240 Identities=35% Similarity=0.572 Sum_probs=212.7
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.||+.. +++|..... ..+..+.+.+|++|++.|+|||||.++++|++..++|+|+|||.| +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 379999999997753 122222212 234566799999999999999999999999999999999999987 9
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|++|+||||+|+....+
T Consensus 87 L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~------------- 153 (808)
T KOG0597|consen 87 LFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN------------- 153 (808)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-------------
Confidence 9999999999999999999999999999999999999999999999999999999999999952110
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......-|||.|||||++.+.+|+..+|+||||||+|||++|++||+.....++...|...
T Consensus 154 ------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 154 ------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD 215 (808)
T ss_pred ------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC
Confidence 11234567999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
...+| ...+..+.+|++.+|.+||.+|+ +..+++.|||.++
T Consensus 216 ~v~~p---~~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 216 PVKPP---STASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred CCCCc---ccccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 87665 57999999999999999999999 9999999999875
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=355.18 Aligned_cols=257 Identities=32% Similarity=0.575 Sum_probs=205.1
Q ss_pred eecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||+|+||.|+.+. +++| +...........+..|+++|++++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999996542 2222 22222233344567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 537 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 537 ~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 98886543 488889999999999999999999999999999999999999999999999874110
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHHHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFD 690 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~----~el~~ 690 (863)
........||+.|+|||++.+..++.++|+|||||++|+|++|..||..... .++..
T Consensus 148 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 148 -------------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred -------------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 0011234689999999999998899999999999999999999999976432 33344
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC-CHHHHHcCCCCCCCChhHHhhc--cCCccC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG-GASEVKQHVFFKDINWDTLARQ--KAAFVP 757 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~-SAeEILqHPFFk~IdW~~l~~~--~ppfvP 757 (863)
.+....... ....++.++.+||++||+.||.+||++. -.++++.||||+.++|..+... .+||+|
T Consensus 209 ~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 209 RTLEDEVKF--EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred Hhhcccccc--ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 444333322 1246899999999999999999999321 1278999999999999999865 467765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=364.74 Aligned_cols=237 Identities=30% Similarity=0.527 Sum_probs=203.1
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEE-EEEeCCe-EE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFY-SFTCREN-LY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~-~f~d~~~-ly 525 (863)
....|.++ .||+|+||+|+.+. .+.|+.. ..+....+....|+.+|++|+|||||++++ .|..+.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34445554 89999999998764 3444433 335566678999999999999999999997 6665555 99
Q ss_pred EEEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHh--CC--ccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 526 LVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHS--LR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs--~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
||||||.+|+|..+++.. +.+++..++.|+.|++.||.++|. .. |+||||||.||+|+.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998653 569999999999999999999998 44 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
++.. ...-..+.+|||.||+||++.+.+|+.++|||||||++|||..-.
T Consensus 177 ~l~s-------------------------------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 177 FLSS-------------------------------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred Hhcc-------------------------------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 6311 112345789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCcCC
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p-~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
+||++.+..++..+|.++.. |.+| ...|.++..||.-|+..||..||+
T Consensus 226 ~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 226 SPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999988855 5566 668999999999999999999994
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.73 Aligned_cols=268 Identities=46% Similarity=0.815 Sum_probs=230.0
Q ss_pred EEeecccceeecccc-------cee---hhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVL---KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvl---KK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. .++ ++.........+.+.+|+++|++++||||+++++++...+.+|+||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 389999999985431 222 2333334455678899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.||+.||.|||+.||+||||+|.|||++.++.+||+|||++.....
T Consensus 87 ~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~------------- 153 (290)
T cd05580 87 ELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------------- 153 (290)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874110
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 154 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 212 (290)
T cd05580 154 ---------------------RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212 (290)
T ss_pred ---------------------CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 02245789999999999988899999999999999999999999998887777777776
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCCcc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSYFT 769 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~F~ 769 (863)
+... ++..++..++++|.+||..||.+|++. .+++++++||||+.++|..+... .+|+.|......+.+.|+
T Consensus 213 ~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (290)
T cd05580 213 GKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFD 288 (290)
T ss_pred CCcc---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCcccccccc
Confidence 5543 456689999999999999999999976 48999999999999999988754 478888887777777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=375.66 Aligned_cols=254 Identities=34% Similarity=0.598 Sum_probs=208.4
Q ss_pred cccceEE-Eeecccceeeccc----------cceehhhhhhch-----------hHHHHHHHHHHHHHhcCCCCeeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDF----------PQVLKKADMIRK-----------NAVESILAERDILISVRNPFVVRFFY 516 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k-----------~~~e~~l~Ei~IL~~L~HPnIVkL~~ 516 (863)
.++|.+. -||+|.||.|..+ .|++.|.+.... ...+.+.+|+.||++|+|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4556554 7999999998332 344444443321 23368899999999999999999999
Q ss_pred EEEeC--CeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecC
Q 002953 517 SFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594 (863)
Q Consensus 517 ~f~d~--~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFG 594 (863)
+..+. +++|||+|||..|.+...--....+++.+++.|++.++.||+|||.+|||||||||+|+||+.+|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 98875 4799999999998886544332339999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC---C-CccceeechhHHH
Q 002953 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---H-GTTADWWSVGIIL 670 (863)
Q Consensus 595 LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---y-s~ksDIWSLGvIL 670 (863)
.+..+..... + .........+|||.|||||.+.+.. + +.+.|||||||+|
T Consensus 256 Vs~~~~~~~~-----------------~---------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 256 VSNEFPQGSD-----------------E---------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred eeeecccCCc-----------------c---------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 9874211100 0 0001112378999999999998732 2 6788999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 671 FELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 671 yELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
|.|+.|+.||.++...+++.+|++....+|..+ .+.+++++||.+||.+||++|+ ++.+|..|||...
T Consensus 310 YCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri---~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRI---TLPDIKLHPWVTR 377 (576)
T ss_pred HHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhhee---ehhhheecceecc
Confidence 999999999999999999999999999888765 5899999999999999999999 9999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=353.93 Aligned_cols=247 Identities=33% Similarity=0.617 Sum_probs=222.8
Q ss_pred CCcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 457 PRTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 457 ~~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
....+|++- .||+|-||.||.+. ||+-|..+........+.+|++|-+.|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 344556654 89999999997652 5666777777777788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHH--hcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 526 LVMEYLNGGDLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk--~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|++||..+|+|+..|. ...+|++..+..|++|++.||.|+|..+||||||||+|+|++..|.+||+|||-+...
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~---- 174 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---- 174 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec----
Confidence 9999999999999998 5578999999999999999999999999999999999999999999999999988741
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
...+..+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||...
T Consensus 175 -----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 -----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred -----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 013456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+..+++++|...+..+| ..++.+++|||.+||.++|.+|+ ...|++.|||...
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 99999999998887654 78999999999999999999999 9999999999753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=375.87 Aligned_cols=246 Identities=32% Similarity=0.510 Sum_probs=210.2
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeec
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYL 531 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~ 531 (863)
.+..||+|.||.||.+. +++||..+.. ........+|+.||++|+||||++|.+...+. +.+|||+|||
T Consensus 121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 34589999999998763 6778877665 44556778999999999999999999998887 6899999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+. ||.-++...+ .|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+++....
T Consensus 201 dh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~------- 272 (560)
T KOG0600|consen 201 DH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG------- 272 (560)
T ss_pred cc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-------
Confidence 87 9999998754 69999999999999999999999999999999999999999999999999999632111
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.....+.+-|++|+|||+++| ..|+.++|+||.||||.||++|++.|.+.++.+.+
T Consensus 273 -----------------------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 273 -----------------------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred -----------------------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 112346789999999999998 56999999999999999999999999999999999
Q ss_pred HHHhhc-----CCCCC--CC-------------------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNR-----KIPWP--RV-------------------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~-----~~~~p--~~-------------------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+|.+- ...|+ .+ ...++..+.+|+..||..||.+|. ||.++|+|+||..
T Consensus 330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~---tA~~aL~seyF~t 405 (560)
T KOG0600|consen 330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG---TASSALQSEYFTT 405 (560)
T ss_pred HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc---cHHHHhcCccccc
Confidence 888761 11122 11 135789999999999999999999 9999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.33 Aligned_cols=242 Identities=29% Similarity=0.407 Sum_probs=200.7
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhH-HHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC-eEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNA-VESILAERDILISVR-NPFVVRFFYSFTCRE-NLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~-~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~-~lyLVmEy~~GG 534 (863)
..||.|.||.|+.+. +++|+.+..-..- .-.-++|++.|++|+ |||||+|.+++.+.+ .+|+|||||+.
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~- 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC- 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-
Confidence 389999999997653 3444433222111 123468999999999 999999999999988 99999999976
Q ss_pred ChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|+++++.. ..|++..++.|+.||++||+|+|++|+.||||||+|||+.....|||+|||+|+... +
T Consensus 95 NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--S---------- 162 (538)
T KOG0661|consen 95 NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--S---------- 162 (538)
T ss_pred hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--c----------
Confidence 999999876 459999999999999999999999999999999999999988999999999999411 0
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.......+.|.+|+|||+++.. -|+.++|+||+|||++|+++-++.|.+.++.+.+.+|
T Consensus 163 --------------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI 222 (538)
T KOG0661|consen 163 --------------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI 222 (538)
T ss_pred --------------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence 0122346899999999999874 4799999999999999999999999999988888887
Q ss_pred hhc-------------------CCCCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 693 LNR-------------------KIPWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 693 l~~-------------------~~~~p~~--------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..- ...+|.. -...+.++.+||.+||.+||.+|| ||.++|+||||+.
T Consensus 223 c~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp---TA~~al~~pffq~ 296 (538)
T KOG0661|consen 223 CEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP---TASQALQHPFFQV 296 (538)
T ss_pred HHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc---cHHHHhcCccccc
Confidence 651 1222321 234789999999999999999999 9999999999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=373.23 Aligned_cols=247 Identities=37% Similarity=0.592 Sum_probs=219.4
Q ss_pred cceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVm 528 (863)
.|.+. .||+|.||.|+.+ .|+++|.........+.+.+|+.||+++. |||||.++++|++...+|+||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 45554 8999999998544 35666666666567788999999999998 999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC----CcEEEeecCCccccccCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~----g~VKLiDFGLAk~~~~~s~ 604 (863)
|+|.||+|++.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 116 EL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--- 191 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--- 191 (382)
T ss_pred EecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---
Confidence 999999999999876 49999999999999999999999999999999999999754 4799999999985210
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.......+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.+.+
T Consensus 192 -----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 192 -----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred -----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 234567899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 685 PQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
....+.+|..+...++. .+..++..+++||++||..||.+|+ +|.++|+|||+++.
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 99999999998876654 3567899999999999999999999 99999999998765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=365.46 Aligned_cols=242 Identities=30% Similarity=0.576 Sum_probs=217.8
Q ss_pred cceEE-Eeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 461 QIDLL-LAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
+|.+. .||+|.||+|..+ .|.++|..+......-++.+|++||+.|+||||+.+|++|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 34443 8999999998433 355667777788888899999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|..+|+|++|+.+.+.+++.+++.+++||+.|+.|+|+++++|||||.+|||+|.++++||+|||++-.+-
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~--------- 204 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA--------- 204 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---------
Confidence 99999999999999999999999999999999999999999999999999999999999999999986421
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
......++||+|.|.+||++.|.+| ++.+|-||||++||-|++|..||.+.+...+
T Consensus 205 -----------------------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 205 -----------------------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred -----------------------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 1234467999999999999999998 7999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.++|..+.+.-| .-|.++.-||++||..||++|. |+++|-.|-|.+
T Consensus 262 vrQIs~GaYrEP----~~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWvN 307 (668)
T KOG0611|consen 262 VRQISRGAYREP----ETPSDASGLIRWMLMVNPERRA---TIEDIASHWWVN 307 (668)
T ss_pred HHHhhcccccCC----CCCchHHHHHHHHHhcCcccch---hHHHHhhhheee
Confidence 999998877544 3567889999999999999999 999999998863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.12 Aligned_cols=243 Identities=25% Similarity=0.416 Sum_probs=200.2
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
-++|+|+||.|+.+. +++||..-.. ....+-.++|+++|++|+|||+|.|+++|..+..+|||+|||+. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 389999999997653 4555533322 22345679999999999999999999999999999999999977 6
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+.+.|... ..++.+.++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+....
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~------------- 153 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA------------- 153 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-------------
Confidence 66666554 5699999999999999999999999999999999999999999999999999995210
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.+......+.|.+|+|||.+.| ..|+..+||||+||++.||++|.+.|.+.+..+.+..|.
T Consensus 154 ------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 154 ------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred ------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 0112234689999999999998 789999999999999999999999999988777766665
Q ss_pred hcC-------------------CCCCCC---------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 694 NRK-------------------IPWPRV---------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 694 ~~~-------------------~~~p~~---------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..- ..+|.. -..++.-+.+|+++||..||.+|+ +.+++|.|+||.+
T Consensus 216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~---sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL---SCEQLLHHPYFDG 289 (396)
T ss_pred HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc---cHHHHhcChHHHH
Confidence 411 112211 124677899999999999999999 9999999999954
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.76 Aligned_cols=261 Identities=34% Similarity=0.617 Sum_probs=209.7
Q ss_pred EEEeecccceeeccc-------cceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..+||+|+||.|+.+ .+++|+.. .........+.+|+.+|+.++|++|+++++.+.+.+.+|+||||++|
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 348999999998643 23333322 22233345678899999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---------- 154 (285)
T cd05630 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------- 154 (285)
T ss_pred CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC----------
Confidence 9999998654 3589999999999999999999999999999999999999999999999999863100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH---HH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ---QI 688 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~---el 688 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ..
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 00112357999999999999999999999999999999999999999865432 22
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhh--ccCCccCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLAR--QKAAFVPT 758 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~--~~ppfvP~ 758 (863)
...+..... ..++..+++++.+||.+||+.||.+||+. ++++++++||||+.++|..+.. ..|+|.|.
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 213 VERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred HHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 222222111 12456789999999999999999999943 2399999999999999998865 35788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.12 Aligned_cols=243 Identities=30% Similarity=0.419 Sum_probs=194.4
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|+.... .....+.+.+|+.+++.++||||+++++++..++.+|+||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 389999999986542 233332211 22345678899999999999999999999999999999999999877
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..+....+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~------------ 154 (287)
T cd07848 87 LELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS------------ 154 (287)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc------------
Confidence 76665555679999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 155 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~ 216 (287)
T cd07848 155 ------------------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKV 216 (287)
T ss_pred ------------------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 00112357899999999999988999999999999999999999999887654443333221
Q ss_pred C-------------------CCCCC----------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 696 K-------------------IPWPR----------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 696 ~-------------------~~~p~----------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
. ..++. ....++.++.+||++||+.||.+|| |++++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~---s~~~~l~hp~f 287 (287)
T cd07848 217 LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY---LTEQCLNHPAF 287 (287)
T ss_pred hCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 1 01111 1123788899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.53 Aligned_cols=218 Identities=32% Similarity=0.572 Sum_probs=198.8
Q ss_pred hHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC
Q 002953 491 NAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 569 (863)
Q Consensus 491 ~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G 569 (863)
...+...+|+.||+++ .||+|+++.++|+++..+++|+|.|+.|.|+++|...-.+++...+.+++|++.|++|||.++
T Consensus 64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~ 143 (411)
T KOG0599|consen 64 EMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN 143 (411)
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh
Confidence 3456788999999997 699999999999999999999999999999999998888999999999999999999999999
Q ss_pred ccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCh
Q 002953 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 649 (863)
Q Consensus 570 IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAP 649 (863)
||||||||+|||++++.++||+|||+|... ..+.+.+..||||.|+||
T Consensus 144 IVHRDLKpENILlddn~~i~isDFGFa~~l--------------------------------~~GekLrelCGTPgYLAP 191 (411)
T KOG0599|consen 144 IVHRDLKPENILLDDNMNIKISDFGFACQL--------------------------------EPGEKLRELCGTPGYLAP 191 (411)
T ss_pred hhhcccChhheeeccccceEEeccceeecc--------------------------------CCchhHHHhcCCCcccCh
Confidence 999999999999999999999999999842 123455678999999999
Q ss_pred hhhcC------CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCc
Q 002953 650 EILLG------TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDP 722 (863)
Q Consensus 650 EvL~g------~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP 722 (863)
|.+.. .+|+..+|+||+|+|||.||.|.+||+.....-+++.|+.++..|.. -+.+++.+.++||.+||+.||
T Consensus 192 EtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp 271 (411)
T KOG0599|consen 192 ETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDP 271 (411)
T ss_pred hheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCc
Confidence 99864 46889999999999999999999999999988999999999987743 357899999999999999999
Q ss_pred CCcCCCCCHHHHHcCCCCCCC
Q 002953 723 HQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 723 ~kRpg~~SAeEILqHPFFk~I 743 (863)
.+|+ |++|+|.||||..+
T Consensus 272 ~~Ri---take~LaHpff~q~ 289 (411)
T KOG0599|consen 272 TKRI---TAKEALAHPFFIQI 289 (411)
T ss_pred hhcc---cHHHHhcChHHHHH
Confidence 9999 99999999999654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=362.68 Aligned_cols=257 Identities=30% Similarity=0.503 Sum_probs=215.8
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
....|.+. +||.|.-+.|+.+. +++|+..+.+-+ ..+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 44556665 99999999997653 455655554433 3588999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 529 EYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
.||.+|++.++++.. ..|+|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+......
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~---- 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS---- 179 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc----
Confidence 999999999999875 45999999999999999999999999999999999999999999999999987642211
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
|. .+. .+.++++|||+|||||++.. .+|+.|+||||||++..||.+|..||....
T Consensus 180 -------G~---------------R~~-~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 180 -------GD---------------RQV-TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred -------Cc---------------eee-EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 10 000 11167899999999999654 679999999999999999999999999999
Q ss_pred hHHHHHHHhhcCCCCCCC-------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 685 PQQIFDNILNRKIPWPRV-------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~-------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+.+++..-+++..+.+.. ...++..++.+|..||++||.+|| ||.++|+|+||+...
T Consensus 237 PmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 237 PMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TASKLLKHAFFKKAK 300 (516)
T ss_pred hHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CHHHHhccHHHhhcc
Confidence 988887777776653321 124678899999999999999999 999999999998753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.05 Aligned_cols=247 Identities=30% Similarity=0.448 Sum_probs=206.8
Q ss_pred EEEeecccceeeccc-------cceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEEEEEe
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENLYLVME 529 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~lyLVmE 529 (863)
+..||+|+||.|..+ .+++||.. +......++..+|+++|+.++|+||+.+++.+... +.+|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 458999999998553 46777776 55666778999999999999999999999999872 35999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+| +-+|...++....++++.++++++||+.||.|+|+.||+||||||.|+|++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~------- 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF------- 178 (359)
T ss_pred HH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-------
Confidence 99 5599999999878999999999999999999999999999999999999999999999999999952110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.........+-|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.+.+....
T Consensus 179 ----------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q 236 (359)
T KOG0660|consen 179 ----------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ 236 (359)
T ss_pred ----------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH
Confidence 00112234688999999999875 6799999999999999999999999999877666
Q ss_pred HHHHhhc-----------------------CC-----CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNR-----------------------KI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~-----------------------~~-----~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..|+.- .. +|.......++.+.+|+.+||..||.+|+ |++|+|+||||
T Consensus 237 l~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi---ta~eAL~hPYl 313 (359)
T KOG0660|consen 237 LQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI---TAEEALAHPYL 313 (359)
T ss_pred HHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC---CHHHHhcChhh
Confidence 6655531 11 11112246889999999999999999999 99999999999
Q ss_pred CCC
Q 002953 741 KDI 743 (863)
Q Consensus 741 k~I 743 (863)
...
T Consensus 314 ~~~ 316 (359)
T KOG0660|consen 314 APY 316 (359)
T ss_pred hhh
Confidence 864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=344.32 Aligned_cols=263 Identities=33% Similarity=0.570 Sum_probs=212.0
Q ss_pred EEEeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..+||+|+||+|+.+. +++|.. ..........+.+|+++|+.++|+||+++++.+..++.+|+||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 3489999999986531 233322 222333445678899999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---------- 154 (285)
T cd05632 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---------- 154 (285)
T ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC----------
Confidence 9999888654 3699999999999999999999999999999999999999999999999999863100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........||+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0011235799999999999998999999999999999999999999987765444333
Q ss_pred HhhcCCC-CCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCC
Q 002953 692 ILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPT 758 (863)
Q Consensus 692 Il~~~~~-~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~ 758 (863)
+...... ...++..++.++.+|+.+||..||++||++ ..+.++++|+||+.++|+.+... .|+|+|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 3221111 123456789999999999999999999943 13899999999999999987654 4788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=348.57 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=195.7
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
|.+ ..||.|+||.|+.+. +++|...... ......+.+|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 443 489999999996542 3333332221 2234467899999999999999999999999999999999997
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--------- 156 (288)
T cd07871 87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--------- 156 (288)
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---------
Confidence 5 9999987654 4789999999999999999999999999999999999999999999999998731100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 157 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~ 214 (288)
T cd07871 157 ----------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214 (288)
T ss_pred ----------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123578999999999876 568999999999999999999999999888766665
Q ss_pred HHhhcCC-------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 691 NILNRKI-------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 691 kIl~~~~-------------------~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+..... .++. ....++.++.+||++||+.||.+|| |++|+++||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~---t~~~~l~hp~f 288 (288)
T cd07871 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI---SAEAALRHSYF 288 (288)
T ss_pred HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC---CHHHHhcCCCC
Confidence 5543110 0110 1124688999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.69 Aligned_cols=293 Identities=40% Similarity=0.747 Sum_probs=224.1
Q ss_pred EEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. +++|... .........+..|+++|..++||||+++++.+......|+||||+.|+
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 489999999986542 2333322 222235567899999999999999999999999999999999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......... ......
T Consensus 87 ~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~ 165 (316)
T cd05574 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP-VSKALR 165 (316)
T ss_pred CHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc-cccccc
Confidence 999998764 56999999999999999999999999999999999999999999999999998742111000 000000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.... ....................+...||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....+..+
T Consensus 166 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 244 (316)
T cd05574 166 KGSR-RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244 (316)
T ss_pred cccc-cccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHH
Confidence 0000 000000000000001112334568999999999999988999999999999999999999999988888888877
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhccCCccCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQKAAFVPTSE 760 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~ 760 (863)
......++.. ..++.++.++|.+||..+|++||+. .+++++++||||++++|..+....+|.+|.+.
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 245 LKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred hcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 7666554432 2379999999999999999999921 12999999999999999999887788777654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=352.34 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=194.5
Q ss_pred EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~lyLVmEy 530 (863)
.+||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++... ..+|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 389999999986542 34443322 1223345688999999999999999999987643 258999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~------ 158 (338)
T cd07859 86 ME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP------ 158 (338)
T ss_pred CC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC------
Confidence 95 69999998888899999999999999999999999999999999999999999999999999874211000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....
T Consensus 159 ----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 159 ----------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred ----------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 0011134679999999999876 6789999999999999999999999987664433
Q ss_pred HHHHhh--------------------------cCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILN--------------------------RKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~--------------------------~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...+.. ... .+......+++++.+||.+||..||++|| +++++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~e~l~hp~f 293 (338)
T cd07859 217 LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP---TAEEALADPYF 293 (338)
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC---CHHHHhcCchh
Confidence 222111 000 00011134678899999999999999999 99999999999
Q ss_pred CCCCh
Q 002953 741 KDINW 745 (863)
Q Consensus 741 k~IdW 745 (863)
+++..
T Consensus 294 ~~~~~ 298 (338)
T cd07859 294 KGLAK 298 (338)
T ss_pred hhcCc
Confidence 87654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=362.35 Aligned_cols=236 Identities=30% Similarity=0.492 Sum_probs=197.9
Q ss_pred Eeecccceeecccc------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-~lyLVmEy~~GGsL 536 (863)
.||.|+||+|+... +++|+.... .....+.+.+|+.+|.+++|||||++++++.... .++|||||+++|+|
T Consensus 48 ~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL 127 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSL 127 (362)
T ss_pred hcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcH
Confidence 59999999996442 233322211 1122668999999999999999999999999888 79999999999999
Q ss_pred HHHHHh--cCCCChhhHHHHHHHHHHHHHHHHhCC-ccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCCCc
Q 002953 537 YSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 537 ~dlLk~--~g~L~e~~i~~Ia~QIl~ALeyLHs~G-IIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
..++.. .+.++...+..++.+|+.||+|||+++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 128 ~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--------- 198 (362)
T KOG0192|consen 128 SVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--------- 198 (362)
T ss_pred HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc---------
Confidence 999987 578999999999999999999999999 99999999999999997 99999999998521100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc--CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~--g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.......||+.|||||++. ...|+.++||||||++||||+||+.||......+...
T Consensus 199 ----------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~ 256 (362)
T KOG0192|consen 199 ----------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS 256 (362)
T ss_pred ----------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 1112368999999999999 5689999999999999999999999999998877777
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..... .|.++..+++.+..|+.+||..||..|| +..+|+.
T Consensus 257 ~v~~~~~-Rp~~p~~~~~~l~~l~~~CW~~dp~~RP---~f~ei~~ 298 (362)
T KOG0192|consen 257 AVVVGGL-RPPIPKECPPHLSSLMERCWLVDPSRRP---SFLEIVS 298 (362)
T ss_pred HHHhcCC-CCCCCccCCHHHHHHHHHhCCCCCCcCC---CHHHHHH
Confidence 7665543 3566777999999999999999999999 6666653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=348.75 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=193.8
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+ ..||+|+||.|+.+. +++|...... ......+.+|+.+|+.++||||+++++++.+...+|+||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3444 489999999996542 3444332221 122345788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-------- 156 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-------- 156 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--------
Confidence 6 5888887654 56899999999999999999999999999999999999999999999999998731100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh-HHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP-QQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~-~el 688 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+... ...
T Consensus 157 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 157 -----------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred -----------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 011123578999999999876 4578999999999999999999999987533 233
Q ss_pred HHHHhhc--C---CCCC------CC---------C---------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 689 FDNILNR--K---IPWP------RV---------P---------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 689 ~~kIl~~--~---~~~p------~~---------p---------~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
+..+... . ..++ .+ + ...+.++.+||.+||+.||.+|| |+.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~---s~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL---SAQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc---CHHHHhcCcc
Confidence 3332210 0 0000 00 0 12457899999999999999999 9999999999
Q ss_pred CCCCCh
Q 002953 740 FKDINW 745 (863)
Q Consensus 740 Fk~IdW 745 (863)
|+++.+
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=369.74 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=210.3
Q ss_pred cceEE-Eeecccceeecccc--------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP--------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||+|+||.|+.+. +++|+...........+.+|+.+|+.++|||||+++++|...+.+||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 35544 89999999986542 3444444444455567888999999999999999999999999999999999
Q ss_pred CCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 532 NGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 532 ~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~---- 223 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV---- 223 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc----
Confidence 99999988754 3468999999999999999999999999999999999999999999999999998421000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 224 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 224 -------------------------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred -------------------------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0012235689999999999999999999999999999999999999999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++..+..+... ..+..++.++.+||.+||..||.+|| ++.+++.|+|++.+
T Consensus 279 ~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 279 IMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 88888766542 34567899999999999999999999 99999999998743
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=349.89 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=200.0
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+ ..||+|+||.|+.+. .++|..... .......+.+|+++|++++||||+++++++..++.+|+||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3444 489999999986542 223322221 2334567999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--------- 156 (331)
T cd06649 86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------- 156 (331)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---------
Confidence 9999999998888899999999999999999999985 699999999999999999999999999873110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++..
T Consensus 157 ------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 157 ------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred ------------------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01124579999999999999999999999999999999999999997765544332
Q ss_pred HHhhc--------------------------------------------CCCCCCC-CCCCCHHHHHHHHhhccCCcCCc
Q 002953 691 NILNR--------------------------------------------KIPWPRV-PEEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 691 kIl~~--------------------------------------------~~~~p~~-p~~iS~el~dLI~k~L~~DP~kR 725 (863)
.+... ....+.. ...+++++++||.+||.+||++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~R 292 (331)
T cd06649 213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAER 292 (331)
T ss_pred HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccC
Confidence 21100 0000111 12468899999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCCC
Q 002953 726 LGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 726 pg~~SAeEILqHPFFk~Id 744 (863)
| ++.+|++||||+...
T Consensus 293 p---t~~ell~h~~~~~~~ 308 (331)
T cd06649 293 A---DLKMLMNHTFIKRSE 308 (331)
T ss_pred C---CHHHHhcChHHhhcc
Confidence 9 999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=336.90 Aligned_cols=256 Identities=36% Similarity=0.671 Sum_probs=207.8
Q ss_pred eecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||+|+||+|+.+. .++| +...........+.+|+++|+.++||||+++++++...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999986542 2222 22222333455678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 537 YSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 537 ~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
.+++.+.+ .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997765 699999999999999999999999999999999999999999999999998863110
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHHHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFD 690 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~----~el~~ 690 (863)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+..
T Consensus 148 -------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 148 -------------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred -------------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 0111234688899999999988899999999999999999999999976543 22222
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-C-CHHHHHcCCCCCCCChhHHhhc--cCCccC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-G-GASEVKQHVFFKDINWDTLARQ--KAAFVP 757 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~-SAeEILqHPFFk~IdW~~l~~~--~ppfvP 757 (863)
.+.... ...+..+++.+.++|.+||+.+|.+||+. . ++.++++||||..++|..+... .|||.|
T Consensus 209 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 209 RTLEMA---VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccccc---ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 222221 23456689999999999999999999975 3 7899999999999999988654 366655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=360.83 Aligned_cols=244 Identities=26% Similarity=0.346 Sum_probs=193.6
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+. .||+|+||.|+.+. +++|+ .....+.+|+++|++|+|||||+++++|......|+|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKA------GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEec------hhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 345544 99999999997653 23332 22345789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
. ++|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~--------- 235 (391)
T PHA03212 166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--------- 235 (391)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc---------
Confidence 5 699999988788999999999999999999999999999999999999999999999999998731100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-------
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH------- 684 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~------- 684 (863)
........+||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 236 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 236 ---------------------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred ---------------------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 0011234689999999999999999999999999999999999998875421
Q ss_pred hHHHHHHHhhcC--------------------------CCCCC-C-----CCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 685 PQQIFDNILNRK--------------------------IPWPR-V-----PEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 685 ~~el~~kIl~~~--------------------------~~~p~-~-----p~~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
....+..+.... ...+. . ...++.++.+||.+||+.||.+|| |++
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp---ta~ 371 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP---SAE 371 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC---CHH
Confidence 111111111100 00000 0 013567899999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 002953 733 EVKQHVFFKDI 743 (863)
Q Consensus 733 EILqHPFFk~I 743 (863)
|+|+||||+.+
T Consensus 372 elL~hp~f~~~ 382 (391)
T PHA03212 372 ALLDFAAFQDI 382 (391)
T ss_pred HHhcChhhccC
Confidence 99999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=367.94 Aligned_cols=247 Identities=30% Similarity=0.526 Sum_probs=218.2
Q ss_pred Eeecccceeecccc----c---eehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP----Q---VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~----k---vlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
-||-|+||+||.+. + +.|.+........+.++-|++||..++||+||+|++.|..++.++|++|||.||-+..
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 68999999998763 2 3334444556677899999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
.+-.. ..+++.++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+...
T Consensus 119 imlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn------------------ 180 (1187)
T KOG0579|consen 119 IMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN------------------ 180 (1187)
T ss_pred HHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc------------------
Confidence 87665 46999999999999999999999999999999999999999999999999987531
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.....+..++.|||+|||||++. ..+|++++||||||++|.||..+.+|-..-++..++-+|
T Consensus 181 -------------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi 247 (1187)
T KOG0579|consen 181 -------------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 247 (1187)
T ss_pred -------------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence 11234556899999999999986 467999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
.+...+..-.|..++..+.||+.+||.+||..|| ++.++|+||||.+++-.
T Consensus 248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccCCcc
Confidence 8877665556788999999999999999999999 99999999999987654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=331.18 Aligned_cols=246 Identities=54% Similarity=0.957 Sum_probs=206.2
Q ss_pred Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHH-hcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~-~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||.|+||.|+.+. +++|.. ..........+..|..++. ..+||||+++++++...+.+|+||||++|+
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 58999999986542 233322 2222233344556665554 458999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 83 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~-------------- 148 (260)
T cd05611 83 DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-------------- 148 (260)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc--------------
Confidence 999999888889999999999999999999999999999999999999999999999999987310
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+....+..+..
T Consensus 149 ---------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 149 ---------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred ---------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 01235688999999999988899999999999999999999999998888888877766
Q ss_pred cCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 695 RKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 695 ~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
....++. ....++.++.++|.+||+.+|.+||++.+++|++.||||++++|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 6554432 234689999999999999999999988888999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.58 Aligned_cols=247 Identities=33% Similarity=0.588 Sum_probs=215.0
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|++. .||+|-|+.|..+. |++-|.++ +.-...++++|++.|+-+.|||||+||++..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 446665 79999999874432 22323222 2234467899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~d 606 (863)
|+-+||+|++||.+. ..+.++.++.|++||+.|+.|+|+..+|||||||+|+.+... |-|||+|||++-.+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf------- 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF------- 169 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-------
Confidence 999999999998765 569999999999999999999999999999999999987655 99999999997632
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCC-ccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys-~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.++.+..+.||+..|-|||+++|..|+ +++||||||||||.|++|++||...+.
T Consensus 170 -------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 170 -------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred -------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 123456789999999999999999984 788999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.+++-+|+..++.. |..++.++++||..||..||.+|. +.++|..|+|++.+|-
T Consensus 225 SETLTmImDCKYtv---PshvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 225 SETLTMIMDCKYTV---PSHVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDR 278 (864)
T ss_pred hhhhhhhhcccccC---chhhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCC
Confidence 99999999999865 578999999999999999999999 9999999999998763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.46 Aligned_cols=240 Identities=32% Similarity=0.486 Sum_probs=191.8
Q ss_pred EEeecccceeecccc--------ceehhhhhh--chhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEe-----CCeEEE
Q 002953 465 LLAGKGALSEHDDFP--------QVLKKADMI--RKNAVESILAERDILISV---RNPFVVRFFYSFTC-----RENLYL 526 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~--------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d-----~~~lyL 526 (863)
..||+|+||+|+.+. .++|..... .......+.+|+.+++.+ +||||+++++++.. ...+|+
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 389999999996542 233332221 122234566788887766 69999999998853 456899
Q ss_pred EEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 527 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 162 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--- 162 (290)
T ss_pred EEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC---
Confidence 999996 5999998754 3589999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 163 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 163 -----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred -----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 011234579999999999999899999999999999999999999999888
Q ss_pred hHHHHHHHhhcCC-----CCC-------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 685 PQQIFDNILNRKI-----PWP-------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 685 ~~el~~kIl~~~~-----~~p-------------------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+.+..+..... .++ .+...++..+.+||.+||+.||++|| ++.++|+||||
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~~~l~hp~f 290 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYF 290 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC---CHHHHhcCCCC
Confidence 7777777654211 010 01135788899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=352.88 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=198.5
Q ss_pred cceEE-Eeecccceeecccc--------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP--------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
+|.+. .||+|+||.|+.+. +++.|... ......+|+++|+.++|||||+++++|.....+|+|||++
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~----~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVT----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecc----ccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 35544 89999999997542 12222111 1123568999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 169 ~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~-------- 239 (392)
T PHA03207 169 K-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP-------- 239 (392)
T ss_pred C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc--------
Confidence 5 5999999777889999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh---HHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP---QQI 688 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~---~el 688 (863)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...
T Consensus 240 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 298 (392)
T PHA03207 240 ---------------------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQ 298 (392)
T ss_pred ---------------------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHH
Confidence 00112346799999999999999999999999999999999999999976532 122
Q ss_pred HHHHhhc----CCC-------------------------CCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 689 FDNILNR----KIP-------------------------WPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 689 ~~kIl~~----~~~-------------------------~p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+... ... .+.. ...++.++.+||.+||..||.+|| ++.++|.|
T Consensus 299 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp---sa~e~l~~ 375 (392)
T PHA03207 299 LRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP---SAQDILSL 375 (392)
T ss_pred HHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC---CHHHHhhC
Confidence 2222210 000 0000 123577899999999999999999 99999999
Q ss_pred CCCCCCChhHHh
Q 002953 738 VFFKDINWDTLA 749 (863)
Q Consensus 738 PFFk~IdW~~l~ 749 (863)
|||....|+.+.
T Consensus 376 p~f~~~~~~~~~ 387 (392)
T PHA03207 376 PLFTKEPINLLN 387 (392)
T ss_pred chhhccchhhhc
Confidence 999999888764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.26 Aligned_cols=252 Identities=37% Similarity=0.647 Sum_probs=197.0
Q ss_pred Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHh---cCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILIS---VRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~---L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
+||+|+||.|+.+. .++| +.............+|..++.. .+||||+.+++++...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999997542 2222 2222222223334455544443 479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
||+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----------- 149 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----------- 149 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCCCChH--HHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ--QIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~--el~ 689 (863)
.......||+.|+|||++. +..++.++|+|||||++|+|++|..||...... ...
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 207 (279)
T cd05633 150 ----------------------KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (279)
T ss_pred ----------------------cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH
Confidence 0112346999999999986 466899999999999999999999999754321 112
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhcc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQK 752 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~~ 752 (863)
...... . ...++..++.++.++|.+||..||.+|++. .++.++++||||++++|..+...+
T Consensus 208 ~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 270 (279)
T cd05633 208 DRMTLT-V-NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQK 270 (279)
T ss_pred HHHhhc-C-CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCC
Confidence 221111 1 123456789999999999999999999953 369999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=353.00 Aligned_cols=243 Identities=30% Similarity=0.513 Sum_probs=199.9
Q ss_pred cceEEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEEE
Q 002953 461 QIDLLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYLVM 528 (863)
Q Consensus 461 ~~~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~lyLVm 528 (863)
.....++|.|+||.|+.+. .++||....++ .-.+|+.||+.++|||||+|..+|.... ++.|||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 3445599999999996652 45554332222 2347999999999999999998887532 456999
Q ss_pred eecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCC
Q 002953 529 EYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 529 Ey~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s 603 (863)
|||+. +|..+++. ...++.-.++.|+.||++||.|||++||+||||||.|||+|.+ |.+||||||.|+....
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~-- 178 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK-- 178 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc--
Confidence 99986 99999984 4679999999999999999999999999999999999999987 9999999999996322
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
+....+...|..|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+
T Consensus 179 ------------------------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 179 ------------------------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ------------------------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 123345778999999999998 5689999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 683 EHPQQIFDNILNR-----------------KIPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 683 ~~~~el~~kIl~~-----------------~~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++....+..|++- ...+|. +...+++++.+|+.++|..+|.+|. ++.+++.
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~---~~~~~l~ 305 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL---SALEALA 305 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC---CHHHHhc
Confidence 9888877777641 111111 2346789999999999999999999 9999999
Q ss_pred CCCCCCC
Q 002953 737 HVFFKDI 743 (863)
Q Consensus 737 HPFFk~I 743 (863)
||||..+
T Consensus 306 h~fFdel 312 (364)
T KOG0658|consen 306 HPFFDEL 312 (364)
T ss_pred chhhHHh
Confidence 9999765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.14 Aligned_cols=247 Identities=39% Similarity=0.784 Sum_probs=206.3
Q ss_pred eecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||.|+||.|+.+. .++| +.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999875442 2223 22222334556799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.+...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~-------------- 146 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-------------- 146 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc--------------
Confidence 999988778999999999999999999999999999999999999999999999999998741100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--hHHHHHHHhh
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH--PQQIFDNILN 694 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~--~~el~~kIl~ 694 (863)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ....+..+..
T Consensus 147 ------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 147 ------------------QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred ------------------cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 01223578999999999988889999999999999999999999998776 6667777664
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChh
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWD 746 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~ 746 (863)
+.. .+.++...+.++.++|.+||..+|.+||+. .++.|+++||||++.+|+
T Consensus 209 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 209 GNG-KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cCC-CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 322 233456678999999999999999999942 239999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=343.49 Aligned_cols=246 Identities=30% Similarity=0.472 Sum_probs=205.9
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHH--HHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLN 532 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~--e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~ 532 (863)
+..|++|+||.||.+. +++|+.++.....- -..++|+.+|.+++|||||.+-.+.... +.+|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 3389999999998763 57777766553221 2468999999999999999998877644 57999999997
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
. +|..++.+.+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+...
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--------- 230 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--------- 230 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC---------
Confidence 6 9999998875 8999999999999999999999999999999999999999999999999999952110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.......+-|.+|+|||++++ ..|+.++|+||+|||+.||+++++.|.+....+.+.
T Consensus 231 ----------------------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 231 ----------------------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred ----------------------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 123345789999999999998 458999999999999999999999999999988888
Q ss_pred HHhhc-------------------CCCCCCCC---------C-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 691 NILNR-------------------KIPWPRVP---------E-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 691 kIl~~-------------------~~~~p~~p---------~-~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
+|... ...++..| . .+++...+|+..+|..||.+|. ||++.|+|.||.
T Consensus 289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~---tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI---TAEDGLKHEYFR 365 (419)
T ss_pred HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc---cHHHhhcccccc
Confidence 88751 11122111 1 2568999999999999999999 999999999998
Q ss_pred CCC
Q 002953 742 DIN 744 (863)
Q Consensus 742 ~Id 744 (863)
+..
T Consensus 366 e~P 368 (419)
T KOG0663|consen 366 ETP 368 (419)
T ss_pred cCC
Confidence 753
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=361.36 Aligned_cols=243 Identities=32% Similarity=0.492 Sum_probs=215.6
Q ss_pred EEEeecccceeeccc-------cceehhhhhhchh--HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-EEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMIRKN--AVESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~--~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~-lyLVmEy~~G 533 (863)
+.++|+|+||.+..+ ..|+|++.+.+.. ......+|+.+++++.|||||.+++.|..++. +||||+||+|
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG 88 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG 88 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence 448999999986433 3677777666533 33478899999999999999999999999988 9999999999
Q ss_pred CChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|+|.+.|.+.+ .|+++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||.|||+|+....
T Consensus 89 g~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~---------- 158 (426)
T KOG0589|consen 89 GDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP---------- 158 (426)
T ss_pred CCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC----------
Confidence 99999997754 599999999999999999999999999999999999999999999999999995211
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
+.....+.+|||.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+
T Consensus 159 ---------------------~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k 217 (426)
T KOG0589|consen 159 ---------------------EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK 217 (426)
T ss_pred ---------------------chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH
Confidence 01244578999999999999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
|..... ..++...+.+++.||+.||.++|..|| ++.++|.+|....
T Consensus 218 i~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 218 INRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLR 263 (426)
T ss_pred HhhccC--CCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhh
Confidence 988873 456788999999999999999999999 9999999988764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=363.43 Aligned_cols=245 Identities=28% Similarity=0.415 Sum_probs=192.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--------CeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--------ENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--------~~l 524 (863)
.|.+. +||+|+||.|+.+. +++|+... ......+|+.+|+.++|||||+++++|... ..+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~----~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEec----CcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 45444 89999999997542 34443211 122345799999999999999999887542 257
Q ss_pred EEEEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCcccc
Q 002953 525 YLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVG 599 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~ 599 (863)
|+||||+++ +|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 899999975 77776643 35799999999999999999999999999999999999999765 6999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~ 678 (863)
.. .......+||+.|+|||++.+. .|+.++|||||||++|||++|.+
T Consensus 222 ~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 222 LA--------------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred cC--------------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 10 0112245789999999998764 68999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcC-----------------CCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 679 PFNAEHPQQIFDNILNRK-----------------IPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~-----------------~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
||.+.+..+.+.++.... ..++. ++...+.++.+||.+||.+||.+|| |+.
T Consensus 270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~---ta~ 346 (440)
T PTZ00036 270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL---NPI 346 (440)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc---CHH
Confidence 999887766665554311 11111 2345788999999999999999999 999
Q ss_pred HHHcCCCCCCCCh
Q 002953 733 EVKQHVFFKDINW 745 (863)
Q Consensus 733 EILqHPFFk~IdW 745 (863)
++|+||||..+..
T Consensus 347 e~l~hp~f~~~~~ 359 (440)
T PTZ00036 347 EALADPFFDDLRD 359 (440)
T ss_pred HHhCChhHHhhhc
Confidence 9999999987644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=335.74 Aligned_cols=245 Identities=31% Similarity=0.518 Sum_probs=206.4
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchh--HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKN--AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~--~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..+||+|.||.|+.+. +++||..+.+.. -.-..++|++.|+.++||||+.++++|...+.+.||+||++.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 3489999999997653 567776655332 134678999999999999999999999999999999999976
Q ss_pred ChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|...++.. ..|+...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+....
T Consensus 86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~---------- 155 (318)
T KOG0659|consen 86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN---------- 155 (318)
T ss_pred cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC----------
Confidence 999999875 458999999999999999999999999999999999999999999999999999642211
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
......+-|.+|+|||++.| ..|+..+|+||.|||+.||+-|.+-|.+.+.-+.+..|
T Consensus 156 ---------------------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 156 ---------------------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred ---------------------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 11112378999999999998 55899999999999999999999999999988888887
Q ss_pred hhc-----CCCCCC--------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 693 LNR-----KIPWPR--------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 693 l~~-----~~~~p~--------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..- ...||. +-...+.++.||+.+||..||.+|+ ++.|+|+|+||+..
T Consensus 215 f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri---ta~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 215 FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI---TASQALKHPYFKSL 287 (318)
T ss_pred HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc---cHHHHhcchhhhcC
Confidence 652 111221 1124578899999999999999999 99999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=345.21 Aligned_cols=246 Identities=30% Similarity=0.515 Sum_probs=206.4
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchh--HHHHHHHHHHHHHhcCCCC-eeEEEEEEEeCC------eEEEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKN--AVESILAERDILISVRNPF-VVRFFYSFTCRE------NLYLV 527 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~--~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~------~lyLV 527 (863)
+..||+|+||+||.+. +++||..+.... .-....+|+.+|+.|+|+| ||++++++.+.+ .+|||
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 3479999999997763 577777666543 3356789999999999999 999999999887 89999
Q ss_pred EeecCCCChHHHHHhcC----CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 528 MEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g----~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+||++. +|..++...+ .++...++.+++||+.||+|||++||+||||||+||||+..|.+||+|||+|+....+
T Consensus 96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip- 173 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP- 173 (323)
T ss_pred EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC-
Confidence 999966 9999998765 4778899999999999999999999999999999999999999999999999842111
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
......-++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+
T Consensus 174 ------------------------------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 174 ------------------------------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred ------------------------------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 1123356899999999999986 689999999999999999999999999
Q ss_pred CChHHHHHHHhhc-----CCCCC-------------CCC---------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 683 EHPQQIFDNILNR-----KIPWP-------------RVP---------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 683 ~~~~el~~kIl~~-----~~~~p-------------~~p---------~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
.+..+.+..|..- ...|| ... ....+++.+++.+||+.+|.+|+ +|..+|
T Consensus 224 ~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~---Sa~~al 300 (323)
T KOG0594|consen 224 DSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI---SAKGAL 300 (323)
T ss_pred CcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc---CHHHHh
Confidence 9998888887651 11222 111 12335899999999999999999 999999
Q ss_pred cCCCCCCCC
Q 002953 736 QHVFFKDIN 744 (863)
Q Consensus 736 qHPFFk~Id 744 (863)
.||||..+.
T Consensus 301 ~h~yf~~~~ 309 (323)
T KOG0594|consen 301 THPYFSELP 309 (323)
T ss_pred cChhhcccc
Confidence 999999874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.96 Aligned_cols=255 Identities=58% Similarity=1.031 Sum_probs=211.0
Q ss_pred eecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||+|+||.|+.+. .++| +.........+.+.+|++++++++||||+++++.+.....+|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6889999885542 2333 22233335567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878899999999999999999999999999999999999999999999999999874211100000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..||......+.+..+..+.
T Consensus 152 --------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (265)
T cd05579 152 --------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217 (265)
T ss_pred --------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 000112234578899999999998889999999999999999999999999988888888887766
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
..++.. ..++..+.+||.+||+.+|.+||++.++.++++||||++++|
T Consensus 218 ~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 218 IEWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cCCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 555432 225899999999999999999996666699999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=373.02 Aligned_cols=128 Identities=52% Similarity=1.046 Sum_probs=118.4
Q ss_pred ccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhcc
Q 002953 640 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719 (863)
Q Consensus 640 ~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~ 719 (863)
.+||+.|||||++.+..++.++|||||||+||||++|.+||.+....+.+..++.....++.....++..+.+++.+||.
T Consensus 540 ~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~ 619 (669)
T cd05610 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT 619 (669)
T ss_pred eeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 47899999999999999999999999999999999999999999999999999888777777666789999999999999
Q ss_pred CCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCCccc
Q 002953 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 770 (863)
Q Consensus 720 ~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~F~s 770 (863)
.||.+|| ++.++++||||..++|..+.....+|.|......|+.+|+.
T Consensus 620 ~dP~~R~---ta~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 620 MDPTKRA---GLKELKQHPLFHGVDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred cChhHCc---CHHHHHhCHhhcCCCHHHhcccCCCCCCCCCCccccccccc
Confidence 9999999 99999999999999999999889999998888888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.91 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=200.0
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~lyLVmEy 530 (863)
..||+|+||.|+.+. +++|+.... .......+.+|+.+|+.++||||+++++++.... .+|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 389999999996542 355543221 2234567889999999999999999999998877 79999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~------- 157 (372)
T cd07853 86 MQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE------- 157 (372)
T ss_pred cc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-------
Confidence 96 5899998887889999999999999999999999999999999999999999999999999987421000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+
T Consensus 158 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 158 -----------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred -----------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 0111234689999999999874 4799999999999999999999999888776655
Q ss_pred HHHhhc-----------------------CCCCC------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 690 DNILNR-----------------------KIPWP------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 690 ~kIl~~-----------------------~~~~p------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+... ....+ ......++++.+||.+||+.||.+|| |+.++++||||
T Consensus 215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~---t~~e~l~hp~~ 291 (372)
T cd07853 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI---SAADALAHPYL 291 (372)
T ss_pred HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc---CHHHHhcCHhh
Confidence 554321 11111 12245688999999999999999999 99999999999
Q ss_pred CCCCh
Q 002953 741 KDINW 745 (863)
Q Consensus 741 k~IdW 745 (863)
.+..+
T Consensus 292 ~~~~~ 296 (372)
T cd07853 292 DEGRL 296 (372)
T ss_pred CCCcc
Confidence 98654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.76 Aligned_cols=239 Identities=28% Similarity=0.423 Sum_probs=189.6
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||+|+||.|+.+. +++|..... .......+.+|+++|+.++|+||+++++++...+.+|+||||+++|+|
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 389999999997542 344432211 223346788999999999999999999999999999999999999998
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 160 ~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-------------- 221 (353)
T PLN00034 160 EGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-------------- 221 (353)
T ss_pred ccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--------------
Confidence 653 34567788899999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCCChHH---H
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ---I 688 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e---l 688 (863)
.......+||+.|+|||++.. ...+.++|||||||++|||++|+.||....... .
T Consensus 222 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 284 (353)
T PLN00034 222 -----------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284 (353)
T ss_pred -----------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 011234579999999998843 234578999999999999999999997433222 2
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
...+.... .+..+..++.++.+||.+||..||++|| ++.|+++||||..-
T Consensus 285 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~~~~ 334 (353)
T PLN00034 285 MCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRW---SAMQLLQHPFILRA 334 (353)
T ss_pred HHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccccC
Confidence 22222221 2334567899999999999999999999 99999999999874
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.85 Aligned_cols=252 Identities=29% Similarity=0.499 Sum_probs=208.9
Q ss_pred EEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||.|+||.|+.+ .+++|..........+.+.+|+.+++.++||||+++++.+..++.+|+||||++|++|.
T Consensus 18 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 97 (292)
T cd06644 18 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97 (292)
T ss_pred heecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHH
Confidence 38999999999654 23444444444556677889999999999999999999999999999999999999999
Q ss_pred HHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.++.+ ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-------------- 163 (292)
T cd06644 98 AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-------------- 163 (292)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--------------
Confidence 88754 356899999999999999999999999999999999999999999999999987631000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........|++.|+|||++. ...++.++|||||||++|+|++|.+||...+....+.+
T Consensus 164 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 226 (292)
T cd06644 164 -----------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226 (292)
T ss_pred -----------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 01112356889999999985 34468899999999999999999999988777666666
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhh
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~ 750 (863)
+.....+....+..++.++.+||.+||..+|++|| +++++++||||..++|....+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 227 IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccccccchhHH
Confidence 65444333334567889999999999999999999 999999999999999987544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.93 Aligned_cols=245 Identities=27% Similarity=0.476 Sum_probs=197.5
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||.|+||.|+.+. .++|..... .......+.+|+++|+.++||||++++++|.+.+.+|+||||+
T Consensus 6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (333)
T cd06650 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (333)
T ss_pred hhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecC
Confidence 34443 89999999996542 122222211 2334567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+||+|.+++...+.+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--------- 156 (333)
T cd06650 86 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--------- 156 (333)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh---------
Confidence 999999999888889999999999999999999997 4799999999999999999999999999863100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......+..
T Consensus 157 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 212 (333)
T cd06650 157 ------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212 (333)
T ss_pred ------------------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 11124579999999999999889999999999999999999999997655433321
Q ss_pred HH--------------------------------------------hhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCc
Q 002953 691 NI--------------------------------------------LNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 691 kI--------------------------------------------l~~~~~~p~~p-~~iS~el~dLI~k~L~~DP~kR 725 (863)
.+ .... .+..+ ..++.++++||.+||++||++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~R 290 (333)
T cd06650 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAER 290 (333)
T ss_pred HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccC
Confidence 11 1111 01111 2367899999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 002953 726 LGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 726 pg~~SAeEILqHPFFk~I 743 (863)
| ++.++++||||+..
T Consensus 291 p---t~~ell~h~~~~~~ 305 (333)
T cd06650 291 A---DLKQLMVHAFIKRS 305 (333)
T ss_pred c---CHHHHhhCHHHhcC
Confidence 9 99999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.71 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=189.9
Q ss_pred cceE-EEeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC-eE
Q 002953 461 QIDL-LLAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRE-NL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~-~l 524 (863)
+|.+ ..||+|+||.|+.+. +++|..... .......+.+|+.+|..+ +||||+++++++...+ .+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 3444 389999999997542 233332211 123456789999999999 8999999999887654 58
Q ss_pred EEEEeecCCCChHHHHHhc-------------------------------------------------------------
Q 002953 525 YLVMEYLNGGDLYSLLRNL------------------------------------------------------------- 543 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~------------------------------------------------------------- 543 (863)
|+||||++||+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 9999999999999998753
Q ss_pred -CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCC
Q 002953 544 -GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622 (863)
Q Consensus 544 -g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~ 622 (863)
..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------------- 228 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------------- 228 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc-------------------
Confidence 236778889999999999999999999999999999999999999999999987421000
Q ss_pred ccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCC
Q 002953 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPR 701 (863)
Q Consensus 623 ~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~ 701 (863)
.........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+...+..... +.
T Consensus 229 ----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-~~ 297 (338)
T cd05102 229 ----------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-MR 297 (338)
T ss_pred ----------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-CC
Confidence 0011223456789999999999999999999999999999997 99999876544433333332222 23
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 702 ~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..+++++.+||.+||..||.+|| ++.++++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 4567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=362.84 Aligned_cols=245 Identities=32% Similarity=0.567 Sum_probs=211.8
Q ss_pred EEEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+.+||+|+||.|+.+. +++|...+. .+..++.+.+|+.+|..++++||.++|+.|.....++++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 4599999999997763 233332222 34566789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
+.++|+..+.+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+....
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~--------------- 162 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT--------------- 162 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee---------------
Confidence 99999987777999999999999999999999999999999999999999999999999986411
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
....+..+++|||.|||||++.+.+|+.++||||||++.|||++|.+||....+...+..|-+.
T Consensus 163 ----------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~ 226 (467)
T KOG0201|consen 163 ----------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS 226 (467)
T ss_pred ----------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC
Confidence 1123447899999999999999999999999999999999999999999988885554444333
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
. .|.+...+++.+++||..||.+||+.|| +|.++|+|+|.+...
T Consensus 227 ~--PP~L~~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 227 A--PPRLDGDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRAK 270 (467)
T ss_pred C--CCccccccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhcC
Confidence 3 3556678999999999999999999999 999999999998743
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.42 Aligned_cols=243 Identities=25% Similarity=0.424 Sum_probs=182.0
Q ss_pred EEEeecccceeecccc---------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEeecC
Q 002953 464 LLLAGKGALSEHDDFP---------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYLN 532 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~---------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy~~ 532 (863)
...||+|+||+|+.+. +++|... .......+.+|+.+|++++||||++++++|.. ...+|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEEC--CCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3489999999997652 2333221 22223457889999999999999999999864 456899999995
Q ss_pred CCChHHHHHhc---------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee----cCCCcEEEeecCCcccc
Q 002953 533 GGDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 533 GGsL~dlLk~~---------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL----d~~g~VKLiDFGLAk~~ 599 (863)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+..
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 4898887532 248899999999999999999999999999999999999 45578999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~ 678 (863)
.... .........+||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 163 ~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 163 NSPL----------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CCCC----------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 1000 000112346799999999999874 58999999999999999999999
Q ss_pred CCCCCCh---------HHHHHHHhhcCC-----------CCC------------------------CCCCCCCHHHHHHH
Q 002953 679 PFNAEHP---------QQIFDNILNRKI-----------PWP------------------------RVPEEMSPEAHDLI 714 (863)
Q Consensus 679 PF~~~~~---------~el~~kIl~~~~-----------~~p------------------------~~p~~iS~el~dLI 714 (863)
||..... ...+..+..... ..+ ......+.++.+||
T Consensus 215 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 294 (317)
T cd07868 215 IFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294 (317)
T ss_pred CccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHH
Confidence 9965332 112222211000 000 00012356789999
Q ss_pred HhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 715 DRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 715 ~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+||+.||.+|| |++|+|+||||
T Consensus 295 ~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 295 QKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred HHHhccCcccCC---CHHHHhcCCCC
Confidence 999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.58 Aligned_cols=244 Identities=31% Similarity=0.529 Sum_probs=202.5
Q ss_pred EEeecccceeecccc-------ceehhhhhh-----chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-----~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+||+|+||.|+.+. .++|..... .......+.+|++++++++||||+++++++..+..+|+||||++
T Consensus 8 ~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 87 (263)
T cd06625 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP 87 (263)
T ss_pred ceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECC
Confidence 389999999986542 233332211 12234578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 88 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--------- 158 (263)
T cd06625 88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--------- 158 (263)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987411000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
..........|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+
T Consensus 159 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 219 (263)
T cd06625 159 -------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219 (263)
T ss_pred -------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence 0000112356889999999999988999999999999999999999999887666655555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...... +.++..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 220 ATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred hccCCC-CCCCccCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 444332 345677899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=328.57 Aligned_cols=244 Identities=30% Similarity=0.491 Sum_probs=202.9
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||.|+||.|+.+. .+++..........+.+.+|+.+++.++||||+++++++...+..|+||||+++++|..
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~ 91 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHH
Confidence 79999999986542 23333333344556778899999999999999999999999999999999999999998
Q ss_pred HHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--------------- 156 (282)
T cd06643 92 VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--------------- 156 (282)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc---------------
Confidence 8765 457999999999999999999999999999999999999999999999999998631100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........||+.|+|||++. +..++.++|||||||++|+|++|.+||...+..+....+
T Consensus 157 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 220 (282)
T cd06643 157 ----------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220 (282)
T ss_pred ----------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence 01122457899999999984 345788999999999999999999999988877776666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..........+..++.++.+||.+||..+|.+|| ++.++++||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 221 AKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred hhcCCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 5544333334567899999999999999999999 99999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=340.25 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=212.4
Q ss_pred Eeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
+||+|+|+.|..+ .+++|...........++.+|++++.++ .|+||++|+++|+++..+|||||-|.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 8999999998332 3455554445556778899999999998 4999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCccccccCCCCCCCCCCccC
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
.+|.+...|++.++..++++|+.||.+||.+||.||||||+|||..... -||||||.+..- +. -..+.+ |..
T Consensus 165 shI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg-~k-~~~~~s-pas-- 239 (463)
T KOG0607|consen 165 SHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG-IK-LNNDCS-PAS-- 239 (463)
T ss_pred HHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc-cc-cCCCCC-CCC--
Confidence 9999999999999999999999999999999999999999999997765 489999998762 11 011111 110
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCC-----
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEH----- 684 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~----- 684 (863)
.....+.+|+..|||||++. ..-|+.++|.||||+|+|-||.|++||.+.-
T Consensus 240 -------------------tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 240 -------------------TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred -------------------CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 11234689999999999874 2448999999999999999999999996531
Q ss_pred ----------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 685 ----------PQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 685 ----------~~el~~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
...++..|..+++.||.- +..+|.++++||+.+|.+++..|+ ++.++++|||+..+.-+
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl---sa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL---SAAQVLNHPWVQRCAPE 370 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh---hhhhccCCccccccchh
Confidence 467888999999988853 467999999999999999999999 99999999999987544
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=329.86 Aligned_cols=240 Identities=30% Similarity=0.454 Sum_probs=189.3
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEeC-----CeEEEE
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISV---RNPFVVRFFYSFTCR-----ENLYLV 527 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~-----~~lyLV 527 (863)
..||+|+||+|+.+. .++|..... .......+.+|+.+++.+ +||||+++++++... ..+++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 489999999996652 233432221 112223456788777765 799999999988653 458999
Q ss_pred EeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 528 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~---- 160 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC---- 160 (288)
T ss_pred Eccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC----
Confidence 999975 899988764 3489999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.....
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 161 ----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred ----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 0011235689999999999998999999999999999999999999988877
Q ss_pred HHHHHHHhhcC-----CCCC-------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 686 QQIFDNILNRK-----IPWP-------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 686 ~el~~kIl~~~-----~~~p-------------------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...+.++.... ..++ .....++.++.+||.+||+.||.+|| ++.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~~~l~hp~f 288 (288)
T cd07863 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI---SAFRALQHPFF 288 (288)
T ss_pred HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 66665554310 0010 11235788899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.83 Aligned_cols=247 Identities=29% Similarity=0.478 Sum_probs=203.9
Q ss_pred Eeecccceeecccc------ceehhhhh------hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------QVLKKADM------IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i------~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||+|+.+. .++|.... ........+.+|+.+|+.++|+||+++++++.+.+.+|+||||++|
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (265)
T cd06631 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86 (265)
T ss_pred eEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence 79999999986542 23333221 1223446788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-------- 158 (265)
T cd06631 87 GSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH-------- 158 (265)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc--------
Confidence 999999988788999999999999999999999999999999999999999999999999998742110000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
...........||..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 159 -----------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 159 -----------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred -----------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 000011234579999999999999889999999999999999999999998776655554554
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
......+..+..++.++.++|++||..+|.+|| ++.++++||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred hccCCCCCCCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 443445566778999999999999999999999 99999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.20 Aligned_cols=251 Identities=35% Similarity=0.618 Sum_probs=199.3
Q ss_pred Eeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHH---HHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDI---LISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~I---L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
+||+|+||.|+.+. +++|... ............|..+ ++...||+|++++++|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999987442 2333221 1111222233444443 444579999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
||+|..++...+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----------- 149 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----------- 149 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc-----------
Confidence 999999998888899999999999999999999999999999999999999999999999999863100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC---ChHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE---HPQQI 688 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~---~~~el 688 (863)
......+||..|+|||++.+ ..++.++||||+||++|+|++|..||... .....
T Consensus 150 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~ 207 (278)
T cd05606 150 ----------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207 (278)
T ss_pred ----------------------cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 01123579999999999975 46899999999999999999999999766 33333
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhcc
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK 752 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~~ 752 (863)
...+.... +..+..++.++.+++.+||..+|.+||... ++.++++||||+.++|..+....
T Consensus 208 ~~~~~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 208 DRMTLTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQK 270 (278)
T ss_pred HHHhhccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhcc
Confidence 33332222 234556799999999999999999999765 89999999999999999887554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=342.95 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=193.2
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~l 524 (863)
.|.+ ..||+|+||.|+.+. +++|+... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 3444 489999999986542 34443322 2233456788999999999999999999988654 357
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+++ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--- 178 (364)
T ss_pred EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC---
Confidence 999999965 78877753 588999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 179 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 179 -----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred -----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 001124578999999999999999999999999999999999999999887
Q ss_pred hHHHHHHHhhcCCC----------------------CC-----------------CCCCCCCHHHHHHHHhhccCCcCCc
Q 002953 685 PQQIFDNILNRKIP----------------------WP-----------------RVPEEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 685 ~~el~~kIl~~~~~----------------------~p-----------------~~p~~iS~el~dLI~k~L~~DP~kR 725 (863)
..+.+.+++..-.. +. ......+.++++||.+||..||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 76666655431100 00 0011235678999999999999999
Q ss_pred CCCCCHHHHHcCCCCCC
Q 002953 726 LGSGGASEVKQHVFFKD 742 (863)
Q Consensus 726 pg~~SAeEILqHPFFk~ 742 (863)
| |+.++|+||||..
T Consensus 310 ~---t~~e~L~hp~~~~ 323 (364)
T cd07875 310 I---SVDEALQHPYINV 323 (364)
T ss_pred C---CHHHHhcCccccc
Confidence 9 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.83 Aligned_cols=240 Identities=28% Similarity=0.453 Sum_probs=196.4
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||+|+||.|+.+. +++|............+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence 79999999986542 34443333333445568889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 539 lLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
++...+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~---------------- 159 (267)
T cd06645 96 IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---------------- 159 (267)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc----------------
Confidence 9988889999999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....+......+...
T Consensus 160 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~ 224 (267)
T cd06645 160 ---------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS 224 (267)
T ss_pred ---------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc
Confidence 01122457999999999985 455789999999999999999999999776654444333333
Q ss_pred CCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 696 KIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 696 ~~~~p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
....+.. ...++..+.+||.+||..+|++|| +++++++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 225 NFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred CCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 3222222 124788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.06 Aligned_cols=246 Identities=31% Similarity=0.520 Sum_probs=206.4
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||.|+||.|+.+. .++|..........+.+.+|+.+|++++||||+++++++.....+|+||||+++++|.+
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence 79999999985542 34444444445566788999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~---------------- 155 (280)
T cd06611 92 IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS---------------- 155 (280)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc----------------
Confidence 98764 5699999999999999999999999999999999999999999999999998763110
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||...+....+.++
T Consensus 156 ---------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (280)
T cd06611 156 ---------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220 (280)
T ss_pred ---------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH
Confidence 001122457899999999985 344678999999999999999999999988877777776
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.....+....+..++.++.++|.+||..+|.+|| ++.++++||||.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~~ 270 (280)
T cd06611 221 LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSDQSD 270 (280)
T ss_pred hcCCCCCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcccch
Confidence 6554433334567899999999999999999999 9999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=358.66 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=189.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCC------CCeeEEEEEEEeC-CeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRN------PFVVRFFYSFTCR-ENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H------PnIVkL~~~f~d~-~~l 524 (863)
..|.+. +||+|+||+|+.+. +++|.... ..........|+.++..++| ++|++++++|... .++
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRN-VPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEec-chhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 345554 89999999997652 23333221 12233445678888877754 4689999988865 478
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCC----------------c
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDG----------------H 587 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g----------------~ 587 (863)
|+|||++ |++|.+++.+.+.+++..++.|+.||+.||+|||+ .|||||||||+|||++.++ .
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 9999998 77999999888899999999999999999999997 5999999999999998765 4
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechh
Q 002953 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667 (863)
Q Consensus 588 VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLG 667 (863)
+||+|||++.... ......+||+.|||||++.+..|+.++||||||
T Consensus 287 vkl~DfG~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG 332 (467)
T PTZ00284 287 VRICDLGGCCDER----------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332 (467)
T ss_pred EEECCCCccccCc----------------------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHH
Confidence 9999999876210 112346899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC------------------------CC-C--------------CCCCH
Q 002953 668 IILFELIVGIPPFNAEHPQQIFDNILNRKIPWP------------------------RV-P--------------EEMSP 708 (863)
Q Consensus 668 vILyELLTGk~PF~~~~~~el~~kIl~~~~~~p------------------------~~-p--------------~~iS~ 708 (863)
|++|||++|++||.+.+..+.+..+......+| .. + ....+
T Consensus 333 vil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (467)
T PTZ00284 333 CIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDD 412 (467)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchH
Confidence 999999999999988776554443322111100 00 0 00135
Q ss_pred HHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 709 el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+.+||.+||++||.+|| |++|+|+||||...
T Consensus 413 ~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 413 LLCDLIYGLLHYDRQKRL---NARQMTTHPYVLKY 444 (467)
T ss_pred HHHHHHHHhCCcChhhCC---CHHHHhcCcccccc
Confidence 678999999999999999 99999999999753
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=335.67 Aligned_cols=245 Identities=28% Similarity=0.500 Sum_probs=195.0
Q ss_pred EEEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
...||+|+||.|+.+. +++|...... ......+.+|+.+|++++||||+++++++..++..|+||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 3489999999996542 3444333222 22234577899999999999999999999999999999999975 8
Q ss_pred hHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------------ 157 (309)
T cd07872 90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP------------ 157 (309)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC------------
Confidence 888886653 5889999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.
T Consensus 158 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 158 -------------------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred -------------------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 001123468999999999876 457999999999999999999999998877655544443
Q ss_pred hcC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 694 NRK-------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 694 ~~~-------------------~~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
... ..++. ....++.++.+||.+||..||.+|| |+.++++||||+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~~ 292 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI---SAEEAMKHAYFRSL 292 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC---CHHHHhcChhhhhc
Confidence 210 00111 1124788999999999999999999 99999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.58 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=191.4
Q ss_pred ccceE-EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------e
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------N 523 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~ 523 (863)
..|.+ ..||+|+||.|+.+. +++|+.. .........+.+|+.+|+.++||||++++++|.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34444 499999999986542 3444332 122344567889999999999999999999987553 5
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~-- 175 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT-- 175 (359)
T ss_pred eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc--
Confidence 7999999965 6777664 3588999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 176 ------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 ------------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ------------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 01112357899999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHhh----------------------cCCCCCC-----------------CCCCCCHHHHHHHHhhccCCcCC
Q 002953 684 HPQQIFDNILN----------------------RKIPWPR-----------------VPEEMSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 684 ~~~el~~kIl~----------------------~~~~~p~-----------------~p~~iS~el~dLI~k~L~~DP~k 724 (863)
+....+..+.. ....++. .....++++++||.+||..||.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65443332221 1111110 01124678999999999999999
Q ss_pred cCCCCCHHHHHcCCCCCC
Q 002953 725 RLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~ 742 (863)
|| |+.|+|+||||..
T Consensus 306 R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 306 RI---SVDEALRHPYITV 320 (359)
T ss_pred CC---CHHHHhcCchhhh
Confidence 99 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.62 Aligned_cols=237 Identities=17% Similarity=0.215 Sum_probs=198.4
Q ss_pred ceEEEeecccceeeccc-----cceehhhhhh---chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEEEe
Q 002953 462 IDLLLAGKGALSEHDDF-----PQVLKKADMI---RKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVME 529 (863)
Q Consensus 462 ~~l~vLGkG~FG~V~~~-----~kvlKK~~i~---~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~lyLVmE 529 (863)
.....||+|++|.|+.. .+++|..... .....+.+.+|+.+|.+++|||||++++++.+ ...+|+|||
T Consensus 23 ~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 23 YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred CCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 33458999999988544 2344433322 22335778899999999999999999999877 357899999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|++||+|.+++.+.+.+++.....++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~------- 175 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS------- 175 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-------
Confidence 99999999999988889999999999999999999998 5999999999999999999999999999873100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..
T Consensus 176 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 176 ---------------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred ---------------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 0113468999999999976 67899999999999999999999999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+++..+......+ ..+..+++++++||.+||+.||.+|| ++.++++
T Consensus 229 ~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 229 EIYDLIINKNNSL-KLPLDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred HHHHHHHhcCCCC-CCCCcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 8888876655443 34557899999999999999999999 8888875
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.12 Aligned_cols=245 Identities=28% Similarity=0.499 Sum_probs=201.1
Q ss_pred Eeecccceeecccc-------ceehhhhhh---------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI---------RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~---------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
+||+|+||.|+.+. +++|..... .....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (267)
T cd06628 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86 (267)
T ss_pred eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence 79999999986542 233322111 12234678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+++++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++........
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 162 (267)
T cd06628 87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---- 162 (267)
T ss_pred ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccccc----
Confidence 9999999999988888999999999999999999999999999999999999999999999999998742110000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
...........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....+
T Consensus 163 ---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 221 (267)
T cd06628 163 ---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI 221 (267)
T ss_pred ---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH
Confidence 00001122456899999999999988999999999999999999999999877665555
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+... ..+..+..++..+.++|++||+.+|.+|| ++.++++||||
T Consensus 222 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 222 FKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred HHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 554432 23455677899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.02 Aligned_cols=240 Identities=29% Similarity=0.487 Sum_probs=203.3
Q ss_pred EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|.... ........+.+|+.+++.++||||+++++++...+.+|+||||++|++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 389999999986542 33333221 234456678999999999999999999999999999999999999999
Q ss_pred hHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 536 LYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 536 L~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus 86 L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----------- 154 (256)
T cd08529 86 LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----------- 154 (256)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----------
Confidence 99999774 56889999999999999999999999999999999999999999999999998742100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 155 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08529 155 --------------------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII 214 (256)
T ss_pred --------------------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011124578999999999999989999999999999999999999999888777777776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+.. +..+..++.++.++|.+||+.+|++|| ++.++++|||+
T Consensus 215 ~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 215 RGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred cCCC--CCCccccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 6543 344557899999999999999999999 99999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=339.27 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=191.2
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~l 524 (863)
+|.+ ..||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||++++++|.... .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4444 489999999996542 33443321 12334567889999999999999999999887543 57
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~--- 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--- 171 (355)
T ss_pred EEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC---
Confidence 999999965 77777753 588999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 172 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 172 -----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred -----------------------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 011224579999999999999999999999999999999999999998876
Q ss_pred hHHHHHHHhhc----------------------CCC-----CC------------CCCCCCCHHHHHHHHhhccCCcCCc
Q 002953 685 PQQIFDNILNR----------------------KIP-----WP------------RVPEEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 685 ~~el~~kIl~~----------------------~~~-----~p------------~~p~~iS~el~dLI~k~L~~DP~kR 725 (863)
..+.+..++.. ... ++ ..+...+.++.+||.+||..||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 54444333221 000 00 0112245778999999999999999
Q ss_pred CCCCCHHHHHcCCCCCC
Q 002953 726 LGSGGASEVKQHVFFKD 742 (863)
Q Consensus 726 pg~~SAeEILqHPFFk~ 742 (863)
| |+.++|+||||..
T Consensus 303 p---s~~ell~hp~~~~ 316 (355)
T cd07874 303 I---SVDEALQHPYINV 316 (355)
T ss_pred C---CHHHHhcCcchhc
Confidence 9 9999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=328.47 Aligned_cols=245 Identities=34% Similarity=0.563 Sum_probs=202.6
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||.|+||.|+.+. +++|..........+.+.+|+.+++.++||||+++++.|......|+||||++|++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 3489999999986542 344444433444557788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 105 ~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~--------------- 168 (296)
T cd06654 105 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--------------- 168 (296)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc---------------
Confidence 999865 5689999999999999999999999999999999999999999999999999873100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|++||....+......+....
T Consensus 169 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (296)
T cd06654 169 ----------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (296)
T ss_pred ----------------cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC
Confidence 0011123578999999999999889999999999999999999999998877655444443333
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
......+..++..+.+||.+||..+|++|| ++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~ 276 (296)
T cd06654 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKIA 276 (296)
T ss_pred CCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhcc
Confidence 222233566889999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=324.95 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=202.3
Q ss_pred cceEE-Eeecccceeeccc------------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDF------------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~------------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
+|.+. .||+|+||.|+.+ .+++|..... .......+.+|+.+++.++||||+++++++......|+
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 34443 8999999999743 1233332211 12334467889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC----------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 527 VMEYLNGGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g----------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 999999999999997532 2455678889999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT- 675 (863)
+....... ........++..|+|||.+.+..++.++|+|||||++|||++
T Consensus 167 ~~~~~~~~-----------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~ 217 (288)
T cd05061 167 RDIYETDY-----------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217 (288)
T ss_pred cccccccc-----------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhC
Confidence 74210000 001122346788999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc------CCCCCCCCh
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ------HVFFKDINW 745 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq------HPFFk~IdW 745 (863)
|.+||.+....+....+..... +..+..+++.+.+++.+||+.+|.+|| ++.++++ ||||.+++|
T Consensus 218 ~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 218 AEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRP---TFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHHHHhhcCCCCCCCCC
Confidence 8999998888777777665433 334567889999999999999999999 8888876 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=316.38 Aligned_cols=240 Identities=27% Similarity=0.514 Sum_probs=200.5
Q ss_pred EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. .++|+... ......+.+.+|+.++++++||||+++++.+.. +..+|+||||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 489999999986442 34444322 223445678899999999999999999998875 44689999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... ..+++..+..++.+++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 86 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---------- 155 (257)
T cd08223 86 DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---------- 155 (257)
T ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----------
Confidence 999999763 45899999999999999999999999999999999999999999999999998742100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+
T Consensus 156 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 156 ---------------------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred ---------------------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 01122457899999999999998999999999999999999999999888877776666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+.. +..+..+++++.+||.+||+.+|.+|| ++.++++||||
T Consensus 215 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred HhcCC--CCCccccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 65543 344567899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.44 Aligned_cols=245 Identities=30% Similarity=0.464 Sum_probs=201.5
Q ss_pred cceEE-Eeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhcC-C-----CCeeEEEEEEEeCCeEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISVR-N-----PFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-H-----PnIVkL~~~f~d~~~lyLV 527 (863)
+|.+. +||+|+||.|..+ ..|..|....++....+...|+.||..|+ | -|||+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 44444 9999999998444 23333444455566677889999999997 4 3899999999999999999
Q ss_pred EeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC--CcEEEeecCCccccccCC
Q 002953 528 MEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~--g~VKLiDFGLAk~~~~~s 603 (863)
+|++. -+|+++|+.. ..|+...++.++.||+.||.+||+.||||+||||+||||... ..|||+|||.|.+.
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~---- 341 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE---- 341 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc----
Confidence 99994 5999999876 459999999999999999999999999999999999999765 47999999999841
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.....+.+.+..|+|||+++|.+|+.+.||||||||++||++|.+.|.++
T Consensus 342 ------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 ------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 11223678899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcC---------------------CCCCC----------------------------CC-----------
Q 002953 684 HPQQIFDNILNRK---------------------IPWPR----------------------------VP----------- 703 (863)
Q Consensus 684 ~~~el~~kIl~~~---------------------~~~p~----------------------------~p----------- 703 (863)
++.+.+..|+.-. ..++. .|
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 9988888876400 00000 11
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 704 ~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..-...+.+||++||.+||.+|+ |+.++|+||||...
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGT 508 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcC---CHHHHhcCcccccc
Confidence 01124678999999999999999 99999999999864
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=355.56 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=207.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-------
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------- 522 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------- 522 (863)
.+|.+. +||+|+||+|+.+. +++|.... ........+.+|+.+|..++|+||++++..+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 455554 99999999996542 34443322 23445567889999999999999999998776432
Q ss_pred -eEEEEEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 523 -NLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 523 -~lyLVmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 378999999999999998653 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
...... ........+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 192 ~~~~~~-----------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 192 MYAATV-----------------------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred eccccc-----------------------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 421100 001123568999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.||.+.+..+++..+..+.. +.++..+++++.+||.+||..||.+|| ++.++++|||++..
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~RP---s~~ell~~p~~~~~ 303 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRY--DPLPPSISPEMQEIVTALLSSDPKRRP---SSSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcccChhhCc---CHHHHHhCHHHHHh
Confidence 99999988888888776554 335678999999999999999999999 99999999998753
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=348.42 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=189.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. +++|. .....+.+|+++|++|+|||||++++++...+..|||||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~------~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEec------ccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 34444 89999999997653 23332 223346789999999999999999999999999999999995
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|..++... +.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.......
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~------- 315 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS------- 315 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc-------
Confidence 6899888664 5699999999999999999999999999999999999999999999999999874210000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--------
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-------- 683 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-------- 683 (863)
.......+||+.|||||++.+..++.++|||||||+||||++|..|+...
T Consensus 316 ----------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~ 373 (461)
T PHA03211 316 ----------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP 373 (461)
T ss_pred ----------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC
Confidence 00112467999999999999999999999999999999999987665322
Q ss_pred ChHHHHHHHhhcCCC---CCCC----------------------------CCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 684 HPQQIFDNILNRKIP---WPRV----------------------------PEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 684 ~~~el~~kIl~~~~~---~p~~----------------------------p~~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
...++.+.+...... ++.. ...++.++.+||.+||+.||.+|| |+.
T Consensus 374 ~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP---sa~ 450 (461)
T PHA03211 374 YDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP---SAA 450 (461)
T ss_pred cHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc---CHH
Confidence 122333333221111 1100 013566899999999999999999 999
Q ss_pred HHHcCCCCCC
Q 002953 733 EVKQHVFFKD 742 (863)
Q Consensus 733 EILqHPFFk~ 742 (863)
|+|+||||+.
T Consensus 451 elL~hp~f~~ 460 (461)
T PHA03211 451 ELLRLPLFQS 460 (461)
T ss_pred HHhhCcccCC
Confidence 9999999974
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.42 Aligned_cols=240 Identities=28% Similarity=0.436 Sum_probs=191.2
Q ss_pred EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEEEEe
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYLVME 529 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~lyLVmE 529 (863)
..||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||++++++|... ..+|++|+
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 489999999986542 34443321 1223345678899999999999999999888644 34799999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++ |++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~--------- 169 (343)
T cd07878 101 LM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--------- 169 (343)
T ss_pred cC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC---------
Confidence 98 7799888764 579999999999999999999999999999999999999999999999999987410
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 170 -------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 224 (343)
T cd07878 170 -------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224 (343)
T ss_pred -------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 01124579999999999987 5689999999999999999999999987766555
Q ss_pred HHHHhhcCC--------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNRKI--------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~~~--------------------~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..+..... .++. .....++.+.+||.+||..||.+|| |+.++++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~---s~~ell~hp~~ 301 (343)
T cd07878 225 LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI---SASEALAHPYF 301 (343)
T ss_pred HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcch
Confidence 444432110 0011 1124567789999999999999999 99999999999
Q ss_pred CCC
Q 002953 741 KDI 743 (863)
Q Consensus 741 k~I 743 (863)
...
T Consensus 302 ~~~ 304 (343)
T cd07878 302 SQY 304 (343)
T ss_pred hcc
Confidence 864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=351.79 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=192.0
Q ss_pred ccceEE-Eeecccceeeccccc-------------------------eehhhhhhchhHHHHHHHHHHHHHhcCCCCeeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFPQ-------------------------VLKKADMIRKNAVESILAERDILISVRNPFVVR 513 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~k-------------------------vlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVk 513 (863)
..|.+. .||+|+||+|+.+.. ++.+...........+.+|+.+|++++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 345554 899999999975310 011111122234456889999999999999999
Q ss_pred EEEEEEeCCeEEEEEeecCCCChHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcE
Q 002953 514 FFYSFTCRENLYLVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 588 (863)
Q Consensus 514 L~~~f~d~~~lyLVmEy~~GGsL~dlLk~~-----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~V 588 (863)
+++++...+..|+||+++. ++|..++... .......++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999995 5888877542 223456788899999999999999999999999999999999999
Q ss_pred EEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhH
Q 002953 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668 (863)
Q Consensus 589 KLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGv 668 (863)
||+|||+++..... ........+||+.|+|||++.+..++.++|||||||
T Consensus 307 kL~DFGla~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 356 (501)
T PHA03210 307 VLGDFGTAMPFEKE------------------------------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356 (501)
T ss_pred EEEeCCCceecCcc------------------------------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHH
Confidence 99999999742100 001123468999999999999999999999999999
Q ss_pred HHHHHHhCCCC-CCCC--ChHHHHHHHhhc----CCCCCC----------------C---------CCCCCHHHHHHHHh
Q 002953 669 ILFELIVGIPP-FNAE--HPQQIFDNILNR----KIPWPR----------------V---------PEEMSPEAHDLIDR 716 (863)
Q Consensus 669 ILyELLTGk~P-F~~~--~~~el~~kIl~~----~~~~p~----------------~---------p~~iS~el~dLI~k 716 (863)
++|||++|..+ |... .....+.+++.. ...+|. . ...++.++.++|.+
T Consensus 357 il~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~k 436 (501)
T PHA03210 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVK 436 (501)
T ss_pred HHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHH
Confidence 99999998754 4322 222222222211 000110 0 11356778899999
Q ss_pred hccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 717 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 717 ~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
||..||.+|| |+.|+|+||||.....+.+.
T Consensus 437 mL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 437 MLTFDWHLRP---GAAELLALPLFSAEEEEEIL 466 (501)
T ss_pred HhccCcccCc---CHHHHhhChhhhcCCchHHH
Confidence 9999999999 99999999999988766553
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.82 Aligned_cols=241 Identities=28% Similarity=0.445 Sum_probs=196.1
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||+|+||.|+.+. .++|............+.+|+.+|.+++||||+++++++...+.+|+||||+++++|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 389999999986542 3444443333344567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 95 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--------------- 159 (267)
T cd06646 95 DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--------------- 159 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---------------
Confidence 99988788999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........|++.|+|||.+. ...++.++|+|||||++|||++|..||....+......+..
T Consensus 160 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06646 160 ----------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223 (267)
T ss_pred ----------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec
Confidence 01122457899999999985 34478899999999999999999999976655443333333
Q ss_pred cCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 695 RKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 695 ~~~~~p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.....+.. ...++..+.+||++||..+|++|| ++++|++|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred CCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 32222221 235789999999999999999999 9999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=329.28 Aligned_cols=242 Identities=29% Similarity=0.484 Sum_probs=195.9
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||+|+||.|+.+. .++|..... .......+.+|+++|.+++||||+++++++.+++.+|+||||++|++|
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L 86 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 86 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence 389999999986542 222322221 233445688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.+++.+.+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------------- 152 (308)
T cd06615 87 DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-------------- 152 (308)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc--------------
Confidence 9999888889999999999999999999997 6999999999999999999999999998763100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 153 -------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (308)
T cd06615 153 -------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213 (308)
T ss_pred -------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc
Confidence 0123467999999999998888999999999999999999999999765543332222110
Q ss_pred CC----------------------------------CCCCCC-CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 696 KI----------------------------------PWPRVP-EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 696 ~~----------------------------------~~p~~p-~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.. ..|..+ ..++.++.+||.+||..+|++|| ++.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ll~~~~~ 290 (308)
T cd06615 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA---DLKELTKHPFI 290 (308)
T ss_pred cccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc---CHHHHhcChhh
Confidence 00 001111 23678899999999999999999 99999999999
Q ss_pred CC
Q 002953 741 KD 742 (863)
Q Consensus 741 k~ 742 (863)
.+
T Consensus 291 ~~ 292 (308)
T cd06615 291 KR 292 (308)
T ss_pred hh
Confidence 75
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=315.97 Aligned_cols=241 Identities=33% Similarity=0.515 Sum_probs=200.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||.|+||.|+.+. .++|..........+.+.+|+.++++++||||+++++++.....+|++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 489999999986542 2334333333445678899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~--------------- 153 (262)
T cd06613 89 DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA--------------- 153 (262)
T ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh---------------
Confidence 999776 7899999999999999999999999999999999999999999999999999873110
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.........|+..|+|||++.+. .++.++|+|||||++|+|++|.+||...+.......+.
T Consensus 154 ----------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 154 ----------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred ----------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00122345789999999999876 78999999999999999999999998877666555554
Q ss_pred hcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 694 NRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 694 ~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
......+ ..+..++.++.+||.+||..+|..|| ++.+++.|+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 218 KSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred hccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 4422222 12344678899999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.53 Aligned_cols=254 Identities=43% Similarity=0.781 Sum_probs=206.3
Q ss_pred EEeecccceeecccc-------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 465 LLAGKGALSEHDDFP-------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..||+|+||.|+.+. +++++.... .......+.+|+.++.++ +||||+++++.+.....+|+|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 389999999986432 223322222 223446788999999999 59999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+++|+|.+++...+.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.....
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------- 158 (288)
T cd05583 86 YVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE------- 158 (288)
T ss_pred cCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-------
Confidence 9999999999987778999999999999999999999999999999999999999999999999998742110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCC---
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNAEH--- 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGvILyELLTGk~PF~~~~--- 684 (863)
.........|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 159 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 215 (288)
T cd05583 159 -----------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215 (288)
T ss_pred -----------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc
Confidence 001122356899999999987755 7889999999999999999999996433
Q ss_pred -hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc
Q 002953 685 -PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 751 (863)
Q Consensus 685 -~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~ 751 (863)
..++...+.... +..+..++.++.++|.+||+.||++||+..++.++|+||||+.++|+.+...
T Consensus 216 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 216 SQSEISRRILKSK---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred hHHHHHHHHHccC---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 233333343333 2345668999999999999999999998778999999999999999888654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.95 Aligned_cols=242 Identities=36% Similarity=0.570 Sum_probs=195.3
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHH--HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~--e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||+|+.+. .++|.......... ....+|+.++++++||||+++++++.....+|+||||+++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 489999999996652 34443333322222 234569999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++...+.+++..+..++.||+.||.+||++||+||||||+|||++.++.++|+|||++.....
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-------------- 150 (260)
T PF00069_consen 85 LQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-------------- 150 (260)
T ss_dssp HHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 999999778899999999999999999999999999999999999999999999999999873100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCCCC---hHHHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEH---PQQIFDN 691 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELLTGk~PF~~~~---~~el~~k 691 (863)
.........+|+.|+|||++. +..++.++||||||+++|+|++|..||.... ....+.+
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~ 213 (260)
T PF00069_consen 151 -----------------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK 213 (260)
T ss_dssp -----------------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH
T ss_pred -----------------cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 012234567899999999998 7888999999999999999999999998873 3333333
Q ss_pred HhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.......... .....+.++.++|.+||+.||++|| ++.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 214 ILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp HHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred cccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 3322111100 0112348999999999999999999 99999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.11 Aligned_cols=246 Identities=31% Similarity=0.557 Sum_probs=207.3
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+..+||+|++|.|+.+. .++|+.........+.+.+|+.+++.++||||+++++++...+..|+|+||++|++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 34599999999986442 45554444444455678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++.. +++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 103 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------------- 167 (285)
T cd06648 103 LTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------------- 167 (285)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------------
Confidence 9999987 6799999999999999999999999999999999999999999999999998763100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...++......+...
T Consensus 168 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 168 -----------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred -----------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence 001112356899999999999888999999999999999999999999988887777776655
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.......+..++..+.+||.+||..+|.+|| ++.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~ 275 (285)
T cd06648 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAKA 275 (285)
T ss_pred CCCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCcccccC
Confidence 4333223344789999999999999999999 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.88 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=180.2
Q ss_pred EEeecccceeecccc---------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP---------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~---------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy~~G 533 (863)
..||+|+||+|+.+. +++|.. ........+.+|+.+|+.++||||+++++++.. +..+|+||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEe--cCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 489999999997653 223322 122233457889999999999999999998854 5678999999965
Q ss_pred CChHHHHHhc---------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee----cCCCcEEEeecCCccccc
Q 002953 534 GDLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 534 GsL~dlLk~~---------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL----d~~g~VKLiDFGLAk~~~ 600 (863)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 888877532 247889999999999999999999999999999999999 456789999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~P 679 (863)
.... .........||+.|+|||++.+. .++.++|||||||++|||++|.+|
T Consensus 164 ~~~~----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 164 SPLK----------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred CCcc----------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence 0000 00112346789999999999874 579999999999999999999999
Q ss_pred CCCCChH---------HHHHHHhhc--------------CCCC---------------------CCCCCCCCHHHHHHHH
Q 002953 680 FNAEHPQ---------QIFDNILNR--------------KIPW---------------------PRVPEEMSPEAHDLID 715 (863)
Q Consensus 680 F~~~~~~---------el~~kIl~~--------------~~~~---------------------p~~p~~iS~el~dLI~ 715 (863)
|...... ..+..+... ...+ .......+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 295 (317)
T cd07867 216 FHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQ 295 (317)
T ss_pred cccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHH
Confidence 9654321 111111100 0000 0001123567889999
Q ss_pred hhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 716 RFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 716 k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+||+.||.+|| |+.|+|+||||
T Consensus 296 ~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 296 KLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred HHhccCccccc---CHHHHhcCCCC
Confidence 99999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=326.58 Aligned_cols=246 Identities=34% Similarity=0.570 Sum_probs=205.4
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.+..||.|+||.|+.+. +++|..........+.+.+|+.+++.++||||+++++++.....+|+||||+++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 102 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCc
Confidence 34489999999986542 34444443444456678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 103 L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~------------- 168 (296)
T cd06655 103 LTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE------------- 168 (296)
T ss_pred HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-------------
Confidence 9998875 46899999999999999999999999999999999999999999999999998731100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 169 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~ 230 (296)
T cd06655 169 ------------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230 (296)
T ss_pred ------------------cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 01112357899999999999888999999999999999999999999888776655555443
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.......+..+++.+.+||.+||..||.+|| ++.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred CCcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 3333334567899999999999999999999 99999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=332.11 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=193.2
Q ss_pred Eeecc--cceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKG--ALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG--~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+| +||+|+.+. +++|..... .......+.+|+.+++.++||||++++++|..++.+|+||||+++|
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 84 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence 78999 677775542 344443322 2344567888999999999999999999999999999999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+......
T Consensus 85 ~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~---------- 154 (327)
T cd08227 85 SAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH---------- 154 (327)
T ss_pred cHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc----------
Confidence 999999653 45899999999999999999999999999999999999999999999999875421100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
+.. .. ..........++..|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus 155 -~~~-----~~--------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 155 -GQR-----LR--------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred -ccc-----cc--------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 000 00 00001123467888999999976 468999999999999999999999998655444333
Q ss_pred HHhhcCCCC-------------------------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 691 NILNRKIPW-------------------------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 691 kIl~~~~~~-------------------------------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
.......+. ......+++++.+||.+||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp- 299 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP- 299 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC-
Confidence 332221100 001123567899999999999999999
Q ss_pred CCCHHHHHcCCCCCCCC
Q 002953 728 SGGASEVKQHVFFKDIN 744 (863)
Q Consensus 728 ~~SAeEILqHPFFk~Id 744 (863)
|++++++||||+.+.
T Consensus 300 --t~~ell~~p~f~~~~ 314 (327)
T cd08227 300 --SASTLLNHSFFKQIK 314 (327)
T ss_pred --CHHHHhcChhhhhcc
Confidence 999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.88 Aligned_cols=241 Identities=29% Similarity=0.518 Sum_probs=204.6
Q ss_pred EEEeecccceeeccc-------cceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+.+||.|+||.++.+ ..++|+.... .......+.+|+++|++++|+||+++++++.+.+.+++||||++++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 448999999976332 2344543332 3445567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--------- 155 (256)
T cd08221 85 TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--------- 155 (256)
T ss_pred cHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc---------
Confidence 999999765 468999999999999999999999999999999999999999999999999987421100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 156 ----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 156 ----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred ----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 0122457899999999999888999999999999999999999999998888888887
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+... ..+..++.++.++|.+||..+|.+|| ++.++++|||+
T Consensus 214 ~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 214 VQGNYT--PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred HcCCCC--CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 765543 33467899999999999999999999 99999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.86 Aligned_cols=244 Identities=33% Similarity=0.559 Sum_probs=201.7
Q ss_pred EEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||.|+||.|+.+ .+++|..........+.+.+|+.+++.++||||+++++++...+++|+||||++|++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 48999999998654 24455444434445567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 105 ~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--------------- 168 (297)
T cd06656 105 DVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------------- 168 (297)
T ss_pred HHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC---------------
Confidence 99865 56899999999999999999999999999999999999999999999999998731000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~ 697 (863)
........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+.....
T Consensus 169 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~ 232 (297)
T cd06656 169 ----------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (297)
T ss_pred ----------------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC
Confidence 0011235689999999999998899999999999999999999999987765443333333222
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+....+..++..+.+||.+||..+|.+|| ++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 275 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhccc
Confidence 22234566889999999999999999999 99999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=320.61 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=197.8
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||.|+.+. +++|..... .......+.+|+.+|..++||||+++++++......|++|||++
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05048 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91 (283)
T ss_pred cccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCC
Confidence 89999999986542 233332222 22344578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 533 GGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 533 GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~ 171 (283)
T cd05048 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171 (283)
T ss_pred CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcce
Confidence 99999999764 34788889999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT- 675 (863)
+...... .........+|+.|+|||.+.+..++.++|||||||++|||++
T Consensus 172 ~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~ 222 (283)
T cd05048 172 RDIYSAD-----------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222 (283)
T ss_pred eeccccc-----------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcC
Confidence 7421000 0011223467889999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|..||.+.+..++...+..... +..+..++.++.+|+.+||+.||.+|| ++.+|+++
T Consensus 223 g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp---~~~~i~~~ 279 (283)
T cd05048 223 GLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRP---RFKDIHTR 279 (283)
T ss_pred CCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999888888877765543 345678999999999999999999999 89998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.79 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=191.4
Q ss_pred cceEE-Eeecccceeecccc-----------------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-----------------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFF 515 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-----------------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~ 515 (863)
.|.+. .||+|+||.|+.+. +++|..... .......+.+|+++|.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 34443 89999999997542 233332221 233456789999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHHhcC-------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCC
Q 002953 516 YSFTCRENLYLVMEYLNGGDLYSLLRNLG-------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 576 (863)
Q Consensus 516 ~~f~d~~~lyLVmEy~~GGsL~dlLk~~g-------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLK 576 (863)
+++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+|||||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlk 165 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcc
Confidence 99999999999999999999999986532 35667888999999999999999999999999
Q ss_pred CcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC
Q 002953 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656 (863)
Q Consensus 577 PeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 656 (863)
|+|||++.++.+||+|||+++...... .........++..|||||++.+..
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGD-----------------------------YYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCc-----------------------------eeEecCcCCCCccccCHHHHhcCC
Confidence 999999999999999999987411000 001122345688999999999888
Q ss_pred CCccceeechhHHHHHHHh--CCCCCCCCChHHHHHHHhhc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC
Q 002953 657 HGTTADWWSVGIILFELIV--GIPPFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 657 ys~ksDIWSLGvILyELLT--Gk~PF~~~~~~el~~kIl~~-----~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
++.++|||||||++|||++ +..||...+..+....+... ...++..+..++..+.+|+.+||..||.+||
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP--- 293 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP--- 293 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc---
Confidence 9999999999999999986 67889877766655544221 1111223456889999999999999999999
Q ss_pred CHHHHHc
Q 002953 730 GASEVKQ 736 (863)
Q Consensus 730 SAeEILq 736 (863)
++.+|.+
T Consensus 294 s~~~i~~ 300 (304)
T cd05096 294 SFSDIHA 300 (304)
T ss_pred CHHHHHH
Confidence 8888743
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.65 Aligned_cols=239 Identities=26% Similarity=0.460 Sum_probs=192.3
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC------CeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR------ENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~------~~lyLVmEy~ 531 (863)
.||+|+||.|+.+. +++|.... .......+.+|+.+|.++ +||||+++++++... ..+|+||||+
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~-~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 91 (272)
T cd06637 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91 (272)
T ss_pred heeecCCeEEEEEEEcCCCcEEEEEEEEc-CCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcC
Confidence 79999999986542 23333222 223445788999999998 699999999998763 4689999999
Q ss_pred CCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 532 NGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 532 ~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 92 ~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~------- 164 (272)
T cd06637 92 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT------- 164 (272)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc-------
Confidence 999999999864 35899999999999999999999999999999999999999999999999998731000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........|++.|+|||++. +..++.++|||||||++|||++|..||....
T Consensus 165 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 165 ------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 01123467999999999986 3457889999999999999999999998766
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.......+...... ...+..++.++.+||.+||..+|.+|| ++.++++||||
T Consensus 221 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~~ 272 (272)
T cd06637 221 PMRALFLIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHhcCCCC-CCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHhhCCCC
Confidence 55544444332221 112346789999999999999999999 99999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.24 Aligned_cols=238 Identities=27% Similarity=0.480 Sum_probs=192.7
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.+||+|+||.|+.+. +++|..... .......+.+|+++|++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 489999999986552 233322211 233446788999999999999999999999999999999999999998
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 87 ~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~--------------- 147 (279)
T cd06619 87 DVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN--------------- 147 (279)
T ss_pred HHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc---------------
Confidence 654 3578899999999999999999999999999999999999999999999999873110
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-------HHHH
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP-------QQIF 689 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~-------~el~ 689 (863)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ....
T Consensus 148 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 209 (279)
T cd06619 148 ------------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209 (279)
T ss_pred ------------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH
Confidence 012245799999999999999999999999999999999999999965321 2222
Q ss_pred HHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 690 DNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 690 ~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
..+..... +.. ....+.++.+||.+||..+|.+|| +++++++||||...+
T Consensus 210 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~~~ 260 (279)
T cd06619 210 QCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQYN 260 (279)
T ss_pred HHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccccc
Confidence 33322221 111 245788999999999999999999 999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.42 Aligned_cols=242 Identities=29% Similarity=0.435 Sum_probs=194.1
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..+||+|+||.|+.+. .++|..........+.+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 3489999999986552 344444444445667889999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCC--ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 537 YSLLRNL-GCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 537 ~dlLk~~-g~L--~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. .+.++|+|||++......
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---------- 162 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI---------- 162 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC----------
Confidence 9999764 455 88889999999999999999999999999999999986 579999999998631100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCChHH-HH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNAEHPQQ-IF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGvILyELLTGk~PF~~~~~~e-l~ 689 (863)
........|++.|+|||++.+.. ++.++|+||||+++|+|++|.+||....... ..
T Consensus 163 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~ 221 (268)
T cd06624 163 ---------------------NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221 (268)
T ss_pred ---------------------CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH
Confidence 00112245899999999987643 7899999999999999999999997543222 11
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+. .....+.++..+++++.+|+.+||..+|.+|| ++.+++.||||
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 222 FKVG-MFKIHPEIPESLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred hhhh-hhccCCCCCcccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 1111 11122345677899999999999999999999 99999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.29 Aligned_cols=246 Identities=32% Similarity=0.553 Sum_probs=200.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|+||+|+.+. .++|...... ......+.+|+.+|+.++||||+++++.+......|+|||+++|++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 86 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcH
Confidence 389999999986542 2333322111 22567789999999999999999999999999999999999999999
Q ss_pred HHHHHhc---CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 537 YSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 537 ~dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
.+++... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~--------- 157 (267)
T cd06610 87 LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD--------- 157 (267)
T ss_pred HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc---------
Confidence 9999764 4589999999999999999999999999999999999999999999999999874211100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.........+|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....+..+
T Consensus 158 ------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 219 (267)
T cd06610 158 ------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT 219 (267)
T ss_pred ------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH
Confidence 000122345799999999999876 7899999999999999999999999888776666666
Q ss_pred hhcCCCC-CCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPW-PRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~-p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
....... +.. ...++..+.+|+.+||..||.+|| ++.++++||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 220 LQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred hcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 5543221 111 136789999999999999999999 99999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.42 Aligned_cols=241 Identities=27% Similarity=0.506 Sum_probs=203.3
Q ss_pred EEEeecccceeeccc-------cceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+..||+|+||.++.+ ..++|..... .......+.+|+.++++++||||+++++++...+..|+||||+.++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 348999999987543 2344433221 2334567899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~----------- 153 (256)
T cd08218 85 DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS----------- 153 (256)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc-----------
Confidence 9999987643 578999999999999999999999999999999999999999999999999873100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 154 --------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred --------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 001112346899999999999988999999999999999999999999988888888777
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+.. +..+..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 214 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 214 IRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred hcCCC--CCCcccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 66554 344667899999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=353.27 Aligned_cols=243 Identities=33% Similarity=0.536 Sum_probs=206.2
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.+||||.||+||.+. .++|.........++-+..|+.+.++|+|.|||++++.+..++++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 499999999997653 4566666666677788999999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCC--ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 538 SLLRNL-GCL--DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 538 dlLk~~-g~L--~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
.+|+.. |++ .+..+-+|.+||+.||.|||.+.|||||||-+|+||+. .|.+||+|||.++.. .
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL--------A----- 727 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL--------A----- 727 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh--------c-----
Confidence 999865 777 78999999999999999999999999999999999975 589999999998841 0
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCC-ChH-HHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAE-HPQ-QIF 689 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~-~~~-el~ 689 (863)
|. ...+-++.||..|||||++.. .+|+.++|||||||++.||.||++||... +++ .++
T Consensus 728 gi------------------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF 789 (1226)
T KOG4279|consen 728 GI------------------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF 789 (1226)
T ss_pred cC------------------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh
Confidence 00 123447889999999999975 56899999999999999999999999643 233 333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+--+... -|.+|..++.+++.||.+|+..+|.+|| +|.++|+.||++.-
T Consensus 790 kVGmyKv--HP~iPeelsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 790 KVGMYKV--HPPIPEELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred hhcceec--CCCCcHHHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 2222211 2567889999999999999999999999 99999999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=317.11 Aligned_cols=247 Identities=29% Similarity=0.515 Sum_probs=198.5
Q ss_pred EEeecccceeecccc-------ceehhhhhhc------hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR------KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~------k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.+||+|+||.|+.+. .++|...... ....+.+.+|+++|++++||||+++++++.+.+.+++||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 479999999986432 3443332211 224567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~------ 159 (268)
T cd06630 86 AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT------ 159 (268)
T ss_pred CCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc------
Confidence 9999999998888899999999999999999999999999999999999998776 599999999874211000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
..........||..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 160 ---------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 218 (268)
T cd06630 160 ---------------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218 (268)
T ss_pred ---------------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH
Confidence 00011223578999999999998889999999999999999999999997554332222
Q ss_pred HHhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 691 NILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 691 kIl~~--~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.+... ....+..+..+++++.+++.+||..+|.+|| ++.++++||||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 219 LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 22211 1122445667899999999999999999999 999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.85 Aligned_cols=238 Identities=37% Similarity=0.674 Sum_probs=199.5
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||.|+||.|+.+. +++.+.........+.+.+|++++++++||||+++++.+.....+|+||||+.|+
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 389999999985542 2233333334456678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|..++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~------------ 153 (258)
T cd05578 86 DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD------------ 153 (258)
T ss_pred CHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC------------
Confidence 99999988778999999999999999999999999999999999999999999999999998741100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh---HHHHHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP---QQIFDN 691 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~---~el~~k 691 (863)
.......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+...
T Consensus 154 --------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (258)
T cd05578 154 --------------------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213 (258)
T ss_pred --------------------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH
Confidence 011235688999999999998899999999999999999999999987763 333333
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH--HHHHcCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA--SEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA--eEILqHPFF 740 (863)
... ..+..+..++.++.++|.+||..||.+|| ++ .++++||||
T Consensus 214 ~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~~l~~~~~~ 258 (258)
T cd05578 214 QET---ADVLYPATWSTEAIDAINKLLERDPQKRL---GDNLKDLKNHPYF 258 (258)
T ss_pred hcc---ccccCcccCcHHHHHHHHHHccCChhHcC---CccHHHHhcCCCC
Confidence 222 22345667899999999999999999999 66 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.86 Aligned_cols=249 Identities=27% Similarity=0.471 Sum_probs=196.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||+|+||.|+.+. +++|...... ......+.+|+.+|+.++||||+++++++...+.+|+||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 34443 89999999986542 3344332221 223346778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
. ++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-------- 157 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-------- 157 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--------
Confidence 7 4999888764 56899999999999999999999999999999999999999999999999998731100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+..
T Consensus 158 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 158 -----------------------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred -----------------------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0011234678999999998764 4788999999999999999999999887766555
Q ss_pred HHHhhcC-------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRK-------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~-------------------~~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..+.... ..++. ....+++++++||.+||+.||.+|| |+.++++||||..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~---t~~eil~h~~f~~ 291 (301)
T cd07873 215 HFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI---SAEEAMKHPYFHC 291 (301)
T ss_pred HHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 4433210 01111 1135788999999999999999999 9999999999987
Q ss_pred CC
Q 002953 743 IN 744 (863)
Q Consensus 743 Id 744 (863)
+.
T Consensus 292 ~~ 293 (301)
T cd07873 292 LG 293 (301)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.36 Aligned_cols=245 Identities=32% Similarity=0.529 Sum_probs=203.4
Q ss_pred EEEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||.|+||.|+.+ .+++|+.........+.+.+|+.+++.++||||+++++.+...++.|+||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 458999999998644 2355554444445566788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-------------- 171 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-------------- 171 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--------------
Confidence 998865 56899999999999999999999999999999999999999999999999998631000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........||+.|+|||++.+..++.++|+||||+++|||++|..||...+....+..+....
T Consensus 172 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (292)
T cd06658 172 -----------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234 (292)
T ss_pred -----------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 011123578999999999998889999999999999999999999998887766665554332
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..........+..+.++|.+||..||.+|| +++++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred CCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 222222335788999999999999999999 99999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=342.92 Aligned_cols=243 Identities=28% Similarity=0.471 Sum_probs=195.7
Q ss_pred EEeecccceeecccc------ceehhhhhh--chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMI--RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+||-++|+.+. ++++|.... +......+.+|+..|.+|+ |.+||+||+|-..++++||||||-+ .+
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~D 445 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-ID 445 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-cc
Confidence 389999999997763 455555433 4556788999999999995 8999999999999999999999975 49
Q ss_pred hHHHHHhcCCC-ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~g~L-~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|..+|++.+.. +.-.+++|..||+.|+.++|.+||||-||||.|+|+- .|.+||+|||+|.......+
T Consensus 446 L~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT---------- 514 (677)
T KOG0596|consen 446 LNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT---------- 514 (677)
T ss_pred HHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc----------
Confidence 99999887553 3358999999999999999999999999999999995 68999999999985221111
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-----------CCccceeechhHHHHHHHhCCCCCCCC
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----------ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.-..-+.+||+.|||||.+.... .++++||||||||||+|++|++||...
T Consensus 515 -------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 515 -------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred -------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 11223579999999999996533 357899999999999999999999654
Q ss_pred C-hHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 684 H-PQQIFDNILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 684 ~-~~el~~kIl~~--~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
. ...-+..|..- .+.||.++.. .++.++++.||.+||.+|| ++.++|+|||...+
T Consensus 576 ~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~---si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 576 INQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRW---SIPELLQHPFLQIQ 633 (677)
T ss_pred HHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCC---CcHHHhcCcccccc
Confidence 3 34444455443 2355555443 3499999999999999999 99999999999864
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.30 Aligned_cols=244 Identities=29% Similarity=0.493 Sum_probs=197.2
Q ss_pred EEeecccceeecccc-------ceehhhhhh-----chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-----~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy 530 (863)
.+||+|+||.|+.+. +++|+.... .......+.+|+.+|+.++||||+++++++... ..+|++|||
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~ 87 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeC
Confidence 489999999986542 333332211 223456788999999999999999999988763 578999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+++++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~------ 161 (266)
T cd06651 88 MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM------ 161 (266)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc------
Confidence 99999999998878899999999999999999999999999999999999999999999999999873110000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.........|+..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 162 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~ 219 (266)
T cd06651 162 ----------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219 (266)
T ss_pred ----------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence 0001123468999999999999889999999999999999999999998776555554
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.+.... ..+.++..+++.++++| +||..+|++|| ++++|++||||+
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 220 KIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred HHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCc---CHHHHhcCcccc
Confidence 443322 23455667889999999 57778999999 999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.69 Aligned_cols=240 Identities=20% Similarity=0.260 Sum_probs=195.3
Q ss_pred ceEE-Eeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 462 IDLL-LAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
+.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|.+++||||+++++++...+.+|+|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 4443 89999999996431 223322221 22344678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+......
T Consensus 87 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~------ 160 (266)
T cd05064 87 YMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE------ 160 (266)
T ss_pred eCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc------
Confidence 99999999999764 57899999999999999999999999999999999999999999999999987631000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~e 687 (863)
.........++..|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 161 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 161 ------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred ------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 0001123346778999999999999999999999999999775 999999888887
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
....+..+.. . ..+..++..+.+++.+||..+|.+|| ++++|++
T Consensus 217 ~~~~~~~~~~-~-~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 217 VIKAVEDGFR-L-PAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred HHHHHHCCCC-C-CCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 7777654432 2 34677899999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.22 Aligned_cols=239 Identities=31% Similarity=0.554 Sum_probs=197.6
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||.|+||.|+.+. .++|.... ....+.+.+|++++++++||||+++++++.+...+|++|||+++++|.+
T Consensus 10 ~i~~g~~~~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 87 (256)
T cd06612 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD 87 (256)
T ss_pred hhcCCCCeEEEEEEEcCCCcEEEEEEeec--HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence 79999999986542 23333221 2226789999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 88 ~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~--------------- 152 (256)
T cd06612 88 IMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--------------- 152 (256)
T ss_pred HHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC---------------
Confidence 99763 56899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~ 697 (863)
........|+..|+|||++.+..++.++||||||+++|+|++|.+||...........+.....
T Consensus 153 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 216 (256)
T cd06612 153 ----------------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP 216 (256)
T ss_pred ----------------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC
Confidence 0011234588999999999999999999999999999999999999987766554444433322
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.....+..++.++.++|.+||+.||.+|| ++.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 217 PTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred CCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 22223456788999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=339.91 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=185.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. +++|. ........|+.+|++++||||+++++++......|+||||+.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEe------CCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 34444 89999999997653 22221 112234679999999999999999999999999999999995
Q ss_pred CCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---------- 209 (357)
T PHA03209 141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---------- 209 (357)
T ss_pred -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----------
Confidence 588888865 35699999999999999999999999999999999999999999999999999873110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC-CCCCCh-----
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP-FNAEHP----- 685 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P-F~~~~~----- 685 (863)
........||+.|+|||++.+..++.++|||||||++|||+++..| |.....
T Consensus 210 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~ 267 (357)
T PHA03209 210 ----------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267 (357)
T ss_pred ----------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence 0111245799999999999999999999999999999999985444 433211
Q ss_pred ----HHHHHHHhhc-C---CCCC-----------------------C---C-CCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 002953 686 ----QQIFDNILNR-K---IPWP-----------------------R---V-PEEMSPEAHDLIDRFLTEDPHQRLGSGG 730 (863)
Q Consensus 686 ----~el~~kIl~~-~---~~~p-----------------------~---~-p~~iS~el~dLI~k~L~~DP~kRpg~~S 730 (863)
...+..++.. . ..++ . + ...++.++.+||.+||+.||.+|| |
T Consensus 268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp---t 344 (357)
T PHA03209 268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP---S 344 (357)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc---C
Confidence 0111111110 0 0011 0 0 024577888999999999999999 9
Q ss_pred HHHHHcCCCCCCC
Q 002953 731 ASEVKQHVFFKDI 743 (863)
Q Consensus 731 AeEILqHPFFk~I 743 (863)
+.|+|+||||+++
T Consensus 345 a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 AEEILNYPMFAQL 357 (357)
T ss_pred HHHHhcCchhccC
Confidence 9999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.04 Aligned_cols=237 Identities=24% Similarity=0.401 Sum_probs=197.0
Q ss_pred Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||.|+.+. .++|............+.+|+.+|++++||||+++++++...+.+|+||||+++
T Consensus 12 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (288)
T cd05093 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 91 (288)
T ss_pred ccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 89999999986542 233333333344566789999999999999999999999999999999999999
Q ss_pred CChHHHHHhcC-------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 534 GDLYSLLRNLG-------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 534 GsL~dlLk~~g-------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 171 (288)
T cd05093 92 GDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171 (288)
T ss_pred CCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCcccccc
Confidence 99999997543 38999999999999999999999999999999999999999999999999987311
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~P 679 (863)
... .........+++.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 172 ~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p 222 (288)
T cd05093 172 STD-----------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222 (288)
T ss_pred CCc-----------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 000 0011123456789999999999889999999999999999998 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 680 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|......+....+..+.. +..+..++.++.+|+.+||+.||.+|| ++.++++
T Consensus 223 ~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~v~~ 274 (288)
T cd05093 223 WYQLSNNEVIECITQGRV--LQRPRTCPKEVYDLMLGCWQREPHMRL---NIKEIHS 274 (288)
T ss_pred CCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 998888888888776553 234566899999999999999999999 7877753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=327.99 Aligned_cols=246 Identities=31% Similarity=0.547 Sum_probs=205.0
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
....||+|+||.|+.+. +++|..........+.+.+|+.++..++||||+++++++...+..|+||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 44589999999985442 34444333333445678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~------------- 170 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------------- 170 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-------------
Confidence 9998765 56899999999999999999999999999999999999999999999999998631100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+|++.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+...
T Consensus 171 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 232 (297)
T cd06659 171 ------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232 (297)
T ss_pred ------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence 01123457999999999999888999999999999999999999999888777766666544
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.......+..++..+.++|.+||+.+|.+|| ++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~~ 277 (297)
T cd06659 233 PPPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQT 277 (297)
T ss_pred CCCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhccC
Confidence 4333334456889999999999999999999 99999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.13 Aligned_cols=244 Identities=30% Similarity=0.485 Sum_probs=201.0
Q ss_pred EEeecccceeeccccceeh--hhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe----CCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFPQVLK--KADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC----RENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~kvlK--K~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d----~~~lyLVmEy~~GGsL~ 537 (863)
.+||-|--|+|..+..-.. |..+.--.+.....+|++..-.. .|||||.++++|+. ...+.+|||+|+||+|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf 147 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF 147 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence 3899999999855421111 11111112334567888887655 59999999998875 35689999999999999
Q ss_pred HHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCCCCCCCc
Q 002953 538 SLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 538 dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
..++..+. |+|.++..|++||..|+.|||+.+|.||||||+|+|.... ..+||+|||+|+.-.
T Consensus 148 sriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~------------ 215 (400)
T KOG0604|consen 148 SRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ------------ 215 (400)
T ss_pred HHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC------------
Confidence 99998765 9999999999999999999999999999999999999765 469999999998410
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC----hHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH----PQQI 688 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~----~~el 688 (863)
......+.|-||+|.|||++-...|+..+|+|||||+||-||+|.+||+... ...+
T Consensus 216 --------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM 275 (400)
T KOG0604|consen 216 --------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275 (400)
T ss_pred --------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH
Confidence 0112346799999999999999999999999999999999999999998754 3567
Q ss_pred HHHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+|..+.+.||.- +..+|+.++++|++||..+|.+|+ |+++++.|||....
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEEVMDHPWINQY 328 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHHhhcCchhccc
Confidence 88899999888752 467899999999999999999999 99999999998753
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=321.45 Aligned_cols=242 Identities=27% Similarity=0.488 Sum_probs=196.8
Q ss_pred Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||+|+||.|+.+. +++|..... .......+.+|+.+|.+++||||+++++.+...+.+|+||||++|++|.
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (286)
T cd06622 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87 (286)
T ss_pred hhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence 89999999985542 334433221 3334567889999999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 538 SLLRNL---GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 538 dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
.++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------------ 155 (286)
T cd06622 88 KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA------------ 155 (286)
T ss_pred HHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC------------
Confidence 998763 379999999999999999999996 6999999999999999999999999999863100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC------CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~------~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......|++.|+|||++.+. .++.++|+|||||++|+|++|..||.......
T Consensus 156 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 156 ---------------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred ---------------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 011234688999999998553 35889999999999999999999997765555
Q ss_pred HHHHHhhc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 688 IFDNILNR-KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 688 l~~kIl~~-~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+..+... ....+.++..++.++.+||.+||..+|.+|| ++.++++||||...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~~~~~~~ 268 (286)
T cd06622 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRP---TYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCC---CHHHHhcChhhhhc
Confidence 44432211 1122445667999999999999999999999 99999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.30 Aligned_cols=242 Identities=33% Similarity=0.573 Sum_probs=202.5
Q ss_pred Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||.|+||.|+.+. .++|..... .......+.+|+++++.++||||+++++++.....+|+|+||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence 78999999986542 333332222 1334567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 88 ~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--------------- 151 (274)
T cd06609 88 DLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST--------------- 151 (274)
T ss_pred HHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccc---------------
Confidence 999864 8999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~ 697 (863)
........|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.....
T Consensus 152 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 215 (274)
T cd06609 152 ----------------MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP 215 (274)
T ss_pred ----------------ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence 0112245789999999999998899999999999999999999999988777666655554432
Q ss_pred CCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 698 PWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 698 ~~p~~p~~-iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+..+.. ++.++.+++.+||..+|++|| +++++++||||....
T Consensus 216 --~~~~~~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 216 --PSLEGNKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred --CCCcccccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 233334 889999999999999999999 999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.44 Aligned_cols=253 Identities=38% Similarity=0.714 Sum_probs=203.9
Q ss_pred EEeecccceeecccc----------ceehhh---hh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKA---DM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~---~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..||.|+||.|+.+. +++|.. .. ......+.+.+|+++|..+ +||||+++++.|+.+..+|+|||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 489999999886432 122221 11 1223346788899999999 58999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------- 158 (290)
T cd05613 86 YINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED------- 158 (290)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-------
Confidence 9999999999988888999999999999999999999999999999999999999999999999998731100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHhCCCCCCCCC---
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPFNAEH--- 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGvILyELLTGk~PF~~~~--- 684 (863)
.........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 215 (290)
T cd05613 159 -----------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215 (290)
T ss_pred -----------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc
Confidence 00111235789999999998753 46889999999999999999999996433
Q ss_pred -hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhh
Q 002953 685 -PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 685 -~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~ 750 (863)
...+...+..... .++..++..+.+|+.+||..+|.+|++. .++++++.||||..++|+.+..
T Consensus 216 ~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 281 (290)
T cd05613 216 SQAEISRRILKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281 (290)
T ss_pred cHHHHHHHhhccCC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence 2333333333332 3456789999999999999999999865 4899999999999999988753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.84 Aligned_cols=241 Identities=29% Similarity=0.473 Sum_probs=190.7
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|+||.|+.+. +++|+.... .......+.+|+.+|+.++||||+++++++.++..+|+||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 489999999986542 344443322 22234568899999999999999999999999999999999997 58
Q ss_pred hHHHHHhc---CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---------- 154 (285)
T cd07861 85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---------- 154 (285)
T ss_pred HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----------
Confidence 98888653 46899999999999999999999999999999999999999999999999998731100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 155 ---------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred ---------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0011234678999999998764 478999999999999999999999987765433322
Q ss_pred HhhcC------------------CCC--------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRK------------------IPW--------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~------------------~~~--------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+.... ..+ ......+++++.+||++||..||.+|| |+.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~~ll~~~~~ 285 (285)
T cd07861 214 IFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI---SAKKALNHPYF 285 (285)
T ss_pred HHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC---CHHHHhcCCCC
Confidence 21100 000 011235789999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.78 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=195.4
Q ss_pred ccceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC------eE
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE------NL 524 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~------~l 524 (863)
..|.+ ..||.|+||.++.+. .++|.. .......+.+.+|+.+++++ +||||+++++++.... .+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEE-ecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34444 389999999986542 222222 22223446788999999999 7999999999997654 48
Q ss_pred EEEEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 525 YLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 9999999999999998653 479999999999999999999999999999999999999999999999999987411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHh
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLT 675 (863)
.. ........|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 165 ~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 165 ST-------------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred cc-------------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 00 011234568999999999864 346789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
|.+||...........+..........+..++.++.+||.+||..||.+|| |+.++++|||+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~ll~~~~~ 275 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPFI 275 (275)
T ss_pred CCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc---CHHHHhcCCCC
Confidence 999998776666655655443322222344788999999999999999999 99999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.81 Aligned_cols=244 Identities=29% Similarity=0.484 Sum_probs=198.2
Q ss_pred EEeecccceeecccc-------ceehhhhhh-----chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-----~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy 530 (863)
.+||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++.+. ..+|+||||
T Consensus 8 ~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (265)
T cd06652 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEH 87 (265)
T ss_pred eEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEe
Confidence 389999999986532 344432211 123456788999999999999999999998764 468999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++|++|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~------- 160 (265)
T cd06652 88 MPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC------- 160 (265)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-------
Confidence 9999999999887889999999999999999999999999999999999999999999999999987411000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
. .........||..|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 161 --------------~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 219 (265)
T cd06652 161 --------------L-------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219 (265)
T ss_pred --------------c-------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH
Confidence 0 0001123568999999999998889999999999999999999999998776555555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.+.... ..+..+..++..+.++|.+||. +|.+|| +++++++|||+.
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 220 KIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRP---SADELLRHTFVH 265 (265)
T ss_pred HHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCC---CHHHHhcCcccC
Confidence 544332 2344566788999999999995 999999 999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.57 Aligned_cols=242 Identities=32% Similarity=0.501 Sum_probs=190.6
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEE-----eCCeEEEEEee
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFT-----CRENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~-----d~~~lyLVmEy 530 (863)
...||+|+||.|+.+. .++|.... .......+.+|+.+++++ +||||+++++++. ....+|+||||
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeecc-ccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 3489999999986542 23332221 122335678899999999 6999999999874 44579999999
Q ss_pred cCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
++|++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---- 177 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST---- 177 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccC----
Confidence 999999998753 246889999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
........||+.|+|||++.. ..++.++|||||||++|+|++|..||.
T Consensus 178 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 178 ---------------------------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred ---------------------------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 011223569999999999853 447889999999999999999999998
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.......+..+..........+..++.++.+||.+||..||++|| ++.++++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~~~~ 286 (286)
T cd06638 231 DLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLLQHVFI 286 (286)
T ss_pred CCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC---CHHHHhhcccC
Confidence 776655444433322211123445688999999999999999999 99999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.56 Aligned_cols=240 Identities=25% Similarity=0.414 Sum_probs=191.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe------CCeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC------RENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d------~~~lyLVmEy 530 (863)
..||.|+||.|+.+. .++|.. .........+..|+.++.++ +||||+++++++.. ...+|+||||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~-~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEE-ecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 489999999986542 233322 22233446688999999998 79999999999853 4578999999
Q ss_pred cCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 531 LNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 531 ~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~------- 173 (282)
T cd06636 101 CGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR------- 173 (282)
T ss_pred CCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc-------
Confidence 9999999999764 3588888999999999999999999999999999999999999999999999873100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.........|++.|+|||++. +..++.++|+|||||++|+|++|.+||...
T Consensus 174 ------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 174 ------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred ------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 001123467999999999986 345788999999999999999999999876
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+......+..... .......++.++.+||.+||..||.+|| ++.+|++||||
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ell~~~~~ 282 (282)
T cd06636 230 HPMRALFLIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRP---STEQLLKHPFI 282 (282)
T ss_pred CHHhhhhhHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCc---CHHHHhcCCCC
Confidence 65544444333221 1112346889999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=336.51 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=192.5
Q ss_pred cceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
.|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+++|+.+ +|||||++++++...+.+|
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 44443 89999999996432 333333221 233456788999999999 8999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc--------------------------------------------------------------
Q 002953 526 LVMEYLNGGDLYSLLRNL-------------------------------------------------------------- 543 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-------------------------------------------------------------- 543 (863)
+|||||++|+|.+++...
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 999999999999998542
Q ss_pred --------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 544 --------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 544 --------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.++++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----------- 267 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----------- 267 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----------
Confidence 1367788999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~ 694 (863)
........+++.|||||++.+..++.++|||||||++|+|++ |+.||........+..+..
T Consensus 268 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~ 329 (374)
T cd05106 268 ------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329 (374)
T ss_pred ------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH
Confidence 001122346678999999999899999999999999999997 9999987765554444444
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..... ..+..+++++.++|.+||+.||.+|| ++.++++
T Consensus 330 ~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 330 RGYQM-SRPDFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred cccCc-cCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 43322 23456789999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.78 Aligned_cols=242 Identities=27% Similarity=0.412 Sum_probs=192.8
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|..... .....+.+.+|+.++++++||||+++++++.....+|+||||++++.
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 389999999986542 233322211 11233467899999999999999999999999999999999999988
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------------- 153 (286)
T cd07847 87 LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP------------- 153 (286)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC-------------
Confidence 8888877678999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........++..|+|||++.+ ..++.++||||||+++|+|++|.+||.+.+..+....+..
T Consensus 154 ------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 154 ------------------GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred ------------------cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 001123468899999999876 4578999999999999999999999987765444333321
Q ss_pred cC-------------------CCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 695 RK-------------------IPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 695 ~~-------------------~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.. ...+. ....++..+.+||.+||..+|++|| ++.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~~~~f 286 (286)
T cd07847 216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL---SCEELLEHPYF 286 (286)
T ss_pred HhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC---CHHHHhcCCCC
Confidence 00 00010 0134688899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=316.32 Aligned_cols=247 Identities=31% Similarity=0.482 Sum_probs=195.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-----CeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR-----ENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~-----~~ly 525 (863)
..|.+. .||+|+||.|+.+. .++|... ........+.+|+.++.++ +||||+++++++... +.+|
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~-~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEec-ccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 345444 89999999986542 2233221 1122345678899999998 899999999998754 3589
Q ss_pred EEEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 526 LVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
+||||++|++|.++++. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999999998863 35689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-----CCCccceeechhHHHHHHHhC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~ksDIWSLGvILyELLTG 676 (863)
. ........|+..|+|||++... .++.++|||||||++|+|++|
T Consensus 181 ~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 181 T-------------------------------RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred c-------------------------------cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 0 0011235689999999998643 368899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
++||...........+..........+..++..+.+||.+||..+|++|| ++.++++||||+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~ 291 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc---CHHHHhcCcccC
Confidence 99998877666655554443322223456788999999999999999999 999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.87 Aligned_cols=237 Identities=24% Similarity=0.382 Sum_probs=196.4
Q ss_pred Eeecccceeecccc------------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||.|+.+. .++|........ ..+.+.+|+++|+.++||||+++++++......|+||||++
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 91 (280)
T cd05049 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91 (280)
T ss_pred hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence 89999999996542 233333222222 45689999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC--------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 533 GGDLYSLLRNLG--------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 533 GGsL~dlLk~~g--------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~ 171 (280)
T cd05049 92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171 (280)
T ss_pred CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCccccee
Confidence 999999997642 378889999999999999999999999999999999999999999999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk 677 (863)
...... ........+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 172 ~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 172 VYTTDY-----------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred cccCcc-----------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 110000 001123356789999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.||...+..+....+..+.. +..+..++..+.+|+.+||..||.+|| ++.|+++
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil~ 276 (280)
T cd05049 223 QPWYGLSNEEVIECITQGRL--LQRPRTCPSEVYDIMLGCWKRDPQQRI---NIKDIHE 276 (280)
T ss_pred CCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 99988888887777765543 233567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.93 Aligned_cols=237 Identities=24% Similarity=0.366 Sum_probs=195.9
Q ss_pred Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||.|+.+. .++|..........+.+.+|+.++++++||||+++++++......++||||+++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (291)
T cd05094 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKH 91 (291)
T ss_pred eecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCC
Confidence 89999999986542 233333333334456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 534 GDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 534 GsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~ 171 (291)
T cd05094 92 GDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171 (291)
T ss_pred CcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCccc
Confidence 99999997542 37889999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-C
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 676 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-G 676 (863)
...... .........|++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 172 ~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 222 (291)
T cd05094 172 DVYSTD-----------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222 (291)
T ss_pred ccCCCc-----------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 411000 0011123467889999999999989999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+||...+..+....+..+.. +..+..++..+.+|+.+||..+|.+|| ++.++++
T Consensus 223 ~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~v~~ 277 (291)
T cd05094 223 KQPWFQLSNTEVIECITQGRV--LERPRVCPKEVYDIMLGCWQREPQQRL---NIKEIYK 277 (291)
T ss_pred CCCCCCCCHHHHHHHHhCCCC--CCCCccCCHHHHHHHHHHcccChhhCc---CHHHHHH
Confidence 999988888777776655443 334566889999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.52 Aligned_cols=230 Identities=27% Similarity=0.391 Sum_probs=193.8
Q ss_pred Eeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHH
Q 002953 466 LAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540 (863)
Q Consensus 466 vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlL 540 (863)
.||+|-||+|... .++..|......-..+.+.+|++||++|+|++||++++++..++.+|||||||+.|+|.++|
T Consensus 213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL 292 (468)
T KOG0197|consen 213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL 292 (468)
T ss_pred HhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence 7999999999432 12222222222344567889999999999999999999999988999999999999999999
Q ss_pred Hh--cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 541 RN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 541 k~--~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
+. .+.+...+...++.||+.|++||+++++|||||-..||||+.+..+||+|||||+....+
T Consensus 293 r~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~---------------- 356 (468)
T KOG0197|consen 293 RTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD---------------- 356 (468)
T ss_pred hhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC----------------
Confidence 87 456999999999999999999999999999999999999999999999999999931100
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCC
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~ 697 (863)
++ ......--...|.|||++....++.++||||||++||||+| |+.||.+.+..++++.+..+..
T Consensus 357 -----~Y---------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR 422 (468)
T KOG0197|consen 357 -----EY---------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR 422 (468)
T ss_pred -----ce---------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc
Confidence 00 00111223568999999999999999999999999999998 9999999999999998876653
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
+| -|..+|+++.+++..||..+|++||+
T Consensus 423 -lp-~P~~CP~~vY~lM~~CW~~~P~~RPt 450 (468)
T KOG0197|consen 423 -LP-RPEGCPDEVYELMKSCWHEDPEDRPT 450 (468)
T ss_pred -CC-CCCCCCHHHHHHHHHHhhCCcccCCC
Confidence 44 37889999999999999999999993
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.35 Aligned_cols=240 Identities=32% Similarity=0.556 Sum_probs=200.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-----hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-----k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+||+|+||.|+.+. .++|...... ....+.+.+|+.+|+.++||||+++++++.....+|+||||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 479999999986542 2333322211 2355678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~---------- 155 (258)
T cd06632 86 GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---------- 155 (258)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc----------
Confidence 9999999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......|++.|+|||.+.... ++.++|+|||||++|+|++|..||...........
T Consensus 156 ----------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 156 ----------------------SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred ----------------------ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 0123456899999999998776 89999999999999999999999977665554444
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+... ...+.++..++.++.+|+.+||..+|.+|| ++.+++.|||+
T Consensus 214 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 214 IGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred HHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 4331 233455677899999999999999999999 99999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=346.92 Aligned_cols=239 Identities=25% Similarity=0.507 Sum_probs=205.1
Q ss_pred Eeecccceeeccccc----------eehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe--EEEEEeecC
Q 002953 466 LAGKGALSEHDDFPQ----------VLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~k----------vlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~--lyLVmEy~~ 532 (863)
+||+|+|-+||.+.. .++-.. .......+++..|+++|+.|+|||||++|+++.+..+ +-+|+|++.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 899999999977632 111111 2234556899999999999999999999999998765 889999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCC-CcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
.|+|..|+++.++.+...++.|++||+.||.|||++. |||||||.+||+|+.+ |.|||+|+|||+..
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~---------- 196 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL---------- 196 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh----------
Confidence 9999999999999999999999999999999999985 9999999999999876 99999999999851
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCC-CCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF-~~~~~~el 688 (863)
........+|||.|||||+.. ..|+..+||||||+.|.||+|+..|| ...++.++
T Consensus 197 -----------------------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 197 -----------------------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred -----------------------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 012234579999999999988 66999999999999999999999999 46789999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
|+++..+..+- .+..--.+++++||.+||.. ..+|+ ++.|+|+||||...
T Consensus 253 YKKV~SGiKP~-sl~kV~dPevr~fIekCl~~-~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKPA-ALSKVKDPEVREFIEKCLAT-KSERL---SAKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCHH-HhhccCCHHHHHHHHHHhcC-chhcc---CHHHHhhChhhccc
Confidence 99999887532 22233468999999999998 99999 99999999999864
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.90 Aligned_cols=242 Identities=22% Similarity=0.365 Sum_probs=195.9
Q ss_pred ceE-EEeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 462 IDL-LLAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
+.+ ..||+|+||.|+.+. .++|.... ........+.+|+.+|++++||||+++++++......|+||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 444 489999999997542 23333321 22334467889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEe
Q 002953 529 EYLNGGDLYSLLRNL-----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 591 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLi 591 (863)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEec
Confidence 999999999998532 237788889999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHH
Q 002953 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671 (863)
Q Consensus 592 DFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILy 671 (863)
|||+++....... ........++..|+|||++.+..++.++|||||||++|
T Consensus 167 dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 217 (283)
T cd05090 167 DLGLSREIYSADY-----------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLW 217 (283)
T ss_pred cccccccccCCcc-----------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHH
Confidence 9999874211000 01122345678899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 672 ELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 672 ELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||++ |.+||.+.+...+...+..... +..+..++..+.+++.+||+.||.+|| ++.+|+++
T Consensus 218 el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~~~ 279 (283)
T cd05090 218 EIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRP---RFKDIHTR 279 (283)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCc---CHHHHHHH
Confidence 9998 9999988877776666654332 334677899999999999999999999 88888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.24 Aligned_cols=237 Identities=24% Similarity=0.389 Sum_probs=196.1
Q ss_pred Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||.|+.+. .++|............+.+|+++++.++||||+++++++......|+||||+++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (280)
T cd05092 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRH 91 (280)
T ss_pred ccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCC
Confidence 89999999997542 233333333445567899999999999999999999999999999999999999
Q ss_pred CChHHHHHhcC---------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 534 GDLYSLLRNLG---------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 534 GsL~dlLk~~g---------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 171 (280)
T cd05092 92 GDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171 (280)
T ss_pred CCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeE
Confidence 99999997643 478899999999999999999999999999999999999999999999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk 677 (863)
..... .........+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 172 ~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 222 (280)
T cd05092 172 IYSTD-----------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222 (280)
T ss_pred cCCCc-----------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence 21000 0011123446788999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+||......+....+..+.. +..+..+++.+.+||.+||+.||.+|| ++.+|++
T Consensus 223 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~l~~ 276 (280)
T cd05092 223 QPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRM---VIKDIHS 276 (280)
T ss_pred CCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 99988877777777655433 233567899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.40 Aligned_cols=236 Identities=22% Similarity=0.363 Sum_probs=194.8
Q ss_pred EEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..||+|+||.|+.+. .++|... ........+.+|+.+|++++||||+++++++.....+|+||||++||+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecc-cCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 379999999986542 2333221 222234568899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-------------- 154 (256)
T cd05114 89 YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-------------- 154 (256)
T ss_pred HHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--------------
Confidence 98753 568999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||++.+..++.++|+||||+++|+|++ |++||...+..+....+..+.
T Consensus 155 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 218 (256)
T cd05114 155 ----------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF 218 (256)
T ss_pred ----------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 001112346678999999998889999999999999999999 999999988888888876654
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. +..+...+.++.+|+.+||..+|.+|| ++.++++
T Consensus 219 ~--~~~~~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 219 R--LYRPKLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred C--CCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 3 223556789999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=308.85 Aligned_cols=237 Identities=28% Similarity=0.477 Sum_probs=198.9
Q ss_pred EEeecccceeeccc-------cceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||+|+||.|+.+ ..++|.... ......+.+.+|+.+++.++||||+++++.+.+.+.+|+||||+++|+|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 48999999998543 234444322 2234567788999999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 537 YSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 537 ~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~------------ 153 (255)
T cd08219 86 MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP------------ 153 (255)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc------------
Confidence 9988653 45899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 154 -------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 154 -------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214 (255)
T ss_pred -------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence 0111235789999999999998899999999999999999999999998888777777665
Q ss_pred cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 695 ~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+.. +..+..++..+.+||.+||..||.+|| ++.+++.-
T Consensus 215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~ 252 (255)
T cd08219 215 GSY--KPLPSHYSYELRSLIKQMFKRNPRSRP---SATTILSR 252 (255)
T ss_pred CCC--CCCCcccCHHHHHHHHHHHhCCcccCC---CHHHHhhc
Confidence 543 334567899999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.35 Aligned_cols=239 Identities=27% Similarity=0.471 Sum_probs=200.0
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|..... .......+.+|+.+|+.++||||+++++.+...+.+|+||||++|++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 489999999986432 233332211 23345678999999999999999999999999999999999999999
Q ss_pred hHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++... ..+++..+..++.+++.||+|||++||+||||||+||+++.+ +.++|+|||++.....
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----------- 154 (256)
T cd08220 86 LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----------- 154 (256)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----------
Confidence 99999764 348999999999999999999999999999999999999865 4689999999874110
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 213 (256)
T cd08220 155 ---------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI 213 (256)
T ss_pred ---------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence 01112356899999999999888999999999999999999999999988877777776
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..... ...+..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 214 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 214 MSGTF--APISDRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred HhcCC--CCCCCCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 65443 334567899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.66 Aligned_cols=243 Identities=21% Similarity=0.317 Sum_probs=195.8
Q ss_pred cceEE-Eeecccceeeccc------------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDF------------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~------------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
+|.+. .||+|+||.|+.+ .+++|+.... .......+.+|+.+++.++||||+++++++......|+
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 34444 8999999998742 1333332211 22334568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC----------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 527 VMEYLNGGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g----------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
||||+++|+|.+++.... .++...+..++.|++.||+|||+.|++||||||+|||++.++.++|+|||++
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCc
Confidence 999999999999997532 2466788899999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT- 675 (863)
+....... ........+++.|||||++.+..++.++|||||||++|||++
T Consensus 167 ~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 217 (277)
T cd05062 167 RDIYETDY-----------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 217 (277)
T ss_pred cccCCcce-----------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcC
Confidence 73110000 001112356788999999999889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|..||...+..+....+..... +..+..++..+.+++.+||+.+|.+|| ++.+++++
T Consensus 218 ~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 274 (277)
T cd05062 218 AEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 274 (277)
T ss_pred CCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 7999998888777777665443 344567899999999999999999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=320.04 Aligned_cols=242 Identities=23% Similarity=0.382 Sum_probs=195.9
Q ss_pred cccceEE-Eeecccceeecccc---------ceehhhh-hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP---------QVLKKAD-MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~---------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
.+.|.+. .||+|+||.|+.+. .++++.. .........+.+|+.+|.++ +||||+++++++...+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3445554 89999999986652 1222222 12234556788999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEE
Q 002953 527 VMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKL 590 (863)
||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999999999999997543 4788899999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002953 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670 (863)
Q Consensus 591 iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvIL 670 (863)
+|||++..... ........++..|+|||++.+..++.++|||||||++
T Consensus 166 ~dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 166 ADFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred CccccCcccch--------------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 99999862000 0011122356789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 671 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 671 yELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|+|++ |.+||...+..+.+..+.... . +..+..++.++.+||.+||..+|.+|| ++++++++
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcCC-c-CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99998 999998888777776654332 1 223456889999999999999999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=306.97 Aligned_cols=240 Identities=31% Similarity=0.542 Sum_probs=199.6
Q ss_pred EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy~~G 533 (863)
..||.|+||.|+.+. .++|... .......+.+.+|+.+|+.++||||+++++++.. ...+|++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 389999999986542 2333221 1233455678899999999999999999998764 4568999999999
Q ss_pred CChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHH-----hCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 534 GDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLH-----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 534 GsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLH-----s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~-- 163 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-- 163 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC--
Confidence 9999998753 57899999999999999999999 899999999999999999999999999998742100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 164 -----------------------------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 164 -----------------------------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred -----------------------------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 001123568999999999998889999999999999999999999999888
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...+...+..... +.++..++.++.+++.+||..+|.+|| ++.+|++|||+
T Consensus 215 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~~ 265 (265)
T cd08217 215 QLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRP---STEELLQLPLI 265 (265)
T ss_pred HHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCC---CHHHHhhCCCC
Confidence 7777766655443 455678899999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=332.97 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=191.2
Q ss_pred ceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 462 IDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
+.+. .||+|+||.|+.+. +++|..... .....+.+.+|+++|..+ +||||+++++++...+..|+
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 4433 89999999996541 233332211 223456788999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC--------------------------------------------------------------
Q 002953 527 VMEYLNGGDLYSLLRNLG-------------------------------------------------------------- 544 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g-------------------------------------------------------------- 544 (863)
|||||+||+|.+++....
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 999999999999986421
Q ss_pred -------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 545 -------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 545 -------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~------- 269 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN------- 269 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc-------
Confidence 367788899999999999999999999999999999999999999999999874210000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
........++..|+|||++.+..++.++|||||||++|||++ |.+||........+.
T Consensus 270 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 270 ----------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred ----------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 001122346778999999999999999999999999999998 899998765544444
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+.+..... +..+...+.++.+||.+||..||++|| ++.+|++.
T Consensus 328 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 370 (375)
T cd05104 328 KMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRP---TFKQIVQL 370 (375)
T ss_pred HHHHhCcc-CCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 44443322 223456789999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=308.14 Aligned_cols=244 Identities=33% Similarity=0.558 Sum_probs=203.7
Q ss_pred EEeecccceeecccc-------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||+|+||.++.+. .++|+...... .....+.+|+.++.+++||||+++++++.....+|+||||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 489999999985542 33343332222 3457789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~------------- 153 (264)
T cd06623 87 ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT------------- 153 (264)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC-------------
Confidence 9999887889999999999999999999999 99999999999999999999999999998742100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE---HPQQIFDNI 692 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~---~~~el~~kI 692 (863)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....+
T Consensus 154 ------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 215 (264)
T cd06623 154 ------------------LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215 (264)
T ss_pred ------------------CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH
Confidence 00112356889999999999988999999999999999999999999776 445555555
Q ss_pred hhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 693 LNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 693 l~~~~~~p~~p~~-iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
..... +..+.. ++..+.++|.+||..+|.+|| ++.++++||||+.++
T Consensus 216 ~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 216 CDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred hcCCC--CCCCcccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 53322 334455 899999999999999999999 999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.75 Aligned_cols=241 Identities=30% Similarity=0.478 Sum_probs=188.7
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|..... .......+.+|+.++++++||||+++++++.+...+|+||||+.+ +
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-D 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-C
Confidence 489999999986542 233332211 122335678899999999999999999999999999999999965 8
Q ss_pred hHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~------------ 152 (284)
T cd07839 85 LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP------------ 152 (284)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC------------
Confidence 8888765 467999999999999999999999999999999999999999999999999998731100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCC-CCCChHHHHHHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNI 692 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF-~~~~~~el~~kI 692 (863)
........+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+
T Consensus 153 -------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 153 -------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred -------------------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 0011234678999999998774 4689999999999999999988875 444444444443
Q ss_pred hhcC-----------------CCCC---------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRK-----------------IPWP---------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~-----------------~~~p---------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...- ..++ .....++.++.+||.+||..||.+|| |++++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~il~h~~f 284 (284)
T cd07839 214 FRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI---SAEEALQHPYF 284 (284)
T ss_pred HHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC---CHHHHhcCCCC
Confidence 2210 0001 11234788999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=343.37 Aligned_cols=249 Identities=31% Similarity=0.538 Sum_probs=217.4
Q ss_pred CCCcccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 456 TPRTSQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 456 ~~~~~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
......|++. .||+|-|++|..+. +++| |... .......+.+|+++|+.|+|||||+++.+.++...+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3455667766 89999999984432 2333 3222 223345589999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+.+|.+++|+.+.++..+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.++..
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--- 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--- 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.....++||++.|.|||++.+..| ++.+|+||||+++|.|+.|.+||.+.
T Consensus 208 -----------------------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 208 -----------------------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred -----------------------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 234457899999999999999887 79999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+..++..+.+.+++.. +..++.++.+||+++|.++|.+|+ +.++|++|.|....
T Consensus 259 ~lk~Lr~rvl~gk~rI---p~~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRI---PFYMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRNDL 312 (596)
T ss_pred ccccccchheeeeecc---cceeechhHHHHHHhhccCccccC---CHHHhhhhcccchh
Confidence 9998888888888765 456899999999999999999999 99999999998743
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.76 Aligned_cols=235 Identities=28% Similarity=0.481 Sum_probs=184.2
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||.|+||.|+.+. .++|.... .... ..|+.+...+ +||||+++++.|...+.+|+||||++|++|.
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~---~~~~--~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKA---KNFN--AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEeh---hhcc--hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 47999999986542 22222111 1111 1133333322 7999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---------------- 161 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---------------- 161 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC----------------
Confidence 9998877899999999999999999999999999999999999999998 99999999987310
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH-HHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF-DNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~-~kIl~~ 695 (863)
......||..|+|||++.+..++.++||||||+++|+|++|..||......... ..+...
T Consensus 162 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 222 (267)
T PHA03390 162 -------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR 222 (267)
T ss_pred -------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh
Confidence 011246899999999999988999999999999999999999999765433221 111111
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.......+..+++.+.+||.+||+.+|.+|++ +++++|+||||++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 223 QQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred hcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 11112334578999999999999999999992 3699999999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.19 Aligned_cols=242 Identities=33% Similarity=0.524 Sum_probs=194.6
Q ss_pred Eeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.||.|+||.|+.+. .++|+..... ......+.+|+.++++++||||+++++++.....+|+||||+ +++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L 85 (286)
T cd07832 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL 85 (286)
T ss_pred ecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCH
Confidence 89999999986542 3344333222 234567899999999999999999999999999999999999 9999
Q ss_pred HHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 537 YSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 537 ~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~------------ 153 (286)
T cd07832 86 SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE------------ 153 (286)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC------------
Confidence 9998653 568999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+..+..
T Consensus 154 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 154 ------------------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred ------------------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 0111235789999999998764 468999999999999999999999988776665555443
Q ss_pred cCC-------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 695 RKI-------------------PWP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 695 ~~~-------------------~~p--------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.-. .++ ......+.++.+||++||..+|.+|| +++++++||||.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~~l~h~~~~ 286 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---SAAEALRHPYFT 286 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC---CHHHHhhCcCcC
Confidence 110 011 11134678999999999999999999 999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.32 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=200.0
Q ss_pred CccCCCcccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEE
Q 002953 453 PLLTPRTSQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYS 517 (863)
Q Consensus 453 p~~~~~~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~ 517 (863)
+........|.+. .||+|+||.|+.+. .++|.... ........+.+|+.++.++ +||||++++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3334444455554 89999999986542 22332221 1223445688999999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCccee
Q 002953 518 FTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581 (863)
Q Consensus 518 f~d~~~lyLVmEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNIL 581 (863)
+...+.+|+||||+++|+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999999642 45888999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccc
Q 002953 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661 (863)
Q Consensus 582 Ld~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 661 (863)
++.++.+||+|||+++....... ........++..|+|||++.+..++.++
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDY-----------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred EcCCCeEEeCccccccccccccc-----------------------------eeccCCCCCCccccCHHHhccCCcCccc
Confidence 99999999999999874210000 0011123356789999999998899999
Q ss_pred eeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 662 DWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 662 DIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||||||++|||++ |..||......+.+..+..... +..+...+.++.+|+.+||..||.+|| |+.+++++
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~eil~~ 287 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRP---TFKQLVED 287 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCc---CHHHHHHH
Confidence 99999999999997 9999998888777777655432 234567889999999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.95 Aligned_cols=240 Identities=33% Similarity=0.576 Sum_probs=204.8
Q ss_pred EEeecccceeeccc-------cceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+ ..++|...... ......+.+|+++++.++|||++++++.+......++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 38999999998643 23444433322 2456678899999999999999999999999999999999999999
Q ss_pred hHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 536 LYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 536 L~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~--------- 156 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--------- 156 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccC---------
Confidence 99999764 67999999999999999999999999999999999999999999999999998741100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+...
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 214 (258)
T cd08215 157 ----------------------VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK 214 (258)
T ss_pred ----------------------cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH
Confidence 0112345789999999999998899999999999999999999999988887777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+.... .+.++..++.++.+++.+||..+|.+|| ++.++++||||
T Consensus 215 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 215 ILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred HhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 66544 3455668899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.27 Aligned_cols=244 Identities=30% Similarity=0.492 Sum_probs=196.2
Q ss_pred EEeecccceeecccc-------ceehhhhhh----------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI----------RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~----------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..||.|+||.|+.+. .++|..... .....+.+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF 86 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence 389999999986542 233332211 112345688899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++|++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 162 (272)
T cd06629 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIY---- 162 (272)
T ss_pred EecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.........|+..|+|||++.... ++.++|+||||+++|+|++|..||.....
T Consensus 163 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 163 -------------------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred -------------------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 001123456899999999998754 78999999999999999999999976655
Q ss_pred HHHHHHHhhcCCC--CC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 686 QQIFDNILNRKIP--WP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 686 ~el~~kIl~~~~~--~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
......+...... ++ .....++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~ 272 (272)
T cd06629 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPFI 272 (272)
T ss_pred HHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCCC
Confidence 4444443322211 11 12235689999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.85 Aligned_cols=238 Identities=29% Similarity=0.413 Sum_probs=199.2
Q ss_pred Eeecccceeecccc----------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. .++|........ ....+.+|++++..++|+||+++++++.+...+|+||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 58999999985542 123322222222 3678899999999999999999999999999999999999999
Q ss_pred ChHHHHHhc---------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 535 DLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 535 sL~dlLk~~---------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~- 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY- 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc-
Confidence 999999875 6799999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~ 684 (863)
........+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 161 ----------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred ----------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 011234568899999999998889999999999999999999 699999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+....+.... ....+..++.++.+++.+||..+|.+|| ++.+++++
T Consensus 213 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 213 NEEVLEYLRKGY--RLPKPEYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred HHHHHHHHHcCC--CCCCCccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 888888776533 2344677899999999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=330.12 Aligned_cols=255 Identities=30% Similarity=0.531 Sum_probs=214.1
Q ss_pred CCCcccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 456 TPRTSQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 456 ~~~~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.+...-|+++ .||+|+||.|+.+. .++..+.+-.....+.+..|+.||++++.|+||++|+.|-....+|+|||
T Consensus 29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3344456655 89999999996652 23333333445667889999999999999999999999988899999999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||-.|++.+.++.. +.++++++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.|-.+
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL--------- 179 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL--------- 179 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh---------
Confidence 99999999998754 67999999999999999999999999999999999999999999999999988631
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.....+.++..|||.|||||++..-+|+.++||||||++..||..|++||..-.+...
T Consensus 180 ----------------------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA 237 (502)
T KOG0574|consen 180 ----------------------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA 237 (502)
T ss_pred ----------------------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce
Confidence 1123466789999999999999999999999999999999999999999988777655
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+-.|-....+.-.-|+.++.++.+||++||.++|++|- ||.++++|||.++..
T Consensus 238 IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 238 IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAP 290 (502)
T ss_pred eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCC
Confidence 44443333222233667899999999999999999999 999999999998653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.69 Aligned_cols=239 Identities=28% Similarity=0.496 Sum_probs=196.3
Q ss_pred Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||+|+||+|+.+. .++|..... .......+.+|+++++.++||||+++++++.....+|+||||+++++|.
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence 89999999986542 222222211 2334567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.++.+.+.+++..+..++.+++.||.|||+ +||+||||||+||+++.++.++|+|||++.....
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~--------------- 156 (284)
T cd06620 92 RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN--------------- 156 (284)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---------------
Confidence 999888889999999999999999999996 6999999999999999999999999998763100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH----------
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ---------- 686 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~---------- 686 (863)
......+||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 157 ------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 218 (284)
T cd06620 157 ------------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218 (284)
T ss_pred ------------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH
Confidence 0112457999999999998888999999999999999999999999865432
Q ss_pred -HHHHHHhhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 687 -QIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 687 -el~~kIl~~~~~~p~~p~-~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+....+..... +.++. .++.++.+||.+||..||.+|| ++.++++|+||..
T Consensus 219 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~~~~~~~~ 271 (284)
T cd06620 219 LDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERP---TPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 23333333221 22222 3788999999999999999999 9999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=313.58 Aligned_cols=244 Identities=32% Similarity=0.529 Sum_probs=203.2
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|+||.|+.+. +++|..... .......+.+|+.++++++||||+++++++.+...+|+||||++||+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 479999999986542 233332222 234456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-------------- 154 (277)
T cd06640 90 LDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-------------- 154 (277)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--------------
Confidence 999875 57899999999999999999999999999999999999999999999999998631100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||++.+..++.++|+|||||++|+|++|.+||....+......+....
T Consensus 155 -----------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 217 (277)
T cd06640 155 -----------------QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN 217 (277)
T ss_pred -----------------ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC
Confidence 011123568899999999998889999999999999999999999998877766655543322
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.+.++..++..+.+||.+||..+|.+|| ++.++++|+||.....
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06640 218 --PPTLTGEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNAK 261 (277)
T ss_pred --CCCCchhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcch
Confidence 2445567889999999999999999999 9999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=309.28 Aligned_cols=239 Identities=32% Similarity=0.577 Sum_probs=197.7
Q ss_pred Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||.|+||.|+.+. .++|..... .......+.+|++++++++||||+++++.+...+.+|+||||+++++|.
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence 79999999986542 233322221 1244567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 538 SLLRNL-GCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 538 dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~-------------- 153 (265)
T cd06605 88 KILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-------------- 153 (265)
T ss_pred HHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH--------------
Confidence 999876 789999999999999999999999 9999999999999999999999999998863100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-----ChHHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-----HPQQIFD 690 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-----~~~el~~ 690 (863)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||... ...+..+
T Consensus 154 -------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (265)
T cd06605 154 -------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214 (265)
T ss_pred -------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence 0111267899999999999999999999999999999999999999654 2334444
Q ss_pred HHhhcCCCCCCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 691 NILNRKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 691 kIl~~~~~~p~~p~~-iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+..... +..+.. ++.++.++|.+||..+|.+|| ++.+++.||||+.
T Consensus 215 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~ 262 (265)
T cd06605 215 YIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKK 262 (265)
T ss_pred HHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhc
Confidence 4443322 333343 889999999999999999999 9999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.76 Aligned_cols=247 Identities=35% Similarity=0.579 Sum_probs=205.0
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||.|+||.|+.+. .++|....... ..+.+.+|+++|+.++|+||+++++.+......|+||||++|++|.
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 389999999986542 23333332222 4567889999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
+++...+ .++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 104 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~--------------- 168 (286)
T cd06614 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK--------------- 168 (286)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc---------------
Confidence 9998876 899999999999999999999999999999999999999999999999998763100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 169 ----------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~ 232 (286)
T cd06614 169 ----------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG 232 (286)
T ss_pred ----------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 0011123468899999999998889999999999999999999999998887766665555443
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
......+..++.++.+||.+||+.+|.+|| ++.++++|+||+...|.
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 322222334889999999999999999999 99999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=344.07 Aligned_cols=243 Identities=28% Similarity=0.394 Sum_probs=210.8
Q ss_pred ccceEEEeecccceeeccc-------cceehhhhhhchh---HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLLLAGKGALSEHDDF-------PQVLKKADMIRKN---AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~---~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
...++.-||.|+||.||-+ .+++||.....+. ....++.|+.+|.+|+|||+|.+-++|-.+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3456668999999999654 2567776665544 34678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||-| +-.+++.-. +++.+..+..|..+.+.||.|||+++.||||||..|||++..|.|||+|||.|...
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--------- 176 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--------- 176 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence 9965 888887543 57999999999999999999999999999999999999999999999999988741
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
...++++|||+|||||+++. +.|+-++||||||++..||.-.+||+...+.
T Consensus 177 --------------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 177 --------------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred --------------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 24568999999999999974 5589999999999999999999999999998
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
...+..|.....+... ...++..+..||..||.+-|.+|| |.+++|.|+|...
T Consensus 231 MSALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 8888888776654322 357899999999999999999999 9999999999864
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.77 Aligned_cols=245 Identities=33% Similarity=0.555 Sum_probs=200.7
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||.|+||.|+.+. .++|..........+.+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 3489999999986542 344444333444556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 104 ~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-------------- 168 (293)
T cd06647 104 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------- 168 (293)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--------------
Confidence 999876 45889999999999999999999999999999999999999999999999987631100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 169 -----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 231 (293)
T cd06647 169 -----------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231 (293)
T ss_pred -----------------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC
Confidence 011123568999999999998889999999999999999999999998776554433332222
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+....+..++..+.++|.+||..+|.+|| ++.+++.|+||+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 211122455788999999999999999999 99999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.54 Aligned_cols=236 Identities=24% Similarity=0.350 Sum_probs=191.1
Q ss_pred Eeecccceeecccc---------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+|+||.|+.+. .++|... .......+.+.+|+.+|+.++||||+++++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 48999999986531 2333222 112334567899999999999999999999875 45679999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~---------- 150 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---------- 150 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC----------
Confidence 9999998878899999999999999999999999999999999999999999999999999874210000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
.........+++.|+|||++.+..++.++|+|||||++|||++ |.+||...+..++...+.
T Consensus 151 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~ 212 (257)
T cd05116 151 ------------------YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212 (257)
T ss_pred ------------------eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 0001112345689999999988889999999999999999998 999999888877777776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
.+.. +..+..++.++.+||.+||+.||++|| ++.+|.
T Consensus 213 ~~~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp---~~~~i~ 249 (257)
T cd05116 213 SGER--MECPQRCPPEMYDLMKLCWTYGVDERP---GFAVVE 249 (257)
T ss_pred CCCC--CCCCCCCCHHHHHHHHHHhccCchhCc---CHHHHH
Confidence 5442 345677999999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.21 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=194.3
Q ss_pred ceEE-Eeecccceeecccc---------ceehhhh-hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 462 IDLL-LAGKGALSEHDDFP---------QVLKKAD-MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~---------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
|.+. +||+|+||.|+.+. .+++... .......+.+.+|+.++.++ +||||+++++++...+.+|+|||
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4433 89999999986531 1222222 22334456789999999999 79999999999999999999999
Q ss_pred ecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeec
Q 002953 530 YLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593 (863)
Q Consensus 530 y~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDF 593 (863)
|+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCc
Confidence 999999999997532 4788899999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHH
Q 002953 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673 (863)
Q Consensus 594 GLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyEL 673 (863)
|++..... .........+..|+|||++.+..++.++|||||||++|||
T Consensus 164 g~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 164 GLSRGEEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred CCCccccc--------------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 99862100 0001112335679999999998899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 674 IV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 674 LT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
++ |.+||......+.+..+..+.. +..+..++.++.+||.+||..+|.+|| +++++++.
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~~ 271 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGYR--MEKPRNCDDEVYELMRQCWRDRPYERP---PFAQISVQ 271 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 97 9999999888888877755432 234567899999999999999999999 89888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.35 Aligned_cols=259 Identities=39% Similarity=0.731 Sum_probs=207.2
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||.|+||.|+.+. +++++...........+.+|+.++.++. ||||+++++++...+.+|+||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 389999999986542 2333333334445567889999999998 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......... ...
T Consensus 87 ~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~-~~~--- 162 (280)
T cd05581 87 GELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE-SNK--- 162 (280)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-cCC---
Confidence 9999999988889999999999999999999999999999999999999999999999999987422111000 000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
... ..................|+..|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+.
T Consensus 163 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 163 GDA-------TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred CCC-------ccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 000 0000000011123345678999999999998889999999999999999999999999888777777776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH----HHHHcCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA----SEVKQHVFF 740 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA----eEILqHPFF 740 (863)
..... ++..+++.+.+||.+||..+|.+|| ++ +++++||||
T Consensus 236 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 KLEYS---FPPNFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred hcCCC---CCCccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 54443 3467899999999999999999999 88 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.29 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=196.2
Q ss_pred cccceEE-Eeecccceeecccc--------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP--------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCR 521 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~ 521 (863)
..++.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3445444 99999999987542 233322211 234456788999999999 699999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
+.+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999999753 247888899999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.+||+|||+++....... ........+++.|||||++.+..++.++||||
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 221 (314)
T cd05099 171 NVMKIADFGLARGVHDIDY-----------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221 (314)
T ss_pred CcEEEcccccccccccccc-----------------------------ccccccCCCCccccCHHHHccCCcCccchhhH
Confidence 9999999999874110000 00111223456899999999988999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 666 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 666 LGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||++|+|++ |..||.+....+.+..+..... +..+..++.++.+|+.+||..+|.+|| ++.++++
T Consensus 222 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~ll~ 288 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRP---TFKQLVE 288 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 9999999999 8999998888888877765432 234567889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.78 Aligned_cols=239 Identities=22% Similarity=0.355 Sum_probs=193.8
Q ss_pred EEeecccceeecccc----------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe------EEE
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN------LYL 526 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~------lyL 526 (863)
..||+|+||.|+.+. +++|.... ........+.+|+.+|+.++||||+++++++..... .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 378999999986432 34443332 223445678999999999999999999988766543 799
Q ss_pred EEeecCCCChHHHHHhc------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 527 VMEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 164 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY 164 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecc
Confidence 99999999999998542 358899999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~P 679 (863)
.... ........++..|+|||.+.+..++.++|||||||++|||++ |.+|
T Consensus 165 ~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 165 SGDY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred cccc-----------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 1000 001112345678999999988889999999999999999999 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 680 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|.+....+++..+..+.. +..+..++.++.+++.+||+.||.+|| ++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~~~ 268 (273)
T cd05035 216 YPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRP---TFTKLREV 268 (273)
T ss_pred CCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 988888888777765432 345677899999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=316.29 Aligned_cols=244 Identities=31% Similarity=0.498 Sum_probs=195.5
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-----hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-----k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..||+|+||.|+.+. .++|+..... ......+..|+++++.++||||+++++++.+...+|+||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 389999999986542 3444332222 123456778999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--------- 155 (298)
T cd07841 85 ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--------- 155 (298)
T ss_pred CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC---------
Confidence 889999998765 7999999999999999999999999999999999999999999999999998741100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
........+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~ 213 (298)
T cd07841 156 ----------------------NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG 213 (298)
T ss_pred ----------------------CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH
Confidence 011123357889999999865 457899999999999999999999998877666555
Q ss_pred HHhhcCCC-----C--------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 691 NILNRKIP-----W--------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 691 kIl~~~~~-----~--------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++...... + .......+.++.+||.+||..+|.+|| ++.++++|+||++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~e~l~~~~~~~~ 288 (298)
T cd07841 214 KIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---TARQALEHPYFSND 288 (298)
T ss_pred HHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc---CHHHHhhCccccCC
Confidence 55321100 0 001134578899999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.68 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=194.8
Q ss_pred cceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 461 QIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+|.+. .||+|+||.|+.+. .++|... ......+.+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEcc-CCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 44544 89999999996542 2333322 2233456789999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-------- 157 (261)
T cd05072 86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-------- 157 (261)
T ss_pred CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc--------
Confidence 9999999753 458889999999999999999999999999999999999999999999999987421000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
........++..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 158 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05072 158 ----------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS 215 (261)
T ss_pred ----------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH
Confidence 001112346778999999998889999999999999999998 999998888777777
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+.... .++ ....++.++.+++.+||..+|++|| +++++.+
T Consensus 216 ~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 256 (261)
T cd05072 216 ALQRGY-RMP-RMENCPDELYDIMKTCWKEKAEERP---TFDYLQS 256 (261)
T ss_pred HHHcCC-CCC-CCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 765442 223 2356899999999999999999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.34 Aligned_cols=245 Identities=31% Similarity=0.533 Sum_probs=202.8
Q ss_pred EEEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||+|+||.|+.+ ..++|+...........+.+|+.+++.++||||+++++.+...++.|+||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 347999999998543 2455554444444556789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. +.+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~-------------- 169 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------------- 169 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--------------
Confidence 998754 56899999999999999999999999999999999999999999999999987631100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........||+.|+|||.+.+..++.++|+||||+++|+|++|.+||.+....+....+....
T Consensus 170 -----------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 170 -----------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred -----------------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence 001123568999999999988888999999999999999999999998877766655554332
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.........++..+.+++.+||..+|.+|| ++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~~ 276 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 276 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhcc
Confidence 221122345789999999999999999999 99999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.02 Aligned_cols=244 Identities=31% Similarity=0.527 Sum_probs=201.5
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||+|+||.|+.+. +++|..... .....+.+.+|+.++++++||||+++++.+.....+|+||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 368999999986542 244432222 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-------------- 154 (277)
T cd06642 90 LDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT-------------- 154 (277)
T ss_pred HHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--------------
Confidence 998865 57899999999999999999999999999999999999999999999999998731100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........|+..|+|||++.+..++.++|+|||||++|||++|..||....+......+....
T Consensus 155 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 217 (277)
T cd06642 155 -----------------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS 217 (277)
T ss_pred -----------------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC
Confidence 011123568999999999999889999999999999999999999998776665554443332
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.+.....++.++.++|.+||..+|.+|| ++.++++||||....+
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06642 218 --PPTLEGQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTK 261 (277)
T ss_pred --CCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhh
Confidence 2344556889999999999999999999 9999999999986554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.79 Aligned_cols=243 Identities=31% Similarity=0.497 Sum_probs=194.9
Q ss_pred EEeecccceeeccc-------cceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|+||.|+.+ .+++|..... .....+.+.+|+++|++++||||+++++++...+.+|+||||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 38999999998554 2344443322 23345678999999999999999999999999999999999999877
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++.+...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.......
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~------------ 154 (288)
T cd07833 87 LELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP------------ 154 (288)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc------------
Confidence 77777666779999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........|+..|+|||++.+. .++.++|+||||+++|+|++|.+||......+....+..
T Consensus 155 ------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 216 (288)
T cd07833 155 ------------------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216 (288)
T ss_pred ------------------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 0012235788999999999887 789999999999999999999999987665443333221
Q ss_pred cC-------------------CCCC----------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 695 RK-------------------IPWP----------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 695 ~~-------------------~~~p----------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.. ..++ .++..++.++.+||++||..+|++|| +++++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~f 288 (288)
T cd07833 217 CLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL---TCDELLQHPYF 288 (288)
T ss_pred HhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc---cHHHHhcCCCC
Confidence 00 0000 12234589999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=313.00 Aligned_cols=242 Identities=29% Similarity=0.448 Sum_probs=193.7
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|..... .....+.+.+|+++|+.++||||+++++++..++..|+||||++++.
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 489999999986542 234432211 22234567899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..+....+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~------------- 153 (286)
T cd07846 87 LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP------------- 153 (286)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC-------------
Confidence 9888776667999999999999999999999999999999999999999999999999998741100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
........|+..|+|||++.+ ..++.++||||||+++|+|++|.+||......+....+..
T Consensus 154 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07846 154 ------------------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIK 215 (286)
T ss_pred ------------------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 011123568899999999876 4478899999999999999999999987665444333332
Q ss_pred cCC-------------------CCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 695 RKI-------------------PWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 695 ~~~-------------------~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
... ..+. ....++..+.+|+.+||..+|.+|| ++.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~~~~ 286 (286)
T cd07846 216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP---SSSQLLHHEFF 286 (286)
T ss_pred HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch---hHHHHhcCCCC
Confidence 100 0111 1235788999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.00 Aligned_cols=244 Identities=36% Similarity=0.600 Sum_probs=196.3
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|...... ......+.+|+.+++.++|+||+++++.+...+.+|+|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 489999999985542 2333322222 3467789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 86 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~---------- 155 (264)
T cd06626 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT---------- 155 (264)
T ss_pred HHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----------
Confidence 9999988777999999999999999999999999999999999999999999999999998742110000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC---CCccceeechhHHHHHHHhCCCCCCCCC-hHHHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDN 691 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---ys~ksDIWSLGvILyELLTGk~PF~~~~-~~el~~k 691 (863)
.........+++.|+|||++.+.. ++.++||||||+++|+|++|..||.... .......
T Consensus 156 -----------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~ 218 (264)
T cd06626 156 -----------------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH 218 (264)
T ss_pred -----------------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH
Confidence 000022357889999999998766 8899999999999999999999997653 3333333
Q ss_pred HhhcCCCCCCCCC--CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKIPWPRVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~~p~--~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+.... .+.++. .++..+.+||.+||+.+|.+|| ++.+++.|||+
T Consensus 219 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 219 VGAGH--KPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred HhcCC--CCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 33222 122333 3589999999999999999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.89 Aligned_cols=235 Identities=23% Similarity=0.383 Sum_probs=193.3
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||+|+||.|+.+. .++|... ........+.+|+++|+.++||||+++++++..+..+|+||||+++++|.+
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~~K~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (263)
T cd05052 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 91 (263)
T ss_pred ecCCcccceEEEEEEecCCceEEEEEec-CCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHH
Confidence 89999999986542 2333222 223345678899999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~------------- 158 (263)
T cd05052 92 YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT------------- 158 (263)
T ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce-------------
Confidence 99754 358899999999999999999999999999999999999999999999999987411000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~ 695 (863)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.+..+...
T Consensus 159 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 159 -----------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred -----------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 001112345678999999999999999999999999999998 99999988887777776543
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.. +..+..++.++.++|.+||..+|++|| ++.++++
T Consensus 222 ~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 257 (263)
T cd05052 222 YR--MERPEGCPPKVYELMRACWQWNPSDRP---SFAEIHQ 257 (263)
T ss_pred CC--CCCCCCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 22 234677899999999999999999999 7877765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.05 Aligned_cols=238 Identities=19% Similarity=0.297 Sum_probs=196.3
Q ss_pred Eeecccceeecccc------------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||.|+.+. .++|...... ....+.+.+|+.++..++||||+++++++......++++||+.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05091 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91 (283)
T ss_pred HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCC
Confidence 78999999986542 2334333222 2234678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 533 GGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 533 GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (283)
T cd05091 92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171 (283)
T ss_pred CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccc
Confidence 99999998532 24788889999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT- 675 (863)
+...... .........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 172 ~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 222 (283)
T cd05091 172 REVYAAD-----------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222 (283)
T ss_pred cccccch-----------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 7411000 0011223456789999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|..||.+....+.+..+..... +..+..++..+.+|+.+||+.+|.+|| ++.+|++.
T Consensus 223 g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~RP---~~~~i~~~ 279 (283)
T cd05091 223 GLQPYCGYSNQDVIEMIRNRQV--LPCPDDCPAWVYTLMLECWNEFPSRRP---RFKDIHSR 279 (283)
T ss_pred CCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHhCCCcccCC---CHHHHHHH
Confidence 8999998888888888776554 234678999999999999999999999 89888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.96 Aligned_cols=240 Identities=51% Similarity=0.924 Sum_probs=202.6
Q ss_pred eecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 467 AGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 467 LGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
||.|+||.|+.+. +++.+...........+..|+.+++.++||||+++++.+..+..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999885432 233333333444667889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-------------- 146 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-------------- 146 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccC--------------
Confidence 999988778999999999999999999999999999999999999999999999999998741100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 147 -----------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (250)
T cd05123 147 -----------------GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP 209 (250)
T ss_pred -----------------CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 011234578999999999998888999999999999999999999998888777777776644
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
. .++..++..+.++|++||..||.+||+...++++++||||
T Consensus 210 ~---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 L---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred C---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 3 3456679999999999999999999933223999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.17 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=196.0
Q ss_pred cceEE-Eeecccceeecccc-----------------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-----------------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFF 515 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-----------------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~ 515 (863)
.|++. .||+|+||.|+.+. .++|..... .....+.+.+|+++|.+++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34443 89999999986431 233332221 224566788999999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCChHHHHHhcC-----------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC
Q 002953 516 YSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584 (863)
Q Consensus 516 ~~f~d~~~lyLVmEy~~GGsL~dlLk~~g-----------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~ 584 (863)
+++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~ 165 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecC
Confidence 99999999999999999999999997765 6899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceee
Q 002953 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664 (863)
Q Consensus 585 ~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 664 (863)
++.++|+|||+++....... ........+|+.|+|||++.+..++.++|||
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDY-----------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216 (296)
T ss_pred CCceEEccccceeecccCcc-----------------------------eeecCcCCCCceecCHHHhhcCCCCccchhh
Confidence 99999999999874211000 0112234578899999999988899999999
Q ss_pred chhHHHHHHHh--CCCCCCCCChHHHHHHHhhc-----CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 665 SVGIILFELIV--GIPPFNAEHPQQIFDNILNR-----KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 665 SLGvILyELLT--Gk~PF~~~~~~el~~kIl~~-----~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
||||++|||++ |..||...+....+..+... .......+..++.++.+|+.+||+.||.+|| ++.+|++
T Consensus 217 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---t~~el~~ 292 (296)
T cd05051 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP---TFREIHL 292 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC---CHHHHHH
Confidence 99999999998 78899887777766665432 1111123455789999999999999999999 8988865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.21 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=195.9
Q ss_pred ccceEE-Eeecccceeecccc--------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 522 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~ 522 (863)
..|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 345443 89999999997542 233322211 233445788899999999 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g 586 (863)
.+|+||||+++|+|.+++...+ .++...+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999999999999997642 378889999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeech
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 666 (863)
.+||+|||+++....... ........+++.|+|||++.+..++.++|||||
T Consensus 178 ~~kL~dfg~a~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 178 VMKIADFGLARDIHHIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred cEEECCCcccccccccch-----------------------------hhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 999999999874210000 001112235678999999999889999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 667 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 667 GvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||++|+|++ |..||......++...+..... +..+..++.++.+||.+||..+|.+|| ++.+++++
T Consensus 229 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~evl~~ 295 (307)
T cd05098 229 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRP---TFKQLVED 295 (307)
T ss_pred HHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCc---CHHHHHHH
Confidence 999999998 8999988887777766654432 234567899999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.79 Aligned_cols=233 Identities=24% Similarity=0.391 Sum_probs=197.6
Q ss_pred eEEEeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 463 DLLLAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
++..||.|+-|.|+.- .+++||....+ ..+++-|++|+||||+.+.+++.....+|||||||..|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 4458999999998543 35566554333 35777899999999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
..|+....++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++...
T Consensus 201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~----------------- 263 (904)
T KOG4721|consen 201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS----------------- 263 (904)
T ss_pred HHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh-----------------
Confidence 999999999999999999999999999999999999999999999999999999999988421
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~ 697 (863)
+....-+++||..|||||++.+.+-+.++|||||||+|||||||..||.+-+...++--+=..-.
T Consensus 264 ---------------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL 328 (904)
T KOG4721|consen 264 ---------------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL 328 (904)
T ss_pred ---------------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc
Confidence 11233468999999999999999999999999999999999999999987665433322212222
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
.+ ..|..+|+-++-||+.||.-.|..|| ++.+||.|-
T Consensus 329 ~L-pvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~Hl 365 (904)
T KOG4721|consen 329 HL-PVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLHL 365 (904)
T ss_pred cc-cCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHHH
Confidence 22 24688999999999999999999999 999999984
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=306.12 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=194.3
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||.|+.+. .++|..... .......+.+|+.+|..++||||+++++++......|+||||++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 92 (277)
T cd05032 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92 (277)
T ss_pred EecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCC
Confidence 89999999986431 233332212 22334578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC----------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 533 GGDLYSLLRNLG----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 533 GGsL~dlLk~~g----------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
+|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~ 172 (277)
T cd05032 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172 (277)
T ss_pred CCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccC
Confidence 999999996532 3677889999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~ 681 (863)
. .........+|..|+|||.+.+..++.++|||||||++|||++ |.+||.
T Consensus 173 ~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 173 D-----------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred c-----------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 0 0011123457889999999998889999999999999999998 999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..+....+.... .+..+..++.++.+||.+||..+|.+|| |+.++++
T Consensus 224 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 273 (277)
T cd05032 224 GLSNEEVLKFVIDGG--HLDLPENCPDKLLELMRMCWQYNPKMRP---TFLEIVS 273 (277)
T ss_pred cCCHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 888888777766432 2345677899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.49 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=198.4
Q ss_pred EEEeecccceeecccc------------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 464 LLLAGKGALSEHDDFP------------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~------------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+..||+|+||.|+.+. .++|........ ....+.+|+++|++++||||+++++++.+....|+||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 4489999999996543 223322222222 356789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC---------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 531 LNGGDLYSLLRNLG---------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 531 ~~GGsL~dlLk~~g---------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~ 169 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCc
Confidence 99999999998765 689999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF 680 (863)
. .........++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 170 ~------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 170 S------------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred c------------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 0 0011223456788999999988889999999999999999998 89999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...........+......++ .+..++..+.+++.+||..+|.+|| ++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~~l~~ 272 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRP---SFSELVSA 272 (275)
T ss_pred cccchHHHHHHHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHH
Confidence 88777777777766555443 3456899999999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=358.94 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=196.9
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyL 526 (863)
...|.+. .||+|+||+|+.+. .++|... .........+..|+.+|..|+|||||+++++|... ..+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3456555 89999999997552 2222222 12334556789999999999999999999988654 56999
Q ss_pred EEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhC-------CccccCCCCcceeecC-----------
Q 002953 527 VMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL-------RVVHRDLKPDNLLIAH----------- 584 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~-------GIIHRDLKPeNILLd~----------- 584 (863)
||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998753 5799999999999999999999985 4999999999999964
Q ss_pred ------CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CC
Q 002953 585 ------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TG 656 (863)
Q Consensus 585 ------~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ 656 (863)
.+.+||+|||++..... .......+||+.|+|||++.+ ..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~--------------------------------~s~~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGI--------------------------------ESMAHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred ccccCCCCceEEccCCccccccc--------------------------------cccccccCCCccccCHHHHhccCCC
Confidence 23589999999874100 011234579999999999965 45
Q ss_pred CCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 657 ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++.++||||||||||+|++|..||...+....+...+.....++ ....+.++.+||.+||..+|.+|| ++.++|.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRP---Sa~QlL~ 294 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERP---SALQCLG 294 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCc---CHHHHhc
Confidence 78999999999999999999999986655444433333332222 245789999999999999999999 9999999
Q ss_pred CCCCCCCCh
Q 002953 737 HVFFKDINW 745 (863)
Q Consensus 737 HPFFk~IdW 745 (863)
|+||+.+..
T Consensus 295 h~~ik~i~~ 303 (1021)
T PTZ00266 295 YQIIKNVGP 303 (1021)
T ss_pred cHHHhhcCC
Confidence 999987643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.60 Aligned_cols=240 Identities=32% Similarity=0.591 Sum_probs=202.2
Q ss_pred EEeecccceeeccc-------cceehhhhhhch--hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIRK--NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~k--~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.++.+ .+++|....... ...+.+.+|++++.+++||||+++++++.+.+..|+||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 48999999998654 233333332222 456789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 86 L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~------------- 152 (254)
T cd06627 86 LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV------------- 152 (254)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCC-------------
Confidence 9999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.......+...
T Consensus 153 ------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (254)
T cd06627 153 ------------------SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD 214 (254)
T ss_pred ------------------cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 00123356899999999998888899999999999999999999999877665555444432
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+.++..++..+.+++.+||..+|++|| ++.+++.||||
T Consensus 215 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 215 --DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred --CCCCCCCCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 23445677899999999999999999999 99999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.15 Aligned_cols=243 Identities=31% Similarity=0.538 Sum_probs=202.3
Q ss_pred EEEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+..||+|+||.|+.+. .++|..... .......+.+|+.++.+++||||+++++++..+..+|+||||+++++
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 3489999999996542 234432221 12344678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|..++.. +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 89 l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~------------- 154 (277)
T cd06641 89 ALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------------- 154 (277)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-------------
Confidence 9999875 56899999999999999999999999999999999999999999999999998631100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...........+...
T Consensus 155 ------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06641 155 ------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN 216 (277)
T ss_pred ------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC
Confidence 00112356899999999998888899999999999999999999999887776666655433
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
. .+.++..++.++.++|.+||..+|.+|| ++.++++||||...
T Consensus 217 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~~ 259 (277)
T cd06641 217 N--PPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVRF 259 (277)
T ss_pred C--CCCCCcccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhhh
Confidence 2 2445567899999999999999999999 99999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=297.62 Aligned_cols=243 Identities=35% Similarity=0.558 Sum_probs=200.9
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
..||+|++|.|+.+. .++|...... ....+.+.+|+.++++++||||+++++.+... ..+|+||||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 489999999985542 2333322222 24567899999999999999999999999988 899999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--------- 156 (260)
T cd06606 86 GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--------- 156 (260)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---------
Confidence 99999998877899999999999999999999999999999999999999999999999999874211000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-hHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~-~~el~~kI 692 (863)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+
T Consensus 157 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (260)
T cd06606 157 --------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216 (260)
T ss_pred --------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc
Confidence 001234578999999999998889999999999999999999999998765 23333333
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.. ....+.++..++..+.+||.+||..+|.+|| ++.++++||||
T Consensus 217 ~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 217 GS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred cc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 22 2233456777899999999999999999999 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.82 Aligned_cols=238 Identities=33% Similarity=0.552 Sum_probs=198.0
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
..||.|+||.|+.+. .++|+...........+.+|+.+++.++||+|+++++++......|++|||++|++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 489999999985542 3444443333346678999999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
+++... +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 86 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-------------- 151 (253)
T cd05122 86 DLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT-------------- 151 (253)
T ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc--------------
Confidence 999876 57999999999999999999999999999999999999999999999999998741100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 152 ------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 213 (253)
T cd05122 152 ------------------KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213 (253)
T ss_pred ------------------ccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC
Confidence 00234578999999999998889999999999999999999999998875555444443322
Q ss_pred CCCCCCCC--CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 697 IPWPRVPE--EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 697 ~~~p~~p~--~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..+. .++..+.++|.+||..||.+|| ++.++++|||
T Consensus 214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 214 --PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred --CCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 222222 3489999999999999999999 9999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.35 Aligned_cols=237 Identities=27% Similarity=0.365 Sum_probs=190.8
Q ss_pred Eeecccceeecccc-------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||+|+||.|+.+. .++|.... ........+.+|+++|+.++||||+++++++.....+|+||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 58999999997542 23332221 22344567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 538 SLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 538 dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~------------ 148 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG-V------------ 148 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc-c------------
Confidence 999764 45899999999999999999999999999999999999999999999999998731100 0
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~ 695 (863)
. ........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...........+...
T Consensus 149 --------~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 149 --------Y--------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred --------c--------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 0 000011223567999999998889999999999999999997 99999877766665555443
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.. +..+..++..+.+|+.+||..+|++|| ++.++++
T Consensus 213 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 248 (252)
T cd05084 213 VR--LPCPELCPDAVYRLMERCWEYDPGQRP---SFSTVHQ 248 (252)
T ss_pred CC--CCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 22 234567899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.45 Aligned_cols=236 Identities=19% Similarity=0.321 Sum_probs=195.1
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||.|+.+. .++|... ......+.+.+|+.++.+++||||+++++++.....+|+||||+.+|+|.++
T Consensus 11 ~lg~G~~~~vy~~~~~~~~~~aik~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd05113 11 ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89 (256)
T ss_pred EecCcccceEEEEEecCCCcEEEEEcC-CCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence 89999999986542 2333322 2222345689999999999999999999999999999999999999999999
Q ss_pred HHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 540 Lk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++......
T Consensus 90 i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~--------------- 154 (256)
T cd05113 90 LREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--------------- 154 (256)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc---------------
Confidence 9764 468999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCC
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~ 697 (863)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+.....
T Consensus 155 ---------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05113 155 ---------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR 219 (256)
T ss_pred ---------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC
Confidence 001112346678999999998889999999999999999998 9999988887777777766543
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
. ..+...+..+.+++.+||..+|.+|| ++.+|+++
T Consensus 220 ~--~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 220 L--YRPHLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred C--CCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 2 23456789999999999999999999 99999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.38 Aligned_cols=246 Identities=19% Similarity=0.319 Sum_probs=198.5
Q ss_pred CcccceEE-Eeecccceeecccc--------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP--------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTC 520 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d 520 (863)
....+.+. .||+|+||.|+.+. +++|.... ........+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 34445543 89999999997442 23333221 1234456789999999999 89999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~ 584 (863)
...+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~ 172 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence 999999999999999999997642 3677788999999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceee
Q 002953 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664 (863)
Q Consensus 585 ~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 664 (863)
++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 173 ~~~~kl~D~g~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 173 NNVMKIADFGLARDVNNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred CCcEEECCCccceecccccc-----------------------------cccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 99999999999874210000 0111234567889999999998899999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 665 SVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 665 SLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||+++|+|++ |..||.+.+..++...+..... ...+..++.++.+||.+||..+|.+|| ++.++++.
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~e~l~~ 292 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRP---TFKQLVED 292 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCC---CHHHHHHH
Confidence 99999999998 8999998888888877755432 233567899999999999999999999 89888865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=308.26 Aligned_cols=239 Identities=22% Similarity=0.320 Sum_probs=193.0
Q ss_pred EEeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..||+|+||.|+.+. .++|..... .......+.+|+.+++.++||||+++++++.+....|+||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 389999999986431 233332222 2334457899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCcccccc
Q 002953 532 NGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLI 601 (863)
Q Consensus 532 ~GGsL~dlLk~~g-------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~~~~ 601 (863)
+|++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||+++....
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~ 171 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCC
Confidence 9999999997653 488899999999999999999999999999999999998765 599999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF 680 (863)
... ........++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 172 ~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 172 ASY-----------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred ccc-----------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 000 001112234568999999998889999999999999999997 99999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...+..+....+..... +..+..++..+.+++.+||..+|++|| ++.++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp---s~~~vl~~ 274 (277)
T cd05036 223 PGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRP---NFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 98887777766554322 234567899999999999999999999 99999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=307.35 Aligned_cols=244 Identities=30% Similarity=0.512 Sum_probs=189.7
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|...... ......+..|+.+ ++.++||||+++++++..++.+|+||||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 389999999986542 3444332211 1223345567665 566789999999999999999999999996 58
Q ss_pred hHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 536 LYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 536 L~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|.+++... ..+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~--------- 156 (283)
T cd06617 86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--------- 156 (283)
T ss_pred HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc---------
Confidence 88877542 4689999999999999999999997 999999999999999999999999999874110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC----CCCCccceeechhHHHHHHHhCCCCCCCC-Ch
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIPPFNAE-HP 685 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~ksDIWSLGvILyELLTGk~PF~~~-~~ 685 (863)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ..
T Consensus 157 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 213 (283)
T cd06617 157 -----------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213 (283)
T ss_pred -----------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC
Confidence 001123468899999999865 45689999999999999999999999653 22
Q ss_pred HHHHHHHhhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 686 QQIFDNILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p-~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
.+.+..+..... +.++ ..+|.++.+||.+||..+|.+|| ++.++++||||....+.
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 214 FQQLKQVVEEPS--PQLPAEKFSPEFQDFVNKCLKKNYKERP---NYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhhhcccc
Confidence 333334333221 2222 45789999999999999999999 99999999999987655
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=302.62 Aligned_cols=240 Identities=27% Similarity=0.472 Sum_probs=198.6
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|..... .....+.+.+|+.+++.++||||+++++.+.....+|+||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 489999999986432 233332221 12344578899999999999999999999999999999999999999
Q ss_pred hHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++ .++|+|||.+......
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---------- 155 (257)
T cd08225 86 LMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---------- 155 (257)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----------
Confidence 999997643 478999999999999999999999999999999999999886 4699999988741100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 156 ---------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (257)
T cd08225 156 ---------------------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214 (257)
T ss_pred ---------------------cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00112346899999999998888999999999999999999999999888777776666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..... +.....++.++.++|.+||..+|++|| ++.++++||||
T Consensus 215 ~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 215 CQGYF--APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred hcccC--CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 55433 334556889999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.49 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=190.5
Q ss_pred Eeecccceeecccc---------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||++++++++ ...+|+||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 38999999986431 233322222 2334467889999999999999999999876 457899999999999
Q ss_pred hHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---------- 150 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---------- 150 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc----------
Confidence 9999875 45799999999999999999999999999999999999999999999999999873210000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 151 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05115 151 ------------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212 (257)
T ss_pred ------------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 0000111234678999999998889999999999999999996 999999888877776665
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+.. +..+...++++.++|.+||..+|++||+..++.+.|+.-|
T Consensus 213 ~~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 213 QGKR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 5443 3345678999999999999999999994444444444443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=310.53 Aligned_cols=242 Identities=30% Similarity=0.485 Sum_probs=191.4
Q ss_pred EEEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+..||.|+||.|+.+. +++|+.... .......+.+|+++|++++||||+++++++.+.+..|+||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 3489999999986542 344433322 12233578899999999999999999999999999999999996 5
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|..++... +.+++..+..++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 84 ~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~---------- 153 (284)
T cd07860 84 DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---------- 153 (284)
T ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC----------
Confidence 899888653 56899999999999999999999999999999999999999999999999998731100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+......+
T Consensus 154 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 212 (284)
T cd07860 154 ---------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212 (284)
T ss_pred ---------------------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 00112335788999999987644 58899999999999999999999987766544444
Q ss_pred HhhcCC------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKI------------------PWP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~------------------~~p--------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..... .++ .....++.++.++|.+||..||.+|| ++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~l~~~~f 284 (284)
T cd07860 213 IFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI---SAKAALAHPFF 284 (284)
T ss_pred HHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC---CHHHHhcCCCC
Confidence 332110 001 01234788999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.91 Aligned_cols=234 Identities=24% Similarity=0.389 Sum_probs=190.9
Q ss_pred Eeecccceeecccc---------ceehhhh-hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKAD-MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. .++|... .......+.+.+|+.++.++ +||||+++++++...+.+|+||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999986542 1223222 12344556788999999999 7999999999999999999999999999
Q ss_pred ChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 535 DLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 535 sL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~ 161 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG 161 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccc
Confidence 9999997542 378889999999999999999999999999999999999999999999999752
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk 677 (863)
... .........+..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 162 ~~~--------------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 162 QEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred cch--------------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 000 000111234667999999998889999999999999999997 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.||.+.+..+.+..+..... ...+..++.++.+|+.+||..+|.+|| ++.++++
T Consensus 210 ~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (270)
T cd05047 210 TPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILV 263 (270)
T ss_pred CCccccCHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 99988887777776654321 233456889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=303.67 Aligned_cols=237 Identities=30% Similarity=0.477 Sum_probs=191.7
Q ss_pred Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|+. ..........+.+|+.+|+.++||||+++++++.+.+.+|+||||+++|+
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 89999999986442 344432 23344555678899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 536 LYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 536 L~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~---------- 158 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---------- 158 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc----------
Confidence 9988853 24588999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--hHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH--PQQIF 689 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~--~~el~ 689 (863)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .....
T Consensus 159 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08228 159 ---------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217 (267)
T ss_pred ---------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH
Confidence 0011124578999999999998889999999999999999999999997653 23444
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+..... .+..+..++..+.++|.+||..+|.+|| ++.++++.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~~ 261 (267)
T cd08228 218 QKIEQCDY-PPLPTEHYSEKLRELVSMCIYPDPDQRP---DIGYVHQI 261 (267)
T ss_pred HHHhcCCC-CCCChhhcCHHHHHHHHHHCCCCcccCc---CHHHHHHH
Confidence 44433222 1222346788999999999999999999 89988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=369.84 Aligned_cols=244 Identities=34% Similarity=0.595 Sum_probs=205.4
Q ss_pred Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+||.|.||.||-+. -++|...+. .......+.+|..+|..|+|||+|++|++-.+.+.+||.||||.||+|
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 79999999996552 233322222 234456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++...+..++...+.|..|++.||.|||++|||||||||.||+++.+|-+|++|||.|.... +...+
T Consensus 1322 a~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~-~~~~~---------- 1390 (1509)
T KOG4645|consen 1322 ASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK-NNAQT---------- 1390 (1509)
T ss_pred HHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec-Cchhc----------
Confidence 9999988889999999999999999999999999999999999999999999999999998521 11110
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCC-CChHHHHHHH
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNI 692 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~-~~~~el~~kI 692 (863)
+ ....+...||+.|||||++.+ .+++.++|||||||++.||+||+.||.. ++...++.++
T Consensus 1391 --------~--------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1391 --------M--------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred --------C--------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 0 122346799999999999976 5678999999999999999999999964 4556666666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
-.+.. |.+|..++.+.++||.+||..||.+|. ++.||++|.|=+
T Consensus 1455 ~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1455 AAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred hccCC--CCCchhhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 66654 677888999999999999999999999 999999998765
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=314.66 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=193.2
Q ss_pred cceE-EEeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
.|.. ..||+|+||.|+.+. +++|..... .....+.+.+|+.+++.++||||+++++++... ..++|
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 3444 389999999997542 234433222 234456788999999999999999999988764 57899
Q ss_pred EeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+||+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 164 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK-- 164 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc--
Confidence 9999999999999874 4688999999999999999999999999999999999999999999999999984211000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~ 685 (863)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 165 ---------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 165 ---------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred ---------------------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 001112345778999999999999999999999999999997 9999988776
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.++.. +......++ .+..++.++.+++.+||..+|.+|| ++.+++.+
T Consensus 218 ~~~~~-~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 218 SEISS-ILEKGERLP-QPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred HHHHH-HHhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 66544 333333333 3456889999999999999999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.37 Aligned_cols=238 Identities=21% Similarity=0.334 Sum_probs=191.0
Q ss_pred Eeecccceeecccc---------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEEEE
Q 002953 466 LAGKGALSEHDDFP---------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYLVM 528 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~lyLVm 528 (863)
+||+|+||.|+.+. +++|... .......+.+.+|+.+|+.++||||+++++++... ...++||
T Consensus 6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~ 85 (272)
T cd05075 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85 (272)
T ss_pred ccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEE
Confidence 79999999996542 2333222 22345567889999999999999999999876432 2478999
Q ss_pred eecCCCChHHHHHhc------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 529 EYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
||+.+|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 165 (272)
T cd05075 86 PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165 (272)
T ss_pred EeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcc
Confidence 999999999887421 34789999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~ 681 (863)
.. ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.
T Consensus 166 ~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 216 (272)
T cd05075 166 DY-----------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216 (272)
T ss_pred cc-----------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 00 001122356788999999999999999999999999999999 899998
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.....+++..+..+.. +..+..++..+.++|.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 267 (272)
T cd05075 217 GVENSEIYDYLRQGNR--LKQPPDCLDGLYSLMSSCWLLNPKDRP---SFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 8887777777765443 233567889999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=347.57 Aligned_cols=242 Identities=27% Similarity=0.450 Sum_probs=198.6
Q ss_pred Eeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEE-EeC------CeEEEEEee
Q 002953 466 LAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSF-TCR------ENLYLVMEY 530 (863)
Q Consensus 466 vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f-~d~------~~lyLVmEy 530 (863)
+|.+|||+.||.+ .+++|+....+......+.+|+++|+.|+ |+|||.+++.. ... -.++|+|||
T Consensus 44 vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEy 123 (738)
T KOG1989|consen 44 VLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEY 123 (738)
T ss_pred EEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhh
Confidence 8999999999765 36788888888889999999999999997 99999999933 221 247899999
Q ss_pred cCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|.||.|-+++... .+|++.+++.|+++++.|+.+||... |||||||-|||||..+|++||||||.|.--..
T Consensus 124 C~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~----- 198 (738)
T KOG1989|consen 124 CKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL----- 198 (738)
T ss_pred ccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC-----
Confidence 9999999999854 56999999999999999999999988 99999999999999999999999999873111
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.+. ...++... ...-...-|+.|+|||++. +.+.+.|+|||+|||+||-|++...||...
T Consensus 199 --~~~---------~~~e~~~v------e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 199 --SPT---------SAQEVNYV------EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred --CCc---------cHHHHHHH------HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 010 00001100 1111234689999999984 677899999999999999999999999876
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
... .|+++++.+|.. ...+..+++||+.||+.||.+|| ++-+++.+
T Consensus 262 g~l----aIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RP---nI~Qv~~~ 307 (738)
T KOG1989|consen 262 GKL----AILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERP---NIYQVLEE 307 (738)
T ss_pred cce----eEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCC---CHHHHHHH
Confidence 433 578888888875 45899999999999999999999 88887754
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.54 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=195.7
Q ss_pred EEeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||.|+.+. +++|..... .......+.+|+.+|+.++||||+++++++...+..|+||||+++
T Consensus 10 ~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 89 (266)
T cd05033 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMEN 89 (266)
T ss_pred eEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCC
Confidence 389999999997542 233332222 233456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++..... ..
T Consensus 90 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~------- 161 (266)
T cd05033 90 GSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS-EA------- 161 (266)
T ss_pred CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc-cc-------
Confidence 9999999764 57899999999999999999999999999999999999999999999999998842100 00
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....
T Consensus 162 ---------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 220 (266)
T cd05033 162 ---------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA 220 (266)
T ss_pred ---------------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 001112345778999999999889999999999999999998 9999988877777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..... ...+...+..+.+|+.+||+.+|.+|| ++.+++++
T Consensus 221 ~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 221 VEDGYR--LPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred HHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 654432 123467899999999999999999999 88888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.02 Aligned_cols=242 Identities=31% Similarity=0.479 Sum_probs=190.1
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCe-----EEEEEe
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVR-NPFVVRFFYSFTCREN-----LYLVME 529 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~-----lyLVmE 529 (863)
..||.|+||.|+.+. +++|+..... ......+.+|+.+++.+. ||||+++++++..... .|+|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 489999999986552 3444333222 223356888999999995 6999999999987766 899999
Q ss_pred ecCCCChHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCC
Q 002953 530 YLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 530 y~~GGsL~dlLk~~-----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s 603 (863)
|+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~- 164 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP- 164 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCC-
Confidence 9986 898887643 35799999999999999999999999999999999999998 789999999998742110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
........+++.|+|||++.+ ..++.++||||||+++|+|++|.+||.+
T Consensus 165 ------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 165 ------------------------------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred ------------------------------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 001122357889999999875 4578999999999999999999999988
Q ss_pred CChHHHHHHHhhcCC-----CC------------C--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 EHPQQIFDNILNRKI-----PW------------P--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ~~~~el~~kIl~~~~-----~~------------p--------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+....+.++..... .+ + .....++.++.+||.+||..||.+|| ++.+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~---~~~eil~~ 291 (295)
T cd07837 215 DSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI---SAKAALTH 291 (295)
T ss_pred CCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC---CHHHHhcC
Confidence 776655554433100 00 0 01135789999999999999999999 99999999
Q ss_pred CCCC
Q 002953 738 VFFK 741 (863)
Q Consensus 738 PFFk 741 (863)
|||+
T Consensus 292 ~~~~ 295 (295)
T cd07837 292 PYFD 295 (295)
T ss_pred CCcC
Confidence 9995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=303.41 Aligned_cols=236 Identities=21% Similarity=0.351 Sum_probs=192.3
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||.|+.+. .++|... ........+.+|+++++.++||||+++++++...+..|+||||++|++|.++
T Consensus 11 ~lg~G~~~~v~~~~~~~~~~~~iK~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd05059 11 ELGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89 (256)
T ss_pred hhccCCCceEEEeEecCCccEEEEEec-cCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence 79999999986542 2333221 1112334678899999999999999999999999999999999999999999
Q ss_pred HHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 540 Lk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
+... +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 90 l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--------------- 154 (256)
T cd05059 90 LRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--------------- 154 (256)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---------------
Confidence 9764 568999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCC
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~ 697 (863)
........++..|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+.....
T Consensus 155 ---------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05059 155 ---------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR 219 (256)
T ss_pred ---------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc
Confidence 000112234568999999999889999999999999999999 8999988877777766654322
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+...+.++.+++.+||..+|++|| ++.++++.
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 233456899999999999999999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.93 Aligned_cols=241 Identities=29% Similarity=0.520 Sum_probs=186.3
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|+||.|+.+. .++|...... ......+.+|+++|+.++||||+++++++.+.+..|+||||+.+ +|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CH
Confidence 389999999986542 3344322211 11234567899999999999999999999999999999999975 99
Q ss_pred HHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 537 YSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 537 ~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------------- 156 (291)
T cd07844 90 KQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP------------- 156 (291)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC-------------
Confidence 9988764 46899999999999999999999999999999999999999999999999998631000
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC-hHHHHHHHh
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNIL 693 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~-~~el~~kIl 693 (863)
........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ..+....+.
T Consensus 157 ------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 218 (291)
T cd07844 157 ------------------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218 (291)
T ss_pred ------------------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 000112357889999999876 458899999999999999999999997655 222222221
Q ss_pred hcC-------------------CCCC--------CCCCCCC--HHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NRK-------------------IPWP--------RVPEEMS--PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~~-------------------~~~p--------~~p~~iS--~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
... ..++ .....++ .++.++|.+||+.+|.+|| ++.++++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp---s~~e~l~~~~f 291 (291)
T cd07844 219 RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI---SAAEAMKHPYF 291 (291)
T ss_pred HhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 100 0000 0001234 7889999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=302.80 Aligned_cols=237 Identities=23% Similarity=0.312 Sum_probs=190.9
Q ss_pred Eeecccceeecccc----------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+|+||.|+.+. .++|....... ...+.+.+|+.+|+.++||||+++++++. ...+++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 58999999986432 23332221111 24567889999999999999999999876 45689999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+|.+++...+.+++..+..++.|++.||+|||..||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~---------- 150 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD---------- 150 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc----------
Confidence 9999998877899999999999999999999999999999999999999999999999999874211000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
.........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 151 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~ 212 (257)
T cd05060 151 ------------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212 (257)
T ss_pred ------------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 0001112235678999999999889999999999999999998 999998888777776665
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.... ...+..++..+.++|.+||..+|.+|| ++.++++
T Consensus 213 ~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~~ 250 (257)
T cd05060 213 SGER--LPRPEECPQEIYSIMLSCWKYRPEDRP---TFSELES 250 (257)
T ss_pred cCCc--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 4432 234567899999999999999999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.43 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=191.7
Q ss_pred cceE-EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~l 524 (863)
.|.. ..||+|+||.|+.+. +++|... .........+.+|+.++++++||||++++++|.... .+
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3443 489999999985542 3444322 122334456788999999999999999999887543 57
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+.+ +|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--- 170 (353)
T cd07850 97 YLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--- 170 (353)
T ss_pred EEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC---
Confidence 999999965 898888653 89999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 171 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 171 -----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred -----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 001123568999999999999999999999999999999999999998776
Q ss_pred hHHHHHHHhhcCCC------------------------------------CCC----CCCCCCHHHHHHHHhhccCCcCC
Q 002953 685 PQQIFDNILNRKIP------------------------------------WPR----VPEEMSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 685 ~~el~~kIl~~~~~------------------------------------~p~----~p~~iS~el~dLI~k~L~~DP~k 724 (863)
....+.++...-.. ++. .+...+..+.+||.+||..||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 55544444321000 000 01134667899999999999999
Q ss_pred cCCCCCHHHHHcCCCCCC
Q 002953 725 RLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~ 742 (863)
|| ++.++|+||||+.
T Consensus 302 R~---t~~eiL~~~~~~~ 316 (353)
T cd07850 302 RI---SVDDALQHPYINV 316 (353)
T ss_pred Cc---CHHHHhcChhHhh
Confidence 99 9999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.58 Aligned_cols=243 Identities=31% Similarity=0.544 Sum_probs=198.2
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||.|+||.|+.+. .++|..... .......+.+|+.+++.++ ||||+++++++......|+||||++|
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 379999999987543 233332221 2344567889999999996 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 87 ~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~----------- 154 (277)
T cd06917 87 GSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN----------- 154 (277)
T ss_pred CcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC-----------
Confidence 999999876 57899999999999999999999999999999999999999999999999998742110
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+
T Consensus 155 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 155 --------------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred --------------------ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 011223568999999999875 45789999999999999999999999887765554433
Q ss_pred hhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 693 LNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 693 l~~~~~~p~~p~-~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
... ..+.++. .++.++.+++.+||..||.+|| ++.++++|+||+...
T Consensus 215 ~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 215 PKS--KPPRLEDNGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred ccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 322 2233333 3889999999999999999999 999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=305.94 Aligned_cols=239 Identities=27% Similarity=0.419 Sum_probs=187.1
Q ss_pred EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVR-NPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
..||+|+||.|+.+. .++|+.... .........+|+.++.++. ||||+++++++.+. +.+|+||||+.+
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM 84 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc
Confidence 379999999986542 233332221 1122234467999999885 99999999999988 889999999975
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||+++. +.+||+|||+++.....
T Consensus 85 -~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---------- 152 (282)
T cd07831 85 -NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---------- 152 (282)
T ss_pred -cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC----------
Confidence 888888653 56899999999999999999999999999999999999999 99999999998741100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......+|+.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..
T Consensus 153 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 153 ----------------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred ----------------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 01112468899999998754 4568999999999999999999999988876665554
Q ss_pred HhhcC------------------CCCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRK------------------IPWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~------------------~~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+.... ..++. ....++.++.+||.+||.++|++|| ++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~~~~ 282 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI---TAKQALRHPYF 282 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc---CHHHHhhCCCC
Confidence 43211 01111 1124689999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.26 Aligned_cols=230 Identities=21% Similarity=0.281 Sum_probs=183.9
Q ss_pred Eeecccceeecccc-------------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 466 LAGKGALSEHDDFP-------------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.||+|+||.|+... +++|............+..|+.+|..++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999987553 23333222233344578889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc-------EEEeecCCccc
Q 002953 527 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-------IKLTDFGLSKV 598 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~-------VKLiDFGLAk~ 598 (863)
||||+++|+|..++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++..
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~ 161 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPIT 161 (262)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcc
Confidence 99999999999988754 56899999999999999999999999999999999999987654 89999998863
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHH-hC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELI-VG 676 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELL-TG 676 (863)
.. ......|+..|+|||++. +..++.++|||||||++|||+ .|
T Consensus 162 ~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 162 VL-----------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred cc-----------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 10 011346788999999987 466899999999999999997 58
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..||......+... +...... .....+.++.+||.+||..||.+|| ++.+|+++
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rp---~~~~il~~ 260 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCM---LVTPSCKELADLMTHCMNYDPNQRP---FFRAIMRD 260 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCcc---CCCCChHHHHHHHHHHcCCChhhCc---CHHHHHHh
Confidence 99997765544332 2222221 1233568899999999999999999 99999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.32 Aligned_cols=230 Identities=21% Similarity=0.327 Sum_probs=184.8
Q ss_pred Eeecccceeecccc--------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP--------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~--------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.||+|+||.|+.+. .++|..........+.+..|+.+|+.++||||+++++++......|+||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999997653 1222222222334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc--------EEEeecCCccccccC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGLSKVGLIN 602 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~--------VKLiDFGLAk~~~~~ 602 (863)
++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||++....
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~-- 159 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL-- 159 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC--
Confidence 9999999997654 5899999999999999999999999999999999999987764 6999999876310
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhC-CCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG-IPPF 680 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTG-k~PF 680 (863)
......+++.|+|||++.+ ..++.++|||||||++|+|++| .+||
T Consensus 160 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 160 ---------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred ---------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 0112468889999999987 4579999999999999999998 5777
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...+...... +..... .++...+.++.+||.+||+.+|++|| ++++|++.
T Consensus 207 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~ 256 (258)
T cd05078 207 SALDSQKKLQ-FYEDRH---QLPAPKWTELANLINQCMDYEPDFRP---SFRAIIRD 256 (258)
T ss_pred hhccHHHHHH-HHHccc---cCCCCCcHHHHHHHHHHhccChhhCC---CHHHHHHh
Confidence 6665544333 222222 33456778999999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.66 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=192.7
Q ss_pred cceEE-Eeecccceeecccc---------------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP---------------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYS 517 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~---------------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~ 517 (863)
+|.+. .||+|+||.|+.+. +++|..... .......+.+|+++|++++||||++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 45554 89999999997532 234433221 23345678999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCChHHHHHhcC------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 518 FTCRENLYLVMEYLNGGDLYSLLRNLG------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 518 f~d~~~lyLVmEy~~GGsL~dlLk~~g------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
+...+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCC
Confidence 999999999999999999999986532 36788889999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.+||+|||++....... .........+++.|+|||++.+..++.++||||
T Consensus 166 ~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS 216 (295)
T cd05097 166 YTIKIADFGMSRNLYSGD-----------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216 (295)
T ss_pred CcEEecccccccccccCc-----------------------------ceeccCcCcCceeecChhhhccCCcCchhhHHH
Confidence 999999999987311000 001112345678999999999888999999999
Q ss_pred hhHHHHHHHh--CCCCCCCCChHHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 666 VGIILFELIV--GIPPFNAEHPQQIFDNILN-----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 666 LGvILyELLT--Gk~PF~~~~~~el~~kIl~-----~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||++|+|++ |..||...+..+....+.. ....+...+..++..+.+|+.+||..+|.+|| ++++|++
T Consensus 217 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP---s~~~i~~ 291 (295)
T cd05097 217 FGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP---TFNKIHH 291 (295)
T ss_pred HHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 9999999988 7789988776666555432 11122233456789999999999999999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=328.19 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=189.4
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
+||+|+||.|+.+. +++|+.... .....+.+.+|+++|+++. |||||++++++.....+|||||||
T Consensus 44 ~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~ 123 (400)
T cd05105 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYC 123 (400)
T ss_pred eecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEec
Confidence 89999999996532 344443322 2334567899999999996 999999999999999999999999
Q ss_pred CCCChHHHHHhc--------------------------------------------------------------------
Q 002953 532 NGGDLYSLLRNL-------------------------------------------------------------------- 543 (863)
Q Consensus 532 ~GGsL~dlLk~~-------------------------------------------------------------------- 543 (863)
++|+|.++|...
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (400)
T cd05105 124 FYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDI 203 (400)
T ss_pred CCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhc
Confidence 999999988642
Q ss_pred ----------------------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCC
Q 002953 544 ----------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 544 ----------------------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 204 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGl 283 (400)
T cd05105 204 QRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL 283 (400)
T ss_pred ccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCc
Confidence 1367778889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT 675 (863)
++....... ........+++.|+|||++.+..++.++|||||||++|||++
T Consensus 284 a~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 284 ARDIMHDSN-----------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred ceecccccc-----------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 874211000 011223467889999999999889999999999999999997
Q ss_pred -CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 676 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 676 -Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|..||........+...+.....+ ..+..++.++.+++.+||..+|++|| ++.+|.+
T Consensus 335 ~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 392 (400)
T cd05105 335 LGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRP---SFLHLSD 392 (400)
T ss_pred CCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCc---CHHHHHH
Confidence 999998765444443333333332 34567899999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=308.53 Aligned_cols=204 Identities=25% Similarity=0.348 Sum_probs=169.4
Q ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCc
Q 002953 492 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRV 570 (863)
Q Consensus 492 ~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GI 570 (863)
....+.+|+.+++.++||||+++++++......|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL 138 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 345688899999999999999999999999999999999999999999865 4678999999999999999999999999
Q ss_pred cccCCCCcceeecCCC-------cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCC
Q 002953 571 VHRDLKPDNLLIAHDG-------HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643 (863)
Q Consensus 571 IHRDLKPeNILLd~~g-------~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGT 643 (863)
+||||||+|||++..+ .+||+|||++.... ......++
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~-----------------------------------~~~~~~~~ 183 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL-----------------------------------SREERVER 183 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccc-----------------------------------cccccccC
Confidence 9999999999997643 48999999876310 00123578
Q ss_pred CCCCChhhhcC-CCCCccceeechhHHHHHHH-hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCC
Q 002953 644 PDYLAPEILLG-TGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721 (863)
Q Consensus 644 p~YmAPEvL~g-~~ys~ksDIWSLGvILyELL-TGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~D 721 (863)
..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+.... ...... .+...+.++.++|.+||+.+
T Consensus 184 ~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~~ 259 (274)
T cd05076 184 IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEKKHR---LPEPSCKELATLISQCLTYE 259 (274)
T ss_pred CcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHhccC---CCCCCChHHHHHHHHHcccC
Confidence 88999999876 56899999999999999984 79999987766554332 222222 23446678999999999999
Q ss_pred cCCcCCCCCHHHHHcC
Q 002953 722 PHQRLGSGGASEVKQH 737 (863)
Q Consensus 722 P~kRpg~~SAeEILqH 737 (863)
|.+|| ++.+|+++
T Consensus 260 p~~Rp---s~~~il~~ 272 (274)
T cd05076 260 PTQRP---SFRTILRD 272 (274)
T ss_pred hhhCc---CHHHHHHh
Confidence 99999 99999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=302.61 Aligned_cols=239 Identities=24% Similarity=0.347 Sum_probs=194.0
Q ss_pred ceE-EEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 462 IDL-LLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+.+ ..||+|+||.|+.+. .++|.... .....+.+.+|+.+|++++||||+++++++...+.+|+||||++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYG 86 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEEeeCC-CcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCC
Confidence 444 489999999986542 23333221 2223456889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 157 (261)
T cd05068 87 SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--------- 157 (261)
T ss_pred cHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc---------
Confidence 9999997654 68999999999999999999999999999999999999999999999999987421000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
........++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+...++..
T Consensus 158 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05068 158 ---------------------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216 (261)
T ss_pred ---------------------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 000011233568999999999889999999999999999999 9999998888777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+.... .. ..+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 217 ~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~l~~ 256 (261)
T cd05068 217 VDQGY-RM-PCPPGCPKELYDIMLDCWKEDPDDRP---TFETLQW 256 (261)
T ss_pred HHcCC-CC-CCCCcCCHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 65442 22 23456899999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.99 Aligned_cols=243 Identities=28% Similarity=0.485 Sum_probs=198.1
Q ss_pred EEeecccceeecccc-------ceehhhhh-----hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM-----IRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i-----~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy 530 (863)
.+||+|+||.|+.+. +++|.... ........+.+|+.++++++||||+++++++.+. ..+++||||
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (264)
T cd06653 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEY 87 (264)
T ss_pred eeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEe
Confidence 389999999986542 33333211 1234456788999999999999999999998764 468999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~------ 161 (264)
T cd06653 88 MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM------ 161 (264)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc------
Confidence 99999999998878899999999999999999999999999999999999999999999999999874210000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.........|+..|+|||++.+..++.++|+|||||++|+|++|.+||..........
T Consensus 162 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 219 (264)
T cd06653 162 ----------------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219 (264)
T ss_pred ----------------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence 0001123568999999999999889999999999999999999999998776666555
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
++.... ..+.++..+++++.++|.+||. +|..|| ++.+++.|||.
T Consensus 220 ~~~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 220 KIATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred HHHcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCc---cHHHHhcCCCC
Confidence 554332 2245678899999999999999 579999 99999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.51 Aligned_cols=238 Identities=22% Similarity=0.315 Sum_probs=195.8
Q ss_pred Eeecccceeecccc----------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||+|+||.|+.+. .++|....... ...+.+.+|+.+|++++||||+++++.+.. ..+|+||||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999986542 23443333333 556788999999999999999999999988 8899999999999
Q ss_pred ChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 152 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED-------- 152 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc--------
Confidence 9999997754 689999999999999999999999999999999999999999999999999874211000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
.........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 153 --------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 212 (257)
T cd05040 153 --------------------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212 (257)
T ss_pred --------------------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 0001113467889999999999889999999999999999998 9999988888777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+......+ ..+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 213 IDKEGERL-ERPEACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred HHhcCCcC-CCCccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 66533332 24566889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=319.62 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=191.5
Q ss_pred ceE-EEeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-CeEE
Q 002953 462 IDL-LLAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCR-ENLY 525 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~-~~ly 525 (863)
|.+ .+||.|+||.|+.+. +++|+.... .....+.+..|+.++.++ +||||+++++++... ..+|
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 444 389999999997552 233332211 223446788999999999 899999999987654 5689
Q ss_pred EEEeecCCCChHHHHHhc-------------------------------------------------------------C
Q 002953 526 LVMEYLNGGDLYSLLRNL-------------------------------------------------------------G 544 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-------------------------------------------------------------g 544 (863)
++|||+++++|.+++... .
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998542 2
Q ss_pred CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCcc
Q 002953 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624 (863)
Q Consensus 545 ~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~ 624 (863)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~--------------------- 227 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--------------------- 227 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc---------------------
Confidence 57888899999999999999999999999999999999999999999999987421100
Q ss_pred chhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCC
Q 002953 625 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVP 703 (863)
Q Consensus 625 ~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p 703 (863)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+..... +..+
T Consensus 228 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~ 298 (337)
T cd05054 228 --------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR-MRAP 298 (337)
T ss_pred --------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-CCCC
Confidence 0011223456788999999999999999999999999999998 99999876554444444333222 2345
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 704 ~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...++++.+++.+||+.+|++|| ++.++++|
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 67889999999999999999999 99999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=310.87 Aligned_cols=240 Identities=27% Similarity=0.389 Sum_probs=195.6
Q ss_pred EEEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
...||+|+||.|+.+. +++|+.. .........+.+|+.+++.++||||+++++++.+.+..|+||||+.|
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g 99 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC
Confidence 3489999999986542 3344322 22233446788999999999999999999999999999999999975
Q ss_pred CChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 100 -~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------------ 166 (307)
T cd06607 100 -SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------ 166 (307)
T ss_pred -CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------------
Confidence 77777654 4578999999999999999999999999999999999999999999999999986310
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
......|++.|+|||++. ...++.++||||||+++|+|++|.+||...+.....
T Consensus 167 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~ 223 (307)
T cd06607 167 -----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (307)
T ss_pred -----------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence 112356888999999985 355789999999999999999999999888776655
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+.....+ ...+..++.++.++|.+||..+|.+|| ++.+++.||||..-
T Consensus 224 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 273 (307)
T cd06607 224 YHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLRE 273 (307)
T ss_pred HHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhccc
Confidence 555433221 111345788999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=310.85 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=194.4
Q ss_pred cceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
.+.+. .||+|+||.|+.+. .++|..... .....+.+.+|+.+|+++ +||||+++++++...+.+|
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 34443 89999999985431 222322211 233456789999999999 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 526 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||+++......
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 9999999999999997643 38999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
. ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 196 ~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 196 N-----------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred c-----------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 0 001123456789999999999889999999999999999998 9999988
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
......+.......... ..+...+.++.+|+.+||..+|++|| ++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell~ 296 (302)
T cd05055 247 MPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIVQ 296 (302)
T ss_pred CCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 77665555554433322 23456789999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.76 Aligned_cols=248 Identities=31% Similarity=0.448 Sum_probs=194.7
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVm 528 (863)
.|.+. .||+|+||.|+.+. +++|...... ......+.+|+.+|++++|+||+++++++... +.+|+||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 34443 89999999986542 3444332221 12223467899999999999999999998765 5689999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~----- 161 (309)
T cd07845 88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP----- 161 (309)
T ss_pred ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-----
Confidence 99965 898888753 66899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 162 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 162 --------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred --------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 001112346889999999876 55799999999999999999999999988887
Q ss_pred HHHHHHhhcCC-------------------CCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 687 QIFDNILNRKI-------------------PWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 687 el~~kIl~~~~-------------------~~p~~--------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
+.+..+..... ..+.. ....++++.+||.+||..||++|| ++.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~---t~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA---TAEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc---CHHHHhcChh
Confidence 77776654210 00000 012588999999999999999999 9999999999
Q ss_pred CCCC
Q 002953 740 FKDI 743 (863)
Q Consensus 740 Fk~I 743 (863)
|+..
T Consensus 293 f~~~ 296 (309)
T cd07845 293 FKEK 296 (309)
T ss_pred hccC
Confidence 9854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=304.90 Aligned_cols=238 Identities=22% Similarity=0.288 Sum_probs=184.4
Q ss_pred Eeecccceeecccc---------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||+|+.+. +++|..... .......+.+|+.+++.++||||+++++.+.....+|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 48999999986541 233322211 22334568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcC-----CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 536 LYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 536 L~dlLk~~g-----~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~------- 154 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED------- 154 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch-------
Confidence 999997642 24677889999999999999999999999999999999999999999999986311000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-------CCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+||..
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 155 ----------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred ----------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 0001123456788999999753 346889999999999999999 8899987
Q ss_pred CChHHHHHHHhhcC-CC--CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 683 EHPQQIFDNILNRK-IP--WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 683 ~~~~el~~kIl~~~-~~--~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
....+.+..+.... .. .+..+..++..+.+++..|+ .||.+|| ++++|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rp---t~~~v~~ 265 (269)
T cd05042 213 LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRP---TAEEVHE 265 (269)
T ss_pred CCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCccccc---CHHHHHH
Confidence 77666665554432 22 23344578899999999998 5999999 7777664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=307.10 Aligned_cols=249 Identities=25% Similarity=0.451 Sum_probs=192.8
Q ss_pred EEeecccceeeccc-------cceehhhhhhc-hhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIR-KNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+ .+++|+..... ......+.+|+.++.++. ||||+++++++..++..|++|||+.+ +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 37999999998643 23444433222 234557889999999996 99999999999999999999999864 6
Q ss_pred hHHHHH-----hcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 536 LYSLLR-----NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 536 L~dlLk-----~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|.++.. ..+.+++..+..++.|++.||+|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~------- 161 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS------- 161 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC-------
Confidence 555432 23579999999999999999999997 59999999999999999999999999998731100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCCCCCh-
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEHP- 685 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGvILyELLTGk~PF~~~~~- 685 (863)
.......||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 162 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 216 (288)
T cd06616 162 -------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216 (288)
T ss_pred -------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH
Confidence 011234689999999999876 689999999999999999999999976542
Q ss_pred HHHHHHHhhcCCC-CC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 686 QQIFDNILNRKIP-WP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 686 ~el~~kIl~~~~~-~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
.+...++.....+ .+ ..+..++.++.+||.+||..+|.+|| ++++|++||||+...|.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELLEHPFIKDYEERNVD 279 (288)
T ss_pred HHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcChhhhchhhcchh
Confidence 2222333222211 11 11235789999999999999999999 99999999999987766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=302.45 Aligned_cols=236 Identities=21% Similarity=0.316 Sum_probs=196.2
Q ss_pred EEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..||.|+||.|+.+. .++|............+.+|+.+|+.++||||+++++++.....+|+||||+++++|.+
T Consensus 12 ~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (261)
T cd05148 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91 (261)
T ss_pred hhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence 389999999997642 23333333333345678899999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~-------------- 157 (261)
T cd05148 92 FLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED-------------- 157 (261)
T ss_pred HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--------------
Confidence 99763 45899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~ 695 (863)
........++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+++..+...
T Consensus 158 -----------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 158 -----------------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred -----------------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 001113346778999999998889999999999999999998 89999988888888877654
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.. +..+..++..+.+++.+||..||.+|| ++.++++
T Consensus 221 ~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~l~~ 256 (261)
T cd05148 221 YR--MPCPAKCPQEIYKIMLECWAAEPEDRP---SFKALRE 256 (261)
T ss_pred Cc--CCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 22 233567899999999999999999999 8877764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.94 Aligned_cols=245 Identities=31% Similarity=0.492 Sum_probs=193.2
Q ss_pred EEEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
...||.|++|.|+.+. .++|..... .......+.+|+++|++++||||++++++|.+. +.+|+||||++|
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 3489999999986542 233322211 123456789999999999999999999988654 468999999999
Q ss_pred CChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 534 GDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 534 GsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~-------- 157 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------- 157 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc--------
Confidence 999988753 34588999999999999999999999999999999999999999999999999863110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-----C
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-----H 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-----~ 684 (863)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||... .
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (287)
T cd06621 158 -------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212 (287)
T ss_pred -------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC
Confidence 0011345788999999999988999999999999999999999999765 2
Q ss_pred hHHHHHHHhhcCCC-CCCCC---CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 685 PQQIFDNILNRKIP-WPRVP---EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 685 ~~el~~kIl~~~~~-~p~~p---~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
..+....+...... .+..+ ..+++.+.+||.+||..+|.+|| |+.|+++||||+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~~ 273 (287)
T cd06621 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDMLEHPWIKAQM 273 (287)
T ss_pred hHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHHHhCccccccc
Confidence 33444444332211 11111 23567899999999999999999 999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.48 Aligned_cols=242 Identities=30% Similarity=0.490 Sum_probs=193.1
Q ss_pred EEEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+..||.|++|.|+.+. .++|...... ......+.+|+.+++.++||||+++++++.+.+..|+||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 3489999999986542 3444333221 22345678899999999999999999999999999999999975 8
Q ss_pred hHHHHHhc---CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---------- 153 (284)
T cd07836 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---------- 153 (284)
T ss_pred HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----------
Confidence 98888654 35899999999999999999999999999999999999999999999999998731100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 154 ---------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred ---------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 0011234678999999998764 578999999999999999999999988876666555
Q ss_pred HhhcCC------------------CCCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKI------------------PWPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~------------------~~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..... .++. +...++..+.++|.+||+.||.+|| ++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~f 284 (284)
T cd07836 213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI---SAHDALQHPWF 284 (284)
T ss_pred HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 443110 0000 1124578899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.36 Aligned_cols=245 Identities=32% Similarity=0.480 Sum_probs=191.9
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|+..... ......+.+|++++++++||||+++++++.....+|+||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 389999999986542 3444433221 2234568899999999999999999999999999999999996 58
Q ss_pred hHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~---------- 156 (294)
T PLN00009 87 LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP---------- 156 (294)
T ss_pred HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC----------
Confidence 8888865433 578888899999999999999999999999999999985 467999999998731100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+.+.+
T Consensus 157 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~ 215 (294)
T PLN00009 157 ---------------------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK 215 (294)
T ss_pred ---------------------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 001123467899999999876 4578999999999999999999999988776655554
Q ss_pred HhhcCC-C-----------------CCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 692 ILNRKI-P-----------------WPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 692 Il~~~~-~-----------------~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+..... + .+. ....++.++.++|.+||+.+|++|| ++.++++||||.+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~~l~~~~~~~~~ 291 (294)
T PLN00009 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI---TARAALEHEYFKDLG 291 (294)
T ss_pred HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc---CHHHHhcCchHhHHh
Confidence 432100 0 000 1235788999999999999999999 999999999998753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.87 Aligned_cols=231 Identities=26% Similarity=0.401 Sum_probs=189.8
Q ss_pred EEeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEE-EeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF-TCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f-~d~~~lyLVmEy~~GGsL~d 538 (863)
..||+|+||.|+.+. +++|.. ......+.+.+|+.++++++|+||+++++++ ......|+||||+++++|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~~~k~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (256)
T cd05082 12 QTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeecccCCCeEEEEEEcCCcEEEEEe--CCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHH
Confidence 389999999986542 233322 2223455788999999999999999999875 45567999999999999999
Q ss_pred HHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++.+.+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--------------- 154 (256)
T cd05082 90 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--------------- 154 (256)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---------------
Confidence 997653 478999999999999999999999999999999999999999999999999873110
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~ 695 (863)
......++..|+|||++.+..++.++|||||||++|+|++ |++||...+..++...+..+
T Consensus 155 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05082 155 -------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215 (256)
T ss_pred -------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 0112345668999999999889999999999999999997 99999888877777666544
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.. +..+..+++.+.+++.+||..+|.+|| ++.++++
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 216 YK--MDAPDGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred CC--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 22 234567899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=301.23 Aligned_cols=240 Identities=23% Similarity=0.297 Sum_probs=189.9
Q ss_pred Eeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~-d~~~lyLVmEy~~G 533 (863)
+||+|+||.|+.+. .++|.... ......+.+.+|+.+++.++||||+++++++. .++..|+||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999986432 34444322 23345678889999999999999999999765 45568999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++.+. ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~-------- 153 (262)
T cd05058 82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY-------- 153 (262)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc--------
Confidence 9999999764 3467778888999999999999999999999999999999999999999999873110000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
..........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...
T Consensus 154 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 154 -------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred -------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 00001123456788999999998889999999999999999999 5778887777777666
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+.. +..+..++..+.+++.+||..+|++|| ++.++++.
T Consensus 215 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~~ 255 (262)
T cd05058 215 LLQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRP---TFSELVSR 255 (262)
T ss_pred HhcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 654432 233456789999999999999999999 88888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.83 Aligned_cols=238 Identities=24% Similarity=0.404 Sum_probs=191.5
Q ss_pred EEeecccceeecccc-----------ceehhhhh-h-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADM-I-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i-~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..||+|+||.|+.+. .+..|... . .......+.+|+.+|+.++||||+++++.+...+..|+||||+
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence 389999999986542 12222111 1 1234567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc------------------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc
Q 002953 532 NGGDLYSLLRNL------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH 587 (863)
Q Consensus 532 ~GGsL~dlLk~~------------------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~ 587 (863)
.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~ 165 (290)
T cd05045 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK 165 (290)
T ss_pred CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc
Confidence 999999998642 24778889999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechh
Q 002953 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667 (863)
Q Consensus 588 VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLG 667 (863)
+||+|||+++...... .........++..|+|||++.+..++.++||||||
T Consensus 166 ~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 216 (290)
T cd05045 166 MKISDFGLSRDVYEED-----------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216 (290)
T ss_pred EEeccccccccccCcc-----------------------------chhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence 9999999987421100 00011233567789999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 668 IILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 668 vILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+++|+|++ |.+||.+..+..+...+... ..+ ..+..++.++.+|+.+||+.+|.+|| ++.++++
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp---~~~~i~~ 281 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM-ERPENCSEEMYNLMLTCWKQEPDKRP---TFADISK 281 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CCCCCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 99999998 99999988887777655433 222 23567899999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.31 Aligned_cols=243 Identities=22% Similarity=0.346 Sum_probs=190.1
Q ss_pred ceEE-Eeecccceeecccc-----------------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEE
Q 002953 462 IDLL-LAGKGALSEHDDFP-----------------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFY 516 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-----------------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~ 516 (863)
|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|+.++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4443 89999999997541 233333221 2334567899999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHHHHhcC-----------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 517 SFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 517 ~f~d~~~lyLVmEy~~GGsL~dlLk~~g-----------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
++...+.+|+||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~ 166 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCC
Confidence 9999999999999999999999997642 35667899999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.++|+|||+++....... ........+++.|+|||+..+..++.++|+||
T Consensus 167 ~~~~l~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS 217 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDY-----------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217 (296)
T ss_pred CCEEeccCcccccccCCcc-----------------------------eeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence 9999999999874210000 00112234578899999998888999999999
Q ss_pred hhHHHHHHHh--CCCCCCCCChHHHHHHHhh-----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 666 VGIILFELIV--GIPPFNAEHPQQIFDNILN-----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 666 LGvILyELLT--Gk~PF~~~~~~el~~kIl~-----~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||++|||++ |..||...+..+....... ........+..++..+.+|+.+||..||.+|| ++.+|++
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~i~~ 292 (296)
T cd05095 218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP---SFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9999999998 7899987766665543321 11111122456789999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.60 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=194.0
Q ss_pred EEeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.+||+|+||.|+.+. .++|+.... .....+.+.+|+.++++++||||+++++++...+..|+||||+++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (268)
T cd05063 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN 90 (268)
T ss_pred eEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCC
Confidence 489999999986442 334433322 233456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
++|.+++... +.+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 91 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-------- 162 (268)
T cd05063 91 GALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE-------- 162 (268)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc--------
Confidence 9999999764 5789999999999999999999999999999999999999999999999999874210000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
..........++.|+|||++.+..++.++|||||||++|||++ |..||...+..++...
T Consensus 163 --------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~ 222 (268)
T cd05063 163 --------------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA 222 (268)
T ss_pred --------------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence 0000111234567999999998889999999999999999997 9999988887777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+.... ..+ .+..++.++.+|+.+||..+|.+|| ++.++++
T Consensus 223 i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 223 INDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred HhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 76542 222 2456889999999999999999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.06 Aligned_cols=245 Identities=21% Similarity=0.331 Sum_probs=197.0
Q ss_pred cccceEE-Eeecccceeecccc--------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP--------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCR 521 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~ 521 (863)
..+|.+. .||+|+||.|+.+. +++|.... ........+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3345544 89999999987542 23332221 1233456789999999999 799999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
+.+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999997532 36777888899999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.+||+|||+++....... ........++..|+|||++.+..++.++||||
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 221 (334)
T cd05100 171 NVMKIADFGLARDVHNIDY-----------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221 (334)
T ss_pred CcEEECCcccceecccccc-----------------------------cccccCCCcCceEcCHHHhccCCcCchhhhHH
Confidence 9999999999874210000 00111234567899999999999999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 666 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 666 LGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||++|||++ |..||.+.+..+.+..+..... +..+..++.++.+|+.+||..+|.+|| ++.+++++
T Consensus 222 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~ell~~ 289 (334)
T cd05100 222 FGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRP---TFKQLVED 289 (334)
T ss_pred HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCc---CHHHHHHH
Confidence 9999999998 8999998888888777755432 234567889999999999999999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=303.69 Aligned_cols=239 Identities=28% Similarity=0.477 Sum_probs=197.0
Q ss_pred EEeecccceeecccc----------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..||+|+||.|+.+. ++++..... .......+..|+.+++.++||||+++++++.+....|+||||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 389999999987431 233322221 22334467789999999999999999999999999999999999
Q ss_pred CCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 533 GGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 533 GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~------ 158 (260)
T cd08222 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS------ 158 (260)
T ss_pred CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC------
Confidence 9999998864 356899999999999999999999999999999999999975 67999999998742100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 159 -------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~ 213 (260)
T cd08222 159 -------------------------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV 213 (260)
T ss_pred -------------------------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 0112235688999999999888899999999999999999999999988777766
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...+..+. .+..+..++.++.++|.+||..+|++|| ++.++++||||
T Consensus 214 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 214 VLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred HHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 66665543 3445667899999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.09 Aligned_cols=232 Identities=26% Similarity=0.393 Sum_probs=194.1
Q ss_pred EEeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 465 LLAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
..||.|+||.|+.+. +++|+..... ...+.+.+|+.+++.++|+||+++++++.+....|+||||+++++|.++
T Consensus 12 ~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 90 (256)
T cd05039 12 ATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY 90 (256)
T ss_pred eeeecCCCceEEEEEecCcEEEEEEeccch-hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHH
Confidence 389999999996542 3444433222 2567789999999999999999999999999999999999999999999
Q ss_pred HHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 540 LRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 540 Lk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~---------------- 154 (256)
T cd05039 91 LRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ---------------- 154 (256)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc----------------
Confidence 98765 689999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+...+...+....
T Consensus 155 ------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05039 155 ------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY 216 (256)
T ss_pred ------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 0012234667999999988889999999999999999997 999998888777766655432
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. +..+..+++++.++|.+||..+|++|| ++.++++
T Consensus 217 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 217 R--MEAPEGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred C--CCCccCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 2 234567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=307.34 Aligned_cols=245 Identities=28% Similarity=0.439 Sum_probs=186.0
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+ ..||+|+||.|+.+. .++|...... ......+.+|+.+|+.++|+||+++++++...+..|+||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 3443 489999999986542 3333322211 222345778999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
. ++|..++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.....
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-------- 156 (291)
T cd07870 86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-------- 156 (291)
T ss_pred c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--------
Confidence 6 577777654 356888899999999999999999999999999999999999999999999998731100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh-HHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP-QQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~-~el 688 (863)
........+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+. .+.
T Consensus 157 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 157 -----------------------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred -----------------------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 001123457899999999876 4578899999999999999999999976543 222
Q ss_pred HHHHhhcC-C----------CCCC----------------CC--CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 689 FDNILNRK-I----------PWPR----------------VP--EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 689 ~~kIl~~~-~----------~~p~----------------~p--~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
+..+.... . ..+. .. -..+.++.+++.+||..||.+|| |+.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~---t~~~~l~h~~ 290 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI---SAQDALLHPY 290 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc---CHHHHhcCCC
Confidence 22221100 0 0000 00 01357899999999999999999 9999999999
Q ss_pred C
Q 002953 740 F 740 (863)
Q Consensus 740 F 740 (863)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=318.92 Aligned_cols=245 Identities=27% Similarity=0.410 Sum_probs=193.4
Q ss_pred EEEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEEEEEe
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENLYLVME 529 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~lyLVmE 529 (863)
...||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++... ..+|+|||
T Consensus 10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence 3489999999986542 34443322 1233445678899999999999999999887654 35899999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------- 161 (337)
T cd07858 90 LMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK------- 161 (337)
T ss_pred CCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC-------
Confidence 995 699999988888999999999999999999999999999999999999999999999999998741100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........||..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....
T Consensus 162 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 217 (337)
T cd07858 162 ------------------------GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217 (337)
T ss_pred ------------------------cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 011123568899999999875 4589999999999999999999999987654433
Q ss_pred HHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..+.... ..+......+++++.+||++||+.+|++|| ++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---s~~ell~h~~~ 294 (337)
T cd07858 218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI---TVEEALAHPYL 294 (337)
T ss_pred HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc---CHHHHHcCcch
Confidence 33222100 000111245789999999999999999999 99999999999
Q ss_pred CCC
Q 002953 741 KDI 743 (863)
Q Consensus 741 k~I 743 (863)
..+
T Consensus 295 ~~~ 297 (337)
T cd07858 295 ASL 297 (337)
T ss_pred hhh
Confidence 764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.40 Aligned_cols=233 Identities=24% Similarity=0.375 Sum_probs=188.8
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||.|+.+. .++|... ......+.+.+|+.+|++++||||+++++++. ....|+||||+++++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~k~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 13 KLGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred eeccccCceEEEEEecCCceeEEEEec-CCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 89999999996542 2333222 22223456889999999999999999998875 4568999999999999999
Q ss_pred HHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 540 LRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 540 Lk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-------------- 156 (260)
T cd05070 91 LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-------------- 156 (260)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc--------------
Confidence 9763 358999999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..+....+....
T Consensus 157 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05070 157 ----------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY 220 (260)
T ss_pred ----------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 001112345678999999998889999999999999999999 999998888777777765432
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
. +..+...+..+.+|+.+||..+|.+|| |+.++.
T Consensus 221 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~ 254 (260)
T cd05070 221 R--MPCPQDCPISLHELMLQCWKKDPEERP---TFEYLQ 254 (260)
T ss_pred C--CCCCCcCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 2 234567899999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.08 Aligned_cols=249 Identities=29% Similarity=0.428 Sum_probs=188.0
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--------
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE-------- 522 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-------- 522 (863)
.|.+ ..||+|+||.|+.+. +++|..... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3444 489999999986552 333332221 1222345678999999999999999999887654
Q ss_pred eEEEEEeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
..|+||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 171 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccC
Confidence 45999999964 8888886643 689999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.... .........++..|+|||++.+. .++.++||||||+++|+|++|.+||
T Consensus 172 ~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 172 SKNS---------------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred Cccc---------------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 0000 00111235688999999998764 3688999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCC-------------------CCCC----------CCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 681 NAEHPQQIFDNILNRKIP-------------------WPRV----------PEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~-------------------~p~~----------p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
.+.+.......+...... .+.. +...+..+.+||.+||..||.+|| ++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~---t~ 301 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI---DA 301 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc---CH
Confidence 887765444333221100 0000 011356788999999999999999 99
Q ss_pred HHHHcCCCC
Q 002953 732 SEVKQHVFF 740 (863)
Q Consensus 732 eEILqHPFF 740 (863)
+++++||||
T Consensus 302 ~e~l~h~~f 310 (310)
T cd07865 302 DTALNHDFF 310 (310)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.11 Aligned_cols=241 Identities=29% Similarity=0.443 Sum_probs=190.9
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
..||.|+||.|+.+. .++|+..... ......+.+|+.+|.+++||||+++++++... ..+|+||||+.+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~ 90 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH 90 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc
Confidence 389999999986542 2333332221 22234567899999999999999999999887 889999999975
Q ss_pred CChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 91 -~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~---------- 159 (293)
T cd07843 91 -DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP---------- 159 (293)
T ss_pred -CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC----------
Confidence 9999887643 5899999999999999999999999999999999999999999999999998742100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........+++.|+|||++.+.. ++.++|+||||+++|+|++|.+||........+.+
T Consensus 160 ---------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (293)
T cd07843 160 ---------------------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218 (293)
T ss_pred ---------------------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 01112346789999999987644 68999999999999999999999988776666555
Q ss_pred HhhcCC-------------------CC---------CCCCCC-CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKI-------------------PW---------PRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~-------------------~~---------p~~p~~-iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+...-. .+ ..++.. +++.+.+||++||+.+|++|| ++.|+++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---t~~ell~~~~f 293 (293)
T cd07843 219 IFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI---SAEDALKHPYF 293 (293)
T ss_pred HHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC---CHHHHhcCCCC
Confidence 432100 00 011222 588899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.00 Aligned_cols=238 Identities=28% Similarity=0.463 Sum_probs=200.5
Q ss_pred EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|+||.++.+. .++|.... ........+.+|+.+++.++||||+++++++......|+||||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 389999999986541 33333222 123445677899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 536 LYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 536 L~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---------- 155 (256)
T cd08530 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---------- 155 (256)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----------
Confidence 9999866 35689999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....
T Consensus 156 -----------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08530 156 -----------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK 212 (256)
T ss_pred -----------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011234688999999999998899999999999999999999999998887777666
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+.... ++..+..++.++.++|.+||..+|.+|| ++.++++||+.
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 213 VQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred HhcCC--CCCCchhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 65443 3445567899999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.42 Aligned_cols=241 Identities=28% Similarity=0.433 Sum_probs=193.3
Q ss_pred EEEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLVM 528 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLVm 528 (863)
+..||+|+||.|+.+. +++|.... ........+.+|+.+|+.++||||+++++++.... .+|+||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 4489999999985542 34443221 12233456889999999999999999999998664 468999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+ |++|..++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 100 e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~-------- 169 (343)
T cd07880 100 PFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-------- 169 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc--------
Confidence 999 7799988865 679999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+...
T Consensus 170 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 170 --------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred --------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 01123467899999999876 457899999999999999999999998877655
Q ss_pred HHHHHhhcCCCC----------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRKIPW----------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~~~~----------------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..+....... ......++.++.++|.+||..||.+|| ++.++++|||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~---t~~~~l~~~~ 300 (343)
T cd07880 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI---TAAEALAHPY 300 (343)
T ss_pred HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC---CHHHHhcCcc
Confidence 555443321110 111245788899999999999999999 9999999999
Q ss_pred CCCC
Q 002953 740 FKDI 743 (863)
Q Consensus 740 Fk~I 743 (863)
|+..
T Consensus 301 ~~~~ 304 (343)
T cd07880 301 FEEF 304 (343)
T ss_pred Hhhh
Confidence 9865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.96 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=191.9
Q ss_pred Eeecccceeecccc------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
+||.|+||.|+.+. .++|..... .......+.+|+++++.++||||+++++++...+..|+||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999986542 333332221 22334568899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~------------- 147 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG-I------------- 147 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-c-------------
Confidence 98754 45889999999999999999999999999999999999999999999999998631000 0
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+....
T Consensus 148 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 148 ----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred ----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 000112245678999999998889999999999999999998 999998887777666665432
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. ...+..++..+.+|+.+||..+|++|| ++.++++
T Consensus 212 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 212 R--MSCPQKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred C--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 2 234567899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.31 Aligned_cols=236 Identities=30% Similarity=0.511 Sum_probs=190.3
Q ss_pred Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. .++|+. ..........+.+|+.+++.++||||+++++++...+.+|+||||++|++
T Consensus 9 ~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08229 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88 (267)
T ss_pred hhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCC
Confidence 79999999986542 233432 22334455678899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 536 LYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 536 L~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--------- 159 (267)
T cd08229 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--------- 159 (267)
T ss_pred HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC---------
Confidence 9998864 345899999999999999999999999999999999999999999999999998742100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh--HHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP--QQIF 689 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~--~el~ 689 (863)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... ....
T Consensus 160 ----------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08229 160 ----------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred ----------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh
Confidence 0011235789999999999998899999999999999999999999976543 3333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.....+ +..+..++.++.+||.+||..+|.+|| |+.+|++
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~~ 260 (267)
T cd08229 218 KKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRP---DITYVYD 260 (267)
T ss_pred hhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCC---CHHHHHH
Confidence 444332221 122346889999999999999999999 8887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.80 Aligned_cols=237 Identities=25% Similarity=0.420 Sum_probs=190.3
Q ss_pred Eeecccceeecccc-------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP-------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.||+|+||.|+.+. .++|..... .......+.+|+.+|+.++||||+++++++......|+||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999987542 122222111 1134567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-----cEEEeecCCcccc
Q 002953 532 NGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-----HIKLTDFGLSKVG 599 (863)
Q Consensus 532 ~GGsL~dlLk~~-------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-----~VKLiDFGLAk~~ 599 (863)
++++|.+++... ..+++..+..++.||+.||+|||+.+++|+||||+|||++.++ .++|+|||+++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~ 161 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence 999999999642 2378899999999999999999999999999999999999877 8999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~ 678 (863)
.... .........++..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 162 ~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 162 YKSD-----------------------------YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred cccc-----------------------------ccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 1000 0001123356788999999999889999999999999999998 999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
||...+..+....+..... +..+..++..+.+||.+||..+|.+|| +++++++
T Consensus 213 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 213 PYPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred CCcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 9988777776666544332 234567899999999999999999999 7887764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.81 Aligned_cols=240 Identities=21% Similarity=0.330 Sum_probs=193.0
Q ss_pred Eeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+|+||.|+.+. +++|..... .......+..|+.+++.++||||+++++++.....+|+||||++++
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T cd05065 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90 (269)
T ss_pred EecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCC
Confidence 89999999986532 233332221 3345568999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~--------- 161 (269)
T cd05065 91 ALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--------- 161 (269)
T ss_pred cHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc---------
Confidence 999999764 5689999999999999999999999999999999999999999999999999874211000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kI 692 (863)
.+ .........++..|+|||.+.+..++.++|||||||++|||++ |..||...+.......+
T Consensus 162 --------~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 162 --------DP---------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred --------cc---------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 00 0000011123567999999999899999999999999999886 99999888877777776
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
... ...+ .+..++..+.+++.+||..+|.+|| ++.+|+.
T Consensus 225 ~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 225 EQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred HcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 433 2222 2457899999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.89 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=200.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~lyLVmEy 530 (863)
..||.|+||.|+.+. .++|+..... ....+.+.+|+.+|+.++||||+++++++.... .+|+||||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 389999999986542 3444333222 344567899999999999999999999998875 78999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+. ++|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~------ 158 (330)
T cd07834 86 ME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED------ 158 (330)
T ss_pred hh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc------
Confidence 97 48999998877899999999999999999999999999999999999999999999999999884211000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.........+|+.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+
T Consensus 159 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~ 216 (330)
T cd07834 159 ----------------------EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL 216 (330)
T ss_pred ----------------------ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence 00112235689999999999887 7899999999999999999999999988877766
Q ss_pred HHHhhcCCCC----------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 690 DNILNRKIPW----------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 690 ~kIl~~~~~~----------------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
..+....... ......++.++.+||.+||+.+|.+|| +++++++||||+
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ll~~~~~~ 293 (330)
T cd07834 217 NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI---TADEALAHPYLA 293 (330)
T ss_pred HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC---CHHHHHhCccHH
Confidence 6655421110 011234688999999999999999999 999999999998
Q ss_pred CC
Q 002953 742 DI 743 (863)
Q Consensus 742 ~I 743 (863)
++
T Consensus 294 ~~ 295 (330)
T cd07834 294 QL 295 (330)
T ss_pred hh
Confidence 64
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.37 Aligned_cols=237 Identities=22% Similarity=0.326 Sum_probs=190.4
Q ss_pred EEeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+||+|+||.|+.+. +++|.... ........+.+|+.++..++||||+++++++.. ...+++|||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCC
Confidence 489999999996542 23333222 223345678899999999999999999998875 45789999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~------- 164 (279)
T cd05109 92 YGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------- 164 (279)
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc-------
Confidence 99999999764 5699999999999999999999999999999999999999999999999999874210000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
........+++.|+|||.+.+..++.++|||||||++|||++ |.+||.......+..
T Consensus 165 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05109 165 ----------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222 (279)
T ss_pred ----------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 000112345678999999999999999999999999999998 999998777666665
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..... +..+..++.++.+++.+||..||++|| ++.++++
T Consensus 223 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 223 LLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HHHCCCc--CCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 5544322 223566899999999999999999999 8999885
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.47 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=193.3
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~lyLVmEy~ 531 (863)
..||.|+||.|+.+. +++|+.... .......+.+|+.+|+.++||||++++++|.. ...+|+||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 489999999986442 344433221 22345677889999999999999999988764 34689999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 91 ~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 162 (334)
T cd07855 91 E-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT------- 162 (334)
T ss_pred h-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc-------
Confidence 5 59999998777899999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.........+|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+.
T Consensus 163 --------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 163 --------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred --------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 00011124578999999999876 458999999999999999999999998776544333
Q ss_pred HHhhc-----------------------C-----CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 691 NILNR-----------------------K-----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 691 kIl~~-----------------------~-----~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+... . ..+.......+.++.++|++||+.+|.+|| ++.+++.||||..
T Consensus 223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~l~~~~~~~ 299 (334)
T cd07855 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI---TVEQALQHPFLAQ 299 (334)
T ss_pred HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc---CHHHHHhChhhhh
Confidence 22210 0 000111245789999999999999999999 9999999999985
Q ss_pred C
Q 002953 743 I 743 (863)
Q Consensus 743 I 743 (863)
.
T Consensus 300 ~ 300 (334)
T cd07855 300 Y 300 (334)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=316.92 Aligned_cols=250 Identities=29% Similarity=0.493 Sum_probs=191.1
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYL 526 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~lyL 526 (863)
.|.+ ..||+|+||.|+.+. +++|..... .......+.+|+.+|++++||||+++++++.... .+|+
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3444 489999999986542 344433221 2234456888999999999999999998776543 5899
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+.+ +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 86 v~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 161 (336)
T cd07849 86 VQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-- 161 (336)
T ss_pred Eehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc--
Confidence 9999965 88888854 5799999999999999999999999999999999999999999999999999874110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 162 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 162 --------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred --------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0001123578999999998765 5689999999999999999999999977654
Q ss_pred HHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 686 QQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 686 ~el~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
......+.... .++.......+.++.+||.+||+.+|.+|| ++.++++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---t~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI---TVEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc---CHHHHhcC
Confidence 43332221100 000001134678899999999999999999 99999999
Q ss_pred CCCCCC
Q 002953 738 VFFKDI 743 (863)
Q Consensus 738 PFFk~I 743 (863)
|||+.+
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=297.30 Aligned_cols=239 Identities=31% Similarity=0.518 Sum_probs=192.8
Q ss_pred ceEE-Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 462 IDLL-LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
|.+. .||.|+||.|+.+. .++|.. ........+.+.+|+++|++++|+||+++++++...+..|+||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 4443 89999999986442 233322 233344567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+++++|..++... ..+++..+..++.+|+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~---- 159 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---- 159 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC----
Confidence 9999999998642 45899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH-- 684 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~-- 684 (863)
........|++.|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 160 ---------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 212 (267)
T cd08224 160 ---------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212 (267)
T ss_pred ---------------------------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc
Confidence 001123568899999999999889999999999999999999999996553
Q ss_pred hHHHHHHHhhcCCCCCCCCC-CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 685 PQQIFDNILNRKIPWPRVPE-EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~-~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.......+..+.. +..+. .++.++.++|.+||..+|.+|| ++.+|++
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il~ 260 (267)
T cd08224 213 LYSLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRP---DISYVLQ 260 (267)
T ss_pred HHHHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 3344444443322 22333 6888999999999999999999 8887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=299.17 Aligned_cols=234 Identities=23% Similarity=0.359 Sum_probs=189.1
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||.|+.+. .++|... ......+.+.+|+++|+.++||||+++++++. .+..|+||||+.+++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~lK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05069 13 KLGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDF 90 (260)
T ss_pred eecCcCCCeEEEEEEcCCceEEEEEcc-cCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHH
Confidence 89999999996542 2333322 22233456889999999999999999998875 4568999999999999999
Q ss_pred HHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 540 LRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 540 Lk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-------------- 156 (260)
T cd05069 91 LKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-------------- 156 (260)
T ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc--------------
Confidence 9764 247889999999999999999999999999999999999999999999999987411000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+....+....+....
T Consensus 157 ----------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05069 157 ----------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY 220 (260)
T ss_pred ----------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 001112346778999999998889999999999999999999 999999888777777765432
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. +..+..++..+.+++.+||.+||.+|| +++++++
T Consensus 221 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 255 (260)
T cd05069 221 -R-MPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQS 255 (260)
T ss_pred -C-CCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 2 233567899999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.39 Aligned_cols=257 Identities=28% Similarity=0.425 Sum_probs=197.2
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhH--------------HHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNA--------------VESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~--------------~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
+||.|+||+|+.+. +++|+........ ...+.+|+++|+.++||||+++++++...+.+
T Consensus 16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (335)
T PTZ00024 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95 (335)
T ss_pred cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence 79999999986652 3344322111111 12477899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+. |+|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 96 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~ 174 (335)
T PTZ00024 96 NLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174 (335)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccc
Confidence 99999996 59999998878899999999999999999999999999999999999999999999999999874221110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.... . .. .............+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...
T Consensus 175 ~~~~----~-----~~--------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 175 SDTL----S-----KD--------ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred cccc----c-----cc--------ccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0000 0 00 000001122234678999999999764 4689999999999999999999999988
Q ss_pred ChHHHHHHHhhcCC-----CCC--------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 684 HPQQIFDNILNRKI-----PWP--------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 684 ~~~el~~kIl~~~~-----~~p--------------------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
+..+.+..+..... .|+ ......+.++.++|.+||..+|++|| ++++++.||
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s~~~~l~~~ 314 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI---SAKEALKHE 314 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc---CHHHHhcCc
Confidence 87776665543110 010 01124578899999999999999999 999999999
Q ss_pred CCCCC
Q 002953 739 FFKDI 743 (863)
Q Consensus 739 FFk~I 743 (863)
||+..
T Consensus 315 ~~~~~ 319 (335)
T PTZ00024 315 YFKSD 319 (335)
T ss_pred ccCCC
Confidence 99864
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.34 Aligned_cols=238 Identities=23% Similarity=0.301 Sum_probs=184.2
Q ss_pred Eeecccceeecccc---------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|+..... ......+.+|+.++++++||||+++++++.+...+|+||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999986542 3444433322 2233478889999999999999999999999999999999999999
Q ss_pred hHHHHHhcC-----CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 536 LYSLLRNLG-----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 536 L~dlLk~~g-----~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++++||+|||+++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~------ 155 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY------ 155 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce------
Confidence 999997532 356677888999999999999999999999999999999999999999999863110000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-------CCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-------GHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-------~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
........|++.|+|||++.+. .++.++|||||||++|||++ |.+||..
T Consensus 156 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 156 -----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred -----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 0011235678899999998643 35789999999999999996 9999987
Q ss_pred CChHHHHHHHhhc-CC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 683 EHPQQIFDNILNR-KI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 683 ~~~~el~~kIl~~-~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
....+........ .. ..+......+..+.+++.+|+ .+|++|| ++++|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp---t~~~l~~ 265 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRP---SAEEVHL 265 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCC---CHHHHHH
Confidence 7666554443332 11 122233457889999999999 6899999 8888764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=297.97 Aligned_cols=235 Identities=23% Similarity=0.345 Sum_probs=190.3
Q ss_pred EEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..||+|+||.|+.+. .++|... ........+.+|+.+|++++||||+++++++. .+.+|+||||+.+++|.+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVD 89 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEec-CCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHH
Confidence 389999999996542 2333222 22233467889999999999999999998874 567899999999999999
Q ss_pred HHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~------------- 156 (260)
T cd05067 90 FLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE------------- 156 (260)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-------------
Confidence 98653 358889999999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~ 695 (863)
........++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+...
T Consensus 157 -----------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05067 157 -----------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219 (260)
T ss_pred -----------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence 001113356788999999998889999999999999999998 99999988877777666443
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. . +..+...+.++.++|.+||..+|++|| ++++++.
T Consensus 220 ~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 220 Y-R-MPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred C-C-CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 2 2 234567889999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.12 Aligned_cols=241 Identities=31% Similarity=0.488 Sum_probs=192.3
Q ss_pred EEeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|++|.|+.+. +++|+..... ......+.+|+++++.++||||+++++++.+.+..|+||||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 479999999986542 3444333221 2234568889999999999999999999999999999999995 59
Q ss_pred hHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 536 LYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 536 L~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~----------- 152 (283)
T cd07835 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP----------- 152 (283)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-----------
Confidence 999987765 6899999999999999999999999999999999999999999999999998631100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
........+++.|+|||++.+. .++.++||||||+++|+|++|.+||...+......++
T Consensus 153 --------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 153 --------------------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred --------------------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011223578899999988764 4689999999999999999999999877665444443
Q ss_pred hhcCC--------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKI--------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~--------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..... ........++..+.++|.+||+.+|.+|| +++++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~ 283 (283)
T cd07835 213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SAKAALQHPYF 283 (283)
T ss_pred HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc---CHHHHhcCCCC
Confidence 32100 00111245778999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.70 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=192.8
Q ss_pred EEeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||.|+.+. +++|..... .......+.+|+.+|.+++||||+++++++...+.+|+||||+++
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 389999999986432 233332221 223456789999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
++|.+++... +.++...+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 90 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-------- 161 (267)
T cd05066 90 GSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-------- 161 (267)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc--------
Confidence 9999999765 4689999999999999999999999999999999999999999999999999874210000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....
T Consensus 162 --------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~ 221 (267)
T cd05066 162 --------------------AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221 (267)
T ss_pred --------------------eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH
Confidence 0001112334678999999998889999999999999999886 9999988877777776
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+.... .. ..+..++..+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 261 (267)
T cd05066 222 IEEGY-RL-PAPMDCPAALHQLMLDCWQKDRNERP---KFEQIVS 261 (267)
T ss_pred HhCCC-cC-CCCCCCCHHHHHHHHHHcccCchhCC---CHHHHHH
Confidence 65542 22 23456889999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.65 Aligned_cols=241 Identities=27% Similarity=0.397 Sum_probs=196.9
Q ss_pred EEEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||+|+.+. +++|+.. .........+.+|+.+++.++||||+++++++.+....|+||||+.|
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 105 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG 105 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC
Confidence 4479999999986542 3333332 22233446788999999999999999999999999999999999964
Q ss_pred CChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 106 -~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~------------- 171 (313)
T cd06633 106 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS------------- 171 (313)
T ss_pred -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc-------------
Confidence 78877755 356899999999999999999999999999999999999999999999999987621
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......|+..|+|||++. +..++.++|||||||++|+|++|.+||...+.....
T Consensus 172 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~ 229 (313)
T cd06633 172 ----------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229 (313)
T ss_pred ----------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0112357899999999985 355788999999999999999999999887766666
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
..+.....+. .....++..+.+|+.+||+.+|.+|| ++.+++.||||...+
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 230 YHIAQNDSPT-LQSNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHhcCCCC-CCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 5554433321 12345788899999999999999999 999999999998755
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.76 Aligned_cols=238 Identities=24% Similarity=0.369 Sum_probs=190.3
Q ss_pred ceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 462 IDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
|.+. .||+|+||.|+.+. .++|+... .....+.+.+|+.+++.++||||+++++.+. ....|+||||+++|
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEeccc-CccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 4444 89999999986542 23333321 1223456889999999999999999998875 45689999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~--------- 156 (262)
T cd05071 86 SLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--------- 156 (262)
T ss_pred cHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc---------
Confidence 999999763 357899999999999999999999999999999999999999999999999987421000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
........++..|+|||++.+..++.++|||||||++|+|++ |.+||......++...
T Consensus 157 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~ 215 (262)
T cd05071 157 ---------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 215 (262)
T ss_pred ---------------------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Confidence 001112346788999999998889999999999999999999 8999988887777776
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+.... .. ..+..++..+.+|+.+||+.+|.+|| ++.++++
T Consensus 216 ~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~~~~ 255 (262)
T cd05071 216 VERGY-RM-PCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 255 (262)
T ss_pred HhcCC-CC-CCccccCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 65432 22 23456899999999999999999999 6766653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.81 Aligned_cols=237 Identities=26% Similarity=0.380 Sum_probs=192.7
Q ss_pred EEeecccceeecccc----------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.+||+|+||.|+.+. +++|...... ....+.+.+|+.++++++||||+++++++.+ ...|+||||+++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~ 90 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPL 90 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCC
Confidence 389999999986432 2333333222 3455688999999999999999999998875 457899999999
Q ss_pred CChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++...+ .+++..+..++.||+.||+|||+.|++||||||+|||++.++.++|+|||+++......
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 161 (270)
T cd05056 91 GELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES--------- 161 (270)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc---------
Confidence 99999997643 58999999999999999999999999999999999999999999999999987421000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....
T Consensus 162 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 220 (270)
T cd05056 162 ---------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR 220 (270)
T ss_pred ---------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 001112345678999999988889999999999999999986 9999988887777766
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+.. +..+..++..+.++|.+||..+|.+|| ++.+++..
T Consensus 221 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~~ 261 (270)
T cd05056 221 IENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRP---RFTELKAQ 261 (270)
T ss_pred HHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 655432 234567899999999999999999999 88888754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=334.15 Aligned_cols=236 Identities=33% Similarity=0.537 Sum_probs=191.1
Q ss_pred cceEE-Eeecccceeeccccceehhh----hhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 461 QIDLL-LAGKGALSEHDDFPQVLKKA----DMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~kvlKK~----~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.|.+. -+|.|+|+.+..+...-+.. +++.+. .....+|+.++... +||||+++++.+.+..+.|+|||++.|+
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG 401 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence 34433 59999999874432111100 011111 23355788777665 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee-cCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL-d~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
.|.+.+.....+. ..+..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++...
T Consensus 402 ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~------------- 467 (612)
T KOG0603|consen 402 ELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE------------- 467 (612)
T ss_pred HHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc-------------
Confidence 9999888766565 7888999999999999999999999999999999 588999999999987310
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH-HHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ-QIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~-el~~kI 692 (863)
....+.|-|..|.|||++...+|+.+|||||||++||+||+|+.||...... ++..+|
T Consensus 468 ---------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 468 ---------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred ---------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 1123567899999999999999999999999999999999999999766554 555555
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
... .+...+|.++++||++||+.||.+|+ ++.+++.||||
T Consensus 527 ~~~-----~~s~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 QMP-----KFSECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred cCC-----ccccccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 333 33478999999999999999999999 99999999999
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.21 Aligned_cols=248 Identities=33% Similarity=0.563 Sum_probs=209.1
Q ss_pred EEeecccceeeccc----------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDF----------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~----------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.+||.|-||+||+. .|++.|.+...+. ...+.+|+.||.+++||.||.+...|++.+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 38999999999764 2455565555444 47799999999999999999999999999999999999966
Q ss_pred ChHHHHH--hcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCCCCC
Q 002953 535 DLYSLLR--NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 535 sL~dlLk--~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++.+.|- +.+++++...++++.||+.||.|||-++|+|.||||+|||+... -.+||||||+|++...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-------- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-------- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--------
Confidence 6666653 35899999999999999999999999999999999999999765 3799999999996321
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
..-.++.+|||.|+|||++.+++|...-|+||+|+|+|--|+|..||+.+. ++-
T Consensus 720 ------------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIn 773 (888)
T KOG4236|consen 720 ------------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DIN 773 (888)
T ss_pred ------------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chh
Confidence 123457899999999999999999999999999999999999999996543 444
Q ss_pred HHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC-ChhHHhhc
Q 002953 690 DNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI-NWDTLARQ 751 (863)
Q Consensus 690 ~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I-dW~~l~~~ 751 (863)
.+|.+....+|. -+.+++.++.+||..+|+..-.+|. +++..|.|||+++. .|-.++..
T Consensus 774 dQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~DLRel 834 (888)
T KOG4236|consen 774 DQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLDLREL 834 (888)
T ss_pred HHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHHHHHH
Confidence 555555555443 3578999999999999999999999 99999999999986 37666543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.47 Aligned_cols=243 Identities=26% Similarity=0.417 Sum_probs=185.7
Q ss_pred Eeecccceeecccc---------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~ 531 (863)
.||+|+||.|+.+. +++|.... ......+.+.+|+.+++.++||||+++++++.+. ..+|+||||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 79999999985432 23333222 1133446778999999999999999999999988 7899999999
Q ss_pred CCCChHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC----CCcEEEeecCCccccccC
Q 002953 532 NGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 532 ~GGsL~dlLk~~-----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~----~g~VKLiDFGLAk~~~~~ 602 (863)
++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCC
Confidence 65 777776432 36899999999999999999999999999999999999999 899999999998742110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.. ........++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 166 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 166 LK----------------------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred cc----------------------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 00 00112345789999999998764 57899999999999999999999997
Q ss_pred CCChHH---------HHHHHhhc-----------------------CCCCCCCC-----------CCCCHHHHHHHHhhc
Q 002953 682 AEHPQQ---------IFDNILNR-----------------------KIPWPRVP-----------EEMSPEAHDLIDRFL 718 (863)
Q Consensus 682 ~~~~~e---------l~~kIl~~-----------------------~~~~p~~p-----------~~iS~el~dLI~k~L 718 (863)
...... .+..++.. .......+ ...+.++.++|.+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 654321 11111100 00000011 156778999999999
Q ss_pred cCCcCCcCCCCCHHHHHcCCCC
Q 002953 719 TEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 719 ~~DP~kRpg~~SAeEILqHPFF 740 (863)
..||++|| |+.++++||||
T Consensus 298 ~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 298 EYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred cCCcccCc---CHHHHhcCCCC
Confidence 99999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.40 Aligned_cols=235 Identities=23% Similarity=0.328 Sum_probs=192.5
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||.|+.+. .++|... ......+.+.+|+.++++++||||+++++++......|+||||+++++|.++
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~vK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 91 (261)
T cd05034 13 KLGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91 (261)
T ss_pred eeccCcceEEEEEEEcCCceEEEEEec-CCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHH
Confidence 89999999996542 2333222 2223346788999999999999999999999998999999999999999999
Q ss_pred HHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 540 LRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 540 Lk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+... ..++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 92 i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~--------------- 156 (261)
T cd05034 92 LKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD--------------- 156 (261)
T ss_pred HhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch---------------
Confidence 9764 36899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+....+..+....
T Consensus 157 ---------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05034 157 ---------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221 (261)
T ss_pred ---------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 0001112335678999999999889999999999999999998 999998888777777775542
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. ...+...+.++.+++.+||..+|.+|| ++.++++
T Consensus 222 ~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 256 (261)
T cd05034 222 R--MPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQS 256 (261)
T ss_pred C--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 2 223456789999999999999999999 7777663
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=294.10 Aligned_cols=237 Identities=25% Similarity=0.329 Sum_probs=192.7
Q ss_pred Eeecccceeecccc------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
+||.|+||.|+.+. .++|....... .....+.+|++++++++||||+++++++......|+||||++|++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 68999999986542 33443322222 345678999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... ..+++..+..++.+++.||.|||++|++||||||+|||++.++.++|+|||++........
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~------------- 148 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY------------- 148 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-------------
Confidence 99663 5688999999999999999999999999999999999999999999999999873110000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||...........+....
T Consensus 149 ----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 149 ----------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred ----------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 000012234677999999998889999999999999999999 899998887766666654432
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. ...+..++.++.+++.+||..+|.+|| ++.++++
T Consensus 213 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 213 -R-MPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred -C-CCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 1 223567899999999999999999999 9999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=292.97 Aligned_cols=236 Identities=28% Similarity=0.425 Sum_probs=196.1
Q ss_pred Eeecccceeeccc-----------cceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDF-----------PQVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~-----------~kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||.|+||.|+.+ ..++|........ ....+..|+.+|..++||||+++++++.+.+..|++|||+++
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~ 85 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEG 85 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCC
Confidence 7899999998543 1233333222222 567899999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++|.+++..... +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~------- 158 (258)
T smart00219 86 GDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY------- 158 (258)
T ss_pred CCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc-------
Confidence 999999976544 99999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
.......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...+.+
T Consensus 159 -----------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~ 215 (258)
T smart00219 159 -----------------------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE 215 (258)
T ss_pred -----------------------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 00001237889999999988889999999999999999998 899999888888887
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..... +..+..++.++.+++.+||..+|.+|| |+.++++
T Consensus 216 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 216 YLKKGYR--LPKPENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred HHhcCCC--CCCCCcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 7766543 234566899999999999999999999 9999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.05 Aligned_cols=228 Identities=26% Similarity=0.419 Sum_probs=181.1
Q ss_pred chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHH
Q 002953 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLH 566 (863)
Q Consensus 489 ~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLH 566 (863)
.......+.+|+.+|+.++||||++++++|...+..|++|||+++|+|.+++... ..+++..+..++.|++.||+|||
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH 118 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999999999999999999999999999764 45899999999999999999999
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCC
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~Y 646 (863)
++||+||||||+|||++.++.+||+|||.+......... . ...........++..|
T Consensus 119 ~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~-----~-------------------~~~~~~~~~~~~~~~y 174 (314)
T cd08216 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR-----Q-------------------RVVHDFPKSSVKNLPW 174 (314)
T ss_pred HCCeecCCCCcceEEEecCCceEEecCccceeecccccc-----c-------------------cccccccccccccccc
Confidence 999999999999999999999999999988742110000 0 0000112345688899
Q ss_pred CChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCC-------CC-----------------
Q 002953 647 LAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIP-------WP----------------- 700 (863)
Q Consensus 647 mAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~-------~p----------------- 700 (863)
+|||++.+ ..++.++|+|||||++|+|++|..||..............+... ++
T Consensus 175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
T cd08216 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254 (314)
T ss_pred cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccc
Confidence 99999976 45889999999999999999999999876544433222111100 00
Q ss_pred -------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 701 -------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 701 -------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.....++.++.+|+.+||..||++|| ++.++++||||+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~ll~~p~~~~~ 301 (314)
T cd08216 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP---SASQLLNHSFFKQC 301 (314)
T ss_pred hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc---CHHHHhcCchHhhh
Confidence 01122356789999999999999999 99999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=337.68 Aligned_cols=231 Identities=27% Similarity=0.411 Sum_probs=198.9
Q ss_pred Eeecccceeecccc------------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||+|+.+. +++|..+-.... ....|.+|+++|..|+|||||+|++++..++.+|||+|||.
T Consensus 493 eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~ 572 (774)
T KOG1026|consen 493 ELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMD 572 (774)
T ss_pred hhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecc
Confidence 79999999996542 344544444444 66789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC--------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 533 GGDLYSLLRNLG--------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 533 GGsL~dlLk~~g--------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.|||.++|+..+ .++..+...|+.||+.|++||-++.+|||||-..|+||..+-.|||+|||+++.
T Consensus 573 ~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRd 652 (774)
T KOG1026|consen 573 HGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRD 652 (774)
T ss_pred cccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchh
Confidence 999999997542 277889999999999999999999999999999999999999999999999984
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccc-cccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-C
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR-SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-G 676 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~-s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-G 676 (863)
. .+.+ ..+.. ...-..+|||||.+....++.++||||+||+|||+++ |
T Consensus 653 i--YssD----------------------------YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 653 I--YSSD----------------------------YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred h--hhhh----------------------------hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 1 1110 11111 2345679999999999999999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
+.||++...+++++.|..++. + ..|+.+|.++.+|+..||+.+|.+||+.
T Consensus 703 ~QPy~glSn~EVIe~i~~g~l-L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF 752 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQL-L-SCPENCPTEVYSLMLECWNENPKRRPSF 752 (774)
T ss_pred cCcccccchHHHHHHHHcCCc-c-cCCCCCCHHHHHHHHHHhhcCcccCCCH
Confidence 999999999999999998887 4 4589999999999999999999999943
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.72 Aligned_cols=236 Identities=19% Similarity=0.287 Sum_probs=188.9
Q ss_pred Eeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||.|+.+. .++|..... .......+..|+.++.+++||||+++++++. ....+++|||+++
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~ 92 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPL 92 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCC
Confidence 89999999996542 223332211 1233456778888999999999999999875 4567899999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.......
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~-------- 164 (279)
T cd05111 93 GSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-------- 164 (279)
T ss_pred CcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc--------
Confidence 9999999764 5689999999999999999999999999999999999999999999999999874211000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
........|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........
T Consensus 165 ---------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~ 223 (279)
T cd05111 165 ---------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223 (279)
T ss_pred ---------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 001123457788999999998889999999999999999998 9999988877665555
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+..+.. +..+..++.++.+++.+||..||.+|| ++.++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 224 LEKGER--LAQPQICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HHCCCc--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 543332 233456788999999999999999999 8988876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.33 Aligned_cols=238 Identities=18% Similarity=0.265 Sum_probs=187.0
Q ss_pred Eeecccceeecccc---------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|..... .....+.+.+|+.+++.++||||+++++.+.....+|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 48999999986542 223322222 12345689999999999999999999999999999999999999999
Q ss_pred hHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 536 LYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 536 L~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|.+++.+. ..+++..+..++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~--------- 152 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE--------- 152 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc---------
Confidence 99999764 23567778899999999999999999999999999999999999999999987631000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-------CCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIILFELIV-GIPPFNAE 683 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGvILyELLT-Gk~PF~~~ 683 (863)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 153 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 153 --------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred --------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00011224578999999999853 235789999999999999997 67899877
Q ss_pred ChHHHHHHHhhcCC---CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 684 HPQQIFDNILNRKI---PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 684 ~~~el~~kIl~~~~---~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+..+.+..+..... ..+..+..+++.+.+++..|| .+|.+|| ++++|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 213 SDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRA---TAEEVHR 264 (268)
T ss_pred CHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCC---CHHHHHH
Confidence 77777776654432 123344567899999999999 6799999 8888865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.83 Aligned_cols=251 Identities=24% Similarity=0.354 Sum_probs=190.1
Q ss_pred Eeecc--cceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKG--ALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG--~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
.||+| +||+|+.+. +++|.... ......+.+.+|+.+++.++||||++++++|...+.+|+||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45666 888885542 23333222 12234577889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.+. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++++|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~-------- 156 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ-------- 156 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc--------
Confidence 999998764 3489999999999999999999999999999999999999999999999986542110000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.... .........++..|+|||++.+ ..++.++|||||||++|+|++|.+||..........
T Consensus 157 ~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 157 KAKV----------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred cccc----------------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 0000 0000112345678999999976 347899999999999999999999998776555444
Q ss_pred HHhhcCCCCC--------------------------------------------CCCCCCCHHHHHHHHhhccCCcCCcC
Q 002953 691 NILNRKIPWP--------------------------------------------RVPEEMSPEAHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 691 kIl~~~~~~p--------------------------------------------~~p~~iS~el~dLI~k~L~~DP~kRp 726 (863)
.++......+ ..+..++..+.+||++||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 4332211000 01123567899999999999999999
Q ss_pred CCCCHHHHHcCCCCCCC
Q 002953 727 GSGGASEVKQHVFFKDI 743 (863)
Q Consensus 727 g~~SAeEILqHPFFk~I 743 (863)
|+.++++||||+.+
T Consensus 301 ---ta~e~l~~~~~~~~ 314 (328)
T cd08226 301 ---SASSLLSHAFFKQV 314 (328)
T ss_pred ---CHHHHhhCHHHHHH
Confidence 99999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.20 Aligned_cols=239 Identities=27% Similarity=0.408 Sum_probs=196.4
Q ss_pred EEEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
...||+|+||.|+.+. .++|+.. .........+.+|+++|+.++|||++++++++..+...|+||||+.|
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g 109 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG 109 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC
Confidence 3489999999986542 3344322 12233446788999999999999999999999999999999999975
Q ss_pred CChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 110 -~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------------ 176 (317)
T cd06635 110 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------------ 176 (317)
T ss_pred -CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------------
Confidence 78777754 4568999999999999999999999999999999999999999999999999876310
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
......|++.|+|||++. +..++.++|||||||++|+|++|.+||...+.....
T Consensus 177 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 233 (317)
T cd06635 177 -----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233 (317)
T ss_pred -----------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 012346889999999984 355789999999999999999999999887776666
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..+........ ....++..+.+||.+||..+|.+|| ++.++++|+|+..
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 234 YHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred HHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 66655543222 2346788999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.35 Aligned_cols=238 Identities=22% Similarity=0.329 Sum_probs=190.7
Q ss_pred ceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 462 IDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+.+. .||+|+||.|+.+. +++.|.........+.+.+|+.+|+.++|+||+++++.+.. ...|+||||+++++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 3443 89999999997542 12222222233345678899999999999999999999887 77899999999999
Q ss_pred hHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 536 LYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 536 L~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|.+++... ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---------- 156 (260)
T cd05073 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---------- 156 (260)
T ss_pred HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC----------
Confidence 99999763 357888899999999999999999999999999999999999999999999987411000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kI 692 (863)
........++..|+|||++.+..++.++|+|||||++|+|++ |.+||...+.......+
T Consensus 157 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05073 157 --------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216 (260)
T ss_pred --------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 001112346678999999998889999999999999999998 99999988777777666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
.... .. ..+...+.++.+++.+||..+|++|| ++.+++
T Consensus 217 ~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~ 254 (260)
T cd05073 217 ERGY-RM-PRPENCPEELYNIMMRCWKNRPEERP---TFEYIQ 254 (260)
T ss_pred hCCC-CC-CCcccCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 5432 22 23467889999999999999999999 666665
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=293.92 Aligned_cols=237 Identities=21% Similarity=0.335 Sum_probs=193.6
Q ss_pred EEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..||.|+||.|+.+. .++|... ........+.+|++++++++||||+++++++......|+||||+++++|.+
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECC-CCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 389999999987542 2333221 112223568899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-------------- 154 (256)
T cd05112 89 YLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-------------- 154 (256)
T ss_pred HHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--------------
Confidence 99764 568999999999999999999999999999999999999999999999999987311000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
........++..|+|||++.+..++.++||||||+++|||++ |.+||.......+...+..+.
T Consensus 155 ----------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 218 (256)
T cd05112 155 ----------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF 218 (256)
T ss_pred ----------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC
Confidence 001112345678999999998889999999999999999998 999999888777777765543
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.. ..+...+..+.+|+.+||..+|.+|| ++.+++++
T Consensus 219 ~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 219 RL--YKPRLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred CC--CCCCCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 22 22455789999999999999999999 99998864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.66 Aligned_cols=241 Identities=33% Similarity=0.511 Sum_probs=191.5
Q ss_pred EEEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEeCCe-----EEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISV---RNPFVVRFFYSFTCREN-----LYL 526 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~~~-----lyL 526 (863)
...||.|+||.|+.+. .++|..... .......+.+|+.++.++ +||||+++++++..... +|+
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 3489999999985542 334433221 122234567788887766 59999999999998876 999
Q ss_pred EEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 527 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+|||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~-- 160 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-- 160 (287)
T ss_pred Eehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC--
Confidence 9999975 8999887643 5899999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.......+++.|+|||++.+..++.++|+|||||++|+|++|.+||....
T Consensus 161 ------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 161 ------------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ------------------------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 01123457899999999999889999999999999999999999999888
Q ss_pred hHHHHHHHhhcC-----CCCC-----------C--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 685 PQQIFDNILNRK-----IPWP-----------R--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 685 ~~el~~kIl~~~-----~~~p-----------~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..+.+.++...- ..++ . ....++..+.+||.+||..||.+|| ++.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC---CHHHHhcCcCC
Confidence 777766665411 0000 0 0123567889999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.97 Aligned_cols=238 Identities=29% Similarity=0.453 Sum_probs=191.3
Q ss_pred EEeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..||.|+||.|+.+. +++|.... ......+.+.+|+++|++++||||+++++++...+.+++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 389999999985532 23333322 233447889999999999999999999999998888999999999
Q ss_pred CCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.++|... ..+++..+..++.||+.||.|||+++|+|+||+|.|||++.++.+||+|||++.......
T Consensus 85 ~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~------- 157 (259)
T PF07714_consen 85 GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS------- 157 (259)
T ss_dssp TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 99999999886 679999999999999999999999999999999999999999999999999987420000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
.........+...|+|||.+.+..++.++||||||+++|||++ |..||...+..++.
T Consensus 158 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~ 215 (259)
T PF07714_consen 158 ----------------------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII 215 (259)
T ss_dssp ----------------------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH
T ss_pred ----------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011223456788999999999889999999999999999999 78999998888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..... +..+..++..+.++|.+||..+|.+|| ++.+|++
T Consensus 216 ~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 216 EKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp HHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred cccccccc--ceeccchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 88855443 334677899999999999999999999 8988874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=299.13 Aligned_cols=240 Identities=21% Similarity=0.307 Sum_probs=183.4
Q ss_pred EEEeecccceeeccc-----------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEe
Q 002953 464 LLLAGKGALSEHDDF-----------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVME 529 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-----------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmE 529 (863)
+..||+|+||+|+.+ .+++|..... .......+.+|+++|++++||||+++++++... ..+|+|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME 88 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence 358999999998432 1233322221 123456788999999999999999999987754 46899999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 89 ~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~------ 161 (283)
T cd05080 89 YVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH------ 161 (283)
T ss_pred CCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc------
Confidence 9999999999976 469999999999999999999999999999999999999999999999999987421000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH--H
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ--Q 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~--e 687 (863)
..........++..|+|||++.+..++.++||||||+++|+|++|..||...... +
T Consensus 162 ----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 219 (283)
T cd05080 162 ----------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219 (283)
T ss_pred ----------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh
Confidence 0000111234667899999999888999999999999999999999998643211 0
Q ss_pred H------------HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 I------------FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 l------------~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. .......... +..+..++.++.+++.+||..+|++|| +++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~i~~ 276 (283)
T cd05080 220 MIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRP---TFRSLIP 276 (283)
T ss_pred hhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 0 1111111111 223566889999999999999999999 8888774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=295.06 Aligned_cols=228 Identities=21% Similarity=0.272 Sum_probs=181.3
Q ss_pred Eeecccceeeccccc----------------eehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 466 LAGKGALSEHDDFPQ----------------VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 466 vLGkG~FG~V~~~~k----------------vlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.||+|+||.|+.+.. +..|...........+.+|+.+|+.++||||+++++++.. ...|+|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 589999999854321 1112111112225678899999999999999999999888 77899999
Q ss_pred ecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-------cEEEeecCCcccccc
Q 002953 530 YLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-------HIKLTDFGLSKVGLI 601 (863)
Q Consensus 530 y~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-------~VKLiDFGLAk~~~~ 601 (863)
|+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~ 160 (259)
T cd05037 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160 (259)
T ss_pred cCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc
Confidence 999999999998765 789999999999999999999999999999999999999887 799999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHh-CCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIV-GIP 678 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGvILyELLT-Gk~ 678 (863)
.....++..|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus 161 -----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~ 205 (259)
T cd05037 161 -----------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205 (259)
T ss_pred -----------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 1124577789999999876 78999999999999999999 688
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
||...+......... .... .+......+.++|.+||..+|.+|| ++.++++
T Consensus 206 p~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 256 (259)
T cd05037 206 PLSTLSSSEKERFYQ-DQHR---LPMPDCAELANLINQCWTYDPTKRP---SFRAILR 256 (259)
T ss_pred CcccCCchhHHHHHh-cCCC---CCCCCchHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 887765444333332 1111 1222348899999999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.59 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=192.1
Q ss_pred EEEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--------------C
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--------------E 522 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--------------~ 522 (863)
...||.|+||.|+.+ .+++|+.........+.+.+|+++|+.++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 448999999998654 2455554444445567788999999999999999999776654 3
Q ss_pred eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCcccccc
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~ 601 (863)
.+|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~ 167 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167 (342)
T ss_pred eEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCC
Confidence 5899999996 589888864 57999999999999999999999999999999999999985 45789999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
... .........||..|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 168 --~~~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 168 --HYS--------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred --ccc--------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 000 0001122368899999998765 56789999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCC---------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 002953 681 NAEHPQQIFDNILNRKI---------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 733 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~---------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeE 733 (863)
...+.......+..... +.......++.++.+||.+||..||.+|| ++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e 296 (342)
T cd07854 220 AGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL---TAEE 296 (342)
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc---CHHH
Confidence 87766555444332110 00011235788999999999999999999 9999
Q ss_pred HHcCCCCCCC
Q 002953 734 VKQHVFFKDI 743 (863)
Q Consensus 734 ILqHPFFk~I 743 (863)
+++||||+.+
T Consensus 297 ll~h~~~~~~ 306 (342)
T cd07854 297 ALMHPYMSCY 306 (342)
T ss_pred HhCCCccccc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=314.30 Aligned_cols=242 Identities=30% Similarity=0.460 Sum_probs=190.1
Q ss_pred EEEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLVM 528 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLVm 528 (863)
...||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++.... .+|+||
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 4599999999986542 33333221 12223456889999999999999999999987653 469999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+.. +|..++. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~-------- 168 (342)
T cd07879 100 PYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-------- 168 (342)
T ss_pred ccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC--------
Confidence 99964 7776653 468999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...
T Consensus 169 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~ 222 (342)
T cd07879 169 --------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222 (342)
T ss_pred --------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00123467899999999876 458899999999999999999999999877655
Q ss_pred HHHHHhhcC-----------------------CCCC-----CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRK-----------------------IPWP-----RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~-----------------------~~~p-----~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..+.... ...+ ......+.++.+||.+||+.||.+|| ++.+++.|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~---~~~e~l~h~~ 299 (342)
T cd07879 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL---TATEALEHPY 299 (342)
T ss_pred HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcc
Confidence 554443310 0000 01124678899999999999999999 9999999999
Q ss_pred CCCCCh
Q 002953 740 FKDINW 745 (863)
Q Consensus 740 Fk~IdW 745 (863)
|..+..
T Consensus 300 f~~~~~ 305 (342)
T cd07879 300 FDSFRD 305 (342)
T ss_pred hhhccc
Confidence 988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=301.27 Aligned_cols=237 Identities=20% Similarity=0.338 Sum_probs=191.4
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||.|+.+. +++|..... .......+.+|+.++++++||||+++++++.....+|+||||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (288)
T cd05050 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMA 91 (288)
T ss_pred cccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCC
Confidence 89999999986542 223322211 22334668899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC----------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEE
Q 002953 533 GGDLYSLLRNLG----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590 (863)
Q Consensus 533 GGsL~dlLk~~g----------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKL 590 (863)
+|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l 171 (288)
T cd05050 92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 171 (288)
T ss_pred CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEE
Confidence 999999997432 3677888999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002953 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670 (863)
Q Consensus 591 iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvIL 670 (863)
+|||++........ ........+++.|+|||++.+..++.++|||||||++
T Consensus 172 ~dfg~~~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 222 (288)
T cd05050 172 ADFGLSRNIYSADY-----------------------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222 (288)
T ss_pred CccccceecccCcc-----------------------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHH
Confidence 99999873110000 0001122356779999999998899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 671 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 671 yELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|+|++ |..||.+.+..+....+..+.. +..+..++.++.+||.+||+.+|.+|| ++.|+++
T Consensus 223 ~el~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~el~~ 284 (288)
T cd05050 223 WEIFSYGMQPYYGMAHEEVIYYVRDGNV--LSCPDNCPLELYNLMRLCWSKLPSDRP---SFASINR 284 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 99997 8899988888888777765543 233567899999999999999999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=309.77 Aligned_cols=247 Identities=29% Similarity=0.403 Sum_probs=191.0
Q ss_pred EEeecccceeecccc---------ceehhhhh--hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC----CeEEEEE
Q 002953 465 LLAGKGALSEHDDFP---------QVLKKADM--IRKNAVESILAERDILISV-RNPFVVRFFYSFTCR----ENLYLVM 528 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~---------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~----~~lyLVm 528 (863)
..||+|+||.|+.+. +++|+... ........+.+|+.++.++ +||||+++++.+... ..+|++|
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 389999999985432 34443221 1222345678999999999 599999999865432 4589999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+|+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 86 e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---- 160 (332)
T cd07857 86 ELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG---- 160 (332)
T ss_pred eccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccc----
Confidence 9995 59999998878899999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+...
T Consensus 161 -----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~ 217 (332)
T cd07857 161 -----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217 (332)
T ss_pred -----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH
Confidence 00011234579999999998866 568999999999999999999999998766544
Q ss_pred HHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..++... ..++.....++..+.+|+.+||+.||.+|| ++.+++.|||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~~ll~~~~ 294 (332)
T cd07857 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI---SVEEALEHPY 294 (332)
T ss_pred HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChh
Confidence 443332210 111112234688999999999999999999 9999999999
Q ss_pred CCC
Q 002953 740 FKD 742 (863)
Q Consensus 740 Fk~ 742 (863)
|+.
T Consensus 295 ~~~ 297 (332)
T cd07857 295 LAI 297 (332)
T ss_pred hhh
Confidence 964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=293.61 Aligned_cols=233 Identities=24% Similarity=0.420 Sum_probs=189.5
Q ss_pred ceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 462 IDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
|.+. .||+|+||.|+... +++|.... ....+.+.+|+.+|++++||||+++++++..+ ..|+||||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEecccCCCceEEEeecC--cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 4443 89999999986542 33443321 22345788999999999999999999988754 5799999999999
Q ss_pred hHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 536 LYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 536 L~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~------------ 152 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM------------ 152 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc------------
Confidence 999997653 478999999999999999999999999999999999999999999999999873100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kI 692 (863)
.......+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+
T Consensus 153 ----------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 153 ----------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred ----------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 0011234567999999998889999999999999999997 99999988887777666
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.. +..+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 211 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 249 (254)
T cd05083 211 EKGYR--MEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLRE 249 (254)
T ss_pred hCCCC--CCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 54422 223567899999999999999999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.99 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=185.8
Q ss_pred EEeecccceeecccc-----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy~ 531 (863)
..||+|+||.|+.+. +++|+.........+.+.+|+++|+.++||||+++++++.. ...+|+||||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 389999999996532 35555444455556788999999999999999999987654 34689999999
Q ss_pred CCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~------ 163 (284)
T cd05081 90 PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE------ 163 (284)
T ss_pred CCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc------
Confidence 999999999764 4689999999999999999999999999999999999999999999999999874210000
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH---
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ--- 687 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e--- 687 (863)
. ........++..|+|||++.+..++.++|||||||++|||++|..|+.......
T Consensus 164 -------------~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 221 (284)
T cd05081 164 -------------Y---------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221 (284)
T ss_pred -------------c---------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence 0 000111234556999999998889999999999999999999877764332110
Q ss_pred ------------HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 ------------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 ------------l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..++.....+ ..+..++.++.+||.+||..+|++|| |+.+|++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRP---SFSELAL 278 (284)
T ss_pred cccccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 011122222222 23467889999999999999999999 8998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.39 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=193.0
Q ss_pred ceEE-Eeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 462 IDLL-LAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
+.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|++++||||+++++++.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 4443 89999999986542 223322212 13345678899999999999999999998887 7899999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+++|+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~--- 164 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK--- 164 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc---
Confidence 999999999999764 5689999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
........++..|+|||.+....++.++|+|||||++|||++ |..||......
T Consensus 165 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 165 --------------------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred --------------------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 000112234678999999988889999999999999999998 99999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++...+..... ...+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 219 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp---~~~~l~~ 263 (279)
T cd05057 219 EIPDLLEKGER--LPQPPICTIDVYMVLVKCWMIDAESRP---TFKELIN 263 (279)
T ss_pred HHHHHHhCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 87777765432 223456789999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=310.01 Aligned_cols=240 Identities=29% Similarity=0.433 Sum_probs=189.6
Q ss_pred EEEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEEEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYLVM 528 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~lyLVm 528 (863)
...||+|+||.|+.+. +++|+... ......+.+.+|+.++.+++||||+++++++... ...|+++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 3489999999985542 33443322 1222345688899999999999999999988653 3478999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+++ |++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~-------- 171 (345)
T cd07877 102 HLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------- 171 (345)
T ss_pred hhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc--------
Confidence 987 7799888765 469999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+...
T Consensus 172 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 172 --------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred --------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 01123568999999999876 567899999999999999999999998776555
Q ss_pred HHHHHhhcCC-----------------------C-----CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRKI-----------------------P-----WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~~-----------------------~-----~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..+..... . +.......++++.+||.+||..||.+|| ++.+++.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~e~l~h~~ 302 (345)
T cd07877 226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAY 302 (345)
T ss_pred HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC---CHHHHhcChh
Confidence 4444322110 0 0011124578899999999999999999 9999999999
Q ss_pred CCC
Q 002953 740 FKD 742 (863)
Q Consensus 740 Fk~ 742 (863)
|..
T Consensus 303 f~~ 305 (345)
T cd07877 303 FAQ 305 (345)
T ss_pred hhh
Confidence 985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=296.14 Aligned_cols=242 Identities=34% Similarity=0.549 Sum_probs=193.1
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
..||.|+||.|+.+. .++|..... .......+.+|+.+++.++||||+++++++... +..|+||||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 489999999986542 233433322 233445688999999999999999999999988 899999999975
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|..++... ..+++..+..++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~--------- 154 (287)
T cd07840 85 -DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN--------- 154 (287)
T ss_pred -cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC---------
Confidence 899988765 579999999999999999999999999999999999999999999999999987421100
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..
T Consensus 155 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 155 ---------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred ---------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 001123457889999998775 4578999999999999999999999988877666655
Q ss_pred HhhcCC-----CCCC-----------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 692 ILNRKI-----PWPR-----------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 692 Il~~~~-----~~p~-----------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..... .++. +...++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l~~~~~ 287 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI---SADQALQHEYF 287 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc---CHHHHhhCcCC
Confidence 543210 0000 0111388999999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.30 Aligned_cols=240 Identities=26% Similarity=0.376 Sum_probs=195.3
Q ss_pred EEEeecccceeecccc-------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
...||+|+||.|+.+. .++|+... ........+.+|+++|+.++|||++++++++......|+||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 3479999999986442 33443321 223345578899999999999999999999999999999999996
Q ss_pred CChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....
T Consensus 99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------------ 166 (308)
T cd06634 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------------ 166 (308)
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec------------
Confidence 588877754 3568999999999999999999999999999999999999999999999999986310
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.....
T Consensus 167 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 223 (308)
T cd06634 167 -----------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (308)
T ss_pred -----------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence 0123468899999999853 45788999999999999999999999887666555
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+.....+.. ....++..+.+||.+||..+|.+|| ++.++++||||...
T Consensus 224 ~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 224 YHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred HHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 55544433221 2346889999999999999999999 99999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=301.18 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=191.5
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-------
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR------- 521 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------- 521 (863)
...|.+. .||.|+||.|+.+. .++|..... .......+.+|+++|+.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 3455554 89999999986542 233332211 111234567899999999999999999887543
Q ss_pred -CeEEEEEeecCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 522 -ENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 522 -~~lyLVmEy~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
..+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 347999999965 77777754 357999999999999999999999999999999999999999999999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~ 678 (863)
........ . .............|++.|+|||++.+. .++.++|||||||++|+|++|++
T Consensus 166 ~~~~~~~~-----~---------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 166 DGPPPNPK-----G---------------GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred cCCCcccc-----c---------------CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 11100000 0 000001122345789999999998764 57899999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCC--------------------CCCC-------CCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 679 PFNAEHPQQIFDNILNRKIP--------------------WPRV-------PEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~--------------------~p~~-------p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
||.+.+.......+...... .... ...++.++.+||.+||..||.+|| |+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~ 302 (311)
T cd07866 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL---TA 302 (311)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc---CH
Confidence 99888776655554431100 0000 023457889999999999999999 99
Q ss_pred HHHHcCCCC
Q 002953 732 SEVKQHVFF 740 (863)
Q Consensus 732 eEILqHPFF 740 (863)
.+++.||||
T Consensus 303 ~ell~~~~f 311 (311)
T cd07866 303 SDALEHPYF 311 (311)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.95 Aligned_cols=239 Identities=25% Similarity=0.342 Sum_probs=191.8
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.||+|+||.|+.+. +++|+.... .....+.+.+|+++|.++. |||||++++++...+.+|+|||||
T Consensus 44 ~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~ 123 (401)
T cd05107 44 TLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYC 123 (401)
T ss_pred hccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEecc
Confidence 89999999997542 344444332 2233457889999999997 999999999999999999999999
Q ss_pred CCCChHHHHHhcC-------------------------------------------------------------------
Q 002953 532 NGGDLYSLLRNLG------------------------------------------------------------------- 544 (863)
Q Consensus 532 ~GGsL~dlLk~~g------------------------------------------------------------------- 544 (863)
++|+|.+++...+
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (401)
T cd05107 124 RYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYAD 203 (401)
T ss_pred CCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhh
Confidence 9999999996532
Q ss_pred -------------------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeec
Q 002953 545 -------------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593 (863)
Q Consensus 545 -------------------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDF 593 (863)
.+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~Df 283 (401)
T cd05107 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDF 283 (401)
T ss_pred hhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEec
Confidence 2556677889999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHH
Q 002953 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFEL 673 (863)
Q Consensus 594 GLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyEL 673 (863)
|+++....... ........|++.|||||++.+..++.++|||||||++|||
T Consensus 284 Gla~~~~~~~~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~ 334 (401)
T cd05107 284 GLARDIMRDSN-----------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334 (401)
T ss_pred Ccceecccccc-----------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHH
Confidence 99874211000 0011234678999999999998899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 674 IV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 674 LT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
++ |..||......+.....+..... +..+..++.++.+|+.+||..+|.+|| ++.+|++.
T Consensus 335 l~~g~~P~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RP---s~~ell~~ 395 (401)
T cd05107 335 FTLGGTPYPELPMNEQFYNAIKRGYR-MAKPAHASDEIYEIMQKCWEEKFEIRP---DFSQLVHL 395 (401)
T ss_pred HHcCCCCCCCCCchHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 98 89999876655554444443322 234567899999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=298.47 Aligned_cols=241 Identities=32% Similarity=0.538 Sum_probs=193.4
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|++|.|+.+. .++|..... .......+.+|+.+|++++||||+++++++.+...+|+||||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 479999999986542 233332222 222446788899999999999999999999999999999999975 8
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|..++... +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----------- 152 (283)
T cd05118 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----------- 152 (283)
T ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----------
Confidence 88888664 579999999999999999999999999999999999999999999999999987421100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+.
T Consensus 153 --------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 153 --------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred --------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 011234688899999999876 78999999999999999999999998877665555443
Q ss_pred hcCCC-------------------C--------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NRKIP-------------------W--------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~~~~-------------------~--------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..... + ......++.++.+||.+||..||.+|| ++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~ll~~~~~ 283 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TAEQALAHPYF 283 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc---CHHHHhhCCCC
Confidence 21100 0 011234688999999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=311.50 Aligned_cols=241 Identities=29% Similarity=0.443 Sum_probs=193.8
Q ss_pred EEEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe------EEEEE
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN------LYLVM 528 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~------lyLVm 528 (863)
...||+|+||.|+.+. .++|+... ........+.+|+.+++.++||||+++++++...+. +|+|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 3489999999986542 34443322 123344667889999999999999999988876654 89999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+ |++|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 100 e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~-------- 169 (343)
T cd07851 100 HLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-------- 169 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc--------
Confidence 999 6799999876 579999999999999999999999999999999999999999999999999987310
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 170 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 170 --------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred --------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 01123468899999999876 467899999999999999999999998877766
Q ss_pred HHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRKIP----------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~~~----------------------------~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+..+...... +......++.++.+||.+||..+|.+|| |+.+|++|||
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp---t~~ell~h~~ 300 (343)
T cd07851 224 QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI---TAAEALAHPY 300 (343)
T ss_pred HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC---CHHHHhcCCC
Confidence 66555432110 0011124688999999999999999999 9999999999
Q ss_pred CCCC
Q 002953 740 FKDI 743 (863)
Q Consensus 740 Fk~I 743 (863)
|...
T Consensus 301 ~~~~ 304 (343)
T cd07851 301 LAEY 304 (343)
T ss_pred cccc
Confidence 9853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.16 Aligned_cols=242 Identities=21% Similarity=0.291 Sum_probs=186.5
Q ss_pred EEEeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEe
Q 002953 464 LLLAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVME 529 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmE 529 (863)
+..||+|+||.|+.+. +++|..... .......+.+|+.+|+.++||||+++++++... ...|+|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 3489999999985331 344433222 233456789999999999999999999998875 56899999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 89 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 164 (284)
T cd05079 89 FLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---- 164 (284)
T ss_pred ccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCcc----
Confidence 99999999999764 3589999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC----
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH---- 684 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~---- 684 (863)
.........|+..|+|||++.+..++.++|||||||++|+|+++..|+....
T Consensus 165 ------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~ 220 (284)
T cd05079 165 ------------------------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL 220 (284)
T ss_pred ------------------------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh
Confidence 0011123567888999999998889999999999999999999877653211
Q ss_pred ----------hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 685 ----------PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 685 ----------~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
............... ..+..++..+.+||.+||+.+|.+|| ++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~ 279 (284)
T cd05079 221 KMIGPTHGQMTVTRLVRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRT---TFQNLIEG 279 (284)
T ss_pred hhcccccccccHHHHHHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 001111112222222 23567899999999999999999999 89998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.34 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=188.0
Q ss_pred cceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-CeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCR-ENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~-~~l 524 (863)
+|++. .||+|+||.|+.+. +++|..... .......+.+|+.+|.++ +||||+++++++... ..+
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 34443 89999999997542 233433221 223456788999999999 689999999877654 468
Q ss_pred EEEEeecCCCChHHHHHhc-------------------------------------------------------------
Q 002953 525 YLVMEYLNGGDLYSLLRNL------------------------------------------------------------- 543 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~------------------------------------------------------------- 543 (863)
|+|||||++|+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 9999999999999998642
Q ss_pred ------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 544 ------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 544 ------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-------------- 233 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-------------- 233 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc--------------
Confidence 135777888899999999999999999999999999999999999999999987421000
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||........+...+...
T Consensus 234 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 298 (343)
T cd05103 234 ---------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 298 (343)
T ss_pred ---------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc
Confidence 0011122346778999999999899999999999999999997 999997755433333332222
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.. +..+...++++.+++.+||..+|.+|| ++.+|++|
T Consensus 299 ~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 299 TR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 22 233456788999999999999999999 99999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.12 Aligned_cols=242 Identities=20% Similarity=0.280 Sum_probs=192.1
Q ss_pred cceE-EEeecccceeecccc-----------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-----------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYL 526 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-----------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~lyL 526 (863)
.|.+ .+||+|+||.|+.+. +++|... .........+.+|+.+|++++||||+++++++.. ....++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 3444 389999999985432 2222222 1234456778999999999999999999997665 567899
Q ss_pred EEeecCCCChHHHHHhc--------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 527 VMEYLNGGDLYSLLRNL--------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~--------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
+++|+++++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999999998653 3488999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk 677 (863)
...... ........++..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 167 ~~~~~~-----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 167 LFPMDY-----------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred ccCCce-----------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 211000 000112346778999999999889999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+||...+..++...+.... .+ ..+..+++++.+++.+||..+|++|| ++.++++
T Consensus 218 ~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 271 (280)
T cd05043 218 TPYVEIDPFEMAAYLKDGY-RL-AQPINCPDELFAVMACCWALDPEERP---SFSQLVQ 271 (280)
T ss_pred CCcCcCCHHHHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999888777666554432 22 23456789999999999999999999 8888774
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=308.66 Aligned_cols=247 Identities=32% Similarity=0.465 Sum_probs=191.7
Q ss_pred Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC--CeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISV-RNPFVVRFFYSFTCR--ENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~--~~lyLVmEy~~G 533 (863)
.||+|+||.|+.+. .++|+... ........+.+|+.+++++ +||||+++++++... ..+|+||||+++
T Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~ 93 (337)
T cd07852 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET 93 (337)
T ss_pred hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc
Confidence 89999999986441 34443321 2233445677899999999 999999999988754 368999999974
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 -~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~-------- 163 (337)
T cd07852 94 -DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN-------- 163 (337)
T ss_pred -CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc--------
Confidence 999998764 7889999999999999999999999999999999999999999999999998742110000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
..........||+.|+|||++.+ ..++.++|+||||+++|+|++|++||.+.........+
T Consensus 164 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 164 ------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred ------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 00011223578999999998865 45789999999999999999999999876655444433
Q ss_pred hhcCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 693 LNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 693 l~~~~----------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..... ........++.++.+||.+||+.+|.+|| ++.++++||||+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~~il~~~~~~~~ 301 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL---TAEEALEHPYVAQF 301 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc---CHHHHhhChhhhhh
Confidence 22110 01111234789999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=340.42 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=189.7
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
+|.+. +||+|+||.|+.+. +++|+... ......+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 34543 99999999996542 34443321 123345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-----------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 530 YLNGGDLYSLLRNL-----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 530 y~~GGsL~dlLk~~-----------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999999998642 2245567788999999999999999999999999999999999999999999985
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
....... ....... ..+ ............+||+.|||||++.+..++.++|||||||++|||++|..
T Consensus 163 i~~~~~~-~~~l~~~---~~~---------s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 163 KKLEEED-LLDIDVD---ERN---------ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred ccccccc-ccccccc---ccc---------ccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 2110000 0000000 000 00000112234689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHh-hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 679 PFNAEHPQQIFDNIL-NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 679 PF~~~~~~el~~kIl-~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
||............. ....... ....+++.+.+++.+||..||.+|++ ++++++
T Consensus 230 PF~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s--s~eeLl 284 (932)
T PRK13184 230 PYRRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS--SVQELK 284 (932)
T ss_pred CCCCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC--HHHHHH
Confidence 998765544332211 1111111 12468899999999999999999984 444444
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.73 Aligned_cols=245 Identities=30% Similarity=0.443 Sum_probs=190.1
Q ss_pred ceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC---------
Q 002953 462 IDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE--------- 522 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--------- 522 (863)
|.+. .||+|+||.|+.+. +++|..... .......+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 4433 89999999985542 233333222 1223356778999999999999999999887755
Q ss_pred -eEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 523 -NLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 523 -~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 167 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccccc
Confidence 79999999976 777777654 468999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
... ........++..|+|||++.+ ..++.++|||||||++|+|++|++|
T Consensus 168 ~~~------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~ 217 (302)
T cd07864 168 SEE------------------------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217 (302)
T ss_pred CCc------------------------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 100 001112356888999998875 4578999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCC-----CCCC----------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 680 FNAEHPQQIFDNILNRKI-----PWPR----------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~-----~~p~----------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
|...+..+.+..+..... .++. ....++..+.++|.+||..+|.+|| ++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~ 294 (302)
T cd07864 218 FQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC---TAE 294 (302)
T ss_pred CCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC---CHH
Confidence 987776655544433110 0000 1124689999999999999999999 999
Q ss_pred HHHcCCCC
Q 002953 733 EVKQHVFF 740 (863)
Q Consensus 733 EILqHPFF 740 (863)
+++.||||
T Consensus 295 ~il~~~~~ 302 (302)
T cd07864 295 EALNSPWL 302 (302)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.92 Aligned_cols=241 Identities=34% Similarity=0.529 Sum_probs=193.3
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. .++|..... .....+.+..|+.+++.++||||+++++++...+.+|+||||+. ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 378999999986532 233332222 23344667889999999999999999999999999999999997 49
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 84 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~------------ 151 (282)
T cd07829 84 LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP------------ 151 (282)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC------------
Confidence 99999876 57999999999999999999999999999999999999999999999999998741100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
........++..|+|||++.+. .++.++|+|||||++|||++|.+||...+....+.++.
T Consensus 152 -------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 152 -------------------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred -------------------ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 0011234567889999999876 78999999999999999999999998877665555443
Q ss_pred hc------------------CCCCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NR------------------KIPWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~------------------~~~~p~~--------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.. ...++.. ...++..+.++|.+||..+|.+|| ++.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~~~l~~p~~ 282 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAKEALKHPYF 282 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC---CHHHHhhCcCC
Confidence 21 0011110 123578899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=293.59 Aligned_cols=203 Identities=32% Similarity=0.522 Sum_probs=169.9
Q ss_pred HHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCC
Q 002953 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 576 (863)
Q Consensus 497 l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLK 576 (863)
..|...+....||||+++++++......|+||||++||+|.+++.+...+++..+..++.|++.||+|||+.||+|||||
T Consensus 33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk 112 (237)
T cd05576 33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLN 112 (237)
T ss_pred hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 34556666677999999999999999999999999999999999887789999999999999999999999999999999
Q ss_pred CcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC
Q 002953 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656 (863)
Q Consensus 577 PeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 656 (863)
|+||+++.++.++|+|||++.... .......++..|+|||.+.+..
T Consensus 113 p~Nil~~~~~~~~l~df~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~ 158 (237)
T cd05576 113 PNNILLDDRGHIQLTYFSRWSEVE----------------------------------DSCDGEAVENMYCAPEVGGISE 158 (237)
T ss_pred HHHEEEcCCCCEEEecccchhccc----------------------------------cccccCCcCccccCCcccCCCC
Confidence 999999999999999999876310 0011235677899999998888
Q ss_pred CCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHH
Q 002953 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEV 734 (863)
Q Consensus 657 ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEI 734 (863)
++.++|+||+|+++|+|++|..||...... + ..... ..++..+++.+.+||.+||+.||.+|+++ .+++++
T Consensus 159 ~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 231 (237)
T cd05576 159 ETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTT-LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231 (237)
T ss_pred CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-ccccc-cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence 999999999999999999999988643221 0 11111 12456689999999999999999999964 356999
Q ss_pred HcCCCC
Q 002953 735 KQHVFF 740 (863)
Q Consensus 735 LqHPFF 740 (863)
++||||
T Consensus 232 ~~h~~~ 237 (237)
T cd05576 232 KSHPFF 237 (237)
T ss_pred HcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.51 Aligned_cols=247 Identities=29% Similarity=0.479 Sum_probs=190.2
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
.+.+. .||+|+||.|+.+. +++|..... .......+..|+.++.++. ||||+++++++.+...+|+||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 34433 99999999985542 233332211 1223455677887777764 99999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 531 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 531 ~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+. ++|..++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~------ 168 (296)
T cd06618 96 MS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS------ 168 (296)
T ss_pred cC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC------
Confidence 85 478777765 3578999999999999999999997 69999999999999999999999999998631100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus 169 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 169 --------------------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred --------------------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 0011235788999999997654 7889999999999999999999997643
Q ss_pred h-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 685 P-QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 685 ~-~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
. .+.+..+.............++.++.+||.+||..||.+|| +++++++||||...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 279 (296)
T cd06618 223 TEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQHPFIRRY 279 (296)
T ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhcc
Confidence 2 34455555443222122234789999999999999999999 99999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.59 Aligned_cols=243 Identities=30% Similarity=0.478 Sum_probs=190.5
Q ss_pred cce-EEEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEe
Q 002953 461 QID-LLLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVME 529 (863)
Q Consensus 461 ~~~-l~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~lyLVmE 529 (863)
.|. ...||.|+||.|+.+. +++|+.. .......+.+.+|+.+|+.++||||++++++|.. ....|+|||
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 344 3499999999986542 3444322 1223345678899999999999999999999876 557899999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+ +++|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 91 ~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~--------- 159 (328)
T cd07856 91 LL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--------- 159 (328)
T ss_pred hh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC---------
Confidence 99 5689888865 568899999999999999999999999999999999999999999999999986310
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01123467889999999866 5689999999999999999999999987664332
Q ss_pred HHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNR----------------------------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~----------------------------~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+..+... ..+.......++.++.++|.+||+.+|++|| ++++++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI---SAAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC---CHHHHhcCCcc
Confidence 2221110 0000111235788999999999999999999 99999999999
Q ss_pred CC
Q 002953 741 KD 742 (863)
Q Consensus 741 k~ 742 (863)
..
T Consensus 292 ~~ 293 (328)
T cd07856 292 AP 293 (328)
T ss_pred cc
Confidence 74
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.18 Aligned_cols=240 Identities=31% Similarity=0.428 Sum_probs=189.2
Q ss_pred EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||.|+||+|+.+. .++|+..... ........+|+..+.+++ ||||+++++++..++..|+||||+ +|+
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 379999999986542 3333322111 112234567999999999 999999999999999999999999 779
Q ss_pred hHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 536 LYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 536 L~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|.+++.... .+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----------- 152 (283)
T cd07830 84 LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----------- 152 (283)
T ss_pred HHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----------
Confidence 999987754 7899999999999999999999999999999999999999999999999998741100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kI 692 (863)
.......|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||........+.++
T Consensus 153 ---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 153 ---------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred ---------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 01123468899999998854 45789999999999999999999999887765555443
Q ss_pred hhcCC-------------------CCC--------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 693 LNRKI-------------------PWP--------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 693 l~~~~-------------------~~p--------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
..... .++ ......+.++.+||.+||..+|.+|| ++.|++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~~~~~ 283 (283)
T cd07830 212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP---TASQALQHPYF 283 (283)
T ss_pred HHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC---CHHHHhhCCCC
Confidence 32100 000 01112368899999999999999999 99999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=289.38 Aligned_cols=238 Identities=20% Similarity=0.351 Sum_probs=189.3
Q ss_pred Eeecccceeecccc----------ceehhh--hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEE
Q 002953 466 LAGKGALSEHDDFP----------QVLKKA--DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLV 527 (863)
Q Consensus 466 vLGkG~FG~V~~~~----------kvlKK~--~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLV 527 (863)
+||+|+||.|+.+. .++|.. ........+.+.+|+.+|+.++||||+++++++.... ..+++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 85 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEE
Confidence 79999999986542 233322 2223445667889999999999999999999886542 24789
Q ss_pred EeecCCCChHHHHHhc------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 528 MEYLNGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
++|+.+|+|..++... ..++...+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~ 165 (273)
T cd05074 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165 (273)
T ss_pred EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccC
Confidence 9999999999887432 2478889999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF 680 (863)
... ........+++.|++||.+.+..++.++|||||||++|+|++ |.+||
T Consensus 166 ~~~-----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~ 216 (273)
T cd05074 166 GDY-----------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216 (273)
T ss_pred Ccc-----------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCC
Confidence 000 001122346678999999999889999999999999999999 99999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...+..+.+..+..... ...+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~~~ 268 (273)
T cd05074 217 AGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRP---SFQHLRDQ 268 (273)
T ss_pred CCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 98888777776655432 223456889999999999999999999 88888754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.34 Aligned_cols=236 Identities=28% Similarity=0.437 Sum_probs=200.1
Q ss_pred EEeecccceeecccc-----------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..||+|+||+|+... +++|... ...+.+...+++|+++|++++|||||++|++...+..+|+|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 399999999984321 2233222 24467788999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+|+.+...
T Consensus 243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~------- 315 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY------- 315 (474)
T ss_pred cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce-------
Confidence 99999999999876 4999999999999999999999999999999999999999999999999999852100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccc-cccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKR-SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQ 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~-s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~e 687 (863)
.... ..--...|+|||.+...-|+.++|||||||++||+++ |..||.+....+
T Consensus 316 -------------------------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 316 -------------------------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred -------------------------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 0001 1135678999999999999999999999999999998 899999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+..+|.....+.+ .+...|.++..++.+|+..+|++|| +..++.+
T Consensus 371 v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~---tm~~i~~ 415 (474)
T KOG0194|consen 371 VKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRP---TMSTIKK 415 (474)
T ss_pred HHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhcc---CHHHHHH
Confidence 9999966555443 3567899999999999999999999 6665553
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.22 Aligned_cols=242 Identities=27% Similarity=0.453 Sum_probs=197.1
Q ss_pred Eeecccceeecccc-----c--eehhhh-hhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-----Q--VLKKAD-MIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-----k--vlKK~~-i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.||.|+.|.|.... + ++|... ..++...++++..++++...+ .|+||+.+++|..+..+++.||.| +.-+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHH
Confidence 79999999986542 2 222221 223455678888999887765 899999999999999999999998 4356
Q ss_pred HHHHHh-cCCCChhhHHHHHHHHHHHHHHHH-hCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 537 YSLLRN-LGCLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 537 ~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLH-s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
..++++ .++++|..+-.+...++.||.||. ++||||||+||+|||+|..|+|||||||++-.....
T Consensus 178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS------------ 245 (391)
T KOG0983|consen 178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS------------ 245 (391)
T ss_pred HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc------------
Confidence 666654 367999999999999999999998 579999999999999999999999999998642211
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCC-CChHHHHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFD 690 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~-~~~~el~~ 690 (863)
.......|-+.|||||.+.- ..|+.++||||||++++||.||..||.+ ....+++.
T Consensus 246 --------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 246 --------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred --------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 11223468999999999964 4689999999999999999999999987 45677888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++++...+.......+|+.+.+|+..||.+|+.+|| ...++|+|||+...
T Consensus 306 kvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 306 KVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLEHPFIKRY 355 (391)
T ss_pred HHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhcCcceeec
Confidence 888866533333345899999999999999999999 89999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=288.48 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=187.5
Q ss_pred EEeecccceeecccc-----------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEee
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEY 530 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy 530 (863)
..||+|+||.|+.+. .++|....... .....+.+|+++++.++||||+++++++.. ....|+||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 489999999986542 23333322222 246689999999999999999999999887 5579999999
Q ss_pred cCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----- 164 (284)
T cd05038 90 LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD----- 164 (284)
T ss_pred CCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCc-----
Confidence 99999999997654 589999999999999999999999999999999999999999999999999874210000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH--
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ-- 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e-- 687 (863)
.........++..|+|||.+.+..++.++|||||||++|||++|..||.......
T Consensus 165 -----------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 221 (284)
T cd05038 165 -----------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR 221 (284)
T ss_pred -----------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc
Confidence 0001112345667999999998889999999999999999999999986543211
Q ss_pred ------------HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 ------------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 ------------l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.....+.....++ .+..++.++.+|+.+||..+|.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~~ 278 (284)
T cd05038 222 MIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRP---SFADLIL 278 (284)
T ss_pred ccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 1122223333222 2456789999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.47 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=188.0
Q ss_pred EEeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..||+|+||.|+.+. +++|..... .......+.+|+.+++.++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 489999999987542 133322211 122334688999999999999999999988654 5789999999
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~-------- 163 (303)
T cd05110 92 HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-------- 163 (303)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc--------
Confidence 999999987653 58999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
.........++..|+|||++.+..++.++|||||||++|||++ |..||.+........
T Consensus 164 ---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~ 222 (303)
T cd05110 164 ---------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222 (303)
T ss_pred ---------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 0001123456789999999999989999999999999999997 999998876655544
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+. ....++ .+...+..+.+++.+||..+|++|| ++.++++.
T Consensus 223 ~~~-~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 223 LLE-KGERLP-QPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HHH-CCCCCC-CCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 443 332222 3456788999999999999999999 88888764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.83 Aligned_cols=246 Identities=14% Similarity=0.224 Sum_probs=177.9
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhH-----------HHHHHHHHHHHHhcCCCCeeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNA-----------VESILAERDILISVRNPFVVRFFY 516 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~-----------~e~~l~Ei~IL~~L~HPnIVkL~~ 516 (863)
...|.+. +||+|+||.|+.+. .++|......... ......+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3455555 89999999996542 1222111111100 011223334455678999999998
Q ss_pred EEEeCC----eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEee
Q 002953 517 SFTCRE----NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 592 (863)
Q Consensus 517 ~f~d~~----~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiD 592 (863)
.+.... ..|++|+++. .++.+.+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 766543 4578899884 47877777666678899999999999999999999999999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002953 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672 (863)
Q Consensus 593 FGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyE 672 (863)
||+|+........ . ...........||+.|+|||++.+..++.++|||||||++||
T Consensus 170 FGla~~~~~~~~~-------------------~-----~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 170 YGIASHFIIHGKH-------------------I-----EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred cCCceeeccCCcc-------------------c-----ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 9999853211000 0 000011234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-HH--------HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 673 LIVGIPPFNAEHP-QQ--------IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 673 LLTGk~PF~~~~~-~e--------l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|++|.+||.+... .. ....+...+.. ....++++.++++.|+..+|++|| +..+|++
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp---~~~~l~~ 291 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKP---DYDALIK 291 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCC---CHHHHHH
Confidence 9999999977632 22 22333333222 235689999999999999999999 7777764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=321.02 Aligned_cols=238 Identities=18% Similarity=0.300 Sum_probs=194.8
Q ss_pred Eeecccceeeccc----cceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDF----PQVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~----~kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|.||+|+.. .+++|...+. ...+.+.|++|+.+|++-+|.||+-+.+++..... .||+-+|+|-+|+.+
T Consensus 399 rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~h 477 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTH 477 (678)
T ss_pred eeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhh
Confidence 7999999999665 2455544443 34578899999999999999999999999988877 999999999999999
Q ss_pred HHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 540 Lk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
|.-. ..|.....+.|+.||++|+.|||.++|||||||..||++..++.|||+||||+..-...
T Consensus 478 lHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w---------------- 541 (678)
T KOG0193|consen 478 LHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW---------------- 541 (678)
T ss_pred ccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee----------------
Confidence 9754 46999999999999999999999999999999999999999999999999998751110
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
..........|...|||||++.. .+|++.+||||||+++|||++|.+||...+.++++-.+-.+
T Consensus 542 -------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 542 -------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred -------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 00112234568899999999974 45899999999999999999999999977766665554444
Q ss_pred C--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 696 K--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 696 ~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. ..........+.++++|+..||.+++++|| ...+||.
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERP---LFPQLLS 648 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCc---cHHHHHH
Confidence 2 122223456788999999999999999999 7777764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.77 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=199.6
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NL 524 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~l 524 (863)
...+|++. .||.|||+-|+.+. +++||.......+.+..++|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34556665 89999999987654 6788888888888899999999999999999999987665433 49
Q ss_pred EEEEeecCCCChHHHHHhc---C-CCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 525 YLVMEYLNGGDLYSLLRNL---G-CLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~---g-~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
||+++|...|+|.+.+... | .+++.++..|+.+|+.||++||+.. +.||||||.|||+...+.++|.|||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999998754 3 5899999999999999999999998 99999999999999999999999998874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHh
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGvILyELLT 675 (863)
.. ..+.++. .....++. ..-..|..|+|||.+.-+ ..+.++|||||||+||+|+.
T Consensus 179 a~---------i~i~~~~----------~a~~lQe~---a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 179 AP---------IQIEGSR----------QALRLQEW---AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred cc---------eEeechH----------HHHHHHHH---HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence 11 0111110 00111111 122458889999998654 45899999999999999999
Q ss_pred CCCCCCCCCh--HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 GIPPFNAEHP--QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 Gk~PF~~~~~--~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|..||...-. ..+.-.+.+.+..+|.-.. +|..+.+||++||+.||.+|| ++.+++.+
T Consensus 237 ~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP---~i~~ll~~ 296 (302)
T KOG2345|consen 237 GESPFERIYQQGGSLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRP---TIPELLSK 296 (302)
T ss_pred cCCcchHHhhcCCeEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 9999953211 1122234455677776444 899999999999999999999 99998865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=331.20 Aligned_cols=238 Identities=24% Similarity=0.387 Sum_probs=202.0
Q ss_pred EEEeecccceeecccc------------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 464 LLLAGKGALSEHDDFP------------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~------------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..+||+|+||+||... +++|+.. ..+......|++|..+|++++|||||+++++.-+....+|++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 3489999999996532 3444433 33556778999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 531 LNGGDLYSLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 531 ~~GGsL~dlLk~~-------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|.||+|..+|++. ..++......++.+|++|+.||+++++|||||...|+||+....+||+|||+|+.....
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~- 855 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK- 855 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc-
Confidence 9999999999876 24888999999999999999999999999999999999999999999999999932110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhcccc-ccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS-AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 681 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s-~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~ 681 (863)
+..+... ..-...|||||.+....++.++|||||||+|||+++ |..||.
T Consensus 856 -----------------------------~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 856 -----------------------------DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred -----------------------------hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 0011111 234568999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+.+..+++...+.+. .+ ..|..+|..+.+++..||+.+|++|| ++..|++
T Consensus 907 ~~~n~~v~~~~~~gg-RL-~~P~~CP~~ly~lM~~CW~~~pe~RP---~F~~i~~ 956 (1025)
T KOG1095|consen 907 SRSNFEVLLDVLEGG-RL-DPPSYCPEKLYQLMLQCWKHDPEDRP---SFRTIVE 956 (1025)
T ss_pred CcchHHHHHHHHhCC-cc-CCCCCCChHHHHHHHHHccCChhhCc---cHHHHHh
Confidence 999999988777766 33 34788999999999999999999999 7888776
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.13 Aligned_cols=249 Identities=30% Similarity=0.481 Sum_probs=198.1
Q ss_pred Eeecccceeecccc------ceehhhhhh--------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-CeEEEEEee
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMI--------RKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEY 530 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~--------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-~~lyLVmEy 530 (863)
+||+|||++||.+. +|..|++.. +.+..++..+|.+|.+.|+||.||++|++|.-+ +.+|-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 89999999997652 333333322 234557889999999999999999999999855 568999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC--CccccCCCCcceeecC---CCcEEEeecCCccccccCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~--GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~~s~~ 605 (863)
|+|.+|..||+..+.+++.+++.|+.||+.||.||.+. .|||-||||.|||+-. .|.|||+|||++++....+.+
T Consensus 550 ceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~ 629 (775)
T KOG1151|consen 550 CEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYN 629 (775)
T ss_pred cCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccC
Confidence 99999999999999999999999999999999999975 5999999999999964 378999999999964322221
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC----CCCccceeechhHHHHHHHhCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----GHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
... ....+....||.+|++||.+.-. ..+.++||||+|||+|.+++|+.||.
T Consensus 630 ~vd------------------------GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 630 SVD------------------------GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred ccc------------------------ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 111 12334457899999999988532 35889999999999999999999996
Q ss_pred CCCh-HHHHHH--Hhh-cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 682 AEHP-QQIFDN--ILN-RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 682 ~~~~-~el~~k--Il~-~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.... +.+++. |++ ....||.- .-++.++++||++||++.-++|. .+.++-.||||..
T Consensus 686 hnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~---DV~qLA~dpyllP 746 (775)
T KOG1151|consen 686 HNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRI---DVQQLACDPYLLP 746 (775)
T ss_pred CchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhh---hHHHHccCccccc
Confidence 6533 333322 222 34455543 45899999999999999999999 8999999999853
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=283.77 Aligned_cols=236 Identities=31% Similarity=0.494 Sum_probs=190.9
Q ss_pred Eeecccceeecccc--------ceehhhh----------hhchhHHHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEE
Q 002953 466 LAGKGALSEHDDFP--------QVLKKAD----------MIRKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 466 vLGkG~FG~V~~~~--------kvlKK~~----------i~~k~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~lyL 526 (863)
.||+|+||.|+.+. .++|... .........+.+|+.++.+ ++||||+++++++...+..|+
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 79999999985432 2223211 1223345567889998875 799999999999999999999
Q ss_pred EEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 527 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
||||++|++|.+++.. ...+++..+..++.|++.||.|||. .||+|+||||+|||++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 166 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccc
Confidence 9999999999988743 3468999999999999999999996 7899999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
. .......|+..|+|||++.+..++.++|+||||+++|+|++|.+||.
T Consensus 167 ~--------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 167 E--------------------------------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred c--------------------------------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 0 01224568999999999998889999999999999999999999998
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+.......+...... +.....++.++.++|.+||..||.+|| ++.++..+
T Consensus 215 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~~ 266 (269)
T cd08528 215 STNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSAM 266 (269)
T ss_pred ccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCC---CHHHHHHH
Confidence 88777766666554432 222336789999999999999999999 88887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=279.87 Aligned_cols=246 Identities=31% Similarity=0.510 Sum_probs=202.9
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhch--hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIRK--NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k--~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.+..||+|.||+|..+. +++|...+... ..-...++|+-+|+.++|.|||++++....++.+-+|+|||..
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 35589999999996653 45555444332 2335789999999999999999999999999999999999965
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|..+.... |.++.+.++.++.|++.||.++|+++++||||||.|+||+.+|.+||+|||+|+.+..+
T Consensus 86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip---------- 154 (292)
T KOG0662|consen 86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP---------- 154 (292)
T ss_pred -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc----------
Confidence 999888764 77999999999999999999999999999999999999999999999999999853211
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
-+....-+-|.+|++|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..+.+.
T Consensus 155 ---------------------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk 213 (292)
T KOG0662|consen 155 ---------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_pred ---------------------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH
Confidence 0122235789999999999985 47999999999999999986 889999999888888
Q ss_pred HHhhc-----CCCCCC------------CC---------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 691 NILNR-----KIPWPR------------VP---------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 691 kIl~~-----~~~~p~------------~p---------~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+|... +..||. ++ ..++...++|++++|.-+|..|+ +|++.++||||.+.
T Consensus 214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri---saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI---SAEAALQHPYFSDF 289 (292)
T ss_pred HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc---CHHHHhcCcccccc
Confidence 88652 122221 11 23456688999999999999999 99999999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=302.07 Aligned_cols=240 Identities=29% Similarity=0.497 Sum_probs=189.3
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCC--C----CeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRN--P----FVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H--P----nIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+||+|.||.|-.+. .+..|....-....+..+-|+++|.++.+ | -+|++.++|...++.|||+|.+ |
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G 174 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-G 174 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-C
Confidence 89999999984331 22223222334555678889999999942 3 3888889999999999999999 6
Q ss_pred CChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC--------------------CCcEEEe
Q 002953 534 GDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--------------------DGHIKLT 591 (863)
Q Consensus 534 GsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~--------------------~g~VKLi 591 (863)
-+++++|.+++ +|+...++.+++|++.++++||+.+++|-||||+|||+.+ +-.|+|+
T Consensus 175 ~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vI 254 (415)
T KOG0671|consen 175 LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVI 254 (415)
T ss_pred hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEE
Confidence 79999998764 6899999999999999999999999999999999999842 2358999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHH
Q 002953 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671 (863)
Q Consensus 592 DFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILy 671 (863)
|||.|++. .....+.+.|..|+|||++++-+++.++||||+||||+
T Consensus 255 DFGsAtf~----------------------------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 255 DFGSATFD----------------------------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred ecCCccee----------------------------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 99998841 11224678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHH---HHHHHhh------------------cCCCCCCCC----------------------CCCCH
Q 002953 672 ELIVGIPPFNAEHPQQ---IFDNILN------------------RKIPWPRVP----------------------EEMSP 708 (863)
Q Consensus 672 ELLTGk~PF~~~~~~e---l~~kIl~------------------~~~~~p~~p----------------------~~iS~ 708 (863)
|+++|...|+..+..+ +++.|+. +...|+... +..-.
T Consensus 301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 9999999998765444 4444432 112222110 01124
Q ss_pred HHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 709 el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++.|||++||..||.+|+ |+.|+|.||||+..
T Consensus 381 ~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred HHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 588999999999999999 99999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=295.60 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=194.1
Q ss_pred cceEE-Eeecccceeecccc-----------ceehhhhhhch--hHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-----------QVLKKADMIRK--NAVESILAERDILISVRNPFVVRFFYSFTC-RENLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~~k--~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~ly 525 (863)
.|+.. .||+|.||.|+.+. .++||.+-.+. .......+|+.+++.|+||||+.|..+|.. +..+|
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 34444 79999999998762 24444333221 223467899999999999999999998887 78899
Q ss_pred EEEeecCCCChHHHHHhc-----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC----CcEEEeecCCc
Q 002953 526 LVMEYLNGGDLYSLLRNL-----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLS 596 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~----g~VKLiDFGLA 596 (863)
|++||.+. +|...|+-. ..++...++.++.||+.|+.|||++-|+||||||.||||..+ |.|||+|||+|
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99999977 999998643 358999999999999999999999999999999999999887 89999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHh
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLT 675 (863)
+.+-.. . .........+-|.+|+|||+++|. .|+.+.|+||+|||+.||++
T Consensus 184 R~~~~p--------l--------------------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 184 RLFNNP--------L--------------------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred HHhhcc--------c--------------------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 963110 0 001122346889999999999984 57999999999999999999
Q ss_pred CCCCCCCCC---------hHHHHHHHhhc-----CCCCCC---CC--------------------------CCCCHHHHH
Q 002953 676 GIPPFNAEH---------PQQIFDNILNR-----KIPWPR---VP--------------------------EEMSPEAHD 712 (863)
Q Consensus 676 Gk~PF~~~~---------~~el~~kIl~~-----~~~~p~---~p--------------------------~~iS~el~d 712 (863)
-.+.|.+.. ....+.+|++- ...||. +| ..-++.+.+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 999886532 12334444431 111221 01 113456899
Q ss_pred HHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 713 LI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
|+.+||+.||.+|+ |++++|+|+||..-
T Consensus 316 LL~klL~yDP~kRI---ta~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRI---TAEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhc---cHHHHhcccccccC
Confidence 99999999999999 99999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=332.31 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=192.6
Q ss_pred EEeecccceeeccc-------cceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----------------
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTC---------------- 520 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d---------------- 520 (863)
.+||+||||.|+.+ .+++||+.+.. ......+.+|+.+|++|+|||||++|..+..
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 39999999998655 47888877664 3344678999999999999999999865521
Q ss_pred --------------------------------------------------------------------------------
Q 002953 521 -------------------------------------------------------------------------------- 520 (863)
Q Consensus 521 -------------------------------------------------------------------------------- 520 (863)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeEEEEEeecCCCChHHHHHhcCCC-ChhhHHHHHHHHHHHHHHHHhCCccccCCC
Q 002953 521 ---------------R--------ENLYLVMEYLNGGDLYSLLRNLGCL-DEDVARVYIAEVVLALEYLHSLRVVHRDLK 576 (863)
Q Consensus 521 ---------------~--------~~lyLVmEy~~GGsL~dlLk~~g~L-~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLK 576 (863)
+ ..+||-||||+.-.|.+++..+... ....+..+++||+.||.|+|++||||||||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLK 724 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLK 724 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCC
Confidence 0 1378999999987777777664443 478889999999999999999999999999
Q ss_pred CcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC
Q 002953 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656 (863)
Q Consensus 577 PeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 656 (863)
|.||+++.++.|||+|||+|+.............. ..+...| .......+.+||.-|+|||++.+..
T Consensus 725 P~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~-~~~~~~g------------~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 725 PRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLS-FSTNRAG------------SNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred cceeEEcCCCCeeecccccchhhhhhhhhHhhccC-ccccccC------------CCCcccccccceeeeecHHHhcccc
Confidence 99999999999999999999852110000000000 0000000 0111335679999999999998755
Q ss_pred ---CCccceeechhHHHHHHHhCCCCCCCC-ChHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 657 ---HGTTADWWSVGIILFELIVGIPPFNAE-HPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 657 ---ys~ksDIWSLGvILyELLTGk~PF~~~-~~~el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
|+.|+|+||||+|++||+. ||... ....++.++..+..+.+ .+...--+.-..+|++||+.||.+|| ||
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP---tA 865 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP---TA 865 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC---CH
Confidence 9999999999999999985 57543 34455666655555443 11233345677899999999999999 99
Q ss_pred HHHHcCCCCC
Q 002953 732 SEVKQHVFFK 741 (863)
Q Consensus 732 eEILqHPFFk 741 (863)
.|+|++.||-
T Consensus 866 ~eLL~s~llp 875 (1351)
T KOG1035|consen 866 TELLNSELLP 875 (1351)
T ss_pred HHHhhccCCC
Confidence 9999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=302.36 Aligned_cols=237 Identities=28% Similarity=0.373 Sum_probs=180.1
Q ss_pred EEeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-~lyLVmEy~~GGsL~ 537 (863)
.+||+|+||.||.. ..++|+...........|.+|+.+|.+++|||+|+|++++.+.+ ..+||+|||++|+|.
T Consensus 81 ~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~ 160 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLE 160 (361)
T ss_pred cceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHH
Confidence 49999999999743 23455333322220445999999999999999999999999998 599999999999999
Q ss_pred HHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCC---ccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 538 SLLRNLG--CLDEDVARVYIAEVVLALEYLHSLR---VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 538 dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~G---IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
++|.... .+++.....|+.+++.||+|||... ||||||||.|||+|.+.+.||+|||+|+.....
T Consensus 161 d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~---------- 230 (361)
T KOG1187|consen 161 DHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG---------- 230 (361)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc----------
Confidence 9997754 8999999999999999999999754 999999999999999999999999999742110
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccc-cCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC------h
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSA-VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH------P 685 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~-vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~------~ 685 (863)
.....+. .||..|+|||.+.....+.++||||||++|.||++|+.|..... .
T Consensus 231 ---------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 231 ---------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred ---------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 0001112 79999999999998889999999999999999999998876432 1
Q ss_pred HHHHHHHhhcC-C---CCCCCC-CCCC--HH---HHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 686 QQIFDNILNRK-I---PWPRVP-EEMS--PE---AHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 686 ~el~~kIl~~~-~---~~p~~p-~~iS--~e---l~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
.+.....+... . --|.+. ...+ .+ +..+..+|++.+|.+|| +..++.
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP---~m~~Vv 346 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERP---TMSQVV 346 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCc---CHHHHH
Confidence 12111222211 0 011222 2223 22 55677899999999999 666653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=270.07 Aligned_cols=213 Identities=48% Similarity=0.843 Sum_probs=184.5
Q ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccc
Q 002953 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 572 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIH 572 (863)
.+.+.+|+.++++++|+||+++++++......+++|||+.+++|..++.....++...+..++.+++.+|.|||+.||+|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 67889999999999999999999999999999999999999999999987666899999999999999999999999999
Q ss_pred cCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh
Q 002953 573 RDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652 (863)
Q Consensus 573 RDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL 652 (863)
+||+|.||+++.++.++|+|||++...... .......|+..|+|||.+
T Consensus 111 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 111 RDLKPENILLDEDGHVKLADFGLARQLDPG--------------------------------GLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred CCcCHHHeEECCCCcEEEccccceeeeccc--------------------------------cccccccCCcCCCCHHHH
Confidence 999999999999999999999998742100 022345788999999999
Q ss_pred cCCCCCccceeechhHHHHHHHhCCCCCCC-CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 653 LGTGHGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 653 ~g~~ys~ksDIWSLGvILyELLTGk~PF~~-~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
.+..++.++|+||||+++|+|++|..||.. .+.......+.............++.++.+++.+||..+|.+|| ++
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~ 235 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TA 235 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc---CH
Confidence 988899999999999999999999999987 55555655555444433222222889999999999999999999 99
Q ss_pred HHHHcCCCC
Q 002953 732 SEVKQHVFF 740 (863)
Q Consensus 732 eEILqHPFF 740 (863)
.++++||||
T Consensus 236 ~~~~~~~~~ 244 (244)
T smart00220 236 EEALQHPFF 244 (244)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=317.48 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=210.1
Q ss_pred CCCcccceEEEeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-----Ce
Q 002953 456 TPRTSQIDLLLAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCR-----EN 523 (863)
Q Consensus 456 ~~~~~~~~l~vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~-----~~ 523 (863)
++.....-.++||+|.+|.|+.+. .++.|+........+.+..|.+||+.+ +|||++.+|++|.-. +.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 333333344599999999986652 344444555556667788999999887 699999999988753 46
Q ss_pred EEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 524 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
+|||||||.||+..+++++. .++.|+.+..|+++++.||.+||++.+||||||-.|||++.++.|||+|||.+....
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld- 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD- 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee-
Confidence 99999999999999999865 568999999999999999999999999999999999999999999999999987411
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-----CCCccceeechhHHHHHHHhC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~ksDIWSLGvILyELLTG 676 (863)
....+.++.+|||.|||||++... .|+.++|+||||++..||.-|
T Consensus 175 ------------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 175 ------------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred ------------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 112456789999999999999753 378899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+|+.+..+...+-.|-....+-..-|..++.++.+||..||.+|.++|| +..++|+|||.+.
T Consensus 225 ~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 225 APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---STEELLKHPFITE 287 (953)
T ss_pred CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc---chhhhccCCcccc
Confidence 99999998887766665444333334678999999999999999999999 9999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-33 Score=316.18 Aligned_cols=265 Identities=39% Similarity=0.702 Sum_probs=232.1
Q ss_pred Eeecccceeeccc-------------cceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGKGALSEHDDF-------------PQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~-------------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
++|.|+||.|..+ .++++|.....+... +...|..++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 4789999987433 245555555544444 7788999999997 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
.||+|...+.+...+.+...+++..+++.+++++|+.||+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---------- 149 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----------
Confidence 9999999999988999999999999999999999999999999999999999999999999999985211
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.. ..|||..|||||++. ++..++||||+|+++|||++|..||.. ++...
T Consensus 150 ----------------------~~---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~ 198 (612)
T KOG0603|consen 150 ----------------------EK---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR 198 (612)
T ss_pred ----------------------hh---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH
Confidence 01 129999999999998 688999999999999999999999988 77778
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALDTSY 767 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDts~ 767 (863)
|...+..+ |..++..+++++..++.++|.+|++. ..+.++++|+||..++|..+..+ .+||.|....+.|+.+
T Consensus 199 Il~~~~~~---p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~ 275 (612)
T KOG0603|consen 199 ILKAELEM---PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQ 275 (612)
T ss_pred HhhhccCC---chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhh
Confidence 87766644 56799999999999999999999998 48999999999999999988765 5899999999999999
Q ss_pred cccccccC
Q 002953 768 FTSRYSWN 775 (863)
Q Consensus 768 F~s~~s~~ 775 (863)
|+..|+..
T Consensus 276 fd~eft~~ 283 (612)
T KOG0603|consen 276 FDPEFTSQ 283 (612)
T ss_pred cCchhccC
Confidence 99877533
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=287.04 Aligned_cols=250 Identities=30% Similarity=0.448 Sum_probs=197.5
Q ss_pred ceEEEeecccceeecccc------c-eehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--------CeE
Q 002953 462 IDLLLAGKGALSEHDDFP------Q-VLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCR--------ENL 524 (863)
Q Consensus 462 ~~l~vLGkG~FG~V~~~~------k-vlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--------~~l 524 (863)
.++.+||+|.||+|+.+. + +++|..+.. ...-...++|+++|..|+|+|++.+++.+... ..+
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 344589999999986542 3 444443322 22235678999999999999999988665432 348
Q ss_pred EEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
||||.+|+. +|..+|.+. -+|+..+++.++.+++.||.|+|+..|+|||+||.|+||+.+|.+||+|||+++.+....
T Consensus 100 ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSK 178 (376)
T ss_pred eeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence 999999976 999999876 579999999999999999999999999999999999999999999999999998532211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
. .. ..+....+-|.+|++||.++| ..|+++.|||+.|||+.||.+|.+-|.+
T Consensus 179 n--~~-------------------------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 179 N--VV-------------------------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred c--cC-------------------------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 0 00 112345678999999999998 5689999999999999999999999999
Q ss_pred CChHHHHHHHhh--c---CCCCCC--------------CCC-------------CCCHHHHHHHHhhccCCcCCcCCCCC
Q 002953 683 EHPQQIFDNILN--R---KIPWPR--------------VPE-------------EMSPEAHDLIDRFLTEDPHQRLGSGG 730 (863)
Q Consensus 683 ~~~~el~~kIl~--~---~~~~p~--------------~p~-------------~iS~el~dLI~k~L~~DP~kRpg~~S 730 (863)
.+..+.+..|.. + +..||. ++. .-.+++.+|+.+||..||.+|+ +
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~---~ 308 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI---D 308 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc---c
Confidence 988877766643 1 112221 111 1245889999999999999999 9
Q ss_pred HHHHHcCCCCCC
Q 002953 731 ASEVKQHVFFKD 742 (863)
Q Consensus 731 AeEILqHPFFk~ 742 (863)
++++++|.||..
T Consensus 309 ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 ADQALNHDFFWK 320 (376)
T ss_pred hHhhhchhhhhc
Confidence 999999999964
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=308.46 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=164.1
Q ss_pred cccceEE-Eeecccceeecccc-----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEE------EEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYS------FTC 520 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~------f~d 520 (863)
...|.+. .||+|+||.||.+. +++|+.. .....+....| .+....+.+++.++.. ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~--~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEec--ccchhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 3445554 89999999997642 2333321 11111212222 1122222333322222 234
Q ss_pred CCeEEEEEeecCCCChHHHHHhcCC--------------------CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcce
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLGC--------------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g~--------------------L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNI 580 (863)
...+||||||+.+++|.+++..... .....+..++.||+.||+|||++||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 5679999999999999999875321 12334668999999999999999999999999999
Q ss_pred eecC-CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC---
Q 002953 581 LIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--- 656 (863)
Q Consensus 581 LLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--- 656 (863)
|++. ++.+||+|||+|+..... ........+||+.|||||.+....
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~------------------------------~~~~~~~~~~t~~Y~APE~~~~~~~~~ 336 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVG------------------------------INYIPKEFLLDPRYAAPEQYIMSTQTP 336 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccc------------------------------cccCCcccccCCCccChHHhhccCCCC
Confidence 9986 589999999999741100 001123468999999999764322
Q ss_pred -------------------CCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh-cCCCC------------CC---
Q 002953 657 -------------------HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-RKIPW------------PR--- 701 (863)
Q Consensus 657 -------------------ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~-~~~~~------------p~--- 701 (863)
++.++|||||||+||||+++..|+.. ....+..++. ....+ +.
T Consensus 337 ~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 414 (566)
T PLN03225 337 SAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR 414 (566)
T ss_pred CCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhh
Confidence 34567999999999999997766532 2222222211 11100 00
Q ss_pred ---CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 702 ---VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 702 ---~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
........+.+||.+||++||.+|| |+.++|+||||.+..+..+
T Consensus 415 ~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 415 GFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred hhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 0111234566999999999999999 9999999999999877543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.42 Aligned_cols=229 Identities=28% Similarity=0.472 Sum_probs=184.1
Q ss_pred eccccceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEEEeecCCCChHHHHHhcCCC
Q 002953 475 HDDFPQVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLVMEYLNGGDLYSLLRNLGCL 546 (863)
Q Consensus 475 V~~~~kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLVmEy~~GGsL~dlLk~~g~L 546 (863)
|....+++||...- .....++..+|..++..++|+||++++.+|.-.. .+|+|||||.. +|...+. -.+
T Consensus 39 v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~--~el 115 (369)
T KOG0665|consen 39 VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL--MEL 115 (369)
T ss_pred hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH--Hhc
Confidence 34444555554332 2334467889999999999999999999997654 47999999965 9999887 357
Q ss_pred ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccch
Q 002953 547 DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLT 626 (863)
Q Consensus 547 ~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~ 626 (863)
+-..+..++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus 116 DH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~------------------------- 170 (369)
T KOG0665|consen 116 DHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT------------------------- 170 (369)
T ss_pred chHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc-------------------------
Confidence 8889999999999999999999999999999999999999999999999983100
Q ss_pred hhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC----------
Q 002953 627 ASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK---------- 696 (863)
Q Consensus 627 ~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~---------- 696 (863)
.-.....+.|..|.|||++.+.+|...+||||+||++.||++|...|.+.+..+.+.++...-
T Consensus 171 -------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 171 -------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred -------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 012345789999999999999999999999999999999999999999877666555554310
Q ss_pred -----------------CC----CCC--C------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 697 -----------------IP----WPR--V------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 697 -----------------~~----~p~--~------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.. +|. + +..-+..+++|+.+||..||++|. +++++|+||||+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri---sv~daL~HPY~~ 314 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI---SVDDALRHPYIK 314 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc---cHHHHhcCCeee
Confidence 00 110 0 011235689999999999999999 999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=294.87 Aligned_cols=230 Identities=24% Similarity=0.393 Sum_probs=192.0
Q ss_pred Eeecccceeeccccc-----------eehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFPQ-----------VLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~k-----------vlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+||.|-||.||...+ ++|.-+. ......+.|+.|.-+|++++|||||+|++++.+ ...|||||+++.
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~ 474 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPL 474 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccc
Confidence 799999999865432 2222111 344567899999999999999999999998764 478999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.|..||+.. ..++......|+.||+.||.|||+..+|||||-..|||+.....|||+|||+++......
T Consensus 475 GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~--------- 545 (974)
T KOG4257|consen 475 GELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA--------- 545 (974)
T ss_pred hhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc---------
Confidence 9999999875 469999999999999999999999999999999999999999999999999999632110
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
..+.....-...|||||.+.-..++.++|||-|||.|||++. |..||.+-...+++..
T Consensus 546 ---------------------yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 546 ---------------------YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred ---------------------hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 111122334568999999999999999999999999999886 9999998877777777
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
|-++.. +..|+.+|+.+..|+.+||+.+|.+||..
T Consensus 605 iEnGeR--lP~P~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 605 IENGER--LPCPPNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred ecCCCC--CCCCCCCChHHHHHHHHHhccCcccCCcH
Confidence 766553 34578999999999999999999999954
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=302.64 Aligned_cols=228 Identities=30% Similarity=0.403 Sum_probs=175.9
Q ss_pred Eeecccceeecccc-------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEEEeec
Q 002953 466 LAGKGALSEHDDFP-------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLVmEy~ 531 (863)
.||+||||.|+... .++|... .......+...+|+++|++|+|||||+++++-++.. ...+|||||
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 89999999996543 2333222 123456778899999999999999999998876654 357999999
Q ss_pred CCCChHHHHHhc---CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC--C--cEEEeecCCccccccCCC
Q 002953 532 NGGDLYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--G--HIKLTDFGLSKVGLINST 604 (863)
Q Consensus 532 ~GGsL~dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~--g--~VKLiDFGLAk~~~~~s~ 604 (863)
.||+|+.+|++. ..+++.+++.++..++.||.|||++|||||||||+||++... | ..||+|||.|+...
T Consensus 100 ~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~---- 175 (732)
T KOG4250|consen 100 SGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD---- 175 (732)
T ss_pred CCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC----
Confidence 999999999753 469999999999999999999999999999999999998543 3 47999999998421
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
+.....+++||+.|++||++.. ..|+..+|.|||||++|+++||..||...
T Consensus 176 ----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 176 ----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 1124567899999999999995 78899999999999999999999999432
Q ss_pred C----hHHHHHHHhhcC---------------CC----CCCCCCCCCHH----HHHHHHhhccCCcCCcC
Q 002953 684 H----PQQIFDNILNRK---------------IP----WPRVPEEMSPE----AHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 684 ~----~~el~~kIl~~~---------------~~----~p~~p~~iS~e----l~dLI~k~L~~DP~kRp 726 (863)
. ..++...+...+ .. +| +|..++.. +-..+..+|..+|.+|.
T Consensus 228 ~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 228 GGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCccccchhhhhhhccCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 222333333211 11 12 13334433 44677888999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=294.30 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=175.8
Q ss_pred cccceEE-Eeecccceeecccc-----------------------ceehhhhhhchhH--------------HHHHHHHH
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----------------------QVLKKADMIRKNA--------------VESILAER 500 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----------------------kvlKK~~i~~k~~--------------~e~~l~Ei 500 (863)
...|++. +||+|+||.|+... +++|+........ .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 3345554 89999999997431 3444433222211 12334577
Q ss_pred HHHHhcCCCCe-----eEEEEEEEe--------CCeEEEEEeecCCCChHHHHHhcC-----------------------
Q 002953 501 DILISVRNPFV-----VRFFYSFTC--------RENLYLVMEYLNGGDLYSLLRNLG----------------------- 544 (863)
Q Consensus 501 ~IL~~L~HPnI-----VkL~~~f~d--------~~~lyLVmEy~~GGsL~dlLk~~g----------------------- 544 (863)
.++.+++|.++ ++++++|.. ++..||||||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876544 666666643 356899999999999999886421
Q ss_pred -CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCc
Q 002953 545 -CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623 (863)
Q Consensus 545 -~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~ 623 (863)
.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...... .
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~------------------- 363 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-I------------------- 363 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-C-------------------
Confidence 2345678889999999999999999999999999999999999999999998631100 0
Q ss_pred cchhhhhhhhhhccccccCCCCCCChhhhcCCC--------------------C--CccceeechhHHHHHHHhCCC-CC
Q 002953 624 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--------------------H--GTTADWWSVGIILFELIVGIP-PF 680 (863)
Q Consensus 624 ~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--------------------y--s~ksDIWSLGvILyELLTGk~-PF 680 (863)
........+|+.|+|||++.... | ..+.||||+||++|+|++|.+ ||
T Consensus 364 ----------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 364 ----------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ----------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 00111234589999999986432 1 234799999999999999976 77
Q ss_pred CCCCh-----------HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCc---CCcCCCCCHHHHHcCCCCCC
Q 002953 681 NAEHP-----------QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP---HQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 681 ~~~~~-----------~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP---~kRpg~~SAeEILqHPFFk~ 742 (863)
..... ...++.+......++ ....+++.+++|+.+||.++| .+|+ |+.|+|+||||..
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~Rl---Sa~eaL~Hp~f~~ 505 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRL---SVGQALSHRFFLP 505 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCcc-cccccChHHHHHHHHHhccCCCCcccCC---CHHHHhCCCCcCC
Confidence 53211 111222222333343 245678999999999999876 6899 9999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=302.24 Aligned_cols=240 Identities=29% Similarity=0.407 Sum_probs=187.7
Q ss_pred Eeecccceee-----ccccceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEH-----DDFPQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V-----~~~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
++|.|+-|++ ++-+-|..|. .-......+.+|+..|..- +|||||++|+.-++...+||++|+|.. +|.++
T Consensus 516 ilG~Gs~Gt~Vf~G~ye~R~VAVKr--ll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dl 592 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVYEGREVAVKR--LLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDL 592 (903)
T ss_pred HcccCCCCcEEEEEeeCCceehHHH--HhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHH
Confidence 7899998875 3322222222 1223445578999999988 599999999999999999999999976 99999
Q ss_pred HHhcCC----CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---C--CcEEEeecCCccccccCCCCCCCCC
Q 002953 540 LRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---D--GHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 540 Lk~~g~----L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~--g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+...+. ......+..+.|++.||++||+.+||||||||.||||.. + ..++|+|||+|+......
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~------- 665 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK------- 665 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc-------
Confidence 987411 112455788999999999999999999999999999986 3 468999999998531110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC-CCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG-k~PF~~~~~~el~ 689 (863)
....+..+..||-.|+|||++.....+.++|||||||++|+.++| ..||...... -
T Consensus 666 ---------------------sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~ 722 (903)
T KOG1027|consen 666 ---------------------SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--Q 722 (903)
T ss_pred ---------------------chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--h
Confidence 112235567899999999999998889999999999999999985 9999665433 3
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.+|+.+....-.+......++.+||.+||..+|..|| +|.++|.||||-
T Consensus 723 ~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlFW 771 (903)
T KOG1027|consen 723 ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRP---SATDVLNHPLFW 771 (903)
T ss_pred hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCC---CHHHHhCCCccC
Confidence 4677776655444333333999999999999999999 999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=293.68 Aligned_cols=240 Identities=31% Similarity=0.481 Sum_probs=191.2
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCC------CCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRN------PFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H------PnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..|+|-|++|..+. -|..|+.-...-..+.=+.|++||++|+. -|+++|+..|...+++|||+|.+ .
T Consensus 439 ~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-s 517 (752)
T KOG0670|consen 439 YTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-S 517 (752)
T ss_pred ccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-h
Confidence 68999999984432 12222222233334556789999999952 48999999999999999999998 4
Q ss_pred CChHHHHHhcCC---CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCCCCC
Q 002953 534 GDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 534 GsL~dlLk~~g~---L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
-+|.++|++.|. |....++.|+.|+..||..|-..||+|.||||+||||+.. ..+||||||.|.....+
T Consensus 518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en------- 590 (752)
T KOG0670|consen 518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN------- 590 (752)
T ss_pred chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc-------
Confidence 599999998864 8889999999999999999999999999999999999976 57899999998742111
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
+++ .+.-+..|.|||+++|.+|++..|+||+||+||||+||+..|.+.+..+++
T Consensus 591 --------------eit------------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 591 --------------EIT------------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred --------------ccc------------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 111 234566899999999999999999999999999999999999998888877
Q ss_pred HHHhhcCCCCCC------------------------------------------------------CCCC---CCHHHHH
Q 002953 690 DNILNRKIPWPR------------------------------------------------------VPEE---MSPEAHD 712 (863)
Q Consensus 690 ~kIl~~~~~~p~------------------------------------------------------~p~~---iS~el~d 712 (863)
.-.+..+..+|. ++.+ +-..+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 666543322221 1111 1246889
Q ss_pred HHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 713 LI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
||.+||..||++|+ ++.++|+||||..
T Consensus 725 LLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 725 LLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred HHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 99999999999999 9999999999974
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=278.29 Aligned_cols=245 Identities=24% Similarity=0.409 Sum_probs=194.4
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
++..||.|+||+|++.. -++|+..... .....+++.|.+...+ -+.||||++|+..-.++..|+.||+|+-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 34489999999996542 3445544333 3556678888887654 4689999999999899999999999954
Q ss_pred CChHHHHH-----hcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 534 GDLYSLLR-----NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 534 GsL~dlLk-----~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+|..+.+ ....++|..+-.|..-.+.||.||-. +.|||||+||+|||++..|.|||||||++-.+..
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~------ 220 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD------ 220 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH------
Confidence 7765543 23579999999999999999999995 6899999999999999999999999999863210
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCC-
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEH- 684 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~- 684 (863)
.-....-.|-..|||||.+.. .+|+.++|+||||++|||+.||..||..-+
T Consensus 221 --------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 221 --------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred --------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 111223468889999999964 568999999999999999999999997654
Q ss_pred hHHHHHHHhhcCCCCCCCCC---CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPE---EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~---~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+.+..++.+..+....+. ..+..+..+|.-||.+|-.+|| ...+++++||++..
T Consensus 275 vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 275 VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chhhhhcCchhhhh
Confidence 44555566666654433333 3899999999999999999999 99999999999854
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=286.99 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=193.8
Q ss_pred Eeecccceeeccc------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDF------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
.||+|-||+|..+ .+++|+.+-. .++....|..|+++|.+|+|||||++++++..++.+++||||+++|+|.+
T Consensus 545 kiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnq 624 (807)
T KOG1094|consen 545 KIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQ 624 (807)
T ss_pred hhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHH
Confidence 8999999998544 2344444333 34455789999999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++.+. ..+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.......
T Consensus 625 Fl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y------------ 692 (807)
T KOG1094|consen 625 FLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY------------ 692 (807)
T ss_pred HHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc------------
Confidence 99876 2345566677999999999999999999999999999999999999999999984211000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh--CCCCCCCCChHHHHHHHhh
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV--GIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT--Gk~PF~~~~~~el~~kIl~ 694 (863)
.+.....+-...|||||.+....++.++|+|+||+++||+++ ...||.....++..++.-.
T Consensus 693 -----------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~ 755 (807)
T KOG1094|consen 693 -----------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE 755 (807)
T ss_pred -----------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence 011123566789999999999999999999999999999775 7889988877776665432
Q ss_pred -----cCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 695 -----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 695 -----~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+....+..|.-++..+.+|+-+||..+-.+|| +.+++-.
T Consensus 756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh~ 799 (807)
T KOG1094|consen 756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLHL 799 (807)
T ss_pred hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHHH
Confidence 11223445678999999999999999999999 7877643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=287.03 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=196.8
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||.|-||+||.-. -+..|....+.-.++.|+.|+.+|+.++|||+|+|++++..+..+|||+|||..|+|.+|
T Consensus 274 KLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdY 353 (1157)
T KOG4278|consen 274 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDY 353 (1157)
T ss_pred ccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHH
Confidence 89999999996542 122222223445678899999999999999999999999999999999999999999999
Q ss_pred HHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 540 LRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 540 Lk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
|+++.+ ++.-.+..++.||..|++||..+++|||||-..|+||..+..||++||||+++... .+
T Consensus 354 LRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-------------DT- 419 (1157)
T KOG4278|consen 354 LRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-------------DT- 419 (1157)
T ss_pred HHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC-------------Cc-
Confidence 998754 77778888899999999999999999999999999999999999999999995210 00
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
++ .....--...|.|||-+....++.++|||+|||+|||+.| |-.||.+.+..++|.-+-++
T Consensus 420 -------YT---------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg- 482 (1157)
T KOG4278|consen 420 -------YT---------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG- 482 (1157)
T ss_pred -------ee---------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-
Confidence 00 0111223567999999999999999999999999999987 99999999988888765443
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
+.+ .-|.++++.+..|++.||++.|.+||++..+.+.++.-|
T Consensus 483 yRM-~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 483 YRM-DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccc-cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 333 347899999999999999999999995444444444443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=263.71 Aligned_cols=240 Identities=29% Similarity=0.500 Sum_probs=187.4
Q ss_pred Eeecccceeeccccceehh----hhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC--eEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFPQVLKK----ADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~kvlKK----~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~--~lyLVmEy~~GGsL~d 538 (863)
.+|+|.|++|.....+..+ .++.++-..+.+.+|+.||..|. ||||++|++...+.. ...||+||+++.+...
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ 124 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQ 124 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHH
Confidence 7999999998665322111 11233444556889999999997 999999999998765 4789999999877776
Q ss_pred HHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+.. .|+...++.|+.|++.||.|+|++||+|||+||.|++|+.. ..++|+|+|+|.+.-.
T Consensus 125 ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp---------------- 185 (338)
T KOG0668|consen 125 LYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---------------- 185 (338)
T ss_pred Hhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC----------------
Confidence 654 58889999999999999999999999999999999999976 5799999999985211
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCC-CCCChHHHHHHHhh-
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILN- 694 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF-~~~~~~el~~kIl~- 694 (863)
+...+..+.+..|-.||++.. +.|+.+-|+|||||++..|+..+-|| .+.+..+.+.+|..
T Consensus 186 ----------------~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 186 ----------------GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred ----------------CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 123445678889999999976 56899999999999999999998887 44444444334332
Q ss_pred ----------------------------cCCCCCCCC-----CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 695 ----------------------------RKIPWPRVP-----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 695 ----------------------------~~~~~p~~p-----~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
...+|..+. .-.++++.||+.++|..|..+|+ ||.|++.||||.
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl---TakEam~HpyF~ 326 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL---TAKEAMAHPYFA 326 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc---chHHHhcCchHH
Confidence 011121111 12579999999999999999999 999999999997
Q ss_pred CC
Q 002953 742 DI 743 (863)
Q Consensus 742 ~I 743 (863)
.+
T Consensus 327 ~~ 328 (338)
T KOG0668|consen 327 PV 328 (338)
T ss_pred HH
Confidence 64
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=272.90 Aligned_cols=245 Identities=29% Similarity=0.468 Sum_probs=197.7
Q ss_pred Eeecccceeeccc-------cceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEEEEEeec
Q 002953 466 LAGKGALSEHDDF-------PQVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~-------~kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~lyLVmEy~ 531 (863)
-||-|+||.|+.+ ..++||....- -...+.+.+|+++|..++|.||+..++..+-.. .+|+|+|+|
T Consensus 60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 6899999999744 34555544332 234568899999999999999999998887654 479999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
.. +|...|-....++.+.++-+++||+.||.|||+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 140 QS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~---------- 208 (449)
T KOG0664|consen 140 QS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ---------- 208 (449)
T ss_pred Hh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch----------
Confidence 65 9999998888899999999999999999999999999999999999999999999999999985110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.+......-+-|-+|+|||++.|. .|+.++||||+|||+.||+..+..|...++.+.++
T Consensus 209 --------------------d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~ 268 (449)
T KOG0664|consen 209 --------------------RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ 268 (449)
T ss_pred --------------------hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence 011112234678899999999985 58999999999999999999999999988887777
Q ss_pred HHhh-----------------------cCCCCCCC--------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 691 NILN-----------------------RKIPWPRV--------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 691 kIl~-----------------------~~~~~p~~--------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.|.. +....|.+ +..-..+..+++.+||..||.+|+ +.++.+.|+|
T Consensus 269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri---s~~~A~~~~~ 345 (449)
T KOG0664|consen 269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI---SVEEALQHRY 345 (449)
T ss_pred HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc---cHhhhccccc
Confidence 6653 11111211 123346788999999999999999 9999999999
Q ss_pred CCCCC
Q 002953 740 FKDIN 744 (863)
Q Consensus 740 Fk~Id 744 (863)
.....
T Consensus 346 ~~e~R 350 (449)
T KOG0664|consen 346 LEEGR 350 (449)
T ss_pred ccccc
Confidence 87654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=288.98 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=195.7
Q ss_pred Eeecccceeeccc----------cceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDF----------PQVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~----------~kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||.|.||.|... .+++|-....... ....|++|+.+|.+|+|||+++||++..+ ..+.||||++++|
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG 195 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence 8999999998432 2344444433333 66789999999999999999999999887 7789999999999
Q ss_pred ChHHHHHh--cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk~--~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
+|.+.|.+ ...|.......|+.||+.||.||..+++|||||-..|+|+.....|||+||||.+.+..+
T Consensus 196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n---------- 265 (1039)
T KOG0199|consen 196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN---------- 265 (1039)
T ss_pred hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC----------
Confidence 99999987 345888999999999999999999999999999999999999999999999998852111
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
+..+ ......--...|+|||.+....++.++|+|++||+||||++ |..||.+-...+++++
T Consensus 266 ---------ed~Y---------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 266 ---------EDMY---------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred ---------Ccce---------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 0000 01112234568999999999999999999999999999998 8999999999999999
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
|-.+. .++ -|..+++++.+++..||..+|++|| ++..|.
T Consensus 328 iD~~e-rLp-RPk~csedIY~imk~cWah~paDRp---tFsair 366 (1039)
T KOG0199|consen 328 IDAGE-RLP-RPKYCSEDIYQIMKNCWAHNPADRP---TFSAIR 366 (1039)
T ss_pred ccccc-cCC-CCCCChHHHHHHHHHhccCCccccc---cHHHHH
Confidence 87433 333 4788999999999999999999999 666554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-30 Score=301.80 Aligned_cols=267 Identities=46% Similarity=0.805 Sum_probs=212.1
Q ss_pred Ccccce-EEEeecccceeeccccceehhhhhhchhHH-HHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 458 RTSQID-LLLAGKGALSEHDDFPQVLKKADMIRKNAV-ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 458 ~~~~~~-l~vLGkG~FG~V~~~~kvlKK~~i~~k~~~-e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
....|+ ++++-.|+||.||.+.....+..+..+.+. ..+++- ||.....|++| |+
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccchhhhc--cccccCCccee---------------------ch
Confidence 344444 458999999999877422112121111111 111111 44455566666 67
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
-.++++..+.++.+. +.+++|||+.||+|||+||+|.||+.-|++|++|||+++.++......+
T Consensus 138 c~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl-------- 201 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL-------- 201 (1205)
T ss_pred hhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh--------
Confidence 778888777777654 7899999999999999999999999999999999999997644322111
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
..|. .. ...........||||.|+|||++..++|+..+|||++|+|+||++.|..||.++.+++++..++..
T Consensus 202 -~eg~-----I~--k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 202 -KEGH-----IE--KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred -hhcc-----hH--HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 0010 00 111223345679999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCCCCCCCCcccc
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s~lDts~F~s~ 771 (863)
...||+-...++++++++|.++|+.+|..|.+.+++-++++|+||..+||..|.+++..|+|.+....|++||+.+
T Consensus 274 ~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTR 349 (1205)
T KOG0606|consen 274 DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTR 349 (1205)
T ss_pred hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhccc
Confidence 9999988788999999999999999999999999999999999999999999999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=290.94 Aligned_cols=239 Identities=22% Similarity=0.319 Sum_probs=200.6
Q ss_pred Eeecccceeeccc----------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDF----------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~----------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+||.|-||+|+.- .+++|..+.- ..++...|+.|+.||.+++||||++|.++......+.||+|||++|
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENG 715 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENG 715 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCC
Confidence 8999999999442 2344443322 3456678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 535 DLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 535 sL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+|..+|+.. |.|+..++.-+++.|+.|++||-++|+|||||-..||||+.+-..|++|||++++.......
T Consensus 716 sLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~-------- 787 (996)
T KOG0196|consen 716 SLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-------- 787 (996)
T ss_pred cHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc--------
Confidence 999999875 77999999999999999999999999999999999999999999999999999963221100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH-hCCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL-TGk~PF~~~~~~el~~kI 692 (863)
...+..---...|.|||.+....++.++||||+|++|||.+ +|..||...+.++++..|
T Consensus 788 --------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI 847 (996)
T KOG0196|consen 788 --------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 847 (996)
T ss_pred --------------------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH
Confidence 00111112246899999999999999999999999999955 599999999999999988
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+- .+|. |-++|..+..|+..||++|-.+|| .+.+|..+
T Consensus 848 e~gy-RLPp-PmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~~ 887 (996)
T KOG0196|consen 848 EQGY-RLPP-PMDCPAALYQLMLDCWQKDRNRRP---KFAQIVST 887 (996)
T ss_pred Hhcc-CCCC-CCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHHH
Confidence 6654 4443 678999999999999999999999 88888764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=304.90 Aligned_cols=226 Identities=23% Similarity=0.303 Sum_probs=171.0
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
+||+|+||.||.+. +++|+..... .....|+++|++++|||||++++++.+.+..|+||||+++|+|.+
T Consensus 697 ~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 772 (968)
T PLN00113 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVN----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772 (968)
T ss_pred EEccCCCeeEEEEEECCCCcEEEEEEccCCc----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHH
Confidence 89999999997652 3444332211 122357889999999999999999999999999999999999999
Q ss_pred HHHhcCCCChhhHHHHHHHHHHHHHHHH---hCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 539 LLRNLGCLDEDVARVYIAEVVLALEYLH---SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 539 lLk~~g~L~e~~i~~Ia~QIl~ALeyLH---s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
+++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+...
T Consensus 773 ~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~---------------- 832 (968)
T PLN00113 773 VLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL---------------- 832 (968)
T ss_pred HHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc----------------
Confidence 9964 889999999999999999999 6799999999999999988887765 6654310
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-----HHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP-----QQIFD 690 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~-----~el~~ 690 (863)
.......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+..+
T Consensus 833 -------------------~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 893 (968)
T PLN00113 833 -------------------CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893 (968)
T ss_pred -------------------ccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence 001123689999999999999999999999999999999999999954211 11111
Q ss_pred HHhhcC-C---CCCCC------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRK-I---PWPRV------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~-~---~~p~~------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...... . .-+.. +.....++.+++.+||+.+|++|| ++.++++.
T Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~~ 947 (968)
T PLN00113 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CANDVLKT 947 (968)
T ss_pred HhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHHHHHH
Confidence 111000 0 00111 111223577899999999999999 88888764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=273.31 Aligned_cols=146 Identities=24% Similarity=0.292 Sum_probs=118.3
Q ss_pred CCCCcccCCCCCCCCCCccCCCcccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcC--
Q 002953 437 DQGMTTSSAGSMTPRSPLLTPRTSQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVR-- 507 (863)
Q Consensus 437 ~~~~s~ss~g~~~p~sp~~~~~~~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-- 507 (863)
.+....+..|+++|+.........+|-+. .||.|-|++|+.+- .|..|.........+..+.|+++|++++
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 34455677899999998888776666654 99999999996552 2333333334455678889999999983
Q ss_pred ---C---CCeeEEEEEEEeCC----eEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHh-CCccccC
Q 002953 508 ---N---PFVVRFFYSFTCRE----NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHS-LRVVHRD 574 (863)
Q Consensus 508 ---H---PnIVkL~~~f~d~~----~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRD 574 (863)
| .+||+|++.|...+ ++|||+|++ |.+|..+|+.. +.++...++.|++||+.||.|||+ .||||-|
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTD 213 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTD 213 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccC
Confidence 3 36999999998754 799999999 78999999765 569999999999999999999995 6999999
Q ss_pred CCCcceeec
Q 002953 575 LKPDNLLIA 583 (863)
Q Consensus 575 LKPeNILLd 583 (863)
|||+|||+.
T Consensus 214 lKPENvLl~ 222 (590)
T KOG1290|consen 214 LKPENVLLC 222 (590)
T ss_pred CCcceeeee
Confidence 999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=282.30 Aligned_cols=236 Identities=26% Similarity=0.436 Sum_probs=191.5
Q ss_pred Eeecccceeecccc--------------ceehhhh-hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 466 LAGKGALSEHDDFP--------------QVLKKAD-MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 466 vLGkG~FG~V~~~~--------------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.||.|+||+|.... +++|... .....+.+.+..|+++|..+ +||||+.+++++..++.+++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 89999999984331 2222211 22335678899999999998 59999999999999999999999
Q ss_pred ecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeec
Q 002953 530 YLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593 (863)
Q Consensus 530 y~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDF 593 (863)
|+..|+|..+|+..+ .++......++.||+.|++||++.++|||||-..|||+..+..+||+||
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDF 462 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADF 462 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccc
Confidence 999999999998765 3888899999999999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhcccccc--CCCCCCChhhhcCCCCCccceeechhHHHH
Q 002953 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV--GTPDYLAPEILLGTGHGTTADWWSVGIILF 671 (863)
Q Consensus 594 GLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~v--GTp~YmAPEvL~g~~ys~ksDIWSLGvILy 671 (863)
|+|+...... ........ -...|||||.+....|+.++||||+|++||
T Consensus 463 Glar~~~~~~------------------------------~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~ 512 (609)
T KOG0200|consen 463 GLARDHYNKD------------------------------YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW 512 (609)
T ss_pred cceeccCCCC------------------------------ceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence 9998411100 01111112 234699999999999999999999999999
Q ss_pred HHHh-CCCCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 672 ELIV-GIPPFNAEH-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 672 ELLT-Gk~PF~~~~-~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
||++ |..||.+-. ..+++..+..+.. ...|..++.++.++++.||..+|++|| +..++.+
T Consensus 513 EifsLG~~PYp~~~~~~~l~~~l~~G~r--~~~P~~c~~eiY~iM~~CW~~~p~~RP---~F~~~~~ 574 (609)
T KOG0200|consen 513 EIFTLGGTPYPGIPPTEELLEFLKEGNR--MEQPEHCSDEIYDLMKSCWNADPEDRP---TFSECVE 574 (609)
T ss_pred HHhhCCCCCCCCCCcHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhCCCcccCC---CHHHHHH
Confidence 9998 899998855 5666665655543 345788999999999999999999999 6666553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=296.15 Aligned_cols=229 Identities=17% Similarity=0.200 Sum_probs=155.4
Q ss_pred hcCC-CCeeEEEEEE-------EeCCeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCC
Q 002953 505 SVRN-PFVVRFFYSF-------TCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 575 (863)
Q Consensus 505 ~L~H-PnIVkL~~~f-------~d~~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDL 575 (863)
.++| +||++++++| .....++++|||+ +++|.++|... ..+++..++.|+.||+.||+|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4445 5788888877 2334678889988 56999999753 46999999999999999999999999999999
Q ss_pred CCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCc--cchhhhhh---hhhhccccccCCCCCCChh
Q 002953 576 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP--QLTASEHQ---QERRKKRSAVGTPDYLAPE 650 (863)
Q Consensus 576 KPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~--~~~~~~~~---~~~~~~~s~vGTp~YmAPE 650 (863)
||+||||+..|.+|++|||++........... ...--|......... ........ .........+||+.|||||
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~-ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATT-KSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcc-cccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999998888888888887763211000000 000000000000000 00000000 0001112357999999999
Q ss_pred hhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 002953 651 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 730 (863)
Q Consensus 651 vL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~S 730 (863)
++.+..|+.++|||||||+||||++|.+||.... ..+..+..... +...........+++.+||..+|.+|| +
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rp---s 258 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRP---S 258 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCc---C
Confidence 9999999999999999999999999999875432 22222222211 111112245677999999999999999 9
Q ss_pred HHHHHcCCCCCC
Q 002953 731 ASEVKQHVFFKD 742 (863)
Q Consensus 731 AeEILqHPFFk~ 742 (863)
+.++++||||..
T Consensus 259 ~~eil~h~~~~~ 270 (793)
T PLN00181 259 MSELLQSEFINE 270 (793)
T ss_pred hHHHhhchhhhh
Confidence 999999999975
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=277.79 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=213.0
Q ss_pred CCcccceEEEeecccceeeccccc-------eehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 457 PRTSQIDLLLAGKGALSEHDDFPQ-------VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 457 ~~~~~~~l~vLGkG~FG~V~~~~k-------vlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
+....+-+..+|.|.||.|+.++. ++|..++.-.....-+..|+-+++.++|||||-+++.+.....++++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 334444456999999999987753 3333344445566778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||.||+|.+.-.-.+.+++.++.+..++.+.||+|||+.|=+|||||-.|||++..|.+||+|||.+-..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi---------- 162 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI---------- 162 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh----------
Confidence 9999999998888899999999999999999999999999999999999999999999999999987521
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
+ ....+..++.|||+|||||+-. ..+|...+|||++|++..|+---.+|-....+.
T Consensus 163 ----------------t-----ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 163 ----------------T-----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------h-----hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 0 0123456789999999999863 567999999999999999999999998888777
Q ss_pred HHHHHHhhcCCCCCCC--CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 687 QIFDNILNRKIPWPRV--PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 687 el~~kIl~~~~~~p~~--p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.....+.+..+..|.+ +..+++.+.+|++.+|.++|.+|| +++.+|+|||...
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~ 276 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeecc
Confidence 7766666655554544 346899999999999999999999 9999999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-28 Score=274.71 Aligned_cols=186 Identities=27% Similarity=0.475 Sum_probs=158.3
Q ss_pred EEEeecccceeeccc----------cceehhhhhhch-----hHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEE
Q 002953 464 LLLAGKGALSEHDDF----------PQVLKKADMIRK-----NAVESILAERDILISVR---NPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 464 l~vLGkG~FG~V~~~----------~kvlKK~~i~~k-----~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~ly 525 (863)
+..||.|+||.|+.+ .|.++|.++... ...-.+-.|+.||..|+ |+||++++++|++++++|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 348999999998543 234445444322 22234567999999997 999999999999999999
Q ss_pred EEEeec-CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYL-NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~-~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||-. +|-+|+++|.....++|.+++.|++|++.|+++||+.||||||||-+|+.++.+|.+||+|||.|....
T Consensus 646 l~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k---- 721 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK---- 721 (772)
T ss_pred EEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc----
Confidence 999975 567999999999999999999999999999999999999999999999999999999999999886411
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
...-..++||..|.|||++.|..| +..-|||+||++||.+++...||+.
T Consensus 722 -----------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 722 -----------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -----------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 012236899999999999999888 7889999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=264.31 Aligned_cols=232 Identities=23% Similarity=0.365 Sum_probs=178.4
Q ss_pred EEEeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHh--cCCCCeeEEEEEEEeCC----eEEEEEeecC
Q 002953 464 LLLAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE----NLYLVMEYLN 532 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~d~~----~lyLVmEy~~ 532 (863)
+.+||+|.||.|+++. +++|. ......+.+.+|.+|.+. ++|+||++++++-+... .++||++|.+
T Consensus 215 ~eli~~Grfg~V~KaqL~~~~VAVKi---fp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDNRLVAVKI---FPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhccCceeEEEe---cCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 3489999999998763 34443 455667789999999885 68999999998776555 7999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh---------CCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs---------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
.|+|.+||+. ..+++.....++..++.||+|||+ ..|+|||||..||||..+++..|+|||||..+....
T Consensus 292 kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~ 370 (534)
T KOG3653|consen 292 KGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK 370 (534)
T ss_pred CCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCC
Confidence 9999999987 579999999999999999999994 469999999999999999999999999998643211
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC------CccceeechhHHHHHHHhCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y------s~ksDIWSLGvILyELLTGk 677 (863)
. .......+||.+|||||++.+.-- -.+.||||+|.+||||++..
T Consensus 371 ~-----------------------------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 371 P-----------------------------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred C-----------------------------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 1 112234799999999999977421 24689999999999999853
Q ss_pred C------------CCC-----CCChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCcCCCC
Q 002953 678 P------------PFN-----AEHPQQIFDNILNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 678 ~------------PF~-----~~~~~el~~kIl~~~~~~p~~p~~-----iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
. ||. ..+.+++...++..+ ..|.++.. -..-+++.+..||..||+.|++++
T Consensus 422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK-~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK-QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred ccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc-cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2 342 123344444444433 33444432 235688999999999999999443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=258.81 Aligned_cols=272 Identities=25% Similarity=0.403 Sum_probs=191.5
Q ss_pred EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||.|.|+.|+.+. .++|+. .......++.+|+++|..+. +.||+++.+.+..++...+||||++.
T Consensus 42 ~kigeGsFssv~~a~~~~~~~~~~~valk~i--~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 42 NKIGEGSFSSVYKATDIEQDTKRRYVALKAI--YRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred ccccccchhhhhhhhHhhhccccceEeeeec--ccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 389999999986542 233332 23344567999999999985 89999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCC-CC---CCC
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINS-TD---DLS 608 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s-~~---dl~ 608 (863)
.+..++... ++...++.|++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|....... .+ ...
T Consensus 120 ~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~ 196 (418)
T KOG1167|consen 120 DRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYS 196 (418)
T ss_pred cCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhh
Confidence 888888865 7789999999999999999999999999999999999876 789999999998311100 00 000
Q ss_pred CC---CccCcccCCCCC-----c-cchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCC
Q 002953 609 GP---AVSGTTLLGDEE-----P-QLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 609 ~p---~~~g~~l~g~~~-----~-~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~ 678 (863)
.+ ...|........ + .+...-........-...||++|+|||++... ..+.++||||.|+|+.-++++..
T Consensus 197 ~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~ 276 (418)
T KOG1167|consen 197 GRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRY 276 (418)
T ss_pred cccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccc
Confidence 00 001111100000 0 00000001112234467899999999999874 46999999999999999999999
Q ss_pred CCCCC-ChHHHHHHHhh--------------cC------CC----------C-----------------CC-CCCCCCHH
Q 002953 679 PFNAE-HPQQIFDNILN--------------RK------IP----------W-----------------PR-VPEEMSPE 709 (863)
Q Consensus 679 PF~~~-~~~el~~kIl~--------------~~------~~----------~-----------------p~-~p~~iS~e 709 (863)
||... +....+..|.. +. .. | .. ..+..+..
T Consensus 277 PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~ 356 (418)
T KOG1167|consen 277 PFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPAL 356 (418)
T ss_pred ccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHH
Confidence 98532 11111111110 11 00 0 00 01234568
Q ss_pred HHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 710 l~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+.+|+.+||+.||.+|+ ||+++|+||||...+
T Consensus 357 ~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 357 LLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred HHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 99999999999999999 999999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=222.63 Aligned_cols=204 Identities=40% Similarity=0.681 Sum_probs=171.5
Q ss_pred eecccceeecccc-------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 467 AGKGALSEHDDFP-------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 467 LGkG~FG~V~~~~-------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
||.|++|.|+.+. .++|........ ..+.+.+|+.+++.+.|++|+++++++......+++||++.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6889998875442 333333222221 34678999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~------------- 147 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK------------- 147 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc-------------
Confidence 99875 47899999999999999999999999999999999999999 8999999999987421000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 148 ------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------- 187 (215)
T cd00180 148 ------------------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187 (215)
T ss_pred ------------------chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------
Confidence 012235688899999999887 789999999999999999
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
..+.+++.+||..+|.+|| ++.++++|+
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 6789999999999999999 999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=238.73 Aligned_cols=199 Identities=31% Similarity=0.543 Sum_probs=158.7
Q ss_pred Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHh-cCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
-||+|++|.|.... -++|..... ..+..++.++|+++..+ ...|++|.+|+.+-....+++.||.|.- +|
T Consensus 53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sl 131 (282)
T KOG0984|consen 53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SL 131 (282)
T ss_pred hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hH
Confidence 69999999874432 233333322 33445678899998765 4789999999999999999999999954 88
Q ss_pred HHHH----HhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 537 YSLL----RNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 537 ~dlL----k~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
..+- ++.+.++|..+-.|+..++.||.|||+ ..+||||+||+||||+.+|++|+||||++-.+. ++.
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-dSi------- 203 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-DSI------- 203 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh-hhh-------
Confidence 7654 445789999999999999999999996 589999999999999999999999999987421 110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC----CCCCccceeechhHHHHHHHhCCCCCCC-CChH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----TGHGTTADWWSVGIILFELIVGIPPFNA-EHPQ 686 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~ksDIWSLGvILyELLTGk~PF~~-~~~~ 686 (863)
....-.|--.|||||.+.. .+|+.++||||||++++||.+++.||.. .++.
T Consensus 204 ------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 204 ------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred ------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 0112457788999999853 4799999999999999999999999964 5778
Q ss_pred HHHHHHhhcCC
Q 002953 687 QIFDNILNRKI 697 (863)
Q Consensus 687 el~~kIl~~~~ 697 (863)
+.+.+++....
T Consensus 260 ~qLkqvVeep~ 270 (282)
T KOG0984|consen 260 QQLKQVVEEPS 270 (282)
T ss_pred HHHHHHhcCCC
Confidence 88888877654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=253.67 Aligned_cols=238 Identities=24% Similarity=0.372 Sum_probs=178.2
Q ss_pred Eeecccceeeccc----cceehhhhhhchhHHHHHHHHHHHHHh--cCCCCeeEEEEEEEeCC----eEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDF----PQVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE----NLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~----~kvlKK~~i~~k~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~d~~----~lyLVmEy~~GGs 535 (863)
.||+|.||+|+.. ..|..|. ........+.+|.+|.+. |+|+||+.+++.-..++ .+|||++|.+.|+
T Consensus 218 ~IGkGRyGEVwrG~wrGe~VAVKi--F~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS 295 (513)
T KOG2052|consen 218 IIGKGRFGEVWRGRWRGEDVAVKI--FSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS 295 (513)
T ss_pred EecCccccceeeccccCCceEEEE--ecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence 8999999999543 2333332 333445678899999986 59999999997765543 5899999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh--------CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs--------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|++||.+ ..++.+....++..++.||++||. -.|.|||||..||||.++|...|+|+|||...... ++.+
T Consensus 296 L~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~-t~~i 373 (513)
T KOG2052|consen 296 LYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD-TDTI 373 (513)
T ss_pred HHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc-CCcc
Confidence 9999988 679999999999999999999994 24999999999999999999999999999742111 0100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC------CccceeechhHHHHHHHhC-----
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH------GTTADWWSVGIILFELIVG----- 676 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y------s~ksDIWSLGvILyELLTG----- 676 (863)
....+..+||..|||||++...-. -..+||||||+++||++..
T Consensus 374 --------------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg 427 (513)
T KOG2052|consen 374 --------------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG 427 (513)
T ss_pred --------------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence 123456899999999999976432 3568999999999999852
Q ss_pred -----CCCCCC----CChHHHHHHHhhcCCCCCCCCCCCC-----HHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 677 -----IPPFNA----EHPQQIFDNILNRKIPWPRVPEEMS-----PEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 677 -----k~PF~~----~~~~el~~kIl~~~~~~p~~p~~iS-----~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++||++ +...+-+++++--+.-.|.+|..+. ..+..|++.||..||.-|+ ||-.|++
T Consensus 428 i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl---tALriKK 498 (513)
T KOG2052|consen 428 IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL---TALRIKK 498 (513)
T ss_pred EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh---HHHHHHH
Confidence 678864 2233444444433333344443322 3466889999999999999 6665553
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=268.78 Aligned_cols=238 Identities=21% Similarity=0.289 Sum_probs=193.2
Q ss_pred eEEEeecccceeecccc-----------ceehh-hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 463 DLLLAGKGALSEHDDFP-----------QVLKK-ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-----------kvlKK-~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+..+||.|+||+|+.-. +++|. ......+....++.|+-+|.+|+|||+++|+++..... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 34599999999986532 22222 11223345677999999999999999999999988776 8899999
Q ss_pred cCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+++|.|.+|++.. +.+.......|..||++||.|||.+++|||||-..||||..-.++||+|||+|+.......
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~----- 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK----- 853 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc-----
Confidence 9999999999865 5788999999999999999999999999999999999999999999999999985211100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el 688 (863)
+ ......--.+.|||-|.+....|+.++||||+||++||++| |..|+.+....++
T Consensus 854 --------------e----------y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 854 --------------E----------YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred --------------c----------ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 1 11112233567999999999999999999999999999998 9999999988877
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
-..+..+.. + ..|..++-++.-++.+||..|+..|| +++++-
T Consensus 910 ~dlle~geR-L-sqPpiCtiDVy~~mvkCwmid~~~rp---~fkel~ 951 (1177)
T KOG1025|consen 910 PDLLEKGER-L-SQPPICTIDVYMVMVKCWMIDADSRP---TFKELA 951 (1177)
T ss_pred hHHHhcccc-C-CCCCCccHHHHHHHHHHhccCcccCc---cHHHHH
Confidence 766655543 3 34778999999999999999999999 555543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=226.24 Aligned_cols=161 Identities=25% Similarity=0.302 Sum_probs=129.7
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++... +.+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 6899999874 45999999999999999999999998 999999999999999 99987410
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-HHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP-QQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~-~el~~k 691 (863)
.....||+.|||||++.+..++.++|||||||++|||++|..||..... ...+..
T Consensus 61 ------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~ 116 (176)
T smart00750 61 ------------------------PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI 116 (176)
T ss_pred ------------------------cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHH
Confidence 0112689999999999999999999999999999999999999976543 233334
Q ss_pred HhhcCCCCC----CCCCCCCH--HHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 692 ILNRKIPWP----RVPEEMSP--EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 692 Il~~~~~~p----~~p~~iS~--el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
+........ ..+..++. ++.++|.+||..+|.+|| ++.++++|+|+.
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 117 LLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred HHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 333222110 01123344 699999999999999999 999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=222.62 Aligned_cols=202 Identities=41% Similarity=0.647 Sum_probs=166.0
Q ss_pred EEeecccceeecccc-------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|++|.|+.+. .++|........ ..+.+.+|++.+.+++|+|++++++++......|+++||+++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 478999999885542 233433332222 567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC-CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 537 YSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 537 ~dlLk~~g~-L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
.+++..... +++..+..++.+++.+|.+||++|++|+||+|.||+++.++.++|+|||++.......
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------------ 152 (225)
T smart00221 85 FDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------------ 152 (225)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------------
Confidence 999988766 8999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh-cCCCCCccceeechhHHHHHHHhCCCCCCC--CChHHHHHHH
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIVGIPPFNA--EHPQQIFDNI 692 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL-~g~~ys~ksDIWSLGvILyELLTGk~PF~~--~~~~el~~kI 692 (863)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+...+.+.+
T Consensus 153 ------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 153 ------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 0012345788899999999 667788899999999999999999999977 4444666666
Q ss_pred hhcC
Q 002953 693 LNRK 696 (863)
Q Consensus 693 l~~~ 696 (863)
..+.
T Consensus 215 ~~~~ 218 (225)
T smart00221 215 SFGV 218 (225)
T ss_pred hcCC
Confidence 6655
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=229.09 Aligned_cols=237 Identities=21% Similarity=0.266 Sum_probs=192.6
Q ss_pred Eeecccceeeccc-----------cceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-CeEEEEEeec
Q 002953 466 LAGKGALSEHDDF-----------PQVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYL 531 (863)
Q Consensus 466 vLGkG~FG~V~~~-----------~kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-~~lyLVmEy~ 531 (863)
++-+|.||.++.. ..++.|.. ....-++..++.|.-.|..+.|||+..+.++...+ ...++++.++
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 7889999998544 12333322 23455677899999999999999999999876654 4578888999
Q ss_pred CCCChHHHHHhc--------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 532 NGGDLYSLLRNL--------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 532 ~GGsL~dlLk~~--------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
.-|+|..+|... ..++..+...++.|++.|++|||++||||.||-..|.+|++.-.+||+|-.+++...+..
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~D 450 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGD 450 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccc
Confidence 889999999733 236777888999999999999999999999999999999999999999999998643322
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
...+ |+ .--....||+||.+.+..|+.++|+||||++||||+| |+.||-.
T Consensus 451 YhcL-----------GD------------------nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae 501 (563)
T KOG1024|consen 451 YHCL-----------GD------------------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE 501 (563)
T ss_pred cccc-----------CC------------------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence 2111 11 1123568999999999999999999999999999998 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
-++.++...+..+.. ...|.++|+++..++..||...|++|| +.+++..
T Consensus 502 IDPfEm~~ylkdGyR--laQP~NCPDeLf~vMacCWallpeeRP---sf~Qlv~ 550 (563)
T KOG1024|consen 502 IDPFEMEHYLKDGYR--LAQPFNCPDELFTVMACCWALLPEERP---SFSQLVI 550 (563)
T ss_pred cCHHHHHHHHhccce--ecCCCCCcHHHHHHHHHHHhcCcccCC---CHHHHHH
Confidence 999999888877654 234778999999999999999999999 7777653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-23 Score=207.93 Aligned_cols=250 Identities=38% Similarity=0.632 Sum_probs=192.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCC-CeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HP-nIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|+||.|+.+. +++.+...........+.+|+.++..+.|+ +|+++++.+......+++++++.+++|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l 85 (384)
T COG0515 6 RKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSL 85 (384)
T ss_pred EeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcH
Confidence 378999999886543 223332222223567899999999999988 799999999888889999999999999
Q ss_pred HHHHHhcC---CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCCCc
Q 002953 537 YSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 537 ~dlLk~~g---~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
.+++.... .++......++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++........
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~------- 158 (384)
T COG0515 86 EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST------- 158 (384)
T ss_pred HHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc-------
Confidence 98887764 799999999999999999999999999999999999999988 7999999998731110000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCCh----
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHP---- 685 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~~~---- 685 (863)
.. ........+||..|+|||.+.+ ..++...|+||+|++++++++|..||.....
T Consensus 159 ------------~~------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~ 220 (384)
T COG0515 159 ------------SS------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220 (384)
T ss_pred ------------cc------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH
Confidence 00 0012356789999999999988 5788999999999999999999999877763
Q ss_pred HHHHHHHhhcCCC-CC-CCCCCC----CHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 686 QQIFDNILNRKIP-WP-RVPEEM----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 686 ~el~~kIl~~~~~-~p-~~p~~i----S~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
......+.....+ .. ...... ...+.+++.+++..+|..|. +..+...++|...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~---~~~~~~~~~~~~~ 280 (384)
T COG0515 221 SQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSDLSHDLLAH 280 (384)
T ss_pred HHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC---CHHHHhhchHhhC
Confidence 4555555444432 11 111111 25789999999999999999 7777777755443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-24 Score=256.61 Aligned_cols=219 Identities=28% Similarity=0.421 Sum_probs=176.4
Q ss_pred HHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCC
Q 002953 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL 575 (863)
Q Consensus 496 ~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDL 575 (863)
+..|.-+-..++|||++..+..+......+-+||||++ +|+.++...+.+....+..++.|++.||+|||.+||.||||
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 55677777788999998887777666666666999999 99999998888999999999999999999999999999999
Q ss_pred CCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC
Q 002953 576 KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655 (863)
Q Consensus 576 KPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~ 655 (863)
||+|+++..+|.+||+|||.+..+..... .........+|+..|+|||++.+.
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e---------------------------~~~~~~~g~~gS~pY~apE~~~~~ 499 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWE---------------------------KNIHESSGIVGSDPYLAPEVLTGK 499 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcc---------------------------hhhhhhcCcccCCcCcCccccccc
Confidence 99999999999999999999886322110 001234568999999999999999
Q ss_pred CCCc-cceeechhHHHHHHHhCCCCCCCCChHHHH--HHHhhcCCC----CCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 656 GHGT-TADWWSVGIILFELIVGIPPFNAEHPQQIF--DNILNRKIP----WPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 656 ~ys~-ksDIWSLGvILyELLTGk~PF~~~~~~el~--~kIl~~~~~----~p~~p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
.|.+ .+||||.|++++.|++|+.||......+.. ......... ...+...++...+.+|.+||+.+|.+|.
T Consensus 500 ~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~-- 577 (601)
T KOG0590|consen 500 EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI-- 577 (601)
T ss_pred ccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee--
Confidence 9965 579999999999999999999755433221 111111111 1123356889999999999999999999
Q ss_pred CCHHHHHcCCCCCCCCh
Q 002953 729 GGASEVKQHVFFKDINW 745 (863)
Q Consensus 729 ~SAeEILqHPFFk~IdW 745 (863)
++++|++.+||+.++=
T Consensus 578 -ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 578 -TIEQILNDEWIRSIEC 593 (601)
T ss_pred -cHHHHhhChHhhhcce
Confidence 9999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=220.94 Aligned_cols=231 Identities=25% Similarity=0.354 Sum_probs=170.6
Q ss_pred cceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEE-EEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFF-YSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~-~~f~d~~~lyLVmEy~ 531 (863)
.|++. .||.|.||..-.+. .++.|...........|.+|...--.|. |.||+.-| ..|++.+.+.++|||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 34443 79999999863331 2222333333345567888988766664 88999887 5789999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC--CcEEEeecCCccccccCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~--g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+.|+|..-+.. ..+.|...+.++.|++.||+|+|++++||||||.+||||-.. ..|||||||+++.
T Consensus 105 P~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k----------- 172 (378)
T KOG1345|consen 105 PRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK----------- 172 (378)
T ss_pred ccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc-----------
Confidence 99999988866 458899999999999999999999999999999999999643 4899999999873
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-----CCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----HGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.|.+ ....--+..|.+||+..... ..+..|+|.||+++|.+++|.+||+...
T Consensus 173 ---~g~t--------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 173 ---VGTT--------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred ---cCce--------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 1111 11122456799999875432 2678899999999999999999997432
Q ss_pred h----HHHHHHHhhc-CCCCCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 002953 685 P----QQIFDNILNR-KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 685 ~----~el~~kIl~~-~~~~p~~p~~iS~el~dLI~k~L~~DP~kRp 726 (863)
. .--+.+...+ ....|.....+++.+..+.++-|..++++|-
T Consensus 230 ~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 230 IMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred ccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 1 1112222222 2233444456899999999999999999994
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=220.83 Aligned_cols=244 Identities=21% Similarity=0.253 Sum_probs=179.8
Q ss_pred cceEE-Eeecccceeeccccc-------eehhhhhhc-hhHHHHHHHHHHHHHhcCC----CCeeEEEEEE-EeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFPQ-------VLKKADMIR-KNAVESILAERDILISVRN----PFVVRFFYSF-TCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~k-------vlKK~~i~~-k~~~e~~l~Ei~IL~~L~H----PnIVkL~~~f-~d~~~lyL 526 (863)
.|.+. .||+|+||.|+.+.. .+.|..... ......+..|..+|..+.. +++..+++.+ ..+.+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45554 999999999976531 222222221 2222267889999998863 6999999999 57888999
Q ss_pred EEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-----CcEEEeecCCccc-
Q 002953 527 VMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-----GHIKLTDFGLSKV- 598 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-----g~VKLiDFGLAk~- 598 (863)
||+.+ |.+|.++.... +.|+..++..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||+|+.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99999 88999988654 579999999999999999999999999999999999999865 3699999999983
Q ss_pred -cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhc-cccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002953 599 -GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK-KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 599 -~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~-~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG 676 (863)
........ ....+. ...+.||..|+++.+..+...+++.|+||++.++.+|+.|
T Consensus 178 ~~~~~~~~~------------------------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 178 KYVGDSGGN------------------------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred cccCCCCcc------------------------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 11110000 000111 2356799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCC--CCCCCCCCCHHHHHHHHhhccCCcCCcCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIP--WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~--~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
.+||..........++...... ........+.++..+...+-..+...+|.+.
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~ 288 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE 288 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHH
Confidence 9999765532222222221111 1112344667888888888888999999443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=211.00 Aligned_cols=238 Identities=21% Similarity=0.291 Sum_probs=189.3
Q ss_pred EEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
..||.|.||+...- .+++|- +. .+.....+..|.+..+.|. .++|...|++.+...+-.||||++ |.+|
T Consensus 34 kKIGeGsFG~lf~G~Nl~nne~VAIKf-EP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLGKNLYNNEPVAIKF-EP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred cccccCcceeeecccccccCceEEEEe-cc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 38999999986432 234433 22 2344566888999998886 599999999999999999999999 8899
Q ss_pred HHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-----cEEEeecCCccccccCCCCCCCCC
Q 002953 537 YSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-----HIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 537 ~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-----~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
.+++.-++ +|+..++..++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+|+......+.
T Consensus 111 EDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk----- 185 (449)
T KOG1165|consen 111 EDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK----- 185 (449)
T ss_pred HHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc-----
Confidence 99997664 599999999999999999999999999999999999998644 5999999999965433222
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC---CChHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA---EHPQQ 687 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~---~~~~e 687 (863)
.+...+...+..||..||+-...+|...+.+.|+-|||-+++++|-|.+||.+ .+..+
T Consensus 186 -------------------qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~ 246 (449)
T KOG1165|consen 186 -------------------QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE 246 (449)
T ss_pred -------------------ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence 11223455678999999999999999999999999999999999999999976 45667
Q ss_pred HHHHHhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCC
Q 002953 688 IFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 688 l~~kIl~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
-+++|-..+...| .+-.++|.++..-+...-..+-.+-|.+.
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 7777755443322 23356888888888777777777777653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-22 Score=205.68 Aligned_cols=266 Identities=21% Similarity=0.256 Sum_probs=204.7
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~~lyLVmE 529 (863)
...|.+. .||.|+||..+... +++| .+- ......++..|.++...|.+ ..|..+..++....+-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK-~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIK-LES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEE-eec-ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3455554 99999999875542 3333 221 22233568889999999976 788888888999999999999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~ 605 (863)
++ |.+|.+++.-+ ..|+..++..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+......+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99 88999998755 569999999999999999999999999999999999999754 46999999999964322111
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-- 683 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-- 683 (863)
.+...+..+...||..|.+-....+...+.+.|+-|+|.+|.++.-|.+||++.
T Consensus 171 ------------------------~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 171 ------------------------QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ------------------------ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 112234456788999999999999999999999999999999999999999875
Q ss_pred -ChHHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC-------CCChhHHhhc
Q 002953 684 -HPQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK-------DINWDTLARQ 751 (863)
Q Consensus 684 -~~~el~~kIl~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk-------~IdW~~l~~~ 751 (863)
+..+-+++|.+.+...| .+-.++|.++.-.+..|-..--++-|.+.-+.++..--|+. -.||+.+.++
T Consensus 227 ~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 227 ATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred hhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 44566777877665543 23467899999999999888888888554344544333332 3589888754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=209.59 Aligned_cols=162 Identities=22% Similarity=0.191 Sum_probs=115.8
Q ss_pred ccceEE-Eeecccceeecccc--------ceehhhhhh-----chhHHHHHHHHHHHHHhcCCCCeeE-EEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------QVLKKADMI-----RKNAVESILAERDILISVRNPFVVR-FFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~-----~k~~~e~~l~Ei~IL~~L~HPnIVk-L~~~f~d~~~l 524 (863)
..|.+. .||+|+||+|+.+. +++|+.... .......+.+|+++|++++|+||+. +++. +..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 345544 89999999997652 234432211 2234567899999999999999985 4432 468
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCC-CCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDL-KPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
||||||++|++|.. +...+ ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+......
T Consensus 94 ~LVmE~~~G~~L~~-~~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEEEEccCCCCHHH-hCccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 99999999999963 21111 1467899999999999999999999 9999999999999999999998531100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~ 655 (863)
. ...........+.+|++.|+|||.+...
T Consensus 167 ~-----------------------~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 167 A-----------------------LYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred c-----------------------hhhhhhhhhhhhhhccCccCCcccCChh
Confidence 0 0000001122367899999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-19 Score=183.54 Aligned_cols=193 Identities=18% Similarity=0.141 Sum_probs=134.0
Q ss_pred eEEEeecccceeeccc----cceehhhhhhchh-----HHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 463 DLLLAGKGALSEHDDF----PQVLKKADMIRKN-----AVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~----~kvlKK~~i~~k~-----~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
...+||+|+||+|+.+ .+++.+..-.... ....+.+|+++|++|. |++|++++++ +..|++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 3458999999999644 2333222212211 2235789999999995 5889999886 45799999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCC-CCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDL-KPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDL-KPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|.+|...+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||+|.......
T Consensus 82 G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~-------- 146 (218)
T PRK12274 82 GAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA-------- 146 (218)
T ss_pred CccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc--------
Confidence 9998754422 1 1357889999999999999999999 7999999999999999999998421000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCC-ccceeechhHHHHHHHhCCCCCCCCC
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHG-TTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys-~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
... .+-.. ..-..-.......++.|++|+...-. ..+ .+.+|++.|+.+|.|+|+..|+.++.
T Consensus 147 --------~~~-r~L~~-rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 --------RWM-RLLAR-EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred --------hHH-HHHHH-HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 000 00000 00000111123378899999875432 223 67899999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=193.11 Aligned_cols=211 Identities=27% Similarity=0.418 Sum_probs=158.7
Q ss_pred CCCCeeEEEEEEEeC---------------------------CeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHH
Q 002953 507 RNPFVVRFFYSFTCR---------------------------ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 559 (863)
Q Consensus 507 ~HPnIVkL~~~f~d~---------------------------~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl 559 (863)
+|||||++..+|.+. ..+|+||...+. +|..|+-. ...+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence 599999999888662 248999999866 99999976 4467778888999999
Q ss_pred HHHHHHHhCCccccCCCCcceeecC--CC--cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhh
Q 002953 560 LALEYLHSLRVVHRDLKPDNLLIAH--DG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635 (863)
Q Consensus 560 ~ALeyLHs~GIIHRDLKPeNILLd~--~g--~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~ 635 (863)
+|+.|||++||.|||||.+||||.- ++ .+.|+|||++-. ++.. |..+ +. ..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA------d~~h-----Glql-----py---------~S 406 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA------DDNH-----GLQL-----PY---------ES 406 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee------cccc-----cccc-----cc---------cc
Confidence 9999999999999999999999953 32 589999999863 1111 1100 00 01
Q ss_pred ccccccCCCCCCChhhhcCCC------CCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHH
Q 002953 636 KKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPE 709 (863)
Q Consensus 636 ~~~s~vGTp~YmAPEvL~g~~------ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~e 709 (863)
..-...|....||||+....+ .-.++|.|+.|.+.||++....||++.....+-..- ..+-.+|.+++.+++.
T Consensus 407 ~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 407 DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPV 485 (598)
T ss_pred ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChH
Confidence 112356888899999987543 146899999999999999999999884432221111 2233567888999999
Q ss_pred HHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 710 l~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
+++|+..+|+.||++|++..-|..+++--.|..-+|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 999999999999999997766777776655554444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-19 Score=214.37 Aligned_cols=230 Identities=25% Similarity=0.349 Sum_probs=166.9
Q ss_pred Eeecccceeeccc--------cceehh-hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDF--------PQVLKK-ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~--------~kvlKK-~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.||.+.|=+|..+ .||+.| .....-....+.+.|++ ...++|||++.+.-+..+++..|||-+|+.. +|
T Consensus 30 ~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nL 107 (1431)
T KOG1240|consen 30 NLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NL 107 (1431)
T ss_pred ccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hh
Confidence 7899998776333 233322 22333344444555666 6677999999998888888899999999965 99
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
++.|.....+..-+.+.|+.||+.||..+|+.||+|+|||.+||||+.-+-+.|+||.--+.-..+ . ..|.
T Consensus 108 yDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP--e--DNPa----- 178 (1431)
T KOG1240|consen 108 YDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP--E--DNPA----- 178 (1431)
T ss_pred hhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC--C--CCcc-----
Confidence 999998777889999999999999999999999999999999999999999999999753310000 0 0000
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-----------CCccceeechhHHHHHHHh-CCCCCCC--
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-----------HGTTADWWSVGIILFELIV-GIPPFNA-- 682 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----------ys~ksDIWSLGvILyELLT-Gk~PF~~-- 682 (863)
+++ .--.+...-.+|+|||.+.... .+++-||||+||++.||++ |.+||.-
T Consensus 179 -------df~--------fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 179 -------DFT--------FFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred -------cce--------EEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 000 0000111224799999886422 4678899999999999987 7999942
Q ss_pred ---------CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 ---------EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ---------~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+++..+++| -+..++.||..|++.||.+|+ +|++.|+.
T Consensus 244 L~aYr~~~~~~~e~~Le~I-------------ed~~~Rnlil~Mi~rdPs~Rl---SAedyL~~ 291 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKI-------------EDVSLRNLILSMIQRDPSKRL---SAEDYLQK 291 (1431)
T ss_pred HHhHhccCccCHHHHHHhC-------------cCccHHHHHHHHHccCchhcc---CHHHHHHh
Confidence 1222222222 123689999999999999999 99999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=177.60 Aligned_cols=131 Identities=16% Similarity=0.149 Sum_probs=103.2
Q ss_pred EEEeecccceeeccc----cceehhhhhhchhHHHHHHHHHHHHHhc-----CCCCeeEEEEEEEeCC---eEE-EEEee
Q 002953 464 LLLAGKGALSEHDDF----PQVLKKADMIRKNAVESILAERDILISV-----RNPFVVRFFYSFTCRE---NLY-LVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-----~HPnIVkL~~~f~d~~---~ly-LVmEy 530 (863)
..+||+|+||.|+.. .+++|+.........+.+.+|+.+|+.+ +||||+++|++++++. .+| +||||
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred cceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 348999999999643 2455554443333556799999999999 5799999999999974 444 78999
Q ss_pred --cCCCChHHHHHhcCCCChhhHHHHHHHHHHHH-HHHHhCCccccCCCCcceeecCC----CcEEEeecCCcc
Q 002953 531 --LNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL-EYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSK 597 (863)
Q Consensus 531 --~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~AL-eyLHs~GIIHRDLKPeNILLd~~----g~VKLiDFGLAk 597 (863)
+.+|+|.+++++ +.+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.+.
T Consensus 87 ~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 87 DGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 557999999976 457666 35688888888 99999999999999999999743 379999954443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-18 Score=179.79 Aligned_cols=128 Identities=16% Similarity=0.189 Sum_probs=98.4
Q ss_pred cceEE-Eeecccceeeccc-----cceehhhh---hhchhHHHH------HHHHHHHHHhcCCCCeeEEEEEEEeC----
Q 002953 461 QIDLL-LAGKGALSEHDDF-----PQVLKKAD---MIRKNAVES------ILAERDILISVRNPFVVRFFYSFTCR---- 521 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~-----~kvlKK~~---i~~k~~~e~------~l~Ei~IL~~L~HPnIVkL~~~f~d~---- 521 (863)
.|+.. +||.|+||.|+.+ .+++|... ......... +.+|+..+.++.||+|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 44444 9999999998543 23333221 112222222 57899999999999999999887754
Q ss_pred ----CeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 522 ----ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 522 ----~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
+..||||||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|||.++
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~ 182 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKR 182 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcc
Confidence 35799999999999988732 333 3456999999999999999999999999999988 9999999876
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.8e-18 Score=173.45 Aligned_cols=100 Identities=24% Similarity=0.202 Sum_probs=82.2
Q ss_pred HHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHH-HhCCccccC
Q 002953 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVVHRD 574 (863)
Q Consensus 496 ~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyL-Hs~GIIHRD 574 (863)
...|+++|.++.+++|........ . ..||||||++|++|...+...+.++...+..++.|++.+|.|| |+.||+|||
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrD 143 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHAD 143 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 345999999998877644332222 2 2389999999988776654557899999999999999999999 799999999
Q ss_pred CCCcceeecCCCcEEEeecCCccc
Q 002953 575 LKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 575 LKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|||+|||++ ++.++|+|||+|..
T Consensus 144 lkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 144 LSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCHHHEEEE-CCcEEEEEcccccc
Confidence 999999998 57899999999973
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.4e-18 Score=203.36 Aligned_cols=246 Identities=28% Similarity=0.434 Sum_probs=191.9
Q ss_pred Eeecccceeecccc--------ceehhhhhh--chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP--------QVLKKADMI--RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~--------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
-||+|+|+.|.... .+.+..... ......++..|..+-..+. |+|++.+++........+++++|..|+
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 58999999873321 122222222 2334456667888888887 999999999999999999999999999
Q ss_pred ChHHHH-HhcC-CCChhhHHHHHHHHHHHHHHHH-hCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCC
Q 002953 535 DLYSLL-RNLG-CLDEDVARVYIAEVVLALEYLH-SLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 535 sL~dlL-k~~g-~L~e~~i~~Ia~QIl~ALeyLH-s~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|..+...
T Consensus 107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~-------- 178 (601)
T KOG0590|consen 107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK-------- 178 (601)
T ss_pred ccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc--------
Confidence 999998 5544 6788899999999999999999 99999999999999999999 9999999999853210
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccC-CCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVG-TPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vG-Tp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
..........+| ++.|+|||...+.. .....|+||.|+++..|++|..||........
T Consensus 179 --------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~ 238 (601)
T KOG0590|consen 179 --------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG 238 (601)
T ss_pred --------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc
Confidence 001123345678 99999999999854 47889999999999999999999976543321
Q ss_pred H-HHHhhcCCC-CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 689 F-DNILNRKIP-WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 689 ~-~kIl~~~~~-~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
. ......... -...+..++....+++.++|..+|..|. +.+++..++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 239 RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNWLSS 291 (601)
T ss_pred cceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccccccc
Confidence 1 111111111 1223567899999999999999999999 9999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.5e-17 Score=162.97 Aligned_cols=101 Identities=22% Similarity=0.088 Sum_probs=83.5
Q ss_pred HHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCcccc
Q 002953 495 SILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHR 573 (863)
Q Consensus 495 ~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHR 573 (863)
.+..|...+.++.|++|.....+... ..||||||++|+++.........++...+..++.|++.+|.+||. .||+||
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr 142 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG 142 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 34679999999999987554433332 248999999988665443344678889999999999999999999 999999
Q ss_pred CCCCcceeecCCCcEEEeecCCccc
Q 002953 574 DLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 574 DLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
||||+|||++ ++.++|+|||+|+.
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred CCChhhEEEE-CCCEEEEEccccee
Confidence 9999999998 89999999999984
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-17 Score=177.86 Aligned_cols=160 Identities=26% Similarity=0.411 Sum_probs=105.4
Q ss_pred EEEEEeecCCCChHHHHHh---cCCC----ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 524 LYLVMEYLNGGDLYSLLRN---LGCL----DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~---~g~L----~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
.+++|+-+. ++|.+++.- .... .......+..|++..+++||..|+||+||||+|++++.+|.++|+||+..
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 478888885 489887642 2222 12222344589999999999999999999999999999999999999876
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC--------CCCccceeechhH
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--------GHGTTADWWSVGI 668 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--------~ys~ksDIWSLGv 668 (863)
... | ........+..|.+||+.... .++.+.|.|+||+
T Consensus 193 ~r~--------------g--------------------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 193 VRA--------------G--------------------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp EET--------------T--------------------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred eec--------------C--------------------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 520 0 111113455789999987542 3688999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCc
Q 002953 669 ILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 669 ILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kR 725 (863)
++|.|.+|..||........... .|.... ++|+.++.||..||+.||.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999976644322111 223333 789999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-16 Score=167.30 Aligned_cols=196 Identities=22% Similarity=0.357 Sum_probs=162.0
Q ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCC-
Q 002953 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLR- 569 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~G- 569 (863)
...|..|.-.|+-+.||||+.+++.+....++.++..||+.|+|+..|..... .+..++..++..|+.|+.|||+..
T Consensus 231 srdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep 310 (448)
T KOG0195|consen 231 SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP 310 (448)
T ss_pred cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch
Confidence 34578888889999999999999999999999999999999999999987643 677899999999999999999864
Q ss_pred -ccccCCCCcceeecCCCcEEE--eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCC
Q 002953 570 -VVHRDLKPDNLLIAHDGHIKL--TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646 (863)
Q Consensus 570 -IIHRDLKPeNILLd~~g~VKL--iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~Y 646 (863)
|.---|....++|+.+-+.+| +|--++. ......-.|.|
T Consensus 311 ~ipr~~lns~hvmidedltarismad~kfsf--------------------------------------qe~gr~y~paw 352 (448)
T KOG0195|consen 311 MIPRFYLNSKHVMIDEDLTARISMADTKFSF--------------------------------------QEVGRAYSPAW 352 (448)
T ss_pred hhhhhhcccceEEecchhhhheecccceeee--------------------------------------eccccccCccc
Confidence 444467888999998866554 4433222 11123457899
Q ss_pred CChhhhcCCCC---CccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcC
Q 002953 647 LAPEILLGTGH---GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 723 (863)
Q Consensus 647 mAPEvL~g~~y---s~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~ 723 (863)
|+||.+...+- -.++|+|||.+++|||.|...||..-++.+.-.+|.-.... +.+|.+++..+..|+.-|+..||.
T Consensus 353 mspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ippgis~hm~klm~icmnedpg 431 (448)
T KOG0195|consen 353 MSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPG 431 (448)
T ss_pred CCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCC
Confidence 99999987654 36789999999999999999999999988887777665544 467889999999999999999999
Q ss_pred CcCC
Q 002953 724 QRLG 727 (863)
Q Consensus 724 kRpg 727 (863)
+||.
T Consensus 432 krpk 435 (448)
T KOG0195|consen 432 KRPK 435 (448)
T ss_pred cCCC
Confidence 9993
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.5e-17 Score=182.67 Aligned_cols=182 Identities=28% Similarity=0.457 Sum_probs=136.1
Q ss_pred eEEEEEeecCCCChHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g---~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
++|+.|++|...+|.++|.... ..+......++.|+..|++| +|.+|||+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 6899999999999999997543 36677888999999999999 99999999999999999999999999997631
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~ 678 (863)
.... ............+||..||+||.+.+..|+.++||||||+||+|+++ -..
T Consensus 407 ~~~~-------------------------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T 461 (516)
T KOG1033|consen 407 DKDE-------------------------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFST 461 (516)
T ss_pred ccCC-------------------------cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhcc
Confidence 1000 00011233445789999999999999999999999999999999997 222
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+|. ...++..+..+.++ |.+..+. ++-.+|+.+||...|.+|| ++.+.--|+|.
T Consensus 462 ~~e---r~~t~~d~r~g~ip-~~~~~d~-p~e~~ll~~lls~~p~~RP---~~~~~~~~~~~ 515 (516)
T KOG1033|consen 462 QFE---RIATLTDIRDGIIP-PEFLQDY-PEEYTLLQQLLSPSPEERP---SAIEVALHEFL 515 (516)
T ss_pred HHH---HHHhhhhhhcCCCC-hHHhhcC-cHHHHHHHHhcCCCcccCc---hHHHHhhhhhc
Confidence 221 12233333333332 1222222 4456899999999999999 77777766654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.8e-16 Score=156.58 Aligned_cols=129 Identities=29% Similarity=0.304 Sum_probs=104.7
Q ss_pred EEeecccceeeccc-----cceehhhhh--------hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 465 LLAGKGALSEHDDF-----PQVLKKADM--------IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-----~kvlKK~~i--------~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..||+|++|.|+.+ ..++|+... ........+.+|+.++..+.|++|+....++.+....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 36899999999765 233332111 11122346788999999999999887777777778899999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
+|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999875432 7788999999999999999999999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.7e-16 Score=154.76 Aligned_cols=125 Identities=26% Similarity=0.270 Sum_probs=97.9
Q ss_pred Eeecccceeecccc----c-eehhhhhh--------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP----Q-VLKKADMI--------RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~----k-vlKK~~i~--------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
+||+|+||.|+.+. . ++|..... .......+.+|++++..+.|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999997653 2 33321111 11223567889999999998876555445556677899999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|++|.+++..... .++.+++.+|.+||+.|++|||++|.|||++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998765321 7899999999999999999999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-16 Score=192.33 Aligned_cols=180 Identities=19% Similarity=0.261 Sum_probs=139.1
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
.||+|+||+||.+. .++|...... .-.+.-=.+++.+|+ -+.|..+...+...+.-+||+||.+.|+|
T Consensus 705 e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtl 781 (974)
T KOG1166|consen 705 EIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTL 781 (974)
T ss_pred eeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccH
Confidence 79999999997653 2333222111 111222233444554 24566666666677788999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-------CcEEEeecCCccccccCCCCCCCC
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-------GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-------g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
.+++...+.+++..+.+++.|++.-+++||..+|||+||||+|+||... --++|+|||.|.....
T Consensus 782 ld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l-------- 853 (974)
T KOG1166|consen 782 LDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL-------- 853 (974)
T ss_pred HHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE--------
Confidence 9999988889999999999999999999999999999999999999642 3599999998863110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
..+..+-...++|-.+-.+|++.|.++++.+|.|.|+.++|-||.|+
T Consensus 854 ---------------------fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 854 ---------------------FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ---------------------cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 01112344678999999999999999999999999999999999985
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=175.79 Aligned_cols=126 Identities=29% Similarity=0.336 Sum_probs=102.4
Q ss_pred EEEeecccceeeccc-----cceehhhh--------hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 464 LLLAGKGALSEHDDF-----PQVLKKAD--------MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-----~kvlKK~~--------i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..+||+|+||+|+.. .+++++.. .......+.+.+|+++|..++|++|+..+.++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 348999999999762 12222111 01112335688999999999999999888777777788999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999886 346789999999999999999999999999999 678999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.1e-14 Score=166.92 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=152.3
Q ss_pred HHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCc-cccCCCCcce
Q 002953 503 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRV-VHRDLKPDNL 580 (863)
Q Consensus 503 L~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GI-IHRDLKPeNI 580 (863)
|+.+.|.|+.++++...+....++|.+||..|+|.+.+... -.++.--...++++|+.||+|||.-.| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45688999999999999999999999999999999999873 346666777788999999999998765 9999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC----
Q 002953 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---- 656 (863)
Q Consensus 581 LLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---- 656 (863)
+++..-.+||+|||+...... .. .. .......-..-|.|||++.+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--~~------------------~~---------~~~~~~~~~~lw~aPellr~~~~~~~ 131 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--TA------------------EP---------EAHHPIRKALLWTAPELLRGALSQSL 131 (484)
T ss_pred eeeeeEEEEechhhhcccccc--cc------------------cc---------cccchhHHHHhccCHHHhcccccccc
Confidence 999999999999999764210 00 00 0000111234689999997642
Q ss_pred ---CCccceeechhHHHHHHHhCCCCCCC----CChHHHHHHHhhcCC--CCCCCC--CCCCHHHHHHHHhhccCCcCCc
Q 002953 657 ---HGTTADWWSVGIILFELIVGIPPFNA----EHPQQIFDNILNRKI--PWPRVP--EEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 657 ---ys~ksDIWSLGvILyELLTGk~PF~~----~~~~el~~kIl~~~~--~~p~~p--~~iS~el~dLI~k~L~~DP~kR 725 (863)
.+.+.|+||+|+++||+++...||.. .++.++...+..+.. ..|.+. ..+++++..++..||..+|.+|
T Consensus 132 ~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~r 211 (484)
T KOG1023|consen 132 ESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKR 211 (484)
T ss_pred cccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhC
Confidence 36679999999999999999999965 233456666655222 122222 2466789999999999999999
Q ss_pred CCCCCH
Q 002953 726 LGSGGA 731 (863)
Q Consensus 726 pg~~SA 731 (863)
|+...+
T Consensus 212 Ps~~~i 217 (484)
T KOG1023|consen 212 PSIEQI 217 (484)
T ss_pred ccHHHH
Confidence 954333
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-14 Score=152.69 Aligned_cols=99 Identities=21% Similarity=0.161 Sum_probs=81.9
Q ss_pred HHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC-cc
Q 002953 495 SILAERDILISVRNP--FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VV 571 (863)
Q Consensus 495 ~~l~Ei~IL~~L~HP--nIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G-II 571 (863)
.+..|+.+|.++.+. .++++++. ...||||||++|++|...+.....+....+..++.||+.+|.+||.+| |+
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~ii 171 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELV 171 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 457899999999753 34555543 235899999999888776544456677778899999999999999999 99
Q ss_pred ccCCCCcceeecCCCcEEEeecCCccc
Q 002953 572 HRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 572 HRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
||||||+||+++ ++.++|+|||+|..
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999999 88999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=144.52 Aligned_cols=101 Identities=25% Similarity=0.346 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHHhcCCCCe--eEEEEEEEeCCe----EEEEEeecCC-CChHHHHHhcCCCChhhHHHHHHHHHHHHHHH
Q 002953 493 VESILAERDILISVRNPFV--VRFFYSFTCREN----LYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 565 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~HPnI--VkL~~~f~d~~~----lyLVmEy~~G-GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyL 565 (863)
...+.+|++++..|.|++| ++.+++...+.. .++|||+++| .+|.+++.. +.+++. .+.+|+.+|.+|
T Consensus 84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~l 158 (239)
T PRK01723 84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARF 158 (239)
T ss_pred hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHH
Confidence 3568899999999998774 677766444322 3599999997 689888865 455554 357899999999
Q ss_pred HhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 566 Hs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|++||+||||||+|||++.++.++|+|||.+..
T Consensus 159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999999999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-13 Score=138.98 Aligned_cols=93 Identities=20% Similarity=0.243 Sum_probs=77.9
Q ss_pred HHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccc
Q 002953 495 SILAERDILISVRNP--FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVH 572 (863)
Q Consensus 495 ~~l~Ei~IL~~L~HP--nIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIH 572 (863)
....|..++..+.|+ .++..++ ....++||||++|++|..+... .....++.+++.++.++|+.||+|
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H 148 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIH 148 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCc
Confidence 467899999999877 4555554 2456999999999998765431 345678899999999999999999
Q ss_pred cCCCCcceeecCCCcEEEeecCCcc
Q 002953 573 RDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 573 RDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
|||||+||+++.++.++|+|||++.
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccc
Confidence 9999999999999999999999986
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.5e-13 Score=126.19 Aligned_cols=126 Identities=22% Similarity=0.227 Sum_probs=101.0
Q ss_pred EEEeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||.|.++.|+.+. .++|...... . ...+.+|..++..+.| .++++++.++...+..|++|||+.|+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~-~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSRE-K-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCC-c-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3478999999886542 2233221111 1 4568899999999976 5999999988888899999999999877
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC---CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~---GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||.+..
T Consensus 81 ~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 654 4556677889999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.5e-12 Score=130.17 Aligned_cols=95 Identities=21% Similarity=0.254 Sum_probs=72.0
Q ss_pred HHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEeecCCCChHH-HHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccc
Q 002953 497 LAERDILISVRNP--FVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVH 572 (863)
Q Consensus 497 l~Ei~IL~~L~HP--nIVkL~~~f~d~~~lyLVmEy~~GGsL~d-lLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIH 572 (863)
..|...+..+.+. .+.+++.. ...++||||++|+.+.. .+.... . ...++.++.+++.++.++|. .||+|
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH 138 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVH 138 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCc
Confidence 4567777777544 35555543 24699999999955432 122211 1 16788999999999999999 99999
Q ss_pred cCCCCcceeecCCCcEEEeecCCccc
Q 002953 573 RDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 573 RDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|||||+||+++ ++.++|+|||.+..
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECccccc
Confidence 99999999999 89999999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.2e-12 Score=146.42 Aligned_cols=243 Identities=24% Similarity=0.221 Sum_probs=178.7
Q ss_pred Eeec--ccceeecccc---------ceehhhhhhch--hHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeec
Q 002953 466 LAGK--GALSEHDDFP---------QVLKKADMIRK--NAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 466 vLGk--G~FG~V~~~~---------kvlKK~~i~~k--~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
-+|. |.+|.++... .+.++...... ....+=++|+....+++ |++.++.+..+...+.+|+-+|+|
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 6889 9999985432 23333222222 33344456777777775 899999999999999999999999
Q ss_pred CCCChHHHHHhcCC-CChhhHHHHHHHHHH----HHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCC
Q 002953 532 NGGDLYSLLRNLGC-LDEDVARVYIAEVVL----ALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 532 ~GGsL~dlLk~~g~-L~e~~i~~Ia~QIl~----ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~ 605 (863)
|.+|..+...... ++...+..++.+... ||.++|..+|+|-|+||.||++..+ ...+++|||+.........
T Consensus 201 -~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~- 278 (524)
T KOG0601|consen 201 -GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNF- 278 (524)
T ss_pred -cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCcc-
Confidence 5699998877655 889999999999999 9999999999999999999999999 8899999999774211100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-- 683 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-- 683 (863)
. ..........|...|++||++.+. ++...|+|+||.++.+-.+|..++...
T Consensus 279 -------~------------------~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 279 -------S------------------SVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred -------c------------------cceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 0 000111223577889999998765 889999999999999988886655332
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+....++.. ..+ .++-...+.++...+..|+..+|-.|+ +++.+++|++....
T Consensus 333 ~~W~~~r~~---~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 333 SSWSQLRQG---YIP-LEFCEGGSSSLRSVTSQMLDEDPRLRL---TAQILTALNVIHSK 385 (524)
T ss_pred CCccccccc---cCc-hhhhcCcchhhhhHHHHhcCcchhhhh---HHHHHhccccccch
Confidence 111111111 111 123345677777799999999999999 99999999998854
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=134.38 Aligned_cols=147 Identities=22% Similarity=0.363 Sum_probs=115.0
Q ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH-hCCc
Q 002953 492 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRV 570 (863)
Q Consensus 492 ~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH-s~GI 570 (863)
..+.+.+-++-|+.|+||||+++++.++.++.+|||+|.+ ..|..++++.+ ...+...+.||+.||.||| +.++
T Consensus 52 ~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~l 126 (690)
T KOG1243|consen 52 VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVCLGLFQILAALSFLNDDCNL 126 (690)
T ss_pred hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCe
Confidence 3455777888999999999999999999999999999998 47888888754 7777888999999999998 6789
Q ss_pred cccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChh
Q 002953 571 VHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650 (863)
Q Consensus 571 IHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPE 650 (863)
+|++|.-+-|+|+..|+.||++|-++... ..... ......---.|..|+
T Consensus 127 vHgNv~~~SVfVn~~GeWkLggle~v~~~-----~~~~~--------------------------~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 127 VHGNVCKDSVFVNESGEWKLGGLELVSKA-----SGFNA--------------------------PAKSLYLIESFDDPE 175 (690)
T ss_pred eeccEeeeeEEEcCCCcEEEeeeEEEecc-----ccCCc--------------------------ccccchhhhcccChh
Confidence 99999999999999999999999887521 00000 001111122356666
Q ss_pred hhcCCCCCccceeechhHHHHHHHhC
Q 002953 651 ILLGTGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 651 vL~g~~ys~ksDIWSLGvILyELLTG 676 (863)
.+.... ...|.|.|||+++|++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 543332 567999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-10 Score=125.44 Aligned_cols=213 Identities=23% Similarity=0.346 Sum_probs=150.3
Q ss_pred HHHHhcCCCCeeEEEEEEEeCCe-----EEEEEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhC--C
Q 002953 501 DILISVRNPFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSL--R 569 (863)
Q Consensus 501 ~IL~~L~HPnIVkL~~~f~d~~~-----lyLVmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~--G 569 (863)
+-|..+.|-|||+++.++.+.++ ..++.|||..|+|..+|++. ..+.....++|+.||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 34556679999999988877654 78999999999999999764 3588889999999999999999986 4
Q ss_pred ccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCh
Q 002953 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 649 (863)
Q Consensus 570 IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAP 649 (863)
|+|+++..+-|++..+|-||+.--..... .+.. .. .....+....|-+.|.||
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~----------h~s~----------------~~-~~~~Ek~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDST----------HPSV----------------NS-TREAEKSVNTSLPGFSAP 251 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcccc----------chhh----------------hh-hhHhhhhccccCCccccC
Confidence 99999999999999888888653211110 0000 00 011112233567889999
Q ss_pred hhhcCCCCCccceeechhHHHHHHHhCCCC-CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 650 EILLGTGHGTTADWWSVGIILFELIVGIPP-FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 650 EvL~g~~ys~ksDIWSLGvILyELLTGk~P-F~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
|.=.....+-++|||++|....+|..|..- -.+.+....-..|.+--.. --...-++++.+||+-.|..||
T Consensus 252 ~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~------len~lqr~~i~kcl~~eP~~rp-- 323 (458)
T KOG1266|consen 252 ESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG------LENGLQRGSITKCLEGEPNGRP-- 323 (458)
T ss_pred CcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee------ccCccccCcCcccccCCCCCCc--
Confidence 976556667899999999999999988643 3333322222222111110 0112235789999999999999
Q ss_pred CCHHHHHcCCCCCCCChhHHh
Q 002953 729 GGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 729 ~SAeEILqHPFFk~IdW~~l~ 749 (863)
++.+++-||-.-++.-..+.
T Consensus 324 -~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 324 -DARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred -chhhhhcCceeeecchHHHH
Confidence 99999999988777655443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.2e-10 Score=112.18 Aligned_cols=122 Identities=19% Similarity=0.254 Sum_probs=83.9
Q ss_pred EEeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcCCCCe-eEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVRNPFV-VRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnI-VkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..|+.|.++.|+.+ ..++|... ........+.+|+.+|..+.+.++ ++++.+.. ...++||||++|.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPG-NGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCC-CCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccc
Confidence 34566666666533 23333321 111112346789999998865444 45555433 34589999999988765
Q ss_pred HHHhcCCCChhhHHHHHHHHHHHHHHHHhCCc-----cccCCCCcceeecCCCcEEEeecCCccc
Q 002953 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRV-----VHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 539 lLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GI-----IHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
. ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 3 11123567899999999999885 9999999999998 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-09 Score=126.11 Aligned_cols=98 Identities=21% Similarity=0.299 Sum_probs=70.1
Q ss_pred HHHHHHHHHhcC-----CCCe--eEEEEEEEeCCeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHH-HHHHHH
Q 002953 496 ILAERDILISVR-----NPFV--VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVL-ALEYLH 566 (863)
Q Consensus 496 ~l~Ei~IL~~L~-----HPnI--VkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~-ALeyLH 566 (863)
+.+|.+.+.++. +++| .+++. ......+|||||++|++|.++.... ..+ ....++..++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 455666665552 3433 23332 2234579999999999999876532 112 23445666655 478899
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..|++|+|+||.||+++.+|.++|+|||++..
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 99999999999999999999999999999874
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.7e-09 Score=109.47 Aligned_cols=97 Identities=20% Similarity=0.237 Sum_probs=76.6
Q ss_pred HHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEeecCCCChHH-HHHhcCCCChhhHHHHHHHHHHHHHHH-HhCCcc
Q 002953 496 ILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLDEDVARVYIAEVVLALEYL-HSLRVV 571 (863)
Q Consensus 496 ~l~Ei~IL~~L~H--PnIVkL~~~f~d~~~lyLVmEy~~GGsL~d-lLk~~g~L~e~~i~~Ia~QIl~ALeyL-Hs~GII 571 (863)
..+|.+.|.++.. -.+++++++ ...+|||||+.++.+.. .++. ..++...+..+..+++.+|..| |+.|||
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4589999999853 567777764 56789999997654432 2332 3456667778889999999999 899999
Q ss_pred ccCCCCcceeecCCCcEEEeecCCccc
Q 002953 572 HRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 572 HRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|+||+|.|||+. ++.+.|+|||.|..
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 999999999996 57899999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.6e-10 Score=127.57 Aligned_cols=235 Identities=23% Similarity=0.199 Sum_probs=167.2
Q ss_pred eEEEeecccceeeccc--------cceehhhh--hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 463 DLLLAGKGALSEHDDF--------PQVLKKAD--MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~--------~kvlKK~~--i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.+..||.|.|+.|..+ .++++... .........-+.|+-+...+ .|.+++.++..+......|+-.|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3457888888876442 22222211 11222223345677777776 4899999998888888888999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||+++.....
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-------- 420 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-------- 420 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--------
Confidence 999988877555668899999999999999999999999999999999999886 77899999987621110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCC--ChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL--APEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~Ym--APEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.....++-.++ ++.......+..++|++|||..+++.++|.+.-.....
T Consensus 421 --------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--- 471 (524)
T KOG0601|consen 421 --------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--- 471 (524)
T ss_pred --------------------------cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---
Confidence 01122233333 55555667789999999999999999998654322211
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
...|..+.. +..+. ...++..+.+.++..++..|+ .+.++..|.=|
T Consensus 472 ~~~i~~~~~--p~~~~-~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 SLTIRSGDT--PNLPG-LKLQLQVLLKVMINPDRKRRP---SAVELSLHSEF 517 (524)
T ss_pred ceeeecccc--cCCCc-hHHhhhhhhhhhcCCccccch---hhhhhcccchh
Confidence 112223322 22233 448899999999999999999 78888777644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.5e-09 Score=106.30 Aligned_cols=104 Identities=28% Similarity=0.296 Sum_probs=84.0
Q ss_pred hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH
Q 002953 487 MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 566 (863)
Q Consensus 487 i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH 566 (863)
+..+-..++..+|+++|.++.--.|...+-++.+.....|+|||++|..|.+++... ...++..+-..+.-||
T Consensus 37 LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH 109 (204)
T COG3642 37 LDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLH 109 (204)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHH
Confidence 333444567889999999987666666565677778889999999998888888764 1356667777788899
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..||||+||.++||++...+ +.++||||+.+
T Consensus 110 ~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 110 KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999999997654 99999999984
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.5e-09 Score=125.48 Aligned_cols=71 Identities=27% Similarity=0.417 Sum_probs=54.3
Q ss_pred CCeEEEEEeecCCCChHHH--HHhcC----CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEE
Q 002953 521 RENLYLVMEYLNGGDLYSL--LRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKL 590 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dl--Lk~~g----~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKL 590 (863)
....+|||||+.|+.|.++ +...+ .+.+..+..++.|+ +..|++|+|+||.||+++.+| .+++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 3457899999999999874 33333 24444455555554 469999999999999999888 9999
Q ss_pred eecCCccc
Q 002953 591 TDFGLSKV 598 (863)
Q Consensus 591 iDFGLAk~ 598 (863)
+|||++..
T Consensus 306 lDFGivg~ 313 (537)
T PRK04750 306 LDFGIVGS 313 (537)
T ss_pred EecceEEE
Confidence 99999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.9e-08 Score=102.12 Aligned_cols=134 Identities=19% Similarity=0.174 Sum_probs=94.3
Q ss_pred EEEeecccceeeccc------cceehhhhhhch-hHHHHHHHHHHHHHhcCC--CCeeEEEEEEEeCC---eEEEEEeec
Q 002953 464 LLLAGKGALSEHDDF------PQVLKKADMIRK-NAVESILAERDILISVRN--PFVVRFFYSFTCRE---NLYLVMEYL 531 (863)
Q Consensus 464 l~vLGkG~FG~V~~~------~kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~---~lyLVmEy~ 531 (863)
+..||.|.++.++.+ ..++|....... .....+.+|++++..+.+ ..+++++.+..... ..|+||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 345677777766442 234443322111 134568899999999975 44677777666542 678999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh--------------------------------------------
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-------------------------------------------- 567 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-------------------------------------------- 567 (863)
+|.+|...+.. ..+++.....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99888776532 346666677777777777777773
Q ss_pred ------------CCccccCCCCcceeecC--CCcEEEeecCCccc
Q 002953 568 ------------LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ------------~GIIHRDLKPeNILLd~--~g~VKLiDFGLAk~ 598 (863)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.8e-08 Score=98.04 Aligned_cols=109 Identities=22% Similarity=0.257 Sum_probs=85.4
Q ss_pred hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC-CChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHH
Q 002953 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLH 566 (863)
Q Consensus 490 k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G-GsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLH 566 (863)
+-...+..+|+++|.++.--.|.-..-+|.+...-.|+|||++| .++.+++.... .........++..|-..|.-||
T Consensus 51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH 130 (229)
T KOG3087|consen 51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH 130 (229)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh
Confidence 34456788999999998755555444557777888999999987 57888876642 2333333678889999999999
Q ss_pred hCCccccCCCCcceeecCCC---cEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~ 598 (863)
..+|||+||..+||++..+| .+.|+|||++..
T Consensus 131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999998775 358999999874
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-08 Score=119.88 Aligned_cols=168 Identities=20% Similarity=0.285 Sum_probs=119.4
Q ss_pred HHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhh
Q 002953 557 EVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635 (863)
Q Consensus 557 QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~ 635 (863)
+++.||.|+|. .++||+.|.|++|.++..|.+||+.|+++..... +.-..... ++ ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~--------~~~~p~~~-------yd-------~~ 164 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG--------PTEYPFSE-------YD-------PP 164 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC--------CCcccccc-------CC-------CC
Confidence 45589999995 5899999999999999999999999998763111 00000000 00 01
Q ss_pred ccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH-hCCCCCCCCChHHHHHHHh-hcCCCCCCCCCCCCHHHHHH
Q 002953 636 KKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNIL-NRKIPWPRVPEEMSPEAHDL 713 (863)
Q Consensus 636 ~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL-TGk~PF~~~~~~el~~kIl-~~~~~~p~~p~~iS~el~dL 713 (863)
......-...|.|||++.+..-+.++|+|||||++|.+. .|+.-+........+..-. ........+...+|.++++=
T Consensus 165 lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 165 LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred CChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHH
Confidence 112234567899999999988899999999999999998 5666565443222221111 11112223456799999999
Q ss_pred HHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 714 I~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
+.++|..++..|| ++.+++.-|||.+..-.+|.
T Consensus 245 l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 245 LKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred HHHHhcCCcccCc---chhhhhcccccCCchhhhhh
Confidence 9999999999999 99999999999986555443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.2e-07 Score=102.60 Aligned_cols=103 Identities=15% Similarity=0.109 Sum_probs=81.2
Q ss_pred HHHHHHHHHHhcCCC--CeeEEEEEEEe-----CCeEEEEEeecCCC-ChHHHHHh--cCCCChhhHHHHHHHHHHHHHH
Q 002953 495 SILAERDILISVRNP--FVVRFFYSFTC-----RENLYLVMEYLNGG-DLYSLLRN--LGCLDEDVARVYIAEVVLALEY 564 (863)
Q Consensus 495 ~~l~Ei~IL~~L~HP--nIVkL~~~f~d-----~~~lyLVmEy~~GG-sL~dlLk~--~g~L~e~~i~~Ia~QIl~ALey 564 (863)
.+.+|...+.+|..- .+++++.+++. ...-|||||++++- +|.+++.. ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 477899998888433 33444555543 23478999999885 79988864 2445667788999999999999
Q ss_pred HHhCCccccCCCCcceeecC-------CCcEEEeecCCcc
Q 002953 565 LHSLRVVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 597 (863)
Q Consensus 565 LHs~GIIHRDLKPeNILLd~-------~g~VKLiDFGLAk 597 (863)
||.+||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999985 4689999999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.7e-07 Score=95.64 Aligned_cols=106 Identities=25% Similarity=0.289 Sum_probs=86.5
Q ss_pred HHHHHHHHHHHHhcCC--CCeeEEEEEEEeCC----eEEEEEeecCC-CChHHHHHhcCCCChhhHHHHHHHHHHHHHHH
Q 002953 493 VESILAERDILISVRN--PFVVRFFYSFTCRE----NLYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYL 565 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~----~lyLVmEy~~G-GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyL 565 (863)
.....+|...+..|.. =.+++.+++.+... ..|||+|+++| .+|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3467788888887753 23556666665533 35899999988 48999998755577888889999999999999
Q ss_pred HhCCccccCCCCcceeecCCC---cEEEeecCCccc
Q 002953 566 HSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKV 598 (863)
Q Consensus 566 Hs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~ 598 (863)
|.+||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.4e-07 Score=105.00 Aligned_cols=204 Identities=20% Similarity=0.233 Sum_probs=145.3
Q ss_pred ceeeccccceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC----CeEEEEEeecCC-CChHHHHHh----
Q 002953 472 LSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR----ENLYLVMEYLNG-GDLYSLLRN---- 542 (863)
Q Consensus 472 FG~V~~~~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~----~~lyLVmEy~~G-GsL~dlLk~---- 542 (863)
|..+++-.+++++.+..+.........-+++++++.|+|||++.++|.+. ..++||++|.++ ++|.++.-.
T Consensus 296 ~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~ 375 (655)
T KOG3741|consen 296 TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPF 375 (655)
T ss_pred eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcc
Confidence 44455556677766444333333445667889999999999999999854 358999999986 577765421
Q ss_pred -----------cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 543 -----------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 543 -----------~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
....+|..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+|+|...|+.-......
T Consensus 376 t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------- 447 (655)
T KOG3741|consen 376 TKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------- 447 (655)
T ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------
Confidence 1247889999999999999999999999999999999999988889988777644211000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC-CCCCChHHH-H
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP-FNAEHPQQI-F 689 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P-F~~~~~~el-~ 689 (863)
+ +-+.+ -.+-|.=.||.+++.|.+|..- +..+..++. .
T Consensus 448 ------------------------------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~ 487 (655)
T KOG3741|consen 448 ------------------------------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL 487 (655)
T ss_pred ------------------------------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHH
Confidence 0 00111 1356788899999999999543 222333222 2
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..| ....+.+++++|..+...++.++ ++.+++.|
T Consensus 488 ~~I----------~~~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 488 TRI----------TTTYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred HHh----------hhhhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 222 34578899999999999998873 67888876
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.8e-07 Score=94.92 Aligned_cols=99 Identities=24% Similarity=0.265 Sum_probs=69.5
Q ss_pred HHHHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEeecC--CCChHHHHHhcCCCChhhHHHHHHHHHHHHHH-HHh
Q 002953 493 VESILAERDILISVRNP--FVVRFFYSFTCRENLYLVMEYLN--GGDLYSLLRNLGCLDEDVARVYIAEVVLALEY-LHS 567 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~HP--nIVkL~~~f~d~~~lyLVmEy~~--GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALey-LHs 567 (863)
.....+|.+.|.++..- ++++++++. ..+|||||++ |..+..+... .++......++.+++..+.. +|+
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~ 125 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK 125 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh
Confidence 35678899999999765 567776542 3479999998 6555443332 23356677888888886655 579
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.||||+||.+.|||++.+ .+.|+|||.+..
T Consensus 126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred cCceecCCChhhEEeecc-eEEEEecCccee
Confidence 999999999999999877 999999999873
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.6e-06 Score=94.03 Aligned_cols=171 Identities=19% Similarity=0.346 Sum_probs=119.3
Q ss_pred EEEEEeecCCCC-hHHHHH------hcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 524 LYLVMEYLNGGD-LYSLLR------NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 524 lyLVmEy~~GGs-L~dlLk------~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
+.++|..+.|.. ...++. ....+.+.-+...++.|+.+.+.||++|.+-+|+.++|+|+.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 788999988752 222221 1234678888899999999999999999999999999999999999999984321
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHH
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILF 671 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILy 671 (863)
.. ...+......+|.+.|.+||.-. +-+-+...|.|.||++++
T Consensus 165 qi--------------------------------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF 212 (637)
T COG4248 165 QI--------------------------------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIF 212 (637)
T ss_pred ee--------------------------------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHH
Confidence 11 00112334578999999999765 334567889999999999
Q ss_pred HHHhC-CCCCCCC-------ChHHHHHHHhhcC-----------CCCCCC--CCCCCHHHHHHHHhhccCC--cCCcCCC
Q 002953 672 ELIVG-IPPFNAE-------HPQQIFDNILNRK-----------IPWPRV--PEEMSPEAHDLIDRFLTED--PHQRLGS 728 (863)
Q Consensus 672 ELLTG-k~PF~~~-------~~~el~~kIl~~~-----------~~~p~~--p~~iS~el~dLI~k~L~~D--P~kRpg~ 728 (863)
++|.| +.||.+- ++-+ ..|..+. .+.|.- ..-++++++.|..+|+..- +.-||+.
T Consensus 213 ~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 213 HLLFGGRHPYSGIPLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred HHHhcCCCCCCcccccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 99986 9999652 1111 1222211 111111 1346889999999999743 4579954
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.1e-07 Score=106.43 Aligned_cols=235 Identities=24% Similarity=0.243 Sum_probs=155.7
Q ss_pred Eeecccceeeccccceehhhhhhc-hhHHHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEeecCCC-ChHHHH-H
Q 002953 466 LAGKGALSEHDDFPQVLKKADMIR-KNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLVMEYLNGG-DLYSLL-R 541 (863)
Q Consensus 466 vLGkG~FG~V~~~~kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~~lyLVmEy~~GG-sL~dlL-k 541 (863)
-++||+++++++.+-...|..... -.......-++++|.+++||| .+..++.++.+.+.+++|+++.++ +-...+ .
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~ 328 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV 328 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh
Confidence 578999998876542222211100 011134556899999999999 788888888888999999999876 222111 1
Q ss_pred hcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCC
Q 002953 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDE 621 (863)
Q Consensus 542 ~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~ 621 (863)
..-.|.......+.+.-+.+|++||+.-=+||| ||+... +..++.||+....+.
T Consensus 329 se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~--------------------- 382 (829)
T KOG0576|consen 329 SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT--------------------- 382 (829)
T ss_pred hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC---------------------
Confidence 112244445556667778899999998778998 777654 688999998765210
Q ss_pred CccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC
Q 002953 622 EPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR 701 (863)
Q Consensus 622 ~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~ 701 (863)
. ....++..+|+.++|||+.....+....|.|++|+-..+|.-|.+|-... ......+-.+. ..+.
T Consensus 383 -----~------~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p-~s~~ 448 (829)
T KOG0576|consen 383 -----R------TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGP-NSPM 448 (829)
T ss_pred -----c------ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCC-Cccc
Confidence 0 01356788999999999999999999999999999888888888775431 11111111111 0011
Q ss_pred CC--CCCCHHHH-HHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 702 VP--EEMSPEAH-DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 702 ~p--~~iS~el~-dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+. ...+.... ++...|+..-|..|+ ....++.|.+|.+.
T Consensus 449 L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfngC 490 (829)
T KOG0576|consen 449 LTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNGC 490 (829)
T ss_pred cchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhccC
Confidence 10 01111111 477788998999888 88889999999865
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=83.98 Aligned_cols=109 Identities=16% Similarity=0.229 Sum_probs=84.1
Q ss_pred hhHHHHHHHHHHHHHhcCC--CCeeEEEEEEEeCC----eEEEEEeecCC-CChHHHHHhc--CCCChhhHHHHHHHHHH
Q 002953 490 KNAVESILAERDILISVRN--PFVVRFFYSFTCRE----NLYLVMEYLNG-GDLYSLLRNL--GCLDEDVARVYIAEVVL 560 (863)
Q Consensus 490 k~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~----~lyLVmEy~~G-GsL~dlLk~~--g~L~e~~i~~Ia~QIl~ 560 (863)
+.....+.+|...|.+|.. -.+++....-.... .-+||+|-+.| .+|.+++.+. .+.+......++.+++.
T Consensus 60 P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~ 139 (216)
T PRK09902 60 PFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVAL 139 (216)
T ss_pred CCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHH
Confidence 3355789999999998853 22566653222222 36899998754 5888888663 34577777899999999
Q ss_pred HHHHHHhCCccccCCCCcceeecCCCc--EEEeecCCccc
Q 002953 561 ALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKV 598 (863)
Q Consensus 561 ALeyLHs~GIIHRDLKPeNILLd~~g~--VKLiDFGLAk~ 598 (863)
+|.-||..|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 140 ~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 140 AFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999999999999999999999987777 99999987663
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1e-05 Score=87.56 Aligned_cols=125 Identities=20% Similarity=0.218 Sum_probs=89.4
Q ss_pred EEEeecccceeeccccc-eehhhhhhc-hhHHHHHHHHHHHHHhcCCC--CeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 464 LLLAGKGALSEHDDFPQ-VLKKADMIR-KNAVESILAERDILISVRNP--FVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~k-vlKK~~i~~-k~~~e~~l~Ei~IL~~L~HP--nIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
+.-+|+-+|-.|..... +..+..... .-......+|.++|.+|... .|++.+++ +...+||||++|-.|...
T Consensus 122 fHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~ 197 (304)
T COG0478 122 FHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL 197 (304)
T ss_pred EeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc
Confidence 34677777777644322 222222221 12334578899999999755 67777764 667899999999777653
Q ss_pred HHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 540 Lk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
- ++.+....++..|+.-+.-+-..||||+|+.+=|||++.+|.+.++||-.+.
T Consensus 198 r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 198 R-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred c-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 2 2355566677777777777779999999999999999999999999997665
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.8e-05 Score=81.25 Aligned_cols=67 Identities=28% Similarity=0.487 Sum_probs=53.5
Q ss_pred CeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
...+|||||++|..|.++.. +++ .+...|..+|.-||+.|++|+|.+|.|++++.+ .++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 34568999999988876542 233 244567788999999999999999999999855 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2e-05 Score=97.76 Aligned_cols=203 Identities=24% Similarity=0.289 Sum_probs=143.5
Q ss_pred HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe----EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh
Q 002953 492 AVESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS 567 (863)
Q Consensus 492 ~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~----lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs 567 (863)
.......|...+.++.|+|++.++.+.-.+.. +.+..++|.+.++...+...+.++...++.+..+++.||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34445667788889999999999877655433 34667899999999999999999999999999999999999999
Q ss_pred CCccccCCCCc---ceeecCCCcEEEe--ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccC
Q 002953 568 LRVVHRDLKPD---NLLIAHDGHIKLT--DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642 (863)
Q Consensus 568 ~GIIHRDLKPe---NILLd~~g~VKLi--DFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vG 642 (863)
....|.=|... +-.++..+.+.++ ||+.++.+... .......-
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--------------------------------~~~~~~~~ 352 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--------------------------------EKSFSDLL 352 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCc--------------------------------ccchhhcC
Confidence 85554444333 3333445556655 77776632111 11122344
Q ss_pred CCCCCChhhhcCCCCCc--cceeechhHHHHHHHhCCCCCC-CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhcc
Q 002953 643 TPDYLAPEILLGTGHGT--TADWWSVGIILFELIVGIPPFN-AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719 (863)
Q Consensus 643 Tp~YmAPEvL~g~~ys~--ksDIWSLGvILyELLTGk~PF~-~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~ 719 (863)
+..+.+||......+.. ..|+|.+|.++..+..|..+-. ..... .+ ++.....+..+++.+|+.
T Consensus 353 ~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~----~~---------l~~~~~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 353 AEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV----SL---------LDVLSTSELLDALPKCLD 419 (1351)
T ss_pred ccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh----hh---------hccccchhhhhhhhhhcc
Confidence 56678888887766544 4699999999999998764421 11111 11 112222377889999999
Q ss_pred CCcCCcCCCCCHHHHHcCCCCCC
Q 002953 720 EDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 720 ~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.++++|+ ++.+++.|+|.+.
T Consensus 420 ~~~~~Rl---~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 420 EDSEERL---SALELLTHPFLRF 439 (1351)
T ss_pred hhhhhcc---chhhhhhchhccc
Confidence 9999999 9999999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00011 Score=77.55 Aligned_cols=132 Identities=18% Similarity=0.117 Sum_probs=78.7
Q ss_pred EEEeecccceeeccc---cceehhhhhhchhHHHHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEeecCCCC-hH
Q 002953 464 LLLAGKGALSEHDDF---PQVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYSFTCRENLYLVMEYLNGGD-LY 537 (863)
Q Consensus 464 l~vLGkG~FG~V~~~---~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPn--IVkL~~~f~d~~~lyLVmEy~~GGs-L~ 537 (863)
...||.|..+.++.. ..++|.... ......+.+|.++|..+..-. +.+.+++....+..++|||+++|.+ +.
T Consensus 6 ~~~i~~G~t~~~y~~~~~~~VlR~~~~--~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~ 83 (226)
T TIGR02172 6 WTQTGEGGNGESYTHKTGKWMLKLYNP--GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFS 83 (226)
T ss_pred heeecCCCCcceeEecCCCEEEEeCCC--CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchh
Confidence 346788888887653 223333222 112345789999999986433 5677777777888899999999964 11
Q ss_pred --------------HHHHh----cCCC-----Chhh-HHHHHH----------HHHH-HHHHHH----hCCccccCCCCc
Q 002953 538 --------------SLLRN----LGCL-----DEDV-ARVYIA----------EVVL-ALEYLH----SLRVVHRDLKPD 578 (863)
Q Consensus 538 --------------dlLk~----~g~L-----~e~~-i~~Ia~----------QIl~-ALeyLH----s~GIIHRDLKPe 578 (863)
..+.. -..+ +... ...+.. .+.. ...+|. ...++|+|+.|.
T Consensus 84 ~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~ 163 (226)
T TIGR02172 84 RIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIG 163 (226)
T ss_pred hhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCC
Confidence 11111 0001 1000 001100 0111 122222 224789999999
Q ss_pred ceeecCCCcEEEeecCCccc
Q 002953 579 NLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 579 NILLd~~g~VKLiDFGLAk~ 598 (863)
||+++.++ +.++||+.+..
T Consensus 164 Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 164 NLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cEEEcCCC-cEEEechhcCc
Confidence 99999888 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00031 Score=73.79 Aligned_cols=105 Identities=20% Similarity=0.115 Sum_probs=66.0
Q ss_pred HHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChHHHH----------------HhcCCCCh-----h-h
Q 002953 494 ESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL----------------RNLGCLDE-----D-V 550 (863)
Q Consensus 494 e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlL----------------k~~g~L~e-----~-~ 550 (863)
..+.+|+++|..+. +--+++++++....+..++|||+++|.+|.... .+...++. . .
T Consensus 36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~ 115 (244)
T cd05150 36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRR 115 (244)
T ss_pred cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchh
Confidence 34678999998884 344678888877777789999999998776431 00001110 0 0
Q ss_pred HHHHHHH-----------------------HHHHHHHH-------HhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 551 ARVYIAE-----------------------VVLALEYL-------HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 551 i~~Ia~Q-----------------------Il~ALeyL-------Hs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
......+ +...+..| ....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 116 LDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0000000 11111222 123489999999999999887788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00083 Score=68.21 Aligned_cols=133 Identities=26% Similarity=0.265 Sum_probs=73.5
Q ss_pred EEEeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcCCC--CeeEEEEEEEe---CCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVRNP--FVVRFFYSFTC---RENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HP--nIVkL~~~f~d---~~~lyLVmEy~~G 533 (863)
+..|+.|..+.++.+ ..++|..... .....+.+|..++..+... -+.+++..... ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 456788888776443 2344432222 4566788999999888533 35666654433 3357999999999
Q ss_pred CChHH----------------HHHh---c-CC---CChhh------HHHH---------------HHHHHH-HHHHHH--
Q 002953 534 GDLYS----------------LLRN---L-GC---LDEDV------ARVY---------------IAEVVL-ALEYLH-- 566 (863)
Q Consensus 534 GsL~d----------------lLk~---~-g~---L~e~~------i~~I---------------a~QIl~-ALeyLH-- 566 (863)
..+.. .+.. . .. +.... .... ...+.. .++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 1111 1 00 00000 0000 111222 233333
Q ss_pred -----hCCccccCCCCcceeec-CCCcEEEeecCCccc
Q 002953 567 -----SLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 -----s~GIIHRDLKPeNILLd-~~g~VKLiDFGLAk~ 598 (863)
...++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 24699999999999999 567778999998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00058 Score=71.75 Aligned_cols=31 Identities=35% Similarity=0.458 Sum_probs=26.4
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.|.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999998765567999998874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00081 Score=83.60 Aligned_cols=106 Identities=23% Similarity=0.400 Sum_probs=66.7
Q ss_pred HHHHHHHHHHHhcC-CCCe--eEEEEEEEeC---CeEEEEEeecCCCChHH--------------------HHHhcCCCC
Q 002953 494 ESILAERDILISVR-NPFV--VRFFYSFTCR---ENLYLVMEYLNGGDLYS--------------------LLRNLGCLD 547 (863)
Q Consensus 494 e~~l~Ei~IL~~L~-HPnI--VkL~~~f~d~---~~lyLVmEy~~GGsL~d--------------------lLk~~g~L~ 547 (863)
..+.+|.++|+.|. |++| ++++.++.+. +..|+||||++|..+.+ .|..-..++
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd 162 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSAD 162 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 46789999999995 6654 7777776654 46799999999864321 111100000
Q ss_pred ----------------hhhHHHHHHH---------------HHHHHHHHHh-----------CCccccCCCCcceeecCC
Q 002953 548 ----------------EDVARVYIAE---------------VVLALEYLHS-----------LRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 548 ----------------e~~i~~Ia~Q---------------Il~ALeyLHs-----------~GIIHRDLKPeNILLd~~ 585 (863)
...+..+..+ +...+++|.. ..+||+|++|.|||++.+
T Consensus 163 ~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~ 242 (822)
T PLN02876 163 VDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT 242 (822)
T ss_pred chhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC
Confidence 1122221111 2233556632 359999999999999853
Q ss_pred -Cc-EEEeecCCcccc
Q 002953 586 -GH-IKLTDFGLSKVG 599 (863)
Q Consensus 586 -g~-VKLiDFGLAk~~ 599 (863)
+. +-|+||+++..+
T Consensus 243 ~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 243 EDRVIGILDWELSTLG 258 (822)
T ss_pred CCeEEEEEeeeccccC
Confidence 33 579999998853
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0015 Score=68.27 Aligned_cols=98 Identities=24% Similarity=0.313 Sum_probs=72.8
Q ss_pred HHHHHHHHHHHHhcC------CCCeeEEEEEEEeCCeEEEEEeecCC------CChHHHHHhcCCCChhhHHHHHHHHHH
Q 002953 493 VESILAERDILISVR------NPFVVRFFYSFTCRENLYLVMEYLNG------GDLYSLLRNLGCLDEDVARVYIAEVVL 560 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~------HPnIVkL~~~f~d~~~lyLVmEy~~G------GsL~dlLk~~g~L~e~~i~~Ia~QIl~ 560 (863)
.....+|+.-...+. +.+|.++|++.+++..+.+|+|.+.. .+|.+++++ +.+++ ... ..+-.
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~ 129 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDE 129 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHH
Confidence 455667777666655 78999999999999999999998643 367888855 44655 333 33344
Q ss_pred HHHHHHhCCccccCCCCcceeecCCC----cEEEee-cCC
Q 002953 561 ALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTD-FGL 595 (863)
Q Consensus 561 ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiD-FGL 595 (863)
-.+||-+++|+.+||+|.||++...+ .+.|+| ||-
T Consensus 130 f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 130 FKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 45788999999999999999997542 588888 454
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.29 E-value=2.2e-05 Score=98.92 Aligned_cols=209 Identities=20% Similarity=0.123 Sum_probs=144.1
Q ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHh
Q 002953 494 ESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHS 567 (863)
Q Consensus 494 e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs 567 (863)
+....|++-++...|+++...+.-.... ...|.+++|+.+|.++..|-+. ..+...-+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 4556677777778899988876555433 3479999999999999998654 223333333333444777777774
Q ss_pred C-----CccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccC
Q 002953 568 L-----RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642 (863)
Q Consensus 568 ~-----GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vG 642 (863)
. --+|++||+-|.+|..+..+|+.++|+.+... | ........++
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn---------p----------------------~~sf~Gl~l~ 1402 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN---------P----------------------VLSFFGLELC 1402 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccC---------c----------------------hHhhhhhhhC
Confidence 3 27899999999999999999999999988310 0 0112335678
Q ss_pred CCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCC---CCCCCCCCCHHHHHHHHhhcc
Q 002953 643 TPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIP---WPRVPEEMSPEAHDLIDRFLT 719 (863)
Q Consensus 643 Tp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~---~p~~p~~iS~el~dLI~k~L~ 719 (863)
++.|++|++...-.++.++|+|..|+.+|+.-.|..+|- ...+.++.+... +-.++.-.|.++......+|-
T Consensus 1403 sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll 1477 (2724)
T KOG1826|consen 1403 SPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLL 1477 (2724)
T ss_pred CHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHH
Confidence 899999999999889999999999999999988887773 223333332221 112222334555555556666
Q ss_pred CCcCCcCCCCCHHHHHcCCCCC
Q 002953 720 EDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 720 ~DP~kRpg~~SAeEILqHPFFk 741 (863)
..-..|| .-..++.-+.|.
T Consensus 1478 ~K~~~rp---~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1478 WKYMERP---GQYISLSRDHFA 1496 (2724)
T ss_pred HHhhhcc---hhhhhccccccc
Confidence 6678888 666677666664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00069 Score=79.93 Aligned_cols=99 Identities=25% Similarity=0.311 Sum_probs=66.3
Q ss_pred HHHHHHHHHhcC-----CCCeeEEEEEEEeCCeEEEEEeecCCCChHHHH--HhcCCCChhhHHHHHHHHHHH-HHHHHh
Q 002953 496 ILAERDILISVR-----NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLA-LEYLHS 567 (863)
Q Consensus 496 ~l~Ei~IL~~L~-----HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlL--k~~g~L~e~~i~~Ia~QIl~A-LeyLHs 567 (863)
+.+|..-+.++. .|+|.-..-+.+-.+.-.|+|||++|-.+.+.. +. ..++.. .++..++.+ +..+-.
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHh
Confidence 456666666652 344332222334445678999999999998884 44 334422 223222222 334445
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.|++|.|.+|.||+++.+|++.+.|||+...
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceec
Confidence 8999999999999999999999999998753
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0012 Score=68.23 Aligned_cols=97 Identities=23% Similarity=0.250 Sum_probs=78.0
Q ss_pred HHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEeecCCCChHHH---HHhcCCCChhhHHHHHHHHHHHHHHHHh---CC
Q 002953 497 LAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL---LRNLGCLDEDVARVYIAEVVLALEYLHS---LR 569 (863)
Q Consensus 497 l~Ei~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl---Lk~~g~L~e~~i~~Ia~QIl~ALeyLHs---~G 569 (863)
..|.-+|+.+.+ ++++++++++- .++|.||...+++... +...-..++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 69999999873 3678999987666421 2222346789999999999999999997 45
Q ss_pred ccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 570 IIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
+.-.|++|+|+-++.+|++|++|...+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcc
Confidence 7789999999999999999999998765
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0054 Score=66.19 Aligned_cols=97 Identities=24% Similarity=0.177 Sum_probs=70.6
Q ss_pred HHHHHHHHHhcC--CCCeeEEEEEEEeCCeEEEEEeecCCC-ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCcc
Q 002953 496 ILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVV 571 (863)
Q Consensus 496 ~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~lyLVmEy~~GG-sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GII 571 (863)
..+|..-|+++. +-.+++.+.++ +-.|||||+... .-.-.|+.. .+....+..+..+++..+.-|-. .|+|
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 456888888874 45566666553 356999999542 111122221 23333688888999999988876 9999
Q ss_pred ccCCCCcceeecCCCcEEEeecCCccc
Q 002953 572 HRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 572 HRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|+||..=|||+. ++.+.|+|||.|..
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cccchhhheEEE-CCeEEEEECccccc
Confidence 999999999998 88999999999873
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.013 Score=64.53 Aligned_cols=73 Identities=10% Similarity=-0.047 Sum_probs=49.3
Q ss_pred eEEEeecccceeeccc----cceehhhhhhchhHHHHHHHHHHHHHhcCC---CCeeEEEEEEEeC---CeEEEEEeecC
Q 002953 463 DLLLAGKGALSEHDDF----PQVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCR---ENLYLVMEYLN 532 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H---PnIVkL~~~f~d~---~~lyLVmEy~~ 532 (863)
...-||.|..+.|+.. .+.++|... .......+.+|...|+.|.. -.|+++++++.+. +..|||||+++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 3447899999988653 232333211 11133578899999998853 3678888776543 66899999999
Q ss_pred CCCh
Q 002953 533 GGDL 536 (863)
Q Consensus 533 GGsL 536 (863)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.013 Score=61.10 Aligned_cols=31 Identities=19% Similarity=0.425 Sum_probs=27.6
Q ss_pred CCccccCCCCcceeecC-CCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 36999999999999998 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.022 Score=67.53 Aligned_cols=83 Identities=27% Similarity=0.416 Sum_probs=55.5
Q ss_pred eeEEEEEEEeCCeEEEEEeecCCCChHHH--HHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC----
Q 002953 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSL--LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---- 584 (863)
Q Consensus 511 IVkL~~~f~d~~~lyLVmEy~~GGsL~dl--Lk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---- 584 (863)
|+++|-.+ ...-.|+||||+|..+.++ |.+. .++...+...+.+.. ++-|=..|++|.|-+|.||++..
T Consensus 266 VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 266 VPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCC
Confidence 55555332 2346899999999887765 4443 355543333222221 22333578999999999999994
Q ss_pred CCcEEEeecCCccc
Q 002953 585 DGHIKLTDFGLSKV 598 (863)
Q Consensus 585 ~g~VKLiDFGLAk~ 598 (863)
++.+.+.|||+...
T Consensus 341 ~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAV 354 (538)
T ss_pred CccEEEEccccccc
Confidence 56899999999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.022 Score=61.53 Aligned_cols=106 Identities=21% Similarity=0.108 Sum_probs=63.3
Q ss_pred HHHHHHHHHHHHhcCCC--CeeEEEE------EEEeCCeEEEEEeecCCCChHH----HHH----------hc-CCCCh-
Q 002953 493 VESILAERDILISVRNP--FVVRFFY------SFTCRENLYLVMEYLNGGDLYS----LLR----------NL-GCLDE- 548 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~HP--nIVkL~~------~f~d~~~lyLVmEy~~GGsL~d----lLk----------~~-g~L~e- 548 (863)
...+..|++++..|.+- .+++++. +....+..++|++|++|..+.. .+. .. ..+..
T Consensus 50 ~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~ 129 (296)
T cd05153 50 AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGE 129 (296)
T ss_pred hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCcc
Confidence 34577788888887432 2555543 2234456789999999976532 110 00 01110
Q ss_pred -------hhHH------------HHHHHHHHHHHHHHh-------CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 549 -------DVAR------------VYIAEVVLALEYLHS-------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 549 -------~~i~------------~Ia~QIl~ALeyLHs-------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.... .....+..++.++.+ .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 130 RNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 0000 011122334444443 4799999999999999877778999998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.023 Score=60.48 Aligned_cols=29 Identities=28% Similarity=0.497 Sum_probs=26.1
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.|.||+++.++ +.|+||..|..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.0086 Score=66.87 Aligned_cols=123 Identities=15% Similarity=0.161 Sum_probs=82.3
Q ss_pred EEeecccceeeccccceehhhhhhchh--HHHHHHHHHHHHHhcC-CCC-eeEEEEEEEeCCeEEEEEeecCCCChHHHH
Q 002953 465 LLAGKGALSEHDDFPQVLKKADMIRKN--AVESILAERDILISVR-NPF-VVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~kvlKK~~i~~k~--~~e~~l~Ei~IL~~L~-HPn-IVkL~~~f~d~~~lyLVmEy~~GGsL~dlL 540 (863)
.-||+-+|-.|..-..-+++.....-- ..-...+|...|+.|. |-+ |++.+++ +..++|||++.|-.|...-
T Consensus 124 HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~ 199 (465)
T KOG2268|consen 124 HRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR 199 (465)
T ss_pred HhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee
Confidence 367888887764433222222111111 1124568999999985 433 4555543 5678999999998876543
Q ss_pred HhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 541 k~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
.- ..+..+...+..-+--|-.+|+||+|..-=||+|+.+++++++||-...
T Consensus 200 ~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 200 HV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred ec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 21 2233455566666778889999999999999999999999999996543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.13 Score=56.49 Aligned_cols=31 Identities=32% Similarity=0.358 Sum_probs=26.7
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.|+||+|++|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999998874
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.036 Score=57.40 Aligned_cols=120 Identities=22% Similarity=0.213 Sum_probs=80.2
Q ss_pred Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCee-EEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVV-RFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIV-kL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|.+|.|+... +++|... .......+..|+++|..+...++- ++|.+.. .++.|||+.|.+|.+.
T Consensus 29 ~L~KG~~s~Vyl~~~~~~~~a~Kvrr--~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~ 102 (201)
T COG2112 29 ELAKGTTSVVYLGEWRGGEVALKVRR--RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhcccccEEEEeeccCceEEEEEec--CCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhh
Confidence 79999999997642 3343321 233456788999999999876654 4554432 3455999999888776
Q ss_pred HHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCC-CcceeecCCCcEEEeecCCccc
Q 002953 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK-PDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 540 Lk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLK-PeNILLd~~g~VKLiDFGLAk~ 598 (863)
-... +. .-+..++.+---|-..||-|..|. |..++|..++.+.|+||.-|++
T Consensus 103 ~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 103 EIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 5421 11 223344444444667899999986 5555555666999999998874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.11 Score=56.64 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=25.8
Q ss_pred CccccCCCCcceeecCCCc-EEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGH-IKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~-VKLiDFGLAk~ 598 (863)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.17 Score=58.41 Aligned_cols=31 Identities=16% Similarity=0.338 Sum_probs=26.7
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...++|+|+.|.|||+..+ .++++||-++..
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 3468999999999999765 699999998875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.31 Score=51.42 Aligned_cols=85 Identities=25% Similarity=0.272 Sum_probs=61.9
Q ss_pred HHHHHHHHHHHhcC---CCCe--eEEEEEEEeCC------------------eEEEEEeecCCCChHHHHHhcCCCChhh
Q 002953 494 ESILAERDILISVR---NPFV--VRFFYSFTCRE------------------NLYLVMEYLNGGDLYSLLRNLGCLDEDV 550 (863)
Q Consensus 494 e~~l~Ei~IL~~L~---HPnI--VkL~~~f~d~~------------------~lyLVmEy~~GGsL~dlLk~~g~L~e~~ 550 (863)
.-|..|.+...+|+ +.++ |++++++.-.. ...||.||++... .+.
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~--- 166 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ--- 166 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc---
Confidence 45788888887774 4566 99998884331 1357888876643 122
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 551 i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
..-+.+|+.-|..+|..||+-+|+|+.|.. .-+|+|||.+
T Consensus 167 -~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 -IRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 233567888889999999999999999997 2389999964
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.057 Score=63.46 Aligned_cols=163 Identities=21% Similarity=0.289 Sum_probs=104.3
Q ss_pred HHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCcccc
Q 002953 495 SILAERDILISVRNPFVVRFFYSFTCRE-NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHR 573 (863)
Q Consensus 495 ~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHR 573 (863)
.++.-..+++.+.|+|...++++-.... ...+|||++ +.+|.+++.... +-.. +++ .+|+.|-
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~-------s~~-------~~~~~~~ 91 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDE-------SLL-------AHGVLHL 91 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchh-------hhc-------cccccee
Confidence 3566778899999999999998776543 478999999 569999987643 2111 111 2333321
Q ss_pred CCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc
Q 002953 574 DLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653 (863)
Q Consensus 574 DLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~ 653 (863)
| .++++| -++.. ..+..|
T Consensus 92 -----~-------~~~~td-~~~t~--------------------------------------~~~~~~----------- 109 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLTK--------------------------------------YPSPIG----------- 109 (725)
T ss_pred -----h-------hhhccc-ccccc--------------------------------------CCCCCC-----------
Confidence 2 223344 11110 001112
Q ss_pred CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC---------CCCCCCHHHHHHHHhhccCCcCC
Q 002953 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR---------VPEEMSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 654 g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~---------~p~~iS~el~dLI~k~L~~DP~k 724 (863)
+++||||+|.++.++.-|...|......+....+..-...... +.-.++.....+..+|+-..|..
T Consensus 110 -----pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 110 -----PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred -----cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccc
Confidence 3999999999999999998777665555544444331110000 01135667788999999999999
Q ss_pred cCCCCCHHHHHcCCCCCCC
Q 002953 725 RLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~I 743 (863)
|| ...++.+|+-|..+
T Consensus 185 r~---l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RP---LPMELSKRCSFTEV 200 (725)
T ss_pred cc---chhHHhcCccHHHH
Confidence 99 88899999888765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.21 Score=56.19 Aligned_cols=31 Identities=23% Similarity=0.458 Sum_probs=27.0
Q ss_pred CCccccCCCCcceeecC-CCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~ 598 (863)
..++|+|+++.|||++. ++.+.|+||..|..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 36899999999999986 46899999998874
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.2 Score=53.75 Aligned_cols=98 Identities=18% Similarity=0.181 Sum_probs=64.8
Q ss_pred eehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHH
Q 002953 481 VLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVV 559 (863)
Q Consensus 481 vlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl 559 (863)
.+||..-..-. ...-+.++.+++++++ .|+++..- ..-.+.+++|+|-..... ...++.-=+
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-------------~~N~i~agi 151 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-------------FSNFITAGI 151 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-------------hhHHHHHhH
Confidence 34444433333 3445678899999885 57777621 223467999999431110 011222225
Q ss_pred HHHHHHHh--CCccccCCCCcceeecCCCcEEEeecCC
Q 002953 560 LALEYLHS--LRVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 560 ~ALeyLHs--~GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
.+|.-.|+ .+.+|+|-.|+|||-|..|.+||.|=+.
T Consensus 152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 66778883 4799999999999999999999999774
|
The function of this family is unknown. |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.097 Score=43.83 Aligned_cols=31 Identities=39% Similarity=0.755 Sum_probs=26.1
Q ss_pred CCCChhHHhhc--cCCccCCCCCCCCCCCcccc
Q 002953 741 KDINWDTLARQ--KAAFVPTSESALDTSYFTSR 771 (863)
Q Consensus 741 k~IdW~~l~~~--~ppfvP~~~s~lDts~F~s~ 771 (863)
++++|+.|..+ .|||+|...+..|+++|+..
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~ 33 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDE 33 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCc
Confidence 46899999754 59999999999999999764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.28 E-value=0.29 Score=54.90 Aligned_cols=30 Identities=30% Similarity=0.532 Sum_probs=27.9
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.+.||+++..+-+-++||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999998899999999985
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.22 Score=56.73 Aligned_cols=71 Identities=27% Similarity=0.433 Sum_probs=53.6
Q ss_pred CeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+.|++|++- |++|.-. ..-..+++..++.+.+..+.-+.. -.+-|||+..+||||+ +|+|.|+||-+|+.
T Consensus 299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4678899987 6566432 123356667777777776666654 3689999999999999 99999999999984
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.62 E-value=0.28 Score=54.81 Aligned_cols=29 Identities=28% Similarity=0.568 Sum_probs=25.7
Q ss_pred ccccCCCCcceeecC-CCcEEEeecCCccc
Q 002953 570 VVHRDLKPDNLLIAH-DGHIKLTDFGLSKV 598 (863)
Q Consensus 570 IIHRDLKPeNILLd~-~g~VKLiDFGLAk~ 598 (863)
++|+|+.+.|||++. ++.++++||..|-.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 47899999998863
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=91.51 E-value=0.24 Score=54.23 Aligned_cols=31 Identities=35% Similarity=0.478 Sum_probs=28.0
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 6899999999999999888778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=91.42 E-value=0.3 Score=53.02 Aligned_cols=30 Identities=20% Similarity=0.418 Sum_probs=26.7
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.46 E-value=0.97 Score=51.92 Aligned_cols=30 Identities=27% Similarity=0.325 Sum_probs=25.2
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..++|.|+-+.|||.+ ++.+.++||-.|..
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence 5689999999999975 45699999988763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.34 E-value=0.35 Score=52.61 Aligned_cols=31 Identities=26% Similarity=0.471 Sum_probs=27.5
Q ss_pred CCccccCCCCcceeecCC----CcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~----g~VKLiDFGLAk~ 598 (863)
.+++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 368999999999999985 8899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=88.98 E-value=1.4 Score=50.47 Aligned_cols=31 Identities=16% Similarity=0.326 Sum_probs=26.2
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...++|+||.+.|||++.+ .++++||.++..
T Consensus 191 ~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 3468999999999999765 488999998875
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.82 E-value=0.36 Score=54.49 Aligned_cols=75 Identities=23% Similarity=0.321 Sum_probs=46.6
Q ss_pred EEEEEeecCC--CChHH-HHHhcCCCC-hhhHHHHHHHHHHHHHHHHh----CCccccCCCCcceeecCCC---------
Q 002953 524 LYLVMEYLNG--GDLYS-LLRNLGCLD-EDVARVYIAEVVLALEYLHS----LRVVHRDLKPDNLLIAHDG--------- 586 (863)
Q Consensus 524 lyLVmEy~~G--GsL~d-lLk~~g~L~-e~~i~~Ia~QIl~ALeyLHs----~GIIHRDLKPeNILLd~~g--------- 586 (863)
-.+|++++.+ ..+.. ...+.|-.+ .+-+++++.||+.-.-.+-+ .+++|-||||+||||-+..
T Consensus 250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 329 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD 329 (444)
T ss_pred cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence 3577776533 22222 122223333 45677788888776544533 4699999999999996443
Q ss_pred ---------cEEEeecCCccc
Q 002953 587 ---------HIKLTDFGLSKV 598 (863)
Q Consensus 587 ---------~VKLiDFGLAk~ 598 (863)
..+|.||.+|+.
T Consensus 330 ~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 330 ATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred eEEEeccchhhhhcccCHHHH
Confidence 256778877764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=87.61 E-value=2.5 Score=49.24 Aligned_cols=30 Identities=20% Similarity=0.352 Sum_probs=25.9
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...+|+||.|.|||++.++ .+++|.-++..
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 4689999999999998765 89999888765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=87.57 E-value=1.5 Score=48.62 Aligned_cols=69 Identities=14% Similarity=0.185 Sum_probs=37.7
Q ss_pred EEEeecccceeeccc----cceehhhhhhchhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDF----PQVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+.-+|.|....++.+ ...+.|... ......+..|.+-|+.|. --.+++.+.+....+.-||||||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEECCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 345666666655322 122222221 334456888999999883 346888999988888889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=87.47 E-value=0.37 Score=54.54 Aligned_cols=74 Identities=23% Similarity=0.346 Sum_probs=44.3
Q ss_pred EEEEeecCC--CChHHHHHh-cCCC-ChhhHHHHHHHHHHHHHHHH----hCCccccCCCCcceeecCCC----------
Q 002953 525 YLVMEYLNG--GDLYSLLRN-LGCL-DEDVARVYIAEVVLALEYLH----SLRVVHRDLKPDNLLIAHDG---------- 586 (863)
Q Consensus 525 yLVmEy~~G--GsL~dlLk~-~g~L-~e~~i~~Ia~QIl~ALeyLH----s~GIIHRDLKPeNILLd~~g---------- 586 (863)
.+|++++.+ ..+...... .|-. -.+-+++++.||+.-.--+- -.+++|-||||+||||-+..
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 477877543 222222211 1222 23456677777765432232 35699999999999995432
Q ss_pred --------cEEEeecCCccc
Q 002953 587 --------HIKLTDFGLSKV 598 (863)
Q Consensus 587 --------~VKLiDFGLAk~ 598 (863)
..+|.||.+|+.
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred EEEecccceeeecccCHHHh
Confidence 367889988875
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.13 E-value=0.53 Score=49.05 Aligned_cols=29 Identities=24% Similarity=0.455 Sum_probs=25.6
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
-.+|+|+.|.||+++.+| ++|+||+.|..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 469999999999998777 99999998874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.26 E-value=1 Score=46.49 Aligned_cols=31 Identities=45% Similarity=0.771 Sum_probs=22.1
Q ss_pred CCccccCCCCcceee-cCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILL-d~~g~VKLiDFGLAk~ 598 (863)
..++|+||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 458999999999999 7889999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=84.45 E-value=1.2 Score=48.69 Aligned_cols=52 Identities=31% Similarity=0.440 Sum_probs=41.1
Q ss_pred ChhhHHHHHHHHHHHHHHHHhC--CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 547 DEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 547 ~e~~i~~Ia~QIl~ALeyLHs~--GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
+....+..+..+-.++.-+|.. -++|+|+.|+|+|.+..+.++|+||--|..
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444555666677777766655 699999999999999999999999988763
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=83.59 E-value=4.7 Score=43.89 Aligned_cols=49 Identities=29% Similarity=0.339 Sum_probs=38.8
Q ss_pred chhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 489 RKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 489 ~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.......+..|+.-|..|. --.|.+.+.+..+.++.|+||||++-|.+.
T Consensus 48 ~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 48 QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3445567888888777663 456888999999999999999999886665
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=83.59 E-value=2.5 Score=48.63 Aligned_cols=97 Identities=28% Similarity=0.262 Sum_probs=66.0
Q ss_pred HHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh-HHHHHhcCCCChhhHHHHHHHHHHHHHHHH-hCCccccC
Q 002953 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL-YSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRD 574 (863)
Q Consensus 497 l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL-~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH-s~GIIHRD 574 (863)
..|++-|.+|+.-.|.-.--.. - ....|||+|+.+... .-.|+. -.++...+..+-.+++.-+.-|. ..++||.|
T Consensus 214 EKE~RNLkRl~~aGIP~PePIl-L-k~hVLVM~FlGrdgw~aPkLKd-~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHAD 290 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKLKD-ASLSTSKARELYQQCVRIMRRLYQKCRLVHAD 290 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCcee-e-ecceEeeeeccCCCCcCccccc-ccCChHHHHHHHHHHHHHHHHHHHHhceeccc
Confidence 4577778888654433211000 0 235799999943111 112222 34777788888888888887765 57999999
Q ss_pred CCCcceeecCCCcEEEeecCCcc
Q 002953 575 LKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 575 LKPeNILLd~~g~VKLiDFGLAk 597 (863)
|.-=|+|+. +|.+.|+|.+.+.
T Consensus 291 LSEfN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 291 LSEFNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred hhhhhheEE-CCEEEEEEccccc
Confidence 999999994 6899999999876
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=83.47 E-value=1.3 Score=48.64 Aligned_cols=31 Identities=16% Similarity=0.177 Sum_probs=28.4
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.++|||++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 863 | ||||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-52 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-52 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-52 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-51 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-51 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-51 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-51 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-51 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-51 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-51 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-51 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-51 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-51 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-51 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-51 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-51 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-51 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-51 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-51 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-51 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-51 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-51 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-51 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-51 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-51 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-51 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-51 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-51 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-51 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-51 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-51 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-51 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-51 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-50 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-50 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-50 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-50 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-50 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-50 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-50 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-50 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-50 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-50 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-50 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-50 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-50 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-50 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-50 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-50 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-50 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-50 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-50 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-50 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-50 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-50 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-50 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-50 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-50 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-50 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-50 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-50 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-50 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-50 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-50 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-50 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-49 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-49 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-49 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-48 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-48 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-48 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-48 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-48 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-48 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-47 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-46 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-46 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-45 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-45 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-44 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-44 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-44 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-44 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-44 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-44 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-44 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-44 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-44 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-44 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-44 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-44 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-44 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-44 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-44 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-44 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-44 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-44 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-44 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-44 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-44 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-43 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-43 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-42 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-41 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-41 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-41 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-40 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-40 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-32 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-32 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-32 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-32 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-32 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-32 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-32 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-31 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-31 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-31 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-31 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-31 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-31 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-31 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-31 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-31 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-31 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-31 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-30 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-30 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-30 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-30 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-29 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-29 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-29 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-28 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-27 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-27 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-27 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-27 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-27 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-27 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-27 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-26 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-26 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-26 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-26 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-26 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-25 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-23 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-23 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-22 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-22 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-22 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-21 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-21 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-21 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-19 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-19 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-19 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-19 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-19 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-19 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-09 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 6e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 |
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 374 bits (963), Expect = e-122
Identities = 113/373 (30%), Positives = 170/373 (45%), Gaps = 70/373 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ K DM+++ V ERD+L++ ++ + ++F LYLVMEY GGDL +LL
Sbjct: 93 IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 541 RNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
G + ++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ GHI+L DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--- 656
+ T + AVGTPDYL+PEIL G
Sbjct: 213 RADGTV------------------------------RSLVAVGTPDYLSPEILQAVGGGP 242
Query: 657 ----HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEA 710
+G DWW++G+ +E+ G PF A+ + + I++ K + P V E + EA
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 711 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 770
D I R L P RLG GGA + + H FF ++WD L F P E A DT F
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNF-- 359
Query: 771 RYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSF 830
D + +SG LS+ +E + V+ F
Sbjct: 360 ---------------DLVEDGLTAMVSGGGETLSDIRE------------GAPLGVHLPF 392
Query: 831 SNFSFKNLSQLAS 843
+S+ ++ S
Sbjct: 393 VGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-116
Identities = 108/371 (29%), Positives = 173/371 (46%), Gaps = 73/371 (19%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L K +M+++ ERD+L++ + ++ Y+F NLYLVM+Y GGDL +LL
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 541 RNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L E++AR Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----- 654
+ + T + AVGTPDY++PEIL
Sbjct: 226 MEDGTV------------------------------QSSVAVGTPDYISPEILQAMEGGK 255
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHD 712
+G DWWS+G+ ++E++ G PF AE + + I+N K +P ++S A D
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRY 772
LI R + H RLG G + K+H FF I+WD + +A ++P S DTS F
Sbjct: 316 LIRRLICSREH-RLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF---- 370
Query: 773 SWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSN 832
D D + +++++ + S + F
Sbjct: 371 -----DV------DDDCLKNSETMPPPTHTAF-------------------SGHHLPFVG 400
Query: 833 FSFKNLSQLAS 843
F++ + L+
Sbjct: 401 FTYTSSCVLSD 411
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-115
Identities = 100/293 (34%), Positives = 159/293 (54%), Gaps = 42/293 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLKK ++R VE ER +L V +PF++R + +F + ++++M+Y+ GG+L+SLL
Sbjct: 38 VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 97
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R VA+ Y AEV LALEYLHS +++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 98 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--- 154
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
P +T + GTPDY+APE++ + +
Sbjct: 155 --------------------YVPDVT-----------YTLCGTPDYIAPEVVSTKPYNKS 183
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWWS GI+++E++ G PF + + ++ ILN ++ +P + + DL+ R +T
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP---FFNEDVKDLLSRLITR 240
Query: 721 DPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESA-LDTSYF 768
D QRLG+ G +VK H +FK++ W+ L + + P + DTS F
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-113
Identities = 90/276 (32%), Positives = 145/276 (52%), Gaps = 35/276 (12%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L+K +I++N V + ERD++ + +PF V+ +++F E LY + Y G+L +
Sbjct: 62 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 121
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R +G DE R Y AE+V ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 122 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 181
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
S + S VGT Y++PE+L +
Sbjct: 182 PESKQA-----------------------------RANSFVGTAQYVSPELLTEKSACKS 212
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
+D W++G I+++L+ G+PPF A + IF I+ + +P + P+A DL+++ L
Sbjct: 213 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---KFFPKARDLVEKLLVL 269
Query: 721 DPHQRLGSG---GASEVKQHVFFKDINWDTLARQKA 753
D +RLG G +K H FF+ + W+ L +Q
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-113
Identities = 107/316 (33%), Positives = 168/316 (53%), Gaps = 52/316 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VMEY+ GG+++S L
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-- 190
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
V G T + GTP+ LAPEI+L G+
Sbjct: 191 -----------VKGRT---------------------WTLCGTPEALAPEIILSKGYNKA 218
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWW++G++++E+ G PPF A+ P QI++ I++ K+ +P S + DL+ L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS---HFSSDLKDLLRNLLQV 275
Query: 721 DPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWNT 776
D +R G+ G +++K H +F +W + ++K A F+P + DTS F
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF-------- 327
Query: 777 TDENIYPASDFEDSSD 792
D+ Y + S +
Sbjct: 328 -DD--YEEEEIRVSIN 340
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-111
Identities = 108/293 (36%), Positives = 161/293 (54%), Gaps = 39/293 (13%)
Query: 481 VLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
VLKKA ++R AER+IL V++PF+V Y+F LYL++EYL+GG+L+
Sbjct: 52 VLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 111
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L G ED A Y+AE+ +AL +LH +++RDLKP+N+++ H GH+KLTDFGL K
Sbjct: 112 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + T T + GT +Y+APEIL+ +GH
Sbjct: 172 IHDGT----------VT---------------------HTFCGTIEYMAPEILMRSGHNR 200
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWWS+G ++++++ G PPF E+ ++ D IL K+ P ++ EA DL+ + L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP---YLTQEARDLLKKLLK 257
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
+ RLG+G A EV+ H FF+ INW+ L +K F P +S D S F
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-111
Identities = 106/292 (36%), Positives = 161/292 (55%), Gaps = 39/292 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLKKA + ++ V ERDIL+ V +PF+V+ Y+F LYL++++L GGDL++ L
Sbjct: 59 VLKKATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL 117
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
E+ + Y+AE+ LAL++LHSL +++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ S GT +Y+APE++ GH +
Sbjct: 178 DH----------EKKA---------------------YSFCGTVEYMAPEVVNRRGHTQS 206
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
ADWWS G+++FE++ G PF + ++ IL K+ P+ +SPEA L+
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ---FLSPEAQSLLRMLFKR 263
Query: 721 DPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
+P RLG+G G E+K+H FF I+W+ L R++ F P + DT YF
Sbjct: 264 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-110
Identities = 118/371 (31%), Positives = 176/371 (47%), Gaps = 77/371 (20%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L K +MI+++ ERDI+ +P+VV+ FY+F LY+VMEY+ GGDL +L+
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
N + E AR Y AEVVLAL+ +HS+ +HRD+KPDN+L+ GH+KL DFG
Sbjct: 161 SN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---- 656
+ +AVGTPDY++PE+L G
Sbjct: 220 KEGMV------------------------------RCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLI 714
+G DWWSVG+ L+E++VG PF A+ + I+N K + +P ++S EA +LI
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLI 308
Query: 715 DRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRY 772
FLT D RLG G E+K+H+FFK+ W + A VP S +DTS F
Sbjct: 309 CAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF---- 363
Query: 773 SWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDECGGLAEFESGSSVNYSFSN 832
D+ ED + ++ + + N+ F
Sbjct: 364 -----DD------LEEDKGEEETFPIPKAFVGNQLP---------------------FVG 391
Query: 833 FSFKNLSQLAS 843
F++ + + S
Sbjct: 392 FTYYSNRRYLS 402
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-109
Identities = 110/292 (37%), Positives = 160/292 (54%), Gaps = 38/292 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L+K +I K+ V + E +L + R+PF+ Y+F + L VMEY NGG+L+ L
Sbjct: 37 ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
E+ AR Y AE+V ALEYLHS VV+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ T ++ GTP+YLAPE+L +G
Sbjct: 157 SD----------GATM---------------------KTFCGTPEYLAPEVLEDNDYGRA 185
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWW +G++++E++ G PF + +++F+ IL +I +PR +SPEA L+ L +
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKK 242
Query: 721 DPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
DP QRLG G A EV +H FF INW + ++K F P S +DT YF
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-108
Identities = 116/357 (32%), Positives = 181/357 (50%), Gaps = 56/357 (15%)
Query: 434 PKSDQGMTTSSAGSMTPRSPLLTPRTSQIDL------LLA--GKGA-----LSEHDDFPQ 480
P+ + M + A P + +S L GKG+ L+ H
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEV 64
Query: 481 -----VLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534
VL+K +++K + I++ER++L+ +V++PF+V +SF + LY V++Y+NGG
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 124
Query: 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594
+L+ L+ C E AR Y AE+ AL YLHSL +V+RDLKP+N+L+ GHI LTDFG
Sbjct: 125 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
L K + + + TT + GTP+YLAPE+L
Sbjct: 185 LCKENIEH----------NSTT---------------------STFCGTPEYLAPEVLHK 213
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 714
+ T DWW +G +L+E++ G+PPF + + +++DNILN+ + ++ A L+
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP---NITNSARHLL 270
Query: 715 DRFLTEDPHQRLGSG-GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
+ L +D +RLG+ E+K HVFF INWD L +K F P D +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-107
Identities = 110/300 (36%), Positives = 165/300 (55%), Gaps = 45/300 (15%)
Query: 481 VLKKADMIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
VLKKA +++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++
Sbjct: 89 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TG 656
+ + T+ GT +Y+AP+I+ G +G
Sbjct: 209 FVADETE---------RA---------------------YDFCGTIEYMAPDIVRGGDSG 238
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEH----PQQIFDNILNRKIPWPRVPEEMSPEAHD 712
H DWWS+G++++EL+ G PF + +I IL + P+P+ EMS A D
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ---EMSALAKD 295
Query: 713 LIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
LI R L +DP +RLG G A E+K+H+FF+ INWD LA +K A F P LD S F
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-106
Identities = 101/291 (34%), Positives = 160/291 (54%), Gaps = 39/291 (13%)
Query: 481 VLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
LKK ++ + VE + E+ +L ++ +PF+ F +F +ENL+ VMEYLNGGDL
Sbjct: 49 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 108
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+++ D A Y AE++L L++LHS +V+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 109 IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
++ T + GTPDY+APEILLG +
Sbjct: 169 MLG----------DAKT---------------------NTFCGTPDYIAPEILLGQKYNH 197
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ DWWS G++L+E+++G PF+ + +++F +I +PR + EA DL+ +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR---WLEKEAKDLLVKLFV 254
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
+P +RLG G +++QH F++INW+ L R++ F P +S D S F
Sbjct: 255 REPEKRLGVRG--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 303
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-105
Identities = 104/294 (35%), Positives = 159/294 (54%), Gaps = 40/294 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
VLKK +++ + VE + E+ IL RN PF+ + F F + L+ VME++NGGDL
Sbjct: 55 VLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH 114
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ DE AR Y AE++ AL +LH +++RDLK DN+L+ H+GH KL DFG+ K G
Sbjct: 115 IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ N TT + GTPDY+APEIL +G
Sbjct: 175 ICNGV----------TT---------------------ATFCGTPDYIAPEILQEMLYGP 203
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
DWW++G++L+E++ G PF AE+ +F+ ILN ++ +P + +A ++ F+T
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT---WLHEDATGILKSFMT 260
Query: 720 EDPHQRLGSG---GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
++P RLGS G + +H FFK+I+W L ++ F P +S D S F
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 328 bits (844), Expect = e-104
Identities = 126/383 (32%), Positives = 184/383 (48%), Gaps = 54/383 (14%)
Query: 402 EDMLDYVPEADNSVFMDDLKGLPSMACKTRFGPKSDQGMTTSSAGSMTPRSPLLTPRTSQ 461
E+ ++ D LK + R G SD S+ +T ++
Sbjct: 94 EEREEWTTAIQTV--ADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM--NE 149
Query: 462 IDLL-LAGKGA-----LSEHDDFPQ-----VLKKADMIRKNAVESILAERDILISVRNPF 510
+ L L GKG L + + +LKK ++ K+ V L E +L + R+PF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 511 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR- 569
+ YSF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASE 629
VV+RDLK +NL++ DGHIK+TDFGL K E
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCK-------------------------------E 298
Query: 630 HQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689
++ ++ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F
Sbjct: 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
Query: 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDT 747
+ IL +I +PR + PEA L+ L +DP QRLG G A E+ QH FF I W
Sbjct: 359 ELILMEEIRFPR---TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415
Query: 748 LARQKAA--FVPTSESALDTSYF 768
+ +K + F P S DT YF
Sbjct: 416 VYEKKLSPPFKPQVTSETDTRYF 438
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-103
Identities = 91/293 (31%), Positives = 153/293 (52%), Gaps = 40/293 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+LKK +I+ + VE + E+ +L PF+ + F + LY VMEY+NGGDL
Sbjct: 52 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 111
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ +G E A Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 112 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + TT ++ GTPDY+APEI+ +G
Sbjct: 172 IWDGV----------TT---------------------KTFCGTPDYIAPEIIAYQPYGK 200
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ DWW+ G++L+E++ G PF E ++F +I+ + +P+ MS EA + +T
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLMT 257
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
+ P +RLG G G ++K+H FF+ I+W+ L R++ + P + + F
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA-CGRNAENF 309
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = e-103
Identities = 93/303 (30%), Positives = 151/303 (49%), Gaps = 49/303 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
V+KK + ++ + E+ + N PF+V F L+ V+EY+NGGDL
Sbjct: 41 VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ L E+ AR Y AE+ LAL YLH +++RDLK DN+L+ +GHIKLTD+G+ K G
Sbjct: 101 MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L + + GTP+Y+APEIL G +G
Sbjct: 161 L-------------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 660 TADWWSVGIILFELIVGIPPFNAEHP---------QQIFDNILNRKIPWPRVPEEMSPEA 710
+ DWW++G+++FE++ G PF+ +F IL ++I PR +S +A
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKA 246
Query: 711 HDLIDRFLTEDPHQRLGSG---GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDT 765
++ FL +DP +RLG G ++++ H FF++++WD + +++ F P
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 306
Query: 766 SYF 768
F
Sbjct: 307 DNF 309
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-102
Identities = 77/298 (25%), Positives = 138/298 (46%), Gaps = 45/298 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ K + +N V ++ E I+ + +PF+V +YSF E++++V++ L GGDL L
Sbjct: 47 YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL 106
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ E+ +++I E+V+AL+YL + R++HRD+KPDN+L+ GH+ +TDF ++
Sbjct: 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--- 163
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGH 657
+ + GT Y+APE+ G G+
Sbjct: 164 -----------------------------MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 658 GTTADWWSVGIILFELIVGIPPF---NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 714
DWWS+G+ +EL+ G P+ ++ ++I + +P S E L+
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS---AWSQEMVSLL 251
Query: 715 DRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTS 770
+ L +P QR S+V+ + DINWD + +++ F+P F
Sbjct: 252 KKLLEPNPDQRF--SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFEL 307
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-100
Identities = 93/303 (30%), Positives = 151/303 (49%), Gaps = 49/303 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
V+KK + ++ + E+ + N PF+V F L+ V+EY+NGGDL
Sbjct: 84 VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ L E+ AR Y AE+ LAL YLH +++RDLK DN+L+ +GHIKLTD+G+ K G
Sbjct: 144 MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L + + GTP+Y+APEIL G +G
Sbjct: 204 L-------------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 660 TADWWSVGIILFELIVGIPPFNAEHP---------QQIFDNILNRKIPWPRVPEEMSPEA 710
+ DWW++G+++FE++ G PF+ +F IL ++I PR +S +A
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKA 289
Query: 711 HDLIDRFLTEDPHQRLGSG---GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDT 765
++ FL +DP +RLG G ++++ H FF++++WD + +++ F P
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349
Query: 766 SYF 768
F
Sbjct: 350 DNF 352
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = 5e-97
Identities = 82/321 (25%), Positives = 152/321 (47%), Gaps = 53/321 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL---- 536
L K + ++ + + E+ IL V + F+V Y+F + +L LVM +NGGD+
Sbjct: 217 KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHI 276
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
Y++ + E A Y A++V LE+LH +++RDLKP+N+L+ DG+++++D GL+
Sbjct: 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
E + + K + GTP ++APE+LLG
Sbjct: 337 V-------------------------------ELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
+ + D++++G+ L+E+I PF A +++ +L + + +P + SP + D
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD---KFSPASKD 422
Query: 713 LIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVP-----TSESAL 763
+ L +DP +RLG ++ H F+DI+W L FVP +++
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
Query: 764 DTSYFTSR--YSWNTTDENIY 782
D F++ ++ D +
Sbjct: 483 DVGAFSTVKGVAFEKADTEFF 503
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 316 bits (811), Expect = 7e-97
Identities = 92/293 (31%), Positives = 154/293 (52%), Gaps = 40/293 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+LKK +I+ + VE + E+ +L PF+ + F + LY VMEY+NGGDL
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ +G E A Y AE+ + L +L S +++RDLK DN+++ +GHIK+ DFG+ K
Sbjct: 433 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + TT ++ GTPDY+APEI+ +G
Sbjct: 493 IWDG----------VTT---------------------KTFCGTPDYIAPEIIAYQPYGK 521
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ DWW+ G++L+E++ G PF E ++F +I+ + +P+ MS EA + +T
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK---SMSKEAVAICKGLMT 578
Query: 720 EDPHQRLGSG--GASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYF 768
+ P +RLG G G ++K+H FF+ I+W+ L R++ + P + S + F
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA-SGRNAENF 630
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 4e-94
Identities = 97/351 (27%), Positives = 151/351 (43%), Gaps = 63/351 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
L K + K L ER +L V PF+V Y+F + L +++ +NGGDL+
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L G E R Y AE++L LE++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTG 656
++VGT Y+APE+L G
Sbjct: 341 DFSKKKP---------------------------------HASVGTHGYMAPEVLQKGVA 367
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHP---QQIFDNILNRKIPWPRVPEEMSPEAHDL 713
+ ++ADW+S+G +LF+L+ G PF +I L + P+ SPE L
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSPELRSL 424
Query: 714 IDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPT-----SESALD 764
++ L D ++RLG GA EVK+ FF+ ++W + QK +P + A D
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 765 TSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNR-QEEVGDEC 814
F + SD + +S R Q+EV +
Sbjct: 485 IGSFDEEDTKGIKL----------LDSDQELYRNFPLTISERWQQEVAETV 525
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 6e-93
Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
L+K + ++ L E+ IL V + FVV Y++ ++ L LV+ +NGGDL +
Sbjct: 216 KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 541 RNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++G E A Y AE+ LE LH R+V+RDLKP+N+L+ GHI+++D GL+
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV- 334
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
H E + + VGT Y+APE++ +
Sbjct: 335 -------------------------------HVPEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 659 TTADWWSVGIILFELIVGIPPFNAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 714
+ DWW++G +L+E+I G PF +++ + + SP+A L
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE---RFSPQARSLC 420
Query: 715 DRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYF 768
+ L +DP +RLG A EVK+H FK +N+ L F P ++
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVL 478
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-84
Identities = 81/261 (31%), Positives = 118/261 (45%), Gaps = 39/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL KA + + + E +I +R+P ++R + F +YL++EY G +Y L
Sbjct: 41 VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 100
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L DE YI E+ AL Y HS RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV--- 157
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
RR GT DYL PE++ G H
Sbjct: 158 ----------------------------HAPSSRRT--DLCGTLDYLPPEMIEGRMHDEK 187
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D WS+G++ +E +VG PPF A Q+ + I + P+ ++ A DLI R L
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---TFPDFVTEGARDLISRLLKH 244
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
+P QR EV +H +
Sbjct: 245 NPSQRP---MLREVLEHPWIT 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-84
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 39/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL K+ + ++ + E +I +R+P ++R + F R+ +YL++E+ G+LY L
Sbjct: 46 VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL 105
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ G DE + ++ E+ AL Y H +V+HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--- 162
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
RR+ + GT DYL PE++ G H
Sbjct: 163 ----------------------------HAPSLRRR--TMCGTLDYLPPEMIEGKTHDEK 192
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D W G++ +E +VG+PPF++ + I+N + + P +S + DLI + L
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---KFPPFLSDGSKDLISKLLRY 249
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
P QRL V +H + K
Sbjct: 250 HPPQRL---PLKGVMEHPWVK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-70
Identities = 63/308 (20%), Positives = 122/308 (39%), Gaps = 65/308 (21%)
Query: 469 KGALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528
K L + DF + + K+ + E I+ ++N + + T + +Y++
Sbjct: 64 KSLLEKKRDFTKS-NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122
Query: 529 EYLNGGDLYSLLRNLGCLD--------EDVARVYIAEVVLALEYLHSLR-VVHRDLKPDN 579
EY+ + LD V + I V+ + Y+H+ + + HRD+KP N
Sbjct: 123 EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
+L+ +G +KL+DFG S+ ++ K
Sbjct: 183 ILMDKNGRVKLSDFGESE-------------------------------YMVDKKIK--G 209
Query: 640 AVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRK 696
+ GT +++ PE +G D WS+GI L+ + + PF+ + ++F+NI +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269
Query: 697 IPWPRVPEE----------------MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
I +P +S E D + FL ++P +R+ + + +H +
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWL 326
Query: 741 KDINWDTL 748
D N + L
Sbjct: 327 ADTNIEDL 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-69
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 39/288 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-------------LYLV 527
+KK + + +IL+E +L S+ + +VVR++ ++ R N L++
Sbjct: 35 AIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93
Query: 528 MEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586
MEY G LY L+ + D +++ AL Y+HS ++HRDLKP N+ I
Sbjct: 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153
Query: 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
++K+ DFGL+K + L LT SA+GT Y
Sbjct: 154 NVKIGDFGLAKNV-----HRSLDILKLDSQNLPGSSDNLT------------SAIGTAMY 196
Query: 647 LAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP-RVPE 704
+A E+L GTGH D +S+GII FE+I P I + + I +P +
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDD 254
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK 752
+I + DP++R GA + + + D + ++
Sbjct: 255 NKMKVEKKIIRLLIDHDPNKRP---GARTLLNSGWLPVKHQDEVIKEA 299
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-68
Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 37/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ K+ +++ + E + E I S+ + VV F F + +++V+E L L
Sbjct: 47 IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 106
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L E AR Y+ ++VL +YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 107 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---- 162
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
T E+ ER+K GTP+Y+APE+L GH
Sbjct: 163 -------------------------TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFE 195
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D WS+G I++ L+VG PPF ++ + I + P+ ++P A LI + L
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQT 252
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
DP R +E+ FF
Sbjct: 253 DPTARP---TINELLNDEFFT 270
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-68
Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 38/262 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ K M + V+ + E I +++P ++ + F +YLV+E + G++ L
Sbjct: 43 MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL 102
Query: 541 RN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+N + E+ AR ++ +++ + YLHS ++HRDL NLL+ + +IK+ DFGL+
Sbjct: 103 KNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--- 159
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
T + E+ + GTP+Y++PEI + HG
Sbjct: 160 --------------------------TQLKMPHEKHY--TLCGTPNYISPEIATRSAHGL 191
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+D WS+G + + L++G PPF+ + + + ++ +P +S EA DLI + L
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY---EMPSFLSIEAKDLIHQLLR 248
Query: 720 EDPHQRLGSGGASEVKQHVFFK 741
+P RL S V H F
Sbjct: 249 RNPADRL---SLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 3e-67
Identities = 77/261 (29%), Positives = 121/261 (46%), Gaps = 37/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ K+ +++ + E + E I S+ + VV F F + +++V+E L L
Sbjct: 73 IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 132
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L E AR Y+ ++VL +YLH RV+HRDLK NL + D +K+ DFGL+
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---- 188
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
T E+ ER+K GTP+Y+APE+L GH
Sbjct: 189 -------------------------TKVEYDGERKK--VLCGTPNYIAPEVLSKKGHSFE 221
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D WS+G I++ L+VG PPF ++ + I + P+ ++P A LI + L
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQT 278
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
DP R +E+ FF
Sbjct: 279 DPTARP---TINELLNDEFFT 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-67
Identities = 65/264 (24%), Positives = 95/264 (35%), Gaps = 46/264 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
K+ LAE V ++P VR ++ LYL E G L
Sbjct: 89 RSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQH 146
Query: 540 LRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
G L E Y+ + +LAL +LHS +VH D+KP N+ + G KL DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ + G P Y+APE+L G +G
Sbjct: 207 --LGTAG------------------------------AGEVQEGDPRYMAPELLQG-SYG 233
Query: 659 TTADWWSVGIILFELIVGIP-PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
T AD +S+G+ + E+ + P E QQ+ L P +S E ++
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAGLSSELRSVLVMM 288
Query: 718 LTEDPHQRLGSGGASEVKQHVFFK 741
L DP R A + +
Sbjct: 289 LEPDPKLRA---TAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 9e-64
Identities = 70/286 (24%), Positives = 131/286 (45%), Gaps = 47/286 (16%)
Query: 468 GKGA-------LSEHDDFPQVLKKADMIRKNA--VESILAERDILISVRNPFVVRFFYSF 518
G+G+ S D V+K+ ++ R ++ E E +L ++++P +V++ SF
Sbjct: 33 GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF 92
Query: 519 TCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLK 576
+LY+VM+Y GGDL+ + + ED + ++ LAL+++H +++HRD+K
Sbjct: 93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIK 152
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
N+ + DG ++L DFG+++V +NST +L
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARV--LNSTVEL----------------------------- 181
Query: 637 KRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696
R+ +GTP YL+PEI + +D W++G +L+EL F A + + I++
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241
Query: 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
P V S + L+ + +P R + + + F
Sbjct: 242 F--PPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-60
Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 56/295 (18%)
Query: 468 GKGALSE-------HDDFPQVLKKADMIRKNA--VESILAERDILISVRNPFVVRFFYSF 518
G G+ D V K+ D + +++E ++L +++P +VR++
Sbjct: 15 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI 74
Query: 519 TCREN--LYLVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLR--- 569
R N LY+VMEY GGDL S++ LDE+ + ++ LAL+ H
Sbjct: 75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134
Query: 570 --VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 627
V+HRDLKP N+ + ++KL DFGL+++ +N +
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------------------- 173
Query: 628 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687
++ VGTP Y++PE + + +D WS+G +L+EL +PPF A ++
Sbjct: 174 ----------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
Query: 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ I K R+P S E +++I R L + R E+ ++ +
Sbjct: 224 LAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENPLILE 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-59
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 49/270 (18%)
Query: 486 DMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ ++S E L ++ + ++R + + +Y+VME DL S L+
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 121
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+D + Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 180
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------- 656
T + K S VGT +Y+ PE +
Sbjct: 181 TSVV-----------------------------KDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 657 ----HGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAH 711
+D WS+G IL+ + G PF + I++ P+ +
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQ 270
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
D++ L DP QR+ E+ H + +
Sbjct: 271 DVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-59
Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 49/270 (18%)
Query: 486 DMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ ++S E L ++ + ++R + + +Y+VME DL S L+
Sbjct: 44 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 102
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+D + Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++
Sbjct: 103 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 161
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------- 656
T + K S VGT +Y+ PE +
Sbjct: 162 TSVV-----------------------------KDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 657 ----HGTTADWWSVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEMSPEAH 711
+D WS+G IL+ + G PF + I++ P+ +
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQ 251
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
D++ L DP QR+ E+ H + +
Sbjct: 252 DVLKCCLKRDPKQRI---SIPELLAHPYVQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 2e-58
Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 49/300 (16%)
Query: 468 GKG-------ALSEHDDFPQVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFT 519
G+G A ++ DD +K+ + + A E ++ E L + +P +VR+F ++
Sbjct: 14 GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 520 CREN------------LYLVMEYLNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEY 564
+ LY+ M+ +L + + + V ++ A+E+
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
LHS ++HRDLKP N+ D +K+ DFGL + +E +
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA-------------------MDQDEEE 174
Query: 625 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684
T + VGT Y++PE + G + D +S+G+ILFEL+ P
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQME 232
Query: 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
+ ++ R + +P + + P + ++ L+ P +R A + ++ F+D++
Sbjct: 233 RVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAINIIENAVFEDLD 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 57/312 (18%)
Query: 437 DQGMTTSSAGSMTPRSPLLTPRTSQ-------IDLLLAGKGA-------LSEHDDFPQVL 482
QGM P+ L + G+G D P L
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKI--GRGQFSEVYRAACLLDGVPVAL 62
Query: 483 KK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
KK D++ A + E D+L + +P V++++ SF L +V+E + GDL +
Sbjct: 63 KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 540 LRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
+++ + E Y ++ ALE++HS RV+HRD+KP N+ I G +KL D GL
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 182
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
+ +S S VGTP Y++PE +
Sbjct: 183 GRF--FSSKTTA-----------------------------AHSLVGTPYYMSPERIHEN 211
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAE--HPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
G+ +D WS+G +L+E+ PF + + + I P P + S E L
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELRQL 270
Query: 714 IDRFLTEDPHQR 725
++ + DP +R
Sbjct: 271 VNMCINPDPEKR 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 6e-58
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 30/244 (12%)
Query: 499 ERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEV 558
E + +P +V + + + + ME L GG L L++ +GCL ED A Y+ +
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 559 VLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617
+ LEYLH+ R++H D+K DN+L++ DG L DFG +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL-------------------- 199
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677
L + GT ++APE+++G D WS ++ ++ G
Sbjct: 200 ------CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
Query: 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
P+ + I + P +P +P I L ++P R A E+++
Sbjct: 254 HPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR---ASAMELRRK 310
Query: 738 VFFK 741
V
Sbjct: 311 VGKA 314
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 8e-58
Identities = 73/265 (27%), Positives = 122/265 (46%), Gaps = 51/265 (19%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+KK+ R +++E+ E +L +++ +V + + YLVM+ ++GG+L+ +
Sbjct: 41 CIKKSPAFRDSSLEN---EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI 97
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
G E A + I +V+ A++YLH +VHRDLKP+NLL + I +TDFGLSK
Sbjct: 98 LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ ++ ++ +A GTP Y+APE+L +
Sbjct: 158 M---------------------EQNGIMS------------TACGTPGYVAPEVLAQKPY 184
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D WS+G+I + L+ G PPF E ++F+ I W + S A D
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDI----SESAKD 240
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQH 737
I L +DP++R + H
Sbjct: 241 FICHLLEKDPNERY---TCEKALSH 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 9e-58
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 48/270 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ + ++ + + E I +++P +VR S YLV + + GG+L+ +
Sbjct: 38 IINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
E A I +++ ++ Y HS +VHR+LKP+NLL+A +KL DFGL+
Sbjct: 97 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ D E GTP YL+PE+L +
Sbjct: 157 E-------------------VNDSEAWHGF-------------AGTPGYLSPEVLKKDPY 184
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D W+ G+IL+ L+VG PPF E +++ I W V +PEA
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKS 240
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
LID LT +P +R+ A + + + +
Sbjct: 241 LIDSMLTVNPKKRI---TADQALKVPWICN 267
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 55/301 (18%), Positives = 111/301 (36%), Gaps = 73/301 (24%)
Query: 468 GKG-------ALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSF-- 518
G G A D V+K+ + A E L + + +V + +
Sbjct: 20 GSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCWDG 75
Query: 519 --------------TCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDVARVYIAEVVLAL 562
+ + L++ ME+ + G L + R LD+ +A ++ +
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622
+Y+HS ++++RDLKP N+ + +K+ DFGL + + +
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDGKRT-------------- 179
Query: 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFN 681
+ GT Y++PE + +G D +++G+IL EL+ V F
Sbjct: 180 ----------------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223
Query: 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+ F ++ + I + + L+ + L++ P R SE+ + +
Sbjct: 224 T---SKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRP---NTSEILRTLTVW 272
Query: 742 D 742
Sbjct: 273 K 273
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-57
Identities = 75/267 (28%), Positives = 109/267 (40%), Gaps = 51/267 (19%)
Query: 494 ESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
E+ L E DIL V P +++ ++ +LV + + G+L+ L L E R
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ ++ + LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-------------- 173
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSV 666
L E GTP YLAPEI+ G+G D WS
Sbjct: 174 -----LDPGEKLRE-------------VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTED 721
G+I++ L+ G PPF + I++ W S DL+ RFL
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQ 271
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTL 748
P +R A E H FF+ + +
Sbjct: 272 PQKRY---TAEEALAHPFFQQYVVEEV 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-57
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 48/277 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+ K + +K ES+L E +L + +P +++ + F + YLV E GG+L+ +
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
+ E A I +V+ + Y+H ++VHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 118 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
++ + +GT Y+APE+L GT +
Sbjct: 178 H--FEASKKMKD------------------------------KIGTAYYIAPEVLHGT-Y 204
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D WS G+IL+ L+ G PPFN + I + K W +V S A D
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----SESAKD 260
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749
LI + LT P R+ A + H + + + ++
Sbjct: 261 LIRKMLTYVPSMRI---SARDALDHEWIQTYTKEQIS 294
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 45/269 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY--- 537
+ K + +E I AE ++L S+ +P +++ F F N+Y+VME GG+L
Sbjct: 54 TINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111
Query: 538 -SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDF 593
S L E + +++ AL Y HS VVH+DLKP+N+L IK+ DF
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
GL+++ S + + +A GT Y+APE+
Sbjct: 172 GLAEL--FKSDEHST------------------------------NAAGTALYMAPEVFK 199
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
D WS G++++ L+ G PF +++ ++ + ++P+A DL
Sbjct: 200 R-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ + LT+DP +R A++V H +FK
Sbjct: 259 LKQMLTKDPERRP---SAAQVLHHEWFKQ 284
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-56
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 52/273 (19%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ ++ E +IL + +P +++ F E+ Y+V+E + GG+L+ +
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVV 231
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKV 598
L E ++Y +++LA++YLH ++HRDLKP+N+L++ D IK+TDFG SK+
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--- 655
LG+ T GTP YLAPE+L+
Sbjct: 292 -------------------LGETSLMRT-------------LCGTPTYLAPEVLVSVGTA 319
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRKI-----PWPRVPEEMSPE 709
G+ D WS+G+ILF + G PPF+ + D I + K W V S +
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV----SEK 375
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
A DL+ + L DP R E +H + +D
Sbjct: 376 ALDLVKKLLVVDPKARF---TTEEALRHPWLQD 405
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-56
Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 49/270 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+ KA K+ +IL E ++L + +P +++ F + Y+V E GG+L+ +
Sbjct: 54 VINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI 112
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
E A I +V + Y+H +VHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ +GT Y+APE+L GT +
Sbjct: 173 C--FQQNTKMK------------------------------DRIGTAYYIAPEVLRGT-Y 199
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D WS G+IL+ L+ G PPF ++ I + K W + S +A D
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI----SDDAKD 255
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
LI + LT P R+ A++ +H + +
Sbjct: 256 LIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-56
Identities = 59/270 (21%), Positives = 103/270 (38%), Gaps = 49/270 (18%)
Query: 486 DMIRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ ++S E L ++ + ++R + + +Y+VME DL S L+
Sbjct: 91 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK 149
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+D + Y ++ A+ +H +VH DLKP N LI DG +KL DFG++ ++
Sbjct: 150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT 208
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------- 656
T + K S VG +Y+ PE +
Sbjct: 209 TSVV-----------------------------KDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 657 ----HGTTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAH 711
+D WS+G IL+ + G PF + I++ P+ +
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQ 298
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
D++ L DP QR+ E+ H + +
Sbjct: 299 DVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-56
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 48/270 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ + + + E I +++P +VR S YLV + + GG+L+ +
Sbjct: 61 IINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
E A I +++ ++ Y HS +VHR+LKP+NLL+A +KL DFGL+
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+N ++ G GTP YL+PE+L +
Sbjct: 180 E--VNDSEAWHG------------------------------FAGTPGYLSPEVLKKDPY 207
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D W+ G+IL+ L+VG PPF E +++ I W V +PEA
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKS 263
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
LID LT +P +R+ A + + + +
Sbjct: 264 LIDSMLTVNPKKRI---TADQALKVPWICN 290
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-56
Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 51/267 (19%)
Query: 487 MIRKNAV---ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
I K V + E +I+ S+ +P ++R + +F ++YLVME GG+L+ + +
Sbjct: 41 KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK 100
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGL 600
E A + +V+ A+ Y H L V HRDLKP+N L D +KL DFGL+
Sbjct: 101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR-- 158
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ R+ VGTP Y++P++L G +G
Sbjct: 159 FKPGKMM------------------------------RTKVGTPYYVSPQVLEG-LYGPE 187
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLID 715
D WS G++++ L+ G PPF+A ++ I W V SP+A LI
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV----SPQAESLIR 243
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKD 742
R LT+ P QR+ + + +H +F+
Sbjct: 244 RLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-56
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 52/273 (19%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+ ++ E +IL + +P +++ F E+ Y+V+E + GG+L+ +
Sbjct: 48 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVV 106
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKV 598
L E ++Y +++LA++YLH ++HRDLKP+N+L++ D IK+TDFG SK+
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--- 655
LG+ T GTP YLAPE+L+
Sbjct: 167 -------------------LGETSLMRT-------------LCGTPTYLAPEVLVSVGTA 194
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRKI-----PWPRVPEEMSPE 709
G+ D WS+G+ILF + G PPF+ + D I + K W V S +
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV----SEK 250
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
A DL+ + L DP R E +H + +D
Sbjct: 251 ALDLVKKLLVVDPKARF---TTEEALRHPWLQD 280
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 54/272 (19%)
Query: 487 MIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
+I K + E L P +V+ F + + +LVME LNGG+L+ ++
Sbjct: 43 IISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH 102
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLIN 602
E A + ++V A+ ++H + VVHRDLKP+NLL + IK+ DFG ++
Sbjct: 103 FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR----- 157
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
L + L + T Y APE+L G+ + D
Sbjct: 158 --------------LKPPDNQPLK------------TPCFTLHYAAPELLNQNGYDESCD 191
Query: 663 WWSVGIILFELIVGIPPFNAEH-------PQQIFDNILNRKI-----PWPRVPEEMSPEA 710
WS+G+IL+ ++ G PF + +I I W V S EA
Sbjct: 192 LWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV----SQEA 247
Query: 711 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
DLI LT DP++RL S ++ + + +D
Sbjct: 248 KDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 70/309 (22%), Positives = 109/309 (35%), Gaps = 83/309 (26%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K I VE I E ++ + +P + R + + + + LVME +GG L L
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 543 LG----------------------------------------CLDEDVARVYIAEVVLAL 562
E + + ++ AL
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
YLH+ + HRD+KP+N L + + IKL DFGLSK
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE---------------------- 219
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH--GTTADWWSVGIILFELIVGIP 678
+ E + GTP ++APE+L T G D WS G++L L++G
Sbjct: 220 -----FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 679 PFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 733
PF + +LN+K+ + + SP A DL+ L + +R A
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVL----SPLARDLLSNLLNRNVDERF---DAMR 327
Query: 734 VKQHVFFKD 742
QH +
Sbjct: 328 ALQHPWISQ 336
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-55
Identities = 70/269 (26%), Positives = 121/269 (44%), Gaps = 51/269 (18%)
Query: 481 VLKKADMIRKNA---VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+KK + E I E +IL +R+P ++ F + ++ L++E ++GG+L+
Sbjct: 37 FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDF 593
L L ED A ++ +++ + YLHS R+ H DLKP+N+++ + IKL DF
Sbjct: 97 DFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G++ I + ++ ++ GTP+++APEI+
Sbjct: 157 GIAHK--IEAGNEF------------------------------KNIFGTPEFVAPEIVN 184
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSP 708
G AD WS+G+I + L+ G PF E Q+ NI + S
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT----SE 240
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
A D I R L +DP +R+ ++ +H
Sbjct: 241 LAKDFIRRLLVKDPKRRM---TIAQSLEH 266
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 76/258 (29%), Positives = 116/258 (44%), Gaps = 48/258 (18%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 548
+ + + E +L+ + +P +++ F + LV+E + GG+L+ + G E
Sbjct: 88 KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE 147
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTD 605
A + +++ A+ YLH +VHRDLKP+NLL A D +K+ DFGLSK+
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI------- 200
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
+ + + + GTP Y APEIL G +G D WS
Sbjct: 201 -------------VEHQVLMK------------TVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 666 VGIILFELIVGIPPFNAEHPQQ-IFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLT 719
VGII + L+ G PF E Q +F ILN + W V S A DL+ + +
Sbjct: 236 VGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV----SLNAKDLVRKLIV 291
Query: 720 EDPHQRLGSGGASEVKQH 737
DP +RL + QH
Sbjct: 292 LDPKKRL---TTFQALQH 306
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-55
Identities = 75/272 (27%), Positives = 111/272 (40%), Gaps = 51/272 (18%)
Query: 482 LKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ + + E+ E IL V P ++ S+ ++LV + + G+L+ L
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
L E R + ++ A+ +LH+ +VHRDLKP+N+L+ + I+L+DFG S
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-- 249
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT----- 655
L E GTP YLAPEIL +
Sbjct: 250 -----------------LEPGEKLRE-------------LCGTPGYLAPEILKCSMDETH 279
Query: 656 -GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPE 709
G+G D W+ G+ILF L+ G PPF + I+ + W S
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR----SST 335
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
DLI R L DP RL A + QH FF+
Sbjct: 336 VKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 8e-55
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 41/283 (14%)
Query: 464 LLLAGKGALSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCR 521
L+ + + + +E + E IL + +P VV+
Sbjct: 51 LIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE 110
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
++LY+V E +N G + + L ED AR Y +++ +EYLH +++HRD+KP NLL
Sbjct: 111 DHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ DGHIK+ DFG+S + L + V
Sbjct: 170 VGEDGHIKIADFGVS-------------------NEFKGSDALL------------SNTV 198
Query: 642 GTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIP 698
GTP ++APE L T G D W++G+ L+ + G PF E + I ++ +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258
Query: 699 WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+P P +++ + DLI R L ++P R+ E+K H +
Sbjct: 259 FPDQP-DIAEDLKDLITRMLDKNPESRI---VVPEIKLHPWVT 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-54
Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 49/272 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+ KA K+ +IL E ++L + +P +++ F + Y+V E GG+L+ +
Sbjct: 54 VINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI 112
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
E A I +V + Y+H +VHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
Q+ K + +GT Y+APE+L GT +
Sbjct: 173 --------------------------------CFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D WS G+IL+ L+ G PPF ++ I + K W + S +A D
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI----SDDAKD 255
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
LI + LT P R+ A++ +H + + +
Sbjct: 256 LIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-54
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 53/276 (19%)
Query: 481 VLKKADMIRKNA--VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY- 537
++ A E + E I +++P +V +++ LY+V E+++G DL
Sbjct: 56 IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115
Query: 538 ---SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLT 591
E VA Y+ +++ AL Y H ++HRD+KP +L+A +KL
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
FG++ LG+ VGTP ++APE+
Sbjct: 176 GFGVAIQ-------------------LGESGLVAG------------GRVGTPHFMAPEV 204
Query: 652 LLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEM 706
+ +G D W G+ILF L+ G PF +++F+ I+ K W +
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI---- 259
Query: 707 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
S A DL+ R L DP +R+ E H + K+
Sbjct: 260 SESAKDLVRRMLMLDPAERI---TVYEALNHPWLKE 292
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-54
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 48/269 (17%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+ R + E I E IL V + V+ + R ++ L++E ++GG+L+ L
Sbjct: 49 QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLTDFGLSKV 598
L E+ A +I +++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
++ + ++ GTP+++APEI+ G
Sbjct: 168 -------------------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDL 713
AD WS+G+I + L+ G PF + Q+ NI + + S A D
Sbjct: 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT----SELAKDF 252
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
I + L ++ +RL E +H +
Sbjct: 253 IRKLLVKETRKRL---TIQEALRHPWITP 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-54
Identities = 72/263 (27%), Positives = 120/263 (45%), Gaps = 46/263 (17%)
Query: 488 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
+ + + E I +++P +VR S + + YL+ + + GG+L+ +
Sbjct: 49 LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS 108
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINST 604
E A I +++ A+ + H + VVHR+LKP+NLL+A +KL DFGL+
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI------- 161
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664
E + E++ GTP YL+PE+L +G D W
Sbjct: 162 ------------------------EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLT 719
+ G+IL+ L+VG PPF E +++ I W V +PEA DLI++ LT
Sbjct: 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV----TPEAKDLINKMLT 253
Query: 720 EDPHQRLGSGGASEVKQHVFFKD 742
+P +R+ A+E +H +
Sbjct: 254 INPSKRI---TAAEALKHPWISH 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-54
Identities = 56/314 (17%), Positives = 102/314 (32%), Gaps = 86/314 (27%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYS 538
V +R V+ + E ++L + + +V+ F T + L+ME+ G LY+
Sbjct: 41 VFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98
Query: 539 LLR---NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLT 591
+L N L E + + +VV + +L +VHR++KP N++ KLT
Sbjct: 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
DFG ++ ++ + S GT +YL P++
Sbjct: 159 DFGAAR--------------------------------ELEDDEQFVSLYGTEEYLHPDM 186
Query: 652 L--------LGTGHGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFDNILNRKIP- 698
+G T D WS+G+ + G PF +++ I+ K
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 699 ---------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
+ + ++ L D + G +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAE 303
Query: 738 VFFKDINWDTLARQ 751
D L R
Sbjct: 304 T------SDILHRG 311
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-54
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 48/287 (16%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+ R + E I E IL +++P V+ + + ++ L++E + GG+L+ L
Sbjct: 48 RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE 107
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKV 598
L E+ A ++ +++ + YLHSL++ H DLKP+N+++ IK+ DFGL+
Sbjct: 108 KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH- 166
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ ++ GTP+++APEI+ G
Sbjct: 167 -------------------------------KIDFGNEFKNIFGTPEFVAPEIVNYEPLG 195
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDL 713
AD WS+G+I + L+ G PF + Q+ N+ + S A D
Sbjct: 196 LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT----SALAKDF 251
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 760
I R L +DP +R+ + QH + K + +KA+ V +
Sbjct: 252 IRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-54
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 48/271 (17%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
+ E I E +L S+ +P +++ F F ++ YLV E+ GG+L+ + N DE
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 550 VARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDD 606
A + +++ + YLH +VHRD+KP+N+L+ + +IK+ DFGLS +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYK 204
Query: 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666
L +GT Y+APE+L + D WS
Sbjct: 205 LRD------------------------------RLGTAYYIAPEVLKK-KYNEKCDVWSC 233
Query: 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTED 721
G+I++ L+ G PPF ++ Q I + K W + S EA +LI LT D
Sbjct: 234 GVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYD 289
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDTLARQK 752
++R A E + K + +
Sbjct: 290 YNKRC---TAEEALNSRWIKKYANNINKSDQ 317
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-54
Identities = 79/292 (27%), Positives = 133/292 (45%), Gaps = 52/292 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+++K + + +L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 69 IIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSK 597
+ +E A V I +V+ + YLH +VHRDLKP+NLL+ D IK+ DFGLS
Sbjct: 128 IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ ++K + +GT Y+APE+L +
Sbjct: 188 --------------------------------VFENQKKMKERLGTAYYIAPEVLRK-KY 214
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
D WS+G+ILF L+ G PPF + Q+I + K W V S A D
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKD 270
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALD 764
LI + L D +R+ A + +H + K+ ++ +P+ +A++
Sbjct: 271 LIKQMLQFDSQRRI---SAQQALEHPWIKE---MCSKKESGIELPSLANAIE 316
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 9e-54
Identities = 66/264 (25%), Positives = 115/264 (43%), Gaps = 48/264 (18%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+ R E I E IL V +P ++ + R ++ L++E ++GG+L+ L
Sbjct: 49 QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ 108
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----DGHIKLTDFGLSKV 598
L E+ A +I +++ + YLH+ ++ H DLKP+N+++ HIKL DFGL+
Sbjct: 109 KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
++ + ++ GTP+++APEI+ G
Sbjct: 168 -------------------------------EIEDGVEFKNIFGTPEFVAPEIVNYEPLG 196
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDL 713
AD WS+G+I + L+ G PF + Q+ NI + + S A D
Sbjct: 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDF 252
Query: 714 IDRFLTEDPHQRLGSGGASEVKQH 737
I + L ++ +RL E +H
Sbjct: 253 IRKLLVKETRKRL---TIQEALRH 273
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-53
Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 39/255 (15%)
Query: 488 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
+ +++ + E I+ + +P +V+ F + LYL+MEY +GG+++ L G +
Sbjct: 53 LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK 112
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
E AR ++V A++Y H R+VHRDLK +NLL+ D +IK+ DFG S N
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS-----NEFTV- 166
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSV 666
G L + G P Y APE+ G G D WS+
Sbjct: 167 ------GGKL--------------------DAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRL 726
G+IL+ L+ G PF+ ++ +++ + +L K R+P MS + +L+ RFL +P +R
Sbjct: 201 GVILYTLVSGSLPFDGQNLKELRERVLRGKY---RIPFYMSTDCENLLKRFLVLNPIKRG 257
Query: 727 GSGGASEVKQHVFFK 741
++ + +
Sbjct: 258 ---TLEQIMKDRWIN 269
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-53
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
LKK + IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 61 FLKKRRRGQDC-RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 540 L--RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFG 594
+ E+ I +++ + YLH +VH DLKP N+L++ G IK+ DFG
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
+S+ + R +GTP+YLAPEIL
Sbjct: 180 MSR--------------------------------KIGHACELREIMGTPEYLAPEILNY 207
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPE 709
T D W++GII + L+ PF E Q+ + NI + + V S
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQL 263
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPT 758
A D I L ++P +R A H + + +++ L + +
Sbjct: 264 ATDFIQSLLVKNPEKRP---TAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 65/257 (25%), Positives = 110/257 (42%), Gaps = 47/257 (18%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LD 547
+ + E IL R+ ++ SF E L ++ E+++G D++ + L+
Sbjct: 41 KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN 100
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTD 605
E Y+ +V AL++LHS + H D++P+N++ IK+ +FG ++
Sbjct: 101 EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-------- 152
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
+ R P+Y APE+ T D WS
Sbjct: 153 ------------------------QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWS 188
Query: 666 VGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTE 720
+G +++ L+ GI PF AE QQI +NI+N + + + S EA D +DR L +
Sbjct: 189 LGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVK 244
Query: 721 DPHQRLGSGGASEVKQH 737
+ R+ ASE QH
Sbjct: 245 ERKSRM---TASEALQH 258
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 39/262 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L + + + V I E L R+P +++ + + + ++VMEY++GG+L+ +
Sbjct: 43 ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI 102
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
G ++E AR +++ A++Y H VVHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 103 CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-- 160
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGT 659
+ R++ G+P+Y APE++ G G
Sbjct: 161 ------------------------------MSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS G+IL+ L+ G PF+ EH +F I +PE ++ L+ L
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---YIPEYLNRSVATLLMHMLQ 247
Query: 720 EDPHQRLGSGGASEVKQHVFFK 741
DP +R ++++H +FK
Sbjct: 248 VDPLKRA---TIKDIREHEWFK 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-53
Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 491 NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV 550
+ E+I E I + + VV+F+ YL +EY +GG+L+ + + E
Sbjct: 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD 106
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
A+ + +++ + YLH + + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV------------ 154
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGII 669
+ R GT Y+APE+L H D WS GI+
Sbjct: 155 -----------------FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 670 LFELIVGIPPFN-AEHPQQIFDNILNRK---IPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
L ++ G P++ Q + + +K PW +++ L+ + L E+P R
Sbjct: 198 LTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSAR 253
Query: 726 LGSGGASEVKQHVFFK 741
+ ++K+ ++
Sbjct: 254 I---TIPDIKKDRWYN 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-53
Identities = 62/345 (17%), Positives = 111/345 (32%), Gaps = 86/345 (24%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYS 538
V +R V+ + E ++L + + +V+ F T + L+ME+ G LY+
Sbjct: 41 VFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98
Query: 539 LL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA----HDGHIKLT 591
+L N L E + + +VV + +L +VHR++KP N++ KLT
Sbjct: 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
DFG ++ ++ + S GT +YL P++
Sbjct: 159 DFGAAR--------------------------------ELEDDEQFVSLYGTEEYLHPDM 186
Query: 652 L--------LGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI------ 697
+G T D WS+G+ + G PF + ++ + I
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 698 --------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
+ + ++ L D + G Q
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG------FDQ- 299
Query: 738 VFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIY 782
FF + D L R + Y S + E +Y
Sbjct: 300 -FFAET-SDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVY 342
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 53/262 (20%), Positives = 109/262 (41%), Gaps = 31/262 (11%)
Query: 486 DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN--- 542
+ + +++ + + V + + LY+ M+ +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
L + V ++ A+E+LHS ++HRDLKP N+ D +K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA---- 213
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
+ +E + T VGT Y++PE + G + D
Sbjct: 214 ---------------MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258
Query: 663 WWSVGIILFELIVGIPPFNAEH-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
+S+G+ILFEL+ F+ + +I ++ R + +P + + P+ H ++ L+
Sbjct: 259 IFSLGLILFELLY---SFSTQMERVRIITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPS 313
Query: 722 PHQRLGSGGASEVKQHVFFKDI 743
P +R A+++ ++ F+++
Sbjct: 314 PTERP---EATDIIENAIFENL 332
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-52
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 52/269 (19%)
Query: 487 MIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
+I K+ E +IL+ ++P ++ + + +Y+V E + GG+L +
Sbjct: 54 IIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF 112
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH----IKLTDFGLSKVGLI 601
E A + + +EYLH+ VVHRDLKP N+L + I++ DFG +K
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--- 169
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
L + +T T +++APE+L G+
Sbjct: 170 ---------------LRAENGLLMTP-------------CYTANFVAPEVLERQGYDAAC 201
Query: 662 DWWSVGIILFELIVGIPPFNA---EHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDL 713
D WS+G++L+ ++ G PF + P++I I + K W V S A DL
Sbjct: 202 DIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDL 257
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ + L DPHQRL A+ V +H +
Sbjct: 258 VSKMLHVDPHQRL---TAALVLRHPWIVH 283
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-52
Identities = 61/269 (22%), Positives = 124/269 (46%), Gaps = 50/269 (18%)
Query: 487 MIRKNAV---ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+I+ + E + E ++ + + +++ + +F + ++ LVMEY++GG+L+ + +
Sbjct: 121 IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE 180
Query: 544 GC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGL 600
L E +++ ++ + ++H + ++H DLKP+N+L + IK+ DFGL++
Sbjct: 181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR--- 237
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ R K + GTP++LAPE++
Sbjct: 238 -----------------------------RYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLID 715
D WSVG+I + L+ G+ PF ++ + +NIL + + + S EA + I
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI----SEEAKEFIS 324
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
+ L ++ R+ ASE +H + D
Sbjct: 325 KLLIKEKSWRI---SASEALKHPWLSDHK 350
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-52
Identities = 54/272 (19%), Positives = 96/272 (35%), Gaps = 38/272 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDL 536
LK+ + E E D+ +P ++R +L++ + G L
Sbjct: 58 ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 537 YSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 592
++ + L L ED + + LE +H+ HRDLKP N+L+ +G L D
Sbjct: 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
G L ++ A++ T Y APE+
Sbjct: 178 LGSMNQ--------ACIHVEGSRQALTLQD---WAAQR-----------CTISYRAPELF 215
Query: 653 LGTGH---GTTADWWSVGIILFELIVGIPPFNAEHPQ-QIFDNILNRKIPWPRVPEEMSP 708
H D WS+G +L+ ++ G P++ + + ++ P+ P S
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP-RHSS 274
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740
L++ +T DPHQR + +
Sbjct: 275 ALWQLLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-51
Identities = 53/265 (20%), Positives = 105/265 (39%), Gaps = 50/265 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY-SL 539
+ + K ++ E I+ + +P ++ +F + + L++E+L+GG+L+ +
Sbjct: 83 FINTPYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSK 597
+ E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ T ++ APEI+
Sbjct: 200 --------------------------------KLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHD 712
G D W++G++ + L+ G+ PF E + N+ + V SPEA D
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----SPEAKD 283
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQH 737
I L ++P +RL + +H
Sbjct: 284 FIKNLLQKEPRKRL---TVHDALEH 305
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-51
Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 491 NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDV 550
+ E+I E I + + VV+F+ YL +EY +GG+L+ + + E
Sbjct: 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD 106
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
A+ + +++ + YLH + + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV------------ 154
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGII 669
+ R GT Y+APE+L H D WS GI+
Sbjct: 155 -----------------FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 670 LFELIVGIPPFNAEH-PQQIFDNILNRK---IPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
L ++ G P++ Q + + +K PW +++ L+ + L E+P R
Sbjct: 198 LTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSAR 253
Query: 726 LGSGGASEVKQHVFFK 741
+ ++K+ ++
Sbjct: 254 I---TIPDIKKDRWYN 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-50
Identities = 35/281 (12%), Positives = 80/281 (28%), Gaps = 69/281 (24%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRE--NLYLVMEYLN------GGDLYSLLRNLGCLD 547
+ D++ + ++R + + + + G L S L
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
+V+ L LH +VH L+P ++++ G + LT F
Sbjct: 205 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---------- 254
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----------GTG 656
+ + + + PE+ T
Sbjct: 255 -------------------------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+ D W++G++++ + P + + I R + + L++
Sbjct: 290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-------RSCKNIPQPVRALLEG 342
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757
FL RL + + ++ L + +A +P
Sbjct: 343 FLRYPKEDRL---LPLQAMETPEYEQ-----LRTELSAALP 375
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 73/259 (28%), Positives = 128/259 (49%), Gaps = 35/259 (13%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K D+ ++ E + E I+ ++ VV + S+ E L+++ME+L GG L ++
Sbjct: 76 KMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ 135
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
L+E+ V+ AL YLH+ V+HRD+K D++L+ DG +KL+DFG
Sbjct: 136 -VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA----- 189
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
Q++ ++ K++S VGTP ++APE++ + + T D
Sbjct: 190 ---------------------QIS-----KDVPKRKSLVGTPYWMAPEVISRSLYATEVD 223
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
WS+GI++ E++ G PP+ ++ P Q + + P + ++SP D ++R L DP
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 723 HQRLGSGGASEVKQHVFFK 741
+R A E+ H F
Sbjct: 284 QER---ATAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 85/263 (32%), Positives = 134/263 (50%), Gaps = 43/263 (16%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
++ ++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 543 LGCLDEDVARVYIA----EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
C+DE IA E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 111 -TCMDEG----QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA- 164
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
Q+T E+ K+ + VGTP ++APE++ +G
Sbjct: 165 -------------------------QIT-----PEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
D WS+GI+ E+I G PP+ E+P + I P + PE++S D ++R L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 719 TEDPHQRLGSGGASEVKQHVFFK 741
D +R G A E+ QH F K
Sbjct: 255 EMDVEKR---GSAKELLQHQFLK 274
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 69/334 (20%), Positives = 121/334 (36%), Gaps = 69/334 (20%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME-YLNGGDLYSLL 540
+ + I + + E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
LDE +A ++V A+ YL ++HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGT 659
+ + + GT +Y APE+L+G G
Sbjct: 180 ------------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ WS+G+ L+ L+ PF + + I P +S E L+ L
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCE------LEETVEAAI---HPPYLVSKELMSLVSGLLQ 260
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDE 779
P +R ++ + + Y+W
Sbjct: 261 PVPERRT---TLEKLVTDPWVT-----------------------QPVNLADYTWEEVFR 294
Query: 780 NIYPASDFEDSSDADSLSGSSSCLSNRQEEVGDE 813
P S ++ + + S S ++ QE G E
Sbjct: 295 VNKPESGVLSAASLEMGNRSLSDVAQAQELCGGE 328
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-50
Identities = 67/262 (25%), Positives = 126/262 (48%), Gaps = 40/262 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ + + + + + E L +R+P +++ + T ++ +V+EY GG+L+ +
Sbjct: 41 FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI 99
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ ED R + +++ A+EY H ++VHRDLKP+NLL+ + ++K+ DFGLS +
Sbjct: 100 VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-- 157
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGT 659
+ +++ G+P+Y APE++ G G
Sbjct: 158 ------------------------------MTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS GI+L+ ++VG PF+ E +F + + +P+ +SP A LI R +
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY---VMPDFLSPGAQSLIRRMIV 244
Query: 720 EDPHQRLGSGGASEVKQHVFFK 741
DP QR+ E+++ +F
Sbjct: 245 ADPMQRI---TIQEIRRDPWFN 263
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-49
Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 47/257 (18%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLD 547
++ E++ E + +R+P +V +F + ++ E+++GG+L+ + +
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 253
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTD 605
ED A Y+ +V L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------- 305
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
H ++ + GT ++ APE+ G G D WS
Sbjct: 306 ------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 666 VGIILFELIVGIPPFNAEHPQQIFDNILNRKI-----PWPRVPEEMSPEAHDLIDRFLTE 720
VG++ + L+ G+ PF E+ + N+ + + + S + D I + L
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI----SEDGKDFIRKLLLA 397
Query: 721 DPHQRLGSGGASEVKQH 737
DP+ R+ + +H
Sbjct: 398 DPNTRM---TIHQALEH 411
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-49
Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 43/268 (16%)
Query: 481 VLKKADMIRKNAVES-ILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGG--D 535
+LKK + R E+ + E +L +R+ V++ ++ +Y+VMEY G +
Sbjct: 37 ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE 96
Query: 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
+ + A Y +++ LEYLHS +VH+D+KP NLL+ G +K++ G+
Sbjct: 97 MLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV 155
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
+ + P + T R++ G+P + PEI G
Sbjct: 156 A---------EALHPFAADDTC--------------------RTSQGSPAFQPPEIANGL 186
Query: 656 G--HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
G D WS G+ L+ + G+ PF ++ ++F+NI +P + P DL
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---AIPGDCGPPLSDL 243
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+ L +P +R +++QH +F+
Sbjct: 244 LKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-49
Identities = 70/277 (25%), Positives = 110/277 (39%), Gaps = 69/277 (24%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGD 535
+L + R+ E D P +V + + L ++ME + GG+
Sbjct: 61 LLYDSPKARQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112
Query: 536 LYS--LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKL 590
L+S R E A + ++ A+++LHS + HRD+KP+NLL D +KL
Sbjct: 113 LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
TDFG +K + L + TP Y+APE
Sbjct: 173 TDFGFAKE---------------------TTQNALQ------------TPCYTPYYVAPE 199
Query: 651 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI----------PWP 700
+L + + D WS+G+I++ L+ G PPF + Q I + R+I W
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWS 258
Query: 701 RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
V S +A LI L DP +RL ++ H
Sbjct: 259 EV----SEDAKQLIRLLLKTDPTERL---TITQFMNH 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-49
Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 42/268 (15%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K+ + + E + +++ +V++ SF+ + + ME + GG L +LLR+
Sbjct: 53 KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112
Query: 543 LG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKV 598
+E Y +++ L+YLH ++VHRD+K DN+LI + G +K++DFG SK
Sbjct: 113 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK- 171
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TG 656
+L + GT Y+APEI+ G
Sbjct: 172 -------------------------RLAGI-----NPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 657 HGTTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+G AD WS+G + E+ G PPF PQ + K+ P +PE MS EA I
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAKAFIL 260
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+ DP +R A+++ F K
Sbjct: 261 KCFEPDPDKRA---CANDLLVDEFLKVS 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 5e-49
Identities = 70/283 (24%), Positives = 110/283 (38%), Gaps = 63/283 (22%)
Query: 487 MIRKNA---VESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+I K + E ++L + V+ F + YLV E + GG + S +
Sbjct: 45 IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVG 599
+E A V + +V AL++LH+ + HRDLKP+N+L H +K+ DF L
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG----- 654
+N T G+ +Y+APE++
Sbjct: 165 KLNGDCSPISTPELLT------------------------PCGSAEYMAPEVVEAFSEEA 200
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEH---------------PQQIFDNILNRKI-- 697
+ + D WS+G+IL+ L+ G PPF +F++I K
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 698 ---PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
W + S A DLI + L D QRL A++V QH
Sbjct: 261 PDKDWAHI----SCAAKDLISKLLVRDAKQRL---SAAQVLQH 296
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-49
Identities = 73/262 (27%), Positives = 126/262 (48%), Gaps = 39/262 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L + + + V I E L R+P +++ + + ++++VMEY++GG+L+ +
Sbjct: 48 ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI 107
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
G LDE +R +++ ++Y H VVHRDLKP+N+L+ + K+ DFGLS
Sbjct: 108 CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---- 163
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGT 659
N D G L R++ G+P+Y APE++ G G
Sbjct: 164 -NMMSD-------GEFL--------------------RTSCGSPNYAAPEVISGRLYAGP 195
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS G+IL+ L+ G PF+ +H +F I + P+ ++P L+ L
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNPSVISLLKHMLQ 252
Query: 720 EDPHQRLGSGGASEVKQHVFFK 741
DP +R ++++H +FK
Sbjct: 253 VDPMKRA---TIKDIREHEWFK 271
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-49
Identities = 69/265 (26%), Positives = 119/265 (44%), Gaps = 45/265 (16%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--------G 544
++ +L E + +P +V ++ SF ++ L+LVM+ L+GG + +++++ G
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 545 CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
LDE + EV+ LEYLH +HRD+K N+L+ DG +++ DFG
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG---------- 166
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE-ILLGTGHGTTADW 663
VS L + +++ VGTP ++APE + G+ AD
Sbjct: 167 -------VSA---------FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI 210
Query: 664 WSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIP-------WPRVPEEMSPEAHDLIDR 716
WS GI EL G P++ P ++ L P + ++ +I
Sbjct: 211 WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL 270
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFK 741
L +DP +R A+E+ +H FF+
Sbjct: 271 CLQKDPEKRP---TAAELLRHKFFQ 292
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-49
Identities = 73/360 (20%), Positives = 120/360 (33%), Gaps = 72/360 (20%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGG 534
++ ++ KN E E I+ + +P VV + L MEY GG
Sbjct: 46 QCRQ-ELSPKN-RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG 103
Query: 535 DLYSLLR---NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---I 588
DL L N L E R ++++ AL YLH R++HRDLKP+N+++
Sbjct: 104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH 163
Query: 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648
K+ D G +K L E VGT YLA
Sbjct: 164 KIIDLGYAKE-------------------LDQGE-------------LCTEFVGTLQYLA 191
Query: 649 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKI----------- 697
PE+L + T D+WS G + FE I G PF + + K
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 698 ----------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 747
+ ++ + + L QR G + F+ ++
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD-SI 307
Query: 748 LARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPASDFEDSSDADSLSGSSSCLSNRQ 807
L+ + + + + T T + + + + + L S L++ Q
Sbjct: 308 LSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIP-EEEQELLQASGLALNSAQ 366
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 7e-49
Identities = 52/269 (19%), Positives = 101/269 (37%), Gaps = 32/269 (11%)
Query: 481 VLKKADMIRKNAVE--SILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+K++ +V+ + L E + ++ VVR+F ++ +++ + EY NGG L
Sbjct: 40 AIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 99
Query: 538 SLL----RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDF 593
+ R + E + + +V L Y+HS+ +VH D+KP N+ I+
Sbjct: 100 DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
+ ++ +GD H + G +LA E+L
Sbjct: 160 EGDEDDWASNKVMFK---------IGD-------LGHVTRISSPQVEEGDSRFLANEVLQ 203
Query: 654 GT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
H AD +++ + + P R+ PR+P+ +S E +
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI-----RQGRLPRIPQVLSQEFTE 258
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
L+ + DP +R A + +H
Sbjct: 259 LLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 77/254 (30%), Positives = 119/254 (46%), Gaps = 49/254 (19%)
Query: 499 ERDILI--SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
+R+I+ S+R+P +VRF +L ++MEY +GG+LY + N G ED AR +
Sbjct: 64 QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123
Query: 557 EVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
+++ + Y HS+++ HRDLK +N L+ + +K+ DFG SK +++S
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------- 172
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFEL 673
+S VGTP Y+APE+LL G AD WS G+ L+ +
Sbjct: 173 --QP-------------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211
Query: 674 IVGIPPFNAEHPQQIFDNILNR------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727
+VG PF + + + R IP +SPE LI R DP R+
Sbjct: 212 LVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRI- 267
Query: 728 SGGASEVKQHVFFK 741
E+K H +F
Sbjct: 268 --SIPEIKTHSWFL 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 37/249 (14%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
+E I E +L +P+V +++ S+ L+++MEYL GG LL G LDE
Sbjct: 64 IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIA 122
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
+ E++ L+YLHS + +HRD+K N+L++ G +KL DFG V
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG-----------------V 165
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
+G QLT + + K+ + VGTP ++APE++ + + + AD WS+GI E
Sbjct: 166 AG---------QLTDT-----QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
Query: 673 LIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732
L G PP + HP ++ I P + S + ++ L ++P R A
Sbjct: 212 LARGEPPHSELHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAK 266
Query: 733 EVKQHVFFK 741
E+ +H F
Sbjct: 267 ELLKHKFIL 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 70/269 (26%), Positives = 103/269 (38%), Gaps = 55/269 (20%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRN----PFVVRFFYSFTCRENLYLVMEY-LNGG 534
+VL + + E +L V P V+R F +E LV+E L
Sbjct: 68 RVLGWSPLSDSVTCPL---EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDF 593
DL+ + G L E +R + +VV A+++ HS VVHRD+K +N+LI G KL DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G A+ GT Y PE +
Sbjct: 185 GSG--------------ALLHDEPY-------------------TDFDGTRVYSPPEWIS 211
Query: 654 GTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
H A WS+GI+L++++ G PF E Q+I + L P +SP+
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPF--ERDQEILEAEL-------HFPAHVSPDCCA 262
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
LI R L P R E+ + +
Sbjct: 263 LIRRCLAPKPSSRP---SLEEILLDPWMQ 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-47
Identities = 73/270 (27%), Positives = 112/270 (41%), Gaps = 60/270 (22%)
Query: 487 MIRKNAVESILAERDILISVRN-PFVVRF--FY--SFTCRENLYLVMEYLNGGDLYS--L 539
M++ E ++ P +VR Y + R+ L +VME L+GG+L+S
Sbjct: 94 MLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 151
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLS 596
R E A + + A++YLHS+ + HRD+KP+NLL + +KLTDFG +
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
K S + L+ P TP Y+APE+L
Sbjct: 212 K--ETTSHNSLTTP------------------------------CYTPYYVAPEVLGPEK 239
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFDNILNRKI-----PWPRVPEEMS 707
+ + D WS+G+I++ L+ G PPF + H + I + W V S
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----S 295
Query: 708 PEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
E LI L +P QR+ +E H
Sbjct: 296 EEVKMLIRNLLKTEPTQRM---TITEFMNH 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-47
Identities = 58/266 (21%), Positives = 97/266 (36%), Gaps = 43/266 (16%)
Query: 488 IRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGC 545
I E +L S +P V+R+F + R+ Y+ +E L + +
Sbjct: 56 ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGL 600
+ + L +LHSL +VHRDLKP N+LI+ ++DFGL K
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK-- 172
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GH 657
+ + ++ GT ++APE+L
Sbjct: 173 --------------------------LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 658 GTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
T D +S G + + +I G PF +Q + + + A +LI++
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKD 742
+ DP +R A V +H FF
Sbjct: 267 MIAMDPQKRP---SAKHVLKHPFFWS 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 76/251 (30%), Positives = 119/251 (47%), Gaps = 35/251 (13%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDVA 551
++ I+ E I+ +P VV+++ S+ +L++VMEY G + ++R L ED
Sbjct: 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI 127
Query: 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+ + LEYLH +R +HRD+K N+L+ +GH KL DFG
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG----------------- 170
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
V+G QLT K+ + +GTP ++APE++ G+ AD WS+GI
Sbjct: 171 VAG---------QLT-----DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAI 216
Query: 672 ELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731
E+ G PP+ HP + I P R PE S D + + L + P QR A
Sbjct: 217 EMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR---ATA 273
Query: 732 SEVKQHVFFKD 742
+++ QH F +
Sbjct: 274 TQLLQHPFVRS 284
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 49/260 (18%), Positives = 110/260 (42%), Gaps = 44/260 (16%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNLGC 545
K+ + E ++L +++P +VRF+ S+ ++ + LV E + G L + L+
Sbjct: 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125
Query: 546 LDEDVARVYIAEVVLALEYLHS--LRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLIN 602
+ V R + +++ L++LH+ ++HRDLK DN+ I G +K+ D GL+
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----- 180
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
+ ++ +GTP+++APE + + + D
Sbjct: 181 ----------------------------LKRASFAKAVIGTPEFMAPE-MYEEKYDESVD 211
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
++ G+ + E+ P++ + + + PE ++I+ + ++
Sbjct: 212 VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNK 271
Query: 723 HQRLGSGGASEVKQHVFFKD 742
+R ++ H FF++
Sbjct: 272 DERY---SIKDLLNHAFFQE 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-47
Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 40/266 (15%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K + + +E + E +IL + +P++V+ ++ L++++E+ GG + +++
Sbjct: 50 KVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE 109
Query: 543 L-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
L L E +V +++ AL +LHS R++HRDLK N+L+ +G I+L DFG
Sbjct: 110 LDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG------- 162
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTG 656
VS + + +K+ S +GTP ++APE+++ T
Sbjct: 163 ----------VSA---------KNLKT-----LQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+ AD WS+GI L E+ PP + +P ++ I P P + S E D +
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKD 742
L ++P R A+++ +H F
Sbjct: 259 ALDKNPETR---PSAAQLLEHPFVSS 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-47
Identities = 34/283 (12%), Positives = 76/283 (26%), Gaps = 53/283 (18%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCR--ENLYLVMEYLNG------GDLYSLLRNLGCLD 547
+ D++ + ++R + + + + L S L
Sbjct: 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 209
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
+V+ L LH +VH L+P ++++ G + LT F
Sbjct: 210 HHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR--------- 260
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-----AD 662
D ++ P+ A +L H T D
Sbjct: 261 ------------DGASAVSPI---------GRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
W++G+ ++ + P + + I + + L++ FL
Sbjct: 300 TWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPK 352
Query: 723 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDT 765
RL + + ++ + + A +
Sbjct: 353 EDRL---LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGG 392
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 63/251 (25%), Positives = 106/251 (42%), Gaps = 50/251 (19%)
Query: 499 ERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYI 555
E +L V + V+R F ++ L++E DL+ + G L E++AR +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
+V+ A+ + H+ V+HRD+K +N+LI + G +KL DFG A+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG--------------ALLK 201
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFEL 673
T+ GT Y PE + HG +A WS+GI+L+++
Sbjct: 202 DTVY-------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242
Query: 674 IVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 733
+ G PF EH ++I + + +S E LI L P R E
Sbjct: 243 VCGDIPF--EHDEEIIRGQV-------FFRQRVSSECQHLIRWCLALRPSDRP---TFEE 290
Query: 734 VKQHVFFKDIN 744
++ H + +D+
Sbjct: 291 IQNHPWMQDVL 301
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-46
Identities = 38/305 (12%), Positives = 88/305 (28%), Gaps = 75/305 (24%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V K A+ + L ++F+ + + LV E + G L + +
Sbjct: 102 VQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 541 R-----NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH----------- 584
+ + + + ++ +E +H ++H D+KPDN ++ +
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644
+ L D G S D+ + + T
Sbjct: 219 SAGLALIDLGQSI--------DMK---------------------LFPKGTIFTAKCETS 249
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ----------------- 687
+ E+L D++ V ++ ++ G +
Sbjct: 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN 309
Query: 688 -IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746
F +LN +P+ + DL+ + L + Q + ++ +
Sbjct: 310 EFFHVMLN-------IPDCHHLPSLDLLRQKLKKVFQQHYTNKI--RALRNRLIVLLLEC 360
Query: 747 TLARQ 751
+R+
Sbjct: 361 KRSRK 365
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-45
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 62/286 (21%)
Query: 488 IRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 546
+ + + L E +L S +P V+R++ S T LY+ +E +L L+ +
Sbjct: 47 MLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVS 105
Query: 547 DEDV-------ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------------DG 586
DE++ + ++ + +LHSL+++HRDLKP N+L++ +
Sbjct: 106 DENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165
Query: 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
I ++DFGL K L + + + + GT +
Sbjct: 166 RILISDFGLCKK-------------------LDSGQSSFRTNLN--------NPSGTSGW 198
Query: 647 LAPEILLGTGH-------GTTADWWSVGIILFELIV-GIPPFNAEHPQQ--IFDNILNRK 696
APE+L + + + D +S+G + + ++ G PF ++ ++ I I +
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLD 258
Query: 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ EA DLI + + DP +R A +V +H F
Sbjct: 259 EMKCLHDRSLIAEATDLISQMIDHDPLKRP---TAMKVLRHPLFWP 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 2e-44
Identities = 46/298 (15%), Positives = 77/298 (25%), Gaps = 60/298 (20%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRF--FYSFTCRENLYLVMEYLNGGDLY 537
L +L D + P + N L+M DL
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLE 175
Query: 538 SLLRNL-------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590
L L G + A+++ L S +VH PDNL I DG + L
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
D + + ++ Y E
Sbjct: 236 GDVSALW----------------------------------KVGTRGPASSVPVTYAPRE 261
Query: 651 ILLG--TGHGTTADWWSVGIILFELIVGIPPF--NAEHPQQIFDNILNRKIPWPRVP--- 703
L + W +G+ ++ + PF + + R +
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS 321
Query: 704 -EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSE 760
+ LI RFL D +RL E + F L + ++ + T +
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRL---LPLEAMETPEFLQ-----LQNEISSSLSTGQ 371
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 47/259 (18%)
Query: 494 ESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
+ IL + D+++ S P++V+ F +F ++++ ME + R G + E +
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG 127
Query: 553 VYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611
+V AL YL V+HRD+KP N+L+ G IKL DFG
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFG----------------- 170
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-----LGTGHGTTADWWSV 666
+SG +L + K + G Y+APE + + AD WS+
Sbjct: 171 ISG---------RLVDD------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215
Query: 667 GIILFELIVGIPPFNAEHPQQIFD---NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 723
GI L EL G P+ F+ +L + P S + + LT+D
Sbjct: 216 GISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 724 QRLGSGGASEVKQHVFFKD 742
+R +++ +H F K
Sbjct: 274 KRP---KYNKLLEHSFIKR 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/260 (25%), Positives = 112/260 (43%), Gaps = 48/260 (18%)
Query: 494 ESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLY-SLLRNLGCLDED 549
+ +L + DI + +V PF V F+ + ++++ ME ++ Y ++ + ED
Sbjct: 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPED 109
Query: 550 VARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V ALE+LHS L V+HRD+KP N+LI G +K+ DFG
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG-------------- 155
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADWW 664
+SG L K G Y+APE + + +D W
Sbjct: 156 ---ISG---------YLVDD------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 665 SVGIILFELIVGIPPFNA-EHPQQIFDNILNRKIPWPRVPEEM-SPEAHDLIDRFLTEDP 722
S+GI + EL + P+++ P Q ++ P P++P + S E D + L ++
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNS 255
Query: 723 HQRLGSGGASEVKQHVFFKD 742
+R E+ QH FF
Sbjct: 256 KERP---TYPELMQHPFFTL 272
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 50/263 (19%)
Query: 494 ESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNL--GCLDE 548
+ +L + D+++ S P++V+F+ + + ++ ME ++ Y + ++ + E
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 549 DVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
++ V AL +L L+++HRD+KP N+L+ G+IKL DFG
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG------------- 171
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT----ADW 663
+SG QL S K G Y+APE + + +D
Sbjct: 172 ----ISG---------QLVDS------IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 664 WSVGIILFELIVGIPPFNAEHP--QQIFDNILNRKIPWPRVPEEM--SPEAHDLIDRFLT 719
WS+GI L+EL G P+ + Q+ ++ P EE SP + ++ LT
Sbjct: 213 WSLGITLYELATGRFPYPKWNSVFDQLT-QVVKGDPPQLSNSEEREFSPSFINFVNLCLT 271
Query: 720 EDPHQRLGSGGASEVKQHVFFKD 742
+D +R E+ +H F
Sbjct: 272 KDESKRP---KYKELLKHPFILM 291
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 61/275 (22%), Positives = 106/275 (38%), Gaps = 43/275 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSF--------TCRENLYLVMEYL 531
LK+ + +I+ E + + P +V+F + T + L+ E
Sbjct: 57 ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 532 NGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGH 587
G + L + G L D + A++++H + ++HRDLK +NLL+++ G
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
Query: 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL 647
IKL DFG + T + +++ + ++ + TP Y
Sbjct: 177 IKLCDFGSA-------------------TTISHYPDYSWSAQRRALVEEEITRNTTPMYR 217
Query: 648 APEILLGTGH---GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPE 704
PEI+ + G D W++G IL+ L PF + I+N K P
Sbjct: 218 TPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHD- 272
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
H LI L +P +RL +EV +
Sbjct: 273 TQYTVFHSLIRAMLQVNPEERL---SIAEVVHQLQ 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 61/266 (22%), Positives = 99/266 (37%), Gaps = 45/266 (16%)
Query: 482 LKKADMIRKNA---VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+KK K + + I+ E L +R+P +++ + +LVMEY G
Sbjct: 84 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 143
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L + L E + L YLHS ++HRD+K N+L++ G +KL DFG
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG---- 199
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---T 655
+ + S VGTP ++APE++L
Sbjct: 200 -------------SAS---------IMA---------PANSFVGTPYWMAPEVILAMDEG 228
Query: 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLID 715
+ D WS+GI EL PP + +I + P + S + +D
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-SGHWSEYFRNFVD 287
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFK 741
L + P R + + +H F
Sbjct: 288 SCLQKIPQDR---PTSEVLLKHRFVL 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 57/298 (19%), Positives = 100/298 (33%), Gaps = 78/298 (26%)
Query: 493 VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDV 550
V + E + +P +V + +F L++V ++ G L+ ++E
Sbjct: 70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA 129
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
+ V+ AL+Y+H + VHR +K ++LI+ DG + L+
Sbjct: 130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLR---------------- 173
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRK--KRSAVGTPDYLAPEIL--LGTGHGTTADWWSV 666
+ + + +Q + +V +L+PE+L G+ +D +SV
Sbjct: 174 -SNL---------SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223
Query: 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKIP---------------------------- 698
GI EL G PF Q+ LN +P
Sbjct: 224 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSD 283
Query: 699 ---------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
SP H +++ L +P R AS + H FFK
Sbjct: 284 SLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR---PSASTLLNHSFFK 338
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 73/289 (25%), Positives = 113/289 (39%), Gaps = 80/289 (27%)
Query: 496 ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYI 555
I+ E +L +P++V F+ +F + + ME+++GG L +L+ G + E +
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS 137
Query: 556 AEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614
V+ L YL +++HRD+KP N+L+ G IKL DFG VSG
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG-----------------VSG 180
Query: 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
QL S S VGT Y++PE L GT + +D WS+G+ L E+
Sbjct: 181 ---------QLIDS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 675 VGIPPFNAE---------------------------------------HPQQIFD---NI 692
VG P P IF+ I
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+N P S E D +++ L ++P +R ++ H F K
Sbjct: 285 VNEPPPKLP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-41
Identities = 61/265 (23%), Positives = 111/265 (41%), Gaps = 49/265 (18%)
Query: 493 VESILAERDILISV-RNPFVVRFFYSF------TCRENLYLVMEYLNGGDLYSLLRNL-- 543
E I E ++L + + ++ +F + L+LVME+ G + L++N
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
L E+ E++ L +LH +V+HRD+K N+L+ + +KL DFG+S
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------ 177
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHG 658
QL + ++ + +GTP ++APE++ +
Sbjct: 178 --------------------QLDRT-----VGRRNTFIGTPYWMAPEVIACDENPDATYD 212
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D WS+GI E+ G PP HP + I P + ++ S + I+ L
Sbjct: 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK-SKKWSKKFQSFIESCL 271
Query: 719 TEDPHQRLGSGGASEVKQHVFFKDI 743
++ QR ++ +H F +D
Sbjct: 272 VKNHSQRP---ATEQLMKHPFIRDQ 293
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 64/270 (23%), Positives = 98/270 (36%), Gaps = 81/270 (30%)
Query: 487 MIRKNAVESILAERDILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--L 539
M++ E ++ P +VR + R+ L +VME L+GG+L+S
Sbjct: 50 MLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLS 596
R E A + + A++YLHS+ + HRD+KP+NLL + +KLTDFG
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-- 165
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
A E G
Sbjct: 166 --------------------------------------------------FAKET-TGEK 174
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHP----QQIFDNILNRKI-----PWPRVPEEMS 707
+ + D WS+G+I++ L+ G PPF + H + I + W V S
Sbjct: 175 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----S 230
Query: 708 PEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
E LI L +P QR+ +E H
Sbjct: 231 EEVKMLIRNLLKTEPTQRM---TITEFMNH 257
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 39/248 (15%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
V L E I+ +R+P +V F + T NL +V EYL+ G LY LL
Sbjct: 69 MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 544 GC---LDEDVARVYIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
G LDE R+ +A +V + YLH+ +VHR+LK NLL+ +K+ DFGLS+
Sbjct: 129 GAREQLDERR-RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ +SA GTP+++APE+L
Sbjct: 188 L-------------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
+D +S G+IL+EL P+ +P Q+ + + +P ++P+ +I+
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 718 LTEDPHQR 725
T +P +R
Sbjct: 276 WTNEPWKR 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 20/247 (8%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V+K+ + + L E ++ + +P V++F + L + EY+ GG L ++
Sbjct: 39 VMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII 98
Query: 541 RNLGC-LDEDVARVYIAE-VVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+++ RV A+ + + YLHS+ ++HRDL N L+ + ++ + DFGL+++
Sbjct: 99 KSMDSQYPWSQ-RVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ T P+ S + +R+K+ + VG P ++APE++ G +
Sbjct: 158 MVDEKTQ-----------------PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
D +S GI+L E+I + P+ + + R P P + R
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCC 260
Query: 719 TEDPHQR 725
DP +R
Sbjct: 261 DLDPEKR 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
LY+ M +NG DL ++LR G L A + ++ AL+ H+ HRD+KP+N+L++
Sbjct: 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
D L DFG++ A + LT + VGT
Sbjct: 169 ADDFAYLVDFGIAS-------------ATTDEK--------LTQL---------GNTVGT 198
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-V 702
Y+APE + AD +++ +L+E + G PP+ + + + +N+ IP P V
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH-INQAIPRPSTV 257
Query: 703 PEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731
+ +I R + ++P R + G
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDRYVTCGD 286
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584
YLVMEY+ G L + + G L D A + +++ +++ H +R+VHRD+KP N+LI
Sbjct: 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS 146
Query: 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644
+ +K+ DFG++K A+S T+ LT + +GT
Sbjct: 147 NKTLKIFDFGIAK-------------ALSETS--------LTQTN---------HVLGTV 176
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP--RV 702
Y +PE G D +S+GI+L+E++VG PPFN E I + +P V
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDV 236
Query: 703 PEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731
+++ ++I R +D R +
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYKTIQE 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 53/251 (21%)
Query: 487 MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNL 543
+ ++ ++ + E L V +P +V+ + + C + LVMEY GG LY++L L
Sbjct: 39 IESESERKAFIVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPL 96
Query: 544 GCLDEDVARVYIA-EVVLALEYLHSLR---VVHRDLKPDNLLIAHDG-HIKLTDFGLSKV 598
+ + + YLHS++ ++HRDLKP NLL+ G +K+ DFG +
Sbjct: 97 PYYTAAH-AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC- 154
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
D + +T + G+ ++APE+ G+ +
Sbjct: 155 ---------------------DIQTHMT------------NNKGSAAWMAPEVFEGSNYS 181
Query: 659 TTADWWSVGIILFELIVGIPPFN--AEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLI 714
D +S GIIL+E+I PF+ +I + N R P + + + L+
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLM 237
Query: 715 DRFLTEDPHQR 725
R ++DP QR
Sbjct: 238 TRCWSKDPSQR 248
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 56/253 (22%), Positives = 97/253 (38%), Gaps = 40/253 (15%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ ++ +++ E R+ VV F + +L ++ G LYS++R+
Sbjct: 64 DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123
Query: 544 GC-LDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
LD + IA E+V + YLH+ ++H+DLK N+ +G + +TDFGL
Sbjct: 124 KIVLDVNK-TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFS---- 177
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT- 660
+SG G E +L G +LAPEI+ T
Sbjct: 178 ----------ISGVLQAGRREDKLRI------------QNGWLCHLAPEIIRQLSPDTEE 215
Query: 661 --------ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
+D +++G I +EL PF + + I + P M E D
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISD 274
Query: 713 LIDRFLTEDPHQR 725
++ + +R
Sbjct: 275 ILLFCWAFEQEER 287
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584
Y+VMEY++G L ++ G + A IA+ AL + H ++HRD+KP N++I+
Sbjct: 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644
+K+ DFG+++ A++ + +T + + +GT
Sbjct: 152 TNAVKVMDFGIAR-------------AIADSG------NSVTQTA---------AVIGTA 183
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VP 703
YL+PE G +D +S+G +L+E++ G PPF + P + + P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGA 731
E +S + ++ + L ++P R +
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAE 271
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 63/271 (23%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
IL +++ +V+ + ++ L LV E+L+ DL LL L+ A+ ++ +++
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
+ Y H RV+HRDLKP NLLI +G +K+ DFGL++ G
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA-------------------FGI 152
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPP 679
+ T H+ + T Y AP++L+G+ +T D WSVG I E++ G P
Sbjct: 153 PVRKYT---HE---------IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 680 F--NAEHPQ--QIFD-----------------NILNRKIPWPRVP-----EEMSPEAHDL 713
F +E Q +IF + +P + + DL
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
+ + L DP+QR+ A + +H +FK+ N
Sbjct: 261 LSKMLKLDPNQRI---TAKQALEHAYFKENN 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-36
Identities = 59/246 (23%), Positives = 91/246 (36%), Gaps = 53/246 (21%)
Query: 491 NAVESILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
A +AER L V +P +V+ F Y+VMEY+ G L
Sbjct: 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QK 178
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
L A Y+ E++ AL YLHS+ +V+ DLKP+N+++ + +KL D G
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-------- 229
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
++ GTP + APEI+ G D ++
Sbjct: 230 -----RINSFG----------------------YLYGTPGFQAPEIVRT-GPTVATDIYT 261
Query: 666 VGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
VG L L + +P N + L P + + L+ R + DP QR
Sbjct: 262 VGRTLAALTLDLPTRNGRYVDG-----LPEDDPVLKTYDSY----GRLLRRAIDPDPRQR 312
Query: 726 LGSGGA 731
+
Sbjct: 313 FTTAEE 318
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 48/257 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
D +E++ E + +++P ++ NL LVME+ GG L +L
Sbjct: 38 ARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97
Query: 541 RNLGCLDEDVARVYIA-EVVLALEYLHS---LRVVHRDLKPDNLLIAHDGH--------I 588
+ D+ V A ++ + YLH + ++HRDLK N+LI +
Sbjct: 98 SGKR-IPPDI-LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648
K+TDFGL++ R K SA G ++A
Sbjct: 156 KITDFGLARE---------------------------------WHRTTKMSAAGAYAWMA 182
Query: 649 PEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSP 708
PE++ + +D WS G++L+EL+ G PF + + K+ +P
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-LPIPSTCPE 241
Query: 709 EAHDLIDRFLTEDPHQR 725
L++ DPH R
Sbjct: 242 PFAKLMEDCWNPDPHSR 258
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 70/272 (25%), Positives = 112/272 (41%), Gaps = 64/272 (23%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L + +P +V L LV E++ DL +L L + ++Y+ +++
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
+ + H R++HRDLKP NLLI DG +KL DFGL++ G
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA-------------------FGI 171
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPP 679
T H+ V T Y AP++L+G+ +T+ D WS+G I E+I G P
Sbjct: 172 PVRSYT---HE---------VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 680 F--NAEHPQ--QIFD-----------------NILNRKIP-WPRVP-----EEMSPEAHD 712
F + Q +IF R + + P E D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
L+ L DP++R+ A + H +FKD++
Sbjct: 280 LLSNMLCFDPNKRI---SARDAMNHPYFKDLD 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 48/252 (19%), Positives = 95/252 (37%), Gaps = 38/252 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L +++ E +L R+ ++ F ++ L +V ++ G LY L
Sbjct: 53 MLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHL 110
Query: 541 RNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
E + IA + ++YLH+ ++HRDLK +N+ + D +K+ DFGL+
Sbjct: 111 HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE- 169
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG- 658
+ G+ ++APE++
Sbjct: 170 ----------------------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 659 --TTADWWSVGIILFELIVGIPPF-NAEHPQQIFDNIL--NRKIPWPRVPEEMSPEAHDL 713
+D ++ GI+L+EL+ G P+ N + QI + + + +V L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 714 IDRFLTEDPHQR 725
+ L + +R
Sbjct: 262 MAECLKKKRDER 273
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 49/254 (19%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ + + E I+ ++ +P +V+ + +VME++ GDLY L +
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDK 115
Query: 544 GC-LDEDVARVYIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDG-----HIKLTDFG 594
+ V ++ + ++ L +EY+ + +VHRDL+ N+ + K+ DFG
Sbjct: 116 AHPIKWSV-KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
LS+ +G ++APE +
Sbjct: 175 LSQQ----------------------------------SVHSVSGLLGNFQWMAPETIGA 200
Query: 655 TGHGTT--ADWWSVGIILFELIVGIPPFNAEHPQQI-FDNILNRKIPWPRVPEEMSPEAH 711
T AD +S +IL+ ++ G PF+ +I F N++ + P +PE+ P
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR 260
Query: 712 DLIDRFLTEDPHQR 725
++I+ + DP +R
Sbjct: 261 NVIELCWSGDPKKR 274
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 68/274 (24%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L +++ +VR + L LV E+ + DL + LD ++ + ++ +++
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
L + HS V+HRDLKP NLLI +G +KL +FGL++ G
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA-------------------FGI 153
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIP 678
+ + V T Y P++L G +T+ D WS G I EL G P
Sbjct: 154 PVRCYS---AE---------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 679 PF--NAEHPQ--QIFDNIL---NRKIPWPRVPE---------------------EMSPEA 710
F N Q +IF +L + WP + + +++
Sbjct: 202 LFPGNDVDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 711 HDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
DL+ L +P QR+ A E QH +F D
Sbjct: 260 RDLLQNLLKCNPVQRI---SAEEALQHPYFSDFC 290
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 67/271 (24%), Positives = 108/271 (39%), Gaps = 64/271 (23%)
Query: 523 NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
L LV E+++ DL + L + + + + + +++ L++LHS RVVHRDLKP N+
Sbjct: 93 KLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
L+ G IKL DFGL+++ + LT
Sbjct: 152 LVTSSGQIKLADFGLARI--------------------YSFQMALT---SV--------- 179
Query: 641 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-HPQQ---IFDNIL--- 693
V T Y APE+LL + + T D WSVG I E+ P F Q I D ++
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD-VIGLP 238
Query: 694 -------NRKIPWPRVPE-----------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735
+ +P ++ DL+ + LT +P +R+ A
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSAL 295
Query: 736 QHVFFKDINWDTLARQKAAFVPTSESALDTS 766
H +F+D+ + S L+T+
Sbjct: 296 SHPYFQDLERCKENLDSHLPPSQNTSELNTA 326
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 74/274 (27%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L + +P ++ +F + N+ LV +++ DL ++++ L + Y+ +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
LEYLH ++HRDLKP+NLL+ +G +KL DFGL+K G
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-------------------FGS 164
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPP 679
T HQ V T Y APE+L G D W+VG IL EL++ +P
Sbjct: 165 PNRAYT---HQ---------VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212
Query: 680 FNAE-HPQQIFDNILNRKI-------------------------PWPRVP-----EEMSP 708
+ Q+ +I +P +P
Sbjct: 213 LPGDSDLDQLT------RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 266
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ DLI +P R+ A++ + +F +
Sbjct: 267 DLLDLIQGLFLFNPCARI---TATQALKMKYFSN 297
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 68/278 (24%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLA 561
+L +++ ++ L+L+ EY DL + + V + ++ +++
Sbjct: 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 562 LEYLHSLRVVHRDLKPDNLLI-----AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616
+ + HS R +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA------------------ 186
Query: 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIV 675
G Q T H+ + T Y PEILLG+ H +T+ D WS+ I E+++
Sbjct: 187 -FGIPIRQFT---HE---------IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
Query: 676 GIPPF--NAEHPQ--QIFD-----------------NILNRKIPWPR------VPEEMSP 708
P F ++E Q +IF+ + + + +
Sbjct: 234 KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDD 293
Query: 709 EAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746
E DL+ L DP +R+ A +H +F ++D
Sbjct: 294 EGLDLLTAMLEMDPVKRI---SAKNALEHPYFSHNDFD 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 64/272 (23%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L +++ +V ++L LV EYL+ DL L + G ++ ++++ +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
L Y H +V+HRDLKP NLLI G +KL DFGL++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA-------------------KSI 152
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPP 679
++ V T Y P+ILLG+ +T D W VG I +E+ G P
Sbjct: 153 PTKTYD---NE---------VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200
Query: 680 F--NAEHPQ--QIFD-----------------NILNRKIP-WPRVP-----EEMSPEAHD 712
F + Q IF P + + + D
Sbjct: 201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGAD 260
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
L+ + L + R+ A + +H FF +
Sbjct: 261 LLTKLLQFEGRNRI---SAEDAMKHPFFLSLG 289
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-34
Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 64/248 (25%)
Query: 523 NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
+ LV E+++ DL + L L + + + + + L++LH+ +VHRDLKP+N+
Sbjct: 93 KVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI 151
Query: 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSA 640
L+ G +KL DFGL+++ + LT
Sbjct: 152 LVTSGGTVKLADFGLARI-------------------YSYQMA-LT---PV--------- 179
Query: 641 VGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF--NAEHPQ--QIFDNIL--- 693
V T Y APE+LL + + T D WSVG I E+ P F N+E Q +IFD ++
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD-LIGLP 238
Query: 694 -------NRKIPWPRVPE-----------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735
+ +P P EM L+ LT +PH+R+ A
Sbjct: 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI---SAFRAL 295
Query: 736 QHVFFKDI 743
QH +
Sbjct: 296 QHSYLHKD 303
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 44/251 (17%), Positives = 83/251 (33%), Gaps = 46/251 (18%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLR 541
K E L +P V+ + + L+ ++ G LY++L
Sbjct: 42 KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH 101
Query: 542 NLGCLDEDVA-RVYIA-EVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
D + V A ++ + +LH+L + L +++I D +++ +
Sbjct: 102 EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ + P ++APE L
Sbjct: 162 S------------------------------------FQSPGRMYAPAWVAPEALQKKPE 185
Query: 658 GTT---ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 714
T AD WS ++L+EL+ PF +I + + P +P +SP L+
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLM 244
Query: 715 DRFLTEDPHQR 725
+ EDP +R
Sbjct: 245 KICMNEDPAKR 255
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 2e-33
Identities = 60/273 (21%), Positives = 104/273 (38%), Gaps = 65/273 (23%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L +++P +V F + L+LV EY + + L + E + + + +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
A+ + H +HRD+KP+N+LI IKL DFG +++ L
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL-------------------LTG 154
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPP 679
+ V T Y +PE+L+G G D W++G + EL+ G+P
Sbjct: 155 PSDYYD---DE---------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202
Query: 680 FNAE-HPQQIF--------------------DNILNRKIPWPRVPE-------EMSPEAH 711
+ + Q++ KIP P E +S A
Sbjct: 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262
Query: 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
L+ L DP +RL ++ H +F++I
Sbjct: 263 GLLKGCLHMDPTERL---TCEQLLHHPYFENIR 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 61/282 (21%), Positives = 108/282 (38%), Gaps = 77/282 (27%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC------LDEDVARVYI 555
++ +++ +VR + L LV E+++ DL + + L+ ++ + +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
+++ L + H +++HRDLKP NLLI G +KL DFGL++
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------------- 157
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELI 674
G + + V T Y AP++L+G+ +T+ D WS G IL E+I
Sbjct: 158 --FGIPVNTFS---SE---------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 675 VGIPPF---------------------------------NAEHPQQIFDNILNRKIPWPR 701
G P F N Q+ ++ R++ P
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL--RQVLQPH 261
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
E + D + L +P RL A + H +F +
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRL---SAKQALHHPWFAEY 300
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 75/285 (26%), Positives = 117/285 (41%), Gaps = 78/285 (27%)
Query: 499 ERDILISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLG----CLDE 548
E I+ V++P VV FFYS +++ L LV+EY+ +Y R+ +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDL 607
+ ++Y+ +++ +L Y+HS+ + HRD+KP NLL+ G +KL DFG +K+
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI--------- 191
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSV 666
S + + Y APE++ G + TT D WS
Sbjct: 192 -----------------------LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWST 228
Query: 667 GIILFELIVGIPPF---------------------------NAEHPQQIFDNILNRKIPW 699
G ++ EL+ G P F N + + F I R P+
Sbjct: 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPF 286
Query: 700 PRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+V P+A DLI R L P RL A E H FF ++
Sbjct: 287 SKVFRPRTPPDAIDLISRLLEYTPSARL---TAIEALCHPFFDEL 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 59/277 (21%), Positives = 105/277 (37%), Gaps = 77/277 (27%)
Query: 502 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVL 560
+L +R+ +V ++ YLV E+++ + L LD V + Y+ +++
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGD 620
+ + HS ++HRD+KP+N+L++ G +KL DFG ++ L
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART-------------------LAA 176
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPP 679
+ V T Y APE+L+G G D W++G ++ E+ +G P
Sbjct: 177 PGEVYD---DE---------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224
Query: 680 FNAE-HPQQIFDNILNRKI------P----WPRV-----------PE------------E 705
F + Q++ I PE +
Sbjct: 225 FPGDSDIDQLY------HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPK 278
Query: 706 MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+S DL + L DP +R +E+ H FF+
Sbjct: 279 LSEVVIDLAKKCLHIDPDKRP---FCAELLHHDFFQM 312
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-30
Identities = 73/285 (25%), Positives = 113/285 (39%), Gaps = 78/285 (27%)
Query: 499 ERDILISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGC----LDE 548
E I+ + + +VR FFYS +++ L LV++Y+ +Y + R+ L
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPV 155
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDL 607
++Y+ ++ +L Y+HS + HRD+KP NLL+ +KL DFG +K
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--------- 206
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSV 666
L EP S + + Y APE++ G T++ D WS
Sbjct: 207 ----------LVRGEP-------------NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243
Query: 667 GIILFELIVGIPPF---------------------------NAEHPQQIFDNILNRKIPW 699
G +L EL++G P F N + + F I + PW
Sbjct: 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPW 301
Query: 700 PRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+V PEA L R L P RL E H FF ++
Sbjct: 302 TKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDEL 343
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 76/307 (24%), Positives = 114/307 (37%), Gaps = 82/307 (26%)
Query: 482 LKKADMIR-KNAVES--ILAERDILI--SVRNPFVVR--------FFYSFTCRENLYLVM 528
LKK + +N E I A R+I I +++ VV C+ ++YLV
Sbjct: 47 LKK---VLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 529 EYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH 587
++ DL LL N+ + + ++ L Y+H +++HRD+K N+LI DG
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 162
Query: 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL 647
+KL DFGL A + + + + T + V T Y
Sbjct: 163 LKLADFGL---------------ARAFSLAKNSQPNRYT------------NRVVTLWYR 195
Query: 648 APEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--NAEHPQ--QIFDNIL---NRKIPW 699
PE+LLG D W G I+ E+ P N E Q I + ++ W
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS-QLCGSITPEV-W 253
Query: 700 PRVPE------------------------EMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735
P V P A DLID+ L DP QR+ + +
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDAL 310
Query: 736 QHVFFKD 742
H FF
Sbjct: 311 NHDFFWS 317
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 65/258 (25%), Positives = 106/258 (41%), Gaps = 75/258 (29%)
Query: 523 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 582
LV E++N D L + L D D+ R Y+ E++ AL+Y HS+ ++HRD+KP N++I
Sbjct: 107 TPALVFEHVNNTDFKQLYQTLT--DYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMI 163
Query: 583 AHD-GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
H+ ++L D+GL++ + R V
Sbjct: 164 DHEHRKLRLIDWGLAEF--------------------YHPGQEYN------VR------V 191
Query: 642 GTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF--NAEHPQQI---------- 688
+ + PE+L+ + D WS+G +L +I PF ++ Q+
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251
Query: 689 ----------------FDNILNR--KIPWPR-VPEE----MSPEAHDLIDRFLTEDPHQR 725
F++IL R + W R V E +SPEA D +D+ L D R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 726 LGSGGASEVKQHVFFKDI 743
L A E +H +F +
Sbjct: 312 L---TAREAMEHPYFYTV 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 84/288 (29%)
Query: 502 ILISVRNPFVVR---FFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC----LDEDV 550
L + +P +V+ +FY+ R+ L +VMEY+ L+ RN +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 551 ARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDL 607
+V++ +++ ++ LH S+ V HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK--------- 181
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSV 666
L EP + + + + Y APE++ G H TTA D WSV
Sbjct: 182 ----------LSPSEPNV-------------AYICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 667 GIILFELIVGIPPF---------------------------NAEHPQQIFDNILNRKIPW 699
G I E+++G P F N H N + IPW
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNS--KGIPW 276
Query: 700 PRV----PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
V + + EA+DL+ L P +R+ E H +F ++
Sbjct: 277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDEL 321
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 72/254 (28%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGC----LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
L ++MEY+ L+ +L++ + ++ +YI ++ A+ ++HSL + HRD+KP N
Sbjct: 113 LNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 580 LLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
LL+ + D +KL DFG +K L EP
Sbjct: 172 LLVNSKDNTLKLCDFGSAKK-------------------LIPSEP-SV------------ 199
Query: 639 SAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF----------------- 680
+ + + Y APE++LG T + D WS+G + ELI+G P F
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 681 ----------NAEHPQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSG 729
N + + F + + W ++ PE A DL+++ L +P R+
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI--- 314
Query: 730 GASEVKQHVFFKDI 743
E H FF +
Sbjct: 315 NPYEAMAHPFFDHL 328
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 54/270 (20%), Positives = 91/270 (33%), Gaps = 70/270 (25%)
Query: 504 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLAL 562
+ +R+ FV + LYLV E + DL ++ + + ++ ++L L
Sbjct: 92 LGLRDIFVHFEEPAM---HKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622
LH VVHRDL P N+L+A + I + DF L++ +
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE--------------------DTAD 187
Query: 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN 681
T + V Y APE+++ T D WS G ++ E+ F
Sbjct: 188 ANKT--HY----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 682 AEHPQQIFDNILN-----------------------------RKIPWPRVPEEMSPEAHD 712
+ I+ W V P A D
Sbjct: 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
LI + L +P +R+ + +H +F+
Sbjct: 296 LIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 59/269 (21%)
Query: 504 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 563
I++ N F +F +Y++ E + DL+ ++ L +D + +I + + A++
Sbjct: 72 ITIFNIQRPDSFENF---NEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVK 126
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623
LH V+HRDLKP NLLI + +K+ DFGL+++ + + + ++
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI---------IDESAADNSEPTGQQS 177
Query: 624 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNA 682
+ E V T Y APE++L + + A D WS G IL EL + P F
Sbjct: 178 GMV--EF----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225
Query: 683 EH----------------PQQIFDNILN-------------RKIPWPRVPEEMSPEAHDL 713
I + P ++ ++P+ DL
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL 285
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+ R L DP +R+ A E +H + +
Sbjct: 286 LQRMLVFDPAKRI---TAKEALEHPYLQT 311
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 60/262 (22%)
Query: 494 ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARV 553
++I+ +IL + S T ++Y+V EY+ DL ++L G L E+ AR+
Sbjct: 68 DNIVKVFEILGP-SGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARL 124
Query: 554 YIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612
++ +++ L+Y+HS V+HRDLKP NL I D +K+ DFGL++
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR--------------- 169
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILF 671
+ L+ E + T Y +P +LL + T A D W+ G I
Sbjct: 170 -IMDPHYSHKGHLS--EG----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 672 ELIVGIPPFNAEHPQQIFDNILN---------------------------RKIPWPRVPE 704
E++ G F H + IL P ++
Sbjct: 217 EMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP 276
Query: 705 EMSPEAHDLIDRFLTEDPHQRL 726
+S EA D +++ LT P RL
Sbjct: 277 GISREAVDFLEQILTFSPMDRL 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 69/250 (27%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+ YLVM ++ DL ++ E+ + + +++ L+Y+HS VVHRDLKP NL
Sbjct: 102 YDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA 158
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ + ++T + V
Sbjct: 159 VNEDCELKILDFGLARH----------------------ADAEMT--GY----------V 184
Query: 642 GTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAEHPQQIFDNILN------ 694
T Y APE++L H D WSVG I+ E++ G F + IL
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244
Query: 695 ----------------------RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732
+ + ++ SP+A DL+++ L D +RL A+
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL---TAA 301
Query: 733 EVKQHVFFKD 742
+ H FF+
Sbjct: 302 QALTHPFFEP 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 70/269 (26%)
Query: 503 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 562
+I + + V + + YLVM ++ G DL L+++ L ED + + +++ L
Sbjct: 86 VIGLLD--VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 141
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622
Y+H+ ++HRDLKP NL + D +K+ DFGL++ +
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ----------------------AD 179
Query: 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN 681
++T V T Y APE++L T D WSVG I+ E+I G F
Sbjct: 180 SEMT------------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 682 AEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDL 713
I+ K + + SP A +L
Sbjct: 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 287
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+++ L D QR+ A E H +F+
Sbjct: 288 LEKMLVLDAEQRV---TAGEALAHPYFES 313
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 69/269 (25%), Positives = 112/269 (41%), Gaps = 65/269 (24%)
Query: 503 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 562
+I + + +++Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 87 IIGINDIIRAPTIEQM---KDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622
+Y+HS V+HRDLKP NLL+ +K+ DFGL++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR----------------VADPDHDHT 185
Query: 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN 681
LT E+ V T Y APEI+L + T + D WSVG IL E++ P F
Sbjct: 186 GFLT--EY----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 233
Query: 682 AEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDL 713
+H ++IL K+PW R+ +A DL
Sbjct: 234 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 293
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+D+ LT +PH+R+ + H + +
Sbjct: 294 LDKMLTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 55/289 (19%), Positives = 95/289 (32%), Gaps = 70/289 (24%)
Query: 487 MIRKNAVESILAERDI--LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLL 540
+ +S E ++ + +R+ ++ F S L+L+ Y G LY L
Sbjct: 38 IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL 97
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTD 592
+ LD + + L +LH + HRDLK N+L+ +G + D
Sbjct: 98 QL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
GL+ + + Q VGT Y+APE+L
Sbjct: 157 LGLAVM---------------------------HSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 653 LGTGHGTT------ADWWSVGIILFELIVGI----------PPFNAEHPQQ-----IFDN 691
T D W+ G++L+E+ + PPF P +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 692 ILNRK----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736
+ + IP + L+ ++P RL A +K+
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL---TALRIKK 295
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 70/269 (26%)
Query: 503 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLAL 562
+I + + V S ++YLV + G DL ++++ L +D + I +++ L
Sbjct: 90 VIGLLD--VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGL 145
Query: 563 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEE 622
+Y+HS ++HRDLKP NL + D +K+ DFGL++
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH----------------------TA 183
Query: 623 PQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFN 681
++T V T Y APEI+L H D WSVG I+ EL+ G F
Sbjct: 184 DEMT------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 682 AEHPQQIFDNILN----------------------------RKIPWPRVPEEMSPEAHDL 713
IL K+ + V +P A DL
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 291
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+++ L D +R+ A++ H +F
Sbjct: 292 LEKMLVLDSDKRI---TAAQALAHAYFAQ 317
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/333 (17%), Positives = 112/333 (33%), Gaps = 109/333 (32%)
Query: 504 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 563
I + N V S +++Y+VME + +L +++ LD + + +++ ++
Sbjct: 87 IGLLN--VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIK 141
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEP 623
+LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------AGTSF 181
Query: 624 QLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683
+T V T Y APE++LG G+ D WSVG I+ E+I G F
Sbjct: 182 MMTPY------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 684 HPQQIFDNILN---------------------------RKIPWPRV------------PE 704
++ ++ + ++ +
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALD 764
+ +A DL+ + L D +R + + AL
Sbjct: 290 LKASQARDLLSKMLVIDASKR-------------------------------ISVDEALQ 318
Query: 765 TSYFTSRYSWNTTDENIYPASDFEDSSDADSLS 797
Y Y + ++ P + D +
Sbjct: 319 HPYINVWY--DPSEAEAPPPKIPDKQLDEREHT 349
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 64/266 (24%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
+YLV +Y+ DL++++R L+ + + +++ ++YLHS ++HRD+KP N+L+
Sbjct: 86 VYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN 143
Query: 584 HDGHIKLTDFGL--SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ H+K+ DFGL S V + T+++ T D++P LT ++ V
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT--DY----------V 191
Query: 642 GTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPF-------------------- 680
T Y APEILLG+ T D WS+G IL E++ G P F
Sbjct: 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS 251
Query: 681 ----------NA--------EHPQQIFDNILNRKIPWPRVPEEM------SPEAHDLIDR 716
A E + N + W + ++ + EA DL+D+
Sbjct: 252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKD 742
L +P++R+ A++ +H F
Sbjct: 312 LLQFNPNKRI---SANDALKHPFVSI 334
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/289 (19%), Positives = 100/289 (34%), Gaps = 70/289 (24%)
Query: 487 MIRKNAVESILAERDI--LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLL 540
+ S E +I + +R+ ++ F LYL+ +Y G LY L
Sbjct: 67 VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLR--------VVHRDLKPDNLLIAHDGHIKLTD 592
++ LD V L +LH+ + HRDLK N+L+ +G + D
Sbjct: 127 KST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
GL+ + ++ + P + VGT Y+ PE+L
Sbjct: 186 LGLAVKFISDTNEVDIPP---------------------------NTRVGTKRYMPPEVL 218
Query: 653 LGTGHGTT------ADWWSVGIILFELIVGI----------PPFNAEHPQQ-----IFDN 691
+ + AD +S G+IL+E+ P++ P + +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
Query: 692 ILNRK----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736
+ +K P +E + L+ +P RL A VK+
Sbjct: 279 VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL---TALRVKK 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 96/310 (30%)
Query: 495 SILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDVAR 552
S E +L +++P V+ F + ++L+ +Y DL+ +++ +
Sbjct: 64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 553 VYIAEVVL---------ALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVG 599
V + ++ + YLH+ V+HRDLKP N+L+ + G +K+ D G ++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-- 180
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L L + V T Y APE+LLG H T
Sbjct: 181 -----------------LFNSPLKPLADLDPV---------VVTFWYRAPELLLGARHYT 214
Query: 660 TA-DWWSVGIILFELIVGIPPF----------NAEHPQQ---IFDNIL---NRKIPWPRV 702
A D W++G I EL+ P F N H Q IF N++ K W +
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF-NVMGFPADKD-WEDI 272
Query: 703 ---PE---------------------------EMSPEAHDLIDRFLTEDPHQRLGSGGAS 732
PE + +A L+ + LT DP +R+ +
Sbjct: 273 KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSE 329
Query: 733 EVKQHVFFKD 742
+ Q +F +
Sbjct: 330 QAMQDPYFLE 339
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 64/288 (22%), Positives = 101/288 (35%), Gaps = 84/288 (29%)
Query: 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
LY+V+E D L R L E + + +++ ++Y+HS ++HRDLKP N L+
Sbjct: 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190
Query: 584 HDGHIKLTDFGLS--------KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERR 635
D +K+ DFGL+ + + + + + QLT H
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT--GH----- 243
Query: 636 KKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPPFNAEHP--------- 685
V T Y APE++L + T A D WS+G I EL+ I A H
Sbjct: 244 -----VVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGS 298
Query: 686 --------------------------QQIFD-------------------NILNRKIPWP 700
IF+ +
Sbjct: 299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE 358
Query: 701 RVP-EEM----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
E S +A L+ R L +P++R+ +E H FFK++
Sbjct: 359 GTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEV 403
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 56/315 (17%), Positives = 109/315 (34%), Gaps = 107/315 (33%)
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
+++YLVME + +L +++ LD + + +++ +++LHS ++HRDLKP N++
Sbjct: 140 QDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 196
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ D +K+ DFGL++ +T V
Sbjct: 197 VKSDCTLKILDFGLART--------------------AGTSFMMTPY------------V 224
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN------- 694
T Y APE++LG G+ D WSVG I+ E++ F ++ ++
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 695 --------------------RKIPWPRV------------PEEMSPEAHDLIDRFLTEDP 722
+ +P++ + + +A DL+ + L DP
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344
Query: 723 HQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIY 782
+R + + AL Y Y + +
Sbjct: 345 AKR-------------------------------ISVDDALQHPYINVWY--DPAEVEAP 371
Query: 783 PASDFEDSSDADSLS 797
P ++ D +
Sbjct: 372 PPQIYDKQLDEREHT 386
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 66/349 (18%), Positives = 115/349 (32%), Gaps = 92/349 (26%)
Query: 439 GMTTSSAGSMTPRSPLLTPRTSQIDLLLA---GKGALSEHDDFPQVLKKAD--------- 486
MTTS +GS PLL RT ++L GKG E + +
Sbjct: 22 DMTTSGSGS---GLPLLVQRTIARTIVLQESIGKGRFGE-------VWRGKWRGEEVAVK 71
Query: 487 MIRKNAVESILAERDI--LISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL 540
+ S E +I + +R+ ++ F + L+LV +Y G L+ L
Sbjct: 72 IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTD 592
+ + L +LH + HRDLK N+L+ +G + D
Sbjct: 132 NRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
GL+ + A H+ VGT Y+APE+L
Sbjct: 191 LGLAVR------------------HDSATDTIDIAPNHR---------VGTKRYMAPEVL 223
Query: 653 LGTGHGTT------ADWWSVGIILFELIVGI----------PPFNAEHP-----QQIFDN 691
+ + AD +++G++ +E+ P+ P +++
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283
Query: 692 ILNRK----IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736
+ +K IP E ++ + RL A +K+
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL---TALRIKK 329
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 79/300 (26%)
Query: 504 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALE 563
I + + + F + LY+V+E DL L + L E+ + + ++L
Sbjct: 88 IRLYDLIIPDDLLKF---DELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 564 YLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV---GLINSTDDLSGPAVSGTTLLGD 620
++H ++HRDLKP N L+ D +K+ DFGL++ + + +
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 621 EEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGIILFELIVGIPP 679
+ QLT H V T Y APE++L + T + D WS G I EL+ +
Sbjct: 204 LKKQLT--SH----------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 680 FNAEHP--------------------------------QQIFD----------------- 690
+ IF+
Sbjct: 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE 311
Query: 691 --NILNRKIPWPRVP-EEM----SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
+ + ++ S + +L++ L +P++R+ + H + KD+
Sbjct: 312 VIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 67/366 (18%), Positives = 114/366 (31%), Gaps = 124/366 (33%)
Query: 455 LTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNAV------------ESILAERDI 502
+ R + ++ GKG+ F QV+K D V E I
Sbjct: 95 VAYRYEVLKVI--GKGS------FGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRI 146
Query: 503 L--ISVRNP----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVY 554
L + ++ V+ +FT R ++ + E L +LY L++ + R +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKF 205
Query: 555 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSGPAV 612
++ L+ LH R++H DLKP+N+L+ G IK+ DFG S
Sbjct: 206 AHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------------- 249
Query: 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFE 672
S Y APE++LG +G D WS+G IL E
Sbjct: 250 ---CYEHQRVYTYIQSRF---------------YRAPEVILGARYGMPIDMWSLGCILAE 291
Query: 673 LIVGIPPF----NAEH-----------PQQI----------FDNILNRKIPWPRVPEEMS 707
L+ G P + Q++ + + + S
Sbjct: 292 LLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS 351
Query: 708 PEAH-------------------------------DLIDRFLTEDPHQRLGSGGASEVKQ 736
+ D + + L DP R+ + +
Sbjct: 352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALR 408
Query: 737 HVFFKD 742
H + +
Sbjct: 409 HPWLRR 414
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 79/369 (21%), Positives = 126/369 (34%), Gaps = 127/369 (34%)
Query: 454 LLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKN---AV----------ESILAER 500
+L+ R +D L G+GA F +V++ D AV E+ +E
Sbjct: 11 VLSARYEIVDTL--GEGA------FGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI 62
Query: 501 DIL--ISVRNPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVAR 552
+L ++ +P V+ F ++ +V E L G Y ++ G D R
Sbjct: 63 QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIR 121
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDF 593
++ ++ +LHS ++ H DLKP+N+L + IK+ DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G ++T D + L ++ H Y APE++L
Sbjct: 182 G-------SATYD------------DEHHSTLVSTRH---------------YRAPEVIL 207
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPF----NAEH-----------PQQIFDNILNRK-- 696
G D WS+G IL E +G F + EH P+ + RK
Sbjct: 208 ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYF 267
Query: 697 ----IPWP-------RVPEEMSP-------------EAHDLIDRFLTEDPHQRLGSGGAS 732
+ W V P DLI + L DP +R+
Sbjct: 268 HHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLR 324
Query: 733 EVKQHVFFK 741
E +H FF
Sbjct: 325 EALKHPFFD 333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 46/285 (16%), Positives = 96/285 (33%), Gaps = 76/285 (26%)
Query: 494 ESILAERDI--LISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLD 547
+S E ++ L +++ +++F + + L+L+ + G L L+ +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVS 119
Query: 548 EDVARVYIAEVVLALEYLHS----------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ + L YLH + HRD+K N+L+ ++ + DFGL+
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ + VGT Y+APE+L G +
Sbjct: 180 KFEAGKSAGDT-----------------------------HGQVGTRRYMAPEVLEGAIN 210
Query: 658 GTT-----ADWWSVGIILFELIVGIPPFNAEHP----------------QQIFDNILNRK 696
D +++G++L+EL + + + + ++++K
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270
Query: 697 IPWPRVPEEMSPEAH-----DLIDRFLTEDPHQRLGSGGASEVKQ 736
P + + A + I+ D RL A V +
Sbjct: 271 KR-PVLRDYWQKHAGMAMLCETIEECWDHDAEARL---SAGCVGE 311
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 46/204 (22%), Positives = 74/204 (36%), Gaps = 47/204 (23%)
Query: 494 ESILAERDI--LISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 546
++ + E++I + + + + RF + R LVMEY G L L
Sbjct: 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTS 108
Query: 547 DEDVARVYIAEVVLALEYLHS---------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
D + V L YLH+ + HRDL N+L+ +DG ++DFGLS
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-- 655
N + + VGT Y+APE+L G
Sbjct: 169 RLTGNRLVRPGEEDNAAISE-----------------------VGTIRYMAPEVLEGAVN 205
Query: 656 -----GHGTTADWWSVGIILFELI 674
D +++G+I +E+
Sbjct: 206 LRDXESALKQVDMYALGLIYWEIF 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 30/236 (12%), Positives = 55/236 (23%), Gaps = 64/236 (27%)
Query: 505 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEY 564
+ P V R R +V E++ GG L + R + + A +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADA 144
Query: 565 LHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQ 624
H V P + ++ DG + L
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------------------ 174
Query: 625 LTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684
+ D +G L+ L+V P
Sbjct: 175 ---------------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAG 206
Query: 685 PQQIFDNILNRKIPWPRVPEEMSPEAH----DLIDRFLTEDPHQRLGSGGASEVKQ 736
+ P P ++ + + R + D R S + ++Q
Sbjct: 207 VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 70/357 (19%), Positives = 114/357 (31%), Gaps = 97/357 (27%)
Query: 454 LLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNAV------------ESILAERD 501
LL I + G G F +VL + K S E D
Sbjct: 32 LLNNAFLVIRKM--GDGT------FGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD 83
Query: 502 ILISVR-----NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVY 554
IL ++ N +V++ F +++ L+ E L G LY ++ + ++Y
Sbjct: 84 ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLY 142
Query: 555 IAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV-- 612
E++ AL YL + + H DLKP+N+L+ K +
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 613 -----SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667
T + S + T Y APE++L G ++D WS G
Sbjct: 203 LIDFGCAT----------------FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 668 IILFELIVGIPPF----NAEH-----------PQQI-----------FDNILNRKIPWPR 701
+L EL G F + EH P+ + + N K+ WP
Sbjct: 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306
Query: 702 V--------PEEMSPEAH---------DLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741
+ + D + L DP R +E+ +H F +
Sbjct: 307 NASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 72/371 (19%), Positives = 114/371 (30%), Gaps = 127/371 (34%)
Query: 454 LLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKN---AVESI----------LAER 500
L R + L G+G F +V++ D R A++ I E
Sbjct: 16 WLQERYEIVGNL--GEGT------FGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI 67
Query: 501 DIL--ISVRNPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVAR 552
++L I ++ V F ++ + E L G + + L+ R
Sbjct: 68 NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVR 126
Query: 553 VYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-------------------IKLTDF 593
++ AL +LH ++ H DLKP+N+L + I++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G T + + A+ H Y PE++L
Sbjct: 187 G-------------------SATFDHEHHTTIVATRH---------------YRPPEVIL 212
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPF----NAEH-----------PQQIFDNILNRK-- 696
G D WS+G ILFE G F N EH P + +K
Sbjct: 213 ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 272
Query: 697 ----IPWPRVPEE--------------------MSPEAHDLIDRFLTEDPHQRLGSGGAS 732
+ W + + DL+ R L DP QR+ +
Sbjct: 273 YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLA 329
Query: 733 EVKQHVFFKDI 743
E H FF +
Sbjct: 330 EALLHPFFAGL 340
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 65/356 (18%), Positives = 114/356 (32%), Gaps = 125/356 (35%)
Query: 468 GKGALSEHDDFPQVLKKADMIRKNAV------------ESILAERDILISVRNP------ 509
G G F V DM+ V E+ E +L V +
Sbjct: 28 GWGH------FSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 510 -----FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEV 558
+++ F + + +V E L G +L +L++ + + ++
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 559 VLALEYLHS-LRVVHRDLKPDNLLIAH------DGHIKLTDFGLSKVGLINSTDDLSGPA 611
+L L+Y+H ++H D+KP+N+L+ IK+ D G + + T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ--- 197
Query: 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671
T +Y +PE+LLG G AD WS ++F
Sbjct: 198 -------------------------------TREYRSPEVLLGAPWGCGADIWSTACLIF 226
Query: 672 ELIVGIPPF----------NAEH---------------------PQQIFDNILNRKI--- 697
ELI G F + +H + F++ +
Sbjct: 227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 286
Query: 698 --PWPRVPE-----EMSPEAH----DLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
WP + S + D + L DP +R A + H + KD
Sbjct: 287 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKD 339
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-21
Identities = 84/373 (22%), Positives = 122/373 (32%), Gaps = 131/373 (35%)
Query: 454 LLTPRTSQIDLLLAGKGALSEHDDFPQVLKKADMIRKNAV------------ESILAERD 501
R L+ GKG+ F QV+K D + + V E
Sbjct: 51 KWMDRYEIDSLI--GKGS------FGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR 102
Query: 502 IL--ISVRNP----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARV 553
+L ++ + ++V F R +L LV E L +LY LLRN + ++ R
Sbjct: 103 LLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK 161
Query: 554 YIAEVVLALEYLHS--LRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDLSG 609
+ ++ AL +L + L ++H DLKP+N+L+ + IK+ DFG S
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------- 208
Query: 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII 669
LG Q S Y +PE+LLG + D WS+G I
Sbjct: 209 ------CQLGQRIYQYIQSRF---------------YRSPEVLLGMPYDLAIDMWSLGCI 247
Query: 670 LFELIVGIPPF----NAEH-----------PQQI----------FDNILN---------- 694
L E+ G P F + P I F+ + +
Sbjct: 248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKD 307
Query: 695 --------------------RKIPWPRVPEEMSPEA------HDLIDRFLTEDPHQRLGS 728
P R E DLI R L DP R+
Sbjct: 308 GKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI-- 365
Query: 729 GGASEVKQHVFFK 741
QH FFK
Sbjct: 366 -QPYYALQHSFFK 377
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 1e-19
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 41/233 (17%)
Query: 494 ESILAERDIL--ISVRNP------FVVRFFYSFT---------CRENLYLVMEYLNGGDL 536
E+ L E +L + +P VV+ F C +V E L G L
Sbjct: 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHL 131
Query: 537 YSLLR--NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDF 593
+ N L + I +V+ L+YLH+ R++H D+KP+N+L++ +
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 594 GLSKVGLINSTDDLSGPAVSGTTL--------------LGDEEPQLTASEHQQERRKKRS 639
+ + SG AVS + ++ + K +
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT 251
Query: 640 AVGTPD-YLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691
Y + E+L+G+G+ T AD WS + FEL G F ++ +
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/249 (23%), Positives = 97/249 (38%), Gaps = 36/249 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK + + A++ + E + + S+ + ++R Y + +V E G L L
Sbjct: 53 CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRL 111
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R + G Y +V + YL S R +HRDL NLL+A +K+ DFGL +
Sbjct: 112 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR-- 169
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHG 658
L + EH++ P + APE L T
Sbjct: 170 -----------------ALPQNDDHYVMQEHRK----------VPFAWCAPESLK-TRTF 201
Query: 659 TTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+ A D W G+ L+E+ G P+ + QI I PR PE+ + ++++ +
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQ 260
Query: 717 FLTEDPHQR 725
P R
Sbjct: 261 CWAHKPEDR 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/246 (22%), Positives = 97/246 (39%), Gaps = 38/246 (15%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
K + + +LAE +++ + NP++VR E+ LVME G L L+
Sbjct: 53 KNEANDPALKDELLAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQN 111
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+ + + +V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA----- 166
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--TTA 661
L +E A H + K + APE + + ++
Sbjct: 167 --------------LRADENYYKAQTHGKWPVK---------WYAPECIN---YYKFSSK 200
Query: 662 -DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS G++++E G P+ ++ + + P E +DL++ T
Sbjct: 201 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-MGC-PAGCPREMYDLMNLCWT 258
Query: 720 EDPHQR 725
D R
Sbjct: 259 YDVENR 264
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYS 538
L+ + + E +IL S+++ +V++ R NL L+MEYL G L
Sbjct: 77 KLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 539 LLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L+ + +D Y +++ +EYL + R +HRDL N+L+ ++ +K+ DFGL+K
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193
Query: 598 V 598
V
Sbjct: 194 V 194
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 36/121 (29%), Positives = 63/121 (52%), Gaps = 6/121 (4%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYS 538
L+ + + E +IL S+++ +V++ R NL L+MEYL G L
Sbjct: 46 KLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102
Query: 539 LLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L+ + +D Y +++ +EYL + R +HRDL N+L+ ++ +K+ DFGL+K
Sbjct: 103 YLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162
Query: 598 V 598
V
Sbjct: 163 V 163
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 58/250 (23%), Positives = 96/250 (38%), Gaps = 41/250 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ + L E IL +P +VR T ++ +Y+VME + GGD + L
Sbjct: 146 SCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 541 RNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R G + + + +EYL S +HRDL N L+ +K++DFG+S+
Sbjct: 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE- 262
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ ++ V + APE L G +
Sbjct: 263 -------------------------EADGVYAASGGLRQVPV---KWTAPEALN-YGRYS 293
Query: 660 TA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLID 715
+ D WS GI+L+E +G P+ QQ + + R P PE L++
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPC-PELCPDAVFRLME 349
Query: 716 RFLTEDPHQR 725
+ +P QR
Sbjct: 350 QCWAYEPGQR 359
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
L++A A + IL E ++ SV NP V R + L+ + + G L +
Sbjct: 51 ELREATS--PKANKEILDEAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV 107
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R + + + ++ + YL R+VHRDL N+L+ H+K+TDFGL+K
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-- 165
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHG 658
LLG EE E+ E K P ++A E +L
Sbjct: 166 -----------------LLGAEE-----KEYHAEGGK------VPIKWMALESIL-HRIY 196
Query: 659 TTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNI 692
T D WS G+ ++EL+ G P++ +I +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 3/110 (2%)
Query: 491 NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 548
E DIL ++ + ++++ +L LVMEY+ G L L +
Sbjct: 75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGL 133
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ ++ + YLH+ +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 48/253 (18%)
Query: 491 NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLD 547
+ E IL ++ + F+V++ R++L LVMEYL G L L+ + LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
+Y +++ +EYL S R VHRDL N+L+ + H+K+ DFGL+K
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK---------- 175
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWS 665
LL ++ E Q +P + APE L + D WS
Sbjct: 176 ---------LLPLDKDYYVVREPGQ----------SPIFWYAPESLS-DNIFSRQSDVWS 215
Query: 666 VGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRV------------PEEMSPEAHD 712
G++L+EL + R+ P E H+
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHE 275
Query: 713 LIDRFLTEDPHQR 725
L+ P R
Sbjct: 276 LMKLCWAPSPQDR 288
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 45/201 (22%)
Query: 497 LAERDILISVRNPFVVRFF-YSFTCREN--LYLVMEYLNGGDLYSLL----RNLGCLDED 549
E + L R+P +V + C E + L+ +Y+ G+L L + +
Sbjct: 83 ETEIETLSFCRHPHLVSLIGF---CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 550 VARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
R+ I L YLH+ ++HRD+K N+L+ + K+TDFG+SK G LS
Sbjct: 140 -QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV-GTPDYLAPEILLGTGHGTT-ADWWSV 666
+ V GT Y+ PE + G T +D +S
Sbjct: 199 ------------------------------TVVKGTLGYIDPEYFI-KGRLTEKSDVYSF 227
Query: 667 GIILFELIVGIPPFNAEHPQQ 687
G++LFE++ P++
Sbjct: 228 GVVLFEVLCARSAIVQSLPRE 248
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 491 NAVESILAERDILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLD 547
N + + E +IL ++ + +V++ + + L+ME+L G L L N ++
Sbjct: 65 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
Y ++ ++YL S + VHRDL N+L+ + +K+ DFGL+K
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 45/204 (22%), Positives = 74/204 (36%), Gaps = 53/204 (25%)
Query: 497 LAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLD----- 547
E ++ ++ +V +S + LV Y+ G L L L
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 548 ---EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604
+ A + +LH +HRD+K N+L+ K++DFGL++
Sbjct: 137 KIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR------- 181
Query: 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADW 663
++ A R VGT Y+APE L G T +D
Sbjct: 182 -------------ASEKF----AQTVMTSR-----IVGTTAYMAPEAL--RGEITPKSDI 217
Query: 664 WSVGIILFELIVGIPPFNAEHPQQ 687
+S G++L E+I G+P + Q
Sbjct: 218 YSFGVVLLEIITGLPAVDEHREPQ 241
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 43/231 (18%)
Query: 469 KGALSEHDDFPQV----LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524
+G V LK+ K E ++ E I+ + NP++VR E L
Sbjct: 28 QGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRL-IGVCQAEAL 84
Query: 525 YLVMEYLNGGDLYSLLR-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
LVME GG L+ L + + +V + ++YL VHRDL N+L+
Sbjct: 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
+ + K++DFGLSK LG ++ TA + K
Sbjct: 145 NRHYAKISDFGLSKA-------------------LGADDSYYTARSAGKWPLK------- 178
Query: 644 PDYLAPEILLGTGHGTTA-DWWSVGIILFELI-VGIPPF----NAEHPQQI 688
+ APE + ++ D WS G+ ++E + G P+ E I
Sbjct: 179 --WYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK M + E+ L E ++ +R+ +V+ + + E +Y+V EY++ G L L
Sbjct: 215 TLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL 269
Query: 541 RNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ + + V +A ++ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
E+ + TA + + K + APE L
Sbjct: 330 I---------------------EDNEYTARQGAKFPIK---------WTAPEAALYGRFT 359
Query: 659 TTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNR-KIPWPRVPEEMSPEAHDLIDR 716
+D WS GI+L EL G P+ +++ D + ++P P E HDL+ +
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPESLHDLMCQ 416
Query: 717 FLTEDPHQR 725
++P +R
Sbjct: 417 CWRKEPEER 425
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 51/256 (19%), Positives = 95/256 (37%), Gaps = 53/256 (20%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL KA N ES ++ + + +V + C + LV E++ G L + L
Sbjct: 47 VLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLT 591
+ N C++ ++ A+ +L ++H ++ N+L+ + IKL+
Sbjct: 104 KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163
Query: 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEI 651
D G+S + + QER ++ PE
Sbjct: 164 DPGISIT--------------------------VLPKDILQERIP---------WVPPEC 188
Query: 652 LLGTGHGTTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPE 709
+ + A D WS G L+E+ G P +A Q+ +R ++P + E
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH----QLPAPKAAE 244
Query: 710 AHDLIDRFLTEDPHQR 725
+LI+ + +P R
Sbjct: 245 LANLINNCMDYEPDHR 260
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
L++A A + IL E ++ SV NP V R + L+ + + G L +
Sbjct: 51 ELREATS--PKANKEILDEAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV 107
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R + + + ++ + YL R+VHRDL N+L+ H+K+TDFGL+K
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-- 165
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHG 658
LLG EE + A + P ++A E +L
Sbjct: 166 -----------------LLGAEEKEYHAEGGK-----------VPIKWMALESIL-HRIY 196
Query: 659 TTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNI 692
T D WS G+ ++EL+ G P++ +I +
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 3e-14
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 39/215 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLK+ K E ++ E I+ + NP++VR E L LVME GG L+ L
Sbjct: 370 VLKQGTE--KADTEEMMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFL 426
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+ + +V + ++YL VHR+L N+L+ + + K++DFGLSK
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA- 485
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
LG ++ TA + K + APE + +
Sbjct: 486 ------------------LGADDSYYTARSAGKWPLK---------WYAPECIN-FRKFS 517
Query: 660 TA-DWWSVGIILFELI-VGIPPF----NAEHPQQI 688
+ D WS G+ ++E + G P+ E I
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK M + E+ L E ++ +R+ +V+ + + E +Y+V EY++ G L L
Sbjct: 298 TLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFL 352
Query: 541 RNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ + + V +A ++ + Y+ + VHRDL+ N+L+ + K+ DFGL+++
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
E+ + TA + + K + APE L
Sbjct: 413 I---------------------EDNEYTARQGAKFPIK---------WTAPEAALYGRFT 442
Query: 659 TTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNR-KIPWPRVPEEMSPEAHDLIDR 716
+D WS GI+L EL G P+ +++ D + ++P P E HDL+ +
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---CPPECPESLHDLMCQ 499
Query: 717 FLTEDPHQR 725
++P +R
Sbjct: 500 CWRKEPEER 508
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 43/250 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK+ M VE L E ++ +++P +V+ T Y++ E++ G+L L
Sbjct: 252 TLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 541 RNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
R + +Y+A ++ A+EYL +HR+L N L+ + +K+ DFGLS++
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ GD TA + K APE L
Sbjct: 368 ------------------MTGDT---YTAHAGAKFPIKW---------TAPESLAYNKFS 397
Query: 659 TTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILN--RKIPWPRVPEEMSPEAHDLID 715
+D W+ G++L+E+ G+ P+ Q+++ + R R PE + ++L+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MER-PEGCPEKVYELMR 453
Query: 716 RFLTEDPHQR 725
+P R
Sbjct: 454 ACWQWNPSDR 463
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 4/119 (3%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
KK + E ++E I+ ++ +P +V+ E +++ME G+L L
Sbjct: 47 TCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYL 103
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
N L +Y ++ A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 104 ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 1/103 (0%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYI 555
L+E I+ +P ++R T +V EY+ G L + LR + G +
Sbjct: 98 LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
V + YL L VHRDL N+L+ + K++DFGLS+V
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 58/249 (23%), Positives = 98/249 (39%), Gaps = 41/249 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
K E L E + +P +V+ ++++ME G+L S L
Sbjct: 425 TCKNCTSDSVR--EKFLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFL 481
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+ LD +Y ++ AL YL S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY- 540
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHG 658
+ D ++ + K P ++APE +
Sbjct: 541 ------------------MEDST------YYKASKGK------LPIKWMAPESIN-FRRF 569
Query: 659 TTA-DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
T+A D W G+ ++E++ G+ PF + I N + P P P + L+ +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PM-PPNCPPTLYSLMTK 627
Query: 717 FLTEDPHQR 725
DP +R
Sbjct: 628 CWAYDPSRR 636
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 39/204 (19%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 492 AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDV 550
+ +++ + S+ + +VR +L LV +YL G L +R + G L +
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 551 ARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610
+ ++ + YL +VHR+L N+L+ +++ DFG++ +
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL------------ 164
Query: 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA-DWWSVGII 669
L + Q + ++ + ++A E + G T D WS G+
Sbjct: 165 --------------LPPDDKQLLYSEAKTPI---KWMALESIH-FGKYTHQSDVWSYGVT 206
Query: 670 LFELI-VGIPPFNAEHPQQIFDNI 692
++EL+ G P+ ++ D +
Sbjct: 207 VWELMTFGAEPYAGLRLAEVPDLL 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 33/134 (24%), Positives = 57/134 (42%), Gaps = 14/134 (10%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLY 537
KAD+I + +E L E + +P V + + +++ ++ GDL+
Sbjct: 60 KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLH 119
Query: 538 SLLRNLGCLDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 591
+ L + V ++ +EYL S +HRDL N ++A D + +
Sbjct: 120 AFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179
Query: 592 DFGLSKVGLINSTD 605
DFGLS+ I S D
Sbjct: 180 DFGLSRK--IYSGD 191
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 30/118 (25%), Positives = 62/118 (52%), Gaps = 5/118 (4%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K+ M + + E ++ + +P +V+F+ + +Y+V EY++ G L + LR
Sbjct: 40 IKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR 95
Query: 542 NLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ G E + + +V + +L S + +HRDL N L+ D +K++DFG+++
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 54/246 (21%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR---- 552
L E ++ VVR + + ++ME + GDL S LR+L +
Sbjct: 76 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 553 -----VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606
+ +A E+ + YL++ + VHRDL N ++A D +K+ DFG+++ I TD
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETD- 192
Query: 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYL-----APEILLGTGHGTTA 661
RK + L +PE L G TT
Sbjct: 193 --------------------------YYRKGGKGL-----LPVRWMSPESLK-DGVFTTY 220
Query: 662 -DWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS G++L+E+ + P+ +Q+ ++ + + P+ +L+
Sbjct: 221 SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDK-PDNCPDMLFELMRMCWQ 278
Query: 720 EDPHQR 725
+P R
Sbjct: 279 YNPKMR 284
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 28/118 (23%), Positives = 57/118 (48%), Gaps = 5/118 (4%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+++ M + E + E ++++ + +P +V+ + + + LV E++ G L LR
Sbjct: 40 IREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR 95
Query: 542 -NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
G + +V + YL V+HRDL N L+ + IK++DFG+++
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 29/118 (24%), Positives = 52/118 (44%), Gaps = 3/118 (2%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
LK + L E I+ + ++R + + + ++ EY+ G L LR
Sbjct: 81 LKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR 138
Query: 542 -NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
G + + ++YL ++ VHRDL N+L+ + K++DFGLS+V
Sbjct: 139 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 31/116 (26%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 487 MIRKNA--VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 544
++++ VE L E ++ +++P +V+ T Y++ E++ G+L LR
Sbjct: 45 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 104
Query: 545 CLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ +Y+A ++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 105 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 4/118 (3%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
K E L E + +P +V+ ++++ME G+L S L+
Sbjct: 51 CKNCTSDS--VREKFLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQ 107
Query: 542 -NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
LD +Y ++ AL YL S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 108 VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 30/103 (29%), Positives = 49/103 (47%), Gaps = 1/103 (0%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDVARVYI 555
L E I+ +P ++R T + + +V EY+ G L S LR + +
Sbjct: 94 LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 556 AEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ ++YL + VHRDL N+LI + K++DFGL +V
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 28/120 (23%), Positives = 65/120 (54%), Gaps = 7/120 (5%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK+ M + ++ LAE +++ +++ +VR + T +E +Y++ EY+ G L L
Sbjct: 44 SLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFL 98
Query: 541 RNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ + + + + +A ++ + ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 30/118 (25%), Positives = 64/118 (54%), Gaps = 5/118 (4%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+K+ M + + + E +++++ + +V+ + T + ++++ EY+ G L + LR
Sbjct: 56 IKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 111
Query: 542 NLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ + + + +V A+EYL S + +HRDL N L+ G +K++DFGLS+
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 27/120 (22%), Positives = 65/120 (54%), Gaps = 7/120 (5%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+K M +VE+ LAE +++ ++++ +V+ T +E +Y++ E++ G L L
Sbjct: 219 TMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFL 273
Query: 541 RNLGCLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
++ + + + + + ++ + ++ +HRDL+ N+L++ K+ DFGL++V
Sbjct: 274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 34/209 (16%)
Query: 491 NAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
V L E I+ +P V+ + +V+ Y+ GDL + +RN
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
Query: 550 VARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V ++YL S + VHRDL N ++ +K+ DFGL++ + +
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEY-- 183
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSV 666
++ P ++A E L T TT D WS
Sbjct: 184 ------------------------YSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSF 218
Query: 667 GIILFELI-VGIPPFNAEHPQQIFDNILN 694
G++L+EL+ G PP+ + I +L
Sbjct: 219 GVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 32/133 (24%), Positives = 55/133 (41%), Gaps = 13/133 (9%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYS 538
K D + +E L+E + +P V+R S +++ ++ GDL++
Sbjct: 71 KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT 130
Query: 539 LLRNLGCLDEDVA-----RVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTD 592
L + ++ L +EYL + +HRDL N ++ D + + D
Sbjct: 131 YLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190
Query: 593 FGLSKVGLINSTD 605
FGLSK I S D
Sbjct: 191 FGLSKK--IYSGD 201
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 8e-12
Identities = 36/115 (31%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 487 MIRKNA-VESILAERDILISVRNPFVVRFFYSFTCRE-NLYLVMEYLNGGDLYSLLRNLG 544
I+ +A ++ LAE ++ +R+ +V+ + LY+V EY+ G L LR+ G
Sbjct: 51 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 545 CLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ + +V A+EYL VHRDL N+L++ D K++DFGL+K
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
LK+A +A + E ++L +++ +VRFF T L +V EY+ GDL LR
Sbjct: 79 LKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 135
Query: 542 NLGCLDEDVAR--------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586
+ G + +A + +A +V + YL L VHRDL N L+
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195
Query: 587 HIKLTDFGLS 596
+K+ DFG+S
Sbjct: 196 VVKIGDFGMS 205
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 52/211 (24%), Positives = 80/211 (37%), Gaps = 49/211 (23%)
Query: 526 LVMEYLNGGDLYSLLRNLG----CLDEDVARVYIAEVVLA--LEYLH---SLRVVHRDLK 576
LV Y+ G + S LR LD R IA + A L YLH +++HRD+K
Sbjct: 104 LVYPYMANGSVASCLRERPESQPPLDWP-KRQRIA-LGSARGLAYLHDHCDPKIIHRDVK 161
Query: 577 PDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRK 636
N+L+ + + DFGL+K+ T V+ T +
Sbjct: 162 AANILLDEEFEAVVGDFGLAKLMDYKDTH------VT-TAV------------------- 195
Query: 637 KRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNAEHPQ-QIFDNILN 694
GT ++APE L TG + D + G++L ELI G F+ +L+
Sbjct: 196 ----RGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 695 RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
+ E+ L+D L +
Sbjct: 251 W--VKGLLKEKKLEA---LVDVDLQGNYKDE 276
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 512 VRFFYSFTCRENLY--LVMEYLNGGDLYSLLRNLGCLDED-VARVYIAEVVLALEYLHSL 568
+ Y +VME L G DL + G + V ++ I ++ LEY+H
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGI-RMLDVLEYIHEN 170
Query: 569 RVVHRDLKPDNLLI--AHDGHIKLTDFGLSK 597
VH D+K NLL+ + + L D+GLS
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 46/209 (22%), Positives = 81/209 (38%), Gaps = 34/209 (16%)
Query: 491 NAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 549
V L E I+ +P V+ + +V+ Y+ GDL + +RN
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
Query: 550 VARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V +++L S + VHRDL N ++ +K+ DFGL++ + +
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEF-- 247
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSV 666
+ ++ P ++A E L T TT D WS
Sbjct: 248 ------------------------DSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSF 282
Query: 667 GIILFELI-VGIPPFNAEHPQQIFDNILN 694
G++L+EL+ G PP+ + I +L
Sbjct: 283 GVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 45/208 (21%), Positives = 73/208 (35%), Gaps = 48/208 (23%)
Query: 509 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-------- 560
+ +Y + LV++ L G L LL G R + + V
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLA 117
Query: 561 ALEYLHSLRVVHRDLKPDNLLI-----AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615
++ +H +V+RD+KPDN LI + I + DFG+ K T
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK---------- 167
Query: 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675
+H R KK + GT Y++ LG D ++G + +
Sbjct: 168 -------------QHIPYREKK-NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 213
Query: 676 GIPP---FNAEHPQQIFDNILNRKIPWP 700
G P A +Q ++ I +K P
Sbjct: 214 GSLPWQGLKAATNKQKYERIGEKKQSTP 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 21/140 (15%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
LK + A + E ++L ++++ +V+F+ + L +V EY+ GDL LR
Sbjct: 53 LKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLR 109
Query: 542 NLGCLDEDVAR---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
G + ++IA ++ + YL S VHRDL N L+ +
Sbjct: 110 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 169
Query: 586 GHIKLTDFGLSKVGLINSTD 605
+K+ DFG+S+ + STD
Sbjct: 170 LLVKIGDFGMSRD--VYSTD 187
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 34/209 (16%)
Query: 491 NAVESILAERDILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLGCLDED 549
VE+ L E ++ + +P V+ E ++++ Y+ GDL +R+
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 550 VARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608
+ +V +EYL + VHRDL N ++ +K+ DFGL++ I + S
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYS 181
Query: 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP-DYLAPEILLGTGHGTTA-DWWSV 666
L P + A E L T TT D WS
Sbjct: 182 VQQHRHARL--------------------------PVKWTALESLQ-TYRFTTKSDVWSF 214
Query: 667 GIILFELI-VGIPPFNAEHPQQIFDNILN 694
G++L+EL+ G PP+ P + +
Sbjct: 215 GVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 32/140 (22%), Positives = 67/140 (47%), Gaps = 23/140 (16%)
Query: 487 MIRKNAVES----ILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ +A E +++E +++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 74 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 542 NLGCLDEDVAR---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
+ + V ++ +EYL S + +HRDL N+L+ +
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193
Query: 586 GHIKLTDFGLSKVGLINSTD 605
+K+ DFGL++ IN+ D
Sbjct: 194 NVMKIADFGLAR--DINNID 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 36/115 (31%), Positives = 60/115 (52%), Gaps = 4/115 (3%)
Query: 487 MIRKNA-VESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLG 544
I+ +A ++ LAE ++ +R+ +V+ + LY+V EY+ G L LR+ G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 545 CLDEDVAR-VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ + +V A+EYL VHRDL N+L++ D K++DFGL+K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 30/147 (20%)
Query: 487 MIRKNAVES----ILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
M+++NA S +L+E ++L V +P V++ + + + L L++EY G L LR
Sbjct: 60 MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 543 LGCLDEDVAR-----------------------VYIA-EVVLALEYLHSLRVVHRDLKPD 578
+ + A ++ ++YL +++VHRDL
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTD 605
N+L+A +K++DFGLS+ + D
Sbjct: 180 NILVAEGRKMKISDFGLSR--DVYEED 204
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 49/226 (21%)
Query: 489 RKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
K+ + E + + + + +Y C + +V+E L G L L
Sbjct: 44 MKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--- 99
Query: 548 EDVARVYIAEVVL--------ALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFG 594
R + + VL +EY+HS +++RD+KP+N LI G+ I + DF
Sbjct: 100 ----RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
L+K + T +H R+ +S GT Y++ LG
Sbjct: 156 LAKEYIDPETK-----------------------KH-IPYREHKSLTGTARYMSINTHLG 191
Query: 655 TGHGTTADWWSVGIILFELIVGIPP---FNAEHPQQIFDNILNRKI 697
D ++G + + G P A+ ++ + I + K
Sbjct: 192 KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 47/224 (20%), Positives = 79/224 (35%), Gaps = 47/224 (20%)
Query: 489 RKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
K + E I ++ + + + +VME L G L L
Sbjct: 44 VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--- 99
Query: 548 EDVARVYIAEVVL--------ALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLS 596
R + + VL +EY+HS +HRD+KPDN L+ + + DFGL+
Sbjct: 100 ----RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
K ++ +H R+ ++ GT Y + LG
Sbjct: 156 K-KYRDARTH----------------------QH-IPYRENKNLTGTARYASINTHLGIE 191
Query: 657 HGTTADWWSVGIILFELIVGIPP---FNAEHPQQIFDNILNRKI 697
D S+G +L +G P A +Q ++ I +K+
Sbjct: 192 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 32/140 (22%), Positives = 67/140 (47%), Gaps = 23/140 (16%)
Query: 487 MIRKNAVES----ILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ +A E +++E +++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 120 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 179
Query: 542 NLGCLDEDVAR---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
+ + V ++ +EYL S + +HRDL N+L+ +
Sbjct: 180 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239
Query: 586 GHIKLTDFGLSKVGLINSTD 605
+K+ DFGL++ IN+ D
Sbjct: 240 NVMKIADFGLAR--DINNID 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 7/89 (7%)
Query: 515 FYSFTCRENLY--LVMEYLNGGDLYSLLRNLGCLDEDVARVY-IAEVVL-ALEYLHSLRV 570
F ++ Y LV+ L G L S L V +A +L ALE+LH
Sbjct: 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180
Query: 571 VHRDLKPDNLLI--AHDGHIKLTDFGLSK 597
VH ++ +N+ + + L +G +
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 33/140 (23%), Positives = 65/140 (46%), Gaps = 23/140 (16%)
Query: 487 MIRKNAVES----ILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ +A E +++E +++ + ++ + T LY+++EY + G+L L+
Sbjct: 108 MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 167
Query: 542 NLGCLDEDVAR---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
+ + V A +V +EYL S + +HRDL N+L+ D
Sbjct: 168 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227
Query: 586 GHIKLTDFGLSKVGLINSTD 605
+K+ DFGL++ I+ D
Sbjct: 228 NVMKIADFGLAR--DIHHID 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 30/125 (24%), Positives = 51/125 (40%), Gaps = 18/125 (14%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIA 556
E + +++P VV T + L ++ Y + GDL+ L + +
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 557 EVVLAL----------------EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
V AL EYL S VVH+DL N+L+ ++K++D GL +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE-- 177
Query: 601 INSTD 605
+ + D
Sbjct: 178 VYAAD 182
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 36/147 (24%), Positives = 60/147 (40%), Gaps = 30/147 (20%)
Query: 487 MIRKNAVESI----LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
M+++ A + E ++ NP +V+ + + L+ EY+ GDL LR+
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 543 ------LGCLDEDVAR-----------------VYIA-EVVLALEYLHSLRVVHRDLKPD 578
D++ + IA +V + YL + VHRDL
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTD 605
N L+ + +K+ DFGLS+ I S D
Sbjct: 204 NCLVGENMVVKIADFGLSRN--IYSAD 228
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 30/142 (21%), Positives = 54/142 (38%), Gaps = 25/142 (17%)
Query: 487 MIRKNAVES----ILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ +A + +++E +L + N +V + T ++ EY GDL + LR
Sbjct: 60 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 542 NLGCLDEDVARVYI------------------AEVVLALEYLHSLRVVHRDLKPDNLLIA 583
+V + +L S +HRDL N+L+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179
Query: 584 HDGHIKLTDFGLSKVGLINSTD 605
H K+ DFGL++ I +
Sbjct: 180 HGRITKICDFGLARD--IKNDS 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 29/138 (21%), Positives = 54/138 (39%), Gaps = 21/138 (15%)
Query: 487 MIRKNAVES----ILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M++ A +++E I+ + +V + T + ++ EY GDL + LR
Sbjct: 83 MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 142
Query: 542 NLGCLDEDVARVYIAEVVLAL--------------EYLHSLRVVHRDLKPDNLLIAHDGH 587
+ E IA + +L S +HRD+ N+L+ +
Sbjct: 143 RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202
Query: 588 IKLTDFGLSKVGLINSTD 605
K+ DFGL++ I +
Sbjct: 203 AKIGDFGLAR--DIMNDS 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 5e-10
Identities = 111/732 (15%), Positives = 206/732 (28%), Gaps = 241/732 (32%)
Query: 136 HMFQFRQSRVLHSADKRIP---QGTLRDGKGSTIAKASKAASSRKSYSQEQHGLDWKRDH 192
H F + + + + + K+ S++ DH
Sbjct: 5 HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEI-----------DH 53
Query: 193 AVKQGN-----------ILSPPGDDNAKSLESSAARDR---MSSWK---KLPSPVGKIMK 235
+ + +LS + K +E + MS K + PS + + M
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR-MY 112
Query: 236 ESPTSKEQNDGKV---------EPLKSSNIRRGLSEIDLTAKPSEFPP------------ 274
+ ND +V +P +R+ L E+ +P++
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLEL----RPAKNVLIDGVLGSGKTWV 166
Query: 275 AAETLEHSSKHQHKVSWG-YWGDQQNISDDSSSIICRICEEEVPTSHVEDHSKICAIADR 333
A + S K Q K+ + +W N+ + +S P + +E K+ +
Sbjct: 167 ALDVCL-SYKVQCKMDFKIFW---LNLKNCNS-----------PETVLEMLQKLLY---Q 208
Query: 334 CDQKGLSVNERLLRISETLEKMMESSVQKDIHNVVVGSPDVAKVSNSSVTEESDVLSPKF 393
D S ++ I + L
Sbjct: 209 IDPNWTSRSDHSSNIKLRIH------------------------------SIQAELRRLL 238
Query: 394 SDWSRRGSEDMLDYVPEADNSV---FMDDLKGLPSMACK----TRFGPKSDQ-GMTTSSA 445
+L V + F +L CK TRF +D T++
Sbjct: 239 KSKPYENCLLVLLNV--QNAKAWNAF--NLS------CKILLTTRFKQVTDFLSAATTTH 288
Query: 446 GSMTPRSPLLTPRTSQIDLLLAGKGALSEHDDFP-QVLKKADMIRKNAVESILAERDILI 504
S+ S LTP LLL K D P +VL SI+AE
Sbjct: 289 ISLDHHSMTLTPDEV-KSLLL--KYLDCRPQDLPREVLTTNPR-----RLSIIAE----- 335
Query: 505 SVRNPFVVRF-FYSFTCRENLYLVME----YLNGGDLYSLLRNLGCLDEDVARVYIAEVV 559
S+R+ + + + + L ++E L + + L +I ++
Sbjct: 336 SIRD-GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTIL 391
Query: 560 LA--------------LEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
L+ + LH +V + K + I +++L
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-PSIYLELK-------------- 436
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQ--ERRKKRSAVGTPDYLAPEILLGTGHGTTAD- 662
+ + E L H+ + + D + P + D
Sbjct: 437 -----------VKLENEYAL----HRSIVDHYNIPKTFDSDDLIPPYL----------DQ 471
Query: 663 --WWSVGIILFELIVGIPPFNAEHPQQI--FDNI------LNRKIPWPRVPEEMSPEAHD 712
+ +G L N EHP+++ F + L +KI S +
Sbjct: 472 YFYSHIG---HHL------KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS-- 770
+ + K ++ D ++ L F+P E L S +T
Sbjct: 523 TLQQL--------------KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568
Query: 771 RYSWNTTDENIY 782
R + DE I+
Sbjct: 569 RIALMAEDEAIF 580
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 27/119 (22%), Positives = 49/119 (41%), Gaps = 12/119 (10%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR---- 552
L E I+ + +VR ++++E + GGDL S LR +
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 553 --VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 605
+++A ++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAG 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 12/119 (10%)
Query: 497 LAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVAR---- 552
L E I+ + +VR +++ME + GGDL S LR +
Sbjct: 81 LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 553 --VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTD 605
+++A ++ +YL +HRD+ N L+ G K+ DFG+++ I
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAS 197
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 21/132 (15%)
Query: 487 MIRKNAVES----ILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+++ A + E ++L + +P ++ + R LYL +EY G+L LR
Sbjct: 59 RMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 542 NLGCLDEDVARVYIAEVVLAL----------------EYLHSLRVVHRDLKPDNLLIAHD 585
L+ D A L +YL + +HRDL N+L+ +
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178
Query: 586 GHIKLTDFGLSK 597
K+ DFGLS+
Sbjct: 179 YVAKIADFGLSR 190
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 30/147 (20%)
Query: 487 MIRKNAVES----ILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
M+++ A S +++E ++ + + +V + T +YL+ EY GDL + LR
Sbjct: 82 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 542 NLGCLDEDVARVYIAEVVLAL-----------------------EYLHSLRVVHRDLKPD 578
+ + Y + L E+L VHRDL
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTD 605
N+L+ H +K+ DFGL++ I S
Sbjct: 202 NVLVTHGKVVKICDFGLAR--DIMSDS 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 24/141 (17%)
Query: 487 MIRKNAVES----ILAERDILISV-RNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLL 540
M+++ A S +++E ILI + + VV + T L +++E+ G+L + L
Sbjct: 64 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 541 RNLGCLDEDVAR---------------VYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAH 584
R+ + + +V +E+L S + +HRDL N+L++
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 585 DGHIKLTDFGLSKVGLINSTD 605
+K+ DFGL++ I
Sbjct: 184 KNVVKICDFGLARD--IYKDP 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 22/98 (22%), Positives = 36/98 (36%), Gaps = 20/98 (20%)
Query: 512 VRFFYSFTCRENLY--LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL--------A 561
Y ++M+ G DL + + + + VL
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-------KRFSRKTVLQLSLRILDI 164
Query: 562 LEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSK 597
LEY+H VH D+K NLL+ + + L D+GL+
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 45/206 (21%), Positives = 72/206 (34%), Gaps = 46/206 (22%)
Query: 509 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVL-------- 560
+ + + LVM+ L G L L R + VL
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMIN 114
Query: 561 ALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617
+E++HS +HRD+KPDN L+ + + DFGL+K ST
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH------------ 162
Query: 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677
+H R+ ++ GT Y + LG D S+G +L + G
Sbjct: 163 -----------QH-IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
Query: 678 PP---FNAEHPQQIFDNILNRKIPWP 700
P A +Q ++ I +K+
Sbjct: 211 LPWQGLKAGTKKQKYEKISEKKVATS 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 3e-08
Identities = 23/83 (27%), Positives = 36/83 (43%), Gaps = 4/83 (4%)
Query: 517 SFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRVVHRD 574
F + L++V+E+ GG DL + L A+ + ++ +L SLR HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRD 187
Query: 575 LKPDNLLIAHDGHIKLTDFGLSK 597
L N+L+ KL K
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGK 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 29/118 (24%)
Query: 557 EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616
+V +E+L S + +HRDL N+L++ +K+ DFGL++ I
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP----------- 247
Query: 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674
+ +K A ++APE + + +D WS G++L+E+
Sbjct: 248 ----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580
+N ++M Y+NG ++ + + + + + LH V+H DL N
Sbjct: 411 LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGE-IVGK-------LHKNDVIHNDLTTSNF 462
Query: 581 LIAHDGHIKLTDFGLSKV 598
+ D + + DFGL K+
Sbjct: 463 IF--DKDLYIIDFGLGKI 478
|
| >3k1f_M Transcription initiation factor IIB; RNA polymerase II, TFIIB, transcription factor, DNA-binding, DNA-directed RNA polymerase; 4.30A {Saccharomyces cerevisiae} Length = 197 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 18/63 (28%), Positives = 27/63 (42%), Gaps = 16/63 (25%)
Query: 292 GYWGDQQNISDDSSSIICRICEEEVPTSHVEDHSK---ICAIADRCDQKGLSVNERLL-R 347
G G NI + C C+ P VE S+ +CA C GL ++++L+
Sbjct: 12 GRRGPNLNIV-----LTCPECKVY-PPKIVERFSEGDVVCA---LC---GLVLSDKLVDT 59
Query: 348 ISE 350
SE
Sbjct: 60 RSE 62
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.76 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.39 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.88 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.86 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 82.98 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-60 Score=512.74 Aligned_cols=266 Identities=35% Similarity=0.709 Sum_probs=233.3
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..+|.+. +||+|+||+|+.+. |++.+..+......+.+.+|+++|++|+|||||+++++|++++++|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457665 99999999996652 444455555566778899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~---- 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES---- 186 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC----
Confidence 9999999999999998999999999999999999999999999999999999999999999999999998521100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
......+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 187 -------------------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 241 (311)
T 4aw0_A 187 -------------------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241 (311)
T ss_dssp -------------------------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0123456899999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC---CHHHHHcCCCCCCCChhHHhhccCCcc
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG---GASEVKQHVFFKDINWDTLARQKAAFV 756 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~---SAeEILqHPFFk~IdW~~l~~~~ppfv 756 (863)
++.+|......+ |..+++++++||.+||++||.+||++. ....|++||||+++||+.+.+++||.+
T Consensus 242 ~~~~i~~~~~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 242 IFAKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp HHHHHHHTCCCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HHHHHHcCCCCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999988655 467999999999999999999999431 234579999999999999998887754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=497.14 Aligned_cols=264 Identities=39% Similarity=0.759 Sum_probs=223.9
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.+|.+. .||+|+||+|+.+. +++|.... ........+.+|+++|++++|||||+++++|++++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 456665 99999999997542 23332211 112233468899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~----- 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID----- 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--------
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 179 --------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 179 --------------------------HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp ----------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 012334679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVP 757 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP 757 (863)
+++.+|.+....+ |..+|+++++||.+||++||.+||++ .+++|+++||||+++||+.+.++ .|||+|
T Consensus 233 ~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 233 ETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHHHHHcCCCCC---CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 9999999877654 56799999999999999999999975 35799999999999999999765 489987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=514.67 Aligned_cols=276 Identities=32% Similarity=0.599 Sum_probs=234.1
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHH---HHHhcCCCCeeEEEEEEEeCCe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERD---ILISVRNPFVVRFFYSFTCREN 523 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~---IL~~L~HPnIVkL~~~f~d~~~ 523 (863)
+..+|.+. +||+|+||+|+.+. |+++|..+........+.+|.. +++.++|||||+++++|++.++
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 35567765 99999999996552 4555555555555566666654 4556789999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+|||||||+||+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~--- 343 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--- 343 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998421
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.....+.|||+.|||||++. +..|+.++|||||||+||||++|.+||.+
T Consensus 344 ------------------------------~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 344 ------------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp ------------------------------SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred ------------------------------CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01234679999999999997 46799999999999999999999999976
Q ss_pred C---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCc
Q 002953 683 E---HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAF 755 (863)
Q Consensus 683 ~---~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppf 755 (863)
. +..+++..+...... +|..+|+++++||.+||++||.+|+++ .+++||++||||+++||+.+..+ .|||
T Consensus 394 ~~~~~~~~i~~~i~~~~~~---~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~ 470 (689)
T 3v5w_A 394 HKTKDKHEIDRMTLTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPL 470 (689)
T ss_dssp GGCCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSC
T ss_pred CChHHHHHHHHhhcCCCCC---CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCc
Confidence 4 445666777766654 457799999999999999999999975 46999999999999999999865 5999
Q ss_pred cCCCCCCCCCCCcc
Q 002953 756 VPTSESALDTSYFT 769 (863)
Q Consensus 756 vP~~~s~lDts~F~ 769 (863)
+|......++++|+
T Consensus 471 ~P~~~~~~~~~~fD 484 (689)
T 3v5w_A 471 IPPRGEVNAADAFD 484 (689)
T ss_dssp CCCTTCSSTTBCCC
T ss_pred cCCCCCCCcCCCCC
Confidence 99887766666655
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-55 Score=479.33 Aligned_cols=247 Identities=31% Similarity=0.545 Sum_probs=216.6
Q ss_pred ce-EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 462 ID-LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 462 ~~-l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
|+ +..||+|+||+|+.+. +++|+.........+.+.+|+.+|+.++|||||+++++|++++.+|||||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 44 4489999999997652 455655444445556788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 156 g~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~----------- 223 (346)
T 4fih_A 156 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----------- 223 (346)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----------
T ss_pred CcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-----------
Confidence 999999976 67999999999999999999999999999999999999999999999999999842110
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|.
T Consensus 224 --------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 283 (346)
T 4fih_A 224 --------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283 (346)
T ss_dssp --------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred --------------------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 112346899999999999999999999999999999999999999999999999999888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.........+..+|+++++||.+||++||.+|| |++|+|+||||+..
T Consensus 284 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 284 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 330 (346)
T ss_dssp HSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred cCCCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcCC
Confidence 765444444567999999999999999999999 99999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=460.45 Aligned_cols=244 Identities=30% Similarity=0.564 Sum_probs=200.8
Q ss_pred cccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
.++|.+. .||+|+||+|+.+. +++| +...........+.+|+++|++++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3456665 99999999996652 2333 33344445567899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||| +|+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~------- 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT------- 163 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC-------
Confidence 9999 67999999998999999999999999999999999999999999999999999999999999998411
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
......+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..
T Consensus 164 -------------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 164 -------------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp ------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 0112345789999999999999886 58999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
++++++..+...+ |..+|+++++||.+||++||++|| |++|+++||||+
T Consensus 219 ~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k 267 (275)
T 3hyh_A 219 VLFKNISNGVYTL---PKFLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFK 267 (275)
T ss_dssp HHHHHHHHTCCCC---CTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHH
T ss_pred HHHHHHHcCCCCC---CCCCCHHHHHHHHHHccCChhHCc---CHHHHHcCcccc
Confidence 9999998877654 567999999999999999999999 999999999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-54 Score=473.60 Aligned_cols=247 Identities=26% Similarity=0.480 Sum_probs=209.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.+|.+. .||+|+||+|+.+. +++|... .......+.+.+|+++|++|+|||||+++++|++++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456655 99999999997652 3444332 2234456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 530 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 530 y~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~------- 176 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN------- 176 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC-------
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec-------
Confidence 99999999999754 357899999999999999999999999999999999999999999999999998410
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+
T Consensus 177 ------------------------~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 232 (350)
T 4b9d_A 177 ------------------------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232 (350)
T ss_dssp ------------------------HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 01122345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
++.+|..+.. +..+..+|+++++||.+||++||.+|| |++|+|+||||+.
T Consensus 233 ~~~~i~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 233 LVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred HHHHHHcCCC--CCCCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 9999988765 455678999999999999999999999 9999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=481.22 Aligned_cols=247 Identities=31% Similarity=0.539 Sum_probs=217.3
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
|.+ ..||+|+||+|+.+. +++|+.........+.+.+|+.+|+.|+|||||+++++|.+++.+|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 444 499999999997652 456655544445556789999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 233 G~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~----------- 300 (423)
T 4fie_A 233 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE----------- 300 (423)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-----------
T ss_pred CcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-----------
Confidence 999999975 67999999999999999999999999999999999999999999999999999842100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHh
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl 693 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..|.
T Consensus 301 --------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 360 (423)
T 4fie_A 301 --------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 360 (423)
T ss_dssp --------------------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred --------------------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 122346899999999999999999999999999999999999999999999999999888
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.........+..+|+++++||.+||++||.+|| |+.|+|+||||+..
T Consensus 361 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 361 DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 407 (423)
T ss_dssp HSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred cCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcCC
Confidence 765544445678999999999999999999999 99999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=455.23 Aligned_cols=243 Identities=22% Similarity=0.454 Sum_probs=202.9
Q ss_pred ceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEEE
Q 002953 462 IDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLV 527 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~lyLV 527 (863)
+++. .||+|+||+|+.+. +++|+.. .......+.+.+|+++|++|+|||||+++++|++ +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3444 69999999997652 2333322 2234456789999999999999999999999976 3568999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecC-CCcEEEeecCCccccccCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~ 604 (863)
||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~---- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---- 183 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC----
Confidence 999999999999999899999999999999999999999998 999999999999985 7999999999998410
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.....+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+
T Consensus 184 -----------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 012345799999999999876 59999999999999999999999997654
Q ss_pred -hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 685 -PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 685 -~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
...++..+..+.. .+.++..+++++++||.+||++||.+|| |++|+|+||||++
T Consensus 234 ~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 234 NAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp SHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred cHHHHHHHHHcCCC-CCCCCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccC
Confidence 4555555554433 3345567899999999999999999999 9999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=459.24 Aligned_cols=282 Identities=37% Similarity=0.723 Sum_probs=242.2
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
....|.+. +||+|+||+|+.+. |++++.........+.+.+|+.+|..+ +||||++++++|++.+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34556655 99999999996542 334444444556677899999999988 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||||+||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~---- 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC---- 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc----
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999984110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 177 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 177 ---------------------------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp ------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 01223457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSE 760 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~ 760 (863)
.+++.+|......+ +..++.++.+||++||++||.+||++ .++++|++||||++++|+.+... .|||+|...
T Consensus 230 ~~~~~~i~~~~~~~---p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~ 306 (353)
T 3txo_A 230 DDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK 306 (353)
T ss_dssp HHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHcCCCCC---CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC
Confidence 99999999887655 45689999999999999999999954 34599999999999999998765 589999999
Q ss_pred CCCCCCCcccccc
Q 002953 761 SALDTSYFTSRYS 773 (863)
Q Consensus 761 s~lDts~F~s~~s 773 (863)
+..|+++|+..+.
T Consensus 307 ~~~~~~~f~~~~~ 319 (353)
T 3txo_A 307 SREDVSNFDPDFI 319 (353)
T ss_dssp STTCCTTSCHHHH
T ss_pred CcccccccCcccc
Confidence 9999999988664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=464.57 Aligned_cols=242 Identities=25% Similarity=0.421 Sum_probs=205.5
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||+|+.+. +++|+..... ...+|+.+|+.|+|||||+++++|++++.+|||||||+
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 34443 79999999997652 3444432211 12479999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
||+|.++|++.+.|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.......
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~------- 206 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL------- 206 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc-------
Confidence 999999999989999999999999999999999999999999999999999987 699999999985211000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
..........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+
T Consensus 207 -------------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 267 (336)
T 4g3f_A 207 -------------------GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267 (336)
T ss_dssp --------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH
T ss_pred -------------------ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 0001123457899999999999999999999999999999999999999999888888889
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|.....++..++..+++++.+||.+||++||.+|| |+.|+++
T Consensus 268 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---sa~el~~ 309 (336)
T 4g3f_A 268 IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRR 309 (336)
T ss_dssp HHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCc---CHHHHHH
Confidence 98887766667889999999999999999999999 9999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=449.33 Aligned_cols=280 Identities=40% Similarity=0.752 Sum_probs=245.9
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. +||+|+||+|+.+. |++++...........+.+|+.+|+.++||||++++++|++.+.+|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 455554 99999999996542 3333444445556778999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~------ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD------ 158 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT------
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999999741100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+
T Consensus 159 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 159 -------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp -------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 1123457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 764 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lD 764 (863)
+..+......+ +..+++++.+||.+||+.||.+||+. .+++++++||||++++|+.+... .|||+|...+..|
T Consensus 214 ~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d 290 (337)
T 1o6l_A 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 290 (337)
T ss_dssp HHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTC
T ss_pred HHHHHcCCCCC---CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcch
Confidence 99998876654 46799999999999999999999976 38999999999999999999765 4899999999999
Q ss_pred CCCcccccc
Q 002953 765 TSYFTSRYS 773 (863)
Q Consensus 765 ts~F~s~~s 773 (863)
+++|+..+.
T Consensus 291 ~~~f~~~~~ 299 (337)
T 1o6l_A 291 TRYFDDEFT 299 (337)
T ss_dssp CTTSCHHHH
T ss_pred hhcccchhc
Confidence 999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=464.63 Aligned_cols=281 Identities=35% Similarity=0.699 Sum_probs=239.1
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
...|.+. +||+|+||+|+.+. |++++...........+.+|+.+|.++ +|||||+++++|++.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4456655 99999999996542 344444444455566788999999887 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||||+||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~----- 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR----- 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-----
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-----
Confidence 999999999999999889999999999999999999999999999999999999999999999999999984111
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE--- 683 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~--- 683 (863)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 206 --------------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~ 259 (396)
T 4dc2_A 206 --------------------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 259 (396)
T ss_dssp --------------------------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-
T ss_pred --------------------------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccc
Confidence 012234679999999999999999999999999999999999999999632
Q ss_pred ------ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--c
Q 002953 684 ------HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--K 752 (863)
Q Consensus 684 ------~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ 752 (863)
....++..+......+ |..++.++.+||++||++||.+||++ .++++|++||||++++|+.+... .
T Consensus 260 ~~~~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~ 336 (396)
T 4dc2_A 260 DNPDQNTEDYLFQVILEKQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336 (396)
T ss_dssp -----CCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred cccchhhHHHHHHHHhccccCC---CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence 3345667777766544 56799999999999999999999975 25799999999999999999865 4
Q ss_pred CCccCCCCCCCCCCCcccccc
Q 002953 753 AAFVPTSESALDTSYFTSRYS 773 (863)
Q Consensus 753 ppfvP~~~s~lDts~F~s~~s 773 (863)
|||+|...+..|+++|++.|+
T Consensus 337 pp~~p~~~~~~d~~~fd~~~~ 357 (396)
T 4dc2_A 337 PPFKPNISGEFGLDNFDSQFT 357 (396)
T ss_dssp CSCCCCCCSSTTGGGSCHHHH
T ss_pred CCCcCCCCCccchhhcChhhc
Confidence 999999999999999998765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=450.41 Aligned_cols=280 Identities=33% Similarity=0.700 Sum_probs=243.0
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
...|.+. +||+|+||+|+.+. |++++.........+.+.+|+.+|..+ +||||++++++|++.+.+||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4456655 99999999996542 334444444455677889999999988 79999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---- 174 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD---- 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999741100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..
T Consensus 175 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 175 ---------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp ---------------------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 11234678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
+++.+|......+ +..++.++.+||.+||..||.+||++ .++++|++||||++++|+.+... .|||+|.....
T Consensus 228 ~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~ 304 (353)
T 2i0e_A 228 ELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR 304 (353)
T ss_dssp HHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC
T ss_pred HHHHHHHhCCCCC---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc
Confidence 9999999877654 46799999999999999999999976 47899999999999999999765 59999999888
Q ss_pred CCCCCcccccc
Q 002953 763 LDTSYFTSRYS 773 (863)
Q Consensus 763 lDts~F~s~~s 773 (863)
|+++|+..+.
T Consensus 305 -~~~~f~~~~~ 314 (353)
T 2i0e_A 305 -NAENFDRFFT 314 (353)
T ss_dssp ---CHHHHHHH
T ss_pred -chhhccchhc
Confidence 9999987553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=457.80 Aligned_cols=282 Identities=38% Similarity=0.723 Sum_probs=234.6
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. +||+|+||+|+.+. |++++...........+.+|+.+|..++||||++++++|++.+++|||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3455554 99999999986542 333333344445556788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||++||+|.+++.+.+ .+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~---- 215 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD---- 215 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT----
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC----
Confidence 99999999999998764 7999999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-------CCCCCccceeechhHHHHHHHhCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-------GTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-------g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
........+||+.|+|||++. +..|+.++|||||||++|||++|.+|
T Consensus 216 --------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 269 (412)
T 2vd5_A 216 --------------------------GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269 (412)
T ss_dssp --------------------------SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred --------------------------CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCC
Confidence 001223568999999999997 35689999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccC
Q 002953 680 FNAEHPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP 757 (863)
|.+.+..+++.+|+... ..+|..+..+++++++||++||. +|.+|++..++++|++||||++++|+.+....|||+|
T Consensus 270 f~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred CCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 99999999999988643 45555567899999999999999 9999988779999999999999999999888899999
Q ss_pred CCCCCCCCCCcccc
Q 002953 758 TSESALDTSYFTSR 771 (863)
Q Consensus 758 ~~~s~lDts~F~s~ 771 (863)
...+..|+++|+..
T Consensus 349 ~~~~~~d~~~f~~~ 362 (412)
T 2vd5_A 349 DFEGATDTCNFDLV 362 (412)
T ss_dssp C-----CCSSCC--
T ss_pred cCCCcccccccCcc
Confidence 99999999999763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=451.59 Aligned_cols=282 Identities=38% Similarity=0.745 Sum_probs=225.6
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHH-HHhcCCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDI-LISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~ly 525 (863)
....|.+. +||+|+||+|+.+. |++++...........+.+|..+ ++.++||||++++++|++.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34456655 99999999996542 34444444445566778888887 46789999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
|||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--- 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--- 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC---
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999742110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 193 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 193 ----------------------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp ----------------------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred ----------------------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 1123467899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC-CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS-GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~-~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
.+++.+|+.....+ +..++.++.+||.+||++||.+||++ ..+.+|++||||++++|+.+... .|||+|...+.
T Consensus 245 ~~~~~~i~~~~~~~---~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~ 321 (373)
T 2r5t_A 245 AEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGP 321 (373)
T ss_dssp HHHHHHHHHSCCCC---CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC-
T ss_pred HHHHHHHHhcccCC---CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCc
Confidence 99999998876544 46799999999999999999999976 46789999999999999999765 58999999999
Q ss_pred CCCCCcccccc
Q 002953 763 LDTSYFTSRYS 773 (863)
Q Consensus 763 lDts~F~s~~s 773 (863)
.|+++|+..+.
T Consensus 322 ~d~~~f~~~~~ 332 (373)
T 2r5t_A 322 NDLRHFDPEFT 332 (373)
T ss_dssp -----------
T ss_pred chhhhcCcccc
Confidence 99999987553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=446.18 Aligned_cols=278 Identities=37% Similarity=0.734 Sum_probs=225.2
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ly 525 (863)
....|.+. +||+|+||.|+.+. |++++.........+.+..|+.+|..+ +||||++++++|++.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 34456555 99999999996542 333343334455667889999999987 8999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--- 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999741100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.
T Consensus 172 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 172 ----------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp ----------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ----------------------------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 0123467899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH-HHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe-EILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
.+++..+......+ +..++.++.+||.+||..||.+|| ++. +|++||||++++|+.+... .|||+|...+.
T Consensus 224 ~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dp~~R~---~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~ 297 (345)
T 1xjd_A 224 EELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSP 297 (345)
T ss_dssp HHHHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHHHHHTTCSCC---------
T ss_pred HHHHHHHHhCCCCC---CcccCHHHHHHHHHHhcCCHhHcC---CChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCc
Confidence 99999998876544 567999999999999999999999 666 9999999999999999765 58999999999
Q ss_pred CCCCCccccc
Q 002953 763 LDTSYFTSRY 772 (863)
Q Consensus 763 lDts~F~s~~ 772 (863)
.|+++|+..+
T Consensus 298 ~d~~~f~~~~ 307 (345)
T 1xjd_A 298 FDCSNFDKEF 307 (345)
T ss_dssp ----------
T ss_pred chhhhcchhh
Confidence 9999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=460.62 Aligned_cols=280 Identities=36% Similarity=0.714 Sum_probs=239.2
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..+|.+. +||+|+||+|+.+. |++++...........+.+|+.+|..++||||++++++|.+.+.+|||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 3455554 99999999996542 233333333344445588999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--- 229 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 229 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS---
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC---
Confidence 999999999999987 4789999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.......+||+.|||||++. ...|+.++|||||||++|||++|++||.
T Consensus 230 ---------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 230 ---------------------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp ---------------------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ---------------------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 01223468999999999997 4568999999999999999999999999
Q ss_pred CCChHHHHHHHhhc--CCCCCCCCCCCCHHHHHHHHhhccCCcCC--cCCCCCHHHHHcCCCCCCCChhHHhhccCCccC
Q 002953 682 AEHPQQIFDNILNR--KIPWPRVPEEMSPEAHDLIDRFLTEDPHQ--RLGSGGASEVKQHVFFKDINWDTLARQKAAFVP 757 (863)
Q Consensus 682 ~~~~~el~~kIl~~--~~~~p~~p~~iS~el~dLI~k~L~~DP~k--Rpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP 757 (863)
+.+..+++.+|+.. ...+|.....+++++++||++||..+|.+ |+ +++++++||||++++|+.+....|||+|
T Consensus 283 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~---~~~eil~Hpff~~i~w~~l~~~~~p~~P 359 (437)
T 4aw2_A 283 AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN---GIEDFKKHPFFSGIDWDNIRNCEAPYIP 359 (437)
T ss_dssp CSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT---TTHHHHTSGGGTTCCTTTGGGSCCSCCC
T ss_pred CCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCC---CHHHHhCCCccCCCCHHHHhhCCCCCCC
Confidence 99999999998764 35556555679999999999999987766 66 9999999999999999999888899999
Q ss_pred CCCCCCCCCCcccc
Q 002953 758 TSESALDTSYFTSR 771 (863)
Q Consensus 758 ~~~s~lDts~F~s~ 771 (863)
...+..|+++|+..
T Consensus 360 ~~~~~~d~~~fd~~ 373 (437)
T 4aw2_A 360 EVSSPTDTSNFDVD 373 (437)
T ss_dssp CCSSTTCCTTSCCC
T ss_pred cCCCccchhhcCCc
Confidence 99999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=454.24 Aligned_cols=278 Identities=40% Similarity=0.719 Sum_probs=235.4
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. +||+|+||+|+.+. |++++...........+.+|+.+|+.++|||||+++++|++.+.+|||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3455554 99999999996542 233333334444455688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||||+||+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~----- 221 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE----- 221 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-----
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-----
Confidence 999999999999976 57999999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCC
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG----HGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
......+.+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.
T Consensus 222 -------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 222 -------------------------GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp -------------------------SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------------------------CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 011234678999999999998766 789999999999999999999999999
Q ss_pred ChHHHHHHHhhcC--CCCCCCCCCCCHHHHHHHHhhccCCcCC--cCCCCCHHHHHcCCCCCCCChhHHh--hccCCccC
Q 002953 684 HPQQIFDNILNRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQ--RLGSGGASEVKQHVFFKDINWDTLA--RQKAAFVP 757 (863)
Q Consensus 684 ~~~el~~kIl~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~k--Rpg~~SAeEILqHPFFk~IdW~~l~--~~~ppfvP 757 (863)
+...++.+|+... ..+|. ...++.++++||.+||..+|.+ |+ ++++|++||||++++|+.+. ...|||+|
T Consensus 277 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~---~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p 352 (410)
T 3v8s_A 277 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRN---GVEEIKRHLFFKNDQWAWETLRDTVAPVVP 352 (410)
T ss_dssp SHHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSS---CHHHHHTSGGGCCSSCCSTTGGGSCCSCCC
T ss_pred ChhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCC---CHHHHhcCccccCCCHHHHhhcccCCCCCC
Confidence 9999999998753 33432 3468999999999999987777 77 99999999999999997654 44699999
Q ss_pred CCCCCCCCCCcccc
Q 002953 758 TSESALDTSYFTSR 771 (863)
Q Consensus 758 ~~~s~lDts~F~s~ 771 (863)
...+..|+++|+..
T Consensus 353 ~~~~~~d~~~fd~~ 366 (410)
T 3v8s_A 353 DLSSDIDTSNFDDL 366 (410)
T ss_dssp CCSSTTCCTTSCCC
T ss_pred cCCCccchhhcCCc
Confidence 99999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=437.95 Aligned_cols=281 Identities=35% Similarity=0.708 Sum_probs=239.5
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
...|.+. +||+|+||.|+.+. |++++.........+.+.+|+.+|.++ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3456554 99999999996542 334444444556677899999999988 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~---- 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---- 163 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC----
Confidence 9999999999999998889999999999999999999999999999999999999999999999999999741100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC----
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA---- 682 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~---- 682 (863)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 164 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 216 (345)
T 3a8x_A 164 ---------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216 (345)
T ss_dssp ---------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-
T ss_pred ---------------------------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccc
Confidence 1123457899999999999999999999999999999999999999975
Q ss_pred -----CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC---CCHHHHHcCCCCCCCChhHHhhc--c
Q 002953 683 -----EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS---GGASEVKQHVFFKDINWDTLARQ--K 752 (863)
Q Consensus 683 -----~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~---~SAeEILqHPFFk~IdW~~l~~~--~ 752 (863)
.....++..+...... ++..++.++.+||.+||+.||.+||++ .+++++++||||++++|+.+... .
T Consensus 217 ~~~~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~ 293 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 293 (345)
T ss_dssp ------CHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred cccccccHHHHHHHHHcCCCC---CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence 3445566777766654 356799999999999999999999965 24699999999999999999765 5
Q ss_pred CCccCCCCCCCCCCCcccccc
Q 002953 753 AAFVPTSESALDTSYFTSRYS 773 (863)
Q Consensus 753 ppfvP~~~s~lDts~F~s~~s 773 (863)
|||+|...+..|+++|+..+.
T Consensus 294 ~p~~p~~~~~~~~~~~~~~~~ 314 (345)
T 3a8x_A 294 PPFKPNISGEFGLDNFDSQFT 314 (345)
T ss_dssp CSCCCCCCTTTCGGGSCHHHH
T ss_pred CCcCCCCCCcchhhhcCcccc
Confidence 899999999999999987553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=438.60 Aligned_cols=258 Identities=24% Similarity=0.435 Sum_probs=189.7
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----------
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRE---------- 522 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---------- 522 (863)
|.+ ..||+|+||+|+.+. +++|+..... ....+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 444 499999999997652 4555544332 334567899999999999999999999997654
Q ss_pred --eEEEEEeecCCCChHHHHHhcCCCC---hhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 523 --NLYLVMEYLNGGDLYSLLRNLGCLD---EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 523 --~lyLVmEy~~GGsL~dlLk~~g~L~---e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
++|||||||+||+|.+++...+.++ +..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 4799999999999999998776544 45688999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
......... +............+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 167 ~~~~~~~~~-------------------~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 167 AMDQDEEEQ-------------------TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp --------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ecCCCcccc-------------------ccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 532110000 00000011123456799999999999999999999999999999999996
Q ss_pred CCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 678 PPFNAEHP-QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 678 ~PF~~~~~-~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
||..... ...+..+.. ..+|..+...++.+.+||.+||++||.+|| |+.++|+||||++++|.
T Consensus 226 -Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAINIIENAVFEDLDFP 289 (299)
T ss_dssp -CCSSHHHHHHHHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGCCC---
T ss_pred -CCCCccHHHHHHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCCCCCC
Confidence 7865432 223333333 233433345677889999999999999999 99999999999999994
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=475.86 Aligned_cols=280 Identities=33% Similarity=0.702 Sum_probs=245.1
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
..+|.+. +||+|+||+|+.+. |++++.........+.+..|+.+|..+ +||||++++++|++.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 3456655 99999999996542 334444444556677889999999987 79999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||++||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~---- 495 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD---- 495 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT----
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC----
Confidence 9999999999999999899999999999999999999999999999999999999999999999999999842110
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..
T Consensus 496 ---------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 496 ---------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp ---------------------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 11234678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESA 762 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~ 762 (863)
+++..|+.....+ +..+++++.+||++||++||.+||++ .++++|++||||++++|+.+... .|||+|....
T Consensus 549 ~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~- 624 (674)
T 3pfq_A 549 ELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG- 624 (674)
T ss_dssp HHHHHHHSSCCCC---CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-
T ss_pred HHHHHHHhCCCCC---CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-
Confidence 9999999887654 46799999999999999999999965 45699999999999999999765 5999999887
Q ss_pred CCCCCcccccc
Q 002953 763 LDTSYFTSRYS 773 (863)
Q Consensus 763 lDts~F~s~~s 773 (863)
.|+++|+..|.
T Consensus 625 ~~~~~f~~~~~ 635 (674)
T 3pfq_A 625 RNAENFDRFFT 635 (674)
T ss_dssp GGHHHHTTTTT
T ss_pred CchhhcCchhc
Confidence 88999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=427.68 Aligned_cols=275 Identities=37% Similarity=0.719 Sum_probs=233.1
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||+|+.+. |++++.........+.+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 3455554 99999999996542 333343344445667889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~------- 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------- 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-------
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999997410
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
....+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...
T Consensus 158 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 158 ---------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp ---------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 11235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCC-C
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES-A 762 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s-~ 762 (863)
++.++......+ +..++.++.+||.+||..||.+||+. .+++++++||||++++|+.+..+ .+||+|.... .
T Consensus 211 ~~~~i~~~~~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~ 287 (318)
T 1fot_A 211 TYEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQ 287 (318)
T ss_dssp HHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC----
T ss_pred HHHHHHhCCCCC---CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCc
Confidence 999998877654 46789999999999999999999976 38999999999999999999765 5899999874 7
Q ss_pred CCCCCccc
Q 002953 763 LDTSYFTS 770 (863)
Q Consensus 763 lDts~F~s 770 (863)
.|+++|+.
T Consensus 288 ~d~~~f~~ 295 (318)
T 1fot_A 288 GDTSQFDK 295 (318)
T ss_dssp --------
T ss_pred cchhhcCC
Confidence 88888875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=447.46 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=209.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~l 524 (863)
+|.+. .||+|+||+|+.+. +++|+.. .......+.+++|+++|+.|+|||||++++++... +.+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 45554 99999999997652 3444432 22334556789999999999999999999998753 579
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|||||||+ |+|.+++.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~- 212 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP- 212 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-----
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc-
Confidence 99999995 6899999988999999999999999999999999999999999999999999999999999998421100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.
T Consensus 213 --------------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 213 --------------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp -----------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred --------------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 0011234568999999999999885 4699999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCC--------------------C--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 684 HPQQIFDNILNRKIPWP--------------------R--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p--------------------~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+..+++..|.......+ . +...+++++.+||.+||++||.+|| ||+|+|
T Consensus 267 ~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L 343 (398)
T 4b99_A 267 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI---SAAAAL 343 (398)
T ss_dssp SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC---CHHHHT
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc---CHHHHh
Confidence 99998888865322111 0 1135789999999999999999999 999999
Q ss_pred cCCCCCCCCh
Q 002953 736 QHVFFKDINW 745 (863)
Q Consensus 736 qHPFFk~IdW 745 (863)
+||||+....
T Consensus 344 ~Hp~f~~~~~ 353 (398)
T 4b99_A 344 RHPFLAKYHD 353 (398)
T ss_dssp TSGGGTTTCC
T ss_pred cCHhhCcCCC
Confidence 9999997653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=430.56 Aligned_cols=274 Identities=38% Similarity=0.750 Sum_probs=242.3
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..+|.+. .||+|+||.|+.+. |++++.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4556654 99999999996542 233333344445667899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~------- 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------- 192 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-------
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999998410
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 193 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 245 (350)
T 1rdq_E 193 ---------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245 (350)
T ss_dssp ---------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH
Confidence 11235689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESAL 763 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~l 763 (863)
++.++..+...+ +..++.++.+||.+||+.||.+||+. .++++|++||||++++|..+... .|||+|......
T Consensus 246 ~~~~i~~~~~~~---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~ 322 (350)
T 1rdq_E 246 IYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPG 322 (350)
T ss_dssp HHHHHHHCCCCC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTT
T ss_pred HHHHHHcCCCCC---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcc
Confidence 999998887654 46799999999999999999999963 35999999999999999999755 589999999999
Q ss_pred CCCCcc
Q 002953 764 DTSYFT 769 (863)
Q Consensus 764 Dts~F~ 769 (863)
|+++|+
T Consensus 323 ~~~~f~ 328 (350)
T 1rdq_E 323 DTSNFD 328 (350)
T ss_dssp CCTTSC
T ss_pred cccccc
Confidence 999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=440.05 Aligned_cols=274 Identities=28% Similarity=0.407 Sum_probs=198.1
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLV 527 (863)
..|.+. .||+|+||+|+.+. +++|+ +........+.+|+++|+.+ +|||||+++++|++.+++|||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~--i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKH--LIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEE--ECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEE--EccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 346665 99999999997652 23332 23334456788999999998 699999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+||+|.++++ .+++..++.|+.||+.||+|||++|||||||||+|||++.+ +++||+|||+|+.........
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~ 175 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGG
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccc
Confidence 99999999999984 59999999999999999999999999999999999999877 899999999998522111000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCC-CC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNA-EH 684 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~-~~ 684 (863)
... ..+... ....................+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.. .+
T Consensus 176 ~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 176 LKF--VQSEAQ-QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp GGG--C---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccc--cccccc-ccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 000 000000 0000000000000112234567999999999999875 589999999999999999999999954 44
Q ss_pred hHHHHHHHhhc--------------------------------------CCCCC-------------CCCCCCCHHHHHH
Q 002953 685 PQQIFDNILNR--------------------------------------KIPWP-------------RVPEEMSPEAHDL 713 (863)
Q Consensus 685 ~~el~~kIl~~--------------------------------------~~~~p-------------~~p~~iS~el~dL 713 (863)
..+.+..|... ....| .....+|+++.||
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 44444443320 00000 1234689999999
Q ss_pred HHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 714 IDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 714 I~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
|++||+.||.+|+ ||+|+|+||||++++
T Consensus 333 l~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 333 LDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred HHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 9999999999999 999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=429.61 Aligned_cols=236 Identities=23% Similarity=0.376 Sum_probs=204.4
Q ss_pred Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||+|+.+. +++|..........+.+.+|+++|++|+|||||++++++.+++.+|||||||+|
T Consensus 20 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~ 99 (299)
T 4asz_A 20 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 99 (299)
T ss_dssp EEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCC
Confidence 89999999997642 455555545556677899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 534 GDLYSLLRNL-------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 534 GsL~dlLk~~-------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
|+|.++|.+. ..+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+...
T Consensus 100 G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 179 (299)
T 4asz_A 100 GDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179 (299)
T ss_dssp CBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred CcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecC
Confidence 9999999764 359999999999999999999999999999999999999999999999999998421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~P 679 (863)
.. .........+||+.|||||++.+..|+.++|||||||+||||+| |++|
T Consensus 180 ~~-----------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~P 230 (299)
T 4asz_A 180 ST-----------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230 (299)
T ss_dssp GG-----------------------------GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CC-----------------------------CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 00 00112234579999999999999999999999999999999998 9999
Q ss_pred CCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 680 FNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
|.+.+..+++..+..+.. +..|..+|+++.+||.+||+.||.+|| |+.+|.
T Consensus 231 f~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RP---s~~~i~ 281 (299)
T 4asz_A 231 WYQLSNNEVIECITQGRV--LQRPRTCPQEVYELMLGCWQREPHMRK---NIKGIH 281 (299)
T ss_dssp TTTSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 999999999999887764 345788999999999999999999999 899984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=430.37 Aligned_cols=238 Identities=26% Similarity=0.386 Sum_probs=202.3
Q ss_pred Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.||+|+||+|+.+. +++|..........+.+.+|+++|++|+|||||++++++.+.+.+|||||||+|
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~ 127 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 89999999997642 455655545556677899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc---------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 534 GDLYSLLRNL---------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 534 GsL~dlLk~~---------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
|+|.++|++. +++++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+.
T Consensus 128 G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~ 207 (329)
T 4aoj_A 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207 (329)
T ss_dssp CBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred CcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEccccccee
Confidence 9999999753 3589999999999999999999999999999999999999999999999999984
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk 677 (863)
.... .........+||+.|||||++.+..|+.++|||||||+||||+| |+
T Consensus 208 ~~~~-----------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~ 258 (329)
T 4aoj_A 208 IYST-----------------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258 (329)
T ss_dssp -----------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCC-----------------------------CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCC
Confidence 2110 00112235689999999999999999999999999999999999 99
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.||.+.+..+++..+..+.. +..|..+|+++.+||.+||+.||++|| |+.+|+++
T Consensus 259 ~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RP---s~~ei~~~ 313 (329)
T 4aoj_A 259 QPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRH---SIKDVHAR 313 (329)
T ss_dssp CTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSC---CHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCc---CHHHHHHH
Confidence 99999999999988877653 345778999999999999999999999 99999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=461.87 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=221.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.+|.+. .||+|+||+|+.+. +++|..........+.+.+|+.+|+.|+|||||+++++|++++.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 456665 89999999997652 3455444344455678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC--CcEEEeecCCccccccCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~--g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+||+|.++|.. .+.|++..++.|++||+.||+|||++||+||||||+|||++.+ +++||+|||+|+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~------- 309 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------- 309 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT-------
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC-------
Confidence 99999999964 4679999999999999999999999999999999999999864 8999999999985210
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..++
T Consensus 310 -------------------------~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 310 -------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp -------------------------TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred -------------------------CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 1223457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 689 FDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 689 ~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
+.+|......++. .+..+|+++++||.+||++||.+|| |+.|+|+||||+..+|...
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCCTTT
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCCCCc
Confidence 9999887765543 3467999999999999999999999 9999999999999888543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=440.05 Aligned_cols=282 Identities=40% Similarity=0.739 Sum_probs=231.2
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
....|.+. +||+|+||.|+.+. |++++...........+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 34456655 99999999997542 23333333344556778899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||++||+|..++...+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++++||+|||+|+....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---- 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK---- 301 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC----
Confidence 99999999999999988899999999999999999999998 9999999999999999999999999999874110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.
T Consensus 302 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 302 ---------------------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp --------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 01123457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES 761 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s 761 (863)
..++..+......+ +..+++++.+||.+||..||.+||+. .+++++++||||++++|+.+... .|||.|...+
T Consensus 355 ~~~~~~i~~~~~~~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~ 431 (446)
T 4ejn_A 355 EKLFELILMEEIRF---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTS 431 (446)
T ss_dssp HHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSS
T ss_pred HHHHHHHHhCCCCC---CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCC
Confidence 99999988877654 46799999999999999999999965 48999999999999999998765 4899999999
Q ss_pred CCCCCCcccccc
Q 002953 762 ALDTSYFTSRYS 773 (863)
Q Consensus 762 ~lDts~F~s~~s 773 (863)
..|+++|++.|+
T Consensus 432 ~~~~~~~~~~~~ 443 (446)
T 4ejn_A 432 ETDTRYFDEEFT 443 (446)
T ss_dssp TTCCTTC-----
T ss_pred ccchhhcchhhh
Confidence 999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=416.42 Aligned_cols=281 Identities=38% Similarity=0.741 Sum_probs=220.7
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhh---hhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKA---DMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCREN 523 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~---~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 523 (863)
...|.+. +||+|+||.|+.+. +++|.. ... .......+.+|+.+|+.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 3456554 99999999997432 222221 111 22344568899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~-- 173 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-- 173 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999873110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 174 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 174 -----------------------------DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp ----------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------------------------CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 011234568999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCccCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVPTS 759 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~ 759 (863)
+....+..+......+ +..++.++.+||.+||..||.+||++. ++.++++||||++++|+.+... .|||.|..
T Consensus 225 ~~~~~~~~i~~~~~~~---p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~ 301 (327)
T 3a62_A 225 NRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLL 301 (327)
T ss_dssp SHHHHHHHHHHTCCCC---CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC-
T ss_pred CHHHHHHHHHhCCCCC---CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCc
Confidence 9999999988876544 467899999999999999999999874 8999999999999999998765 58999999
Q ss_pred CCCCCCCCcccccc
Q 002953 760 ESALDTSYFTSRYS 773 (863)
Q Consensus 760 ~s~lDts~F~s~~s 773 (863)
.+..|.++|+..+.
T Consensus 302 ~~~~~~~~~~~~~~ 315 (327)
T 3a62_A 302 QSEEDVSQFDSKFT 315 (327)
T ss_dssp --------------
T ss_pred CChhhhhhcchhhh
Confidence 99899988887543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=421.72 Aligned_cols=240 Identities=19% Similarity=0.293 Sum_probs=194.7
Q ss_pred EEeecccceeecccc----ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 465 LLAGKGALSEHDDFP----QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
..||+|+||+|+.+. +++|.... ......+.+.+|+.+|++++|||||++++++. ++.+|||||||+||+|.+
T Consensus 42 ~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~ 120 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYK 120 (307)
T ss_dssp EECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHH
T ss_pred eEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHH
Confidence 389999999997652 33443322 23456678999999999999999999999765 567999999999999999
Q ss_pred HHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 539 LLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 539 lLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+|... +.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 121 ~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~--------------- 185 (307)
T 3omv_A 121 HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW--------------- 185 (307)
T ss_dssp HHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------------------
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC---------------
Confidence 99764 57999999999999999999999999999999999999999999999999999842100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+.+||+.|||||++.+. .|+.++|||||||+||||+||++||.+.+....+..++.
T Consensus 186 --------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~ 251 (307)
T 3omv_A 186 --------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG 251 (307)
T ss_dssp ----------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred --------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 001223457899999999999753 589999999999999999999999988776655555554
Q ss_pred cCCCC---CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 695 RKIPW---PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 695 ~~~~~---p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..... +..+..+|+++.+||.+||+.||.+|| |+.+|+++
T Consensus 252 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 294 (307)
T 3omv_A 252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQILSS 294 (307)
T ss_dssp TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHHHH
T ss_pred cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 43333 345678999999999999999999999 88877543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=419.63 Aligned_cols=238 Identities=21% Similarity=0.317 Sum_probs=203.7
Q ss_pred Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 466 LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 466 vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.||+|+||+|+.+. +++|..... .....+.+.+|+.+|++|+|||||++++++.+++.+|||||||+
T Consensus 33 ~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~ 112 (308)
T 4gt4_A 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 112 (308)
T ss_dssp EEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCS
T ss_pred EeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCC
Confidence 89999999997642 344443222 22345789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 533 GGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 533 GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
+|+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|
T Consensus 113 ~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGla 192 (308)
T 4gt4_A 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192 (308)
T ss_dssp SCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCB
T ss_pred CCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccc
Confidence 99999999643 35899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV- 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT- 675 (863)
+..... .........+||+.|||||++.+..|+.++|||||||+||||+|
T Consensus 193 r~~~~~-----------------------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~ 243 (308)
T 4gt4_A 193 REVYAA-----------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243 (308)
T ss_dssp CGGGGG-----------------------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eeccCC-----------------------------CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhC
Confidence 842110 00112345689999999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|.+||.+.+..+++..+..+.. +..|..+|+++.+|+.+||+.||.+|| |+.+|+++
T Consensus 244 g~~Pf~~~~~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~C~~~dP~~RP---s~~ei~~~ 300 (308)
T 4gt4_A 244 GLQPYCGYSNQDVVEMIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRP---RFKDIHSR 300 (308)
T ss_dssp TCCTTTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCcccchHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 8999999999999988877654 345788999999999999999999999 89988865
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=423.22 Aligned_cols=266 Identities=30% Similarity=0.644 Sum_probs=225.5
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
....|.+. +||+|+||.|+.+. |++.+...........+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34566655 99999999996542 23334444455567789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+.||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~----- 167 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----- 167 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...
T Consensus 168 ---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 168 ---------------------------ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp ---------------------------TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred ---------------------------CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 112345789999999999974 45899999999999999999999999743
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc--cCCccCC
Q 002953 684 ---HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ--KAAFVPT 758 (863)
Q Consensus 684 ---~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~ 758 (863)
...+++..+...... ++..++.++.+||.+||+.||.+||+ +++++++||||++++|+.+... .|||+|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 221 SSTSSKEIVHTFETTVVT---YPSAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp TTSCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred CCccHHHHHHHHhhcccC---CCCcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 445555555554443 45679999999999999999999994 4999999999999999999765 4899997
Q ss_pred CC
Q 002953 759 SE 760 (863)
Q Consensus 759 ~~ 760 (863)
..
T Consensus 296 ~~ 297 (384)
T 4fr4_A 296 KG 297 (384)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=444.01 Aligned_cols=267 Identities=31% Similarity=0.620 Sum_probs=227.3
Q ss_pred ccceE-EEeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDL-LLAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+ .+||+|+||+|+.+. |++++...........+.+|+.+|++++||||++++++|++...+||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34444 489999999996542 3333333444455678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 529 EYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||++||+|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~-- 342 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-- 342 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC--
Confidence 999999999999764 36999999999999999999999999999999999999999999999999999842100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE- 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~- 683 (863)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 343 -----------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 343 -----------------------------QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp -----------------------------CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred -----------------------------CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 01123468999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCcc
Q 002953 684 ---HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFV 756 (863)
Q Consensus 684 ---~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfv 756 (863)
...++...+......+ +..++.++.+||.+||+.||.+||+. .++++|++||||++++|+.+... .|||+
T Consensus 394 ~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~ 470 (543)
T 3c4z_A 394 EKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFV 470 (543)
T ss_dssp CCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred cchhHHHHHHHHhhcccCC---CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCC
Confidence 3467777777766543 56799999999999999999999976 36899999999999999999864 58999
Q ss_pred CCCC
Q 002953 757 PTSE 760 (863)
Q Consensus 757 P~~~ 760 (863)
|...
T Consensus 471 P~~~ 474 (543)
T 3c4z_A 471 PDSR 474 (543)
T ss_dssp CCSS
T ss_pred CCcc
Confidence 9864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=415.54 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=198.7
Q ss_pred cceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeC-CeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISVRN-PFVVRFFYSFTCR-ENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~-~~l 524 (863)
++.+. .||+|+||+|+.+. +++|.... ......+.+.+|+++|.+++| ||||++++++... +.+
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 44444 89999999997642 22333221 123445679999999999965 9999999998764 579
Q ss_pred EEEEeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcE
Q 002953 525 YLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHI 588 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~V 588 (863)
|||||||+||+|.++|++. ..+++..+..|+.||+.||+|||+++||||||||+|||++.++++
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCE
Confidence 9999999999999999753 248899999999999999999999999999999999999999999
Q ss_pred EEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhH
Q 002953 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668 (863)
Q Consensus 589 KLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGv 668 (863)
||+|||+|+...... ......+.+||+.|||||++.+..|+.++|||||||
T Consensus 225 Ki~DFGlar~~~~~~-----------------------------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv 275 (353)
T 4ase_A 225 KICDFGLARDIYKDP-----------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 275 (353)
T ss_dssp EECCCGGGSCTTTCT-----------------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred EECcchhhhhcccCC-----------------------------CceeeccccccccccCHHHHhcCCCCCcccEeehHH
Confidence 999999998421100 011234568999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 669 ILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 669 ILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+||||+| |.+||.+.+..+.+.+++..... +..|..+++++.+||.+||+.||.+|| |+.+|++|
T Consensus 276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RP---t~~eil~~ 341 (353)
T 4ase_A 276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 341 (353)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCc---CHHHHHHH
Confidence 9999998 99999887654444444433322 345778999999999999999999999 99999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=433.66 Aligned_cols=267 Identities=33% Similarity=0.585 Sum_probs=226.5
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. +||+|+||.|+.+. |++.+..+........+.+|+.+|..++|||||+++++|++.+.+|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3445544 99999999996542 333333444455567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
|||++||+|.+++...+. +++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~---- 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---- 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT----
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc----
Confidence 999999999999987544 99999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH- 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~- 684 (863)
.......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+
T Consensus 339 ----------------------------~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 339 ----------------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp ----------------------------TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred ----------------------------CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 011234689999999999999999999999999999999999999998753
Q ss_pred ---hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCccC
Q 002953 685 ---PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAFVP 757 (863)
Q Consensus 685 ---~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppfvP 757 (863)
...+...+...... ++..+++++.+||.+||+.||.+||++. ++++|++||||++++|+.+... .|||+|
T Consensus 391 ~~~~~~i~~~i~~~~~~---~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 391 KIKREEVERLVKEVPEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp CCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred chhHHHHHHHhhccccc---CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCC
Confidence 45566666655543 3567999999999999999999999763 8999999999999999999864 589999
Q ss_pred CCC
Q 002953 758 TSE 760 (863)
Q Consensus 758 ~~~ 760 (863)
...
T Consensus 468 ~~~ 470 (576)
T 2acx_A 468 DPQ 470 (576)
T ss_dssp CCC
T ss_pred Ccc
Confidence 764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=395.69 Aligned_cols=249 Identities=30% Similarity=0.544 Sum_probs=216.5
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
....|.+. .||+|+||.|+.+. +++|... .......+.+.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 44556665 99999999996542 3444322 22345567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~------ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV------ 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS------
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC------
Confidence 99999999999998889999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCC-ccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-TTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys-~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..
T Consensus 167 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 167 --------------------------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp --------------------------SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 0122356899999999999988874 8999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
++...+..+...+ |..+++++.+||++||..||.+|| |++++++||||+...
T Consensus 221 ~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 221 ELRERVLRGKYRI---PFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCCCC---CTTSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTTC
T ss_pred HHHHHHHhCCCCC---CCCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCCC
Confidence 9999998877654 456899999999999999999999 999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=402.89 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=219.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc------hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR------KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~------k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 45554 99999999996542 2333222111 1135678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEEeecCCccccccC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLIN 602 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiDFGLAk~~~~~ 602 (863)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++....
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~- 171 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED- 171 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC-
Confidence 999999999999998888899999999999999999999999999999999999998876 799999999974210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 172 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 172 -------------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp -------------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred -------------------------------CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 0122356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc
Q 002953 683 EHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 751 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~ 751 (863)
.+..+++..+......++. .+..+++++++||.+||..||.+|| |+.++++||||+.++|......
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~ 287 (361)
T 2yab_A 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDTQQAMVR 287 (361)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTSCSSHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcCcCCCchhhhhhc
Confidence 9999999999887765542 2357899999999999999999999 9999999999999999776543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=394.27 Aligned_cols=277 Identities=39% Similarity=0.748 Sum_probs=223.9
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhh---hh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKAD---MI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRE 522 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~---i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~ 522 (863)
...|.+. .||+|+||.|+.+. +++|... .. .....+.+.+|+.+|..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 3456655 89999999997542 2233221 11 123345677899999999 6999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
.+||||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~- 211 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA- 211 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG-
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 212 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 212 -----------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp -----------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 00112335689999999999986 34789999999999999999999999
Q ss_pred CCC----ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhcc--
Q 002953 681 NAE----HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK-- 752 (863)
Q Consensus 681 ~~~----~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~~-- 752 (863)
... ....+...+..... .++..++..+.+||.+||..||.+||+.. +++++++||||+.++|+.+...+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~ 339 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILKSEP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 339 (355)
T ss_dssp SCTTSCCCHHHHHHHHHHCCC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ccCCccchHHHHHHHHhccCC---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCC
Confidence 743 33445555555443 34577999999999999999999999764 99999999999999999998764
Q ss_pred CCccCCCCCCCCCCCc
Q 002953 753 AAFVPTSESALDTSYF 768 (863)
Q Consensus 753 ppfvP~~~s~lDts~F 768 (863)
+||.|......|.++|
T Consensus 340 ~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 340 APFKPVIRDELDVSNF 355 (355)
T ss_dssp CSCCCCCCC-CCC---
T ss_pred CCCCCccccccccccC
Confidence 7999999888888776
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.64 Aligned_cols=245 Identities=33% Similarity=0.559 Sum_probs=212.7
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||+|+||+|+.+. +++|..........+.+.+|+.+|+.++||||++++++|...+.+|+||||++||+|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 3489999999997652 455554444445567789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------- 169 (297)
T 3fxz_A 105 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------- 169 (297)
T ss_dssp HHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--------------
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--------------
Confidence 999976 46999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 170 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 170 -----------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp -----------------TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred -----------------ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 012235689999999999999999999999999999999999999999988887777776655
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
......+..++..+.+||.+||+.||.+|| |+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp SCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 444445677999999999999999999999 99999999999854
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=382.78 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=216.5
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc------hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR------KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~------k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34444 89999999996642 2333222111 1135678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEEeecCCccccccC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLIN 602 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiDFGLAk~~~~~ 602 (863)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~- 170 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 170 (326)
T ss_dssp EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT-
T ss_pred EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC-
Confidence 999999999999998888899999999999999999999999999999999999999887 899999999974210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+
T Consensus 171 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 171 -------------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp -------------------------------TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred -------------------------------CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 0112346799999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhh
Q 002953 683 EHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~ 750 (863)
.+..+.+..+......++. .+..++..+.+||.+||..||.+|| |+.++++||||+..+|.....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~~~~~ 285 (326)
T 2y0a_A 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALS 285 (326)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTSCCSHHHHHH
T ss_pred CCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCccCCcchhhhh
Confidence 9988888888776554432 2356899999999999999999999 999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=382.61 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=203.5
Q ss_pred cccceEE-Eeecccceeecccc------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..+|.+. .||+|+||+|+.+. +++|+.... .......+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3456554 99999999997653 344433222 22334678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~------ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP------ 172 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC------
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC------
Confidence 9975 888888664 45999999999999999999999999999999999999999999999999999742100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....+
T Consensus 173 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 173 -------------------------VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp -------------------------CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred -------------------------cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 011234578999999999987 568999999999999999999999998877766
Q ss_pred HHHHHhhcCCC-----C----------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 688 IFDNILNRKIP-----W----------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 688 l~~kIl~~~~~-----~----------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+..+...... + ......+++++.+||.+||+.||.+|| |++++++||||
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f 304 (311)
T 3niz_A 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI---SARDAMNHPYF 304 (311)
T ss_dssp HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC---CHHHHhcCccc
Confidence 66665431100 0 001235788999999999999999999 99999999999
Q ss_pred CCCChh
Q 002953 741 KDINWD 746 (863)
Q Consensus 741 k~IdW~ 746 (863)
++++++
T Consensus 305 ~~~~~~ 310 (311)
T 3niz_A 305 KDLDPQ 310 (311)
T ss_dssp TTSCTT
T ss_pred ccCCcc
Confidence 998864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=382.29 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=200.6
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
....|.+. .||+|+||+|+.+. +++|..... .......+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 44556655 99999999997652 344433222 222345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec-----CCCcEEEeecCCccccccC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-----HDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd-----~~g~VKLiDFGLAk~~~~~ 602 (863)
|||++| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~- 189 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI- 189 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC-
Confidence 999975 9999999888899999999999999999999999999999999999995 445699999999874210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 190 ------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 239 (329)
T 3gbz_A 190 ------------------------------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP 239 (329)
T ss_dssp ----------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ------------------------------cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 01122345789999999999874 48999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCC-----C-------------CCC---------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 682 AEHPQQIFDNILNRKIP-----W-------------PRV---------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~-----~-------------p~~---------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
+.+..+.+..+...... + +.. +..+++++.+||.+||+.||.+|| |+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~ 316 (329)
T 3gbz_A 240 GDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI---SAKNA 316 (329)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC---CHHHH
Confidence 98888777776543110 0 000 011689999999999999999999 99999
Q ss_pred HcCCCCCCCChh
Q 002953 735 KQHVFFKDINWD 746 (863)
Q Consensus 735 LqHPFFk~IdW~ 746 (863)
|+||||++++|+
T Consensus 317 l~hp~f~~~~~~ 328 (329)
T 3gbz_A 317 LEHPYFSHNDFD 328 (329)
T ss_dssp HTSGGGSSSCSC
T ss_pred hCCcccCCCCCC
Confidence 999999999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=384.43 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=211.7
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. .++|... ........+.+|+.+|+.++||||+++++++.+.+.+|+|||||+
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-CCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEe-cCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 45544 89999999997652 2333322 233455678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC--CCcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~--~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-------- 156 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-------- 156 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--------
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--------
Confidence 99999999765 46999999999999999999999999999999999999987 78999999999974210
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++
T Consensus 157 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 212 (321)
T 1tki_A 157 ------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp ------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH
Confidence 01123467999999999999988999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+......++. ....++.++.+||.+||..||.+|| |+.++|+||||+..
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~ 264 (321)
T 1tki_A 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHSC
T ss_pred HHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhccC
Confidence 999887765442 1246899999999999999999999 99999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=385.31 Aligned_cols=237 Identities=21% Similarity=0.282 Sum_probs=177.5
Q ss_pred Eeecccceeecccc-----ceehhhhhhchhHHHHHH--HHHHHHHhcCCCCeeEEEEEEEeCC----eEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-----QVLKKADMIRKNAVESIL--AERDILISVRNPFVVRFFYSFTCRE----NLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l--~Ei~IL~~L~HPnIVkL~~~f~d~~----~lyLVmEy~~GG 534 (863)
.||+|+||+|+.+. +++|+.. ......+. .|+.++.+++|||||++++++..++ .+|||||||+||
T Consensus 10 ~iG~G~fG~Vy~~~~~g~~VAvK~l~---~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 10 SIGKGRFGEVWRGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECSSSEEEEEEETTEEEEEEEEC---GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCEEEEEEEEC---ccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 89999999997652 3444332 22233333 4555567889999999999998764 589999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC--------CccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~--------GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+|.++|+. ..++++.+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|+.......
T Consensus 87 sL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-- 163 (303)
T 3hmm_A 87 SLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD-- 163 (303)
T ss_dssp BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT--
T ss_pred cHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC--
Confidence 99999986 5689999999999999999999987 999999999999999999999999999985211000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC------CCCccceeechhHHHHHHHhCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~------~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.........+||+.|||||++.+. .|+.++|||||||+||||+||.+||
T Consensus 164 -------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~ 218 (303)
T 3hmm_A 164 -------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp -------------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred -------------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence 000122346899999999999765 3577999999999999999998766
Q ss_pred CCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAE---------------HPQQIFDNILNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~---------------~~~el~~kIl~~~~~~p~~p~~-----iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
... ....+...+..... .|.+|.. .+..+.+|+.+||+.||.+|| |+.+|++.
T Consensus 219 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ei~~~ 291 (303)
T 3hmm_A 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARL---TALRIKKT 291 (303)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC---CHHHHHHH
T ss_pred CccccccccchhcccccchHHHHHHHHhcccC-CCCCCccccchHHHHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 321 22334444443332 2333322 335788999999999999999 89998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=386.05 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=212.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
.|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 45554 89999999997542 33333221 2334567789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCccccccCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~~~~~s~~dl 607 (863)
++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~------ 183 (362)
T 2bdw_A 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------ 183 (362)
T ss_dssp CCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT------
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC------
Confidence 99999999998888899999999999999999999999999999999999998654 599999999874110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...
T Consensus 184 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 184 --------------------------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp --------------------------CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 011234689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 688 IFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 688 l~~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
++..+..+...++.. ...+++++.+||.+||..||.+|| ++.++|+||||..
T Consensus 238 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 238 LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHT
T ss_pred HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCC
Confidence 999988877665432 246899999999999999999999 9999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=384.77 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=205.5
Q ss_pred CCcccceEE-Eeecc--cceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 457 PRTSQIDLL-LAGKG--ALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 457 ~~~~~~~l~-vLGkG--~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
+....|.+. .||+| +||.|+.+. +++|.... ......+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 345566665 99999 999996552 34443322 2345567888999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 525 YLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999999999999875 67999999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.... ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 182 ~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 182 GQRQ------------------------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp TEEC------------------------SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccc------------------------cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 0000 000012234589999999999988 67899999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCC-------------------------------------------CCCCCCCCCHHHHHHHHhh
Q 002953 681 NAEHPQQIFDNILNRKIP-------------------------------------------WPRVPEEMSPEAHDLIDRF 717 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~-------------------------------------------~p~~p~~iS~el~dLI~k~ 717 (863)
.+.+....+..+..+..+ ....+..+++++.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 887665555444332211 0113456889999999999
Q ss_pred ccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 718 LTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 718 L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
|+.||.+|| |+.++|+||||+.+.|.
T Consensus 318 L~~dP~~Rp---ta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 318 LQRNPDARP---SASTLLNHSFFKQIKRR 343 (389)
T ss_dssp TCSCTTTSC---CHHHHTTSGGGGGC---
T ss_pred hhcCcccCC---CHHHHhcCHHHHHHhhc
Confidence 999999999 99999999999988774
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=394.63 Aligned_cols=248 Identities=30% Similarity=0.507 Sum_probs=211.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
.|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|+.++|||||++++++.+.+.+|+||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 45544 99999999997652 23332221 2234456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccccCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 92 ~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~----- 166 (444)
T 3soa_A 92 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE----- 166 (444)
T ss_dssp CBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-----
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-----
Confidence 999999999998889999999999999999999999999999999999999984 578999999999742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 167 --------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 167 --------------------------QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp --------------------------CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred --------------------------CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 011234689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 688 IFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 688 l~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
++..+..+...++. ....+++++.+||.+||+.||.+|| |+.++|+||||+.
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 221 LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 99999888766553 2357899999999999999999999 9999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=369.05 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=199.4
Q ss_pred ceE-EEeecccceeecccc------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 462 IDL-LLAGKGALSEHDDFP------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
|.+ ..||+|+||.|+.+. +++|+..... ......+.+|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 444 499999999997652 3444433222 2234678899999999999999999999999999999999997
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 152 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI---------- 152 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc----------
Confidence 6 999998764 6799999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus 153 ---------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (288)
T 1ob3_A 153 ---------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (288)
T ss_dssp ------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------cccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00112345789999999999764 58999999999999999999999999988777776
Q ss_pred HHhhcCC-----CC---------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 691 NILNRKI-----PW---------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 691 kIl~~~~-----~~---------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
.+..... .+ ......+++++.+||.+||+.||.+|| |+.++++||||++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYFKENN 288 (288)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSGGGGC--
T ss_pred HHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC---CHHHHhcCcchhhcC
Confidence 6654110 00 112245889999999999999999999 999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=366.97 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=199.6
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+|.+. .||+|+||+|+.+. +++|.... ........+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 34444 99999999996552 34443322 2334456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+++ +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~------- 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP------- 154 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-------
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-------
Confidence 976 66665544 578999999999999999999999999999999999999999999999999999742100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCC-CCCCChHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPP-FNAEHPQQ 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~P-F~~~~~~e 687 (863)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+
T Consensus 155 ------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 155 ------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ------------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ------------------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 01223467999999999998766 79999999999999999987766 56666666
Q ss_pred HHHHHhhcCCC--------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 688 IFDNILNRKIP--------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 688 l~~kIl~~~~~--------------------------~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.+..+...... .......++.++.+||.+||+.||.+|| |++|+++||||+
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~ 287 (292)
T 3o0g_A 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPYFS 287 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGT
T ss_pred HHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC---CHHHHhcCcccc
Confidence 66666542110 0112235789999999999999999999 999999999998
Q ss_pred CC
Q 002953 742 DI 743 (863)
Q Consensus 742 ~I 743 (863)
++
T Consensus 288 ~~ 289 (292)
T 3o0g_A 288 DF 289 (292)
T ss_dssp TC
T ss_pred cC
Confidence 75
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=372.20 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=217.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhch------hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRK------NAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k------~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
..|.+. .||+|+||.|+.+. +++|....... ...+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345554 89999999996552 23333221111 13567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEEeecCCcccccc
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLI 601 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiDFGLAk~~~~ 601 (863)
+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999999888899999999999999999999999999999999999999887 799999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 172 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 172 --------------------------------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp --------------------------------TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred --------------------------------cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 011234579999999999999999999999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhc
Q 002953 682 AEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 751 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~ 751 (863)
+.+..+.+..+......++. .+..++..+.+||.+||..||.+|| |+.++++||||+.++|......
T Consensus 220 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp CSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTTTSCSSHHHHHHH
T ss_pred CCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCccccCCCccccccc
Confidence 99988888888776554331 2356899999999999999999999 9999999999999999776543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=380.75 Aligned_cols=248 Identities=32% Similarity=0.558 Sum_probs=196.6
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
...+|.+. .||+|+||.|+.+. +++|.... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEES-STTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEec-CccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 34456655 99999999986542 34443321 22233568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc--EEEeecCCccccccCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~--VKLiDFGLAk~~~~~s~~dl 607 (863)
|++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~------ 170 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------ 170 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc------
Confidence 9999999999988889999999999999999999999999999999999999987765 99999999873110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCcc-ceeechhHHHHHHHhCCCCCCCCCh-
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT-ADWWSVGIILFELIVGIPPFNAEHP- 685 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k-sDIWSLGvILyELLTGk~PF~~~~~- 685 (863)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+...
T Consensus 171 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 171 --------------------------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp ------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred --------------------------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 011234679999999999998888655 8999999999999999999976443
Q ss_pred ---HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 686 ---QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 686 ---~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
......+......++. ...+++++.+||.+||..||.+|| |+.++++||||..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~ 280 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRI---SIPEIKTHSWFLK 280 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHHHHT
T ss_pred HHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcchhc
Confidence 4555566555554443 346899999999999999999999 9999999999953
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=386.45 Aligned_cols=245 Identities=29% Similarity=0.553 Sum_probs=205.7
Q ss_pred cccceEE-Eeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||+|+.+. +++|. ...........+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4556655 99999999996553 23332 2222233345788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~------ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD------ 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT------
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC------
Confidence 9999 789999998888999999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....
T Consensus 161 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 161 --------------------------GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp --------------------------SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred --------------------------CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 112245689999999999998876 78999999999999999999999887665
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.++..+..... ..+..+++++.+||.+||..||.+|| |++++++||||+.
T Consensus 215 ~~~~~i~~~~~---~~p~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 215 NLFKKVNSCVY---VMPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp TCBCCCCSSCC---CCCTTSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred HHHHHHHcCCC---CCcccCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 55444433332 34567899999999999999999999 9999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.33 Aligned_cols=245 Identities=33% Similarity=0.581 Sum_probs=210.0
Q ss_pred cccceEE-Eeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|. ...........+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4456654 89999999997552 23332 2222333456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~------- 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------- 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999886310
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+
T Consensus 161 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 161 --------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ---------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred --------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 011234579999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
....+......+ +..++.++.+||.+||..||.+|| ++.++++||||+.
T Consensus 215 ~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~ 263 (279)
T 3fdn_A 215 TYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 263 (279)
T ss_dssp HHHHHHHTCCCC---CTTSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHH
T ss_pred HHHHHHhCCCCC---CCcCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccC
Confidence 888887766543 467899999999999999999999 9999999999965
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.04 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=206.1
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh---c--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI---R--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~---~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
..|.+. .||+|+||.|+.+. +++|..... . ....+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 345554 99999999997652 333332211 1 1135678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc---EEEeecCCcccc
Q 002953 527 VMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVG 599 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~---VKLiDFGLAk~~ 599 (863)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999999887643 25899999999999999999999999999999999999987654 999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 184 ~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 184 GES-------------------------------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp CTT-------------------------------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCC-------------------------------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 100 0112346899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 680 FNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
|.+. ...++..+..+...++. .+..++.++.+||.+||..||.+|| ++.++++||||+..++
T Consensus 233 f~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 233 FYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPWLKERDR 295 (351)
T ss_dssp SCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHTHHH
T ss_pred CCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChhhcCCcc
Confidence 9875 45667777766554321 2256899999999999999999999 9999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=385.23 Aligned_cols=248 Identities=25% Similarity=0.471 Sum_probs=207.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.+||+|+||.|+.+. +++|..........+.+.+|+.+|++++||||+++++++.+.+.+||||||++||+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 379999999997642 3444433333455678999999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee--cCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 538 SLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI--AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 538 dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL--d~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 175 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~------------- 241 (373)
T 2x4f_A 175 DRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP------------- 241 (373)
T ss_dssp HHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT-------------
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC-------------
Confidence 988654 469999999999999999999999999999999999999 5567999999999984210
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN 694 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~ 694 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 242 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 302 (373)
T 2x4f_A 242 -------------------REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302 (373)
T ss_dssp -------------------TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred -------------------ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 0112345799999999999999899999999999999999999999999999989888887
Q ss_pred cCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhH
Q 002953 695 RKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 747 (863)
Q Consensus 695 ~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~ 747 (863)
....++. ....+++++.+||.+||..||.+|| ++.++++||||++..|..
T Consensus 303 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKLHS 353 (373)
T ss_dssp TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHHHH
T ss_pred ccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCchhh
Confidence 7654432 2356899999999999999999999 999999999999877643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=390.02 Aligned_cols=283 Identities=26% Similarity=0.378 Sum_probs=192.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~l 524 (863)
..|.+. +||+|+||.|+.+. +++|+.. .......+.+.+|+.+|+.++|||||++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 345554 89999999997652 3444432 22344567899999999999999999999999543 579
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+ +++|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 9999998 569999999888899999999999999999999999999999999999999999999999999985321110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHh--------
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIV-------- 675 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELLT-------- 675 (863)
.....+ .... ......................+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 212 ~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 212 GNSQLP-ISPR---EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp CCCCCC-------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred cccccc-cCcc---ccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 000000 0000 00000000000001112345678999999999874 5669999999999999999998
Q ss_pred ---CCCCCCCCCh--------------------HHHHHHHhhc----------------------------CCCCCCCCC
Q 002953 676 ---GIPPFNAEHP--------------------QQIFDNILNR----------------------------KIPWPRVPE 704 (863)
Q Consensus 676 ---Gk~PF~~~~~--------------------~el~~kIl~~----------------------------~~~~p~~p~ 704 (863)
|.+||.+.+. ...+..|... ...+.....
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7777766441 1222222110 000111124
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhh
Q 002953 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 705 ~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~ 750 (863)
.+++++.+||.+||..||.+|| |++|+|+||||+++.|.....
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGCC
T ss_pred CCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccCC
Confidence 5699999999999999999999 999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=370.80 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=202.1
Q ss_pred cceE--EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDL--LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l--~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
.|.+ .+||+|+||.|+.+. +++|............+.+|+.+|.++ +||||+++++++.+.+.+|+||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 4555 379999999997652 344443333334567789999999985 799999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc---EEEeecCCccccccCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~---VKLiDFGLAk~~~~~s~~dl 607 (863)
++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.........
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~-- 170 (316)
T 2ac3_A 93 MRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC-- 170 (316)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc--
Confidence 999999999998888999999999999999999999999999999999999998765 999999998742110000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----TGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 171 ----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 171 ----------------------SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp ---------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------------------ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 0000112234679999999999975 4578999999999999999999999977
Q ss_pred CC---------------hHHHHHHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 683 EH---------------PQQIFDNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 683 ~~---------------~~el~~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
.. ...++..+......++.. ...++.++.+||.+||..||.+|| ++.++++||||++..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---SAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSTTCC-----
T ss_pred cccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC---CHHHHhcChhhcCCCCc
Confidence 54 244566666666544321 146899999999999999999999 99999999999987665
Q ss_pred H
Q 002953 747 T 747 (863)
Q Consensus 747 ~ 747 (863)
.
T Consensus 306 ~ 306 (316)
T 2ac3_A 306 N 306 (316)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=376.98 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=203.4
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
...|.+. .||+|+||+|+.+. +++|...... ....+.+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3456555 99999999997652 3344322221 1223568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~------ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------ 159 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT------
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC------
Confidence 99999999999888889999999999999999999999999999999999999999999999999997421100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChH-H
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ-Q 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~-e 687 (863)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .
T Consensus 160 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 160 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp -----------------------EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred -----------------------cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 0112235789999999999988775 78999999999999999999999876543 3
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+......... ......++.++.+||.+||..||.+|| |+.|+++||||+..
T Consensus 217 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 268 (323)
T 3tki_A 217 EYSDWKEKKTY-LNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred HHHHHhccccc-CCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhccc
Confidence 33333333222 222356899999999999999999999 99999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=383.93 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=212.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+. .||+|+||.|+.+. +++|............+.+|+.+|+.++||||+++++++.+...+|+||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 345554 99999999997652 3344333333344567899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC--CCcEEEeecCCccccccCCCCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~--~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++....
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~------- 203 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP------- 203 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-------
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC-------
Confidence 9999999997654 6999999999999999999999999999999999999974 47899999999984210
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 204 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 258 (387)
T 1kob_A 204 -------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 258 (387)
T ss_dssp -------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred -------------------------CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence 0112245799999999999999999999999999999999999999999998888
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 689 FDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 689 ~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
+..+......++. ....+++++.+||.+||..||.+|| |+.++++||||++..+
T Consensus 259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 8888776654432 3457899999999999999999999 9999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=363.07 Aligned_cols=247 Identities=30% Similarity=0.511 Sum_probs=203.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+++|++++||||+++++++.+...+|+||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 345554 99999999997542 334433222 223457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec---CCCcEEEeecCCccccccCC
Q 002953 531 LNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 531 ~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd---~~g~VKLiDFGLAk~~~~~s 603 (863)
++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-- 179 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-- 179 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC--
Confidence 9999999998543 6799999999999999999999999999999999999994 457899999999874110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.
T Consensus 180 ------------------------------~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~ 228 (285)
T 3is5_A 180 ------------------------------DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228 (285)
T ss_dssp -------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence 01123467999999999986 46899999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+..+....+......++.....+++++.+||.+||+.||.+|| ++.++++||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~ 284 (285)
T 3is5_A 229 SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFKQ 284 (285)
T ss_dssp SHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGGC
T ss_pred CHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhhc
Confidence 9888887777666555444456899999999999999999999 9999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=367.51 Aligned_cols=247 Identities=31% Similarity=0.537 Sum_probs=201.7
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhc--------------------------hhHHHHHHHHHHHHH
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR--------------------------KNAVESILAERDILI 504 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~--------------------------k~~~e~~l~Ei~IL~ 504 (863)
...|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3456655 99999999997652 2333221111 112356889999999
Q ss_pred hcCCCCeeEEEEEEEe--CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee
Q 002953 505 SVRNPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 582 (863)
Q Consensus 505 ~L~HPnIVkL~~~f~d--~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL 582 (863)
+++||||+++++++.+ ...+|+||||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999987 5689999999999999987643 679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC---CCc
Q 002953 583 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGT 659 (863)
Q Consensus 583 d~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---ys~ 659 (863)
+.++.+||+|||+++..... .......+||+.|+|||++.+.. ++.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 219 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGS-------------------------------DALLSNTVGTPAFMAPESLSETRKIFSGK 219 (298)
T ss_dssp CTTSCEEECCCTTCEECSSS-------------------------------SCEECCCCSCGGGCCGGGCCTTCCCEESH
T ss_pred CCCCCEEEecCCCccccccc-------------------------------cccccCCcCCccccChhhhccCCCCCCCc
Confidence 99999999999999742100 01123468999999999998765 378
Q ss_pred cceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 660 ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
++|||||||++|+|++|..||.......+...+......++. ...+++++.+||.+||+.||.+|| ++.++++|||
T Consensus 220 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~---s~~e~l~hp~ 295 (298)
T 2zv2_A 220 ALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRI---VVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTTCHH
T ss_pred hhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCC---CHHHHhcCcc
Confidence 899999999999999999999998888888887776665543 356899999999999999999999 9999999999
Q ss_pred CC
Q 002953 740 FK 741 (863)
Q Consensus 740 Fk 741 (863)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 85
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=372.63 Aligned_cols=246 Identities=30% Similarity=0.523 Sum_probs=211.1
Q ss_pred EEEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
...||+|+||.|+.+ .+++|..........+.+.+|+.+|++++||||+++++++...+.+|+||||++|++|
T Consensus 50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 348999999999654 2455544444445567789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 130 ~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-------------- 194 (321)
T 2c30_A 130 TDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-------------- 194 (321)
T ss_dssp HHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--------------
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--------------
Confidence 999875 57999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 195 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 195 -----------------VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp -----------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred -----------------ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 011234689999999999999999999999999999999999999999998888888777655
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
.+....+..+++++.+||.+||+.||.+|| ++.++++||||....
T Consensus 258 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp CCCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred CCCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 433333456899999999999999999999 999999999997643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=360.78 Aligned_cols=246 Identities=32% Similarity=0.558 Sum_probs=211.5
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. +++|+.........+.+.+|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 45544 89999999997542 34554443334556789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee---cCCCcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL---d~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~-------- 161 (277)
T 3f3z_A 90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-------- 161 (277)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT--------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC--------
Confidence 99999999888899999999999999999999999999999999999999 7788999999999874210
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
........||+.|+|||++.+. ++.++||||||+++|+|++|..||...+..+..
T Consensus 162 ------------------------~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (277)
T 3f3z_A 162 ------------------------GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216 (277)
T ss_dssp ------------------------TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0122346799999999998765 899999999999999999999999999998888
Q ss_pred HHHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..+......++.. ...+++++.+||.+||+.||.+|| ++.++++||||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 217 LKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHH
T ss_pred HHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhc
Confidence 8888876654421 136899999999999999999999 9999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=382.55 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=207.7
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||+|+||.|+.+. +++|...... ....+|+++|.++ +||||++++++|.+.+.+|+|||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 45544 99999999986652 2333321111 1245789999888 7999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC----CcEEEeecCCccccccCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~----g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+... +.+||+|||+++.....
T Consensus 99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~----- 173 (342)
T 2qr7_A 99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE----- 173 (342)
T ss_dssp CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT-----
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC-----
Confidence 999999999988899999999999999999999999999999999999998543 35999999999842110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC---CC
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA---EH 684 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~---~~ 684 (863)
.....+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.. .+
T Consensus 174 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 227 (342)
T 2qr7_A 174 --------------------------NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT 227 (342)
T ss_dssp --------------------------TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred --------------------------CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence 0122356899999999999988899999999999999999999999975 46
Q ss_pred hHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhh
Q 002953 685 PQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~ 750 (863)
..+++..+..+...++. .+..+++++.+||.+||..||.+|| ++.++++||||. +|+.+..
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~--~~~~~~~ 289 (342)
T 2qr7_A 228 PEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIV--HWDQLPQ 289 (342)
T ss_dssp HHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHH--TGGGSCC
T ss_pred HHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCeec--Ccccccc
Confidence 67788888877765542 3467899999999999999999999 999999999995 5776643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=357.43 Aligned_cols=252 Identities=29% Similarity=0.473 Sum_probs=214.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..|.+. .||+|+||.|+.+. +++|... .......+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345544 99999999997542 2333322 1233455778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc---EEEeecCCccccccCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~---VKLiDFGLAk~~~~~s~~d 606 (863)
|++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~----- 160 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----- 160 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-----
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-----
Confidence 9999999999988888999999999999999999999999999999999999987655 99999999874110
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 161 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 161 ---------------------------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp ---------------------------SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 01123467999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 687 QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 687 el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
.....+......++. ....+++++.+||.+||+.||.+|| ++.++++||||++..+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRERV 271 (284)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCCCG
T ss_pred HHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCChhH
Confidence 888888877665443 2357899999999999999999999 99999999999887654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=375.16 Aligned_cols=248 Identities=33% Similarity=0.512 Sum_probs=195.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. +++|... .....+.+.+|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE--C----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEec--cchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 45554 99999999997542 2333322 22344568899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~-------- 203 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-------- 203 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--------
Confidence 9999999998888999999999999999999999999999999999999976 78999999999874100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH-H
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ-I 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e-l 688 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... +
T Consensus 204 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 259 (349)
T 2w4o_A 204 ------------------------QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259 (349)
T ss_dssp ---------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH
T ss_pred ------------------------ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH
Confidence 011234679999999999999999999999999999999999999997765544 6
Q ss_pred HHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 689 FDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 689 ~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
+..+......++ .....++.++.+||.+||..||.+|| ++.++++||||.+..+
T Consensus 260 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 260 FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTTSTTC
T ss_pred HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCcc
Confidence 667766654433 23457899999999999999999999 9999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.63 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=210.1
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+. .||+|+||.|+.+. +++|..........+.+.+|+.+|+.++||||+++++++...+.+|+||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 345544 89999999996552 3444333334445678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---------- 168 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---------- 168 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH----------
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc----------
Confidence 99999999876 4669999999999999999999999999999999999999999999999999876310
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
..........||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 169 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 169 ---------------------KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp ---------------------HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ---------------------ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 0112233567999999999984 66789999999999999999999999999888
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
......+..........+..++.++.+||.+||..||.+|| |+.++++||||+.+.|...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 228 MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSC---CHHHHTTSTTTTTCCCCHH
T ss_pred HHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCC---CHHHHhcChHHhhhccchh
Confidence 88877777665543334567899999999999999999999 9999999999999988653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=396.06 Aligned_cols=250 Identities=31% Similarity=0.514 Sum_probs=212.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.|.+. +||+|+||.|+.+. +++|. .........+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 45544 99999999997542 23332 223334556789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee---cCCCcEEEeecCCccccccCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL---d~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---- 182 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---- 182 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC----
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc----
Confidence 99999999999988899999999999999999999999999999999999999 45689999999998742100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..
T Consensus 183 ----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 183 ----------------------------KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp ----------------------------CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 01123579999999999987 5999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 687 QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 687 el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
+++..+..+...++. .+..+++++++||.+||+.||.+|| |+.++|+||||+...++
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKE 291 (484)
T ss_dssp HHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHHTC-
T ss_pred HHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhcccccc
Confidence 999999887765432 2356899999999999999999999 99999999999865553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=358.64 Aligned_cols=246 Identities=31% Similarity=0.584 Sum_probs=211.8
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
....|.+. .||+|+||.|+.+. +++|.. ..........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 34556655 89999999997652 233322 22223335678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~----- 166 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----- 166 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-----
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-----
Confidence 999999999999999888999999999999999999999999999999999999999999999999999863100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 167 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 167 ----------------------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp ----------------------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 1123467999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+....+...... ++..++.++.+||.+||..||.+|| ++.++++||||+.
T Consensus 219 ~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~ 268 (284)
T 2vgo_A 219 ETHRRIVNVDLK---FPPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKA 268 (284)
T ss_dssp HHHHHHHTTCCC---CCTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHH
T ss_pred HHHHHHhccccC---CCCcCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHh
Confidence 888888776554 3467899999999999999999999 9999999999964
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.68 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=195.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
+|.+. .||+|+||.|+.+. +++|...... ......+.+|+.+|++++||||+++++++.+++.+|+||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 34443 89999999997552 3444332222 223467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 532 NGGDLYSLLRNL------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 532 ~GGsL~dlLk~~------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--- 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC---
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC---
Confidence 7 4999998754 35899999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus 162 ----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 162 ----------------------------VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp ----------------------------CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----------------------------cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 011224579999999999987 468999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCC-----C--------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 002953 685 PQQIFDNILNRKIP-----W--------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 733 (863)
Q Consensus 685 ~~el~~kIl~~~~~-----~--------------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeE 733 (863)
..+.+..+...... + +..+..++.++.+||.+||+.||.+|| |+.+
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e 290 (317)
T 2pmi_A 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---SAKQ 290 (317)
T ss_dssp HHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC---CHHH
T ss_pred hHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC---CHHH
Confidence 88777776542100 0 001235788999999999999999999 9999
Q ss_pred HHcCCCCCCCChhH
Q 002953 734 VKQHVFFKDINWDT 747 (863)
Q Consensus 734 ILqHPFFk~IdW~~ 747 (863)
+|+||||++..|..
T Consensus 291 ~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 291 ALHHPWFAEYYHHA 304 (317)
T ss_dssp HTTSGGGGGGCC--
T ss_pred HhCChhhhcccchh
Confidence 99999999876653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=358.58 Aligned_cols=256 Identities=31% Similarity=0.511 Sum_probs=212.6
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhc---------hhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR---------KNAVESILAERDILISVR-NPFVVRFFYSFTC 520 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~---------k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d 520 (863)
...|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 3455554 99999999996542 3444332211 233467889999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
.+.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc------CCCCCccceeechhHHHHHHH
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL------GTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~------g~~ys~ksDIWSLGvILyELL 674 (863)
. ........||+.|+|||++. ...++.++||||||+++|+|+
T Consensus 176 ~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~ 223 (298)
T 1phk_A 176 P--------------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223 (298)
T ss_dssp T--------------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred C--------------------------------CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH
Confidence 0 01123467999999999985 456789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 675 VGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 675 TGk~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
+|..||...+.......+......++. ....++.++.+||.+||..||.+|| ++.++++||||++..|+.+.
T Consensus 224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 224 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCTTC-----
T ss_pred HCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHHHhChHhhhccchhhc
Confidence 999999999888888888777655432 1246899999999999999999999 99999999999999887664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.90 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=201.3
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+|.+ ..||+|+||+|+.+. +++|+.... .....+.+.+|+.+|++++||||+++++++...+.+|+||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3444 499999999997542 344433222 223356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+++++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------- 155 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-------- 155 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--------
Confidence 999999999988888999999999999999999999999999999999999999999999999999742100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+..
T Consensus 156 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 212 (311)
T 4agu_A 156 -----------------------SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212 (311)
T ss_dssp ---------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -----------------------ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 011234579999999999986 66899999999999999999999999988877666
Q ss_pred HHHhhcC-------------------CCCCCC---------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 690 DNILNRK-------------------IPWPRV---------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 690 ~kIl~~~-------------------~~~p~~---------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
..+.... ...+.. ...++.++.+||.+||..||.+|| |++++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~ 289 (311)
T 4agu_A 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL---TCEQLLHHPYFE 289 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC---CHHHHHTSGGGT
T ss_pred HHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC---CHHHHhcChHHH
Confidence 5543311 111110 135789999999999999999999 999999999999
Q ss_pred CCChhH
Q 002953 742 DINWDT 747 (863)
Q Consensus 742 ~IdW~~ 747 (863)
++.+..
T Consensus 290 ~~~~~~ 295 (311)
T 4agu_A 290 NIREIE 295 (311)
T ss_dssp TCC---
T ss_pred hccCHH
Confidence 987754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=377.90 Aligned_cols=269 Identities=27% Similarity=0.434 Sum_probs=196.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC--eEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRE--NLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~--~lyL 526 (863)
.+|.+. .||+|+||.|+.+. +++|+.. .........+.+|+.+|..+. ||||+++++++...+ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 345554 89999999997652 3455432 233455677889999999997 999999999998654 7999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||||. ++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~- 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV- 165 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC-
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc-
Confidence 999997 599999976 67999999999999999999999999999999999999999999999999999853211000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.. ........ ...............+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.
T Consensus 166 -~~----~~~~~~~~----~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 166 -TN----NIPLSINE----NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp -CC----CGGGCCC-------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -cc----cccccccc----cccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 00 00000000 00000111223445789999999999987 6789999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCCCC---------------------------------------------CCCCCCHHHHHHHHhhccC
Q 002953 686 QQIFDNILNRKIPWPR---------------------------------------------VPEEMSPEAHDLIDRFLTE 720 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~---------------------------------------------~p~~iS~el~dLI~k~L~~ 720 (863)
...+..|+.... .|. .+..+++++.+||.+||+.
T Consensus 237 ~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 887777753211 110 0126789999999999999
Q ss_pred CcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 721 DPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 721 DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
||.+|| |++++|+||||+.+.
T Consensus 316 dP~~R~---t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 316 NPNKRI---SANDALKHPFVSIFH 336 (388)
T ss_dssp SGGGSC---CHHHHTTSTTTTTTC
T ss_pred CcccCC---CHHHHhCCHHHHHhc
Confidence 999999 999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=393.53 Aligned_cols=246 Identities=29% Similarity=0.553 Sum_probs=212.8
Q ss_pred cccceEE-Eeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|. ...........+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456654 89999999996542 23332 2222334456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~------ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------ 168 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT------
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc------
Confidence 99999999999999888999999999999999999999999999999999999999999999999999974110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..
T Consensus 169 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 222 (476)
T 2y94_A 169 --------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222 (476)
T ss_dssp --------------------------TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH
T ss_pred --------------------------cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH
Confidence 012235689999999999998776 78999999999999999999999999988
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.++.++..+... .+..+++++.+||.+||..||.+|| |+.++++||||+.
T Consensus 223 ~~~~~i~~~~~~---~p~~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 223 TLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHHHTTCCC---CCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred HHHHHHhcCCcC---CCccCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 899888877654 3567899999999999999999999 9999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=371.40 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=205.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhh---hh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKA---DM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
..|.+. .||+|+||.|+.+. +++|.. .. ......+.+.+|+++|++++||||+++++++.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 345554 99999999997552 233322 11 133456789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc----------------------------------------CCCChhhHHHHHHHHHHHHHHHH
Q 002953 527 VMEYLNGGDLYSLLRNL----------------------------------------GCLDEDVARVYIAEVVLALEYLH 566 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~----------------------------------------g~L~e~~i~~Ia~QIl~ALeyLH 566 (863)
|||||+||+|.+++... ..+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 12467788899999999999999
Q ss_pred hCCccccCCCCcceeecCCC--cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCC
Q 002953 567 SLRVVHRDLKPDNLLIAHDG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g--~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp 644 (863)
++||+||||||+|||++.++ .+||+|||+++....... ..........||+
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~---------------------------~~~~~~~~~~gt~ 238 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN---------------------------GEYYGMTTKAGTP 238 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC---------------------------C--------CCCG
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCc---------------------------cccccccccCCCc
Confidence 99999999999999998776 899999999974211000 0011223567999
Q ss_pred CCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCC
Q 002953 645 DYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTED 721 (863)
Q Consensus 645 ~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~D 721 (863)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. ....+++++.+||.+||+.|
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 9999999975 67899999999999999999999999999998888888877655432 12348999999999999999
Q ss_pred cCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 722 PHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 722 P~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
|.+|| ++.++++||||+++.|.
T Consensus 319 p~~Rp---s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 319 VDERF---DAMRALQHPWISQFSDK 340 (345)
T ss_dssp TTTSC---CHHHHHHSHHHHTTSSC
T ss_pred hhHCC---CHHHHhcChhhccChHh
Confidence 99999 99999999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=364.19 Aligned_cols=247 Identities=31% Similarity=0.506 Sum_probs=209.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. .||+|+||.|+.+. +++|............+.+|+.+|+.++||||+++++++.+.+.+|+||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 44444 99999999997542 34444333223344568899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee---cCCCcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL---d~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-------- 161 (304)
T 2jam_A 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-------- 161 (304)
T ss_dssp SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--------
T ss_pred CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--------
Confidence 99999999888889999999999999999999999999999999999999 6778999999999873100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+...++
T Consensus 162 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 216 (304)
T 2jam_A 162 -------------------------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216 (304)
T ss_dssp -------------------------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -------------------------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0112346999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+..+...++ ..+..++.++.+||.+||..||.+|| ++.++++||||++.
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 217 EKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 88887765543 23467899999999999999999999 99999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=368.43 Aligned_cols=247 Identities=31% Similarity=0.522 Sum_probs=212.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.+. +||+|+||.|+.+. .++| +.........+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 345444 99999999997542 2222 222334456678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~------ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------ 194 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 195 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 249 (335)
T 2owb_A 195 -------------------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249 (335)
T ss_dssp -------------------------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 0112346799999999999999999999999999999999999999999888888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+..+...... ++..++.++.+||.+||..||.+|| ++.++++||||...
T Consensus 250 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~ 298 (335)
T 2owb_A 250 YLRIKKNEYS---IPKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHTCCC---CCTTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTS
T ss_pred HHHHhcCCCC---CCccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCC
Confidence 8887776554 3567899999999999999999999 99999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.16 Aligned_cols=247 Identities=21% Similarity=0.445 Sum_probs=201.4
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~l 524 (863)
...|.+. .||+|+||.|+.+. +++|... .......+.+.+|+.+|+.++||||+++++++.. ...+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 3445555 79999999997652 2223221 2234556788999999999999999999999876 3568
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeec-CCCcEEEeecCCcccccc
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd-~~g~VKLiDFGLAk~~~~ 601 (863)
|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~- 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence 999999999999999998889999999999999999999999999 99999999999998 78999999999987310
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 184 --------------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 184 --------------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp --------------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --------------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 011234579999999998875 48999999999999999999999998
Q ss_pred CCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 682 AEHP-QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 682 ~~~~-~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.... ...+..+... ......+...++++.+||.+||..||.+|| ++.++++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~f~~~ 289 (290)
T 1t4h_A 231 ECQNAAQIYRRVTSG-VKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQEE 289 (290)
T ss_dssp TCSSHHHHHHHHTTT-CCCGGGGGCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC--
T ss_pred CcCcHHHHHHHHhcc-CCccccCCCCCHHHHHHHHHHccCChhhCC---CHHHHhhCcccccC
Confidence 7544 4444444433 333344566889999999999999999999 99999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=361.95 Aligned_cols=248 Identities=29% Similarity=0.434 Sum_probs=198.6
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhc-----hhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEeCC-
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-----KNAVESILAERDILISV---RNPFVVRFFYSFTCRE- 522 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-----k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~~- 522 (863)
.+|.+. .||+|+||+|+.+. +++|...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 456554 99999999997653 3444332211 11123566788877766 4999999999998765
Q ss_pred ----eEEEEEeecCCCChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCc
Q 002953 523 ----NLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596 (863)
Q Consensus 523 ----~lyLVmEy~~GGsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLA 596 (863)
.+|+||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 5899999996 599999987654 999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG 676 (863)
+.... .......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 168 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 215 (308)
T 3g33_A 168 RIYSY--------------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215 (308)
T ss_dssp TTSTT--------------------------------CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS
T ss_pred cccCC--------------------------------CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC
Confidence 74110 0112346799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCC-----CCC-------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 677 IPPFNAEHPQQIFDNILNRKIP-----WPR-------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~-----~p~-------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
.+||.+.+..+.+.++...... ++. ....+++++.+||.+||+.||.+|| |+.
T Consensus 216 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~ 292 (308)
T 3g33_A 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI---SAF 292 (308)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC---CHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC---CHH
Confidence 9999999988888777653111 110 1135789999999999999999999 999
Q ss_pred HHHcCCCCCCC
Q 002953 733 EVKQHVFFKDI 743 (863)
Q Consensus 733 EILqHPFFk~I 743 (863)
++|+||||+..
T Consensus 293 e~l~h~~~~~~ 303 (308)
T 3g33_A 293 RALQHSYLHKD 303 (308)
T ss_dssp HHHTSTTC---
T ss_pred HHhcCccccCC
Confidence 99999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=358.21 Aligned_cols=247 Identities=31% Similarity=0.522 Sum_probs=212.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.+. +||+|+||.|+.+. .++| +.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 445444 99999999986542 2222 222334456678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD------ 168 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST------
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........||+.|+|||++.+..++.++||||||+++|+|++|..||......+.
T Consensus 169 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 223 (294)
T 2rku_A 169 -------------------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223 (294)
T ss_dssp -------------------------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred -------------------------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112346799999999999999899999999999999999999999999988888
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+..+...... ++..++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 224 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~ 272 (294)
T 2rku_A 224 YLRIKKNEYS---IPKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHTTCCC---CCTTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTS
T ss_pred HHHHhhccCC---CccccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecC
Confidence 8777766543 3567899999999999999999999 99999999999754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=356.34 Aligned_cols=248 Identities=29% Similarity=0.553 Sum_probs=183.5
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|.. ........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3455554 89999999996552 233322 222223356789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~---- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---- 165 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC----
Confidence 9999999999999875 57999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 166 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 218 (278)
T 3cok_A 166 ---------------------------HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218 (278)
T ss_dssp -----------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred ---------------------------CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH
Confidence 01122457999999999999988999999999999999999999999887766
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.....+..... ..+..++.++.+||.+||..||.+|| ++.++++||||...
T Consensus 219 ~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 219 NTLNKVVLADY---EMPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp -----CCSSCC---CCCTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred HHHHHHhhccc---CCccccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 66655544433 23567899999999999999999999 99999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=375.75 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=199.2
Q ss_pred cceE-EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~l 524 (863)
.|.+ ..||+|+||.|+.+. +++|+.. .......+.+.+|+.+|+.++||||+++++++.... .+
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3444 489999999996552 4555432 223345567899999999999999999999998764 46
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+ |++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~---- 179 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---- 179 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc----
Confidence 9999999 8899999986 679999999999999999999999999999999999999999999999999998410
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 180 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 180 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01224689999999999987 67999999999999999999999999998
Q ss_pred ChHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 684 HPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 684 ~~~el~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+..+.+..|.... ..+.......++++.+||.+||..||.+|| |++++|
T Consensus 230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~---t~~e~l 306 (367)
T 1cm8_A 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAGEAL 306 (367)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC---CHHHHh
Confidence 8877776665421 112223356799999999999999999999 999999
Q ss_pred cCCCCCCCChh
Q 002953 736 QHVFFKDINWD 746 (863)
Q Consensus 736 qHPFFk~IdW~ 746 (863)
+||||+.+.+.
T Consensus 307 ~hp~f~~~~~~ 317 (367)
T 1cm8_A 307 AHPYFESLHDT 317 (367)
T ss_dssp HSGGGTTTC--
T ss_pred cChHHHhhcCC
Confidence 99999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=391.03 Aligned_cols=249 Identities=30% Similarity=0.533 Sum_probs=210.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..|.+. +||+|+||+|+.+. +++|... .........+.+|+.+|++++||||+++++++.+...+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 455554 99999999997552 3333321 1223345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec---CCCcEEEeecCCccccccCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd---~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----- 176 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ----- 176 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-----
Confidence 999999999998888999999999999999999999999999999999999995 456799999999874210
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..
T Consensus 177 ---------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 177 ---------------------------NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp ---------------------------C----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ---------------------------CCccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0112346799999999999874 999999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 687 QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 687 el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+++..+..+...++. .+..+++++++||.+||+.||.+|| |+.++|+||||+...
T Consensus 229 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTC
T ss_pred HHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCc
Confidence 999998887765432 2356899999999999999999999 999999999997653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=366.30 Aligned_cols=243 Identities=27% Similarity=0.421 Sum_probs=200.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-----CCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-----NPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-----HPnIVkL~~~f~d~~~lyL 526 (863)
..|.+. .||+|+||+|+.+. +++|... ........+..|+.+|+.+. ||||+++++++...+.+|+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC-SCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEec-cchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 345544 99999999997652 2333322 23445567788999999986 9999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC--------------------
Q 002953 527 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-------------------- 584 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-------------------- 584 (863)
||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 99999 889999998754 5999999999999999999999999999999999999975
Q ss_pred -----CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCc
Q 002953 585 -----DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659 (863)
Q Consensus 585 -----~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ 659 (863)
++.+||+|||+|+... ......+||+.|+|||++.+..++.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 238 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKS----------------------------------DYHGSIINTRQYRAPEVILNLGWDV 238 (360)
T ss_dssp EEEESCCCEEECCCTTCEETT----------------------------------SCCCSCCSCGGGCCHHHHTTCCCCT
T ss_pred ccccCCCCEEEEeccCceecC----------------------------------CCCcCccCcccccCcHHHcCCCCCC
Confidence 7899999999997410 1123467999999999999999999
Q ss_pred cceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-----------------------CC-------------
Q 002953 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-----------------------VP------------- 703 (863)
Q Consensus 660 ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~-----------------------~p------------- 703 (863)
++|||||||++|+|++|.+||...+..+.+..+.....++|. .+
T Consensus 239 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 318 (360)
T 3llt_A 239 SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318 (360)
T ss_dssp THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhh
Confidence 999999999999999999999988877777666543322210 00
Q ss_pred -------CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 704 -------EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 704 -------~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
...++.+.+||.+||+.||.+|| |+.++|+||||+
T Consensus 319 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp TCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred hcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 11237788999999999999999 999999999995
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=367.10 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=209.6
Q ss_pred EEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
..||+|+||.|+.+. +++|..... .......+.+|+.+|..+. ||||+++++++.+.+.+|+||||++||
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 479999999996542 333332221 2233567899999999995 699999999999999999999999999
Q ss_pred ChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccccCCCCCCCC
Q 002953 535 DLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 535 sL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~-------- 186 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-------- 186 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC--------
Confidence 999998653 67999999999999999999999999999999999999998 78999999999974110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+
T Consensus 187 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 187 ------------------------ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp -------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 01123467999999999999999999999999999999999999999999988888
Q ss_pred HHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 690 DNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 690 ~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
..+......++. ....+++.+.+||.+||+.||.+|| |++++|+||||++++|+.+.
T Consensus 243 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 243 LNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCCCCTTCC-
T ss_pred HHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhccccccccc
Confidence 887766554432 3457899999999999999999999 99999999999999997653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=372.41 Aligned_cols=241 Identities=30% Similarity=0.498 Sum_probs=185.7
Q ss_pred Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 466 LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 466 vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.||+|+||.|+.+. +++|.. .......+.+|+.+|+.+. ||||+++++++.+...+|+||||++||+|.
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vavK~~---~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 18 PLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CSEEETTEEEEEEEETTTCCEEEEEEE---EGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEE---ChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 69999999997642 233332 3344567889999999997 999999999999999999999999999999
Q ss_pred HHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCccccccCCCCCCCCCCccC
Q 002953 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 538 dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~------------ 162 (325)
T 3kn6_A 95 ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD------------ 162 (325)
T ss_dssp HHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC------------
Confidence 9999988999999999999999999999999999999999999998765 8999999999741100
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-------hHH
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH-------PQQ 687 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~-------~~e 687 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+ ..+
T Consensus 163 -------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 223 (325)
T 3kn6_A 163 -------------------NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223 (325)
T ss_dssp ----------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH
T ss_pred -------------------CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH
Confidence 012234678999999999999999999999999999999999999997643 356
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 688 IFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 688 l~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++..+..+...++. .+..+++++.+||.+||..||.+|| ++.++++||||++.
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~h~w~~~~ 277 (325)
T 3kn6_A 224 IMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTTSTTCGGGCTT
T ss_pred HHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHHHhcChhhccC
Confidence 67777666654332 1135899999999999999999999 99999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=389.98 Aligned_cols=248 Identities=32% Similarity=0.520 Sum_probs=206.8
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
.|.+. .||+|+||+|+.+. +++|..... .......+.+|+.+|+.++|||||+++++|.+...+|+||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 45544 99999999997542 233332211 123356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|+....
T Consensus 118 ~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~------ 191 (494)
T 3lij_A 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN------ 191 (494)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT------
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC------
Confidence 9999999999888899999999999999999999999999999999999999764 4599999999974210
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 192 --------------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 244 (494)
T 3lij_A 192 --------------------------QKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244 (494)
T ss_dssp --------------------------TBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 012235689999999999864 59999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 688 IFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 688 l~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
++..+..+...++. .+..+++++.+||.+||+.||.+|| |+.++|+||||+...
T Consensus 245 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 245 ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHH
T ss_pred HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCc
Confidence 99999887765542 2356899999999999999999999 999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=371.18 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=205.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 345544 99999999997642 233332221 344557789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++|++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--------- 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------- 183 (360)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---------
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc---------
Confidence 99999999999888999999999999999999999985 99999999999999999999999999986310
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++.
T Consensus 184 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 184 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp ------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred ------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11233568999999999999999999999999999999999999999876654432
Q ss_pred HH------------------------------------------HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 690 DN------------------------------------------ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 690 ~k------------------------------------------Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
.. +...... ......++.++.+||.+||..||.+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rp- 317 (360)
T 3eqc_A 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERA- 317 (360)
T ss_dssp HHHC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSSTTTSC-
T ss_pred HHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcChhhCC-
Confidence 22 2222211 111245799999999999999999999
Q ss_pred CCCHHHHHcCCCCCCCChhHH
Q 002953 728 SGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 728 ~~SAeEILqHPFFk~IdW~~l 748 (863)
|+.++++||||+..+|+.+
T Consensus 318 --t~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 318 --DLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp --CHHHHHTSHHHHHHHHSCC
T ss_pred --CHHHHhhChHhhcchHhhh
Confidence 9999999999987665433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=363.08 Aligned_cols=257 Identities=24% Similarity=0.419 Sum_probs=193.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC---------
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRE--------- 522 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--------- 522 (863)
.|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||++++++|.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 34444 89999999997552 345543322 2335578999999999999999999999986543
Q ss_pred ------------------------------------------------eEEEEEeecCCCChHHHHHhcCC---CChhhH
Q 002953 523 ------------------------------------------------NLYLVMEYLNGGDLYSLLRNLGC---LDEDVA 551 (863)
Q Consensus 523 ------------------------------------------------~lyLVmEy~~GGsL~dlLk~~g~---L~e~~i 551 (863)
++|+|||||+||+|.+++..... .++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 38999999999999999987654 445568
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhh
Q 002953 552 RVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQ 631 (863)
Q Consensus 552 ~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~ 631 (863)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .......
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~-------------------~~~~~~~ 227 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE-------------------QTVLTPM 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------------------------
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhh-------------------ccccccc
Confidence 899999999999999999999999999999999999999999999852111000 0000000
Q ss_pred hhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHH
Q 002953 632 QERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAH 711 (863)
Q Consensus 632 ~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~ 711 (863)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+... .++......++++.
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYPQEH 303 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCChhHH
Confidence 011233456899999999999999999999999999999999999777522 12223333222 22323345678899
Q ss_pred HHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 712 DLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 712 dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+||.+||+.||.+|| ++.++++||||+++
T Consensus 304 ~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 304 MMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred HHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 999999999999999 99999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.57 Aligned_cols=245 Identities=30% Similarity=0.539 Sum_probs=201.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. +++|.. ........+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 445554 99999999986542 333322 2222334567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 163 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD------- 163 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874110
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+...
T Consensus 164 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 164 -------------------------GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp --------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------------------------CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 011224579999999999988766 689999999999999999999999988888
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+..+...... .+..++.++.+||.+||+.||.+|| ++.++++||||++
T Consensus 219 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 219 LFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHHHhhcCccc---CchhcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 88887766543 3567899999999999999999999 9999999999965
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=388.60 Aligned_cols=245 Identities=25% Similarity=0.420 Sum_probs=194.8
Q ss_pred ccceE-EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------Ce
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------EN 523 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~ 523 (863)
.+|.+ ..||+|+||+|+.+. +++|+.. .........+.+|+.+|+.++|||||+++++|... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 34554 489999999996552 3444432 22445567889999999999999999999999765 35
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+||||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 216 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------
T ss_pred EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC--
Confidence 7999999976 67777753 599999999999999999999999999999999999999999999999999974110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 217 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 217 ------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp ------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01223468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCC-------------------CCCC---------CCC-----------CCHHHHHHHHhhccCCcCC
Q 002953 684 HPQQIFDNILNRKIP-------------------WPRV---------PEE-----------MSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 684 ~~~el~~kIl~~~~~-------------------~p~~---------p~~-----------iS~el~dLI~k~L~~DP~k 724 (863)
+..+.+..|+..... .+.. +.. .++++.+||.+||+.||.+
T Consensus 267 ~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 888777776542110 0000 000 1567999999999999999
Q ss_pred cCCCCCHHHHHcCCCCCC
Q 002953 725 RLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~ 742 (863)
|| |++|+|+||||+.
T Consensus 347 R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 347 RI---SVDDALQHPYINV 361 (464)
T ss_dssp SC---CHHHHHTSTTTGG
T ss_pred CC---CHHHHhcChhhhh
Confidence 99 9999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=375.61 Aligned_cols=277 Identities=24% Similarity=0.390 Sum_probs=199.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~l 524 (863)
..|.+. +||+|+||.|+.+. +++|+... ......+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 345554 99999999997652 34554322 2344567899999999999999999999999877 579
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 99999996 59999999888899999999999999999999999999999999999999999999999999985321100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh-cCCCCCccceeechhHHHHHHHh--------
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-LGTGHGTTADWWSVGIILFELIV-------- 675 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL-~g~~ys~ksDIWSLGvILyELLT-------- 675 (863)
..... ..... .................+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 185 ~~~~~------~~~~~---~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 185 TNIVN------DLEEN---EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred ccccc------ccccc---ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 00000 00000 00000000011234567999999999997 45669999999999999999998
Q ss_pred ---CCCCCCCCCh-----------------HHHHHHHhh------------------------cCCCCC----CCCCCCC
Q 002953 676 ---GIPPFNAEHP-----------------QQIFDNILN------------------------RKIPWP----RVPEEMS 707 (863)
Q Consensus 676 ---Gk~PF~~~~~-----------------~el~~kIl~------------------------~~~~~p----~~p~~iS 707 (863)
|.++|.+.+. ...+..|.. .....+ .....++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 4455544331 112222211 000000 0114589
Q ss_pred HHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 708 PEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 708 ~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
+++.+||.+||+.||.+|| |++|+|+||||+++.|....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e 374 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLE 374 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC
T ss_pred HHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccC
Confidence 9999999999999999999 99999999999999987654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.60 Aligned_cols=250 Identities=27% Similarity=0.442 Sum_probs=204.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 45544 89999999996542 344433222 2234577899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-------- 159 (276)
T 2yex_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-------- 159 (276)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--------
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc--------
Confidence 999999999887889999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChH-HHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQ-QIF 689 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~-el~ 689 (863)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..+
T Consensus 160 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (276)
T 2yex_A 160 ---------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218 (276)
T ss_dssp ---------------------EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH
T ss_pred ---------------------chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence 0112235689999999999988765 78899999999999999999999876543 333
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..+...... ......++..+.+||.+||..||.+|| |+.++++||||++.
T Consensus 219 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 219 SDWKEKKTY-LNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHTTCTT-STTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred HHhhhcccc-cCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 333333222 222356899999999999999999999 99999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=386.84 Aligned_cols=247 Identities=31% Similarity=0.480 Sum_probs=207.3
Q ss_pred cceE-EEeecccceeecccc-------ceehhhh---hhc----------hhHHHHHHHHHHHHHhcCCCCeeEEEEEEE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKAD---MIR----------KNAVESILAERDILISVRNPFVVRFFYSFT 519 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~---i~~----------k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~ 519 (863)
.|.+ ..||+|+||+|+.+. +++|... ... ....+.+.+|+.+|++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4544 499999999997542 2333221 111 133567899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCc
Q 002953 520 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLS 596 (863)
Q Consensus 520 d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLA 596 (863)
+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 196 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCC
Confidence 9999999999999999999998888999999999999999999999999999999999999999876 6999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG 676 (863)
+.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 197 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g 243 (504)
T 3q5i_A 197 SFFSK--------------------------------DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243 (504)
T ss_dssp EECCT--------------------------------TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHS
T ss_pred EEcCC--------------------------------CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhC
Confidence 74210 012234689999999999875 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+||.+.+..+++..+..+...++. .+..+++++.+||.+||+.||.+|| |+.++|+||||+..
T Consensus 244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKY 308 (504)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHHhcCHhhhhc
Confidence 9999999999999999887765431 1256899999999999999999999 99999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=355.56 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=208.6
Q ss_pred ceEE-Eeecccceeecccc-------ceehhhhhh---c---hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 462 IDLL-LAGKGALSEHDDFP-------QVLKKADMI---R---KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~---~---k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
|.+. .||+|+||.|+.+. +++|..... . ....+.+.+|+.+|++++||||+++++++.+...+|+|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI 86 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence 4443 89999999996552 233322211 1 11356789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEEeecCCccccccCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLINS 603 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiDFGLAk~~~~~s 603 (863)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~-- 164 (283)
T 3bhy_A 87 LELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-- 164 (283)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---
T ss_pred EeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC--
Confidence 99999999999998888899999999999999999999999999999999999998877 899999999874110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 165 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 165 ------------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp -------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ------------------------------CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 01122457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 684 HPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
+..+....+......++ ..+..++..+.+||.+||..||.+|| ++.++++||||+.+.+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 215 TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHHHHHC
T ss_pred chHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHHHHHH
Confidence 88888888776554432 12356899999999999999999999 99999999999876553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=368.54 Aligned_cols=249 Identities=28% Similarity=0.473 Sum_probs=196.7
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhhhchh-HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADMIRKN-AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~-~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
|.+ ..||+|+||+|+.+. +++|........ ....+.+|+.+|+.++||||+++++++.+.+.+|+||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 444 499999999997652 344433222111 11245679999999999999999999999999999999997
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~---------- 152 (324)
T 3mtl_A 84 K-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI---------- 152 (324)
T ss_dssp E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------
T ss_pred c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC----------
Confidence 4 9999987754 599999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+...
T Consensus 153 ---------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 211 (324)
T 3mtl_A 153 ---------------------PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211 (324)
T ss_dssp -------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0011234578999999999987 568999999999999999999999999998888777
Q ss_pred HHhhcCCC-----CCC----------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 691 NILNRKIP-----WPR----------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 691 kIl~~~~~-----~p~----------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.+...... ++. ....+++++.+||.+||+.||.+|| |++|+|+||||.++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI---SAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSGGGGGG
T ss_pred HHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC---CHHHHhcChhhhhc
Confidence 76542111 110 1135789999999999999999999 99999999999876
Q ss_pred Ch
Q 002953 744 NW 745 (863)
Q Consensus 744 dW 745 (863)
..
T Consensus 289 ~~ 290 (324)
T 3mtl_A 289 GE 290 (324)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=357.42 Aligned_cols=261 Identities=28% Similarity=0.528 Sum_probs=187.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+.+|++++||||+++++++...+.+|+||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 445544 99999999986652 3444332221 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh--------cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 531 LNGGDLYSLLRN--------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 531 ~~GGsL~dlLk~--------~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 999999999974 356999999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
. ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 175 ~--------------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 228 (303)
T 2vwi_A 175 G--------------------------DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228 (303)
T ss_dssp ---------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred C--------------------------CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 0 0000112235679999999999976 568999999999999999999999998
Q ss_pred CCChHHHHHHHhhcCCCC-------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 682 AEHPQQIFDNILNRKIPW-------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~-------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
.................. +.....++.++.+||.+||..||.+|| ++.++++||||+...+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~~ 300 (303)
T 2vwi_A 229 KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---TAAELLRHKFFQKAKNKEFL 300 (303)
T ss_dssp TSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSTTC---------
T ss_pred cCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc---CHHHHhhChhhhcCCCCccc
Confidence 877766655554433211 123356889999999999999999999 99999999999988766543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=347.61 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=195.8
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.|.+. .||+|+||.|+.+. +++|.... ........+.+|+.++..+ +||||+++++++.+.+.+|+|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 45444 99999999996642 34443222 2234556788999999999 89999999999999999999999
Q ss_pred ecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-------------------C
Q 002953 530 YLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-------------------G 586 (863)
Q Consensus 530 y~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-------------------g 586 (863)
|++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CC
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 99999999999765 669999999999999999999999999999999999999844 4
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeec
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWS 665 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWS 665 (863)
.+||+|||++.... ......||+.|+|||++.+. .++.++||||
T Consensus 172 ~~kl~Dfg~~~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 216 (289)
T 1x8b_A 172 MFKIGDLGHVTRIS-----------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADIFA 216 (289)
T ss_dssp CEEECCCTTCEETT-----------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHH
T ss_pred EEEEcccccccccC-----------------------------------CccccCCCccccChhHhcCCCCCCchhhHHH
Confidence 79999999987411 01234699999999999876 5678999999
Q ss_pred hhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 666 VGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 666 LGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
|||++|+|++|.+|+.... ....+.... .+.++..+++++.+||.+||..||.+|| ++.++++||||.+.
T Consensus 217 lG~il~~l~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 217 LALTVVCAAGAEPLPRNGD---QWHEIRQGR--LPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHHTTCCCCCSSSH---HHHHHHTTC--CCCCSSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTCTTC---
T ss_pred HHHHHHHHhcCCCCCcchh---HHHHHHcCC--CCCCCcccCHHHHHHHHHHhCCCcccCC---CHHHHhhChHhhhh
Confidence 9999999999998876543 233444433 3456778999999999999999999999 99999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.61 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=207.4
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
....|.+. +||+|+||.|+.+. +++|+... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 44566655 99999999996542 34443221 2233456688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||+++++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA------ 176 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC------
Confidence 99999999999888778899999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 177 -------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 177 -------------------------PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp --------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -------------------------CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 01122345799999999999875 6899999999999999999999999988877
Q ss_pred HHHHHHhhcC-------------------CCCCCC---------CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 687 QIFDNILNRK-------------------IPWPRV---------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 687 el~~kIl~~~-------------------~~~p~~---------p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
+.+..+.... ..++.. ...+++++.+||.+||+.||.+|| |+.++|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp 308 (331)
T 4aaa_A 232 DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP---FCAELLHHD 308 (331)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSH
T ss_pred HHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC---CHHHHhcCc
Confidence 6665554311 111111 135789999999999999999999 999999999
Q ss_pred CCCCCChhHH
Q 002953 739 FFKDINWDTL 748 (863)
Q Consensus 739 FFk~IdW~~l 748 (863)
||+..+|...
T Consensus 309 ~f~~~~~~~~ 318 (331)
T 4aaa_A 309 FFQMDGFAER 318 (331)
T ss_dssp HHHGGGHHHH
T ss_pred hhccCChhhh
Confidence 9998776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=364.02 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=198.2
Q ss_pred cccceEE-Eeecccceeecccc------ceehhhhh--hchhHHHHHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------QVLKKADM--IRKNAVESILAERDILISVRN--PFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|..++| |||+++++++.+...+|||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3446554 99999999997552 34443322 234455788999999999976 9999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~----- 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD----- 160 (343)
T ss_dssp ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc-----
Confidence 995 5789999999988999999999999999999999999999999999999996 688999999999742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----------CCCCccceeechhHHHHHHHhC
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----------~~ys~ksDIWSLGvILyELLTG 676 (863)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 161 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 161 ------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp ---------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 00112235689999999999975 6688999999999999999999
Q ss_pred CCCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 677 IPPFNAEHP-QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 677 k~PF~~~~~-~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..||..... ...+..+...... ..++...+.++.+||.+||..||.+|| |+.++++||||+.
T Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~ 279 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQI 279 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHS
T ss_pred CCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCC---CHHHHHhCccccc
Confidence 999976533 3344444433322 344667789999999999999999999 9999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=367.83 Aligned_cols=245 Identities=19% Similarity=0.315 Sum_probs=204.8
Q ss_pred cccceEE-Eeecccceeecccc--------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP--------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCR 521 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~ 521 (863)
...|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 3455554 89999999997552 334433222 334567899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999998653 47889999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.+||+|||+++...... .........||+.|+|||++.+..++.++||||
T Consensus 240 ~~~kl~DFG~a~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws 290 (370)
T 2psq_A 240 NVMKIADFGLARDINNID-----------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 290 (370)
T ss_dssp CCEEECCCSSCEETTCCC-----------------------------TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHH
T ss_pred CCEEEccccCCcccCccc-----------------------------ceecccCCCcccceECHhHhcCCCCCcHHHHHH
Confidence 999999999998421100 001122356889999999999999999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 666 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 666 LGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||++|||++ |..||.+.+..+++..+..+.. +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 291 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~ 358 (370)
T 2psq_A 291 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRP---TFKQLVED 358 (370)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999 9999999888888877766543 345678999999999999999999999 99999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=366.93 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=199.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------e
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------N 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~ 523 (863)
..|.+. .||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 345444 89999999996552 34443321 23445567889999999999999999999998765 7
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+|+||||+++ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~-- 179 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 179 (371)
T ss_dssp EEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc--
Confidence 8999999975 8888886 4699999999999999999999999999999999999999999999999999874100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 180 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 180 ------------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123468999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhhcCCCC-------------------CCC--------------CC------CCCHHHHHHHHhhccCCcCC
Q 002953 684 HPQQIFDNILNRKIPW-------------------PRV--------------PE------EMSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~-------------------p~~--------------p~------~iS~el~dLI~k~L~~DP~k 724 (863)
+....+..++...... +.+ +. ..+.++.+||.+||..||.+
T Consensus 230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 8877777765432110 000 00 01567999999999999999
Q ss_pred cCCCCCHHHHHcCCCCCCCChhHHhhccCCccCC
Q 002953 725 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVPT 758 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~ 758 (863)
|| |++++|+||||+...........+|.+|.
T Consensus 310 R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 310 RI---SVDEALQHPYINVWYDPSEAEAPPPKIPD 340 (371)
T ss_dssp SC---CHHHHHHSHHHHTTCCHHHHTCCCCCCCT
T ss_pred CC---CHHHHhCCcchhhhcCccccCCCCCCCCC
Confidence 99 99999999999864333333334555554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.12 Aligned_cols=242 Identities=30% Similarity=0.493 Sum_probs=193.5
Q ss_pred cceE--EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHh-cCCCCeeEEEEEEEe----CCeEEE
Q 002953 461 QIDL--LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILIS-VRNPFVVRFFYSFTC----RENLYL 526 (863)
Q Consensus 461 ~~~l--~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d----~~~lyL 526 (863)
.|.+ .+||+|+||+|+.+. +++|... ....+.+|+.++.+ ++||||++++++|.. ..++||
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeC-----cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 3444 389999999997652 3444321 12356789998854 589999999999886 667999
Q ss_pred EEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCcccccc
Q 002953 527 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~ 601 (863)
|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999999998753 5999999999999999999999999999999999999998 78999999999984110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 217 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 217 --------------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp ------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------------------------CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 011235689999999999999999999999999999999999999997
Q ss_pred CCChH----HHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 682 AEHPQ----QIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 682 ~~~~~----el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+.+.. .+...+..+...++. ....++.++.+||.+||..||.+|| |+.++++||||..
T Consensus 265 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 327 (400)
T 1nxk_A 265 SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327 (400)
T ss_dssp CCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred CCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccC
Confidence 76532 245556666555442 2356899999999999999999999 9999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.67 Aligned_cols=255 Identities=24% Similarity=0.472 Sum_probs=213.1
Q ss_pred ccceEE-Eeecccceeecccc-----ceehhhhhhc---h--------------hHHHHHHHHHHHHHhcCCCCeeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----QVLKKADMIR---K--------------NAVESILAERDILISVRNPFVVRFFY 516 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~---k--------------~~~e~~l~Ei~IL~~L~HPnIVkL~~ 516 (863)
.+|.+. .||+|+||.|+.+. +++|...... . ...+.+.+|+.+|++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 455554 99999999997652 3333322111 1 11277899999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCChHHH------HHh--cCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCc
Q 002953 517 SFTCRENLYLVMEYLNGGDLYSL------LRN--LGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGH 587 (863)
Q Consensus 517 ~f~d~~~lyLVmEy~~GGsL~dl------Lk~--~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~ 587 (863)
++.+.+.+|+||||++||+|.++ +.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc
Confidence 99999999999999999999998 665 4679999999999999999999999 99999999999999999999
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCc-cceeec
Q 002953 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGT-TADWWS 665 (863)
Q Consensus 588 VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~-ksDIWS 665 (863)
+||+|||++..... .......||+.|+|||++.+. .++. ++||||
T Consensus 191 ~kl~dfg~~~~~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s 237 (348)
T 2pml_X 191 VKLSDFGESEYMVD---------------------------------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237 (348)
T ss_dssp EEECCCTTCEECBT---------------------------------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHH
T ss_pred EEEecccccccccc---------------------------------ccccCCCCCcCccCchhhcCCCCCCcchhhHHH
Confidence 99999999874110 122346799999999999887 5666 999999
Q ss_pred hhHHHHHHHhCCCCCCCCCh-HHHHHHHhhcCCCCCCC----------------CCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 666 VGIILFELIVGIPPFNAEHP-QQIFDNILNRKIPWPRV----------------PEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 666 LGvILyELLTGk~PF~~~~~-~el~~kIl~~~~~~p~~----------------p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
|||++|+|++|..||..... .++...+......++.. ...++.++.+||.+||+.||.+||
T Consensus 238 lG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-- 315 (348)
T 2pml_X 238 LGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-- 315 (348)
T ss_dssp HHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC--
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC--
Confidence 99999999999999988776 77777877665554421 156899999999999999999999
Q ss_pred CCHHHHHcCCCCCCCChhHHhh
Q 002953 729 GGASEVKQHVFFKDINWDTLAR 750 (863)
Q Consensus 729 ~SAeEILqHPFFk~IdW~~l~~ 750 (863)
++.++++||||++.+|..+..
T Consensus 316 -s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 316 -TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp -CHHHHHTSGGGTTCCHHHHHH
T ss_pred -CHHHHhcCccccCCCHHHHHH
Confidence 999999999999999988754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.19 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=191.5
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEe
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
.|.+ ..||+|+||+|+.+. +++|+... ...........|+..+.++ +||||+++++++.+.+.+|+|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 4444 499999999997642 34443221 2233444566677666665 89999999999999999999999
Q ss_pred ecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 530 y~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 138 ~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~------- 209 (311)
T 3p1a_A 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT------- 209 (311)
T ss_dssp CC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc-------
Confidence 99 669999887654 599999999999999999999999999999999999999999999999999874110
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........||+.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus 210 -------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--- 260 (311)
T 3p1a_A 210 -------------------------AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--- 260 (311)
T ss_dssp ------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---
T ss_pred -------------------------CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---
Confidence 011234579999999999887 699999999999999999999777655432
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
...+..... .+.++..+++++.+||.+||+.||.+|| |+.++++||||+.
T Consensus 261 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 261 WQQLRQGYL-PPEFTAGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp HHHHTTTCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred HHHHhccCC-CcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 333333322 2234567899999999999999999999 9999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=356.32 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=199.8
Q ss_pred cceE-EEeecccceeeccc-------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEE-------------
Q 002953 461 QIDL-LLAGKGALSEHDDF-------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT------------- 519 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~-------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~------------- 519 (863)
+|.+ ..||+|+||.|+.+ .+++|+.........+.+.+|+.+|++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3444 49999999999655 24555554455566778999999999999999999999874
Q ss_pred -eCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec-CCCcEEEeecCCcc
Q 002953 520 -CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSK 597 (863)
Q Consensus 520 -d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd-~~g~VKLiDFGLAk 597 (863)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 3467899999997 599999975 6799999999999999999999999999999999999997 45799999999997
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhC
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTG 676 (863)
...... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 170 ~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 170 IMDPHY----------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp CC------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred ccCCCc----------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhC
Confidence 421000 00112234578999999999876 6789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCC---------------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPW---------------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~---------------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
..||.+.+..+.+..+....... ......++.++.+||.+||+.||.+||
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--- 298 (320)
T 2i6l_A 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL--- 298 (320)
T ss_dssp SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC---
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC---
Confidence 99999988877777665432110 012246899999999999999999999
Q ss_pred CHHHHHcCCCCCCCChhH
Q 002953 730 GASEVKQHVFFKDINWDT 747 (863)
Q Consensus 730 SAeEILqHPFFk~IdW~~ 747 (863)
++.++++||||+.++|..
T Consensus 299 t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 299 TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHTSHHHHTTCC--
T ss_pred CHHHHhCCcccccccCcc
Confidence 999999999999888753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.61 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=201.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh--------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI--------RKNAVESILAERDILISVRNPFVVRFFYSFTCREN 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 523 (863)
..|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|++++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 345544 89999999997652 233322211 11133457789999999999999999999999999
Q ss_pred EEEEEeecCCC-ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 524 LYLVMEYLNGG-DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 524 lyLVmEy~~GG-sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
+|+||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~- 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER- 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC-
Confidence 99999999776 9999999888999999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 183 -------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 183 -------------------------------GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp -------------------------------TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred -------------------------------CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 011234679999999999998877 889999999999999999999997
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC------CChhHHhh
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD------INWDTLAR 750 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~------IdW~~l~~ 750 (863)
.... ...... ..+..+++++.+||.+||..||.+|| ++.++++||||+. .+|+.+..
T Consensus 232 ~~~~------~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~~~~~~~~~~~~ 294 (335)
T 3dls_A 232 ELEE------TVEAAI---HPPYLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQPVNLADYTWEEVFR 294 (335)
T ss_dssp SGGG------GTTTCC---CCSSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred hHHH------HHhhcc---CCCcccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccCCccccccCHHHHhh
Confidence 6321 122222 23456899999999999999999999 9999999999975 45655543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=364.85 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=202.0
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhch-----hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRK-----NAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k-----~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
...|.+. +||+|+||.|+.+. +++|....... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 3445544 99999999997652 34444332211 11246789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+||||+++ +|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC--
Confidence 99999976 899888765 46999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.
T Consensus 166 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 166 -----------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp -----------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 0112346899999999999764 5899999999999999999999999999
Q ss_pred ChHHHHHHHhhcCC-----CCCC--------------------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 684 HPQQIFDNILNRKI-----PWPR--------------------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 684 ~~~el~~kIl~~~~-----~~p~--------------------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
+..+.+..+..... .++. ....++.++.+||.+||..||.+|| |+.|+++||
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~h~ 293 (346)
T 1ua2_A 217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMK 293 (346)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHHHHTSG
T ss_pred CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC---CHHHHhcCh
Confidence 88888777765311 1110 0145678999999999999999999 999999999
Q ss_pred CCCCCChh
Q 002953 739 FFKDINWD 746 (863)
Q Consensus 739 FFk~IdW~ 746 (863)
||++..|.
T Consensus 294 ~f~~~~~~ 301 (346)
T 1ua2_A 294 YFSNRPGP 301 (346)
T ss_dssp GGTSSSCC
T ss_pred hhhcCCCC
Confidence 99986553
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.67 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=201.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe----E
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN----L 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~----l 524 (863)
..|.+. .||+|+||.|+.+. +++|... .........+.+|+.++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 345554 99999999997553 3344322 2234455678999999999999999999999887653 4
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 170 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG- 170 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc-
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 171 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 171 ---------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp --------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112234679999999999999999999999999999999999999999998
Q ss_pred hHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 685 PQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.......+.......+ .....++.++.+||.+||+.||.+|| ++.+++.|+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~ 278 (311)
T 3ork_A 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHH
Confidence 8887777666543322 12356899999999999999999999 899999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=366.95 Aligned_cols=246 Identities=32% Similarity=0.546 Sum_probs=208.0
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhc--------hhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIR--------KNAVESILAERDILISV-RNPFVVRFFYSFTCREN 523 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~--------k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ 523 (863)
.|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+.+|.++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 45554 89999999996642 3444322211 12245788999999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
.|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~-- 252 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-- 252 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT--
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC--
Confidence 999999999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC------CCCCccceeechhHHHHHHHhCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g------~~ys~ksDIWSLGvILyELLTGk 677 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 253 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 253 ------------------------------GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp ------------------------------TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 012234689999999999864 35789999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.||...+....+..+..+...++. .+..++.++.+||.+||..||.+|| ++.++++||||+
T Consensus 303 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~ 364 (365)
T 2y7j_A 303 PPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364 (365)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCcccC
Confidence 999998888888888777654431 1246889999999999999999999 999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.00 Aligned_cols=237 Identities=25% Similarity=0.421 Sum_probs=195.1
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhh---hhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKA---DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.+. .||+|+||.|+.+. +++|.. ........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 345544 99999999997552 334432 2223455678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET------ 164 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc------
Confidence 99999999999998889999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 165 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 165 ------------------------SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp ----------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred ------------------------cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 01122346799999999999999999999999999999999999999999888776
Q ss_pred HHHHhhcCCCC--CCCCCCCCHHHHHHHHhhccCCcCCcC
Q 002953 689 FDNILNRKIPW--PRVPEEMSPEAHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 689 ~~kIl~~~~~~--p~~p~~iS~el~dLI~k~L~~DP~kRp 726 (863)
..+......+. ...+..+++.+.++|.+||..||.+||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 260 (294)
T 4eqm_A 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260 (294)
T ss_dssp HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHcc
Confidence 66655544321 123467899999999999999999999
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.82 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=187.3
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~l 524 (863)
+|.+. .||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 34443 89999999997652 34554322 2334567788999999999999999999999765 568
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~---- 183 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---- 183 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc----
Confidence 9999999 7899999876 679999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 184 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 233 (367)
T 2fst_X 184 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233 (367)
T ss_dssp -------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01224689999999999987 67899999999999999999999999998
Q ss_pred ChHHHHHHHhhcCC-----------------------CCC-----CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 684 HPQQIFDNILNRKI-----------------------PWP-----RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 684 ~~~el~~kIl~~~~-----------------------~~p-----~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+....+..+..... ..+ ......++++.+||.+||+.||.+|| |+.++|
T Consensus 234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~---t~~e~L 310 (367)
T 2fst_X 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQAL 310 (367)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC---CHHHHH
T ss_pred CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc---CHHHHh
Confidence 88777766654210 001 11235789999999999999999999 999999
Q ss_pred cCCCCCCCCh
Q 002953 736 QHVFFKDINW 745 (863)
Q Consensus 736 qHPFFk~IdW 745 (863)
+||||+.+..
T Consensus 311 ~hp~~~~~~~ 320 (367)
T 2fst_X 311 AHAYFAQYHD 320 (367)
T ss_dssp TSGGGTTTCC
T ss_pred cChhhhhccC
Confidence 9999997654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.51 Aligned_cols=254 Identities=30% Similarity=0.499 Sum_probs=207.3
Q ss_pred ccceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+ ..||+|+||.|+.+. +++|... .....+.+.+|+.+|..++||||+++++++...+.+|+||||+
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEE--TTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 34544 499999999986552 3344322 2234567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-------- 178 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT-------- 178 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--------
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--------
Confidence 99999999974 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 179 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 235 (314)
T 3com_A 179 -----------------------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235 (314)
T ss_dssp -----------------------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred -----------------------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 011234679999999999999999999999999999999999999999888776665
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
.+..........+..++.++.+||.+||..||.+|| ++.++++||||+...+..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCCGGGG
T ss_pred HHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCcchHH
Confidence 555544332233556899999999999999999999 99999999999988765543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=373.95 Aligned_cols=247 Identities=30% Similarity=0.446 Sum_probs=196.5
Q ss_pred cceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLV 527 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~lyLV 527 (863)
.|.+. +||+|+||.|+.+. +++|+... .. ....+|+.+|+.++||||++++++|...+ ++|+|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~-~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-DK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEEC-CT---TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEec-Cc---chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 45544 99999999997652 33333221 11 12347999999999999999999996544 38999
Q ss_pred EeecCCCChHHHHH----hcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec-CCCcEEEeecCCccccccC
Q 002953 528 MEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 528 mEy~~GGsL~dlLk----~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd-~~g~VKLiDFGLAk~~~~~ 602 (863)
|||+++ +|...+. ..+.+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+....
T Consensus 117 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~- 194 (394)
T 4e7w_A 117 LEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA- 194 (394)
T ss_dssp EECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC-
Confidence 999987 4444433 246799999999999999999999999999999999999999 789999999999984211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
.......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.
T Consensus 195 -------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 195 -------------------------------GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp -------------------------------TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 0112346789999999999775 58999999999999999999999999
Q ss_pred CCChHHHHHHHhhcC-----------------CCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 682 AEHPQQIFDNILNRK-----------------IPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 682 ~~~~~el~~kIl~~~-----------------~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+.+..+.+..+.... ..++. ++..+++++.+||.+||+.||.+|| |+.+++
T Consensus 244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l 320 (394)
T 4e7w_A 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL---TAIEAL 320 (394)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC---CHHHHh
Confidence 988877776665421 11111 2345889999999999999999999 999999
Q ss_pred cCCCCCCCChhH
Q 002953 736 QHVFFKDINWDT 747 (863)
Q Consensus 736 qHPFFk~IdW~~ 747 (863)
+||||+++.|..
T Consensus 321 ~hp~f~~~~~~~ 332 (394)
T 4e7w_A 321 CHPFFDELRTGE 332 (394)
T ss_dssp TSGGGSTTTSSC
T ss_pred cChhhhhhcccc
Confidence 999999988754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=357.35 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=194.0
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE--
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL-- 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l-- 524 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 345544 99999999997552 23443222 1344567899999999999999999999999887665
Q ss_pred ----EEEEeecCCCChHHHHHhcC------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecC
Q 002953 525 ----YLVMEYLNGGDLYSLLRNLG------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594 (863)
Q Consensus 525 ----yLVmEy~~GGsL~dlLk~~g------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFG 594 (863)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 99999999999999996542 58999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002953 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 595 LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL 674 (863)
+++...... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 183 ~a~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 183 LSRKIYSGD-----------------------------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp C----------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccc-----------------------------cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH
Confidence 997421100 001122345788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC-------HHHHHcCCCCCCCChh
Q 002953 675 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG-------ASEVKQHVFFKDINWD 746 (863)
Q Consensus 675 T-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~S-------AeEILqHPFFk~IdW~ 746 (863)
+ |.+||.+.+..++...+..... +..+..+++++.+||.+||..||.+|| + ++++++|||+....++
T Consensus 234 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 234 TRGQTPYAGIENAEIYNYLIGGNR--LKQPPECMEEVYDLMYQCWSADPKQRP---SFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHHHHHHHC---------
T ss_pred hCCCCCccccChHHHHHHHhcCCC--CCCCCccCHHHHHHHHHHccCChhhCc---CHHHHHHHHHHHHHHhhhcCCCCC
Confidence 9 9999999888888888776543 334677999999999999999999999 7 7889999999887665
Q ss_pred HHh
Q 002953 747 TLA 749 (863)
Q Consensus 747 ~l~ 749 (863)
.+.
T Consensus 309 pl~ 311 (323)
T 3qup_A 309 PLY 311 (323)
T ss_dssp ---
T ss_pred CCC
Confidence 554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=355.80 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=195.6
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEe--CCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTC--RENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d--~~~lyLVm 528 (863)
..|.+. .||+|+||+|+.+. +++|.. .....+.+.+|+.+|++++ ||||+++++++.+ ....|+||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~---~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE---CSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEe---cccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 445554 99999999997652 333332 2334567889999999997 9999999999998 66799999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+++++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~------ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP------ 183 (330)
T ss_dssp ECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT------
T ss_pred eccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC------
Confidence 99999999998854 89999999999999999999999999999999999999776 899999999974210
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC-Ch
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE-HP 685 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~-~~ 685 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +.
T Consensus 184 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 184 --------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp --------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred --------------------------CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 011234679999999999987 66899999999999999999999999543 32
Q ss_pred HHHHHHHhh-------------cCCCC---------------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 686 QQIFDNILN-------------RKIPW---------------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 686 ~el~~kIl~-------------~~~~~---------------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
.+.+..+.. ..... ...+..+++++.+||.+||+.||.+|| |+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta 314 (330)
T 3nsz_A 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL---TA 314 (330)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC---CH
T ss_pred HHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC---CH
Confidence 222222211 11110 011123799999999999999999999 99
Q ss_pred HHHHcCCCCCCCChh
Q 002953 732 SEVKQHVFFKDINWD 746 (863)
Q Consensus 732 eEILqHPFFk~IdW~ 746 (863)
+++|+||||+++.|+
T Consensus 315 ~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 315 REAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHTSGGGTTCC--
T ss_pred HHHhcCccHhhhccC
Confidence 999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=360.82 Aligned_cols=256 Identities=29% Similarity=0.396 Sum_probs=202.3
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-------
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR------- 521 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------- 521 (863)
...|.+. .||+|+||.|+.+. +++|+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4556654 99999999996552 344433222 222345678999999999999999999999874
Q ss_pred -CeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 522 -ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 522 -~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
+.+|+||||+.| +|...+... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 468999999975 787777654 57999999999999999999999999999999999999999999999999999752
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 175 ~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 175 SLAKNS---------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp CCCSSS---------------------------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccc---------------------------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 111000 0112235689999999999987 458999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCC-CCCC----------------------------CCHHHHHHHHhhccCCcCCcCCCC
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPR-VPEE----------------------------MSPEAHDLIDRFLTEDPHQRLGSG 729 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~-~p~~----------------------------iS~el~dLI~k~L~~DP~kRpg~~ 729 (863)
||.+.+.......+......++. .... .++++.+||.+||+.||.+||
T Consensus 228 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--- 304 (351)
T 3mi9_A 228 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI--- 304 (351)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC---
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC---
Confidence 99999888877776553222111 1111 267899999999999999999
Q ss_pred CHHHHHcCCCCCCCCh
Q 002953 730 GASEVKQHVFFKDINW 745 (863)
Q Consensus 730 SAeEILqHPFFk~IdW 745 (863)
|++++|+||||....+
T Consensus 305 t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 305 DSDDALNHDFFWSDPM 320 (351)
T ss_dssp CHHHHHTSGGGGSSSC
T ss_pred CHHHHhCCCCcCCCCC
Confidence 9999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.34 Aligned_cols=243 Identities=29% Similarity=0.470 Sum_probs=197.8
Q ss_pred cccceEE-Eeecccceeecccc-----ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
...|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+++|++++||||+++++++.+.+.+|+||||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 3455554 99999999997652 33333221 2334556789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC---CChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 531 LNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~---L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
++||+|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---- 191 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS---- 191 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc----
Confidence 999999999987653 999999999999999999999999 99999999999999999999999999874110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 192 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 192 ---------------------------TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp -------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ---------------------------cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 00112346799999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+....+...... ...+..+++++.+||.+||..||.+|| ++.++++
T Consensus 245 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~ 291 (309)
T 3p86_A 245 AQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRP---SFATIMD 291 (309)
T ss_dssp HHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 8877776543332 345678999999999999999999999 8999886
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.51 Aligned_cols=247 Identities=25% Similarity=0.415 Sum_probs=181.4
Q ss_pred Eeecccceeecccc---------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLVmEy~~GG 534 (863)
+||+|+||+|+.+. +++|... .......+.+|+.+|++++|||||+++++|.. ...+||||||+.|
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~- 104 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECS--SSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-
Confidence 79999999997653 3344322 22233468899999999999999999999955 6789999999964
Q ss_pred ChHHHHHhc---------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee----cCCCcEEEeecCCcccccc
Q 002953 535 DLYSLLRNL---------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 535 sL~dlLk~~---------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL----d~~g~VKLiDFGLAk~~~~ 601 (863)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+....
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 184 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCC
Confidence 888887632 249999999999999999999999999999999999999 6678999999999984210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
. ..........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 185 ~----------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 236 (405)
T 3rgf_A 185 P----------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236 (405)
T ss_dssp ----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred C----------------------------CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCC
Confidence 0 0001123356899999999999884 4899999999999999999999999
Q ss_pred CCCCh---------HHHHHHHhhcCC-CCCC----------------------------------CCCCCCHHHHHHHHh
Q 002953 681 NAEHP---------QQIFDNILNRKI-PWPR----------------------------------VPEEMSPEAHDLIDR 716 (863)
Q Consensus 681 ~~~~~---------~el~~kIl~~~~-~~p~----------------------------------~p~~iS~el~dLI~k 716 (863)
.+... .+.+..+...-. +... .....+.++.+||.+
T Consensus 237 ~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~ 316 (405)
T 3rgf_A 237 HCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316 (405)
T ss_dssp CCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH
T ss_pred CCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH
Confidence 76554 233333332110 0000 011237789999999
Q ss_pred hccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 717 FLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 717 ~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
||+.||.+|| |++|+|+||||.+..|.
T Consensus 317 ~L~~dP~~R~---ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 317 LLTMDPIKRI---TSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp HSCSSGGGSC---CHHHHHTSGGGTSSSCC
T ss_pred HccCCcccCC---CHHHHhcChhhccCCCC
Confidence 9999999999 99999999999986554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=377.31 Aligned_cols=252 Identities=31% Similarity=0.549 Sum_probs=194.9
Q ss_pred cceEE-Eeecccceeecccc-------ceehh---hhhh-----chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKK---ADMI-----RKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~-----~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
.|.+. .||+|+||+|+.+. +++|. .... .......+.+|+.+|++++||||+++++++. .+.+
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 45544 89999999997652 23332 2111 1112235789999999999999999999885 4568
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCCcccccc
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGLSKVGLI 601 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGLAk~~~~ 601 (863)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~ 294 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCC
Confidence 99999999999999998888999999999999999999999999999999999999997654 599999999984110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus 295 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 295 --------------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp ------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 012235689999999999864 567889999999999999999999
Q ss_pred CCCCCChH-HHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 679 PFNAEHPQ-QIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 679 PF~~~~~~-el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
||...... .+...+..+...++ ..+..+++++.+||.+||+.||.+|| ++.++|+||||++.+|...
T Consensus 343 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp SSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGCCHHHHHH
T ss_pred CCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHHhCCcccCChhHHHH
Confidence 99765433 34444544444332 22356899999999999999999999 9999999999999887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.72 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=203.7
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe------CCe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC------REN 523 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d------~~~ 523 (863)
...|.+. .||+|+||.|+.+. +++|... ........+.+|+.+|+++ +||||+++++++.. .+.
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-CCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEe-cCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 3455554 99999999997652 2333322 2233456788999999999 79999999999987 468
Q ss_pred EEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccccc
Q 002953 524 LYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~ 601 (863)
+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999999864 4699999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTG 676 (863)
.........||+.|+|||++. +..++.++|||||||++|+|++|
T Consensus 182 -------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 182 -------------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp ----------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHS
T ss_pred -------------------------------CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhC
Confidence 001123457999999999997 56689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
..||...+.......+.....+. ..+..++..+.+||.+||..||.+|| ++.++++||||++..+...
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 231 APPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKHPFIRDQPNERQ 298 (326)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCC-CSCSCSCHHHHHHHHHHCCSSGGGSC---CHHHHHTSHHHHCCTTHHH
T ss_pred CCCCCCCcHHHHHHHhhcCcccc-CCccccCHHHHHHHHHHhccChhhCC---CHHHHhhChHHhhCccccc
Confidence 99999888777766665544321 22456899999999999999999999 9999999999998877543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=349.94 Aligned_cols=245 Identities=29% Similarity=0.419 Sum_probs=196.4
Q ss_pred EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.+||+|+||.|+.+. +++|..........+.+.+|+.+++.++||||+++++++...+.+|+||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 389999999996552 3444443334445677899999999999999999999999999999999999999999
Q ss_pred HHHHhcC---CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-CCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 538 SLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 538 dlLk~~g---~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~----------- 176 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI----------- 176 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------------
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-----------
Confidence 9998652 4678889999999999999999999999999999999988 899999999998742100
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCChHH-HHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG--HGTTADWWSVGIILFELIVGIPPFNAEHPQQ-IFD 690 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGvILyELLTGk~PF~~~~~~e-l~~ 690 (863)
........||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ...
T Consensus 177 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (295)
T 2clq_A 177 --------------------NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF 236 (295)
T ss_dssp ------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH
T ss_pred --------------------CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH
Confidence 01123467999999999997643 8899999999999999999999997643322 222
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
...... ..+.++..++.++.+||.+||..||.+|| ++.++++||||+...
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 237 KVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSC---CHHHHHTSGGGCC--
T ss_pred hhcccc-ccccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhhcc
Confidence 221111 22445678999999999999999999999 999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.66 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=201.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCC------eeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPF------VVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPn------IVkL~~~f~d~~~ly 525 (863)
..|.+. .||+|+||+|+.+. .++.|.........+.+.+|+.+|+.++|++ ++.+++++...+.+|
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 345554 99999999997542 1222222223345567889999999987655 999999999999999
Q ss_pred EEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee-------------------cC
Q 002953 526 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-------------------AH 584 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL-------------------d~ 584 (863)
+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence 999999 66888877665 369999999999999999999999999999999999999 56
Q ss_pred CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceee
Q 002953 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664 (863)
Q Consensus 585 ~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 664 (863)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||
T Consensus 178 ~~~~kl~Dfg~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 223 (355)
T 2eu9_A 178 NTSIRVADFGSATFDH----------------------------------EHHTTIVATRHYRPPEVILELGWAQPCDVW 223 (355)
T ss_dssp CCCEEECCCTTCEETT----------------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred CCcEEEeecCcccccc----------------------------------ccccCCcCCCcccCCeeeecCCCCCccchH
Confidence 7899999999987410 112346799999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCC-----------------------------------------CC
Q 002953 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-----------------------------------------VP 703 (863)
Q Consensus 665 SLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~-----------------------------------------~p 703 (863)
||||++|||++|.+||...+..+....+.......|. ..
T Consensus 224 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (355)
T 2eu9_A 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303 (355)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccccccc
Confidence 9999999999999999988776655544332111110 00
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 704 ~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
...+.++.+||.+||+.||.+|| |+.++++||||++++|+...
T Consensus 304 ~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 304 SLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHHC
T ss_pred chhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhcc
Confidence 11245788999999999999999 99999999999999987553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.96 Aligned_cols=249 Identities=26% Similarity=0.492 Sum_probs=202.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehh---hhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEE--eCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKK---ADMI-RKNAVESILAERDILISVRNPFVVRFFYSFT--CRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~--d~~~lyL 526 (863)
.|.+. .||+|+||.|+.+. +++|. .... .......+.+|+.+|+.++||||+++++++. ....+|+
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 34443 89999999996542 23332 2211 1344577999999999999999999999984 4567999
Q ss_pred EEeecCCCChHHHHHh--cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 527 VMEYLNGGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~--~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||||+.++ |.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~- 163 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA- 163 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc-
Confidence 99999875 7777765 3569999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC--CccceeechhHHHHHHHhCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH--GTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y--s~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.........||+.|+|||++.+... +.++|||||||++|+|++|..||.+
T Consensus 164 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 164 ----------------------------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ----------------------------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------------------------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0012234679999999999987543 7899999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.+..+.+..+...... ++..+++++.+||.+||..||.+|| ++.++++||||+....
T Consensus 216 ~~~~~~~~~i~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 216 DNIYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSHHHHHHHHHHCCCC---CCSSSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHHSCCC
T ss_pred chHHHHHHHHhcCCCC---CCCccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccccCCC
Confidence 9988888888776653 3567899999999999999999999 9999999999987544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=355.07 Aligned_cols=244 Identities=25% Similarity=0.428 Sum_probs=198.1
Q ss_pred cceEE-Eeecccceeecccc--------ceehhhhhhchhHHHHHHHHHHHHHhcCCC------CeeEEEEEEEeCCeEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP--------QVLKKADMIRKNAVESILAERDILISVRNP------FVVRFFYSFTCRENLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HP------nIVkL~~~f~d~~~ly 525 (863)
+|.+. .||+|+||.|+.+. +++|.. .......+.+.+|+.+|+.++|+ +|+++++++...+.+|
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEE-CSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEE-ecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 45554 99999999997542 233322 22334556788999999988655 5999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-------------------
Q 002953 526 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH------------------- 584 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~------------------- 584 (863)
+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence 999999 889999998765 6889999999999999999999999999999999999987
Q ss_pred CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceee
Q 002953 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664 (863)
Q Consensus 585 ~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 664 (863)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||
T Consensus 173 ~~~~kl~Dfg~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 218 (339)
T 1z57_A 173 NPDIKVVDFGSATYDD----------------------------------EHHSTLVSTRHYRAPEVILALGWSQPCDVW 218 (339)
T ss_dssp CCCEEECCCSSCEETT----------------------------------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHH
T ss_pred CCCceEeeCcccccCc----------------------------------cccccccCCccccChHHhhCCCCCcchhhH
Confidence 6689999999987410 112346899999999999999999999999
Q ss_pred chhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCC-----------------------------------------CCC
Q 002953 665 SVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP-----------------------------------------RVP 703 (863)
Q Consensus 665 SLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p-----------------------------------------~~p 703 (863)
||||++|||++|..||...+..+....+.....++| ...
T Consensus 219 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (339)
T 1z57_A 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298 (339)
T ss_dssp HHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence 999999999999999998887665554432211111 001
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 704 ~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
...++++.+||.+||..||.+|| |+.|+++||||+.+
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 335 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLL 335 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGG
T ss_pred hhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHH
Confidence 22357789999999999999999 99999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=373.77 Aligned_cols=246 Identities=28% Similarity=0.430 Sum_probs=195.0
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~lyL 526 (863)
.|.+. +||+|+||.|+.+. +++|+.... .....+|+++|+.++|||||+++++|... .++++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 45443 89999999997652 344433211 12234799999999999999999988542 24789
Q ss_pred EEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCcccccc
Q 002953 527 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLI 601 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~ 601 (863)
||||+++ +|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++....
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9999976 67666543 4679999999999999999999999999999999999999965 6789999999984210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.......+||+.|+|||++.+. .|+.++|||||||++|||++|++||
T Consensus 210 --------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf 257 (420)
T 1j1b_A 210 --------------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257 (420)
T ss_dssp --------------------------------TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred --------------------------------CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 0112346899999999999875 7899999999999999999999999
Q ss_pred CCCChHHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 681 NAEHPQQIFDNILNR-----------------KIPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 681 ~~~~~~el~~kIl~~-----------------~~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
.+.+..+.+.+++.. ...++. ++..+++++.+||.+||..||.+|| ++.++
T Consensus 258 ~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~---t~~e~ 334 (420)
T 1j1b_A 258 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEA 334 (420)
T ss_dssp CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC---CHHHH
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC---CHHHH
Confidence 998877766666541 112222 2345789999999999999999999 99999
Q ss_pred HcCCCCCCCChh
Q 002953 735 KQHVFFKDINWD 746 (863)
Q Consensus 735 LqHPFFk~IdW~ 746 (863)
++||||+.+.+.
T Consensus 335 l~hp~f~~~~~~ 346 (420)
T 1j1b_A 335 CAHSFFDELRDP 346 (420)
T ss_dssp HTSGGGGGGGCT
T ss_pred hCCHhhcccccc
Confidence 999999876554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=367.34 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=200.3
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhh--hchhHHHHHHHHHHHHHhcC--CCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADM--IRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|.++. ||||+++++++...+.+||||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 345554 99999999997552 34443322 23455678999999999996 599999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~------ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD------ 207 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC------
Confidence 9 55889999999888899999999999999999999999999999999999995 689999999999842100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----------CCCCccceeechhHHHHHHHhCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----------~~ys~ksDIWSLGvILyELLTGk 677 (863)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 208 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 208 -----------------------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp -----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 00012235689999999999976 35889999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 678 PPFNAEH-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 678 ~PF~~~~-~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+||.... ....+..++..... ..++...+.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 265 ~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~ 327 (390)
T 2zmd_A 265 TPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQIQ 327 (390)
T ss_dssp CTTTTCCCHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHSC
T ss_pred CcchhhhHHHHHHHHHhCcccc-CCCCccchHHHHHHHHHHcccChhhCC---CHHHHhhCcCcccc
Confidence 9998754 33455555554433 234566789999999999999999999 99999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.01 Aligned_cols=241 Identities=27% Similarity=0.375 Sum_probs=203.7
Q ss_pred EEEeecccceeecccc-------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
+..||+|+||.|+.+. +++|+... ......+.+.+|+++|++++||||+++++++...+..|+||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 3489999999997552 34444322 223445678999999999999999999999999999999999997
Q ss_pred CChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 138 g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------------ 205 (348)
T 1u5q_A 138 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------------ 205 (348)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------------
T ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------------
Confidence 588888754 4679999999999999999999999999999999999999999999999999987410
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.....+||+.|+|||++. +..++.++|||||||++|||++|.+||...+.....
T Consensus 206 -----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 262 (348)
T 1u5q_A 206 -----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 262 (348)
T ss_dssp -----------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -----------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 112467999999999995 466899999999999999999999999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
..+.....+. ..+..+++.+.+||.+||+.||.+|| |++++++||||....
T Consensus 263 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 263 YHIAQNESPA-LQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHSCCCC-CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSCC
T ss_pred HHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhccC
Confidence 7776655432 23457899999999999999999999 999999999996543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=364.45 Aligned_cols=250 Identities=30% Similarity=0.488 Sum_probs=202.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~lyL 526 (863)
.|.+. .||+|+||.|+.+. +++|+... ........+.+|+++|.+++||||+++++++... ..+|+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 45554 99999999997652 34454332 2234457789999999999999999999999765 36899
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-- 183 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD-- 183 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC--
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC--
Confidence 999996 499999976 5799999999999999999999999999999999999999999999999999984211000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 184 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 184 --------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp --------------------------BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred --------------------------ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 0011234689999999998765 5589999999999999999999999998887
Q ss_pred HHHHHHHhhcCC----------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 686 QQIFDNILNRKI----------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 686 ~el~~kIl~~~~----------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+.+..+..... ++......+++++.+||.+||+.||.+|| |+.++|+|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~h 314 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---EVEQALAH 314 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC---CHHHHhcC
Confidence 776666643110 01112246789999999999999999999 99999999
Q ss_pred CCCCCC
Q 002953 738 VFFKDI 743 (863)
Q Consensus 738 PFFk~I 743 (863)
|||+..
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=364.18 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=190.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC--------CCCeeEEEEEEE----
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR--------NPFVVRFFYSFT---- 519 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~--------HPnIVkL~~~f~---- 519 (863)
.+|.+. .||+|+||+|+.+. +++|... ......+.+.+|+.+|+.+. ||||++++++|.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEe-cCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 345554 99999999997662 3344322 23345677899999999985 788999999998
Q ss_pred eCCeEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCC----------
Q 002953 520 CRENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDG---------- 586 (863)
Q Consensus 520 d~~~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g---------- 586 (863)
....+||||||+ +++|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456899999999 56777776554 4699999999999999999999998 999999999999998775
Q ss_pred ---------------------------------------cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchh
Q 002953 587 ---------------------------------------HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTA 627 (863)
Q Consensus 587 ---------------------------------------~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~ 627 (863)
.+||+|||+|....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--------------------------- 247 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--------------------------- 247 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT---------------------------
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc---------------------------
Confidence 79999999997411
Q ss_pred hhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh------HHHHHHHhhcCCCCC-
Q 002953 628 SEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP------QQIFDNILNRKIPWP- 700 (863)
Q Consensus 628 ~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~------~el~~kIl~~~~~~p- 700 (863)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+. ......+.......|
T Consensus 248 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~ 320 (397)
T 1wak_A 248 -------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPR 320 (397)
T ss_dssp -------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCH
T ss_pred -------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCCh
Confidence 112345799999999999999999999999999999999999999976542 222222221100000
Q ss_pred --------------------------------------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 701 --------------------------------------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 701 --------------------------------------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..+...+.++.+||.+||+.||.+|| |+.++|+||||++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~ 397 (397)
T 1wak_A 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA---TAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC---CHHHHHTSGGGGC
T ss_pred HHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC---CHHHHhhCccccC
Confidence 01122356788999999999999999 9999999999963
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.62 Aligned_cols=242 Identities=31% Similarity=0.541 Sum_probs=207.0
Q ss_pred EEEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+..||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++.....+|+||||++|++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 4599999999997652 334433222 13456789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCc
Q 002953 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGT 615 (863)
Q Consensus 536 L~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~ 615 (863)
|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~------------- 172 (303)
T 3a7i_A 107 ALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT------------- 172 (303)
T ss_dssp HHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT-------------
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc-------------
Confidence 9999875 67999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 616 TLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 616 ~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 173 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (303)
T 3a7i_A 173 ------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234 (303)
T ss_dssp ------------------BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ------------------ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC
Confidence 01123467999999999999999999999999999999999999999988887777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 696 ~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.. +..+..++..+.+||.+||..||.+|| ++.++++||||..
T Consensus 235 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 235 NP--PTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILR 276 (303)
T ss_dssp CC--CCCCSSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHH
T ss_pred CC--CCCccccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhc
Confidence 43 345678999999999999999999999 9999999999953
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.45 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=202.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-----CeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCR-----ENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~ly 525 (863)
..|.+. .||+|+||.|+.+. +++|.... ........+.+|+.+|++++||||+++++++... ..+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 345544 99999999996552 34444332 2234456788999999999999999999988765 6799
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 9999996 599999876 67999999999999999999999999999999999999999999999999999852111000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
..............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+
T Consensus 169 ---------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 169 ---------------------NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ---------------------ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0000000112335689999999999865 678999999999999999999999999888
Q ss_pred hHHHHHHHhhcCC------------------------CCC-----CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 685 PQQIFDNILNRKI------------------------PWP-----RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 685 ~~el~~kIl~~~~------------------------~~p-----~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
....+..+..... ..+ .....+++++.+||.+||..||.+|| |+.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell 304 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI---TAKEAL 304 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC---CHHHHH
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC---CHHHHh
Confidence 7665554432100 000 01246899999999999999999999 999999
Q ss_pred cCCCCCCCChhH
Q 002953 736 QHVFFKDINWDT 747 (863)
Q Consensus 736 qHPFFk~IdW~~ 747 (863)
+||||+.+.+..
T Consensus 305 ~hp~~~~~~~~~ 316 (353)
T 2b9h_A 305 EHPYLQTYHDPN 316 (353)
T ss_dssp TSGGGTTTCCTT
T ss_pred cCccccccCCcc
Confidence 999999887643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.59 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=199.3
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc------CCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV------RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L------~HPnIVkL~~~f~d~~~lyL 526 (863)
+|.+. +||+|+||+|+.+. +++|.. .........+.+|+.+|..+ +|+||+++++++...+.+|+
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~-~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEE-CSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEE-CCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 45544 99999999997652 233332 22334456778899999887 57899999999999999999
Q ss_pred EEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc--EEEeecCCccccccC
Q 002953 527 VMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKVGLIN 602 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~--VKLiDFGLAk~~~~~ 602 (863)
||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|....
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~-- 253 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-- 253 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--
Confidence 999996 59999997753 4999999999999999999999999999999999999999887 9999999987410
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
....+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+
T Consensus 254 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 254 --------------------------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp --------------------------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 112346899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCC--------------------CCC------------------------------------CCCCC
Q 002953 683 EHPQQIFDNILNRKIP--------------------WPR------------------------------------VPEEM 706 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~--------------------~p~------------------------------------~p~~i 706 (863)
.+..+.+..+...... ++. ++...
T Consensus 302 ~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 381 (429)
T 3kvw_A 302 EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381 (429)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCC
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccc
Confidence 8887777666532100 000 11234
Q ss_pred CHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 707 SPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 707 S~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
++++.+||.+||+.||.+|| |+.|+|+||||+..
T Consensus 382 ~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRRR 415 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC--
T ss_pred hHHHHHHHHHHCCCChhhCC---CHHHHhCChhhccC
Confidence 78899999999999999999 99999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.02 Aligned_cols=244 Identities=25% Similarity=0.396 Sum_probs=193.8
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
....|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++. ++.+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34455554 89999999996542 33343222 23345567899999999999999999999884 56789
Q ss_pred EEEeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 169 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc--
Confidence 9999999999999998654 6999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~ 683 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.
T Consensus 170 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 170 ----------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ----------------------------cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 0011223467889999999999999999999999999999996 99999998
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...+....+..... +..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 222 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 270 (281)
T 1mp8_A 222 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 270 (281)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 88888877766543 345678999999999999999999999 89998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.38 Aligned_cols=248 Identities=29% Similarity=0.519 Sum_probs=206.3
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyL 526 (863)
...|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 3455554 99999999986542 23333321 234456789999999999999999999998854 568999
Q ss_pred EEeecCCCChHHHHHhc----CCCChhhHHHHHHHHHHHHHHHHhCC-----ccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 527 VMEYLNGGDLYSLLRNL----GCLDEDVARVYIAEVVLALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~----g~L~e~~i~~Ia~QIl~ALeyLHs~G-----IIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
||||++|++|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999764 34999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk 677 (863)
.... .........||+.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 165 ~~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 165 ILNH-------------------------------DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp HC----------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred eecc-------------------------------ccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 4100 001112357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 678 PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 678 ~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.||...+..++...+..+.. +.++..++.++.+||.+||..||.+|| ++.++++|+|+..
T Consensus 214 ~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 214 PPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENPLILE 273 (279)
T ss_dssp CSSCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTCCG
T ss_pred CCCcccCHHHHHHHHhhccc--ccCCcccCHHHHHHHHHHcCCCcccCC---CHHHHHhChhhhh
Confidence 99999988888888877654 345678999999999999999999999 9999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.40 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=203.7
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
...|.+. +||+|+||+|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 3456554 99999999996542 344443322 34455779999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 527 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 206 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD- 206 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-----
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc-
Confidence 99999999999999765 5799999999999999999999999999999999999999999999999999985211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~ 684 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 207 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 207 ---------------------------AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ---------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ---------------------------ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 0011223457889999999999999999999999999999999 999999999
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..++...+..... +..+..+++++.+||.+||..||.+|| ++.+|++.
T Consensus 260 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~~ 307 (325)
T 3kul_A 260 NRDVISSVEEGYR--LPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVSV 307 (325)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 8888888766532 234678999999999999999999999 88888863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=366.99 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=207.5
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
..|.+. .||+|+||+|+.+. +++|.... ........+.+|+.+|++++||||+++++++......|
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 345444 89999999997654 34444322 23445567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC-------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC---cEEEeecCC
Q 002953 526 LVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG---HIKLTDFGL 595 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g-------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g---~VKLiDFGL 595 (863)
+|||||+||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999999998653 488999999999999999999999999999999999999655 599999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT 675 (863)
|+..... ..........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 231 a~~~~~~-----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 231 ARDIYRA-----------------------------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp HHHHHHH-----------------------------SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccccccc-----------------------------cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9742110 00112234678999999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 676 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 676 -Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
|.+||...+..+++..+..+.. +..+..++..+.+||.+||+.||.+|| ++.+|++|.++-
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~eil~~l~~~ 343 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEYC 343 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCCHhHCc---CHHHHHHHHHHH
Confidence 9999999999888888876653 234577999999999999999999999 999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.67 Aligned_cols=251 Identities=31% Similarity=0.456 Sum_probs=202.9
Q ss_pred ccceEE-Eeecccceeecccc--------ceehhhhhhc--hhHHHHHHHHHHHHHhc---CCCCeeEEEEEEE-----e
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------QVLKKADMIR--KNAVESILAERDILISV---RNPFVVRFFYSFT-----C 520 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~-----d 520 (863)
..|.+. .||+|+||.|+.+. +++|...... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 445554 99999999997552 2333322111 11223466788887766 8999999999987 5
Q ss_pred CCeEEEEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...+|+||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 567999999997 59999998753 499999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
... ........||+.|+|||++.+..++.++|||||||++|+|++|.+
T Consensus 170 ~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 170 YSF--------------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CCG--------------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccC--------------------------------CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 100 012235689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCC------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 679 PFNAEHPQQIFDNILNRKI------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
||.+.+....+..++.... ....+...++..+.+||.+||..||.+|| ++.++
T Consensus 218 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~ 294 (326)
T 1blx_A 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSA 294 (326)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC---CHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC---CHHHH
Confidence 9999888877777654210 01122356899999999999999999999 99999
Q ss_pred HcCCCCCCCChh
Q 002953 735 KQHVFFKDINWD 746 (863)
Q Consensus 735 LqHPFFk~IdW~ 746 (863)
++||||+++++.
T Consensus 295 l~hp~~~~~~~~ 306 (326)
T 1blx_A 295 LSHPYFQDLERC 306 (326)
T ss_dssp HTSGGGTTCCCC
T ss_pred hcCccccccchh
Confidence 999999988764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=342.75 Aligned_cols=242 Identities=20% Similarity=0.347 Sum_probs=204.1
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. .||+|+||.|+.+. +++|+.. ......+.+.+|+++|++++||||+++++++.+.+.+|+||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEEC-TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEec-ccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 345544 99999999997652 2333322 222334678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 158 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---------- 158 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC----------
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc----------
Confidence 99999999764 5689999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+...
T Consensus 159 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 159 --------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp --------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred --------------------cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 01122334567889999999999999999999999999999999 999999999988888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..... +..+..+++++.+||.+||..||.+|| ++.++++|
T Consensus 219 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 219 DISTGFR--LYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp HHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCcc--CCCCCcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 8876543 234567899999999999999999999 99999876
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.32 Aligned_cols=243 Identities=20% Similarity=0.323 Sum_probs=201.6
Q ss_pred cccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
...|.+. .||+|+||.|+.+. +++|... ......+.+.+|+++|.+++||||+++++++.+.+.+|+||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEEC-TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEec-CCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 3455554 99999999996542 2333322 22223467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~--------- 172 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--------- 172 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC---------
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc---------
Confidence 99999999977 46799999999999999999999999999999999999999999999999999874110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
..........||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 173 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~ 231 (283)
T 3gen_A 173 ---------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231 (283)
T ss_dssp ---------------------HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ---------------------cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH
Confidence 01122234567889999999999999999999999999999998 99999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+...... ..+...++.+.+||.+||+.||.+|| ++.++++|
T Consensus 232 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 232 EHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHhcccCC--CCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 887765432 33567899999999999999999999 99999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.66 Aligned_cols=243 Identities=18% Similarity=0.270 Sum_probs=196.6
Q ss_pred ccceEE-Eeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
..|.+. +||+|+||+|+.+. +++|.... ........+.+|+.++.+++||||+++++++. .+..|+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 445544 99999999997653 12222111 11223345778999999999999999999886 567999
Q ss_pred EEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 527 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 170 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK- 170 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT-
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc-
Confidence 99999999999999774 5799999999999999999999999999999999999999999999999999985211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~ 684 (863)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 171 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 171 ----------------------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp ----------------------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ----------------------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence 011234578889999999999999999999999999999999 999999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..++...+..... +..+..++.++.+||.+||..||.+|| ++.++++|
T Consensus 223 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 223 LAEVPDLLEKGER--LAQPQICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp TTHHHHHHHTTCB--CCCCTTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 8777777765543 234567889999999999999999999 99999886
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.94 Aligned_cols=253 Identities=23% Similarity=0.406 Sum_probs=197.6
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
...|.+. +||+|+||+|+.+. +++|+.........+.+.+|+.+|++++||||+++++++.+.+.+|+||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4445544 99999999996652 345544444556678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP--- 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc---
Confidence 999999999987 4679999999999999999999999999999999999999999999999999998521111000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH--
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ-- 687 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e-- 687 (863)
.................+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 166 --------------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 166 --------------EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp ----------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred --------------cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 0000000011223346789999999999999999999999999999999999999986533211
Q ss_pred ---HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 ---IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 ---l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
........ ..+..+++++.+||.+||+.||.+|| ++.++++
T Consensus 232 ~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~ 275 (310)
T 3s95_A 232 FGLNVRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRP---SFVKLEH 275 (310)
T ss_dssp SSBCHHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred Hhhhhhccccc-----cCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 01111111 12467889999999999999999999 8999886
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.79 Aligned_cols=251 Identities=32% Similarity=0.560 Sum_probs=199.2
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh--------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI--------RKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
.|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|++++||||+++++++..+. +
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 44444 89999999997652 233322111 1122345789999999999999999999987665 8
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc---EEEeecCCcccccc
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKVGLI 601 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~---VKLiDFGLAk~~~~ 601 (863)
|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 169 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc
Confidence 999999999999999988888999999999999999999999999999999999999987664 99999999874100
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
.......+||+.|+|||++. +..++.++|||||||++|+|++|..
T Consensus 170 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 170 --------------------------------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp --------------------------------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 00112357999999999984 4668999999999999999999999
Q ss_pred CCCCCChH-HHHHHHhhcCCCC-CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhH
Q 002953 679 PFNAEHPQ-QIFDNILNRKIPW-PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDT 747 (863)
Q Consensus 679 PF~~~~~~-el~~kIl~~~~~~-p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~ 747 (863)
||...... .+...+..+...+ +..+..++.++.+||.+||..||.+|| ++.++++||||++.+|..
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDEDMKR 285 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGCCHHHHH
T ss_pred CCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHhhCcCcCCHHHHH
Confidence 99765433 3444444444332 122356899999999999999999999 999999999999887753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.50 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=204.8
Q ss_pred CcccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 523 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 523 (863)
....|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 34455554 89999999997652 23333222 234456788999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhcCC------------------------CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcc
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGC------------------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~------------------------L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeN 579 (863)
+|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 9999999999999999987543 8899999999999999999999999999999999
Q ss_pred eeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCc
Q 002953 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659 (863)
Q Consensus 580 ILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ 659 (863)
||++.++.+||+|||+++...... .........||+.|+|||++.+..++.
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~ 231 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEED-----------------------------SYVKRSQGRIPVKWMAIESLFDHIYTT 231 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTS-----------------------------CEECSSCCCSCGGGCCHHHHHHCEECH
T ss_pred EEEcCCCCEEEccccccccccccc-----------------------------cceeccCCCCcccccChhhhcCCCcCc
Confidence 999999999999999987421100 001123456789999999999988999
Q ss_pred cceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 660 TADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 660 ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
++|||||||++|+|++ |..||.+.....+...+..... +..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 232 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~l~~~ 305 (314)
T 2ivs_A 232 QSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRP---VFADISKD 305 (314)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999999999999999 9999999888887777665442 345678999999999999999999999 99999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=365.30 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=195.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-----------
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----------- 520 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----------- 520 (863)
..|.+. .||+|+||.|+.+. +++|+.... .....+|+.+|+.++||||++++++|..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 345554 99999999997652 344433211 1223479999999999999999999854
Q ss_pred ---------------------------CCeEEEEEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCC
Q 002953 521 ---------------------------RENLYLVMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLR 569 (863)
Q Consensus 521 ---------------------------~~~lyLVmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~G 569 (863)
..++|+||||++| +|.+.+.. .+.+++..++.++.||+.||.|||++|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 3458999999975 87776653 467999999999999999999999999
Q ss_pred ccccCCCCcceeec-CCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCC
Q 002953 570 VVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLA 648 (863)
Q Consensus 570 IIHRDLKPeNILLd-~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmA 648 (863)
|+||||||+|||++ .++.+||+|||+|+.... .......+||+.|+|
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~--------------------------------~~~~~~~~~t~~y~a 209 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP--------------------------------SEPSVAYICSRFYRA 209 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCT--------------------------------TSCCCCCCCCSSCCC
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCC--------------------------------CCCCcCcccCCCccC
Confidence 99999999999998 578999999999984211 011234678999999
Q ss_pred hhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc-----------------CCCCCC---------
Q 002953 649 PEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR-----------------KIPWPR--------- 701 (863)
Q Consensus 649 PEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~-----------------~~~~p~--------- 701 (863)
||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..++.. ...++.
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 210 PELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289 (383)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred HHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence 99998754 899999999999999999999999998888777776541 111111
Q ss_pred CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 702 ~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
++..+++++.+||.+||+.||.+|| |+.|+++||||+.+.
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLR 329 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHH
Confidence 3456899999999999999999999 999999999998653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.15 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=197.6
Q ss_pred CCCCCCCCCccCCCcccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC---------
Q 002953 445 AGSMTPRSPLLTPRTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR--------- 507 (863)
Q Consensus 445 ~g~~~p~sp~~~~~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~--------- 507 (863)
++++.|...........|.+. .||+|+||+|+.+. +++|.. .......+.+.+|+.+|.+++
T Consensus 4 ~~~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 82 (373)
T 1q8y_A 4 PGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82 (373)
T ss_dssp ---CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE-CSCHHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEe-cCCccchhhhhHHHHHHHHhhcccccchhc
Confidence 344555544444445566655 99999999997653 233332 223344567889999999886
Q ss_pred --CCCeeEEEEEEEeCC----eEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCc
Q 002953 508 --NPFVVRFFYSFTCRE----NLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPD 578 (863)
Q Consensus 508 --HPnIVkL~~~f~d~~----~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPe 578 (863)
||||+++++++...+ .+++||||+ +++|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+
T Consensus 83 ~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred cccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 899999999998765 789999999 88999999864 4599999999999999999999998 9999999999
Q ss_pred ceeecC------CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh
Q 002953 579 NLLIAH------DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652 (863)
Q Consensus 579 NILLd~------~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL 652 (863)
||||+. .+.+||+|||+++... ......+||+.|+|||++
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~----------------------------------~~~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYD----------------------------------EHYTNSIQTREYRSPEVL 207 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETT----------------------------------BCCCSCCSCGGGCCHHHH
T ss_pred HeEEeccCCCcCcceEEEcccccccccC----------------------------------CCCCCCCCCccccCcHHH
Confidence 999953 3489999999997411 012235799999999999
Q ss_pred cCCCCCccceeechhHHHHHHHhCCCCCCCCC------hHHHHHHHhhcCCCC---------------------------
Q 002953 653 LGTGHGTTADWWSVGIILFELIVGIPPFNAEH------PQQIFDNILNRKIPW--------------------------- 699 (863)
Q Consensus 653 ~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~------~~el~~kIl~~~~~~--------------------------- 699 (863)
.+..++.++|||||||++|+|++|..||...+ ....+..+......+
T Consensus 208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 99999999999999999999999999997654 222222222110000
Q ss_pred ------------CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 700 ------------PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 700 ------------p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
..++..++.++.+||.+||+.||.+|| |+.++++||||++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 012234567899999999999999999 99999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=361.47 Aligned_cols=246 Identities=28% Similarity=0.404 Sum_probs=200.0
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE------
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL------ 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l------ 524 (863)
.|.+ ..||+|+||.|+.+. +++|+... ........+.+|+.+|+.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3443 389999999997652 34443322 2334457788999999999999999999999987765
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~---- 195 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD---- 195 (371)
T ss_dssp EEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred EEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc----
Confidence 99999997 58888874 359999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 196 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 196 ------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp ----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 11234679999999999987 67899999999999999999999999998
Q ss_pred ChHHHHHHHhhcCCC----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 684 HPQQIFDNILNRKIP----------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 684 ~~~el~~kIl~~~~~----------------------------~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+..+.+..+...... +...+..+++++.+||.+||+.||.+|| |+.++|
T Consensus 246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell 322 (371)
T 4exu_A 246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL---TAAQAL 322 (371)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC---CHHHHH
T ss_pred ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC---CHHHHh
Confidence 877777666541110 0011245799999999999999999999 999999
Q ss_pred cCCCCCCCChh
Q 002953 736 QHVFFKDINWD 746 (863)
Q Consensus 736 qHPFFk~IdW~ 746 (863)
+||||+.+...
T Consensus 323 ~hp~f~~~~~~ 333 (371)
T 4exu_A 323 THPFFEPFRDP 333 (371)
T ss_dssp TSGGGTTTCCG
T ss_pred cCcccccCCCc
Confidence 99999987544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.89 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=206.3
Q ss_pred CcccceEE-Eeecccceeecccc--------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP--------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTC 520 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d 520 (863)
....|.+. .||+|+||.|+.+. +++|.... ........+.+|+++|+++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 33455554 89999999997653 33443222 2334557889999999999 89999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~ 584 (863)
.+.+|+||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999998753 4899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceee
Q 002953 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWW 664 (863)
Q Consensus 585 ~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 664 (863)
++.+||+|||+|+...... .........||+.|+|||++.+..++.++|||
T Consensus 227 ~~~~kL~DFG~a~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 277 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHID-----------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 277 (382)
T ss_dssp TCCEEECSCSCCCCSSCCC-----------------------------TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHH
T ss_pred CCcEEEcccCccccccccc-----------------------------ccccccCCCCCcceeCHHHhcCCCCCchhHHH
Confidence 9999999999997421100 00112235678999999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 665 SVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 665 SLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||||++|+|++ |..||.+.+..++...+..... +..+..+++++.+||.+||+.||.+|| ++.+++++
T Consensus 278 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 346 (382)
T 3tt0_A 278 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRP---TFKQLVED 346 (382)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99999999999 9999999998888887766543 334678999999999999999999999 99999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=363.95 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=188.2
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-------
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN------- 523 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~------- 523 (863)
...|.+. .||+|+||.|+.+. +++|+. ...........+|+..|..++||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEE-ECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEE-ecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3456554 89999999997542 344432 2222333456788888999999999999999976443
Q ss_pred EEEEEeecCCCChHHHHH----hcCCCChhhHHHHHHHHHHHHHHHH--hCCccccCCCCcceeecC-CCcEEEeecCCc
Q 002953 524 LYLVMEYLNGGDLYSLLR----NLGCLDEDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLIAH-DGHIKLTDFGLS 596 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk----~~g~L~e~~i~~Ia~QIl~ALeyLH--s~GIIHRDLKPeNILLd~-~g~VKLiDFGLA 596 (863)
+|+||||+++ +|...+. ....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 8999999987 5554443 4567899999999999999999999 999999999999999997 899999999999
Q ss_pred cccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHh
Q 002953 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIV 675 (863)
Q Consensus 597 k~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLT 675 (863)
+.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 180 ~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~ 227 (360)
T 3e3p_A 180 KKLSP--------------------------------SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227 (360)
T ss_dssp BCCCT--------------------------------TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred eecCC--------------------------------CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 74210 01123457899999999997654 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhhcCCC-----------------------------CCCCCCCCCHHHHHHHHhhccCCcCCcC
Q 002953 676 GIPPFNAEHPQQIFDNILNRKIP-----------------------------WPRVPEEMSPEAHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 676 Gk~PF~~~~~~el~~kIl~~~~~-----------------------------~p~~p~~iS~el~dLI~k~L~~DP~kRp 726 (863)
|.+||.+.+....+..+...... ++......++++.+||.+||+.||.+||
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 307 (360)
T 3e3p_A 228 GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307 (360)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC
Confidence 99999998888777776542110 1112233678999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCh
Q 002953 727 GSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 727 g~~SAeEILqHPFFk~IdW 745 (863)
|+.++|+||||+++.+
T Consensus 308 ---t~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 308 ---KPYEALCHPYFDELHD 323 (360)
T ss_dssp ---CHHHHTTSGGGGGGGC
T ss_pred ---CHHHHhcCccccccCC
Confidence 9999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.37 Aligned_cols=250 Identities=30% Similarity=0.528 Sum_probs=209.3
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+|.+. .||+|+||.|+.+. +++|.... ........+.+|+++|++++||||+++++++...+.+|+||||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 45544 99999999997542 23333221 2233567789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccccCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 103 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~----- 177 (287)
T 2wei_A 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----- 177 (287)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-----
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-----
Confidence 9999999999888889999999999999999999999999999999999999764 47999999998742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+
T Consensus 178 ---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 178 ---------------------------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp ---------------------------SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 011234688999999998765 8999999999999999999999999999888
Q ss_pred HHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 688 IFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 688 l~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
+...+..+...++. ....++.++.+||.+||..||.+|| ++.++++||||+..+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 230 ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 88888777654331 1256899999999999999999999 99999999999876553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.03 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=186.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..|.+. .||+|+||+|+.+. +++|..... .......+..+...++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 445554 99999999996653 344433222 22223344455555778899999999999999999999999
Q ss_pred ecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 530 YLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 530 y~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
|++| +|.+++.. .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 162 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--- 162 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc---
Confidence 9975 88777754 46799999999999999999999998 999999999999999999999999999874110
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh----cCCCCCccceeechhHHHHHHHhCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL----LGTGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL----~g~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
........||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 163 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 163 -----------------------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp ------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred -----------------------------cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 0112234799999999996 4567899999999999999999999999
Q ss_pred CC-CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 681 NA-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 681 ~~-~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.. .........+...... ...+..+++++.+||.+||+.||.+|| |+.++++||||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l~hp~f~~ 272 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEPSP-QLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPFFTL 272 (290)
T ss_dssp CCCSCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHH
T ss_pred cccCchHHHHHHHhccCCC-CcccccCCHHHHHHHHHHhhcChhhCc---CHHHHHhCccccc
Confidence 76 3444444444443322 122356899999999999999999999 9999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=358.86 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=194.9
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhh-----------hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKAD-----------MIRKNAVESILAERDILISVRNPFVVRFFYSFTC- 520 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~-----------i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d- 520 (863)
..|.+. .||+|+||.|+.+. +++|+.. .......+.+.+|+.+|++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 345544 99999999997652 3444321 1223344789999999999999999999999854
Q ss_pred ----CCeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCC
Q 002953 521 ----RENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 521 ----~~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
...+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 336899999997 5888888754 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHH
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELL 674 (863)
++.... .......+||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 181 ~~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 228 (362)
T 3pg1_A 181 AREDTA--------------------------------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228 (362)
T ss_dssp -----------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred cccccc--------------------------------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence 873110 011234679999999999987 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCC------------------------CCC-----CCCCCCCHHHHHHHHhhccCCcCCc
Q 002953 675 VGIPPFNAEHPQQIFDNILNRKI------------------------PWP-----RVPEEMSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 675 TGk~PF~~~~~~el~~kIl~~~~------------------------~~p-----~~p~~iS~el~dLI~k~L~~DP~kR 725 (863)
+|..||.+.+..+.+..+..... ..+ .....+++.+.+||.+||+.||.+|
T Consensus 229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 99999999887777766653111 000 1124568899999999999999999
Q ss_pred CCCCCHHHHHcCCCCCCC
Q 002953 726 LGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 726 pg~~SAeEILqHPFFk~I 743 (863)
| |+.++++||||+.+
T Consensus 309 p---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 309 I---STEQALRHPYFESL 323 (362)
T ss_dssp C---CHHHHHTSGGGTTT
T ss_pred C---CHHHHHcCchhhhc
Confidence 9 99999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=375.87 Aligned_cols=238 Identities=14% Similarity=0.172 Sum_probs=189.8
Q ss_pred ccceE-EEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHH---HHHhcCCCCeeEEE-------EEE
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERD---ILISVRNPFVVRFF-------YSF 518 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~---IL~~L~HPnIVkL~-------~~f 518 (863)
..|.+ ..||+|+||+|+.+. +++|... .......+.+.+|+. +|++++|||||+++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 44554 499999999997542 3444332 334456678999995 55566899999998 777
Q ss_pred EeCCe-----------------EEEEEeecCCCChHHHHHhcCCCCh-------hhHHHHHHHHHHHHHHHHhCCccccC
Q 002953 519 TCREN-----------------LYLVMEYLNGGDLYSLLRNLGCLDE-------DVARVYIAEVVLALEYLHSLRVVHRD 574 (863)
Q Consensus 519 ~d~~~-----------------lyLVmEy~~GGsL~dlLk~~g~L~e-------~~i~~Ia~QIl~ALeyLHs~GIIHRD 574 (863)
.+.+. .||||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 76643 89999999 6799999987666666 77788999999999999999999999
Q ss_pred CCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC
Q 002953 575 LKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654 (863)
Q Consensus 575 LKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g 654 (863)
|||+||||+.++.+||+|||+|+.. .......+| +.|+|||++.+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~----------------------------------~~~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRD----------------------------------GARVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEET----------------------------------TCEEECCCC-TTCCCHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheec----------------------------------CCcccCCCC-cCccChhhhcc
Confidence 9999999999999999999998731 012234678 99999999998
Q ss_pred C-----------CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcC
Q 002953 655 T-----------GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPH 723 (863)
Q Consensus 655 ~-----------~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~ 723 (863)
. .++.++|||||||++|||++|..||...+.......+.. .+..+++++.+||.+||+.||.
T Consensus 277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-------SCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-------SCCCCCHHHHHHHHHHTCSSGG
T ss_pred cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-------hccCCCHHHHHHHHHHcCCCch
Confidence 7 899999999999999999999999987665444333322 1256899999999999999999
Q ss_pred CcCCCCCHHHHHcCCCCCCC
Q 002953 724 QRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 724 kRpg~~SAeEILqHPFFk~I 743 (863)
+|| ++.++++||||+.+
T Consensus 350 ~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 350 DRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp GCC---CHHHHHTSHHHHHH
T ss_pred hCC---CHHHHhhChHHHHH
Confidence 999 99999999999765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.26 Aligned_cols=245 Identities=24% Similarity=0.383 Sum_probs=199.0
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe-
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCREN- 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~- 523 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+++|.++ +||||+++++++...+.
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 445544 99999999997652 34443322 2234456799999999999 78999999999988654
Q ss_pred EEEEEeecCCCChHHHHHhcCC----------------------------------------------------------
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGC---------------------------------------------------------- 545 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~---------------------------------------------------------- 545 (863)
+|+|||||+||+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 9999999999999999976533
Q ss_pred --------CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCccc
Q 002953 546 --------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTL 617 (863)
Q Consensus 546 --------L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l 617 (863)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-------------- 247 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-------------- 247 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------------
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------------
Confidence 8899999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcC
Q 002953 618 LGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 618 ~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~ 696 (863)
.........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+......+...+...
T Consensus 248 ---------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 312 (359)
T 3vhe_A 248 ---------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312 (359)
T ss_dssp ---------------TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ---------------cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC
Confidence 0012234678999999999999999999999999999999998 999998876555444444433
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.. +..+..+++++.+||.+||..||.+|| ++.++++|
T Consensus 313 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 313 TR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 22 344677999999999999999999999 99999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=340.45 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=203.3
Q ss_pred cccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
...|.+. .||+|+||.|+.+. +++|... ......+.+.+|+.+|.+++||||+++++++.+.+.+|+||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC-BTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEec-cCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3445544 99999999997542 2333322 22234466899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-------- 157 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-------- 157 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT--------
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh--------
Confidence 9999999998754 5999999999999999999999999999999999999999999999999998742110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.....
T Consensus 158 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 215 (268)
T 3sxs_A 158 ----------------------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215 (268)
T ss_dssp ----------------------CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ----------------------hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH
Confidence 0011234567888999999999889999999999999999999 99999999888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+...... ..+...++++.+||.+||+.||.+|| |+.++++|
T Consensus 216 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 216 LKVSQGHRL--YRPHLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp HHHHTTCCC--CCCTTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcCCCC--CCCCcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 777665532 33567899999999999999999999 99999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.58 Aligned_cols=245 Identities=21% Similarity=0.341 Sum_probs=204.1
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
...|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 3445544 89999999996542 233332221 234456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc------------------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcce
Q 002953 525 YLVMEYLNGGDLYSLLRNL------------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~------------------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNI 580 (863)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 9999999999999999764 5689999999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCcc
Q 002953 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660 (863)
Q Consensus 581 LLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k 660 (863)
|++.++.+||+|||+++...... .........||+.|+|||++.+..++.+
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 256 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSAD-----------------------------YYKADGNDAIPIRWMPPESIFYNRYTTE 256 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGG-----------------------------CBC----CCBCGGGCCHHHHHHCCCCHH
T ss_pred EECCCCeEEEeecCCCcccccCc-----------------------------cccccCCCcccceecChhhhccCCcCcc
Confidence 99999999999999987421000 0011234578999999999999999999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 661 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 661 sDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+|||||||++|+|++ |..||.+.+..++...+..+.. +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 257 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~~~~~ 329 (343)
T 1luf_A 257 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRP---SFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc--CCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHHH
Confidence 999999999999999 9999999998888888776554 345678999999999999999999999 88888764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=353.68 Aligned_cols=245 Identities=28% Similarity=0.412 Sum_probs=199.8
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe------EE
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN------LY 525 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~------ly 525 (863)
|.+ ..||+|+||.|+.+. +++|.... ........+.+|+.+|+.++||||+++++++..... +|
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 444 489999999996652 34443322 233445678999999999999999999999988764 49
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||+. ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~----- 177 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----- 177 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-----
Confidence 9999997 599888753 59999999999999999999999999999999999999999999999999987310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 178 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 178 -----------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp -----------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred -----------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01124578999999999987 678999999999999999999999999888
Q ss_pred hHHHHHHHhhc----------------------------CCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 685 PQQIFDNILNR----------------------------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 685 ~~el~~kIl~~----------------------------~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.+..+... ...+......+++++.+||.+||..||.+|| |+.++++
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~ 305 (353)
T 3coi_A 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL---TAAQALT 305 (353)
T ss_dssp HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC---CHHHHHT
T ss_pred HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC---CHHHHhc
Confidence 77666655431 1122333456899999999999999999999 9999999
Q ss_pred CCCCCCCChh
Q 002953 737 HVFFKDINWD 746 (863)
Q Consensus 737 HPFFk~IdW~ 746 (863)
||||+.+...
T Consensus 306 hp~f~~~~~~ 315 (353)
T 3coi_A 306 HPFFEPFRDP 315 (353)
T ss_dssp SGGGTTTCCG
T ss_pred CcchhhccCc
Confidence 9999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.50 Aligned_cols=265 Identities=28% Similarity=0.470 Sum_probs=197.5
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe------------
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------------ 520 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d------------ 520 (863)
.|.+ ..||+|+||.|+.+. +++|.. .......+.+.+|+.+|++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEE-EEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEE-eccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 3444 499999999996652 234433 2234456788999999999999999999998865
Q ss_pred -CCeEEEEEeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 521 -RENLYLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 521 -~~~lyLVmEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 165 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence 456899999999999999998654 578899999999999999999999999999999999999999999999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk 677 (863)
..... ... ..................||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 166 ~~~~~-~~~----------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 226 (303)
T 1zy4_A 166 VHRSL-DIL----------------KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226 (303)
T ss_dssp TTC------------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccccc-chh----------------ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--
Confidence 21100 000 00000000011223456899999999999875 68999999999999999998
Q ss_pred CCCCC-CChHHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 678 PPFNA-EHPQQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 678 ~PF~~-~~~~el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
||.. .+.......+......++ .++...+..+.+||.+||..||.+|| |+.++++||||+...++...
T Consensus 227 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~~~~~~~ 296 (303)
T 1zy4_A 227 -PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLNSGWLPVKHQDEVI 296 (303)
T ss_dssp -CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CHHHHHHSSCSCCCCHHHHH
T ss_pred -ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc---CHHHHhCCCCcCCCChHHHH
Confidence 5543 334455555555444433 34456788899999999999999999 99999999999988887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=351.91 Aligned_cols=244 Identities=23% Similarity=0.336 Sum_probs=194.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--~lyLVm 528 (863)
..|.+. +||+|+||+|+.+. +++|..... .....+.+.+|+++|++++||||+++++++.... .+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 345544 99999999996542 344432211 1234567889999999999999999999998765 789999
Q ss_pred eecCCCChHHHHHhcCC---CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee----cCCCcEEEeecCCcccccc
Q 002953 529 EYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~---L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL----d~~g~VKLiDFGLAk~~~~ 601 (863)
||++|++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 99999999999986543 9999999999999999999999999999999999999 7778899999999974210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc--------CCCCCccceeechhHHHHHH
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--------GTGHGTTADWWSVGIILFEL 673 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~--------g~~ys~ksDIWSLGvILyEL 673 (863)
.......+||+.|+|||++. +..++.++|||||||++|||
T Consensus 169 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 169 --------------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp --------------------------------TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred --------------------------------CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 01123467999999999987 56789999999999999999
Q ss_pred HhCCCCCCCC----ChHHHHHHHhhcCCC-------------------CC---CCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 674 IVGIPPFNAE----HPQQIFDNILNRKIP-------------------WP---RVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 674 LTGk~PF~~~----~~~el~~kIl~~~~~-------------------~p---~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
++|..||... ...+++..+..+... ++ .+...++..+.+||.+||+.||++||
T Consensus 217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~- 295 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW- 295 (319)
T ss_dssp HHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-
T ss_pred HhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc-
Confidence 9999999643 234555555554321 11 11223456889999999999999999
Q ss_pred CCCHHHHHcCC
Q 002953 728 SGGASEVKQHV 738 (863)
Q Consensus 728 ~~SAeEILqHP 738 (863)
|++|+|+||
T Consensus 296 --s~~ell~h~ 304 (319)
T 4euu_A 296 --GFDQFFAET 304 (319)
T ss_dssp --CHHHHHHHH
T ss_pred --cHHHhhhcc
Confidence 999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=342.64 Aligned_cols=236 Identities=20% Similarity=0.312 Sum_probs=193.9
Q ss_pred ccceEE-Eeecccceeecccc--------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
..|.+. .||+|+||.|+.+. +++|..........+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345544 89999999996642 344443334455667899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCC-CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc--------EEEeecCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH--------IKLTDFGL 595 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~-L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~--------VKLiDFGL 595 (863)
|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~ 167 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence 999999999999999987654 999999999999999999999999999999999999998887 99999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHH
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELL 674 (863)
+.... ......||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 168 ~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 212 (289)
T 4fvq_A 168 SITVL-----------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212 (289)
T ss_dssp CTTTS-----------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred ccccc-----------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence 86310 0012457889999999988 67899999999999999999
Q ss_pred hC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 675 VG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 675 TG-k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+| .+||.......... +..... ..+...+.++.+||.+||+.||.+|| |+.++++|
T Consensus 213 ~g~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 269 (289)
T 4fvq_A 213 SGGDKPLSALDSQRKLQ-FYEDRH---QLPAPKAAELANLINNCMDYEPDHRP---SFRAIIRD 269 (289)
T ss_dssp TTTCCTTTTSCHHHHHH-HHHTTC---CCCCCSSCTTHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred cCCCCCccccchHHHHH-HhhccC---CCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 95 55555555544433 333332 33456788999999999999999999 99999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=350.71 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=200.3
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCREN 523 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ 523 (863)
...|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 3455554 99999999996543 233332211 223446789999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhcC-----------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcce
Q 002953 524 LYLVMEYLNGGDLYSLLRNLG-----------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g-----------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNI 580 (863)
+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999999999999997653 278999999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCcc
Q 002953 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660 (863)
Q Consensus 581 LLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k 660 (863)
|++.++.+||+|||++....... .........||+.|+|||++.+..++.+
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 254 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDS-----------------------------NYVVRGNARLPVKWMAPESLFEGIYTIK 254 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCT-----------------------------TSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred EEcCCCcEEeCCCccCcccccCc-----------------------------cceeccCccCccCccCHHHhccCCCChh
Confidence 99999999999999997421100 0012234568899999999999999999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 661 ADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 661 sDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+|||||||++|+|++ |..||.+......+..++..... +..+..+++++.+||.+||..||.+|| ++.++++|
T Consensus 255 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~~ 328 (344)
T 1rjb_A 255 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRP---SFPNLTSF 328 (344)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHHH
Confidence 999999999999998 99999887766666565555433 234667899999999999999999999 99999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.24 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=197.9
Q ss_pred CcccceEE-Eeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
....|.+. +||+|+||+|+.+. +++|.... ........+.+|+.+|++++||||+++++++.+.. .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 34456554 99999999997653 13332221 12344567899999999999999999999998754 7
Q ss_pred EEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 8999999999999999874 579999999999999999999999999999999999999999999999999998421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
. ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 172 ~-----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 172 K-----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp C------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred c-----------------------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 0 011223467889999999999999999999999999999999 9999998
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+...+...+..... ...+..++.++.+|+.+||+.||.+|| ++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 223 IPASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 888777666655432 234567899999999999999999999 99999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=367.78 Aligned_cols=248 Identities=19% Similarity=0.186 Sum_probs=180.5
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhh---hchhHHHHHHHHHHHHHhc--CCCCeeEEE-------EEEEeC
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADM---IRKNAVESILAERDILISV--RNPFVVRFF-------YSFTCR 521 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L--~HPnIVkL~-------~~f~d~ 521 (863)
|.+ ..||+|+||.|+.+. +++|.... ......+.+.+|+.++..| +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 444 499999999996652 34443332 2334566788886555554 699988866 455443
Q ss_pred -----------------CeEEEEEeecCCCChHHHHHhcC-CCChhhH------HHHHHHHHHHHHHHHhCCccccCCCC
Q 002953 522 -----------------ENLYLVMEYLNGGDLYSLLRNLG-CLDEDVA------RVYIAEVVLALEYLHSLRVVHRDLKP 577 (863)
Q Consensus 522 -----------------~~lyLVmEy~~GGsL~dlLk~~g-~L~e~~i------~~Ia~QIl~ALeyLHs~GIIHRDLKP 577 (863)
..+|||||||+ |+|.+++...+ .+++... ..++.||+.||+|||++||+||||||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 34899999998 79999998753 3444444 56779999999999999999999999
Q ss_pred cceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--C
Q 002953 578 DNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--T 655 (863)
Q Consensus 578 eNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~ 655 (863)
+||||+.++.+||+|||+|+... .......||+.|+|||++.+ .
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~----------------------------------~~~~~~~~t~~y~aPE~~~~~~~ 268 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVG----------------------------------TRGPASSVPVTYAPREFLNASTA 268 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETT----------------------------------CEEEGGGSCGGGCCHHHHTCSEE
T ss_pred HHEEECCCCCEEEEecceeeecC----------------------------------CCccCccCCcCCcChhhccCCCC
Confidence 99999999999999999998410 01113467799999999987 6
Q ss_pred CCCccceeechhHHHHHHHhCCCCCCCCChHHH--HHHH-----hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC
Q 002953 656 GHGTTADWWSVGIILFELIVGIPPFNAEHPQQI--FDNI-----LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS 728 (863)
Q Consensus 656 ~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el--~~kI-----l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~ 728 (863)
.++.++|||||||++|+|++|.+||........ +..+ ......++ .+..+++++.+||.+||+.||.+||
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp-- 345 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRL-- 345 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCC--
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCC--
Confidence 799999999999999999999999987643211 1100 01111222 1247899999999999999999999
Q ss_pred CCHHHHHcCCCCCCCChhHH
Q 002953 729 GGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 729 ~SAeEILqHPFFk~IdW~~l 748 (863)
++.++++||||+++.|...
T Consensus 346 -t~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 346 -LPLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp -CHHHHTTSHHHHHHHHHHH
T ss_pred -CHHHHhcCHHHHHHHHHHh
Confidence 9999999999999887643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.63 Aligned_cols=240 Identities=25% Similarity=0.433 Sum_probs=193.9
Q ss_pred ccceEE-Eeecccceeecccc-----ceehhhhhhc----hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----QVLKKADMIR----KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~----k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..|.+. .||+|+||.|+.+. +++|...... ....+.+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 345544 99999999997652 3333322211 2334678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC---ccccCCCCcceeecC--------CCcEEEeecCCccc
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR---VVHRDLKPDNLLIAH--------DGHIKLTDFGLSKV 598 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G---IIHRDLKPeNILLd~--------~g~VKLiDFGLAk~ 598 (863)
|++|++|.+++.. +.+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++.
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999999864 67999999999999999999999999 999999999999986 67899999999873
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 166 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 166 WHR---------------------------------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp -------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred ccc---------------------------------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 110 11123579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||.+.+.......+....... ..+..+++++.+||.+||..||.+|| ++.++++|
T Consensus 213 p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 267 (271)
T 3dtc_A 213 PFRGIDGLAVAYGVAMNKLAL-PIPSTCPEPFAKLMEDCWNPDPHSRP---SFTNILDQ 267 (271)
T ss_dssp TTTTSCHHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCHHHHHHhhhcCCCCC-CCCcccCHHHHHHHHHHhcCCcccCc---CHHHHHHH
Confidence 999988877777766655443 35678999999999999999999999 99999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.62 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=203.7
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
..|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 445554 99999999997542 333332211 2234557889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc----------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCC
Q 002953 526 LVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~----------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~ 184 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcc
Confidence 999999999999999753 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT 675 (863)
++..... ..........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 185 ~~~~~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 185 TRDIYET-----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235 (322)
T ss_dssp CCGGGGG-----------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccc-----------------------------cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 8742100 00112234567999999999999999999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 676 -GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 676 -Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|..||.+.+..+....+..... +..+..++.++.+||.+||..||.+|| ++.++++|
T Consensus 236 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~e~l~~ 293 (322)
T 1p4o_A 236 LAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 293 (322)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cCCCccccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 8999999988888888776543 344678999999999999999999999 99999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.34 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=194.1
Q ss_pred cccceEE-Eeecccceeecccc-----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~l 524 (863)
..+|.+. .||+|+||.|+.+. +++|+.........+.+.+|+.+|++++||||+++++++... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3455554 99999999996542 455555444556667899999999999999999999998654 569
Q ss_pred EEEEeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 169 ----------------------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -----------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ----------------------------ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 0001122346788899999999999999999999999999999999998643
Q ss_pred ChH----------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 684 HPQ----------------QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 684 ~~~----------------el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
... .....+... .. +..+..+++++.+||.+||..||.+|| |+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~el~~ 284 (295)
T 3ugc_A 221 PAEFMRMIGNDKQGQMIVFHLIELLKNN-GR-LPRPDGCPDEIYMIMTECWNNNVNQRP---SFRDLAL 284 (295)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred hHHHHhhhcCccccchhHHHHHHHHhcc-Cc-CCCCcCcCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 211 122222222 22 234678999999999999999999999 8988875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.10 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=200.9
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~l 524 (863)
..|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|+++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 445544 99999999996542 333333222 223457789999999999 999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcC------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLG------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g 586 (863)
|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 99999999999999997654 389999999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeech
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 666 (863)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||
T Consensus 183 ~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 183 ITKICDFGLARDIKNDS-----------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp EEEECCCGGGSCTTSCT-----------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CEEEccccccccccccc-----------------------------cceeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 99999999987421100 0011234568899999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 667 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 667 GvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||++|+|++ |..||.+......+..+....... ..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 301 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRP---TFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCc---CHHHHHHH
Confidence 999999998 999998877655555555444332 23567899999999999999999999 99999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=346.08 Aligned_cols=247 Identities=19% Similarity=0.309 Sum_probs=205.3
Q ss_pred CCcccceEE-Eeecccceeecccc--------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEE
Q 002953 457 PRTSQIDLL-LAGKGALSEHDDFP--------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFT 519 (863)
Q Consensus 457 ~~~~~~~l~-vLGkG~FG~V~~~~--------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~ 519 (863)
.....|.+. .||+|+||.|+.+. +++|..... .......+.+|+.+|+++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 334556554 99999999997552 333333221 334567789999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec
Q 002953 520 CRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583 (863)
Q Consensus 520 d~~~lyLVmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd 583 (863)
..+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9999999999999999999998653 388999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCcccee
Q 002953 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 663 (863)
Q Consensus 584 ~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDI 663 (863)
.++.+||+|||+++...... .........||+.|+|||++.+..++.++||
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 242 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNID-----------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242 (334)
T ss_dssp TTCCEEECCCTTCEECTTTS-----------------------------SEECCSCCCCCGGGCCHHHHHHCEECHHHHH
T ss_pred CCCCEEEccccccccccccc-----------------------------cccccCCCCcccceeChHHhcCCCcChHHHH
Confidence 99999999999987421000 0011233567899999999999889999999
Q ss_pred echhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 664 WSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 664 WSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||||++|+|++ |..||.+.+..++...+..... +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 243 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 312 (334)
T 2pvf_A 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRP---TFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC--CCCCccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 999999999999 9999999988888877766543 334677999999999999999999999 99999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.28 Aligned_cols=238 Identities=20% Similarity=0.295 Sum_probs=200.5
Q ss_pred cccceEE-Eeecccceeecccc-----ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLYLVM 528 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~lyLVm 528 (863)
...|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++.+. +.+|+||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3445554 99999999997652 344433222 334556799999999999999999999999987 7899999
Q ss_pred eecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 529 EYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||++||+|.+++...+ .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~----- 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----- 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-----
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-----
Confidence 9999999999998765 4899999999999999999999999 999999999999999999999999986520
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCc---cceeechhHHHHHHHhCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT---TADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~---ksDIWSLGvILyELLTGk~PF~ 681 (863)
......||+.|+|||++.+..++. ++|||||||++|+|++|..||.
T Consensus 164 -------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 164 -------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp -------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred -------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 112357899999999998866544 7999999999999999999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.......+...... +..+..+++++.+||.+||+.||.+|| |+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (271)
T 3kmu_A 213 DLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRP---KFDMIVP 263 (271)
T ss_dssp TSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred ccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 98888887777665443 445778999999999999999999999 8998885
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.43 Aligned_cols=247 Identities=29% Similarity=0.429 Sum_probs=196.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-CC-----CeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-NP-----FVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HP-----nIVkL~~~f~d~~~ly 525 (863)
..|.+. .||+|+||+|+.+. +++|... ........+..|+.+|..++ |+ +|+++++++...+.+|
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC-SSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEe-ccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 455554 99999999997652 3333322 23344567788999998885 44 4999999999999999
Q ss_pred EEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHH--hCCccccCCCCcceeec--CCCcEEEeecCCcccc
Q 002953 526 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLH--SLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSKVG 599 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLH--s~GIIHRDLKPeNILLd--~~g~VKLiDFGLAk~~ 599 (863)
|||||+.| +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+|+..
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999965 999999875 45999999999999999999999 57999999999999995 4678999999999741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
. ......+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 212 ~----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 212 G----------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp T----------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred c----------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 0 112346899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC---------------CCC------------------C---------------------
Q 002953 680 FNAEHPQQIFDNILNRKIPWPR---------------VPE------------------E--------------------- 705 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~---------------~p~------------------~--------------------- 705 (863)
|.+.+..+.+..+.......+. ++. .
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 9999888877776642111000 000 0
Q ss_pred -------CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 706 -------MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 706 -------iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
.++++.+||.+||+.||.+|| |+.++|+||||+...+
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 013789999999999999999 9999999999997654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=337.69 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=203.3
Q ss_pred CcccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
....|.+. .||+|+||.|+.+. +++|.. .......+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEE-CSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEec-CcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34455554 89999999996652 233332 2334456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 530 YLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 530 y~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----- 164 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS-----
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC-----
Confidence 99999999999874 44899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
.........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 165 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 165 -------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp -------------------------SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred -------------------------ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0012234567889999999999999999999999999999999 99999998887
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.....+..... +..+..+++++.+||.+||..||.+|| ++.++++.
T Consensus 220 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~~ 265 (288)
T 3kfa_A 220 QVYELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQA 265 (288)
T ss_dssp GHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHhccCC--CCCCCCCCHHHHHHHHHHhCCChhhCc---CHHHHHHH
Confidence 77776655432 234677999999999999999999999 88888763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.93 Aligned_cols=242 Identities=20% Similarity=0.344 Sum_probs=202.9
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. .||+|+||.|+.+. +++|... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC-TTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEcc-ccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 345544 89999999996542 2333322 222234678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~---------- 156 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---------- 156 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC----------
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc----------
Confidence 99999999875 5689999999999999999999999999999999999999999999999999874110
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
..........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+...
T Consensus 157 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (267)
T 3t9t_A 157 --------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 216 (267)
T ss_dssp --------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred --------------------ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH
Confidence 00112234568889999999999999999999999999999999 999999998888888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..... +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 217 ~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 217 DISTGFR--LYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp HHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCCc--CCCCccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 8776543 233567899999999999999999999 99999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.70 Aligned_cols=244 Identities=22% Similarity=0.309 Sum_probs=199.5
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
....|.+. .||+|+||+|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++.+ +..|
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34456554 99999999997642 344433222 23456789999999999999999999999875 4579
Q ss_pred EEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 166 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-- 166 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc--
Confidence 999999999999999765 45999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~ 683 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 167 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 167 ----------------------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp ----------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ----------------------------cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 0011234567889999999999999999999999999999998 99999887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
........+..... +..+..+++.+.+||.+||..||.+|| ++.+++++
T Consensus 219 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 219 ENKDVIGVLEKGDR--LPKPDLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp CGGGHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ChHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 77777766655433 234567899999999999999999999 99999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=341.70 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=192.9
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|... .......+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4556655 99999999997652 2333322 22334457889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~----- 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----- 187 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc-----
Confidence 999999999999998889999999999999999999999999999999999999999999999999998741100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||...+...
T Consensus 188 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (309)
T 2h34_A 188 -------------------------KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242 (309)
T ss_dssp ----------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred -------------------------ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence 0011234579999999999999999999999999999999999999998877665
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+...+..........+..++.++.+||.+||..||.+||+ +++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~~ 289 (309)
T 2h34_A 243 MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLSA 289 (309)
T ss_dssp HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHHH
T ss_pred HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHHH
Confidence 4444433332222345679999999999999999999994 5666664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.51 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=203.7
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
...|.+. .||+|+||.|+.+. +++|.... ........+.+|+.+|++++||||+++++++.....+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 3445544 99999999997654 34444322 2334556789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcC-------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecC
Q 002953 525 YLVMEYLNGGDLYSLLRNLG-------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFG 594 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g-------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFG 594 (863)
|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999998753 48899999999999999999999999999999999999854 469999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002953 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 595 LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL 674 (863)
++....... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 189 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 239 (327)
T 2yfx_A 189 MARDIYRAS-----------------------------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239 (327)
T ss_dssp HHHHHHC-----------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccc-----------------------------ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 987421100 011223457899999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 675 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 675 T-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+ |..||......+....+..... +..+..++..+.+||.+||..||.+|| ++.++++|.++
T Consensus 240 t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~l~~ 301 (327)
T 2yfx_A 240 SLGYMPYPSKSNQEVLEFVTSGGR--MDPPKNCPGPVYRIMTQCWQHQPEDRP---NFAIILERIEY 301 (327)
T ss_dssp TTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred cCCCCCCCCcCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHHHHH
Confidence 8 9999999888888877766543 334577999999999999999999999 99999999765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=345.56 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=199.6
Q ss_pred cccceEE-Eeecccceeecccc---------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP---------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~---------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyL 526 (863)
...|.+. .||+|+||.|+.+. .++|.... ......+.+.+|+.+|.++ +||||+++++++.+.+.+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 3455554 99999999997652 13333221 2233456789999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC----------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEE
Q 002953 527 VMEYLNGGDLYSLLRNLG----------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g----------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKL 590 (863)
||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 999999999999997654 6999999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002953 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670 (863)
Q Consensus 591 iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvIL 670 (863)
+|||+++.... ........+|+.|+|||++.+..++.++|||||||++
T Consensus 184 ~Dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 231 (327)
T 1fvr_A 184 ADFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231 (327)
T ss_dssp CCTTCEESSCE--------------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred cccCcCccccc--------------------------------cccccCCCCCccccChhhhccccCCchhcchHHHHHH
Confidence 99999873100 0111234678999999999998899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 671 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 671 yELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|+|++ |..||.+.+..+++..+..+.. +..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 232 ~ellt~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 294 (327)
T 1fvr_A 232 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 294 (327)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcCCCCCCCCCcHHHHHHHhhcCCC--CCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99998 9999999998888887765532 234567899999999999999999999 99999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.29 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=198.2
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+ ..||+|+||+|+.+. +++|.... ....+.+.+|+.+|+.+ +||||+++++++.+.+..|+||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEET--TCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecc--ccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3544 499999999997653 34443221 22234588999999999 9999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc-----EEEeecCCccccccCCCC
Q 002953 532 NGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 532 ~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~-----VKLiDFGLAk~~~~~s~~ 605 (863)
|++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 89999999864 67999999999999999999999999999999999999998887 999999999852211100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-- 683 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-- 683 (863)
. ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 167 ~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 167 K------------------------HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp C------------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred c------------------------cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 0 00011234678999999999999999999999999999999999999999874
Q ss_pred -ChHHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc----------CCCCCCCChh
Q 002953 684 -HPQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ----------HVFFKDINWD 746 (863)
Q Consensus 684 -~~~el~~kIl~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq----------HPFFk~IdW~ 746 (863)
...+.+..+.......+ .....+| ++.+||.+||..||.+|| ++++|++ ..+...++|+
T Consensus 223 ~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP---~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 223 DTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKP---DYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCC---CHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred ccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 44455555544332222 1123355 999999999999999999 7766654 3344567776
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=341.43 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=196.9
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhh--hchhHHHHHHHHHHHHHhcC--CCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADM--IRKNAVESILAERDILISVR--NPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|.+++ ||||+++++++...+.+|+||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 445554 99999999997552 34443322 23445678899999999997 599999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~----- 180 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT----- 180 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc-----
Confidence 9 45789999999888899999999999999999999999999999999999996 5899999999987421000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-----------CCCCccceeechhHHHHHHHhCC
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-----------TGHGTTADWWSVGIILFELIVGI 677 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----------~~ys~ksDIWSLGvILyELLTGk 677 (863)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 181 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 181 ------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp ---------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 0011234579999999999976 46788999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 678 PPFNAEHP-QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 678 ~PF~~~~~-~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
.||..... ...+..+...... ..++...+.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 299 (313)
T 3cek_A 237 TPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQIQ 299 (313)
T ss_dssp CTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHCC
T ss_pred CchhhHHHHHHHHHHHHhcccc-cCCcccchHHHHHHHHHHccCCcccCc---CHHHHhcCccccCC
Confidence 99976543 3344444433322 234566789999999999999999999 99999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=336.74 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=197.2
Q ss_pred CcccceEE-Eeecccceeecccc----------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN 523 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 523 (863)
....|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34456655 99999999997642 23443322 23345678999999999999999999999998765
Q ss_pred EEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 524 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
.++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 89999999999999999764 56999999999999999999999999999999999999999999999999998742110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFN 681 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~ 681 (863)
.. .........||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 175 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 226 (291)
T 1u46_A 175 DD----------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 226 (291)
T ss_dssp CC----------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cc----------------------------chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 00 0011223568889999999999889999999999999999999 999999
Q ss_pred CCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 682 AEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 682 ~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+..+....+......++ .+..++.++.++|.+||..||.+|| ++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 278 (291)
T 1u46_A 227 GLNGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cCCHHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 9998888888876654433 4567999999999999999999999 89998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=343.25 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=200.5
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~l 524 (863)
..|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.+ +||||+++++++...+.+
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 445544 99999999997642 233322211 234557789999999999 899999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc--------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEE
Q 002953 525 YLVMEYLNGGDLYSLLRNL--------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~--------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKL 590 (863)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 9999999999999999753 35799999999999999999999999999999999999999999999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002953 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670 (863)
Q Consensus 591 iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvIL 670 (863)
+|||+++...... .........||+.|+|||++.+..++.++|||||||++
T Consensus 206 ~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 256 (333)
T 2i1m_A 206 GDFGLARDIMNDS-----------------------------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256 (333)
T ss_dssp CCCGGGCCGGGCT-----------------------------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Ccccccccccccc-----------------------------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHH
Confidence 9999997421100 00122345678999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 671 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 671 yELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|+|++ |..||.+......+..+....... ..+...+.++.+||.+||+.||.+|| ++.+++++
T Consensus 257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 320 (333)
T 2i1m_A 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRP---TFQQICSF 320 (333)
T ss_dssp HHHTTTSCCSSTTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcCCCCCCcccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCc---CHHHHHHH
Confidence 99998 999998877666666665554332 34567899999999999999999999 99998874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.89 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=198.8
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEE-EeCCeEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSF-TCRENLY 525 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f-~d~~~ly 525 (863)
...|.+. +||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++ ..++..|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3345544 99999999997543 23333222 2344567899999999999999999999985 4566889
Q ss_pred EEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999974211000
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~ 683 (863)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 184 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 184 ---------------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp ---------------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ---------------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 00112234578899999999999999999999999999999999 77888887
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+....+...... ..+..++.++.+||.+||..||.+|| ++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 285 (298)
T 3f66_A 237 NTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 285 (298)
T ss_dssp CTTTHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 777777776665542 33567899999999999999999999 89888863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.34 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=200.1
Q ss_pred Eeecccceeecccc---------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++ ..+.+|+||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 89999999997542 333333221 344567899999999999999999999999 5567999999999999
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---------- 165 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---------- 165 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC----------
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc----------
Confidence 99999654 5699999999999999999999999999999999999999999999999999974211000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..++...+.
T Consensus 166 ------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~ 227 (287)
T 1u59_A 166 ------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227 (287)
T ss_dssp ------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred ------------------eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh
Confidence 0011223467899999999998889999999999999999998 999999988888887776
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
.+.. +..+..+++++.+||.+||..||.+|| ++.++++|.
T Consensus 228 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l 267 (287)
T 1u59_A 228 QGKR--MECPPECPPELYALMSDCWIYKWEDRP---DFLTVEQRM 267 (287)
T ss_dssp TTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHH
T ss_pred cCCc--CCCCCCcCHHHHHHHHHHcCCChhhCc---CHHHHHHHH
Confidence 6543 345678999999999999999999999 999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.36 Aligned_cols=240 Identities=23% Similarity=0.397 Sum_probs=191.8
Q ss_pred CCcccceEE-Eeecccceeecccc-------ceehhhhhhc---hh----HHHHHHHHHHHHHhcCCCCeeEEEEEEEeC
Q 002953 457 PRTSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR---KN----AVESILAERDILISVRNPFVVRFFYSFTCR 521 (863)
Q Consensus 457 ~~~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~---k~----~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 521 (863)
.....|.+. .||+|+||.|+.+. +++|...... .. ..+.+.+|+.+|++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 344556655 89999999997542 3444322111 11 116788999999999999999999998766
Q ss_pred CeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCc-----EEEeec
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGH-----IKLTDF 593 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~-----VKLiDF 593 (863)
. ++||||+++|+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 7999999999999988654 46999999999999999999999999 999999999999988776 999999
Q ss_pred CCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc--CCCCCccceeechhHHHH
Q 002953 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL--GTGHGTTADWWSVGIILF 671 (863)
Q Consensus 594 GLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~--g~~ys~ksDIWSLGvILy 671 (863)
|+++... .......||+.|+|||++. ...++.++|||||||++|
T Consensus 174 g~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~ 219 (287)
T 4f0f_A 174 GLSQQSV----------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219 (287)
T ss_dssp TTCBCCS----------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH
T ss_pred Ccccccc----------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH
Confidence 9987310 0122467999999999994 455789999999999999
Q ss_pred HHHhCCCCCCCCChHHH--HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 672 ELIVGIPPFNAEHPQQI--FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 672 ELLTGk~PF~~~~~~el--~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+|++|..||........ ...+..... .+..+..+++++.+||.+||+.||.+|| ++.++++
T Consensus 220 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 282 (287)
T 4f0f_A 220 TILTGEGPFDEYSYGKIKFINMIREEGL-RPTIPEDCPPRLRNVIELCWSGDPKKRP---HFSYIVK 282 (287)
T ss_dssp HHHHSSCTTTTCCCCHHHHHHHHHHSCC-CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHcCCCCCccccccHHHHHHHHhccCC-CCCCCcccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999976654333 334433332 3456778999999999999999999999 8998875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.54 Aligned_cols=246 Identities=19% Similarity=0.317 Sum_probs=187.8
Q ss_pred CcccceEE-Eeecccceeecccc----ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP----QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~----kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
...+|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||++++++ .....+|+||||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~ 100 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQW 100 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSSCEEEEEC
T ss_pred CccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCccEEEEEe
Confidence 34455554 99999999997652 33443322 234556789999999999999999999995 456678999999
Q ss_pred cCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------- 173 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW------- 173 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc-------
Confidence 9999999999654 56999999999999999999999999999999999999999999999999998741100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
..........||+.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 174 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 231 (289)
T 3og7_A 174 ----------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231 (289)
T ss_dssp --------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred ----------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH
Confidence 0011223457999999999997 566889999999999999999999999876555
Q ss_pred HHHHHHhh-cCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 687 QIFDNILN-RKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 687 el~~kIl~-~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.....+.. ... .+......+++++.+||.+||..||.+|| ++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 281 (289)
T 3og7_A 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRILA 281 (289)
T ss_dssp HHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 44444433 322 22234457899999999999999999999 8998875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.88 Aligned_cols=241 Identities=23% Similarity=0.309 Sum_probs=197.6
Q ss_pred EEeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE-EEEEeecC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL-YLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l-yLVmEy~~ 532 (863)
.+||+|+||+|+.+. +++|.... ......+.+.+|+.+|+.++||||+++++++.+.+.. |+||||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 489999999997542 33443322 2334567889999999999999999999999877665 99999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 107 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-------- 178 (298)
T 3pls_A 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE-------- 178 (298)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG--------
T ss_pred CCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc--------
Confidence 99999999873 568999999999999999999999999999999999999999999999999997421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
...........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+...+..
T Consensus 179 -------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~ 239 (298)
T 3pls_A 179 -------------------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239 (298)
T ss_dssp -------------------GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH
T ss_pred -------------------ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH
Confidence 000122334678999999999999999999999999999999999 566677777777766
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..... +..+..+++++.+||.+||..||.+|| |+.++++.
T Consensus 240 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 281 (298)
T 3pls_A 240 FLAQGRR--LPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVGE 281 (298)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhhcCCC--CCCCccchHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 6655443 234677899999999999999999999 89988863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.98 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=183.9
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhc--hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR--KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~--k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
...|.+. .||+|+||.|+.+. +++|...... ....+.+..+..+++.++||||+++++++...+.+|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3455544 89999999986652 3444332221 122334445556778889999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 529 EYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 529 Ey~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||+ ++.+..++.. .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----- 177 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-----
Confidence 999 5566655544 46799999999999999999999995 999999999999999999999999999874110
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFN 681 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~ 681 (863)
........||+.|+|||++. +..++.++|||||||++|+|++|..||.
T Consensus 178 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (318)
T 2dyl_A 178 ---------------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230 (318)
T ss_dssp ------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ---------------------------CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence 01122357999999999995 4568899999999999999999999998
Q ss_pred C-CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 682 A-EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 682 ~-~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
. ....+.+..+.............++.++.+||.+||..||.+|| ++.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKRY 290 (318)
T ss_dssp TCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHHH
T ss_pred CCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhhCHHHHhc
Confidence 6 45556666666655433333346899999999999999999999 99999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=338.78 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=197.8
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCC-
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRE- 522 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~- 522 (863)
...|.+. .||+|+||+|+.+. +++|.... ........+.+|+.+|.++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 3455554 99999999997652 23333222 1233456789999999999 7899999999988765
Q ss_pred eEEEEEeecCCCChHHHHHhcCC----------------CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLGC----------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g~----------------L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g 586 (863)
.+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 59999999999999999987543 88999999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeech
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 666 (863)
.+||+|||+++...... .........||+.|+|||++.+..++.++|||||
T Consensus 186 ~~kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 186 VVKICDFGLARDIYKDP-----------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp CEEECCCGGGSCTTTCT-----------------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CEEECCCccccccccCc-----------------------------cceeccCCCcceeecCchhhccccccchhHHHHH
Confidence 99999999987421000 0112234578999999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 667 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 667 GvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||++|+|++ |..||.+......+...+..... +..+..+++++.++|.+||..||.+|| ++.++++|
T Consensus 237 G~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 304 (316)
T 2xir_A 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 304 (316)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccchhHHHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999998 99999877654444333333222 234567899999999999999999999 99999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.25 Aligned_cols=240 Identities=19% Similarity=0.283 Sum_probs=196.4
Q ss_pred EEeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+||+|+||.|+.+. +++|..... .......+.+|+.+|+.++||||+++++++...+.+|+||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 489999999997642 334433222 23445678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 130 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------- 201 (333)
T 1mqb_A 130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-------- 201 (333)
T ss_dssp TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc--------
Confidence 99999999765 579999999999999999999999999999999999999999999999999987421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..++..
T Consensus 202 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 261 (333)
T 1mqb_A 202 --------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 261 (333)
T ss_dssp -----------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred --------------------ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 00011123457889999999999999999999999999999998 999999988888887
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..+.. +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 262 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 262 AINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHCCCc--CCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 7765532 233567899999999999999999999 89888865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=345.10 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=196.5
Q ss_pred CcccceEE-Eeecccceeeccccc-----------eehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFPQ-----------VLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~k-----------vlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~l 524 (863)
....|.+. +||+|+||.|+.+.. ++|... .........+.+|+.+|+.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 34456554 999999999976531 222221 112345677899999999999999999999998765 8
Q ss_pred EEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
++||+|+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 8999999999999999764 569999999999999999999999999999999999999999999999999997421000
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+
T Consensus 172 -----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 172 -----------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp -------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred -----------------------------ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0111223567889999999999999999999999999999999 9999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
....++...+..... +..+..++.++.+||.+||..||.+|| ++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 272 (327)
T 3lzb_A 223 IPASEISSILEKGER--LPQPPICTIDVYMIMRKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp CCGGGHHHHHHTTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 888777776655442 234567899999999999999999999 99999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.52 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=188.2
Q ss_pred cceEE-Eeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|.+. +||+|+||+|... .+++|+... .....+.+|+.+|+.+ +|||||++++++.+...+|||||||.
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECT---TTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 34443 8999999996321 234443321 2223356899999999 79999999999999999999999996
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---C--CcEEEeecCCccccccCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---D--GHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~--g~VKLiDFGLAk~~~~~s~~d 606 (863)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+|+......
T Consensus 102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~--- 177 (432)
T 3p23_A 102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR--- 177 (432)
T ss_dssp -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC---
Confidence 59999997653 4667778899999999999999999999999999999953 2 358899999998421100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL---GTGHGTTADWWSVGIILFELIV-GIPPFNA 682 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGvILyELLT-Gk~PF~~ 682 (863)
.........+||+.|+|||++. +..++.++|||||||++|||++ |.+||..
T Consensus 178 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 178 -------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp ---------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred -------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 0011233568999999999998 4567889999999999999999 9999976
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
.........+..........+...+..+.+||.+||+.||.+|| |+.++++||||..++|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 233 SLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp TTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHHHHHTSTTTCCHHHH
T ss_pred hhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCC---CHHHHHhCccccChHHH
Confidence 65544333222222211111233456789999999999999999 99999999999998884
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.63 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=191.8
Q ss_pred cceE-EEeecccceeecccc----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 461 QIDL-LLAGKGALSEHDDFP----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.|.+ .+||+|+||+|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++...+.+|+||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3443 499999999997542 344443322 3345568999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---- 201 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP---- 201 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC----
Confidence 9999999999998754 69999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
..........+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..
T Consensus 202 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~ 257 (373)
T 2qol_A 202 ------------------------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257 (373)
T ss_dssp ------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH
T ss_pred ------------------------ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 00011123356889999999999999999999999999999997 99999999888
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++...+..+.. +..+..++.++.+||.+||+.||.+|| ++.++++
T Consensus 258 ~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 258 DVIKAVDEGYR--LPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHHHHHHTTEE--CCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHcCCC--CCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 88877765432 223567899999999999999999999 8888876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.55 Aligned_cols=247 Identities=19% Similarity=0.225 Sum_probs=195.6
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. .||+|+||.|+.+. +++|.. ......+.+.+|+.++..+ +|+||+++++++......|+||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE--ECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEe--ccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 45544 89999999997653 233322 2223345688999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc-----EEEeecCCccccccCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH-----IKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~-----VKLiDFGLAk~~~~~s~~ 605 (863)
|++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence 999999998754 5999999999999999999999999999999999999987765 999999999852111000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-- 683 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-- 683 (863)
. ..........+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 ~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 168 Q------------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp C------------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred c------------------------cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 0 00001234578999999999999999999999999999999999999999874
Q ss_pred -ChHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 -HPQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 -~~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.....+..+..... +.+.....+++++.+||.+||..||.+|| ++++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP---~~~~l~~~ 277 (298)
T 1csn_A 224 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYLQGL 277 (298)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHHHHH
T ss_pred cccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 34455555443322 22223457899999999999999999999 78877653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.52 Aligned_cols=242 Identities=29% Similarity=0.469 Sum_probs=167.9
Q ss_pred ccceE--EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHH-HHHHhcCCCCeeEEEEEEEe----CCeEE
Q 002953 460 SQIDL--LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAER-DILISVRNPFVVRFFYSFTC----RENLY 525 (863)
Q Consensus 460 ~~~~l--~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei-~IL~~L~HPnIVkL~~~f~d----~~~ly 525 (863)
..|.+ .+||+|+||+|+.+. +++|.... . . ...+|+ ..++.++||||+++++++.. ...+|
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~---~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-S---P-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES-S---H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC-c---H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 45665 379999999997552 34443211 1 1 122333 34567799999999999987 45689
Q ss_pred EEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC---CcEEEeecCCccccc
Q 002953 526 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD---GHIKLTDFGLSKVGL 600 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~---g~VKLiDFGLAk~~~ 600 (863)
+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999999998764 69999999999999999999999999999999999999864 559999999987411
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 183 ---------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 229 (336)
T 3fhr_A 183 ---------------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229 (336)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred ---------------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 01123457899999999998888999999999999999999999999
Q ss_pred CCCChHHH----HHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 681 NAEHPQQI----FDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 681 ~~~~~~el----~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
........ ...+......++. ....++.++.+||.+||..||.+|| |+.++++||||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 293 (336)
T 3fhr_A 230 YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWINQ 293 (336)
T ss_dssp ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHHT
T ss_pred CCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccccc
Confidence 77655443 2222222222221 2356899999999999999999999 9999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.05 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=195.0
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC---
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRE--- 522 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--- 522 (863)
...|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3445554 89999999997541 344433322 3445677999999999999999999999998765
Q ss_pred --eEEEEEeecCCCChHHHHHh------cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecC
Q 002953 523 --NLYLVMEYLNGGDLYSLLRN------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594 (863)
Q Consensus 523 --~lyLVmEy~~GGsL~dlLk~------~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFG 594 (863)
..|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 35999999999999999843 3569999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002953 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 595 LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL 674 (863)
+++...... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 193 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 243 (313)
T 3brb_A 193 LSKKIYSGD-----------------------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243 (313)
T ss_dssp CC---------------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred cceeccccc-----------------------------ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH
Confidence 987421000 001122356788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 675 V-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 675 T-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+ |.+||.......+...+..... +..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 244 ~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~~ 302 (313)
T 3brb_A 244 TRGMTPYPGVQNHEMYDYLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRP---TFSVLRLQ 302 (313)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCC--CCCBTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred hcCCCCCccCCHHHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9 9999999888888877766543 345678999999999999999999999 99999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.34 Aligned_cols=240 Identities=21% Similarity=0.336 Sum_probs=199.6
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..+.+. .||+|+||+|+.+. +++|.... .....+.+.+|+.+|++++|||||++++++. .+.+|+||||++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECT-TSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecC-CCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 345544 99999999996552 34443322 2235678999999999999999999999886 667999999999
Q ss_pred CCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~--------- 336 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--------- 336 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC---------
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC---------
Confidence 99999999754 3689999999999999999999999999999999999999999999999999984110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
..........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++.
T Consensus 337 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~ 395 (454)
T 1qcf_A 337 ---------------------NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395 (454)
T ss_dssp ---------------------HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ---------------------CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 00111234457889999999998899999999999999999999 99999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..+.. . ..+..+++++.+||.+||..||.+|| |+++|++
T Consensus 396 ~~i~~~~~-~-~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 396 RALERGYR-M-PRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp HHHHHTCC-C-CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHcCCC-C-CCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 88766532 2 34678999999999999999999999 8887764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=354.41 Aligned_cols=243 Identities=26% Similarity=0.361 Sum_probs=199.6
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..+.+. .||+|+||+|+.+. +++|.... ........+.+|+++|++++||||+++++++...+.+|+||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 344443 89999999996542 33443221 1233445788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~------ 267 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV------ 267 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE------
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc------
Confidence 99999999998754 59999999999999999999999999999999999999999999999999987411000
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el 688 (863)
. ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 268 ---------------~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~ 324 (377)
T 3cbl_A 268 ---------------Y--------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324 (377)
T ss_dssp ---------------E--------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH
T ss_pred ---------------e--------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 0 001112346778999999998889999999999999999998 9999999888877
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
...+..+.. ...+..+++++.+||.+||+.||.+|| |+.++++
T Consensus 325 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 325 REFVEKGGR--LPCPELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 776655432 234677999999999999999999999 8888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.56 Aligned_cols=236 Identities=26% Similarity=0.414 Sum_probs=197.4
Q ss_pred ccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-eEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-NLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-~lyLVmEy~~ 532 (863)
..+.+. .||+|+||+|+.+. +++|... .....+.+.+|+.+|++++||||+++++++.... .+|+||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEES--SCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeC--CchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 345444 99999999996542 3343322 2234567899999999999999999999987665 7999999999
Q ss_pred CCChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~---------- 340 (450)
T 1k9a_A 271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---------- 340 (450)
T ss_dssp TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc----------
Confidence 9999999987654 7999999999999999999999999999999999999999999999999987310
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..++.
T Consensus 341 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 396 (450)
T 1k9a_A 341 ------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396 (450)
T ss_dssp ------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred ------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 00112367899999999999999999999999999999998 99999988887777
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..+.. +..+..+++++.+||.+||..||.+|| |+.++++
T Consensus 397 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~~ 438 (450)
T 1k9a_A 397 PRVEKGYK--MDAPDGCPPAVYDVMKNCWHLDAATRP---TFLQLRE 438 (450)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 77765532 345678999999999999999999999 8888774
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.17 Aligned_cols=237 Identities=25% Similarity=0.406 Sum_probs=192.8
Q ss_pred cccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC-CeEEEEEeec
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR-ENLYLVMEYL 531 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-~~lyLVmEy~ 531 (863)
...|.+. .||+|+||.|+.+. +++|... .....+.+.+|+.+|++++||||+++++++... +.+|+||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC--CCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEec--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4456555 99999999997642 3333322 233567789999999999999999999987654 4799999999
Q ss_pred CCCChHHHHHhcCC--CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 532 ~GGsL~dlLk~~g~--L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~--------- 168 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--------- 168 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc---------
Confidence 99999999987543 8999999999999999999999999999999999999999999999999987310
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el 688 (863)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..+.
T Consensus 169 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 223 (278)
T 1byg_A 169 -------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223 (278)
T ss_dssp --------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred -------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 01123467899999999999999999999999999999998 9999998888777
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
...+..... +..+..+++++.+||.+||..||.+|| ++.++++
T Consensus 224 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 224 VPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 777755432 345678999999999999999999999 8888875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.31 Aligned_cols=240 Identities=22% Similarity=0.342 Sum_probs=198.2
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. .||+|+||.|+.+. +++|... ......+.+.+|+++|+.++||||+++++++. .+..|+||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEEC-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEec-CCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 345544 99999999997642 3333322 22234567899999999999999999999876 456899999999
Q ss_pred CCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------- 163 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------- 163 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-------
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-------
Confidence 999999997643 69999999999999999999999999999999999999999999999999997421100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.
T Consensus 164 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 220 (279)
T 1qpc_A 164 -----------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (279)
T ss_dssp -----------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -----------------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 011123467889999999998889999999999999999999 99999998888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..... +..+..++.++.+||.+||..||.+|| ++.++++
T Consensus 221 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 221 QNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHhcccC--CCCcccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 77765532 234567899999999999999999999 8888875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.48 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred ccceEE--Eeecccceeecccc---------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL--LAGKGALSEHDDFP---------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~--vLGkG~FG~V~~~~---------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|+.++||||+++++++ ..+.+|+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 344443 89999999997651 23332221 1233457799999999999999999999998 5677899
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 172 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-- 172 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC--
Confidence 999999999999999888899999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~ 685 (863)
.........||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 173 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 173 --------------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp --------------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred --------------------------cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0011123457889999999999889999999999999999999 9999999988
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.++...+..... +..+..+++++.+||.+||..||.+|| ++.++++
T Consensus 227 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 227 SEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 888777766543 345678999999999999999999999 8888875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=335.30 Aligned_cols=236 Identities=27% Similarity=0.448 Sum_probs=187.7
Q ss_pred cccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
...|.+. .||+|+||.|+.+. +++|.. ......+.+.+|+.+|++++||||+++++++. +..|+||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEC--SSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEe--cChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 3445554 99999999997652 333332 23345677899999999999999999999876 45899999999
Q ss_pred CCChHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHh---CCccccCCCCcceeecCCCc-EEEeecCCccccccCCCC
Q 002953 533 GGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHS---LRVVHRDLKPDNLLIAHDGH-IKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 533 GGsL~dlLk~~g---~L~e~~i~~Ia~QIl~ALeyLHs---~GIIHRDLKPeNILLd~~g~-VKLiDFGLAk~~~~~s~~ 605 (863)
||+|.+++...+ .++...+..++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~----- 157 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----- 157 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc-----
Confidence 999999998754 37888999999999999999999 89999999999999998886 7999999987310
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 158 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 158 -----------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp ------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred -----------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 011234699999999999999999999999999999999999999975432
Q ss_pred --HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 686 --QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 686 --~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
......+.... .+..+..++..+.+||.+||..||.+|| ++.+++++
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~~ 257 (307)
T 2eva_A 209 PAFRIMWAVHNGT--RPPLIKNLPKPIESLMTRCWSKDPSQRP---SMEEIVKI 257 (307)
T ss_dssp SHHHHHHHHHTTC--CCCCBTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred cHHHHHHHHhcCC--CCCcccccCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 23333333322 2445678999999999999999999999 89998874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=354.54 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=183.4
Q ss_pred EEeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChH
Q 002953 465 LLAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537 (863)
Q Consensus 465 ~vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~ 537 (863)
.+||+|+||+|+.. .+++|... ....+.+.+|+.+|.++ +|||||++++++.+.+.+|||||||. |+|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~---~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEE---GGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEc---HHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 48999999998422 23444332 23345678999999886 89999999999999999999999996 5999
Q ss_pred HHHHhcCCC-------ChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-------------CcEEEeecCCcc
Q 002953 538 SLLRNLGCL-------DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-------------GHIKLTDFGLSK 597 (863)
Q Consensus 538 dlLk~~g~L-------~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-------------g~VKLiDFGLAk 597 (863)
+++...+.. ++..+..++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~ 176 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCE
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccce
Confidence 999875432 344567899999999999999999999999999999754 489999999998
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-------CCCCccceeechhHHH
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGIIL 670 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGvIL 670 (863)
....... .........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 177 ~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il 229 (434)
T 2rio_A 177 KLDSGQS---------------------------SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229 (434)
T ss_dssp ECCC-----------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred ecCCCCc---------------------------cceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence 5211000 00011234689999999999976 5689999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCC----CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 671 FELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVP----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 671 yELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p----~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
|||++ |..||....... ..+......++... ..++.++.+||.+||+.||.+|| ++.++++||||...
T Consensus 230 ~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~hp~f~~~ 302 (434)
T 2rio_A 230 YYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP---TAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSCH
T ss_pred HHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC---CHHHHHhCCccCCc
Confidence 99999 999997665433 34444444333321 13458899999999999999999 99999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.71 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=195.1
Q ss_pred ccceEE-Eeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. +||+|+||.|+.+ .+++|+.........+.+.+|+.+|+.++||||+++++++...+.+|+||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 344443 8999999999754 245554444445567789999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC----CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 533 GGDLYSLLRNLG----CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 533 GGsL~dlLk~~g----~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 194 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---- 194 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC----
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc----
Confidence 999999997543 489999999999999999999999999999999999999999999999999874210000
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||....+.+.
T Consensus 195 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 195 -------------------------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp -------------------------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred -------------------------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 0112345699999999999998999999999999999999999999976543221
Q ss_pred H-------HHHhhcCCC---CC----CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCC
Q 002953 689 F-------DNILNRKIP---WP----RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738 (863)
Q Consensus 689 ~-------~kIl~~~~~---~p----~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHP 738 (863)
. ......... .+ ..+...+..+.+|+.+||+.||.+|| ++.++++|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~L 310 (321)
T 2qkw_B 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP---SMGDVLWKL 310 (321)
T ss_dssp CCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc---CHHHHHHHH
Confidence 1 011111100 01 11223456789999999999999999 999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.61 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=198.3
Q ss_pred CcccceEE-Eeecccceeecccc-----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEE--eCCe
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT--CREN 523 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~--d~~~ 523 (863)
....|.+. .||+|+||.|+.+. +++|..........+.+.+|+++|++++||||+++++++. ....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 34455555 99999999996543 4555554445566678999999999999999999999887 4567
Q ss_pred EEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 524 LYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
+|+||||++|++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999999774 56999999999999999999999999999999999999999999999999999842110
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 181 ~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 181 KD----------------------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CS----------------------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred Cc----------------------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 00 00122345789999999999999899999999999999999999999865
Q ss_pred CChH---------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 EHPQ---------------QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ~~~~---------------el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.... .+...+. .... +..+..+++++.+||.+||..||.+|| ++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 297 (327)
T 3lxl_A 233 PSAEFLRMMGCERDVPALSRLLELLE-EGQR-LPAPPACPAEVHELMKLCWAPSPQDRP---SFSALGPQ 297 (327)
T ss_dssp HHHHHHHHCC----CCHHHHHHHHHH-TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred ccchhhhhcccccccccHHHHHHHhh-cccC-CCCCCcccHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 4322 2222222 2222 334678999999999999999999999 88888654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=330.32 Aligned_cols=245 Identities=21% Similarity=0.278 Sum_probs=191.0
Q ss_pred ccceE-EEeecccceeecccc-----------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeE
Q 002953 460 SQIDL-LLAGKGALSEHDDFP-----------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENL 524 (863)
Q Consensus 460 ~~~~l-~vLGkG~FG~V~~~~-----------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~l 524 (863)
..|.+ ..||+|+||.|+.+. +++|..... .....+.+.+|+.+|+.++||||+++++++... ..+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 33444 499999999996543 334432211 223456789999999999999999999999887 668
Q ss_pred EEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|+||||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 9999999999999999554 679999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 181 ~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 181 E----------------------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp C----------------------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred c----------------------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 0 001223457899999999999999999999999999999999999886322
Q ss_pred --------------ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 684 --------------HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 684 --------------~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
............... ...+..+++++.+||.+||..||.+|| |+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 295 (302)
T 4e5w_A 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRT---SFQNLIE 295 (302)
T ss_dssp HHHHHHHHCSCCGGGHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHH
T ss_pred hhHHhhccCCcccccCHHHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCC---CHHHHHH
Confidence 111122222222222 234678999999999999999999999 8988875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=339.82 Aligned_cols=240 Identities=30% Similarity=0.438 Sum_probs=190.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhch------hHHHHHHHHHHHHHhc----CCCCeeEEEEEEEeC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRK------NAVESILAERDILISV----RNPFVVRFFYSFTCR 521 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k------~~~e~~l~Ei~IL~~L----~HPnIVkL~~~f~d~ 521 (863)
..|.+. .||+|+||.|+.+. +++|....... .....+.+|+.++.++ +||||+++++++...
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 445554 99999999997652 34443222111 1233466799999998 899999999999999
Q ss_pred CeEEEEEee-cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec-CCCcEEEeecCCcccc
Q 002953 522 ENLYLVMEY-LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVG 599 (863)
Q Consensus 522 ~~lyLVmEy-~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd-~~g~VKLiDFGLAk~~ 599 (863)
+..|+|||| +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 999999999 78999999999888899999999999999999999999999999999999999 7899999999998742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~ 678 (863)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.
T Consensus 191 ~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 191 HD---------------------------------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp CS---------------------------------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cc---------------------------------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 10 11234579999999999987766 458999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
||.... .+..... .++..++.++.+||.+||..||.+|| ++.++++||||+...
T Consensus 238 pf~~~~------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 238 PFERDQ------EILEAEL---HFPAHVSPDCCALIRRCLAPKPSSRP---SLEEILLDPWMQTPA 291 (312)
T ss_dssp SCCSHH------HHHHTCC---CCCTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSTTTCC--
T ss_pred CCCChH------HHhhhcc---CCcccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhcCch
Confidence 996532 2233333 24567899999999999999999999 999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=342.83 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=187.7
Q ss_pred cccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NLYLVM 528 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----~lyLVm 528 (863)
...|.+. +||+|+||+|+.+. +++|.... ..........|+.+|++++||||+++++++.... .+|+||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECG-GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeec-CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 3455554 99999999997652 34443322 2334445667999999999999999999998854 479999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC----------CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL----------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~----------GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
||+++|+|.+++.. +.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+|+.
T Consensus 102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 99999999999976 5699999999999999999999999 999999999999999999999999999974
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-----CCCccceeechhHHHHHH
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-----GHGTTADWWSVGIILFEL 673 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~ksDIWSLGvILyEL 673 (863)
...... .......+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 181 ~~~~~~-----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el 231 (322)
T 3soc_A 181 FEAGKS-----------------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231 (322)
T ss_dssp ECTTSC-----------------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccC-----------------------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence 211000 0112346899999999999873 456788999999999999
Q ss_pred HhCCCCCCCCC----------------hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCcCCCCCHH
Q 002953 674 IVGIPPFNAEH----------------PQQIFDNILNRKIPWPRVPE-----EMSPEAHDLIDRFLTEDPHQRLGSGGAS 732 (863)
Q Consensus 674 LTGk~PF~~~~----------------~~el~~kIl~~~~~~p~~p~-----~iS~el~dLI~k~L~~DP~kRpg~~SAe 732 (863)
++|..||.+.. ...+...+.... ..+..+. ..+.++.+||.+||+.||.+|| |+.
T Consensus 232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ 307 (322)
T 3soc_A 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL---SAG 307 (322)
T ss_dssp HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred HhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCc---CHH
Confidence 99999996532 222333332222 2222222 1245699999999999999999 899
Q ss_pred HHHcC
Q 002953 733 EVKQH 737 (863)
Q Consensus 733 EILqH 737 (863)
++++.
T Consensus 308 ell~~ 312 (322)
T 3soc_A 308 CVGER 312 (322)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=330.71 Aligned_cols=244 Identities=29% Similarity=0.490 Sum_probs=188.8
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
...|.+. .||+|+||.|+.+. +++|+.. .........+.+|+.+|++++||||+++++++...+.+|+|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3456654 89999999997542 3444332 23445667889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 528 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 528 mEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~-- 188 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 188 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC--
Confidence 999999999999864 35689999999999999999999999999999999999999999999999999874110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.
T Consensus 189 -----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 189 -----------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ---------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred -----------------------------CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 001123457999999999999999999999999999999999999999764
Q ss_pred C--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 684 H--PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 684 ~--~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
. .......+.....+ +.....++.++.+||.+||..||.+|| ++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~~ 291 (310)
T 2wqm_A 240 KMNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRP---DVTYVYDV 291 (310)
T ss_dssp -CCHHHHHHHHHTTCSC-CCCTTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred chhHHHHHHHhhcccCC-CCcccccCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 3 34445555443332 112356899999999999999999999 99999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.52 Aligned_cols=250 Identities=15% Similarity=0.160 Sum_probs=184.9
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhhhc-----------hhHHHHHHHHHHHHHhcCCCCeeEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADMIR-----------KNAVESILAERDILISVRNPFVVRF 514 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~~-----------k~~~e~~l~Ei~IL~~L~HPnIVkL 514 (863)
...|.+. .||+|+||.|+.+. +++|...... ......+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3456655 99999999997651 2333211111 1111234456666777889999999
Q ss_pred EEEEEeC----CeEEEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec--CCCc
Q 002953 515 FYSFTCR----ENLYLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGH 587 (863)
Q Consensus 515 ~~~f~d~----~~lyLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd--~~g~ 587 (863)
++++... .++||||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998875 4689999999 99999999876 6799999999999999999999999999999999999999 7899
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechh
Q 002953 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667 (863)
Q Consensus 588 VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLG 667 (863)
+||+|||+|+......... ..........+||+.|+|||++.+..++.++||||||
T Consensus 193 ~kl~DFG~a~~~~~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 248 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHK------------------------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248 (364)
T ss_dssp EEECCCTTCEESSGGGCCC------------------------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred EEEEECCcceecccCCccc------------------------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH
Confidence 9999999997522110000 0001122456799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhhcC--CCCCC------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 668 IILFELIVGIPPFNAEHPQQIFDNILNRK--IPWPR------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 668 vILyELLTGk~PF~~~~~~el~~kIl~~~--~~~p~------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|++|||++|..||.+......+....... ...+. ....++.++.+||..||..||.+|| ++.+|++
T Consensus 249 ~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP---~~~~l~~ 322 (364)
T 3op5_A 249 YCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP---LYENLRD 322 (364)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC---CHHHHHH
T ss_pred HHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC---CHHHHHH
Confidence 99999999999998543222211111100 00000 1256899999999999999999999 7777664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=360.82 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=200.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..+.+. .||+|+||.|+.+. +++|... ......+.+.+|+.+|++++|||||++++++.....+||||||+
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECC-SSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEec-CcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 344444 89999999996542 3333322 22334677999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 532 NGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 532 ~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~------- 371 (495)
T 1opk_A 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------- 371 (495)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-------
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-------
Confidence 999999999864 45899999999999999999999999999999999999999999999999999842100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el 688 (863)
.........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++
T Consensus 372 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~ 428 (495)
T 1opk_A 372 -----------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428 (495)
T ss_dssp -----------------------CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred -----------------------ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 0011223457889999999999889999999999999999999 9999999888877
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+..+..... ...+..+++++.+||.+||+.||.+|| ++.+|++
T Consensus 429 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 429 YELLEKDYR--MERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHcCCC--CCCCCCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 776654432 234678999999999999999999999 8888875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=342.38 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=199.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhch------hHHHHHHHHHHHHHhcC--CCCeeEEEEEEEeCCe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRK------NAVESILAERDILISVR--NPFVVRFFYSFTCREN 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k------~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~ 523 (863)
..|.+. .||+|+||.|+.+. +++|....... .....+.+|+.+|++++ ||||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 345554 99999999997652 33333221111 12245678999999996 5999999999999999
Q ss_pred EEEEEeecCC-CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec-CCCcEEEeecCCcccccc
Q 002953 524 LYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-HDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 524 lyLVmEy~~G-GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd-~~g~VKLiDFGLAk~~~~ 601 (863)
+|+|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 9999999976 89999999888999999999999999999999999999999999999999 679999999999874210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF 680 (863)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 203 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 203 ---------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp ---------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------------------------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 11224579999999999987765 78899999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHH
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l 748 (863)
.... .+..... .++..+++++.+||.+||..||.+|| ++.++++||||+++.+...
T Consensus 250 ~~~~------~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 250 EHDE------EIIRGQV---FFRQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp CSHH------HHHHCCC---CCSSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCCCHHH
T ss_pred CChh------hhhcccc---cccccCCHHHHHHHHHHccCChhhCc---CHHHHhcCHhhcCccCccc
Confidence 6542 2233332 23467899999999999999999999 9999999999999876543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=339.35 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=192.1
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYL 526 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~lyL 526 (863)
...|.+. .||+|+||.|+.+. +++|..........+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 3455554 99999999996542 35554444455667789999999999999999999999873 347899
Q ss_pred EEeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 527 VMEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999999999999976 367999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC---CCccceeechhHHHHHHHhCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG---HGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---ys~ksDIWSLGvILyELLTGk~P 679 (863)
.................||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 188 ----------------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 188 ----------------------VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp ----------------------EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred ----------------------cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 00000011111223456899999999998654 68999999999999999999999
Q ss_pred CCCCC--hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 680 FNAEH--PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 680 F~~~~--~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|.... .......+ .....++ .+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 300 (317)
T 2buj_A 246 YDMVFQKGDSVALAV-QNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRP---HIPLLLSQ 300 (317)
T ss_dssp THHHHHTTSCHHHHH-HCC--CC-CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhhhhcccchhhHHh-hccCCCC-ccccCCHHHHHHHHHHhhcChhhCC---CHHHHHHH
Confidence 95311 11111222 2222322 2456899999999999999999999 99999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.98 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=191.4
Q ss_pred ceE-EEeecccceeecccc----------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEE-eCCeEEEEE
Q 002953 462 IDL-LLAGKGALSEHDDFP----------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFT-CRENLYLVM 528 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~----------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~-d~~~lyLVm 528 (863)
|.+ .+||+|+||+|+.+. +++|... .......+.+.+|+.+|++++||||+++++++. .++..|+||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 443 389999999997542 2333322 223456678999999999999999999999864 456889999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--- 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc---
Confidence 999999999999865 4588999999999999999999999999999999999999999999999999974211000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
..........||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..
T Consensus 248 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 248 ------------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ------------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 00011233568899999999999999999999999999999999 78899887777
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
++...+..+.. +..+..++.++.+||.+||..||.+|| ++.+++++
T Consensus 304 ~~~~~~~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 304 DITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp CHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 77666665543 234577999999999999999999999 99999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.60 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=195.8
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..+.+. .||+|+||+|+.+. +++|.... .....+.+.+|+.+|++++||||+++++++.. +.+|+||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEecc-CCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 344444 89999999996542 34443322 22335678999999999999999999998876 67999999999
Q ss_pred CCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-------- 333 (452)
T 1fmk_A 262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-------- 333 (452)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC--------
Confidence 99999999753 56999999999999999999999999999999999999999999999999999742100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
.........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....++.
T Consensus 334 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 334 ----------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp -------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ----------------------ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 0011123457889999999999999999999999999999999 99999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+..+.. +..+..+++.+.+||.+||..||.+|| |+++|++
T Consensus 392 ~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 392 DQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp HHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 87765532 234678999999999999999999999 8888875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=333.71 Aligned_cols=243 Identities=21% Similarity=0.277 Sum_probs=191.9
Q ss_pred cceE-EEeecccceeeccc-----------cceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC--CeEE
Q 002953 461 QIDL-LLAGKGALSEHDDF-----------PQVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCR--ENLY 525 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~-----------~kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~ly 525 (863)
.+.+ ..||+|+||+|+.+ .+++|..... .....+.+.+|+++|++++||||+++++++.+. ..+|
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3344 49999999999432 1344433322 234567789999999999999999999999984 6799
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+||||+++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 189 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE- 189 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS-
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc-
Confidence 999999999999999764 599999999999999999999999999999999999999999999999999984211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 190 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 190 ---------------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp ---------------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred ---------------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 00112345688999999999998899999999999999999999999965422
Q ss_pred H--------------HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 686 Q--------------QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 686 ~--------------el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
. ......+.... .+..+..++.++.+||.+||..||.+|| ++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~ 303 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRP---TFENLIP 303 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 1 01112222222 2344678999999999999999999999 8999885
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.72 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=186.3
Q ss_pred ccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHh--cCCCCeeEEEEEEEeC----CeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCR----ENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~d~----~~lyLV 527 (863)
..|.+. .||+|+||+|+.+. +++|.. .......+..|.+++.. ++||||+++++++... ..+|+|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~---~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEE---CGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEe---ccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 345544 99999999997652 344432 23345566778888877 7999999999886543 468999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH--------hCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH--------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH--------s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
|||+++|+|.++++. +.+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+..
T Consensus 85 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 163 (301)
T 3q4u_A 85 THYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163 (301)
T ss_dssp ECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred hhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeec
Confidence 999999999999965 57999999999999999999999 999999999999999999999999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC------CCCccceeechhHHHHHH
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT------GHGTTADWWSVGIILFEL 673 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~------~ys~ksDIWSLGvILyEL 673 (863)
..... .........+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 164 ~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 164 SQSTN---------------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp ETTTT---------------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccc---------------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence 11000 000112345899999999999876 445799999999999999
Q ss_pred HhC----------CCCCCCCC----hHHHHHHHhhcCCCCCCCC-----CCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 674 IVG----------IPPFNAEH----PQQIFDNILNRKIPWPRVP-----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 674 LTG----------k~PF~~~~----~~el~~kIl~~~~~~p~~p-----~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
++| ..||.... .......+.......+..+ ...+.++.+||.+||+.||.+|| |+.++
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i 293 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL---TALRI 293 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC---CHHHH
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC---CHHHH
Confidence 999 88986532 2233333333322223332 22557899999999999999999 89998
Q ss_pred Hc
Q 002953 735 KQ 736 (863)
Q Consensus 735 Lq 736 (863)
++
T Consensus 294 ~~ 295 (301)
T 3q4u_A 294 KK 295 (301)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.40 Aligned_cols=250 Identities=24% Similarity=0.418 Sum_probs=176.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHH-HHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERD-ILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~-IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..|.+. .||+|+||.|+.+. +++|..... .......+..|+. +++.++||||+++++++...+..|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 444444 89999999996542 344433222 2233445666666 6667899999999999999999999999
Q ss_pred ecCCCChHHHHHh-----cCCCChhhHHHHHHHHHHHHHHHHhC-CccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 530 YLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYLHSL-RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 530 y~~GGsL~dlLk~-----~g~L~e~~i~~Ia~QIl~ALeyLHs~-GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|+.| +|.+++.. .+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-- 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc--
Confidence 9975 88888763 46799999999999999999999998 999999999999999999999999999874110
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh----cCCCCCccceeechhHHHHHHHhCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL----LGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL----~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
........||+.|+|||++ .+..++.++|||||||++|+|++|..|
T Consensus 179 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 179 ------------------------------SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp ---------------------------------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ------------------------------ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 0111234799999999999 456689999999999999999999999
Q ss_pred CCCCCh-HHHHHHHhhcCCC-CC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 680 FNAEHP-QQIFDNILNRKIP-WP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 680 F~~~~~-~el~~kIl~~~~~-~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
|..... .+.+..+..+... ++ .....+++++.+||.+||..||.+|| ++.++++||||....+
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 229 YPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP---KYKELLKHPFILMYEE 294 (327)
T ss_dssp SSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHHHHH
T ss_pred CCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCc---CHHHHHhChHHHHhHh
Confidence 976542 2233333332221 11 11246899999999999999999999 9999999999976544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=366.10 Aligned_cols=238 Identities=23% Similarity=0.328 Sum_probs=196.4
Q ss_pred EEeecccceeecccc---------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP---------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~---------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||+|+.+. +++|... .......+.+.+|+++|++++|||||++++++.. +.+|||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 379999999997541 2333322 2233446789999999999999999999998864 568999999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|.+++...+.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~--------- 524 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--------- 524 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc---------
Confidence 99999999888899999999999999999999999999999999999999999999999999984211000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kI 692 (863)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus 525 -------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 585 (635)
T 4fl3_A 525 -------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585 (635)
T ss_dssp -----------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred -------------------ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0011223457889999999999999999999999999999998 99999999998888887
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.. +..+..+++++.+||.+||..||.+|| ++.+|++
T Consensus 586 ~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 624 (635)
T 4fl3_A 586 EKGER--MGCPAGCPREMYDLMNLCWTYDVENRP---GFAAVEL 624 (635)
T ss_dssp HTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 76543 345678999999999999999999999 8888764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.78 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=173.7
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEE--------eCC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFT--------CRE 522 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~--------d~~ 522 (863)
..|.+. +||+|+||.|+.+. +++|............+.+|+.+|.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 345554 99999999997653 3555443344455678899999999996 999999999994 344
Q ss_pred eEEEEEeecCCCChHHHHHh---cCCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 523 NLYLVMEYLNGGDLYSLLRN---LGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~---~g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
.+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 5899999996 699998865 467999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh---cCCCCCccceeechhHHHHHHH
Q 002953 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL---LGTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 598 ~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL---~g~~ys~ksDIWSLGvILyELL 674 (863)
........ ... .............+||+.|+|||++ .+..++.++|||||||++|+|+
T Consensus 187 ~~~~~~~~------------------~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 187 TISHYPDY------------------SWS-AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp CCSSCC--------------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred eccccCcc------------------ccc-ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 52111000 000 0000001122356799999999999 5667899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 675 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 675 TGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+|..||.......... .....+ .+...+..+.+||.+||+.||.+|| ++.++++|
T Consensus 248 ~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 302 (337)
T 3ll6_A 248 FRQHPFEDGAKLRIVN----GKYSIP-PHDTQYTVFHSLIRAMLQVNPEERL---SIAEVVHQ 302 (337)
T ss_dssp HSSCCC----------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSC---CHHHHHHH
T ss_pred hCCCCCcchhHHHhhc----CcccCC-cccccchHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 9999997765543332 222222 2456788999999999999999999 99999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.79 Aligned_cols=234 Identities=22% Similarity=0.389 Sum_probs=190.9
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe------------
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC------------ 520 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d------------ 520 (863)
.|.+ ..||+|+||.|+.+. +++|...... +.+.+|+.+|++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3444 489999999986552 3444332221 346789999999999999999998865
Q ss_pred ----CCeEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecC
Q 002953 521 ----RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594 (863)
Q Consensus 521 ----~~~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFG 594 (863)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcch
Confidence 44589999999999999999754 579999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002953 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI 674 (863)
Q Consensus 595 LAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELL 674 (863)
++...... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 168 ~~~~~~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 168 LVTSLKND--------------------------------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp TCEESSCC--------------------------------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred hheecccc--------------------------------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 98742110 0122357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 675 VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 675 TGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
+|..||... ......+.... ++..++.++.+||.+||..||.+|| ++.++++|++.
T Consensus 216 ~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~~l~~ 271 (284)
T 2a19_B 216 HVCDTAFET--SKFFTDLRDGI-----ISDIFDKKEKTLLQKLLSKKPEDRP---NTSEILRTLTV 271 (284)
T ss_dssp SCCSSHHHH--HHHHHHHHTTC-----CCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHH
T ss_pred hcCCcchhH--HHHHHHhhccc-----ccccCCHHHHHHHHHHccCChhhCc---CHHHHHHHHHH
Confidence 999988532 23333333322 3456899999999999999999999 99999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=337.88 Aligned_cols=250 Identities=19% Similarity=0.185 Sum_probs=184.8
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhc-----------hhHHHHHHHHHHHHHhcCCCCeeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIR-----------KNAVESILAERDILISVRNPFVVRFFY 516 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~-----------k~~~e~~l~Ei~IL~~L~HPnIVkL~~ 516 (863)
...|.+. .||+|+||.|+.+. +++|...... ......+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3456655 99999999986542 2333222111 112234678889999999999999999
Q ss_pred EEEe----CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC--cEEE
Q 002953 517 SFTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG--HIKL 590 (863)
Q Consensus 517 ~f~d----~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g--~VKL 590 (863)
++.. ...+|+||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 67899999999 999999998878999999999999999999999999999999999999999887 9999
Q ss_pred eecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002953 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIIL 670 (863)
Q Consensus 591 iDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvIL 670 (863)
+|||+|+......... ...........||+.|+|||++.+..++.++|||||||++
T Consensus 195 ~Dfg~a~~~~~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 250 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHK------------------------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM 250 (345)
T ss_dssp CCCTTCEESSGGGCCC------------------------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred EeCCCceecccccccc------------------------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHH
Confidence 9999997521110000 0001122456899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC--ChHHHHHHHhhcCCCCCC------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 671 FELIVGIPPFNAE--HPQQIFDNILNRKIPWPR------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 671 yELLTGk~PF~~~--~~~el~~kIl~~~~~~p~------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||++|..||... +...............+. ....++.++.+||.+||..||.+|| ++++|++
T Consensus 251 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 321 (345)
T 2v62_A 251 LRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP---NYQALKK 321 (345)
T ss_dssp HHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC---CHHHHHH
T ss_pred HHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 9999999999652 322222211111111111 0126899999999999999999999 8888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=335.01 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=186.7
Q ss_pred Eeecccceeecccc------ceehhhhhhch-hHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRK-NAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k-~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d 538 (863)
+||+|+||.|+.+. +++|....... .....+.+|+++|+.++||||+++++++.+.+..|+||||++||+|.+
T Consensus 37 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 116 (326)
T 3uim_A 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 116 (326)
T ss_dssp EEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHH
T ss_pred eEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHH
Confidence 89999999997652 33443322111 122368899999999999999999999999999999999999999999
Q ss_pred HHHhcC----CCChhhHHHHHHHHHHHHHHHHhC---CccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 539 LLRNLG----CLDEDVARVYIAEVVLALEYLHSL---RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 539 lLk~~g----~L~e~~i~~Ia~QIl~ALeyLHs~---GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
++.... .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++......
T Consensus 117 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------- 188 (326)
T 3uim_A 117 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-------- 188 (326)
T ss_dssp HHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS--------
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc--------
Confidence 998653 389999999999999999999999 99999999999999999999999999997421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-----Ch-
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE-----HP- 685 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~-----~~- 685 (863)
........||+.|+|||++.+..++.++|||||||++|+|++|..||... ..
T Consensus 189 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (326)
T 3uim_A 189 ----------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246 (326)
T ss_dssp ----------------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred ----------------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence 01223456999999999999888999999999999999999999999521 11
Q ss_pred --HHHHHHHhhcCC-C-------CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 686 --QQIFDNILNRKI-P-------WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 686 --~el~~kIl~~~~-~-------~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
............ . ....+...+..+.+|+.+||+.||.+|| |+.++++|..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ell~~L~ 307 (326)
T 3uim_A 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP---KMSEVVRMLE 307 (326)
T ss_dssp BHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC---CHHHHHHHHH
T ss_pred hHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC---CHHHHHHHhc
Confidence 111111111100 0 0011122347799999999999999999 9999998853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.57 Aligned_cols=244 Identities=27% Similarity=0.370 Sum_probs=185.8
Q ss_pred ccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhc--CCCCeeEEEEEEEeC----CeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISV--RNPFVVRFFYSFTCR----ENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L--~HPnIVkL~~~f~d~----~~lyLV 527 (863)
..|.+. .||+|+||.|+.+. +++|.. ..........|.+++..+ +||||+++++++... ..+|+|
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~---~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEE---EGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEE---eccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 355554 99999999997652 333332 223344556677777654 899999999999887 789999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC--------CccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--------RVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~--------GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
|||++||+|.++++. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 114 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 114 TDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp ECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 999999999999976 4799999999999999999999998 9999999999999999999999999999742
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCcc------ceeechhHHHHHH
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT------ADWWSVGIILFEL 673 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k------sDIWSLGvILyEL 673 (863)
..... .........+||+.|+|||++.+..++.. +|||||||++|||
T Consensus 193 ~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 193 ISDTN---------------------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp C------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred ccccc---------------------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 11000 00112235689999999999988777665 9999999999999
Q ss_pred HhC----------CCCCCCCC----hHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 674 IVG----------IPPFNAEH----PQQIFDNILNRKIPWPRVPE-----EMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 674 LTG----------k~PF~~~~----~~el~~kIl~~~~~~p~~p~-----~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
++| ..||.... ...............+..+. .+++++.+||.+||+.||.+|| ++.++
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 322 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL---TALRV 322 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC---CHHHH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC---CHHHH
Confidence 999 77775431 22223333222222222232 4567799999999999999999 99999
Q ss_pred HcC
Q 002953 735 KQH 737 (863)
Q Consensus 735 LqH 737 (863)
++|
T Consensus 323 l~~ 325 (337)
T 3mdy_A 323 KKT 325 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=362.52 Aligned_cols=237 Identities=24% Similarity=0.335 Sum_probs=194.2
Q ss_pred Eeecccceeecccc---------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||.|+.+. +++|..... .....+.+.+|+++|++++|||||++++++.. +.+|||||||+||+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 79999999997542 234433222 23456789999999999999999999999976 56999999999999
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~---------- 491 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS---------- 491 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc----------
Confidence 99999754 4599999999999999999999999999999999999999999999999999984210000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
.........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++...+.
T Consensus 492 ------------------~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 492 ------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp ----------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred ------------------eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 0011123456789999999999999999999999999999998 999999998888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+.. +..+..+++++.+||.+||..||.+|| ++.+|++
T Consensus 554 ~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 591 (613)
T 2ozo_A 554 QGKR--MECPPECPPELYALMSDCWIYKWEDRP---DFLTVEQ 591 (613)
T ss_dssp TTCC--CCCCTTCCHHHHHHHHHTTCSSTTTSC---CHHHHHH
T ss_pred cCCC--CCCCCcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 6543 345678999999999999999999999 7777653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.09 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=189.4
Q ss_pred EEeecccceeecccc-----ceehhhhh----hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 465 LLAGKGALSEHDDFP-----QVLKKADM----IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----kvlKK~~i----~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
..||+|+||.|+.+. +++|+... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++|++
T Consensus 37 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 116 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116 (307)
T ss_dssp CEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence 489999999997642 33443221 223456789999999999999999999999999999999999999999
Q ss_pred hHHHHHhc---CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 536 LYSLLRNL---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 536 L~dlLk~~---g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 117 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--------- 187 (307)
T 2nru_A 117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--------- 187 (307)
T ss_dssp HHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS---------
T ss_pred HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc---------
Confidence 99999743 458999999999999999999999999999999999999999999999999987421000
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH----H
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ----I 688 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e----l 688 (863)
.........||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... +
T Consensus 188 --------------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 188 --------------------QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp --------------------SCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred --------------------ccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 00112346799999999998764 8899999999999999999999997654322 2
Q ss_pred HHHHhhcCC--------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 689 FDNILNRKI--------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 689 ~~kIl~~~~--------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
...+..... ..+..+...+..+.+|+.+||..||.+|| ++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~~ 300 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQL 300 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 222211111 11122334567899999999999999999 89998864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=327.13 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=186.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEE-EEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~-~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||.|+.+. +++|. .........+.+|+.+++.++|++++..+ .++......|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~--~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEE--EEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEe--ecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 345544 99999999997653 23332 11222334578999999999887755555 555777889999999
Q ss_pred cCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee---cCCCcEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL---d~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 9 8899999985 4579999999999999999999999999999999999999 788999999999998521110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP- 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~- 685 (863)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 166 ------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 166 ------------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp ------------------------BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ------------------------cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 0001123456899999999999999999999999999999999999999976432
Q ss_pred --HHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 686 --QQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 686 --~el~~kIl~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
...+..+.......+ .....+++++.+||.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~ 273 (296)
T 4hgt_A 222 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp SSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred hhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCC---CHHHHHH
Confidence 233333333222111 22356899999999999999999999 8887775
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=347.02 Aligned_cols=243 Identities=23% Similarity=0.343 Sum_probs=191.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--~lyLVm 528 (863)
..|.+. +||+|+||+|+.+. +++|..... .....+.+.+|+++|++++||||+++++++.... .+|+||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 345554 99999999997552 344432211 1234567789999999999999999999998765 789999
Q ss_pred eecCCCChHHHHHhcCC---CChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee----cCCCcEEEeecCCcccccc
Q 002953 529 EYLNGGDLYSLLRNLGC---LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI----AHDGHIKLTDFGLSKVGLI 601 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~---L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL----d~~g~VKLiDFGLAk~~~~ 601 (863)
|||+||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 99999999999976533 9999999999999999999999999999999999999 7778899999999974210
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--------CCCCccceeechhHHHHHH
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--------TGHGTTADWWSVGIILFEL 673 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--------~~ys~ksDIWSLGvILyEL 673 (863)
.......+||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 169 --------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 169 --------------------------------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp --------------------------------GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 112234679999999999875 4578899999999999999
Q ss_pred HhCCCCCCC----CChHHHHHHHhhcCCC-------------------CC---CCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 674 IVGIPPFNA----EHPQQIFDNILNRKIP-------------------WP---RVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 674 LTGk~PF~~----~~~~el~~kIl~~~~~-------------------~p---~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
++|..||.. ....+.+.++..+... ++ .+...++..+.+||.+||..||++||
T Consensus 217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~- 295 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW- 295 (396)
T ss_dssp HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-
T ss_pred HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-
Confidence 999999964 3344556666554321 00 11123456788999999999999999
Q ss_pred CCCHHHHHcC
Q 002953 728 SGGASEVKQH 737 (863)
Q Consensus 728 ~~SAeEILqH 737 (863)
++.+++++
T Consensus 296 --s~~e~l~~ 303 (396)
T 4eut_A 296 --GFDQFFAE 303 (396)
T ss_dssp --CHHHHHHH
T ss_pred --cHHHHHHH
Confidence 89988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=356.30 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=199.4
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..+.+. .||+|+||+|+.+. +++|.... .....+.+.+|+++|++++||||+++++++.. +.+||||||+.
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCC-CCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 345544 89999999996542 33433222 22335678999999999999999999998876 67999999999
Q ss_pred CCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+++....
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--------- 415 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--------- 415 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC---------
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC---------
Confidence 99999999753 5699999999999999999999999999999999999999999999999999974110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
..........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....+++
T Consensus 416 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~ 474 (535)
T 2h8h_A 416 ---------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474 (535)
T ss_dssp ---------------------HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred ---------------------CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 00112234567889999999999999999999999999999999 99999999888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..+..+.. ...+..++.++.+||.+||..||.+|| ++++|++.
T Consensus 475 ~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~~ 517 (535)
T 2h8h_A 475 DQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAF 517 (535)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 88765532 234567999999999999999999999 88887753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.14 Aligned_cols=246 Identities=15% Similarity=0.202 Sum_probs=190.3
Q ss_pred CcccceEE-Eeecccceeecccc---------------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeE--------
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP---------------QVLKKADMIRKNAVESILAERDILISVRNPFVVR-------- 513 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~---------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVk-------- 513 (863)
....|.+. .||+|+||.|+.+. +++|... ..+.+.+|+++|++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA-----KDGRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEE-----TTSTHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEec-----ccchHHHHHHHHHHhcccchhhhhhhhccC
Confidence 34566665 99999999997652 2222221 1145889999999999999887
Q ss_pred -------EEEEEEe-CCeEEEEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec
Q 002953 514 -------FFYSFTC-RENLYLVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583 (863)
Q Consensus 514 -------L~~~f~d-~~~lyLVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd 583 (863)
+++++.. ...+|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 6777776 67899999999 99999999876 6799999999999999999999999999999999999999
Q ss_pred CCC--cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccc
Q 002953 584 HDG--HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661 (863)
Q Consensus 584 ~~g--~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 661 (863)
.++ .+||+|||+++......... ...........||+.|+|||++.+..++.++
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHV------------------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCC------------------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred CCCCceEEEecCcceeeccCCCccc------------------------cccccccccccCCccccCHHHHccCCCCchh
Confidence 998 99999999997421110000 0001122345899999999999999999999
Q ss_pred eeechhHHHHHHHhCCCCCCCCC--hHHHHHHHh---hcCCCCCC---CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHH
Q 002953 662 DWWSVGIILFELIVGIPPFNAEH--PQQIFDNIL---NRKIPWPR---VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASE 733 (863)
Q Consensus 662 DIWSLGvILyELLTGk~PF~~~~--~~el~~kIl---~~~~~~p~---~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeE 733 (863)
|||||||++|+|++|..||.... ...+..... .....++. ....++.++.+||.+||..||.+|| ++++
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ 326 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP---PYAM 326 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC---CHHH
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC---CHHH
Confidence 99999999999999999997653 333333222 11111111 0125799999999999999999999 8888
Q ss_pred HHc
Q 002953 734 VKQ 736 (863)
Q Consensus 734 ILq 736 (863)
+++
T Consensus 327 l~~ 329 (352)
T 2jii_A 327 LRN 329 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.77 Aligned_cols=235 Identities=14% Similarity=0.221 Sum_probs=186.4
Q ss_pred cccceEE-Eeecccceeecccc------------ceehhhhhhchhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP------------QVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRE 522 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~ 522 (863)
...|.+. +||+|+||+|+.+. +++|.. .......+..|+.++..++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~---~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEE---SSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEe---CCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3445554 99999999998761 233332 2334556788999998887 899999999999999
Q ss_pred eEEEEEeecCCCChHHHHHh-----cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-----------CC
Q 002953 523 NLYLVMEYLNGGDLYSLLRN-----LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-----------DG 586 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~-----~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-----------~g 586 (863)
..|||||||+||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+||||+. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999999974 456999999999999999999999999999999999999998 89
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeech
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 666 (863)
.+||+|||+|+..... .........+||+.|||||++.+..++.++|||||
T Consensus 221 ~~kl~DFG~a~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 271 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLF-----------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271 (365)
T ss_dssp TEEECCCTTCEEGGGS-----------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH
T ss_pred CEEEeeCchhhhhhcc-----------------------------CCCceeeeecCCCCCCChHHhcCCCCCccccHHHH
Confidence 9999999999742100 00123345789999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 667 GIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 667 GvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
||++|||++|+.||....... ......+... ..++.+.+++.+||..+|.+|+. ++.++
T Consensus 272 G~il~elltg~~pf~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~--~~~~l 330 (365)
T 3e7e_A 272 AATVYCMLFGTYMKVKNEGGE-----CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLP--SLDLL 330 (365)
T ss_dssp HHHHHHHHHSSCCCEEEETTE-----EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCC--CHHHH
T ss_pred HHHHHHHHhCCCccccCCCCc-----eeechhcccc--CcHHHHHHHHHHHcCCCCCCcch--HHHHH
Confidence 999999999999996543210 0111112222 24678999999999999999973 44443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=333.48 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=195.7
Q ss_pred ccceEE-Eeecccceeecccc----ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. .||+|+||.|+.+. +++|..... .....+.+.+|+.+|++++||||+++++++.+.+.+|+||||++
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred HHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 334443 89999999997652 333333222 12233557789999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~-------- 183 (319)
T 2y4i_B 113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ-------- 183 (319)
T ss_dssp SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc--------
Confidence 999999998754 699999999999999999999999999999999999998 6899999999987421000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---------CCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---------TGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---------~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
............||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 184 ------------------~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 184 ------------------AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp ----------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred ------------------ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0001122334579999999999975 3478899999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 683 EHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.........+.....+. ..+..++.++.+||.+||..||.+|| ++.++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~~ 296 (319)
T 2y4i_B 246 QPAEAIIWQMGTGMKPN-LSQIGMGKEISDILLFCWAFEQEERP---TFTKLMDM 296 (319)
T ss_dssp CCHHHHHHHHHTTCCCC-CCCSSCCTTHHHHHHHHHCSSTTTSC---CHHHHHHH
T ss_pred CCHHHHHHHhccCCCCC-CCcCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 98888887776654432 22346889999999999999999999 89888863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=328.74 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=193.8
Q ss_pred cccceEE-Eeecccceeecccc-----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC--eE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE--NL 524 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--~l 524 (863)
...|.+. .||+|+||.|+.+. +++|+.........+.+.+|+.+|++++||||+++++++...+ .+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3445544 99999999996542 3555544445556678999999999999999999999987654 78
Q ss_pred EEEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 525 YLVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999999875 469999999999999999999999999999999999999999999999999998421100
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 200 ~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 200 E----------------------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp S----------------------------EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred c----------------------------ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 0 001122346788899999999988999999999999999999999998643
Q ss_pred Ch------------H----HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 684 HP------------Q----QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 684 ~~------------~----el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.. . .+...+ ..... +..+..++.++.+||.+||..||.+|| ++.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~el~~ 315 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELL-KNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRP---SFRDLAL 315 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHH-HTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHh-hcCCC-CCCCCcccHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 11 0 111122 22222 234677999999999999999999999 8988875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.23 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=188.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEE-EEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~-~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||.|+.+. +++|... .....+.+.+|+.+++.++|++++..+ .++......|+||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEE--SCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEec--CCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 345544 99999999997653 3344321 122234688999999999987755544 555677889999999
Q ss_pred cCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec---CCCcEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd---~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 9 8899999974 45799999999999999999999999999999999999994 78899999999998521110000
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH-- 684 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~-- 684 (863)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 166 ------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 166 ------------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp ------------------------BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ------------------------ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 000112345689999999999999999999999999999999999999997633
Q ss_pred -hHHHHHHHhhcCCCCC--CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 685 -PQQIFDNILNRKIPWP--RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 685 -~~el~~kIl~~~~~~p--~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
..+.+..+.......+ ..+..+++++.+||.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 273 (296)
T 3uzp_A 222 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp SSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred hhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC---CHHHHHH
Confidence 2334444433322211 22356899999999999999999999 8888775
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.44 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=179.1
Q ss_pred CcccceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHH--HhcCCCCeeEEEEEEEe-----CCeE
Q 002953 458 RTSQIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDIL--ISVRNPFVVRFFYSFTC-----RENL 524 (863)
Q Consensus 458 ~~~~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL--~~L~HPnIVkL~~~f~d-----~~~l 524 (863)
....|.+. .||+|+||.|+.+. +++|... ......+..|.+++ ..++||||+++++.+.. ...+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~---~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEE---GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEECCeEEEEEEee---ccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 34455554 99999999997652 3444322 22334455555554 45899999999976543 2367
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC---------CccccCCCCcceeecCCCcEEEeecCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL---------RVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~---------GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
|+||||+++|+|.+++... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 9999999999999999764 458899999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-------CCCCccceeechhH
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-------TGHGTTADWWSVGI 668 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGv 668 (863)
|+........ ............+||+.|+|||++.+ ..++.++|||||||
T Consensus 167 a~~~~~~~~~-----------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 223 (336)
T 3g2f_A 167 SMRLTGNRLV-----------------------RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223 (336)
T ss_dssp CEECSSSSCC--------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHH
T ss_pred eeeccccccc-----------------------CccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHH
Confidence 9852111000 00001122335689999999999987 34567899999999
Q ss_pred HHHHHHhCCCCCCCCC-----------------hHHHHHHHhhcCCCCCCCCCC------CCHHHHHHHHhhccCCcCCc
Q 002953 669 ILFELIVGIPPFNAEH-----------------PQQIFDNILNRKIPWPRVPEE------MSPEAHDLIDRFLTEDPHQR 725 (863)
Q Consensus 669 ILyELLTGk~PF~~~~-----------------~~el~~kIl~~~~~~p~~p~~------iS~el~dLI~k~L~~DP~kR 725 (863)
++|||++|..||.... ...............+.++.. +++++.+||.+||..||.+|
T Consensus 224 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303 (336)
T ss_dssp HHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhC
Confidence 9999999977663321 111222222222223333333 34579999999999999999
Q ss_pred CCCCCHHHHHc
Q 002953 726 LGSGGASEVKQ 736 (863)
Q Consensus 726 pg~~SAeEILq 736 (863)
| |+.++++
T Consensus 304 p---s~~e~l~ 311 (336)
T 3g2f_A 304 L---TAQXAEE 311 (336)
T ss_dssp C---CHHHHHH
T ss_pred c---chHHHHH
Confidence 9 8999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=359.21 Aligned_cols=242 Identities=25% Similarity=0.398 Sum_probs=198.9
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.+|++++||||+++++++. ++.+|+|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 445544 89999999996542 33443322 23344578999999999999999999999884 5678999
Q ss_pred EeecCCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
|||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~---- 544 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---- 544 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC----
Confidence 99999999999998654 6899999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~ 685 (863)
.........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 545 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 545 --------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp -----------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred --------------------------cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 0011123467889999999999999999999999999999997 9999999998
Q ss_pred HHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 686 QQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 686 ~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+....+..+.. +..+..+++.+.+||.+||..||.+|| ++.++++.
T Consensus 599 ~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~RP---s~~el~~~ 645 (656)
T 2j0j_A 599 NDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHcCCC--CCCCccccHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 888888876543 345678999999999999999999999 89888763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=343.33 Aligned_cols=232 Identities=18% Similarity=0.211 Sum_probs=179.6
Q ss_pred EEEeecccceeecccc-----ceehhhhhh--------chhHHHHHHHHHHHHHhcC---------CCCeeEEEEEEE--
Q 002953 464 LLLAGKGALSEHDDFP-----QVLKKADMI--------RKNAVESILAERDILISVR---------NPFVVRFFYSFT-- 519 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-----kvlKK~~i~--------~k~~~e~~l~Ei~IL~~L~---------HPnIVkL~~~f~-- 519 (863)
...||+|+||+|+.+. +++|..... .....+.+.+|+.+|+.++ |||||++++.+.
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp CEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred eeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 3499999999997652 344443322 2233477889999999885 888888877654
Q ss_pred ----------------------------eCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH-hCCc
Q 002953 520 ----------------------------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH-SLRV 570 (863)
Q Consensus 520 ----------------------------d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH-s~GI 570 (863)
..+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||+||| ++||
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~i 183 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRF 183 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 26789999999999987777754 67899999999999999999999 9999
Q ss_pred cccCCCCcceeecCCC--------------------cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhh
Q 002953 571 VHRDLKPDNLLIAHDG--------------------HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEH 630 (863)
Q Consensus 571 IHRDLKPeNILLd~~g--------------------~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~ 630 (863)
+||||||+||||+.++ .+||+|||+|+...
T Consensus 184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------------------------ 233 (336)
T 2vuw_A 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------------------------ 233 (336)
T ss_dssp BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE------------------------------
T ss_pred eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC------------------------------
Confidence 9999999999999887 89999999998410
Q ss_pred hhhhhccccccCCCCCCChhhhcCCCCCccceeechhHH-HHHHHhCCCCCCCCCh-HHHHHHHhhcCC----CCCCCCC
Q 002953 631 QQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGII-LFELIVGIPPFNAEHP-QQIFDNILNRKI----PWPRVPE 704 (863)
Q Consensus 631 ~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvI-LyELLTGk~PF~~~~~-~el~~kIl~~~~----~~p~~p~ 704 (863)
....+||+.|||||++.+.. +.++||||||++ .++++.|..||..... ......+..... ..+..+.
T Consensus 234 ------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 234 ------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp ------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred ------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 11358999999999999876 899999998777 7888999999954221 223333332111 1111123
Q ss_pred CCCHHHHHHHHhhccCCcCCcCCCCCHHHHH-cCCCCC
Q 002953 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVK-QHVFFK 741 (863)
Q Consensus 705 ~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL-qHPFFk 741 (863)
.+++++.+||++||++| |++|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d--------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS--------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS--------SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC--------CHHHHHhcCCCcC
Confidence 47889999999999976 899999 999995
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.30 Aligned_cols=222 Identities=30% Similarity=0.510 Sum_probs=174.5
Q ss_pred ccceE--EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHH-HhcCCCCeeEEEEEEEe----CCeEE
Q 002953 460 SQIDL--LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTC----RENLY 525 (863)
Q Consensus 460 ~~~~l--~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL-~~L~HPnIVkL~~~f~d----~~~ly 525 (863)
..|.+ .+||+|+||.|+.+. +++|... ....+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEec-----ccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 34444 479999999997652 3344321 124567899998 55689999999999987 67899
Q ss_pred EEEeecCCCChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccc
Q 002953 526 LVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGL 600 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~ 600 (863)
+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~- 170 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET- 170 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC-
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc-
Confidence 9999999999999998764 6999999999999999999999999999999999999998 788999999998731
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.+..++.++|||||||++|+|++|.+||
T Consensus 171 ----------------------------------------------------~~~~~~~~~DiwslG~il~el~tg~~pf 198 (299)
T 3m2w_A 171 ----------------------------------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPF 198 (299)
T ss_dssp ----------------------------------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------------------------------------------ccccCCchhhHHHHHHHHHHHHHCCCCC
Confidence 0123678999999999999999999999
Q ss_pred CCCChHHHHHHHhhcCC-CCCCCC----CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 681 NAEHPQQIFDNILNRKI-PWPRVP----EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~-~~p~~p----~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
...........+..... .....+ ..+++++.+||.+||..||.+|| ++.++++||||++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 199 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 262 (299)
T ss_dssp CC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHT
T ss_pred CCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHHHHhcChhhcc
Confidence 87665443322211110 001112 46899999999999999999999 9999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=326.04 Aligned_cols=242 Identities=22% Similarity=0.313 Sum_probs=189.6
Q ss_pred cceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHh--cCCCCeeEEEEEEEeCC----eEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILIS--VRNPFVVRFFYSFTCRE----NLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~d~~----~lyLVm 528 (863)
.|.+. .||+|+||.|+.+. +++|.. .......+.+|++++.. ++||||+++++++.... .+|+||
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~---~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEETTEEEEEEEE---CGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEEcCccEEEEEe---CchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 45554 99999999997652 344432 23345668889999987 78999999999999876 799999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH--------hCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLH--------SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH--------s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
||+++|+|.+++.+ ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++....
T Consensus 120 e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 198 (342)
T 1b6c_B 120 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198 (342)
T ss_dssp CCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEE
T ss_pred eecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecc
Confidence 99999999999976 56999999999999999999999 8999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC------CCccceeechhHHHHHHH
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIILFELI 674 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~------ys~ksDIWSLGvILyELL 674 (863)
.... ..........||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 199 ~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 199 SATD---------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp TTTT---------------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccc---------------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 1000 0001223568999999999998763 336899999999999999
Q ss_pred hC----------CCCCCCC-----ChHHHHHHHhhcCCCCCCCCC-----CCCHHHHHHHHhhccCCcCCcCCCCCHHHH
Q 002953 675 VG----------IPPFNAE-----HPQQIFDNILNRKIPWPRVPE-----EMSPEAHDLIDRFLTEDPHQRLGSGGASEV 734 (863)
Q Consensus 675 TG----------k~PF~~~-----~~~el~~kIl~~~~~~p~~p~-----~iS~el~dLI~k~L~~DP~kRpg~~SAeEI 734 (863)
+| ..||... ....+...+...... +.++. ..+..+.+||.+||..||.+|| ++.++
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~~i 327 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARL---TALRI 327 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC---CHHHH
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCC---CHHHH
Confidence 99 7898654 233444444333322 22222 2346799999999999999999 99999
Q ss_pred HcC
Q 002953 735 KQH 737 (863)
Q Consensus 735 LqH 737 (863)
++|
T Consensus 328 ~~~ 330 (342)
T 1b6c_B 328 KKT 330 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.14 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=201.6
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.|.+. +||+|+||.|+.+. +++|.... ......+.+|+++|..|.| ++|+.+..++...+..||||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~--~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEET--TCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecc--ccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 34443 89999999997653 34442221 2223457899999999987 66777777778888999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceee---cCCCcEEEeecCCccccccCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI---AHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILL---d~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.........
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~- 163 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ- 163 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC-
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc-
Confidence 8999999985 4679999999999999999999999999999999999999 578999999999998532111000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC---
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH--- 684 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~--- 684 (863)
..........+||+.|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus 164 -----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 164 -----------------------HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp -----------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred -----------------------ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 000112336789999999999999999999999999999999999999997643
Q ss_pred hHHHHHHHhhcCCC--CCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH----------cCCCCCCCChhHHhhc
Q 002953 685 PQQIFDNILNRKIP--WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK----------QHVFFKDINWDTLARQ 751 (863)
Q Consensus 685 ~~el~~kIl~~~~~--~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL----------qHPFFk~IdW~~l~~~ 751 (863)
..+.+..+...... ...+...++.++.+||.+||..+|.+|| ++.+|+ .++|+..++|+.+...
T Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP---s~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 221 KKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC---CHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc---CHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 34444444433211 1122356899999999999999999999 666544 4799999999988654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=358.52 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=196.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe------CCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTC------RENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d------~~~l 524 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+++|++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 445554 89999999997642 34443322 234456779999999999999999999998766 6678
Q ss_pred EEEEeecCCCChHHHHHhcC---CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc---EEEeecCCccc
Q 002953 525 YLVMEYLNGGDLYSLLRNLG---CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH---IKLTDFGLSKV 598 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g---~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~---VKLiDFGLAk~ 598 (863)
|+|||||+||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999999998754 5999999999999999999999999999999999999997764 99999999874
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
... ........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 174 ~~~--------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~ 221 (676)
T 3qa8_A 174 LDQ--------------------------------GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221 (676)
T ss_dssp TTS--------------------------------CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCS
T ss_pred ccc--------------------------------ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCC
Confidence 210 011234689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHH--------------HhhcCCCCC-------CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 679 PFNAEHPQQIFDN--------------ILNRKIPWP-------RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 679 PF~~~~~~el~~k--------------Il~~~~~~p-------~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||........+.. ...+...+. .+...+++.+.+||.+||..||.+|| |+.++++|
T Consensus 222 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP---Ta~elL~h 298 (676)
T 3qa8_A 222 PFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG---TDPQNPNV 298 (676)
T ss_dssp SCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC------CCTTCCCC
T ss_pred CCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc---CHHHHhcC
Confidence 9976533221100 011111111 12234678899999999999999999 99999999
Q ss_pred CCCCCCChhHHhhc
Q 002953 738 VFFKDINWDTLARQ 751 (863)
Q Consensus 738 PFFk~IdW~~l~~~ 751 (863)
|||+. ++.+...
T Consensus 299 p~F~~--l~~iL~~ 310 (676)
T 3qa8_A 299 GCFQA--LDSILSL 310 (676)
T ss_dssp TTHHH--HHHHHCC
T ss_pred HHHHH--HHHHHhc
Confidence 99986 4455443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=332.92 Aligned_cols=234 Identities=15% Similarity=0.152 Sum_probs=178.1
Q ss_pred EEeecccceeecccc-------ceehhhhhh---chhHHHHHHHHHHHHHhcCC-CC---------------------ee
Q 002953 465 LLAGKGALSEHDDFP-------QVLKKADMI---RKNAVESILAERDILISVRN-PF---------------------VV 512 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-------kvlKK~~i~---~k~~~e~~l~Ei~IL~~L~H-Pn---------------------IV 512 (863)
.+||+|+||.|+.+. +++|..... .....+.+.+|+.++..+.| ++ ..
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 389999999997653 344433312 22235678899999999976 21 11
Q ss_pred EEEEEEEe-----CCeEEEEEeecCCCChHHHHHh-------cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcce
Q 002953 513 RFFYSFTC-----RENLYLVMEYLNGGDLYSLLRN-------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNL 580 (863)
Q Consensus 513 kL~~~f~d-----~~~lyLVmEy~~GGsL~dlLk~-------~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNI 580 (863)
.++.++.. ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||+|||++|||||||||+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NI 242 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceE
Confidence 11122222 12467888877 6799999852 23477888999999999999999999999999999999
Q ss_pred eecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhh--------
Q 002953 581 LIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL-------- 652 (863)
Q Consensus 581 LLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL-------- 652 (863)
||+.++.+||+|||+++... ......+| +.|+|||++
T Consensus 243 Ll~~~~~~kL~DFG~a~~~~----------------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 243 VLDQRGGVFLTGFEHLVRDG----------------------------------ASAVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp EECTTCCEEECCGGGCEETT----------------------------------EEECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred EEecCCeEEEEeccceeecC----------------------------------CccccCCC-CceeCchhhhccccccc
Confidence 99999999999999987410 11345678 999999999
Q ss_pred --cCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCC
Q 002953 653 --LGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGG 730 (863)
Q Consensus 653 --~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~S 730 (863)
.+..++.++|||||||++|||++|+.||...+..+....+... ...+|+++.+||.+||+.||.+|| +
T Consensus 288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~dP~~Rp---t 357 (413)
T 3dzo_A 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKEDRL---L 357 (413)
T ss_dssp GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhh-------cccCCHHHHHHHHHHccCChhhCc---C
Confidence 5556788999999999999999999999887665544444332 235789999999999999999999 9
Q ss_pred HHHHHcCCCCCCCC
Q 002953 731 ASEVKQHVFFKDIN 744 (863)
Q Consensus 731 AeEILqHPFFk~Id 744 (863)
+.++++||||+.+.
T Consensus 358 ~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 358 PLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHTTSHHHHHHH
T ss_pred HHHHHhCHHHHHHH
Confidence 99999999998753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=305.94 Aligned_cols=213 Identities=16% Similarity=0.153 Sum_probs=168.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh---hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM---IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i---~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||.|+.+. +++|.... ......+.+.+|+.++.+++||||+++++++.+.+.+|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 446655 99999999997542 23443322 22445578999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||++|++|.++++. + .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 99999999999965 3 4556788899999999999999999999999999999999999988543
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
|++| ++.++|||||||++|+|++|+.||.+.+....
T Consensus 175 -------------------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 175 -------------------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp -------------------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred -------------------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 2222 68899999999999999999999987665332
Q ss_pred HH---HHhhcCCCC-CCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 689 FD---NILNRKIPW-PRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 689 ~~---kIl~~~~~~-p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+. +........ ......+++++.+||.+||+.||.+| |+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R----s~~el~~ 258 (286)
T 3uqc_A 211 LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR----SASTLLN 258 (286)
T ss_dssp SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC----CHHHHHH
T ss_pred hHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC----CHHHHHH
Confidence 11 111111111 12235789999999999999999999 5777775
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=342.42 Aligned_cols=231 Identities=28% Similarity=0.346 Sum_probs=182.4
Q ss_pred ccceEE-Eeecccceeecccc--------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCe-----E
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCREN-----L 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~-----l 524 (863)
..|.+. .||+|+||.|+.+. +++|.... ........+.+|+.+|.+++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 456555 99999999996542 34443322 223455678999999999999999999999998765 7
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~---- 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN---- 232 (681)
T ss_dssp EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT----
T ss_pred EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc----
Confidence 999999999999998765 79999999999999999999999999999999999999875 99999999987410
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+..
T Consensus 233 -------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 233 -------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp -------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred -------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccc
Confidence 01346799999999999775 4899999999999999999999987532
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
.. ...........++.+.+||.+||..||.+|| +..+.+.|+|+.
T Consensus 281 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~ 325 (681)
T 2pzi_A 281 VD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF---TTAEEMSAQLTG 325 (681)
T ss_dssp CS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHH
T ss_pred cc---------cccccccccccCHHHHHHHhhhccCChhhCC---CHHHHHHHHHHH
Confidence 11 0000000112467899999999999999999 788888888764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-30 Score=299.41 Aligned_cols=154 Identities=18% Similarity=0.155 Sum_probs=118.8
Q ss_pred hHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC
Q 002953 491 NAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR 569 (863)
Q Consensus 491 ~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G 569 (863)
...+.+.+|+++|+++ .|+||+++++++++++.+|||||||+|++|.++|...+++++. .|+.||+.||+|||++|
T Consensus 283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G 359 (569)
T 4azs_A 283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG 359 (569)
T ss_dssp HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC
Confidence 4456799999999999 6999999999999999999999999999999999998888764 57899999999999999
Q ss_pred ccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCCh
Q 002953 570 VVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 649 (863)
Q Consensus 570 IIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAP 649 (863)
||||||||+||||+.+|++||+|||+|+..... .....+.+||+.||||
T Consensus 360 IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-------------------------------~~~~~t~vGTp~YmAP 408 (569)
T 4azs_A 360 FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-------------------------------CSWPTNLVQSFFVFVN 408 (569)
T ss_dssp CEESCCCGGGEEECTTSCEEECCCTTEESCC----------------------------------CCSHHHHHHHHHHHH
T ss_pred ceeccCchHhEEECCCCCEEEeecccCeeCCCC-------------------------------CccccCceechhhccH
Confidence 999999999999999999999999999842100 1122357899999999
Q ss_pred hhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002953 650 EILLGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 650 EvL~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
|++.+. +..++|+||+|+++|+|.++..|
T Consensus 409 E~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCCC-CCCcccccccccchhhhccccch
Confidence 999875 67889999999999888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-25 Score=258.22 Aligned_cols=183 Identities=19% Similarity=0.198 Sum_probs=135.7
Q ss_pred EEEeecccceeeccc----c-ceehhhh--------hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 464 LLLAGKGALSEHDDF----P-QVLKKAD--------MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~----~-kvlKK~~--------i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..+||+|+||.|+.+ . .++|+.. .......+.+.+|+++|++++||||+++..++...+..||||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 348999999999833 1 2222211 11222345689999999999999999555555577788999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
++|++|.+++.. +..++.||+.||+|||++||+||||||+|||++. ++||+|||+|+....
T Consensus 421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~--------- 481 (540)
T 3en9_A 421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL--------- 481 (540)
T ss_dssp CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC---------
T ss_pred CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC---------
Confidence 999999999976 6689999999999999999999999999999998 999999999985210
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCC
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.............+.+||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|
T Consensus 482 ---------------~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 ---------------DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ---------------ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 00000000112346789999999999987 66888899999999888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=200.32 Aligned_cols=121 Identities=22% Similarity=0.250 Sum_probs=94.7
Q ss_pred EEeecccceeecccc------ceehhhhhhch------------------hHHHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADMIRK------------------NAVESILAERDILISVRNPFVVRFFYSFTC 520 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i~~k------------------~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 520 (863)
..||+|+||.|+.+. +++|....... .....+.+|+.+|++++|++++. ++..
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~---~~~~ 172 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK---VYAW 172 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC---EEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCe---EEec
Confidence 489999999997542 34443321111 23567899999999998544444 3433
Q ss_pred CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk 597 (863)
+..|+||||++||+|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+
T Consensus 173 -~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 173 -EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp -ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred -cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 55799999999999988 42 234567999999999999999999999999999999 9999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-16 Score=165.57 Aligned_cols=96 Identities=22% Similarity=0.199 Sum_probs=78.2
Q ss_pred HHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEeecCC-C----ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHH
Q 002953 494 ESILAERDILISVRNPF--VVRFFYSFTCRENLYLVMEYLNG-G----DLYSLLRNLGCLDEDVARVYIAEVVLALEYLH 566 (863)
Q Consensus 494 e~~l~Ei~IL~~L~HPn--IVkL~~~f~d~~~lyLVmEy~~G-G----sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLH 566 (863)
..+.+|+.+|.++.|++ ++.+++. +..||||||+.+ | +|.++... .++..+..++.||+.||.|||
T Consensus 115 ~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 115 IWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHH
Confidence 36789999999998875 3445442 357899999942 3 66665432 346688899999999999999
Q ss_pred -hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 -SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 -s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
++||+||||||+|||++. .++|+|||+|..
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999999988 999999999974
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.35 E-value=7.5e-13 Score=148.28 Aligned_cols=91 Identities=12% Similarity=0.105 Sum_probs=71.2
Q ss_pred HHHHHHHHhcCCCCe--eEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccC
Q 002953 497 LAERDILISVRNPFV--VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRD 574 (863)
Q Consensus 497 l~Ei~IL~~L~HPnI--VkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRD 574 (863)
.+|...|.++.+.++ ...++. ...+|||||++|++|..+. ....+..++.||+.+|.|||++||||||
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrD 230 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGD 230 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 467888888865544 333322 1247999999998886543 2345667889999999999999999999
Q ss_pred CCCcceeecCCC----------cEEEeecCCcc
Q 002953 575 LKPDNLLIAHDG----------HIKLTDFGLSK 597 (863)
Q Consensus 575 LKPeNILLd~~g----------~VKLiDFGLAk 597 (863)
|||.|||++.+| .+.|+||+.+.
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 999999998876 38999999876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=4e-10 Score=116.37 Aligned_cols=128 Identities=18% Similarity=0.120 Sum_probs=94.5
Q ss_pred Eeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.+|.|+.+.|+.+ ..++|............+.+|+++|+.+. +..++++++++.+.+..|+||||++|.+|.+.
T Consensus 21 ~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 100 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred eccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhc
Confidence 4455555555433 23444332211122345889999999985 67788999999999999999999999998775
Q ss_pred HHhcCCCChhhHHHHHHHHHHHHHHHHh----------------------------------------------------
Q 002953 540 LRNLGCLDEDVARVYIAEVVLALEYLHS---------------------------------------------------- 567 (863)
Q Consensus 540 Lk~~g~L~e~~i~~Ia~QIl~ALeyLHs---------------------------------------------------- 567 (863)
+. +......++.++..+|..||+
T Consensus 101 ~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 175 (263)
T 3tm0_A 101 YE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp CC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred cC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence 31 233445788899999999998
Q ss_pred -------CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 -------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 -------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998755567999998874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=110.51 Aligned_cols=128 Identities=18% Similarity=0.133 Sum_probs=88.4
Q ss_pred ccceEEEeeccc-ceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCC--eeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLLLAGKGA-LSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPF--VVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~vLGkG~-FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPn--IVkL~~~f~d~~~lyLVmEy 530 (863)
..+.+..++.|+ .+.|+.+. .++|.... .....+.+|+.+|+.+.+.+ ++++++++...+..|+||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~---~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLS---GALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECS---CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCc---ccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345555565444 46654332 33333211 12245778999999986434 66789888888889999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR----------------------------------------- 569 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G----------------------------------------- 569 (863)
++|.+|. .. .. ....++.+++..|..||+..
T Consensus 97 i~G~~l~--~~---~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--SS---HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--TS---CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--cC---cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998884 21 11 12356677777788888643
Q ss_pred -----------------ccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 570 -----------------VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 570 -----------------IIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766667999999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.86 E-value=4.5e-09 Score=114.10 Aligned_cols=135 Identities=16% Similarity=0.243 Sum_probs=98.5
Q ss_pred ceEEEeecccceeeccc-----cceehhhh--hhc-hhHHHHHHHHHHHHHhcC--CCCeeEEEEEEEeC---CeEEEEE
Q 002953 462 IDLLLAGKGALSEHDDF-----PQVLKKAD--MIR-KNAVESILAERDILISVR--NPFVVRFFYSFTCR---ENLYLVM 528 (863)
Q Consensus 462 ~~l~vLGkG~FG~V~~~-----~kvlKK~~--i~~-k~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~---~~lyLVm 528 (863)
..+..|+.|.++.++.+ ..++|+.. ... ......+.+|..+|+.|. +..+++++.++.+. +..|+||
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34567888888776544 24554432 111 122346788999999997 45688999888776 4589999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-----------------------------------------
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS----------------------------------------- 567 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs----------------------------------------- 567 (863)
||++|..|.+.. ...++......++.+++.+|..||+
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998875421 1346788888899999999999997
Q ss_pred -----------------CCccccCCCCcceeecCCCc--EEEeecCCccc
Q 002953 568 -----------------LRVVHRDLKPDNLLIAHDGH--IKLTDFGLSKV 598 (863)
Q Consensus 568 -----------------~GIIHRDLKPeNILLd~~g~--VKLiDFGLAk~ 598 (863)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=2.7e-09 Score=113.31 Aligned_cols=130 Identities=18% Similarity=0.243 Sum_probs=93.1
Q ss_pred EEeecccceeeccc--cceehhhhhhchhHHHHHHHHHHHHHhcC-CCC--eeEEEEEEEeCC---eEEEEEeecCCCCh
Q 002953 465 LLAGKGALSEHDDF--PQVLKKADMIRKNAVESILAERDILISVR-NPF--VVRFFYSFTCRE---NLYLVMEYLNGGDL 536 (863)
Q Consensus 465 ~vLGkG~FG~V~~~--~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPn--IVkL~~~f~d~~---~lyLVmEy~~GGsL 536 (863)
..++.|....++.+ ..++|... .......+.+|.++|+.+. +.. +.+++....... ..|+||++++|.+|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l 103 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPL 103 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEEC
T ss_pred EecCCCCcceEEEECCEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeEC
Confidence 35788888887654 23444322 2234567889999999883 322 455655544433 35899999999988
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-------------------------------------------------
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHS------------------------------------------------- 567 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs------------------------------------------------- 567 (863)
..... ..++......++.+++..|..||+
T Consensus 104 ~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l 181 (304)
T 3sg8_A 104 TPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDIL 181 (304)
T ss_dssp CHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHH
T ss_pred Ccccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHH
Confidence 76433 346777778888888888888885
Q ss_pred ---------CCccccCCCCcceeecC--CCcEEEeecCCccc
Q 002953 568 ---------LRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ---------~GIIHRDLKPeNILLd~--~g~VKLiDFGLAk~ 598 (863)
..++|+|++|.|||++. .+.+.|+||+.+..
T Consensus 182 ~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 182 ENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp TCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred hccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 23799999999999998 45678999999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=1e-05 Score=86.52 Aligned_cols=132 Identities=17% Similarity=0.190 Sum_probs=87.2
Q ss_pred eEEEeecccceeeccc--cceehhhhhhchhHHHHHHHHHHHHHhcCCC---CeeEEEEEEE-eCCeEEEEEeecCCCCh
Q 002953 463 DLLLAGKGALSEHDDF--PQVLKKADMIRKNAVESILAERDILISVRNP---FVVRFFYSFT-CRENLYLVMEYLNGGDL 536 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~--~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HP---nIVkL~~~f~-d~~~lyLVmEy~~GGsL 536 (863)
.+..++.|....++.+ ..++|.. ........+.+|.++|..|.+. .|.+.+.+.. ..+..|+||||++|..|
T Consensus 23 ~v~~l~~G~~n~v~~vg~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 23 SVESLGEGFRNYAILVNGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp CEEEEEECSSEEEEEETTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eeeecCCCcceeEEEECCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 3446677776666544 3344432 2223456789999999999752 3667776664 45567899999999888
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSL------------------------------------------------ 568 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~------------------------------------------------ 568 (863)
....- ..++......++.++...|..||+.
T Consensus 101 ~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 101 GEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred chhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 76321 2234444444555555555555532
Q ss_pred ------------CccccCCCCcceeecC---CCc-EEEeecCCccc
Q 002953 569 ------------RVVHRDLKPDNLLIAH---DGH-IKLTDFGLSKV 598 (863)
Q Consensus 569 ------------GIIHRDLKPeNILLd~---~g~-VKLiDFGLAk~ 598 (863)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4599999999999987 455 48999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=5.9e-05 Score=77.78 Aligned_cols=103 Identities=18% Similarity=0.218 Sum_probs=76.7
Q ss_pred HHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhC--
Q 002953 492 AVESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSL-- 568 (863)
Q Consensus 492 ~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~-- 568 (863)
....+.+|..+|+.|. +--|.+++.+..+.+..|+|||+++|.++.+.... .......+..++...|..||..
T Consensus 62 ~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 62 VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCG
T ss_pred CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCc
Confidence 4456788999999885 32377888889999999999999999887765533 1223334555555556666521
Q ss_pred --------------------------------------------------------CccccCCCCcceeecCCCcEEEee
Q 002953 569 --------------------------------------------------------RVVHRDLKPDNLLIAHDGHIKLTD 592 (863)
Q Consensus 569 --------------------------------------------------------GIIHRDLKPeNILLd~~g~VKLiD 592 (863)
.++|+|+.|.|||++.++.+-|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD 217 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID 217 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence 268999999999999877777999
Q ss_pred cCCccc
Q 002953 593 FGLSKV 598 (863)
Q Consensus 593 FGLAk~ 598 (863)
|+.+..
T Consensus 218 we~a~~ 223 (272)
T 4gkh_A 218 VGRVGI 223 (272)
T ss_dssp CTTCEE
T ss_pred Cccccc
Confidence 999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=4e-05 Score=82.61 Aligned_cols=44 Identities=16% Similarity=0.100 Sum_probs=32.6
Q ss_pred HHHHHHHHHHHhcC-C--CCeeEEEEEEEeC---CeEEEEEeecCCCChH
Q 002953 494 ESILAERDILISVR-N--PFVVRFFYSFTCR---ENLYLVMEYLNGGDLY 537 (863)
Q Consensus 494 e~~l~Ei~IL~~L~-H--PnIVkL~~~f~d~---~~lyLVmEy~~GGsL~ 537 (863)
..+.+|+.+|+.|. + -.+.+++.+..+. +..|+||||++|..|.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 35678999998884 2 3577888777655 3578999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0006 Score=72.04 Aligned_cols=31 Identities=19% Similarity=0.327 Sum_probs=28.3
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 6799999999999998888999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00025 Score=77.81 Aligned_cols=31 Identities=16% Similarity=0.295 Sum_probs=26.8
Q ss_pred hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...++|+|+.|.|||++.+ .++|+||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3579999999999999765 489999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0011 Score=70.11 Aligned_cols=29 Identities=21% Similarity=0.281 Sum_probs=25.3
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.|.||| ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667899999998874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0032 Score=69.93 Aligned_cols=32 Identities=19% Similarity=0.380 Sum_probs=28.6
Q ss_pred HhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 566 HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 566 Hs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456899999999999998776 99999999885
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.015 Score=62.98 Aligned_cols=70 Identities=17% Similarity=0.059 Sum_probs=47.7
Q ss_pred EEEeecccceeeccc-----cceehhhhhhchhHHHHHHHHHHHHHhcC---CCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 464 LLLAGKGALSEHDDF-----PQVLKKADMIRKNAVESILAERDILISVR---NPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 464 l~vLGkG~FG~V~~~-----~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
+..|+.|.+..++.+ ..++|... ......+..|.+.|+.|. ...|++++.+....+..|+||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINE---RSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEE---GGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCC---cccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 345566665555333 23333221 223566889999998884 3578889988888889999999999976
Q ss_pred h
Q 002953 536 L 536 (863)
Q Consensus 536 L 536 (863)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.88 E-value=0.02 Score=61.01 Aligned_cols=32 Identities=31% Similarity=0.537 Sum_probs=28.0
Q ss_pred hCCccccCCCCcceeecCC----CcEEEeecCCccc
Q 002953 567 SLRVVHRDLKPDNLLIAHD----GHIKLTDFGLSKV 598 (863)
Q Consensus 567 s~GIIHRDLKPeNILLd~~----g~VKLiDFGLAk~ 598 (863)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999874 6799999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.63 E-value=0.028 Score=59.45 Aligned_cols=29 Identities=21% Similarity=0.260 Sum_probs=25.7
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..++|+|++|.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4689999999999998 4 899999998874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.63 E-value=0.043 Score=57.07 Aligned_cols=122 Identities=20% Similarity=0.201 Sum_probs=79.5
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHH-HhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYL-HSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyL-Hs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
-+|.+.|+.. .+|++++++.++.|.+.+|.-+ ++..-..+=+-|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3788998765 5799999999999999998776 211112333457899999999888664 2111
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
.....+.|||... ...+.+.=|||||++||..+-=..|
T Consensus 98 -----------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------ 135 (229)
T 2yle_A 98 -----------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------ 135 (229)
T ss_dssp --------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------
T ss_pred -----------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------
Confidence 1122355777653 3346778899999999987741111
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~ 720 (863)
+..+..+|+.+..||..|...
T Consensus 136 --------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 136 --------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------TTEEECCCHHHHHHHHHHTTC
T ss_pred --------cccchhhCHHHHHHHHHHHhc
Confidence 112356899999999999865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.55 E-value=0.013 Score=63.70 Aligned_cols=30 Identities=27% Similarity=0.523 Sum_probs=25.2
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|++|.|||++.++ +.|+||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 3599999999999997654 89999998874
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.48 E-value=0.013 Score=65.07 Aligned_cols=102 Identities=17% Similarity=0.273 Sum_probs=64.7
Q ss_pred HHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChHH--------------HHHh---c----CC-CC--
Q 002953 493 VESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYS--------------LLRN---L----GC-LD-- 547 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~d--------------lLk~---~----g~-L~-- 547 (863)
...+.+|..+|+.|. +....++++.+.. .+||||++|..|.. .|.+ . +. ..
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 345568999998874 3334677766553 29999999866531 1111 0 11 11
Q ss_pred hhhHHHHHHHHHH-------------------HHHHHH----h----CCccccCCCCcceeecCC----CcEEEeecCCc
Q 002953 548 EDVARVYIAEVVL-------------------ALEYLH----S----LRVVHRDLKPDNLLIAHD----GHIKLTDFGLS 596 (863)
Q Consensus 548 e~~i~~Ia~QIl~-------------------ALeyLH----s----~GIIHRDLKPeNILLd~~----g~VKLiDFGLA 596 (863)
...+..+..++-. .++.|. . ..++|+|+.+.|||++.+ +.+.|+||..|
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 2345555544322 233333 2 359999999999999876 78999999998
Q ss_pred cc
Q 002953 597 KV 598 (863)
Q Consensus 597 k~ 598 (863)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 74
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.25 E-value=0.014 Score=61.71 Aligned_cols=31 Identities=32% Similarity=0.366 Sum_probs=26.8
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 4799999999999998765568999998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.09 E-value=0.025 Score=63.54 Aligned_cols=39 Identities=18% Similarity=0.246 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 494 ESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 494 e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+.+.+|..+|..|. +...+++++.+.. .+||||++|.+|
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 45568999998885 3334677766542 389999987544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.05 E-value=0.074 Score=55.55 Aligned_cols=70 Identities=14% Similarity=-0.058 Sum_probs=43.0
Q ss_pred eEEEeecccceeeccc------cceehhhhhhchhHHHHHHHHHHHHHhcCC---CCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 463 DLLLAGKGALSEHDDF------PQVLKKADMIRKNAVESILAERDILISVRN---PFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~------~kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H---PnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.+.-+|.|..+.|+.+ ..++|...-........+..|.+.|+.|.. --+++++.+ +.-++||||+++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 4557888888887544 234443222222223457789999998842 235566654 234789999987
Q ss_pred CCh
Q 002953 534 GDL 536 (863)
Q Consensus 534 GsL 536 (863)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.74 E-value=0.28 Score=55.31 Aligned_cols=29 Identities=31% Similarity=0.610 Sum_probs=26.2
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.+.||| +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7778999999999874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.86 E-value=0.36 Score=53.35 Aligned_cols=30 Identities=27% Similarity=0.427 Sum_probs=25.5
Q ss_pred CccccCCCCcceeec------CCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIA------HDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd------~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.+.|||+. .++.+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 368999999999993 456799999999874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=82.98 E-value=0.64 Score=50.06 Aligned_cols=31 Identities=19% Similarity=0.439 Sum_probs=28.0
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 863 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-73 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-70 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-66 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-64 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-61 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-60 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-59 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-55 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-53 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-47 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 1e-73
Identities = 90/280 (32%), Positives = 149/280 (53%), Gaps = 35/280 (12%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L+K +I++N V + ERD++ + +PF V+ +++F E LY + Y G+L +
Sbjct: 40 ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 99
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R +G DE R Y AE+V ALEYLH ++HRDLKP+N+L+ D HI++TDFG +KV
Sbjct: 100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-- 157
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ ++ + S VGT Y++PE+L +
Sbjct: 158 ---------------------------LSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
+D W++G I+++L+ G+PPF A + IF I+ + + PE+ P+A DL+++ L
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVL 247
Query: 721 DPHQRLGS---GGASEVKQHVFFKDINWDTLARQKAAFVP 757
D +RLG G +K H FF+ + W+ L +Q +
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 5e-70
Identities = 104/321 (32%), Positives = 166/321 (51%), Gaps = 40/321 (12%)
Query: 481 VLKKADMIRKNAVESILAERDIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
LKK ++ + VE + E+ +L ++ +PF+ F +F +ENL+ VMEYLNGGDL
Sbjct: 34 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 93
Query: 540 LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+++ D A Y AE++L L++LHS +V+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 94 IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-- 151
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
E+ K + GTPDY+APEILLG +
Sbjct: 152 -----------------------------ENMLGDAKTNTFCGTPDYIAPEILLGQKYNH 182
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
+ DWWS G++L+E+++G PF+ + +++F +I +PR + EA DL+ +
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR---WLEKEAKDLLVKLFV 239
Query: 720 EDPHQRLGSGGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRYSWNTT 777
+P +RLG +++QH F++INW+ L R++ F P +S D S F + N
Sbjct: 240 REPEKRLGV--RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFL-NEK 296
Query: 778 DENIYPASDFEDSSDADSLSG 798
+ +S D +
Sbjct: 297 PRLSFADRALINSMDQNMFRN 317
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 4e-67
Identities = 111/319 (34%), Positives = 164/319 (51%), Gaps = 38/319 (11%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L+K +I K+ V + E +L + R+PF+ Y+F + L VMEY NGG+L+ L
Sbjct: 37 ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
E+ AR Y AE+V ALEYLHS VV+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG- 155
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ ++ GTP+YLAPE+L +G
Sbjct: 156 ------------------------------ISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWW +G++++E++ G PF + +++F+ IL +I +PR +SPEA L+ L +
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---TLSPEAKSLLAGLLKK 242
Query: 721 DPHQRLGSG--GASEVKQHVFFKDINWDTLARQKAA--FVPTSESALDTSYFTSRYSWNT 776
DP QRLG G A EV +H FF INW + ++K F P S +DT YF ++ +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQS 302
Query: 777 TDENIYPASDFEDSSDADS 795
D + D
Sbjct: 303 ITITPPDRYDSLGLLELDQ 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-66
Identities = 79/261 (30%), Positives = 120/261 (45%), Gaps = 39/261 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VL KA + + + E +I +R+P ++R + F +YL++EY G +Y L
Sbjct: 38 VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 97
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L DE YI E+ AL Y HS RV+HRD+KP+NLL+ G +K+ DFG S
Sbjct: 98 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV--- 154
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
++ + GT DYL PE++ G H
Sbjct: 155 ------------------------------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
D WS+G++ +E +VG PPF A Q+ + I + + P+ ++ A DLI R L
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF---PDFVTEGARDLISRLLKH 241
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
+P QR EV +H +
Sbjct: 242 NPSQRP---MLREVLEHPWIT 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 219 bits (558), Expect = 3e-65
Identities = 98/293 (33%), Positives = 156/293 (53%), Gaps = 42/293 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLKK ++R VE ER +L V +PF++R + +F + ++++M+Y+ GG+L+SLL
Sbjct: 36 VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 95
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R VA+ Y AEV LALEYLHS +++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 96 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--- 152
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ GTPDY+APE++ + +
Sbjct: 153 -------------------------------YVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWWS GI+++E++ G PF + + ++ ILN ++ + P + + DL+ R +T
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---PPFFNEDVKDLLSRLITR 238
Query: 721 DPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPT-SESALDTSYF 768
D QRLG+ G +VK H +FK++ W+ L + + P + DTS F
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQF 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 5e-64
Identities = 71/277 (25%), Positives = 123/277 (44%), Gaps = 41/277 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
K D + +E + E DIL S +P +V+ +F NL++++E+ GG + +++
Sbjct: 41 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 100
Query: 541 RNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
L L E +V + + AL YLH +++HRDLK N+L DG IKL DFG+S
Sbjct: 101 LELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---- 655
+ +++ S +GTP ++APE+++
Sbjct: 161 -------------------------------TRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 656 -GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLI 714
+ AD WS+GI L E+ PP + +P ++ I + P P S D +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249
Query: 715 DRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQ 751
+ L ++ R S++ QH F ++ + R+
Sbjct: 250 KKCLEKNVDARW---TTSQLLQHPFVT-VDSNKPIRE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 216 bits (552), Expect = 6e-64
Identities = 93/343 (27%), Positives = 151/343 (44%), Gaps = 47/343 (13%)
Query: 481 VLKKADMIRKNAVESILAER---DILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
L K + K L ER ++ + PF+V Y+F + L +++ +NGGDL+
Sbjct: 36 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 95
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L G E R Y AE++L LE++H+ VV+RDLKP N+L+ GH++++D GL+
Sbjct: 96 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTG 656
++K ++VGT Y+APE+L G
Sbjct: 156 ---------------------------------DFSKKKPHASVGTHGYMAPEVLQKGVA 182
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDR 716
+ ++ADW+S+G +LF+L+ G PF + + +P+ SPE L++
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
Query: 717 FLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYFTSRY 772
L D ++RLG GA EVK+ FF+ ++W + QK +P F
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGS 302
Query: 773 SWNTTDENIYPASDFEDSSDADSLSGSSSCLSNR-QEEVGDEC 814
+ I SD + +S R Q+EV +
Sbjct: 303 FDEEDTKGIKL-----LDSDQELYRNFPLTISERWQQEVAETV 340
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-62
Identities = 80/261 (30%), Positives = 130/261 (49%), Gaps = 35/261 (13%)
Query: 482 LKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 541
+++ ++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 542 NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
C+DE E + ALE+LHS +V+HRD+K DN+L+ DG +KLTDFG
Sbjct: 110 E-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---- 164
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661
+ E+ K+ + VGTP ++APE++ +G
Sbjct: 165 ---------------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
D WS+GI+ E+I G PP+ E+P + I P + PE++S D ++R L D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 722 PHQRLGSGGASEVKQHVFFKD 742
+R A E+ QH F K
Sbjct: 258 VEKRG---SAKELLQHQFLKI 275
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-61
Identities = 58/262 (22%), Positives = 112/262 (42%), Gaps = 35/262 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++ + + E+I E I + + VV+F+ YL +EY +GG+L+ +
Sbjct: 37 IVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 94
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ E A+ + +++ + YLH + + HRD+KP+NLL+ ++K++DFGL+ V
Sbjct: 95 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGT 659
N+ + L GT Y+APE+L H
Sbjct: 155 YNNRERLLN-----------------------------KMCGTLPYVAPELLKRREFHAE 185
Query: 660 TADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLT 719
D WS GI+L ++ G P++ + K + +++ L+ + L
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245
Query: 720 EDPHQRLGSGGASEVKQHVFFK 741
E+P R+ ++K+ ++
Sbjct: 246 ENPSARI---TIPDIKKDRWYN 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 208 bits (531), Expect = 5e-61
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 39/295 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
K ++ E++ E + +R+P +V +F + ++ E+++GG+L+ +
Sbjct: 55 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 114
Query: 541 -RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSK 597
+ ED A Y+ +V L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 115 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 174
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
H ++ + GT ++ APE+ G
Sbjct: 175 --------------------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDR 716
G D WSVG++ + L+ G+ PF E+ + N+ + +S + D I +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSR 771
L DP+ R+ + +H + N Q + T + + +
Sbjct: 263 LLLADPNTRM---TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 314
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 3e-60
Identities = 101/292 (34%), Positives = 162/292 (55%), Gaps = 41/292 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VMEY+ GG+++S L
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
R +G E AR Y A++VL EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
+ + + + GTP+ LAPEI+L G+
Sbjct: 190 -------------------------------RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTE 720
DWW++G++++E+ G PPF A+ P QI++ I++ K+ + P S + DL+ L
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQV 275
Query: 721 DPHQRLGS--GGASEVKQHVFFKDINWDTLARQK--AAFVPTSESALDTSYF 768
D +R G+ G +++K H +F +W + ++K A F+P + DTS F
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 202 bits (514), Expect = 1e-59
Identities = 74/261 (28%), Positives = 110/261 (42%), Gaps = 43/261 (16%)
Query: 489 RKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
+ E+ L E DIL V P +++ ++ +LV + + G+L+ L L
Sbjct: 49 VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 108
Query: 548 EDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607
E R + ++ + LH L +VHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 109 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---------- 158
Query: 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTA 661
K R GTP YLAPEI+ G+G
Sbjct: 159 ----------------------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTE 720
D WS G+I++ L+ G PPF + I++ + ++ S DL+ RFL
Sbjct: 197 DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 256
Query: 721 DPHQRLGSGGASEVKQHVFFK 741
P +R A E H FF+
Sbjct: 257 QPQKRY---TAEEALAHPFFQ 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 203 bits (517), Expect = 4e-59
Identities = 56/294 (19%), Positives = 115/294 (39%), Gaps = 39/294 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
V K + ++ E I+ + +P ++ +F + + L++E+L+GG+L+ +
Sbjct: 58 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 541 RNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSK 597
+ E Y+ + L+++H +VH D+KP+N++ +K+ DFGL+
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ T ++ APEI+
Sbjct: 178 --------------------------------KLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDR 716
G D W++G++ + L+ G+ PF E + N+ + +SPEA D I
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTS 770
L ++P +RL + +H + K + + +R ++ + Y
Sbjct: 266 LLQKEPRKRL---TVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADW 316
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 70/270 (25%), Positives = 120/270 (44%), Gaps = 48/270 (17%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYS 538
L M + +++E ++L +++P +VR++ R N LY+VMEY GGDL S
Sbjct: 36 ELDYGSMTEAE-KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS 94
Query: 539 LLRNL----GCLDEDVARVYIAEVVLALEYLHSL-----RVVHRDLKPDNLLIAHDGHIK 589
++ LDE+ + ++ LAL+ H V+HRDLKP N+ + ++K
Sbjct: 95 VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154
Query: 590 LTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAP 649
L DFGL++ +L + A TP Y++P
Sbjct: 155 LGDFGLAR-------------------ILNHDTSFAKAFVG------------TPYYMSP 183
Query: 650 EILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPE 709
E + + +D WS+G +L+EL +PPF A +++ I K + R+P S E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--FRRIPYRYSDE 241
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739
+++I R L + R E+ ++
Sbjct: 242 LNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 3e-58
Identities = 107/293 (36%), Positives = 161/293 (54%), Gaps = 39/293 (13%)
Query: 481 VLKKADMIRK-NAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
VLKKA +++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++
Sbjct: 59 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 118
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
L E ++Y+ E+VLALE+LH L +++RD+K +N+L+ +GH+ LTDFGLSK
Sbjct: 119 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG--TG 656
+ + T+ GT +Y+AP+I+ G +G
Sbjct: 179 FVADETERAYDF------------------------------CGTIEYMAPDIVRGGDSG 208
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPW-PRVPEEMSPEAHDLID 715
H DWWS+G++++EL+ G PF + + I R + P P+EMS A DLI
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 268
Query: 716 RFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQK--AAFVPTSESALD 764
R L +DP +RLG G A E+K+H+FF+ INWD LA +K A F P LD
Sbjct: 269 RLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 9e-58
Identities = 59/264 (22%), Positives = 96/264 (36%), Gaps = 42/264 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ + + I+ E L +R+P +++ + +LVMEY G L
Sbjct: 47 KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600
+ L E + L YLHS ++HRD+K N+L++ G +KL DFG + +
Sbjct: 107 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-- 164
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG-- 658
S VGTP ++APE++L G
Sbjct: 165 ---------------------------------MAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 659 -TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
D WS+GI EL PP + +I + P + S + +D
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-SGHWSEYFRNFVDSC 250
Query: 718 LTEDPHQRLGSGGASEVKQHVFFK 741
L + P R + + +H F
Sbjct: 251 LQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-57
Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 78/301 (25%)
Query: 488 IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 547
I+ I+ E +L +P++V F+ +F + + ME+++GG L +L+ G +
Sbjct: 43 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 102
Query: 548 EDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606
E + V+ L YL +++HRD+KP N+L+ G IKL DFG+S
Sbjct: 103 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--------- 153
Query: 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666
Q S VGT Y++PE L GT + +D WS+
Sbjct: 154 ------------------------QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 189
Query: 667 GIILFELIVGIPPF---NAEHPQQIFDNILN----------------------------- 694
G+ L E+ VG P +A+ + +F +
Sbjct: 190 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249
Query: 695 --------RKIPWPRVPEE-MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745
P P++P S E D +++ L ++P +R ++ H F K +
Sbjct: 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDA 306
Query: 746 D 746
+
Sbjct: 307 E 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 1e-57
Identities = 73/269 (27%), Positives = 123/269 (45%), Gaps = 41/269 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ K + + S+ E +L +++P +V + +LYL+M+ ++GG+L+ +
Sbjct: 41 CIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSK 597
G E A I +V+ A++YLH L +VHRDLKP+NLL D I ++DFGLSK
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
+ + +A GTP Y+APE+L +
Sbjct: 159 M--------------------------------EDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDR 716
D WS+G+I + L+ G PPF E+ ++F+ IL + + +++S A D I
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 717 FLTEDPHQRLGSGGASEVKQHVFFKDINW 745
+ +DP +R + QH +
Sbjct: 247 LMEKDPEKRF---TCEQALQHPWIAGDTA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-57
Identities = 50/268 (18%), Positives = 113/268 (42%), Gaps = 45/268 (16%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGDL 536
L+ + K+ + E ++L +++P +VRF+ S+ ++ + LV E + G L
Sbjct: 41 ELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 99
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSL--RVVHRDLKPDNLLI-AHDGHIKLTDF 593
+ L+ + V R + +++ L++LH+ ++HRDLK DN+ I G +K+ D
Sbjct: 100 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
GL+ + + ++ +GTP+++APE+
Sbjct: 160 GLATL---------------------------------KRASFAKAVIGTPEFMAPEMYE 186
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDL 713
+ + D ++ G+ + E+ P++ + + + PE ++
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245
Query: 714 IDRFLTEDPHQRLGSGGASEVKQHVFFK 741
I+ + ++ +R ++ H FF+
Sbjct: 246 IEGCIRQNKDERY---SIKDLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-55
Identities = 71/304 (23%), Positives = 129/304 (42%), Gaps = 45/304 (14%)
Query: 480 QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ K ++ + E IL R+ ++ SF E L ++ E+++G D++
Sbjct: 32 TYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFER 91
Query: 540 LRNLGC-LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLS 596
+ L+E Y+ +V AL++LHS + H D++P+N++ IK+ +FG +
Sbjct: 92 INTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
+ + R P+Y APE+
Sbjct: 152 R--------------------------------QLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLID 715
T D WS+G +++ L+ GI PF AE QQI +NI+N + + +E+S EA D +D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 716 RFLTEDPHQRLGSGGASEVKQHVFFKD----INWDTL--ARQKAAFVPTSESALDTSYFT 769
R L ++ R+ ASE QH + K ++ + + + + + L+
Sbjct: 240 RLLVKERKSRM---TASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSA 296
Query: 770 SRYS 773
+R S
Sbjct: 297 ARIS 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-54
Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 43/280 (15%)
Query: 481 VLKKADMIRKN---AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 537
+KK + E I E IL +++P V+ + + ++ L++E + GG+L+
Sbjct: 42 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 101
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDF 593
L L E+ A ++ +++ + YLHSL++ H DLKP+N+++ IK+ DF
Sbjct: 102 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
GL+ + ++ GTP+++APEI+
Sbjct: 162 GLAH--------------------------------KIDFGNEFKNIFGTPEFVAPEIVN 189
Query: 654 GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHD 712
G AD WS+G+I + L+ G PF + Q+ N+ + S A D
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQK 752
I R L +DP +R+ + QH + K +
Sbjct: 250 FIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQALSSA 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-53
Identities = 52/264 (19%), Positives = 99/264 (37%), Gaps = 32/264 (12%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
K + + +LAE +++ + NP++VR E+ LVME G L L+
Sbjct: 43 KNEANDPALKDELLAEANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQN 101
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
+ + + +V + ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA----- 156
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 663
+ + + + APE + + +D
Sbjct: 157 -----------------------LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 664 WSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
WS G++++E G P+ ++ + + P E +DL++ T D
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDV 251
Query: 723 HQRLGSGGASEVKQHVFFKDINWD 746
R G ++ ++ +N
Sbjct: 252 ENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 44/262 (16%), Positives = 94/262 (35%), Gaps = 40/262 (15%)
Query: 483 KKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
+++ E +L R+ ++ F ++ L +V ++ G LY L
Sbjct: 38 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHI 96
Query: 543 L-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLI 601
+ + + ++YLH+ ++HRDLK +N+ + D +K+ DFGL+ V
Sbjct: 97 IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV--- 153
Query: 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG--- 658
+ G+ ++APE++
Sbjct: 154 --------------------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWP---RVPEEMSPEAHDLID 715
+D ++ GI+L+EL+ G P++ + + ++ R P +V L+
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247
Query: 716 RFLTEDPHQRLGSGGASEVKQH 737
L + +R ++
Sbjct: 248 ECLKKKRDERP---LFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 179 bits (454), Expect = 3e-51
Identities = 55/261 (21%), Positives = 109/261 (41%), Gaps = 35/261 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDL 536
VL+ + E ++ +P +V + + Y+VMEY++G L
Sbjct: 39 VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL 98
Query: 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLS 596
++ G + A IA+ AL + H ++HRD+KP N++I+ +K+ DFG++
Sbjct: 99 RDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158
Query: 597 KVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG 656
+ ++ + + +GT YL+PE G
Sbjct: 159 R----------------------------AIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLID 715
+D +S+G +L+E++ G PPF + P + + P E +S + ++
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250
Query: 716 RFLTEDPHQRLGSGGASEVKQ 736
+ L ++P R + A+E++
Sbjct: 251 KALAKNPENRYQT--AAEMRA 269
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-50
Identities = 55/263 (20%), Positives = 94/263 (35%), Gaps = 35/263 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
VLK+ K E ++ E I+ + NP++VR L LVME GG L+ L
Sbjct: 43 VLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL 99
Query: 541 RNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
+ + +V + ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 100 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA- 158
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
+ + + APE + +
Sbjct: 159 ---------------------------LGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 660 TADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D WS G+ ++E + G P+ ++ I K P E PE + L+
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCW 249
Query: 719 TEDPHQRLGSGGASEVKQHVFFK 741
R + + ++
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYS 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 5e-49
Identities = 72/278 (25%), Positives = 117/278 (42%), Gaps = 60/278 (21%)
Query: 481 VLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSF----TCRENLYLVMEYLNGGD 535
+L+ R+ E ++ + P +VR + R+ L +VME L+GG+
Sbjct: 44 MLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 95
Query: 536 LYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKL 590
L+S +++ G E A + + A++YLHS+ + HRD+KP+NLL + +KL
Sbjct: 96 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
TDFG +K + TP Y+APE
Sbjct: 156 TDFGFAK--------------------------------ETTSHNSLTTPCYTPYYVAPE 183
Query: 651 ILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR------KIPWPRVPE 704
+L + + D WS+G+I++ L+ G PPF + H I + R + P P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS- 242
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
E+S E LI L +P QR+ +E H +
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 7e-49
Identities = 63/290 (21%), Positives = 103/290 (35%), Gaps = 62/290 (21%)
Query: 481 VLKKADMIRKN--AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 538
+K + L E +L + +P ++ +F + N+ LV +++
Sbjct: 30 KIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI 89
Query: 539 LLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+ N L + Y+ + LEYLH ++HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 90 IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK- 148
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGH 657
R V T Y APE+L G +
Sbjct: 149 ------------------------------SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN----------------------- 694
G D W+VG IL EL++ +P + I
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 695 --RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
IP + + DLI +P R+ A++ + +F +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMKYFSN 285
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 5e-48
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 50/279 (17%)
Query: 468 GKGA-----LSEHDDFPQVLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCR 521
GKG L ++ +K + ++ LAE ++ +R+ +V+ +
Sbjct: 16 GKGEFGDVMLGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73
Query: 522 ENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDN 579
LY+V EY+ G L LR+ G L D + +V A+EYL VHRDL N
Sbjct: 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133
Query: 580 LLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRS 639
+L++ D K++DFGL+K +ST D +
Sbjct: 134 VLVSEDNVAKVSDFGLTK--EASSTQD--------------------------------T 159
Query: 640 AVGTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIP 698
+ APE L T +D WS GI+L+E+ G P+ + + +
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK- 218
Query: 699 WPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
P+ P ++++ D R ++++
Sbjct: 219 -MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 168 bits (427), Expect = 1e-47
Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 61/286 (21%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ + + + + E IL +++ +V+ + ++ L LV E+L+ L
Sbjct: 35 RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE 94
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
G L+ A+ ++ +++ + Y H RV+HRDLKP NLLI +G +K+ DFGL++
Sbjct: 95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----- 149
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTAD 662
RK + T Y AP++L+G+ + TT D
Sbjct: 150 --------------------------FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILN--------------------------RK 696
WSVG I E++ G P F I
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
+PW + + DL+ + L DP+QR+ A + +H +FK+
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYFKE 286
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 53/271 (19%)
Query: 481 VLKKADMIRKNAVES---ILAERDIL--ISVRNPFVVRFFYSFTCRENLYLVMEYLNGG- 534
++K + + + + E +L +S V+R F ++ L++E
Sbjct: 36 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 95
Query: 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI-AHDGHIKLTDF 593
DL+ + G L E++AR + +V+ A+ + H+ V+HRD+K +N+LI + G +KL DF
Sbjct: 96 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 594 GLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL 653
G + + GT Y PE +
Sbjct: 156 GSGAL---------------------------------LKDTVYTDFDGTRVYSPPEWIR 182
Query: 654 G-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHD 712
HG +A WS+GI+L++++ G PF + + I+ ++ + + +S E
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF---RQRVSSECQH 233
Query: 713 LIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743
LI L P R E++ H + +D+
Sbjct: 234 LIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 51/247 (20%), Positives = 91/247 (36%), Gaps = 32/247 (12%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
LK + + A++ + E + + S+ + ++R + + +V E G L L
Sbjct: 43 CLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL 101
Query: 541 -RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
++ G Y +V + YL S R +HRDL NLL+A +K+ DFGL +
Sbjct: 102 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA- 160
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
++ + + APE L
Sbjct: 161 ---------------------------LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 660 TADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D W G+ L+E+ G P+ + QI I PR PE+ + ++++ +
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 252
Query: 719 TEDPHQR 725
P R
Sbjct: 253 AHKPEDR 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 5e-45
Identities = 49/247 (19%), Positives = 87/247 (35%), Gaps = 30/247 (12%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ + L+E I+ +P V+ T + ++ E++ G L S L
Sbjct: 59 IKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 118
Query: 541 R-NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R N G + + ++YL + VHRDL N+L+ + K++DFGLS+
Sbjct: 119 RQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-- 176
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
L + APE + +
Sbjct: 177 ------------------------FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212
Query: 660 TADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D WS GI+++E++ G P+ Q + + I P P + H L+
Sbjct: 213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP--PMDCPSALHQLMLDCW 270
Query: 719 TEDPHQR 725
+D + R
Sbjct: 271 QKDRNHR 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-44
Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 69/296 (23%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGD 535
+ + + + L E IL+ R+ ++ + +++YLV + G D
Sbjct: 40 KISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GAD 96
Query: 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
LY LL+ L D ++ +++ L+Y+HS V+HRDLKP NLL+ +K+ DFGL
Sbjct: 97 LYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-G 654
++V A V T Y APEI+L
Sbjct: 156 ARV----------------------------ADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-------------------- 694
G+ + D WSVG IL E++ P F +H ++IL
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 695 --------RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
K+PW R+ +A DL+D+ LT +PH+R+ + H + +
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-44
Identities = 50/273 (18%), Positives = 97/273 (35%), Gaps = 58/273 (21%)
Query: 490 KNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN------ 542
+ E++++E ++ + + +V + T +YL+ EY GDL + LR+
Sbjct: 81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 543 -----------------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585
L L + + +V +E+L VHRDL N+L+ H
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPD 645
+K+ DFGL++ + +A
Sbjct: 201 KVVKICDFGLARD-----------------------------IMSDSNYVVRGNARLPVK 231
Query: 646 YLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPE 704
++APE L + +D WS GI+L+E+ +G+ P+ F ++ + P
Sbjct: 232 WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PF 290
Query: 705 EMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
+ E + ++ D +R +
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRP---SFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 45/260 (17%), Positives = 102/260 (39%), Gaps = 41/260 (15%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
++K+ M + E +++++ + +V+ + T + ++++ EY+ G L + L
Sbjct: 35 MIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 90
Query: 541 RNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
R + +V A+EYL S + +HRDL N L+ G +K++DFGLS+
Sbjct: 91 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR-- 148
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
E + + PE+L+ + +
Sbjct: 149 ----------------------------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 660 TADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D W+ G++++E+ +G P+ + ++I + P S + + ++
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR--PHLASEKVYTIMYSCW 238
Query: 719 TEDPHQRLGSGGASEVKQHV 738
E +R + ++
Sbjct: 239 HEKADERP---TFKILLSNI 255
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 69/295 (23%), Positives = 109/295 (36%), Gaps = 68/295 (23%)
Query: 484 KADMIRKNAVESILAERDI---LISVRNPFVVRFFYSFTCREN-----LYLVMEYLNGGD 535
+ + S + E + L + +P VVR F T L LV E+++
Sbjct: 42 RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101
Query: 536 L-YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFG 594
Y + + + + +++ L++LHS RVVHRDLKP N+L+ G IKL DFG
Sbjct: 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161
Query: 595 LSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG 654
L+++ + S V T Y APE+LL
Sbjct: 162 LARI--------------------------------YSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-------------------- 694
+ + T D WSVG I E+ P F IL+
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 695 ----RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745
P + ++ DL+ + LT +P +R+ A H +F+D+
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 46/255 (18%), Positives = 98/255 (38%), Gaps = 39/255 (15%)
Query: 487 MIRKNAV--ESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 544
IR+ A+ E + E ++++ + +P +V+ + + + LV E++ G L LR
Sbjct: 36 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95
Query: 545 CL-DEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
L + +V + YL V+HRDL N L+ + IK++DFG+++
Sbjct: 96 GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV---- 151
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADW 663
+ + +PE+ + + + +D
Sbjct: 152 --------------------------LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 664 WSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDP 722
WS G++++E+ G P+ ++ ++I + P S + +++ E P
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK--PRLASTHVYQIMNHCWKERP 243
Query: 723 HQRLGSGGASEVKQH 737
R S + +
Sbjct: 244 EDRP---AFSRLLRQ 255
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-43
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 62/289 (21%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRN 542
+ D + + + E +L + +P +V+ LYLV E+L+ +
Sbjct: 36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
L + + + Y+ +++ L + HS RV+HRDLKP NLLI +G IKL DFGL++
Sbjct: 96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA---- 151
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA- 661
R V T Y APEILLG + +TA
Sbjct: 152 ---------------------------FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 662 DWWSVGIILFELIVGIPPFNAEHPQQIFDNILN--------------------------R 695
D WS+G I E++ F + I
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
+ + +V + + L+ + L DP++R+ A H FF+D+
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAKAALAHPFFQDVT 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-43
Identities = 47/262 (17%), Positives = 89/262 (33%), Gaps = 56/262 (21%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---- 544
+ E ++ NP +V+ + + L+ EY+ GDL LR++
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 545 --------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH 584
L +V + YL + VHRDL N L+
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175
Query: 585 DGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTP 644
+ +K+ DFGLS+ G +
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADG-----------------------------NDAIPI 206
Query: 645 DYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVP 703
++ PE + + T +D W+ G++L+E+ G+ P+ +++ + + I P
Sbjct: 207 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACP 264
Query: 704 EEMSPEAHDLIDRFLTEDPHQR 725
E E ++L+ ++ P R
Sbjct: 265 ENCPLELYNLMRLCWSKLPADR 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 51/268 (19%), Positives = 106/268 (39%), Gaps = 45/268 (16%)
Query: 468 GKGA-----LSEHDDFPQVLKKADMIRKNAV--ESILAERDILISVRNPFVVRFFYSFTC 520
G G + ++ +V K +++ ++ ++ LAE +++ +++ +VR Y+
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVT 78
Query: 521 RENLYLVMEYLNGGDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 578
+E +Y++ EY+ G L L+ L + A++ + ++ +HRDL+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
N+L++ K+ DFGL+++ E +
Sbjct: 139 NILVSDTLSCKIADFGLARLI------------------------------EDNEYTARE 168
Query: 639 SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697
A + APE + +D WS GI+L E++ G P+ ++ N+ +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL--ERG 226
Query: 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQR 725
P+ E + L+ E P R
Sbjct: 227 YRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-43
Identities = 53/275 (19%), Positives = 102/275 (37%), Gaps = 55/275 (20%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+ + + K+ E ++L + + P ++ + R LYL +EY G+L
Sbjct: 42 IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101
Query: 540 LRN----------------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
LR L + A+V ++YL + +HRDL N+L+
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
+ K+ DFGLS+ Q+ KK
Sbjct: 162 ENYVAKIADFGLSR--------------------------------GQEVYVKKTMGRLP 189
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRV 702
++A E L + + T +D WS G++L+E++ G P+ ++++ +
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEK 247
Query: 703 PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
P E +DL+ + E P++R +++
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 279
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-43
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 38/259 (14%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ + + E L E + +P +V+ T ++++ME G+L S L
Sbjct: 40 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL 98
Query: 541 -RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599
LD +Y ++ AL YL S R VHRD+ N+L++ + +KL DFGLS+
Sbjct: 99 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-- 156
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGT 659
K ++APE + +
Sbjct: 157 ----------------------------YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 660 TADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFL 718
+D W G+ ++E+++ G+ PF + I N + +P P + L+ +
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCW 246
Query: 719 TEDPHQRLGSGGASEVKQH 737
DP +R +E+K
Sbjct: 247 AYDPSRRP---RFTELKAQ 262
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 63/297 (21%), Positives = 100/297 (33%), Gaps = 68/297 (22%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFT--------CRENLYLVMEYLNGGD 535
+ ++ + L E IL +++ VV C+ ++YLV ++
Sbjct: 44 LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL 103
Query: 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
L L + + ++ L Y+H +++HRD+K N+LI DG +KL DFGL
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG- 654
++ + + + V T Y PE+LLG
Sbjct: 164 ARAFSLAKNSQ---------------------------PNRYTNRVVTLWYRPPELLLGE 196
Query: 655 TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-------------------- 694
+G D W G I+ E+ P Q I
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 695 ---------RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
RK+ P A DLID+ L DP QR+ + + H FF
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFWS 310
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 50/286 (17%)
Query: 468 GKGA-----LSEHDDFPQVLKKADMIRKNAV--ESILAERDILISVRNPFVVRFFYSFTC 520
G+G + + +V K ++ + E+ L E ++ +R+ +V+ Y+
Sbjct: 26 GQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQL-YAVVS 82
Query: 521 RENLYLVMEYLNGGDLYSLLRNLGC--LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPD 578
E +Y+V EY++ G L L+ L A++ + Y+ + VHRDL+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142
Query: 579 NLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKR 638
N+L+ + K+ DFGL+++ E ++
Sbjct: 143 NILVGENLVCKVADFGLARLI------------------------------EDNEYTARQ 172
Query: 639 SAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697
A + APE L +D WS GI+L EL G P+ +++ D +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 232
Query: 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ--HVFFK 741
P E HDL+ + ++P +R ++ +F
Sbjct: 233 --MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 55/310 (17%), Positives = 103/310 (33%), Gaps = 45/310 (14%)
Query: 486 DMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
+ A + IL E ++ SV NP V R + G L + +
Sbjct: 48 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN 107
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605
+ + ++ + YL R+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK- 166
Query: 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665
++A E +L + +D WS
Sbjct: 167 ----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 666 VGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQ 724
G+ ++EL+ G P++ +I + + P + + + ++ + D
Sbjct: 199 YGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADS 256
Query: 725 RLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSESALDTSYFTSRYSWNTTDENIYPA 784
R E+ + + S D++++ + DE
Sbjct: 257 RP---KFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRA-----LMDE----- 303
Query: 785 SDFEDSSDAD 794
D +D DAD
Sbjct: 304 EDMDDVVDAD 313
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 4e-42
Identities = 42/278 (15%), Positives = 83/278 (29%), Gaps = 40/278 (14%)
Query: 487 MIRKNAVESILAERDILISVRNP-FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
K + E I ++ + + + +VME L
Sbjct: 40 ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK 99
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLIN 602
+ +++ +EY+HS +HRD+KPDN L+ + + DFGL+K
Sbjct: 100 FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
T R+ ++ GT Y + LG D
Sbjct: 160 RT------------------------HQHIPYRENKNLTGTARYASINTHLGIEQSRRDD 195
Query: 663 WWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK-----IPWPRVPEEMSPEAHDLIDRF 717
S+G +L +G P+ P + + E ++
Sbjct: 196 LESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFC 255
Query: 718 LTEDPHQRLGSGGASEVKQHVFFKD-------INWDTL 748
+ + ++ +++F + +W+ L
Sbjct: 256 RSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 74/317 (23%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NLYLVMEYLNGGDLY 537
+ + E +L +R+ V+ FT E + YLVM ++ G DL
Sbjct: 52 YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG 110
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
L+++ L ED + + +++ L Y+H+ ++HRDLKP NL + D +K+ DFGL++
Sbjct: 111 KLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG- 656
Q + V T Y APE++L
Sbjct: 170 ----------------------------------QADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 657 HGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN---------------------- 694
+ T D WSVG I+ E+I G F I+
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 695 ------RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748
K + + SP A +L+++ L D QR+ A E H +F+ ++
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFESLHDTED 312
Query: 749 ARQKAAFVPTSESALDT 765
Q + + + T
Sbjct: 313 EPQVQKYDDSFDDVDRT 329
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-41
Identities = 64/296 (21%), Positives = 100/296 (33%), Gaps = 72/296 (24%)
Query: 490 KNAVESILAERDILISVRNPFVVRFFYSFTC------RENLYLVMEYLNGGDLYSLLRNL 543
E I+ + + +VR Y F L LV++Y+
Sbjct: 54 LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 544 ---GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVG 599
L ++Y+ ++ +L Y+HS + HRD+KP NLL+ D +KL DFG +K
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK-- 171
Query: 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHG 658
S + + Y APE++ G +
Sbjct: 172 ------------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYT 201
Query: 659 TTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN------------------------ 694
++ D WS G +L EL++G P F + I+
Sbjct: 202 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 261
Query: 695 -RKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTL 748
+ PW +V PEA L R L P RL E H FF ++ +
Sbjct: 262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV 314
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (374), Expect = 5e-40
Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 78/300 (26%)
Query: 487 MIRKNAVESILAERDILISVR-NPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL 543
+++ + I E IL ++R P ++ + LV E++N D L + L
Sbjct: 67 ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL 126
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLIN 602
+ R Y+ E++ AL+Y HS+ ++HRD+KP N++I H+ ++L D+GL++
Sbjct: 127 ---TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--- 180
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTA 661
++ V + + PE+L+ + +
Sbjct: 181 -----------------------------HPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211
Query: 662 DWWSVGIILFELIVGIPPF-----NAEHPQQI-----------------------FDNIL 693
D WS+G +L +I PF N + +I F++IL
Sbjct: 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271
Query: 694 NR-------KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746
R + +SPEA D +D+ L D RL A E +H +F + D
Sbjct: 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 65/287 (22%), Positives = 102/287 (35%), Gaps = 62/287 (21%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 543
+ D + S L E +L +++ +VR + L LV E+ +
Sbjct: 36 RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN 95
Query: 544 GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603
G LD ++ + ++ +++ L + HS V+HRDLKP NLLI +G +KL +FGL++
Sbjct: 96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA----- 150
Query: 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTAD 662
R + V T Y P++L G + T+ D
Sbjct: 151 --------------------------FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 663 WWSVGIILFELIVG-IPPFNAEHPQQIFDNILN--------------------------R 695
WS G I EL P F I
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 696 KIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742
V +++ DL+ L +P QR+ A E QH +F D
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPYFSD 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 52/265 (19%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539
+LK + + + E++++E +L + N +V + T ++ EY GDL +
Sbjct: 60 MLKPSAHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 540 LR------------------NLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581
LR + LD + + +V + +L S +HRDL N+L
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177
Query: 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAV 641
+ H K+ DFGL++ ++ K +A
Sbjct: 178 LTHGRITKICDFGLARD-----------------------------IKNDSNYVVKGNAR 208
Query: 642 GTPDYLAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWP 700
++APE + + +D WS GI L+EL +G P+ F ++
Sbjct: 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 268
Query: 701 RVPEEMSPEAHDLIDRFLTEDPHQR 725
PE E +D++ DP +R
Sbjct: 269 S-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (365), Expect = 3e-39
Identities = 39/250 (15%), Positives = 78/250 (31%), Gaps = 35/250 (14%)
Query: 487 MIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 545
R++ + E + + +Y + LV++ L L
Sbjct: 38 EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK 97
Query: 546 LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA-----HDGHIKLTDFGLSKVGL 600
+ +++ ++ +H +V+RD+KPDN LI + I + DFG+ K
Sbjct: 98 FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157
Query: 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTT 660
T + R+K++ GT Y++ LG
Sbjct: 158 DPVT------------------------KQHIPYREKKNLSGTARYMSINTHLGREQSRR 193
Query: 661 ADWWSVGIILFELIVGIPPFNAEHPQ---QIFDNILNRKIPWPR--VPEEMSPEAHDLID 715
D ++G + + G P+ Q ++ I +K P + E + +
Sbjct: 194 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH 253
Query: 716 RFLTEDPHQR 725
Sbjct: 254 YARNLAFDAT 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-39
Identities = 51/281 (18%), Positives = 99/281 (35%), Gaps = 53/281 (18%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 540
+ +A +R+ L E ++ VVR + + ++ME + GDL S L
Sbjct: 57 TVNEAASMRE--RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 541 RN----------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKL 590
R+ L E+ + YL++ + VHRDL N ++A D +K+
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174
Query: 591 TDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPE 650
DFG+++ RK + +++PE
Sbjct: 175 GDFGMTRD-----------------------------IYETDYYRKGGKGLLPVRWMSPE 205
Query: 651 ILLGTGHGTTADWWSVGIILFELIVGI-PPFNAEHPQQIFDNILNRKIPWPRVPEEMSPE 709
L T +D WS G++L+E+ P+ +Q+ ++ + P+
Sbjct: 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDM 263
Query: 710 AHDLIDRFLTEDPHQRLGSGGASEVKQ------HVFFKDIN 744
+L+ +P R E+ F++++
Sbjct: 264 LFELMRMCWQYNPKMRP---SFLEIISSIKEEMEPGFREVS 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 51/260 (19%), Positives = 91/260 (35%), Gaps = 35/260 (13%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSL 539
V + V L E I+ +P V+ + +V+ Y+ GDL +
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 540 LRNLGCLDEDVARVYIA-EVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598
+RN + +V +++L S + VHRDL N ++ +K+ DFGL++
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR- 178
Query: 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHG 658
+ K A ++A E L
Sbjct: 179 --------------------------DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 659 TTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRF 717
T +D WS G++L+EL+ G PP+ + I +L + PE ++++ +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--PEYCPDPLYEVMLKC 270
Query: 718 LTEDPHQRLGSGGASEVKQH 737
R SE+
Sbjct: 271 WHPKAEMRP---SFSELVSR 287
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 2e-38
Identities = 52/266 (19%), Positives = 103/266 (38%), Gaps = 42/266 (15%)
Query: 487 MIRKNA--VESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RN 542
++++ VE L E ++ +++P +V+ T Y++ E++ G+L L N
Sbjct: 49 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108
Query: 543 LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602
+ V ++ A+EYL +HRDL N L+ + +K+ DFGLS++
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---- 164
Query: 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTAD 662
A + APE L +D
Sbjct: 165 --------------------------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 663 WWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTED 721
W+ G++L+E+ G+ P+ Q+++ + K PE + ++L+ +
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELL--EKDYRMERPEGCPEKVYELMRACWQWN 256
Query: 722 PHQRLGSGGASEVKQHVFFKDINWDT 747
P R +E+ Q F+ + ++
Sbjct: 257 PSDRP---SFAEIHQ--AFETMFQES 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-38
Identities = 50/260 (19%), Positives = 101/260 (38%), Gaps = 50/260 (19%)
Query: 484 KADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 542
K+D K+ + +++E +++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 54 KSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA 112
Query: 543 LGC----------------LDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586
L +V +EYL S + +HRDL N+L+ D
Sbjct: 113 RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172
Query: 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
+K+ DFGL++ H +K + +
Sbjct: 173 VMKIADFGLARD-----------------------------IHHIDYYKKTTNGRLPVKW 203
Query: 647 LAPEILLGTGHGTTADWWSVGIILFELI-VGIPPFNAEHPQQIFDNILNRKIPWPRVPEE 705
+APE L + +D WS G++L+E+ +G P+ +++F + P
Sbjct: 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSN 261
Query: 706 MSPEAHDLIDRFLTEDPHQR 725
+ E + ++ P QR
Sbjct: 262 CTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 45/262 (17%), Positives = 89/262 (33%), Gaps = 34/262 (12%)
Query: 469 KGALSEHDDFPQVLKKADMIRKNAVES----ILAERDILISVRNPFVVRFFYSFTCRENL 524
KG L +V ++ E L E I+ + ++R + + +
Sbjct: 25 KGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84
Query: 525 YLVMEYLNGGDLYSL-LRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA 583
++ EY+ G L G + + ++YL ++ VHRDL N+L+
Sbjct: 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 144
Query: 584 HDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGT 643
+ K++DFGLS+V + +
Sbjct: 145 SNLVCKVSDFGLSRV----------------------------LEDDPEATYTTSGGKIP 176
Query: 644 PDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPRVP 703
+ APE + + +D WS GI+++E++ E +N P P
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-P 235
Query: 704 EEMSPEAHDLIDRFLTEDPHQR 725
+ + L+ + ++ +R
Sbjct: 236 MDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 54/276 (19%), Positives = 104/276 (37%), Gaps = 54/276 (19%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYS 538
+LK+ + ++++E ILI + + V + L +++E+ G+L +
Sbjct: 50 MLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 539 LLRN----------------LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLI 582
LR+ L + Y +V +E+L S + +HRDL N+L+
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167
Query: 583 AHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVG 642
+ +K+ DFGL++ + +K A
Sbjct: 168 SEKNVVKICDFGLARD-----------------------------IYKDPDYVRKGDARL 198
Query: 643 TPDYLAPEILLGTGHGTTADWWSVGIILFELIVGI-PPFNAEHPQQIFDNILNRKIPWPR 701
++APE + + +D WS G++L+E+ P+ + F L R
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MR 257
Query: 702 VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737
P+ +PE + + +P QR SE+ +H
Sbjct: 258 APDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 49/289 (16%), Positives = 88/289 (30%), Gaps = 70/289 (24%)
Query: 487 MIRKNAVESILAERDILI--SVRNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL 540
+ S E +I +R+ ++ F + L+LV +Y G L+ L
Sbjct: 33 IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92
Query: 541 RNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTD 592
E + ++ + L +LH + HRDLK N+L+ +G + D
Sbjct: 93 NRYTVTVEGMIKLAL-STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151
Query: 593 FGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEIL 652
GL+ S VGT Y+APE+L
Sbjct: 152 LGLAV---------------------------RHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 653 LGTGH------GTTADWWSVGIILFELIVGIPPFNAEHPQQ------------------- 687
+ + AD +++G++ +E+ Q
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736
+ + L IP E ++ + RL A +K+
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL---TALRIKK 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 5e-35
Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 83/304 (27%)
Query: 484 KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLY 537
+ + E ++ V + ++ FT + +++YLVME ++
Sbjct: 51 SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 110
Query: 538 SLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ LD + + +++ +++LHS ++HRDLKP N+++ D +K+ DFGL++
Sbjct: 111 VIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 598 VGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH 657
V T Y APE++LG G+
Sbjct: 168 --------------------------------TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 658 GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN----------------------- 694
D WSVG I+ E++ F ++ ++
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255
Query: 695 ----RKIPWPRV------------PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHV 738
+ +P++ + + +A DL+ + L DP +R+ + QH
Sbjct: 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHP 312
Query: 739 FFKD 742
+
Sbjct: 313 YINV 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-34
Identities = 67/298 (22%), Positives = 112/298 (37%), Gaps = 73/298 (24%)
Query: 481 VLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFT-----CRENLYLVMEYLNGGD 535
L + +A + E +L +++ V+ FT N ++ +L G D
Sbjct: 50 KLSRPFQSIIHA-KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 108
Query: 536 LYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595
L ++++ L +D + I +++ L+Y+HS ++HRDLKP NL + D +K+ DFGL
Sbjct: 109 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167
Query: 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT 655
+ + + V T Y APEI+L
Sbjct: 168 A----------------------------------RHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 656 GH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILN-------------------- 694
H T D WSVG I+ EL+ G F IL
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 695 --------RKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744
K+ + V +P A DL+++ L D +R+ A++ H +F +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFAQYH 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.3 bits (246), Expect = 6e-23
Identities = 49/321 (15%), Positives = 102/321 (31%), Gaps = 91/321 (28%)
Query: 481 VLKKADMIRKNAVESILAERDI-------LISVRNPFVVRFFYSFT--CRENLYLVMEYL 531
+++ + + A + I + + S+ +++ F +++VM +
Sbjct: 45 IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104
Query: 532 NGG---DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR-VVHRDLKPDNLLIAHDGH 587
G + + +++L L+Y+H ++H D+KP+N+L+
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164
Query: 588 I-KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDY 646
L ++ +G +++ T +Y
Sbjct: 165 PENLIQIKIADLG-----------------------------NACWYDEHYTNSIQTREY 195
Query: 647 LAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNI-------------- 692
+PE+LLG G AD WS ++FELI G F + +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 693 ----------------------LNRKIPWP---------RVPEEMSPEAHDLIDRFLTED 721
+++ WP + ++ + E D + L D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 722 PHQRLGSGGASEVKQHVFFKD 742
P +R A + H + KD
Sbjct: 316 PRKRA---DAGGLVNHPWLKD 333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.8 bits (157), Expect = 2e-12
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 12/109 (11%)
Query: 489 RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 548
A+ S E L ++ V + + ++ME ++ +LY +
Sbjct: 54 SVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRV 102
Query: 549 DVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSK 597
+ + ++ + + +VH DL N+L+ + I + DF S
Sbjct: 103 ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 863 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.66 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.2 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.43 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.92 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-57 Score=492.39 Aligned_cols=280 Identities=40% Similarity=0.749 Sum_probs=247.8
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEE
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLV 527 (863)
..+|++. +||+|+||.|+.+. |+++|.........+.+.+|+.+|++++|||||+++++|++++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3456655 99999999996542 444454555566778899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 528 MEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
||||+||+|..++.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~----- 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----- 158 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-----
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999842110
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 159 --------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 159 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp --------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 122345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCC
Q 002953 688 IFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESAL 763 (863)
Q Consensus 688 l~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~l 763 (863)
++..+......+ |..+|+++++||++||++||.+|++. .+++++++||||++++|+.+..+ .|||+|......
T Consensus 213 ~~~~i~~~~~~~---p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~ 289 (337)
T d1o6la_ 213 LFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEV 289 (337)
T ss_dssp HHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTT
T ss_pred HHHHHhcCCCCC---CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChh
Confidence 999998887654 56799999999999999999999975 36999999999999999998765 489999999999
Q ss_pred CCCCccccc
Q 002953 764 DTSYFTSRY 772 (863)
Q Consensus 764 Dts~F~s~~ 772 (863)
|+++|+..+
T Consensus 290 ~~~~f~~~~ 298 (337)
T d1o6la_ 290 DTRYFDDEF 298 (337)
T ss_dssp CCTTSCHHH
T ss_pred hhhhcCchh
Confidence 999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=471.59 Aligned_cols=266 Identities=35% Similarity=0.707 Sum_probs=228.0
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.+. +||+|+||+|+.+. |++++.........+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 456665 99999999996552 2333344445556678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~------ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------ 161 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC------
Confidence 99999999999999899999999999999999999999999999999999999999999999999999852110
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..++
T Consensus 162 -----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 162 -----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp -------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 001223457899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC---CHHHHHcCCCCCCCChhHHhhccCCccC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG---GASEVKQHVFFKDINWDTLARQKAAFVP 757 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~---SAeEILqHPFFk~IdW~~l~~~~ppfvP 757 (863)
+.+|......+ |..+++++++||++||+.||.+||++. ....|++||||++++|+.+.++.||-+|
T Consensus 219 ~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHHTTCCCC---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHHcCCCCC---CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 99998877654 567999999999999999999999331 2234799999999999999998888766
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-55 Score=470.33 Aligned_cols=275 Identities=37% Similarity=0.734 Sum_probs=222.9
Q ss_pred cceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHH-hcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILI-SVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~-~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
+|.+. .||+|+||+|+.+. |++++.........+.+..|..+|. .++|||||+++++|.+++.+||||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 35544 99999999997652 3333333444556677888888876 689999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~------ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG------ 156 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT------
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc------
Confidence 99999999999999899999999999999999999999999999999999999999999999999999842110
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~ 211 (320)
T d1xjda_ 157 -------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211 (320)
T ss_dssp -------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 1122346899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHH-HHHcCCCCCCCChhHHhhc--cCCccCCCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGAS-EVKQHVFFKDINWDTLARQ--KAAFVPTSESALDT 765 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAe-EILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lDt 765 (863)
+.++..+... +|..+|+++.+||++||++||.+|| ++. ++++||||++++|+.+..+ .||++|...+..|+
T Consensus 212 ~~~i~~~~~~---~p~~~s~~~~dli~~~L~~dP~~R~---s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~ 285 (320)
T d1xjda_ 212 FHSIRMDNPF---YPRWLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 285 (320)
T ss_dssp HHHHHHCCCC---CCTTSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHHHHHTTCSCC------------
T ss_pred HHHHHcCCCC---CCccCCHHHHHHHHHhcccCCCCCc---CHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccch
Confidence 9999877654 4567999999999999999999999 775 8999999999999998765 58999999999999
Q ss_pred CCccccc
Q 002953 766 SYFTSRY 772 (863)
Q Consensus 766 s~F~s~~ 772 (863)
++|+..+
T Consensus 286 ~~f~~~~ 292 (320)
T d1xjda_ 286 SNFDKEF 292 (320)
T ss_dssp -------
T ss_pred hhcChHh
Confidence 9997644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-54 Score=465.84 Aligned_cols=273 Identities=37% Similarity=0.726 Sum_probs=232.6
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|++. .||+|+||+|+.+. |++++.........+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 456654 89999999996652 2333333445556788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|||+||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~-------- 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-------- 155 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS--------
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec--------
Confidence 999999999999998999999999999999999999999999999999999999999999999999998421
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 156 --------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 156 --------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp --------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 112357899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCC-CC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSES-AL 763 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s-~l 763 (863)
+.++......+ +..+++++.++|.+||.+||.+|++. .|++++|+||||++++|+.+..+ ++||+|.... ..
T Consensus 210 ~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~ 286 (316)
T d1fota_ 210 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQG 286 (316)
T ss_dssp HHHHHHCCCCC---CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----
T ss_pred HHHHHcCCCCC---CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcc
Confidence 99998887654 46799999999999999999999864 48999999999999999998754 5789887544 45
Q ss_pred CCCCcc
Q 002953 764 DTSYFT 769 (863)
Q Consensus 764 Dts~F~ 769 (863)
|+++|+
T Consensus 287 d~~~f~ 292 (316)
T d1fota_ 287 DTSQFD 292 (316)
T ss_dssp ------
T ss_pred hhhhcC
Confidence 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-54 Score=471.13 Aligned_cols=274 Identities=38% Similarity=0.747 Sum_probs=242.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
..|.+. .||+|+||+|+.+. +++| +.........+.+.+|+++|+.++|||||+++++|.+...+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 456554 99999999996652 2333 333444556678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~-------- 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------- 192 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS--------
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc--------
Confidence 999999999999988999999999999999999999999999999999999999999999999999998410
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+...+
T Consensus 193 --------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 193 --------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp --------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred --------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 112356899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSESALD 764 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~s~lD 764 (863)
+.+|......+ +..+++++.+||++||.+||.+|+.. .+++++++||||++++|+.+..+ .|||+|......|
T Consensus 247 ~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d 323 (350)
T d1rdqe_ 247 YEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323 (350)
T ss_dssp HHHHHHCCCCC---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTC
T ss_pred HHHHhcCCCCC---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcch
Confidence 99998877544 56799999999999999999999643 48999999999999999998765 5899999998889
Q ss_pred CCCccc
Q 002953 765 TSYFTS 770 (863)
Q Consensus 765 ts~F~s 770 (863)
+++|+.
T Consensus 324 ~s~~~~ 329 (350)
T d1rdqe_ 324 TSNFDD 329 (350)
T ss_dssp CTTSCC
T ss_pred hhhcCC
Confidence 988864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-52 Score=462.15 Aligned_cols=277 Identities=31% Similarity=0.551 Sum_probs=217.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceeh---hhhhhchhHHHHHHHH---HHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLK---KADMIRKNAVESILAE---RDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlK---K~~i~~k~~~e~~l~E---i~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
..|++. +||+|+||+|+.+. +++| +..+........+.+| +.+|+.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 456665 99999999997552 2333 2233333333444455 56666778999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~---- 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---- 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS----
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999984210
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+
T Consensus 160 -----------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 160 -----------------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp -----------------------------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred -----------------------------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 12235689999999999974 668999999999999999999999998765
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCC--CCHHHHHcCCCCCCCChhHHhhc--cCCccCCCC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGS--GGASEVKQHVFFKDINWDTLARQ--KAAFVPTSE 760 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~--~SAeEILqHPFFk~IdW~~l~~~--~ppfvP~~~ 760 (863)
...............+.++..+|+++.+||.+||++||.+||+. .+|+++++||||++++|..+..+ .||++|...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~ 290 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290 (364)
T ss_dssp SSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCC
Confidence 43332222222222234567899999999999999999999953 24899999999999999998765 488998776
Q ss_pred CCCCCCCcc
Q 002953 761 SALDTSYFT 769 (863)
Q Consensus 761 s~lDts~F~ 769 (863)
.....+.|+
T Consensus 291 ~~~~~~~~d 299 (364)
T d1omwa3 291 EVNAADAFD 299 (364)
T ss_dssp ---------
T ss_pred CCCcCCccc
Confidence 655544443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=443.71 Aligned_cols=243 Identities=34% Similarity=0.594 Sum_probs=214.7
Q ss_pred ccceEE-Eeecccceeecccc----------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+|.+. .||+|+||+|+.+. |++.+.........+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 345554 89999999996542 2333333444455678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
|||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~------- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-------
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-------
Confidence 9999999999999889999999999999999999999999999999999999999999999999999974110
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++
T Consensus 159 --------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 159 --------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp --------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred --------------------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 112346899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
+.++......+ |..+|+++++||.+||+.||.+|| |++|+|+||||+
T Consensus 213 ~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~ 259 (263)
T d2j4za1 213 YKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWIT 259 (263)
T ss_dssp HHHHHTTCCCC---CTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHH
T ss_pred HHHHHcCCCCC---CccCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcC
Confidence 99998877544 567999999999999999999999 999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=447.09 Aligned_cols=244 Identities=34% Similarity=0.563 Sum_probs=213.5
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
+..||+|+||+|+.+. +++|+.........+.+.+|+++|++++|||||+++++|.+++++|||||||+||+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 4589999999997652 455554444444567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcc
Q 002953 537 YSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTT 616 (863)
Q Consensus 537 ~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~ 616 (863)
.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 105 ~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-------------- 169 (293)
T d1yhwa1 105 TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------- 169 (293)
T ss_dssp HHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--------------
T ss_pred HHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc--------------
Confidence 998876 57999999999999999999999999999999999999999999999999999842100
Q ss_pred cCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhcC
Q 002953 617 LLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRK 696 (863)
Q Consensus 617 l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~~ 696 (863)
.......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 170 -----------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 232 (293)
T d1yhwa1 170 -----------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (293)
T ss_dssp -----------------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred -----------------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 112345689999999999999999999999999999999999999999998888877777665
Q ss_pred CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 697 IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 697 ~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
......+..+++++++||.+||+.||.+|| |++|+|+||||+.
T Consensus 233 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 233 TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 544455678999999999999999999999 9999999999974
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=443.14 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=205.0
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEe
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVME 529 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmE 529 (863)
..+|.+. .||+|+||+|+.+. +++|...... ....+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3456654 99999999996652 3444332221 2234568999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 530 YLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 530 y~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~------ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------ 157 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT------
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC------
Confidence 99999999999888899999999999999999999999999999999999999999999999999998521100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
......+.+||+.|||||++.+..+ +.++|||||||++|||++|++||........
T Consensus 158 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 158 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -----------------------ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 0122345789999999999998876 6789999999999999999999977654333
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..............+..+++++.+||.+||+.||.+|| |++|+|+||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred HHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 33333333333333467899999999999999999999 9999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=442.40 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=216.0
Q ss_pred cceE-EEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.|++ ..||+|+||+|+.+. +++|..........+.+.+|+++|++++|||||+++++|.+++.+|||||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3554 489999999997652 35555444445566788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~----------- 161 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT----------- 161 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH-----------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC-----------
Confidence 99999997654 569999999999999999999999999999999999999999999999999997410
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-----GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQ 686 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~ 686 (863)
.......+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+..
T Consensus 162 --------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 162 --------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp --------------------HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred --------------------CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 1112334678999999999984 456899999999999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+++.++.....+....+..+|+++.+||.+||+.||.+|| |++|+|+||||+..
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~~ 275 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTVD 275 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCCC
T ss_pred HHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCC
Confidence 9999998877655555678999999999999999999999 99999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-51 Score=441.75 Aligned_cols=246 Identities=32% Similarity=0.543 Sum_probs=199.7
Q ss_pred ceEE-Eeecccceeecccc-------ceehhhhhhc-hhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 462 IDLL-LAGKGALSEHDDFP-------QVLKKADMIR-KNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 462 ~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~-k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
|.+. .||+|+||+|+.+. +++|...... ......+.+|+++|++++|||||+++++|.+++.+|||||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 5554 89999999997652 3344322111 2233567899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec---CCCcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA---HDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd---~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+....
T Consensus 91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-------- 162 (307)
T d1a06a_ 91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-------- 162 (307)
T ss_dssp SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC--------
Confidence 999999999888999999999999999999999999999999999999995 468999999999984110
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++
T Consensus 163 ------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 218 (307)
T d1a06a_ 163 ------------------------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218 (307)
T ss_dssp ----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ------------------------CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 11234578999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
..+......++ ..+..+|+++.+||.+||++||.+|| |++|+++||||++
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 269 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAG 269 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTS
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCC
Confidence 99988776554 23467999999999999999999999 9999999999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=435.25 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=214.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehhh---hhh---chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKA---DMI---RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~---~i~---~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.|++. .||+|+||+|+.+. +++|.. ... .....+.+.+|+++|++++|||||+++++|.+++.+||
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45654 89999999997652 233322 111 11245789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC----cEEEeecCCccccccC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG----HIKLTDFGLSKVGLIN 602 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g----~VKLiDFGLAk~~~~~ 602 (863)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~- 169 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF- 169 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT-
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC-
Confidence 999999999999999888999999999999999999999999999999999999998776 599999999984210
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNA 682 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~ 682 (863)
.....+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+
T Consensus 170 -------------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 170 -------------------------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp -------------------------------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------------------------CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 1123356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHh
Q 002953 683 EHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLA 749 (863)
Q Consensus 683 ~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~ 749 (863)
.+..+++.++......++. .+..+|+++++||++||+.||.+|| |++++|+||||+..+|....
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC-------
T ss_pred CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCChhHhh
Confidence 9999999999887765542 3467899999999999999999999 99999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=430.86 Aligned_cols=243 Identities=22% Similarity=0.444 Sum_probs=202.6
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe----CCeEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC----RENLYL 526 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~lyL 526 (863)
.+++. .||+|+||+|+.+. +++|+... ......+.+.+|+++|++++|||||+++++|.+ +..+||
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 34554 79999999997652 23343222 234456789999999999999999999999876 346899
Q ss_pred EEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCC--ccccCCCCcceeecC-CCcEEEeecCCccccccCC
Q 002953 527 VMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLR--VVHRDLKPDNLLIAH-DGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~G--IIHRDLKPeNILLd~-~g~VKLiDFGLAk~~~~~s 603 (863)
|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999998889999999999999999999999998 999999999999974 7899999999997410
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||...
T Consensus 167 ------------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 167 ------------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp ------------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ------------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 012235689999999999876 5999999999999999999999999765
Q ss_pred C-hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCC
Q 002953 684 H-PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFK 741 (863)
Q Consensus 684 ~-~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk 741 (863)
. ...+++.+..+.. .+.++..+++++++||.+||+.||++|| |++|+|+||||+
T Consensus 216 ~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 216 QNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp SSHHHHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred ccHHHHHHHHHcCCC-CcccCccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 4 4555666655433 3345567899999999999999999999 999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=444.42 Aligned_cols=250 Identities=28% Similarity=0.489 Sum_probs=204.5
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
..|.+. .||+|+||+|+.+. +++|..... .......+.+|+.+|++++|||||+++++|.+++++||||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 345544 89999999997652 334433222 334456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
|+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+...
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~--------- 156 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--------- 156 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH---------
T ss_pred CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC---------
Confidence 9999999999988999999999999999999999997 599999999999999999999999999998410
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus 157 ------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~ 212 (322)
T d1s9ja_ 157 ------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 212 (322)
T ss_dssp ------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHH
T ss_pred ------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 12234679999999999999999999999999999999999999999775533221
Q ss_pred H------------------------------------------HHhhcCCCCCCCC-CCCCHHHHHHHHhhccCCcCCcC
Q 002953 690 D------------------------------------------NILNRKIPWPRVP-EEMSPEAHDLIDRFLTEDPHQRL 726 (863)
Q Consensus 690 ~------------------------------------------kIl~~~~~~p~~p-~~iS~el~dLI~k~L~~DP~kRp 726 (863)
. .+... ..+..+ ..+|.++.+||.+||+.||.+||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 290 (322)
T d1s9ja_ 213 LMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290 (322)
T ss_dssp HHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence 1 11111 111222 24689999999999999999999
Q ss_pred CCCCHHHHHcCCCCCCCChhH
Q 002953 727 GSGGASEVKQHVFFKDINWDT 747 (863)
Q Consensus 727 g~~SAeEILqHPFFk~IdW~~ 747 (863)
|++|+|+||||+..+|+.
T Consensus 291 ---ta~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 291 ---DLKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp ---CHHHHHTSHHHHHHHHSC
T ss_pred ---CHHHHhhCHhhCcCCccc
Confidence 999999999998776643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.7e-51 Score=445.63 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=218.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
.+|.+. .||+|+||+|+.+. +++|+.........+.+.+|+++|++|+|||||+++++|.+++.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 356654 89999999997652 3555544444556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC--CCcEEEeecCCccccccCCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH--DGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~--~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~------- 178 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------- 178 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-------
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-------
Confidence 99999999854 467999999999999999999999999999999999999964 57899999999984210
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 179 -------------------------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 233 (350)
T d1koaa2 179 -------------------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 233 (350)
T ss_dssp -------------------------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -------------------------ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 0122357899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChh
Q 002953 689 FDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWD 746 (863)
Q Consensus 689 ~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~ 746 (863)
+.+|......++. ....+|+++++||.+||+.||.+|| |++|+|+||||+..+|.
T Consensus 234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTCC
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCC
Confidence 9999887765543 2356899999999999999999999 99999999999987764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-50 Score=441.74 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=216.1
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+. .||+|+||+|+.+. +++|............+.+|+.+|++|+|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 346655 99999999997652 3455443333445567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeec--CCCcEEEeecCCccccccCCCCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIA--HDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd--~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+||+|.+++...+ ++++..++.|+.||+.||+|||++|||||||||+||||+ .++++||+|||+|+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~------- 181 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP------- 181 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-------
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-------
Confidence 9999999876654 699999999999999999999999999999999999998 568999999999984210
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQI 688 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el 688 (863)
.....+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..++
T Consensus 182 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 182 -------------------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp -------------------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred -------------------------CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1123456899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCC
Q 002953 689 FDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDI 743 (863)
Q Consensus 689 ~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~I 743 (863)
+..+......++. .+..+|+++.+||.+||++||.+|| |++|+|+||||++.
T Consensus 237 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 9999888766543 3467999999999999999999999 99999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=427.31 Aligned_cols=245 Identities=29% Similarity=0.527 Sum_probs=200.3
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--CCeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC--RENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~lyLV 527 (863)
.+|++. .||+|+||+|+.+. +++|.... ......+.+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 346555 99999999997652 34443322 234456789999999999999999999999865 4568999
Q ss_pred EeecCCCChHHHHHh----cCCCChhhHHHHHHHHHHHHHHHHhCC-----ccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 528 MEYLNGGDLYSLLRN----LGCLDEDVARVYIAEVVLALEYLHSLR-----VVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 528 mEy~~GGsL~dlLk~----~g~L~e~~i~~Ia~QIl~ALeyLHs~G-----IIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 357999999999999999999999876 99999999999999999999999999984
Q ss_pred cccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002953 599 GLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIP 678 (863)
Q Consensus 599 ~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~ 678 (863)
... ........+||+.|||||++.+..|+.++|||||||++|||++|.+
T Consensus 164 ~~~-------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 164 LNH-------------------------------DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp C------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccc-------------------------------CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC
Confidence 210 0112345789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 679 PFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 679 PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
||.+.+..+++.++..+.. +.++..+|+++.+||.+||+.||.+|| |++|+++|||.
T Consensus 213 Pf~~~~~~~~~~~i~~~~~--~~~~~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~hp~i 269 (269)
T d2java1 213 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENPLI 269 (269)
T ss_dssp SCCCSSHHHHHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTC
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcccCHHHHHHHHHHcCCChhHCc---CHHHHHhCCcC
Confidence 9999999999999887765 345678999999999999999999999 99999999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-50 Score=433.85 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=209.4
Q ss_pred eEEEeecccceeecccc-------ceehhhh---hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKAD---MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~---i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+..||+|+||+|+.+. +++|... .......+.+.+|+++|++++|||||+++++|.+++.+|||||||.
T Consensus 19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecC
Confidence 35589999999997652 3444332 2234455779999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 533 GGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 533 GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||+|+..
T Consensus 99 ~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~------------- 165 (309)
T d1u5ra_ 99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------- 165 (309)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS-------------
T ss_pred CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc-------------
Confidence 9999888887788999999999999999999999999999999999999999999999999999841
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG---TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
......+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+
T Consensus 166 ----------------------~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~ 223 (309)
T d1u5ra_ 166 ----------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223 (309)
T ss_dssp ----------------------SSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ----------------------CCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 01234689999999999975 45899999999999999999999999999988888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.++.....+.+ .+..+|+++.+||.+||+.||.+|| |++++|+||||..
T Consensus 224 ~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 224 YHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred HHHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 88877665432 2456899999999999999999999 9999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=422.44 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=203.7
Q ss_pred eEEEeecccceeecccc-------ceehhhhhhchh-----HHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 463 DLLLAGKGALSEHDDFP-------QVLKKADMIRKN-----AVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 463 ~l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~-----~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
++.+||+|+||+|+.+. +++|+....... ....+.+|+.+|++++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 45699999999997652 344443322211 124688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
|.|+++..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-------- 153 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-------- 153 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--------
Confidence 999888877776778999999999999999999999999999999999999999999999999999742110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.....+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++
T Consensus 154 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l 210 (299)
T d1ua2a_ 154 -----------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210 (299)
T ss_dssp -----------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred -----------------------cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH
Confidence 112235689999999999875 45799999999999999999999999999988888
Q ss_pred HHHhhcCCC-----C---------------CC-----CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 690 DNILNRKIP-----W---------------PR-----VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 690 ~kIl~~~~~-----~---------------p~-----~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
.+|...... + +. ....+++++.+||.+||+.||++|| ||+|+|+||||++..
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~---sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHHHHTSGGGTSSS
T ss_pred HHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc---CHHHHhCCHhhCCCC
Confidence 877642110 0 00 1135689999999999999999999 999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-48 Score=414.41 Aligned_cols=247 Identities=32% Similarity=0.531 Sum_probs=211.5
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhh---------chhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeCC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMI---------RKNAVESILAERDILISVR-NPFVVRFFYSFTCRE 522 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~---------~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~ 522 (863)
+|.+. .||+|+||+|+.+. +++|..... .+...+.+.+|+.+|++++ |||||+++++|.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 45554 99999999997652 233332111 1223457889999999997 999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
++|||||||+||+|.++|+..+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~- 162 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP- 162 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT-
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC-
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999985211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC------CCCCccceeechhHHHHHHHhC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG------TGHGTTADWWSVGIILFELIVG 676 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g------~~ys~ksDIWSLGvILyELLTG 676 (863)
.......+||+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 163 -------------------------------~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 163 -------------------------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp -------------------------------TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred -------------------------------CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence 012234689999999999863 3468899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 677 IPPFNAEHPQQIFDNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 677 k~PF~~~~~~el~~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+||.+.+....+..+..+...++. ....+|+++++||.+||+.||.+|| |++|+|+||||+.
T Consensus 212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil~h~~~~~ 275 (277)
T d1phka_ 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQ 275 (277)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCT
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHHHH
Confidence 9999999999999999887765443 2347999999999999999999999 9999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=425.62 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=212.0
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
+|.+. .||+|+||+|+.+. +++|.... .......+.+|+++|+.++|||||+++++|++++++|||||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcC-CcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 35554 99999999997652 34443322 23344568899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC--CcEEEeecCCccccccCCCCCCCC
Q 002953 533 GGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD--GHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 533 GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~--g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-------- 156 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-------- 156 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--------
Confidence 999999998765 79999999999999999999999999999999999999854 4899999999984210
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQIF 689 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~ 689 (863)
.......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++
T Consensus 157 ------------------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~ 212 (321)
T d1tkia_ 157 ------------------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212 (321)
T ss_dssp ------------------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 11234568999999999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCC-CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 690 DNILNRKIPWPR-VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 690 ~kIl~~~~~~p~-~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+|......++. .+..+|+++++||.+||++||.+|| |++|+|+||||+.
T Consensus 213 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred HHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 999988776542 2346899999999999999999999 9999999999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=423.04 Aligned_cols=276 Identities=38% Similarity=0.729 Sum_probs=224.7
Q ss_pred cccceEE-Eeecccceeecccc----------ceehhhh---hh-chhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeCC
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP----------QVLKKAD---MI-RKNAVESILAERDILISVRN-PFVVRFFYSFTCRE 522 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~----------kvlKK~~---i~-~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~ 522 (863)
..+|++. .||+|+||+|+.+. +++|... .. .....+.+.+|+++|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 3556664 99999999997652 2444322 11 22344668899999999976 89999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccC
Q 002953 523 NLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLIN 602 (863)
Q Consensus 523 ~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~ 602 (863)
.+|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~- 181 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA- 181 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG-
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHhCCCCC
Q 002953 603 STDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT--GHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 603 s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.......+..||+.|+|||.+.+. .++.++|||||||+||+|++|..||
T Consensus 182 -----------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 182 -----------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp -----------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 011223457899999999999764 3688999999999999999999999
Q ss_pred CCCChHHHHHHHhhcC-CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCC--CHHHHHcCCCCCCCChhHHhhc--cCCc
Q 002953 681 NAEHPQQIFDNILNRK-IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSG--GASEVKQHVFFKDINWDTLARQ--KAAF 755 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~-~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~--SAeEILqHPFFk~IdW~~l~~~--~ppf 755 (863)
.+.+.......+.... ...+.++..+++++.+||.+||+.||.+||+.. +++|+|+||||++++|+.+..+ .+|+
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~ 312 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 312 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred CCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCC
Confidence 8765544444433321 111334567999999999999999999999763 7999999999999999999876 4899
Q ss_pred cCCCCCCCC
Q 002953 756 VPTSESALD 764 (863)
Q Consensus 756 vP~~~s~lD 764 (863)
+|.+.+..|
T Consensus 313 ~p~~~~~~~ 321 (322)
T d1vzoa_ 313 KPVIRDELD 321 (322)
T ss_dssp CCCCCC-CC
T ss_pred CCCCCCCCC
Confidence 998877665
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=406.41 Aligned_cols=251 Identities=30% Similarity=0.423 Sum_probs=202.7
Q ss_pred ccceEE-Eeecccceeecccc--------ceehhhhhh--chhHHHHHHHHHHHHHhc---CCCCeeEEEEEEEe-----
Q 002953 460 SQIDLL-LAGKGALSEHDDFP--------QVLKKADMI--RKNAVESILAERDILISV---RNPFVVRFFYSFTC----- 520 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~--------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d----- 520 (863)
.+|++. .||+|+||+|+.+. +++|..... .......+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 456655 99999999996652 234433221 122233566788887766 79999999999864
Q ss_pred CCeEEEEEeecCCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCcccc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVG 599 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~ 599 (863)
...+|++||||.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 3468999999988776655443 356999999999999999999999999999999999999999999999999998741
Q ss_pred ccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002953 600 LINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 600 ~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P 679 (863)
. ........+||+.|||||++.+..|+.++|||||||++|||++|++|
T Consensus 167 ~--------------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 167 S--------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp C--------------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred c--------------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCC
Confidence 1 01233467899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCC------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 680 FNAEHPQQIFDNILNRKI------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
|.+.+..+.+.+++.... +.+.++..+++++.+||.+||++||.+|| ||+|+|
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---sa~e~L 291 (305)
T d1blxa_ 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSAL 291 (305)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred CCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc---CHHHHh
Confidence 999998888877754210 01123456899999999999999999999 999999
Q ss_pred cCCCCCCCCh
Q 002953 736 QHVFFKDINW 745 (863)
Q Consensus 736 qHPFFk~IdW 745 (863)
+||||+++++
T Consensus 292 ~Hpff~~i~~ 301 (305)
T d1blxa_ 292 SHPYFQDLER 301 (305)
T ss_dssp TSGGGTTCCC
T ss_pred cChhhcCchh
Confidence 9999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=407.17 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=201.9
Q ss_pred EEeecccceeecccc---------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 465 LLAGKGALSEHDDFP---------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~---------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
..||+|+||+|+.+. +++|... .......+.+.+|+++|++++|||||++++++.+ +..|||||||+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 379999999997542 2344322 2233445789999999999999999999999865 457899999999
Q ss_pred CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCcc
Q 002953 534 GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVS 613 (863)
Q Consensus 534 GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~ 613 (863)
|+|.+++...+.+++..+..|+.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~--------- 162 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--------- 162 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS---------
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc---------
Confidence 99999999988999999999999999999999999999999999999999999999999999984211000
Q ss_pred CcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002953 614 GTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNI 692 (863)
Q Consensus 614 g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kI 692 (863)
.........||+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..++...+
T Consensus 163 -------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 163 -------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp -------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred -------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 0011234579999999999999999999999999999999997 89999999988888888
Q ss_pred hhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHH---HcCCCCCC
Q 002953 693 LNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEV---KQHVFFKD 742 (863)
Q Consensus 693 l~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEI---LqHPFFk~ 742 (863)
..+.. +..|..+|+++.+||.+||+.||.+|| |+.+| |+|+|+.-
T Consensus 224 ~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~RP---s~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 224 EKGER--MGCPAGCPREMYDLMNLCWTYDVENRP---GFAAVELRLRNYYYDV 271 (277)
T ss_dssp HTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHHHHHHHHHH
T ss_pred HcCCC--CCCCcccCHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhCHHhhc
Confidence 76543 455788999999999999999999999 77776 67777643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-47 Score=405.42 Aligned_cols=246 Identities=20% Similarity=0.300 Sum_probs=196.5
Q ss_pred cceEE-Eeecccceeecccc----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
.+++. +||+|+||+|+.+. +++|+... ......+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34444 89999999997652 23333222 23445678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++++||+|||+|+.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~--- 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--- 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC---
Confidence 999999999988774 5699999999999999999999999999999999999999999999999999985211000
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
...........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..
T Consensus 184 -----------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 184 -----------------------DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp -----------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -----------------------cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 000112223568999999999999999999999999999999998 89999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
++...+..+.. +..+..+++++.+||.+||+.||.+|| |+.+|+++
T Consensus 241 ~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~~ 286 (299)
T d1jpaa_ 241 DVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVNT 286 (299)
T ss_dssp HHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 88888876543 334678999999999999999999999 88888764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=402.46 Aligned_cols=246 Identities=30% Similarity=0.492 Sum_probs=198.9
Q ss_pred EEEeecccceeecccc-------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCC
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 534 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GG 534 (863)
+..||+|+||+|+.+. +++|..... .....+.+.+|+++|++++|||||+++++|.+++++|+||||+.+
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~- 85 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ- 85 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence 3499999999997652 344443222 223356789999999999999999999999999999999999976
Q ss_pred ChHHHHH-h-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 535 DLYSLLR-N-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 535 sL~dlLk-~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
.+..++. . .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~----------- 154 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------- 154 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-----------
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-----------
Confidence 5555443 3 35699999999999999999999999999999999999999999999999999974210
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF~~~~~~el~~k 691 (863)
........+||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.+
T Consensus 155 --------------------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 155 --------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp --------------------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred --------------------CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHH
Confidence 0122345689999999999887664 8899999999999999999999999888777776
Q ss_pred HhhcCCC------------------CCC--------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCC
Q 002953 692 ILNRKIP------------------WPR--------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDIN 744 (863)
Q Consensus 692 Il~~~~~------------------~p~--------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~Id 744 (863)
+...... ++. ....+++++.+||++||+.||.+|| |++|+|+||||++++
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI---SAKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSGGGTTCC
T ss_pred HHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhCCHhhccCC
Confidence 6542110 000 0125688999999999999999999 999999999999873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=411.17 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=201.3
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~l 524 (863)
.+|.+. +||+|+||+|+.+. +++|.... ........+.+|+.+|.++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345554 89999999997652 12222111 1233445789999999998 899999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc-----------------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCccee
Q 002953 525 YLVMEYLNGGDLYSLLRNL-----------------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~-----------------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNIL 581 (863)
|||||||+||+|.++|+.. +.+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999999999999754 24889999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccc
Q 002953 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661 (863)
Q Consensus 582 Ld~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 661 (863)
++.++++||+|||+|+...... ......+.+||+.|||||++.+..|+.++
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~ 247 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDS-----------------------------NYVVRGNARLPVKWMAPESLFEGIYTIKS 247 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCT-----------------------------TSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred cccCCeEEEeeccccccccCCC-----------------------------ceeeeccccCCCccCChHHHcCCCCCcce
Confidence 9999999999999998421100 01122356789999999999999999999
Q ss_pred eeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 662 DWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 662 DIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|||||||++|||++ |.+||.+.+..+.+.+++..... +..|..+|+++.+||.+||+.||++|| |++||++|
T Consensus 248 DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RP---t~~ei~~~ 320 (325)
T d1rjba_ 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWAFDSRKRP---SFPNLTSF 320 (325)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred eccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCCcCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 99999999999997 89999988777777777766544 345778999999999999999999999 99999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=401.64 Aligned_cols=239 Identities=20% Similarity=0.302 Sum_probs=194.9
Q ss_pred Eeecccceeecccc----ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP----QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~----kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||+|+.+. +++|.... ......+.+.+|+.+|++++|||||++++++ .++.+|||||||+||+|.++
T Consensus 15 ~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~~g~L~~~ 93 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHH 93 (276)
T ss_dssp EEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHH
T ss_pred EEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEEEEecCCCCCHHHH
Confidence 89999999997653 34444322 2345667899999999999999999999875 45678999999999999999
Q ss_pred HHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 540 Lk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
+... +.+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 94 l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~---------------- 157 (276)
T d1uwha_ 94 LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---------------- 157 (276)
T ss_dssp HHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------------------
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc----------------
Confidence 9764 56999999999999999999999999999999999999999999999999999742100
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHHHhhc
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT---GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNR 695 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~kIl~~ 695 (863)
.......+.+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++..
T Consensus 158 -------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 224 (276)
T d1uwha_ 158 -------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224 (276)
T ss_dssp ---------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH
T ss_pred -------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 001123457899999999999753 4799999999999999999999999887766555555444
Q ss_pred CCCCC---CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 696 KIPWP---RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 696 ~~~~p---~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
....| ..+..+|+++.+||.+||..||.+|| |+.+|+++
T Consensus 225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 33222 34667999999999999999999999 99999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=401.13 Aligned_cols=241 Identities=27% Similarity=0.407 Sum_probs=198.8
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh---hhch---hHHHHHHHHHHHHHhcC--CCCeeEEEEEEEeCCe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD---MIRK---NAVESILAERDILISVR--NPFVVRFFYSFTCREN 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~---i~~k---~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~ 523 (863)
++|.+. +||+|+||+|+.+. +++|... .... .....+.+|+.+|++++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 356664 89999999996542 2343322 1111 11234678999999997 8999999999999999
Q ss_pred EEEEEeecCC-CChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC-CcEEEeecCCcccccc
Q 002953 524 LYLVMEYLNG-GDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD-GHIKLTDFGLSKVGLI 601 (863)
Q Consensus 524 lyLVmEy~~G-GsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~-g~VKLiDFGLAk~~~~ 601 (863)
+|+||||+.+ +++.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 6888899888899999999999999999999999999999999999999855 7999999999974110
Q ss_pred CCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCC
Q 002953 602 NSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGH-GTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 602 ~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGvILyELLTGk~PF 680 (863)
....+.+||+.|||||++.+..+ +.++|||||||++|||++|.+||
T Consensus 164 ---------------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 164 ---------------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp ---------------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ---------------------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 12235689999999999987765 67899999999999999999999
Q ss_pred CCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCCh
Q 002953 681 NAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINW 745 (863)
Q Consensus 681 ~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW 745 (863)
...+ .+...... ++..+|+++++||++||+.||.+|| |++|+|+||||+++-.
T Consensus 211 ~~~~------~i~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 211 EHDE------EIIRGQVF---FRQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVLL 263 (273)
T ss_dssp CSHH------HHHHCCCC---CSSCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCCC
T ss_pred CCch------HHhhcccC---CCCCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCCCCC
Confidence 7642 34444443 3567999999999999999999999 9999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-47 Score=397.20 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=199.1
Q ss_pred cceEE-Eeecccceeecccc-------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----~ly 525 (863)
+|.+. .||+|+||+|+.+. +++|. ...........+.+|+++|+.++|||||++++++...+ .+|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 35554 89999999997652 23333 23334555678999999999999999999999998764 389
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
||||||+||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||+++......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~-- 165 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-- 165 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc--
Confidence 999999999999999998999999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.........+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 166 --------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 166 --------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --------------------------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH
Confidence 011233457899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhcCCCCC-CCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 686 QQIFDNILNRKIPWP-RVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 686 ~el~~kIl~~~~~~p-~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
.+++.+++......+ .....+|+++.+||.+||++||.+||+ ++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~ 268 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR 268 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH
T ss_pred HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH
Confidence 888888877665433 234679999999999999999999994 566665
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-46 Score=398.77 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=198.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
..|.+. .||+|+||+|+.+. +++|+.. ......+.+.+|+++|++++|||||++++++.+.+.+|||||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECC-TTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEEC-CccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 345544 89999999997652 3444332 23344567999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCC
Q 002953 532 NGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSG 609 (863)
Q Consensus 532 ~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~ 609 (863)
++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~------ 169 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT------ 169 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS------
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC------
Confidence 999999999764 568999999999999999999999999999999999999999999999999998421100
Q ss_pred CCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC-CCCCChHHH
Q 002953 610 PAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPP-FNAEHPQQI 688 (863)
Q Consensus 610 p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~P-F~~~~~~el 688 (863)
........||+.|||||++.+..|+.++|||||||++|||++|..| |.+.+...+
T Consensus 170 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~ 225 (287)
T d1opja_ 170 ------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225 (287)
T ss_dssp ------------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred ------------------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH
Confidence 0112234689999999999999999999999999999999996555 556666666
Q ss_pred HHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 689 FDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 689 ~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
++.+..+. . +..+..+|+++.+||.+||+.||.+|| |+.+|++
T Consensus 226 ~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 226 YELLEKDY-R-MERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp HHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhcCC-C-CCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 65554432 2 345778999999999999999999999 8999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-46 Score=396.90 Aligned_cols=248 Identities=30% Similarity=0.473 Sum_probs=202.6
Q ss_pred cce-EEEeecccceeecccc------ceehhhhhh--chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QID-LLLAGKGALSEHDDFP------QVLKKADMI--RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~-l~vLGkG~FG~V~~~~------kvlKK~~i~--~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
+|. +..||+|+||+|+.+. +++|+.... .....+.+.+|+.+|++++|||||+++++|.+++..|++|||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 344 4499999999997653 345543322 2333578999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 532 NGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 532 ~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|.....
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~---------- 152 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI---------- 152 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc----------
Confidence 8877777777778899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~~el~~ 690 (863)
.........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 153 ---------------------PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp ------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ---------------------CccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence 01122345799999999999764 46999999999999999999999999988887777
Q ss_pred HHhhcCC--------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 691 NILNRKI--------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 691 kIl~~~~--------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
++..... ++......+++++.+||++||+.||++|| |++|+|+||||++
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSGGGGC
T ss_pred HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCc
Confidence 7653110 01112346789999999999999999999 9999999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=403.03 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=202.1
Q ss_pred Eeecccceeecccc---------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCC
Q 002953 466 LAGKGALSEHDDFP---------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 535 (863)
Q Consensus 466 vLGkG~FG~V~~~~---------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGs 535 (863)
.||+|+||+|+.+. +++|.... ......+.+.+|+++|++++|||||++++++.+ +.+|||||||+||+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999997652 23443322 234556789999999999999999999999875 46899999999999
Q ss_pred hHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccC
Q 002953 536 LYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSG 614 (863)
Q Consensus 536 L~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g 614 (863)
|.+++... +.+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---------- 164 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS---------- 164 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC----------
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc----------
Confidence 99998654 5799999999999999999999999999999999999999999999999999985211000
Q ss_pred cccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHh
Q 002953 615 TTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNIL 693 (863)
Q Consensus 615 ~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl 693 (863)
........+||+.|||||++.+..++.++|||||||++|||+| |.+||.+.+..+++..+.
T Consensus 165 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~ 226 (285)
T d1u59a_ 165 ------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226 (285)
T ss_dssp ------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred ------------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 0112234579999999999999999999999999999999998 999999988888888887
Q ss_pred hcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 694 NRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 694 ~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
.+.. +..|..+|+++.+||.+||+.||++||++.++.+.|+|+|+
T Consensus 227 ~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 227 QGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 6553 45578899999999999999999999943334444777765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=414.60 Aligned_cols=243 Identities=30% Similarity=0.486 Sum_probs=196.4
Q ss_pred ccceEE--Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEe----CCeEE
Q 002953 460 SQIDLL--LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISV-RNPFVVRFFYSFTC----RENLY 525 (863)
Q Consensus 460 ~~~~l~--vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d----~~~ly 525 (863)
..|.+. +||+|+||+|+.+. +++|... ....+.+|+.++.++ +|||||+++++|++ +.++|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~-----~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC-----CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 456654 69999999997663 3444321 224577899997655 89999999999986 46799
Q ss_pred EEEeecCCCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccc
Q 002953 526 LVMEYLNGGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGL 600 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~ 600 (863)
||||||+||+|.++|.+. ..|++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999999875 36999999999999999999999999999999999999986 4679999999998421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF 680 (863)
. .......+||+.|||||++.+..|+.++|||||||++|+|++|.+||
T Consensus 166 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 166 S--------------------------------HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp C--------------------------------CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred C--------------------------------CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCC
Confidence 1 01223568999999999999999999999999999999999999999
Q ss_pred CCCChHHHHH----HHhhcCCCCCCC-CCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 681 NAEHPQQIFD----NILNRKIPWPRV-PEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 681 ~~~~~~el~~----kIl~~~~~~p~~-p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
.+.+...... .+......+|.. ...+|+++.+||++||+.||.+|| |+.|+++||||..
T Consensus 214 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~ 277 (335)
T d2ozaa1 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 277 (335)
T ss_dssp EETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSHHHHT
T ss_pred CCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHhhC
Confidence 8776544433 333334333321 135899999999999999999999 9999999999954
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=391.25 Aligned_cols=241 Identities=20% Similarity=0.348 Sum_probs=196.5
Q ss_pred cceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCC
Q 002953 461 QIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 533 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~G 533 (863)
.|.+. .||+|+||+|+.+. +++|+... .....+.+.+|+++|++++|||||++++++..++.+|+|||||++
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 34443 89999999997652 34444332 233456799999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCc
Q 002953 534 GDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAV 612 (863)
Q Consensus 534 GsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~ 612 (863)
|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~---------- 154 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD---------- 154 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC----------
Confidence 9999998765 56889999999999999999999999999999999999999999999999999842110
Q ss_pred cCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHH
Q 002953 613 SGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDN 691 (863)
Q Consensus 613 ~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~k 691 (863)
.........||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..+++..
T Consensus 155 --------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~ 214 (263)
T d1sm2a_ 155 --------------------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214 (263)
T ss_dssp ------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred --------------------CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 0012234579999999999999999999999999999999999 6788888888888888
Q ss_pred HhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 692 ILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 692 Il~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..+.. +..|..+++++.+||.+||+.||.+|| |+++|++|
T Consensus 215 i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 215 ISTGFR--LYKPRLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp HHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHhcCC--CCCccccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 877643 334677899999999999999999999 99999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=393.59 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=202.3
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
..|.+. .||+|+||+|+.+. +++|+... .....+.+.+|+.+|++++|||||++++++. ++.+|||||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT-TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc-CcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 345544 89999999997552 34444322 2334567999999999999999999999765 567899999999
Q ss_pred CCChHHHHHhc--CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRNL--GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~~--g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~------- 163 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------- 163 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-------
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-------
Confidence 99999987544 359999999999999999999999999999999999999999999999999998521100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~ 689 (863)
........||+.|||||++.+..++.++|||||||++|||+| |.+||...+..+++
T Consensus 164 -----------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~ 220 (272)
T d1qpca_ 164 -----------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (272)
T ss_dssp -----------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred -----------------------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 012234679999999999999899999999999999999999 56677777888888
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc--CCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ--HVFFK 741 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq--HPFFk 741 (863)
..+..+.. +..|..+++++.+||.+||+.||++|| |+++|++ |+||.
T Consensus 221 ~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 221 QNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHH
T ss_pred HHHHhcCC--CCCcccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhhhhh
Confidence 88766543 345678999999999999999999999 9999988 67764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=400.13 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=196.4
Q ss_pred cceE-EEeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC------eE
Q 002953 461 QIDL-LLAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE------NL 524 (863)
Q Consensus 461 ~~~l-~vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------~l 524 (863)
.|.+ ..||+|+||+|+.+. +++|+.. .......+.+.+|+++|+.++|||||+++++|...+ ++
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4544 489999999997652 3444432 234455678999999999999999999999998765 57
Q ss_pred EEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
||||||| |.+|..+++. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~---- 172 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---- 172 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC----
Confidence 9999999 6677777654 689999999999999999999999999999999999999999999999999998410
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.
T Consensus 173 ------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 173 ------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp ------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 112356899999999999874 5689999999999999999999999988
Q ss_pred ChHHHHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHH
Q 002953 684 HPQQIFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVK 735 (863)
Q Consensus 684 ~~~el~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEIL 735 (863)
+....+..+.... ..+......+++++.+||.+||..||.+|| |++|+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---ta~eiL 299 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAGEAL 299 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC---CHHHHH
T ss_pred ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc---CHHHHh
Confidence 7766655543311 111223456899999999999999999999 999999
Q ss_pred cCCCCCCCChh
Q 002953 736 QHVFFKDINWD 746 (863)
Q Consensus 736 qHPFFk~IdW~ 746 (863)
+||||+.+.+.
T Consensus 300 ~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 300 AHPYFESLHDT 310 (346)
T ss_dssp HSGGGTTTC--
T ss_pred cChhhCcCCCc
Confidence 99999988653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=388.25 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=195.6
Q ss_pred cceEE-Eeecccceeecccc----------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP----------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVM 528 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~----------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVm 528 (863)
+|.+. .||+|+||+|+.+. +++|+.. .......+.+.+|+.+|++++|||||++++++. ++.+|+||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 45544 89999999997642 2333332 223445578999999999999999999999985 56799999
Q ss_pred eecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||++|+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~----- 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----- 161 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-----
Confidence 999999999987654 57999999999999999999999999999999999999999999999999999842100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQ 686 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~ 686 (863)
.........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..
T Consensus 162 -------------------------~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 162 -------------------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp ----------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred -------------------------cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 0112234578999999999999999999999999999999998 89999999999
Q ss_pred HHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 687 QIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 687 el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+++.++..+.. +..+..+|+++.+||.+||+.||.+|| |+.+|++|
T Consensus 217 ~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 217 DVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp GHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99988877654 345778999999999999999999999 99999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=384.42 Aligned_cols=239 Identities=19% Similarity=0.278 Sum_probs=194.3
Q ss_pred EEeecccceeecccc-----------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP-----------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~-----------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.+||+|+||+|+.+. +++|+... ........+++|+++|++++|||||++++++.+.+.+|+|||||.
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~ 92 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 92 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecc
Confidence 489999999997642 34444322 233445678999999999999999999999999999999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~-------- 164 (283)
T d1mqba_ 93 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-------- 164 (283)
T ss_dssp TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------------
T ss_pred cCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC--------
Confidence 99999988665 579999999999999999999999999999999999999999999999999998421100
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC-CCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG-k~PF~~~~~~el~~ 690 (863)
..........||+.|||||++.+..++.++|||||||++|||++| .+||...+..+++.
T Consensus 165 --------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~ 224 (283)
T d1mqba_ 165 --------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK 224 (283)
T ss_dssp -----------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred --------------------ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHH
Confidence 001122345789999999999999999999999999999999995 56666777777777
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.+..+.. +..+..++.++.+||.+||..||.+|| ++.+|++
T Consensus 225 ~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 225 AINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHhccCC--CCCchhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 7765543 345678999999999999999999999 8999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=383.82 Aligned_cols=236 Identities=19% Similarity=0.324 Sum_probs=202.8
Q ss_pred Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecCCCChHHH
Q 002953 466 LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 539 (863)
Q Consensus 466 vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dl 539 (863)
.||+|+||+|+.+. +++|+... .....+.+++|+.+|++++|||||++++++.+++.+|+||||+++|+|..+
T Consensus 11 ~iG~G~fg~Vy~~~~~~~~~vAvK~l~~-~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~ 89 (258)
T d1k2pa_ 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 89 (258)
T ss_dssp CCCEETTEEEEEEEETTTEEEEEEEEES-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHH
T ss_pred EEecCCCeEEEEEEECCCCEEEEEEECc-CcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHh
Confidence 89999999996642 33443322 233456799999999999999999999999999999999999999999999
Q ss_pred HHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCCccCcccC
Q 002953 540 LRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLL 618 (863)
Q Consensus 540 Lk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~ 618 (863)
+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--------------- 154 (258)
T d1k2pa_ 90 LREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--------------- 154 (258)
T ss_dssp HHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS---------------
T ss_pred hhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC---------------
Confidence 7654 568999999999999999999999999999999999999999999999999997421100
Q ss_pred CCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCC
Q 002953 619 GDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFDNILNRKI 697 (863)
Q Consensus 619 g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~ 697 (863)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++..+..
T Consensus 155 ---------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 219 (258)
T d1k2pa_ 155 ---------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 219 (258)
T ss_dssp ---------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred ---------------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence 011223579999999999999999999999999999999998 8999999999999988877543
Q ss_pred CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 698 PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 698 ~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
+..|..+++++.+||.+||+.||++|| |+++|++|
T Consensus 220 --~~~p~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 220 --LYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred --CCCcccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 345678999999999999999999999 99999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=390.26 Aligned_cols=254 Identities=28% Similarity=0.366 Sum_probs=201.1
Q ss_pred cccceEE-Eeecccceeecccc-------ceehhhhh--hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe--------
Q 002953 459 TSQIDLL-LAGKGALSEHDDFP-------QVLKKADM--IRKNAVESILAERDILISVRNPFVVRFFYSFTC-------- 520 (863)
Q Consensus 459 ~~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i--~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-------- 520 (863)
..+|++. .||+|+||+|+.+. +++|+... ........+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4567665 99999999997652 34443322 223345678899999999999999999998865
Q ss_pred CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGL 600 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~ 600 (863)
++++|+|||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999887776666666789999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002953 601 INSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPP 679 (863)
Q Consensus 601 ~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~P 679 (863)
.... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 169 ~~~~---------------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 169 LAKN---------------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp C--------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc---------------------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 1000 011223456899999999999865 689999999999999999999999
Q ss_pred CCCCChHHHHHHHhhcCCCCCC-CCC----------------------------CCCHHHHHHHHhhccCCcCCcCCCCC
Q 002953 680 FNAEHPQQIFDNILNRKIPWPR-VPE----------------------------EMSPEAHDLIDRFLTEDPHQRLGSGG 730 (863)
Q Consensus 680 F~~~~~~el~~kIl~~~~~~p~-~p~----------------------------~iS~el~dLI~k~L~~DP~kRpg~~S 730 (863)
|.+.+.......+......++. ... ..++++.+||.+||+.||++|| |
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~---s 298 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI---D 298 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC---C
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc---C
Confidence 9998888777766543221110 000 1367889999999999999999 9
Q ss_pred HHHHHcCCCCCC
Q 002953 731 ASEVKQHVFFKD 742 (863)
Q Consensus 731 AeEILqHPFFk~ 742 (863)
|+|+|+||||+.
T Consensus 299 a~elL~Hpff~~ 310 (318)
T d3blha1 299 SDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSGGGSS
T ss_pred HHHHHcChhhcc
Confidence 999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=398.15 Aligned_cols=241 Identities=28% Similarity=0.421 Sum_probs=191.9
Q ss_pred EEEeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------CeEEEEEee
Q 002953 464 LLLAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------ENLYLVMEY 530 (863)
Q Consensus 464 l~vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~lyLVmEy 530 (863)
+.+||+|+||+|+.+. +++|+.... .....+|+++|++++|||||+++++|... .++||||||
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECcc----chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 4589999999997653 344433211 12234799999999999999999998543 358999999
Q ss_pred cCCCChHHHH---HhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCC
Q 002953 531 LNGGDLYSLL---RNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 531 ~~GGsL~dlL---k~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~d 606 (863)
|+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~----- 175 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR----- 175 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT-----
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC-----
Confidence 9775333332 3346799999999999999999999999999999999999999875 899999999974210
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLG-TGHGTTADWWSVGIILFELIVGIPPFNAEHP 685 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGvILyELLTGk~PF~~~~~ 685 (863)
.....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...+.
T Consensus 176 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 176 ---------------------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp ---------------------------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ---------------------------CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 112235689999999999876 5689999999999999999999999999888
Q ss_pred HHHHHHHhhc-----------------CCCCCC---------CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 686 QQIFDNILNR-----------------KIPWPR---------VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 686 ~el~~kIl~~-----------------~~~~p~---------~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
.+.+..+... ...++. ....+++++.+||.+||..||.+|| ||.|+|+|||
T Consensus 229 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~ 305 (350)
T d1q5ka_ 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSF 305 (350)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGG
T ss_pred HHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHh
Confidence 7777766531 111111 1235789999999999999999999 9999999999
Q ss_pred CCCC
Q 002953 740 FKDI 743 (863)
Q Consensus 740 Fk~I 743 (863)
|+++
T Consensus 306 f~~~ 309 (350)
T d1q5ka_ 306 FDEL 309 (350)
T ss_dssp GGGG
T ss_pred hccc
Confidence 9765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-45 Score=391.13 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=195.9
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-CCCeeEEEEEEEeC--CeEEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-NPFVVRFFYSFTCR--ENLYLVM 528 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~--~~lyLVm 528 (863)
.+|.+. .||+|+||+|+.+. +++|.. +....+.+.+|+++|+++. ||||++++++|... ..+|+||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i---~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEE---CSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEE---CHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 456654 89999999997653 344432 2334567889999999995 99999999999854 5699999
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC-cEEEeecCCccccccCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG-HIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g-~VKLiDFGLAk~~~~~s~~dl 607 (863)
|||.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~------ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP------ 182 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT------
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC------
Confidence 999999998764 4699999999999999999999999999999999999998765 699999999984210
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCCh-
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGT-GHGTTADWWSVGIILFELIVGIPPFNAEHP- 685 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGvILyELLTGk~PF~~~~~- 685 (863)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....
T Consensus 183 --------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 183 --------------------------GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp --------------------------TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred --------------------------CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 0123456899999999998875 479999999999999999999999976542
Q ss_pred HHHHHHHhh-------------cCC---------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCH
Q 002953 686 QQIFDNILN-------------RKI---------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGA 731 (863)
Q Consensus 686 ~el~~kIl~-------------~~~---------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SA 731 (863)
......+.. ... ........+++++.+||++||+.||.+|| |+
T Consensus 237 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---ta 313 (328)
T d3bqca1 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL---TA 313 (328)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred HHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc---CH
Confidence 222222211 000 00011234789999999999999999999 99
Q ss_pred HHHHcCCCCCCCChh
Q 002953 732 SEVKQHVFFKDINWD 746 (863)
Q Consensus 732 eEILqHPFFk~IdW~ 746 (863)
+|+|+||||+++.|+
T Consensus 314 ~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 314 REAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHTSGGGTTSCCC
T ss_pred HHHhcCcccCCCCCC
Confidence 999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=378.17 Aligned_cols=249 Identities=28% Similarity=0.402 Sum_probs=205.2
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEee
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEY 530 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy 530 (863)
+|++. .||+|+||+|+.+. +++|... .........+.+|+.+|+.++|||||++++++.+...+++||++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 45544 99999999997652 3455432 22345567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 531 LNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 531 ~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-------- 154 (292)
T d1unla_ 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-------- 154 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--------
T ss_pred ccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--------
Confidence 999999999988889999999999999999999999999999999999999999999999999999852110
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCC-CCCChHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPF-NAEHPQQI 688 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF-~~~~~~el 688 (863)
........+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.
T Consensus 155 -----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~ 211 (292)
T d1unla_ 155 -----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_dssp -----------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH
T ss_pred -----------------------CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH
Confidence 01122356889999999998765 689999999999999999999885 55566666
Q ss_pred HHHHhhcCC--------------------------CCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCC
Q 002953 689 FDNILNRKI--------------------------PWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKD 742 (863)
Q Consensus 689 ~~kIl~~~~--------------------------~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~ 742 (863)
+.++..... ........+++++.+||++||+.||.+|| ||+|+|+||||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPYFSD 288 (292)
T ss_dssp HHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHTTSGGGSS
T ss_pred HHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc---CHHHHhcChhhcC
Confidence 665543111 11122346789999999999999999999 9999999999986
Q ss_pred C
Q 002953 743 I 743 (863)
Q Consensus 743 I 743 (863)
+
T Consensus 289 ~ 289 (292)
T d1unla_ 289 F 289 (292)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=388.21 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=198.4
Q ss_pred ccceEE-Eeecccceeecccc-----------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-----------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYL 526 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-----------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyL 526 (863)
.+|++. +||+|+||+|+.+. +++|+.. .......+.+.+|+.+|++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 345554 99999999997552 2333322 12334567899999999999999999999998764 5778
Q ss_pred EEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 527 VMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 527 VmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
+|||+.+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+.......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~- 166 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK- 166 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc-
Confidence 89999999999988764 5799999999999999999999999999999999999999999999999999985211000
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~ 684 (863)
........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+
T Consensus 167 ----------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 167 ----------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp ------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ----------------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence 011233569999999999999999999999999999999998 899999988
Q ss_pred hHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 685 PQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 685 ~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
..++...+..+.. +..+..+++++.+||.+||..||.+|| |+.+|++|
T Consensus 219 ~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCcccCHHHHHHHHHhCCCChhhCc---CHHHHHHH
Confidence 8888777766543 345678999999999999999999999 99999988
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=383.66 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=200.4
Q ss_pred ccceEE-Eeecccceeecccc------ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEEEEEeecC
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLYLVMEYLN 532 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~lyLVmEy~~ 532 (863)
.++.+. .||+|+||+|+.+. +++|+.. ......+.+.+|+.+|++++|||||++++++. ++.+|+|||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECC-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEEC-cccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 345554 89999999997652 3444432 22334567999999999999999999999985 456899999999
Q ss_pred CCChHHHHHh--cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCC
Q 002953 533 GGDLYSLLRN--LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGP 610 (863)
Q Consensus 533 GGsL~dlLk~--~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p 610 (863)
+|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-------- 166 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-------- 166 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC--------
Confidence 9999998854 357999999999999999999999999999999999999999999999999999741100
Q ss_pred CccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC-CCCCCCCChHHHH
Q 002953 611 AVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVG-IPPFNAEHPQQIF 689 (863)
Q Consensus 611 ~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTG-k~PF~~~~~~el~ 689 (863)
.........||+.|+|||++.+..++.++|||||||++|||++| .+||......+++
T Consensus 167 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 167 ----------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp -------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred ----------------------CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 01122345799999999999999999999999999999999995 6666777777788
Q ss_pred HHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc--CCCCCCC
Q 002953 690 DNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ--HVFFKDI 743 (863)
Q Consensus 690 ~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq--HPFFk~I 743 (863)
..+..+.. +..+..+++++++||.+||+.||++|| ++++|++ |+||+..
T Consensus 225 ~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 DQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHTTTSCS
T ss_pred HHHHhcCC--CCCCcccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHhhhhcCC
Confidence 77766532 345778999999999999999999999 9999988 8888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=382.60 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=191.1
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC-Ce
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCR-EN 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~-~~ 523 (863)
.+|.+. .||+|+||+|+.+. +++|+... ......+.+.+|..++.++ +|||||.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 345554 89999999997542 23443322 2334456788888888887 689999999887665 46
Q ss_pred EEEEEeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCc
Q 002953 524 LYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGH 587 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~ 587 (863)
+|+|||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 89999999999999999753 24889999999999999999999999999999999999999999
Q ss_pred EEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechh
Q 002953 588 IKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVG 667 (863)
Q Consensus 588 VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLG 667 (863)
+||+|||+|+...... ........+||+.|||||++.+..++.++||||||
T Consensus 173 ~Kl~DFGla~~~~~~~-----------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~G 223 (299)
T d1ywna1 173 VKICDFGLARDIYKDP-----------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 223 (299)
T ss_dssp EEECC------CCSCT-----------------------------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred EEEccCcchhhccccc-----------------------------cccccCceeeCccccchhHhhcCCCCcccceeehH
Confidence 9999999998421100 00122356899999999999999999999999999
Q ss_pred HHHHHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 668 IILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 668 vILyELLTG-k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
|++|||++| .+||.+.+..+.+..++..... +..+..+++++.+||.+||+.||.+|| |+++|++|
T Consensus 224 vil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~eil~~ 290 (299)
T d1ywna1 224 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 290 (299)
T ss_dssp HHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 999999986 6788877655555555444333 456778999999999999999999999 99999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=390.50 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=195.1
Q ss_pred ceE-EEeecccceeecccc-------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC----eEEEEE
Q 002953 462 IDL-LLAGKGALSEHDDFP-------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRE----NLYLVM 528 (863)
Q Consensus 462 ~~l-~vLGkG~FG~V~~~~-------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----~lyLVm 528 (863)
|.+ ..||+|+||+|+.+. +++|+.... .....+.+++|+.+|++|+||||+++++++.... ..+++|
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 444 499999999997652 345543322 3445668899999999999999999999997654 234444
Q ss_pred eecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCC
Q 002953 529 EYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLS 608 (863)
Q Consensus 529 Ey~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~ 608 (863)
+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 90 ~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~---- 164 (345)
T d1pmea_ 90 THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD---- 164 (345)
T ss_dssp EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC----
T ss_pred EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc----
Confidence 55668999999976 5799999999999999999999999999999999999999999999999999985211100
Q ss_pred CCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 609 GPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILL-GTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 609 ~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........+||+.|+|||++. +..++.++||||+||++|+|++|.+||.+.+...
T Consensus 165 ------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 165 ------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp ------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 011234578999999999985 4567999999999999999999999999887766
Q ss_pred HHHHHhhcC----------------------------CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCC
Q 002953 688 IFDNILNRK----------------------------IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVF 739 (863)
Q Consensus 688 l~~kIl~~~----------------------------~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPF 739 (863)
....+.... .++......+++++.+||.+||+.||.+|| |++++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---ta~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---EVEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGG
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHh
Confidence 555443210 001112346789999999999999999999 9999999999
Q ss_pred CCCC
Q 002953 740 FKDI 743 (863)
Q Consensus 740 Fk~I 743 (863)
|+..
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred hccC
Confidence 9854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=379.64 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=195.7
Q ss_pred ccceEE-Eeecccceeecccc----------ceehh---hhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP----------QVLKK---ADMIRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~----------kvlKK---~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
.+|++. .||+|+||+|+.+. +++|+ .........+.+.+|+.+|++++|||||++++++.+ ..+|
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 345554 89999999997542 23333 223344556789999999999999999999999965 5789
Q ss_pred EEEeecCCCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCC
Q 002953 526 LVMEYLNGGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINST 604 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~ 604 (863)
+|||||++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999999887654 5799999999999999999999999999999999999999999999999999985211100
Q ss_pred CCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002953 605 DDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAE 683 (863)
Q Consensus 605 ~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~ 683 (863)
.........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 167 ----------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 167 ----------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp ----------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ----------------------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence 0112234568899999999999999999999999999999998 89999999
Q ss_pred ChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 684 HPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 684 ~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
+..+++.++......+ ..+..+|+++.+||.+||..||.+|| |+.+|++
T Consensus 219 ~~~~~~~~i~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RP---t~~ei~~ 267 (273)
T d1u46a_ 219 NGSQILHKIDKEGERL-PRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 267 (273)
T ss_dssp CHHHHHHHHHTSCCCC-CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CHHHHHHHHHhCCCCC-CCcccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999999988776543 45678999999999999999999999 8888863
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=384.57 Aligned_cols=241 Identities=23% Similarity=0.373 Sum_probs=200.9
Q ss_pred ccceEE-Eeecccceeecccc---------ceehhhh-hhchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeEEEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP---------QVLKKAD-MIRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENLYLV 527 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~---------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~lyLV 527 (863)
..|.+. +||+|+||+|+.+. +++|+.. .......+.+.+|+++|+++ +|||||++++++.+++.+|+|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 445554 89999999997652 2333322 22334556799999999998 799999999999999999999
Q ss_pred EeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEe
Q 002953 528 MEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLT 591 (863)
Q Consensus 528 mEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLi 591 (863)
|||++||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999653 568999999999999999999999999999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHH
Q 002953 592 DFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILF 671 (863)
Q Consensus 592 DFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILy 671 (863)
|||+|+.... ........||+.|+|||.+.+..|+.++|||||||++|
T Consensus 170 DfG~a~~~~~--------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 170 DFGLSRGQEV--------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp CTTCEESSCE--------------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred cccccccccc--------------------------------cccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999974110 01122457999999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 672 ELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 672 ELLTG-k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
||++| .+||.+.+..+++..+..+.. +..+..+++++.+||.+||+.||++|| |+.+|++|
T Consensus 218 ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~ 279 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP---SFAQILVS 279 (309)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 99996 568999999999988877543 455678999999999999999999999 99999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-44 Score=380.23 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=204.1
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhhh-chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADMI-RKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
+.|++. .||+|+||+|+.+. +++|+.... .....+.+.+|+.+|++++||||+++++++.+.+.++
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 345554 99999999997652 345543322 2334567999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC------------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCccee
Q 002953 526 LVMEYLNGGDLYSLLRNLG------------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLL 581 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g------------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNIL 581 (863)
+||||+++|+|.+++.... .+++..+..|+.||+.||+|||++|||||||||+|||
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence 9999999999999996532 3788999999999999999999999999999999999
Q ss_pred ecCCCcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccc
Q 002953 582 IAHDGHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTA 661 (863)
Q Consensus 582 Ld~~g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 661 (863)
|+.++++||+|||+|+..... .......+.+||+.|||||++.+..|+.++
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ks 223 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSA-----------------------------DYYKADGNDAIPIRWMPPESIFYNRYTTES 223 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGG-----------------------------GCBC----CCBCGGGCCHHHHHHCCCCHHH
T ss_pred ECCCCcEEEccchhheeccCC-----------------------------ccccccCCCCcCcCcCCHHHHccCCCChhh
Confidence 999999999999999742110 001123356899999999999999999999
Q ss_pred eeechhHHHHHHHhC-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 662 DWWSVGIILFELIVG-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 662 DIWSLGvILyELLTG-k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||||||++|||++| .+||.+.+..++...+..+.. +..+..+++++.+||.+||+.||.+|| |+.+|++
T Consensus 224 DVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RP---t~~ev~~ 294 (301)
T d1lufa_ 224 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRP---SFCSIHR 294 (301)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999999999998 478999999999988877654 556788999999999999999999999 8988864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=376.92 Aligned_cols=244 Identities=21% Similarity=0.332 Sum_probs=200.7
Q ss_pred cccceE-EEeecccceeecccc--------------ceehhhhhh-chhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeC
Q 002953 459 TSQIDL-LLAGKGALSEHDDFP--------------QVLKKADMI-RKNAVESILAERDILISV-RNPFVVRFFYSFTCR 521 (863)
Q Consensus 459 ~~~~~l-~vLGkG~FG~V~~~~--------------kvlKK~~i~-~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~ 521 (863)
..+|.+ ..||+|+||.|+.+. +++|+.... .......+.+|..++.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 345555 489999999997653 244443322 234557788999999888 799999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhc----------------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCC
Q 002953 522 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHD 585 (863)
Q Consensus 522 ~~lyLVmEy~~GGsL~dlLk~~----------------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~ 585 (863)
+.+|+|||||++|+|.++|... ..+++..++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 9999999999999999999754 248999999999999999999999999999999999999999
Q ss_pred CcEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeec
Q 002953 586 GHIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWS 665 (863)
Q Consensus 586 g~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 665 (863)
+.+||+|||+++...... ........+||+.|+|||++.+..|+.++||||
T Consensus 172 ~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS 222 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHID-----------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222 (299)
T ss_dssp CCEEECSTTCCCCGGGCC-----------------------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH
T ss_pred CCeEeccchhhccccccc-----------------------------cccccccCCCChhhhhhhHhcCCCCCchhhhHH
Confidence 999999999998421110 011234567999999999999999999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 666 VGIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 666 LGvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
|||++|||++ |.+||.+.+..+++..+..+.. +..+..+++++.+||.+||+.||.+|| |+.||++
T Consensus 223 ~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rp---s~~eil~ 289 (299)
T d1fgka_ 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRP---TFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHCc---CHHHHHH
Confidence 9999999998 7999999998888887766533 456788999999999999999999999 9999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=386.11 Aligned_cols=245 Identities=29% Similarity=0.401 Sum_probs=197.6
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCC-----eEE
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCRE-----NLY 525 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~ly 525 (863)
+|++. .||+|+||+|+.+. +++|... .......+.+.+|+++|++++|||||+++++|.... ..+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 35544 89999999997652 3444432 223345567899999999999999999999997543 346
Q ss_pred EEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCC
Q 002953 526 LVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~ 605 (863)
++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|...
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~------ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT------ 171 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC------
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc------
Confidence 66777789999999865 57999999999999999999999999999999999999999999999999998731
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCC
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG-HGTTADWWSVGIILFELIVGIPPFNAEH 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGvILyELLTGk~PF~~~~ 684 (863)
.....+..||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+
T Consensus 172 ----------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 172 ----------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp ----------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ----------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 01234568999999999987754 5899999999999999999999999988
Q ss_pred hHHHHHHHhhcCCCC-----------------------CC-----CCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 685 PQQIFDNILNRKIPW-----------------------PR-----VPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 685 ~~el~~kIl~~~~~~-----------------------p~-----~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
.......+....... +. ....+++++.+||.+||+.||.+|| ||.|+|+
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~---ta~elL~ 300 (348)
T d2gfsa1 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALA 300 (348)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHT
T ss_pred HHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc---CHHHHhc
Confidence 877777765432111 00 1235789999999999999999999 9999999
Q ss_pred CCCCCCC
Q 002953 737 HVFFKDI 743 (863)
Q Consensus 737 HPFFk~I 743 (863)
||||+.+
T Consensus 301 Hp~f~~~ 307 (348)
T d2gfsa1 301 HAYFAQY 307 (348)
T ss_dssp SGGGTTT
T ss_pred CHhhCCC
Confidence 9999865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=374.55 Aligned_cols=236 Identities=25% Similarity=0.413 Sum_probs=194.8
Q ss_pred cceEE-Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEeecCC
Q 002953 461 QIDLL-LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVMEYLNG 533 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~lyLVmEy~~G 533 (863)
++.+. .||+|+||.|+.+. +++|+. .+....+.+.+|+++|++++|||||++++++.+ .+.+||||||+++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTEEEEEEEC--CCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HeEEeEEEecCCCeEEEEEEECCeEEEEEEE--CcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 44444 89999999997652 344432 234456789999999999999999999998854 4678999999999
Q ss_pred CChHHHHHhcC--CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 534 GDLYSLLRNLG--CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 534 GsL~dlLk~~g--~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
|+|.++|.+.+ .+++..++.++.||+.||.|||+.+|+||||||+|||++.++++||+|||+++...
T Consensus 86 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~----------- 154 (262)
T d1byga_ 86 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------- 154 (262)
T ss_dssp EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC-----------
Confidence 99999997643 48999999999999999999999999999999999999999999999999987410
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV-GIPPFNAEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT-Gk~PF~~~~~~el~~ 690 (863)
.......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+++.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 155 -----------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp ------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred -----------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 11224568999999999999999999999999999999998 899999999888888
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..+.. +.++..+++++.+||++||..||.+|| |+.+++++
T Consensus 212 ~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 212 RVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp HHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 8876543 456778999999999999999999999 99998874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=388.61 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=194.4
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhh--hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeC------Ce
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKAD--MIRKNAVESILAERDILISVRNPFVVRFFYSFTCR------EN 523 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~--i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~~ 523 (863)
.+|++. +||+|+||+|+.+. +++|... .........+.+|+.+|++++|||||+++++|... .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 346654 99999999996652 3444332 23345566789999999999999999999999643 68
Q ss_pred EEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCC
Q 002953 524 LYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINS 603 (863)
Q Consensus 524 lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s 603 (863)
+|+|||||.| +|.+.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~--- 170 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--- 170 (355)
T ss_dssp EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc---
Confidence 9999999976 5555543 569999999999999999999999999999999999999999999999999987411
Q ss_pred CCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002953 604 TDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAE 683 (863)
Q Consensus 604 ~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~ 683 (863)
........+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.
T Consensus 171 -----------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 171 -----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 012234568999999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHhhcCC----------------------CCCCC-----------------CCCCCHHHHHHHHhhccCCcCC
Q 002953 684 HPQQIFDNILNRKI----------------------PWPRV-----------------PEEMSPEAHDLIDRFLTEDPHQ 724 (863)
Q Consensus 684 ~~~el~~kIl~~~~----------------------~~p~~-----------------p~~iS~el~dLI~k~L~~DP~k 724 (863)
+......+++.... ..... ...+++++.+||++||..||++
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhH
Confidence 87776666543111 00000 0113678999999999999999
Q ss_pred cCCCCCHHHHHcCCCCCCCChhHHhhccCC
Q 002953 725 RLGSGGASEVKQHVFFKDINWDTLARQKAA 754 (863)
Q Consensus 725 Rpg~~SAeEILqHPFFk~IdW~~l~~~~pp 754 (863)
|| ||+|+|+||||+..-+..-....+|
T Consensus 302 R~---ta~elL~Hpw~~~~~~~~~~~~~~~ 328 (355)
T d2b1pa1 302 RI---SVDDALQHPYINVWYDPAEVEAPPP 328 (355)
T ss_dssp SC---CHHHHHTSTTTGGGCCHHHHTCCCC
T ss_pred Cc---CHHHHhcCcccCCCCCcccccCCCC
Confidence 99 9999999999997544333333344
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=374.94 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=202.8
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhc-CCCCeeEEEEEEEeCCeE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISV-RNPFVVRFFYSFTCRENL 524 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~l 524 (863)
.++.+. +||+|+||.|+.+. +++|+... ........+.+|+.+++++ +|||||++++++.+.+.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 344444 89999999997652 34444332 2334556789999999999 699999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcC------------------CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCC
Q 002953 525 YLVMEYLNGGDLYSLLRNLG------------------CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDG 586 (863)
Q Consensus 525 yLVmEy~~GGsL~dlLk~~g------------------~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g 586 (863)
|||||||++|+|.+++.... .+++..+..|+.||+.||+|||++|||||||||+|||++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 99999999999999997543 588999999999999999999999999999999999999999
Q ss_pred cEEEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeech
Q 002953 587 HIKLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSV 666 (863)
Q Consensus 587 ~VKLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 666 (863)
.+||+|||+++...... ........+||+.|+|||++.+..++.++|||||
T Consensus 183 ~~ki~DfG~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~ 233 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDS-----------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (311)
T ss_dssp EEEECCCGGGSCTTSCT-----------------------------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cccccccchheeccCCC-----------------------------cceEeeecccChHHcCHHHhcCCCCCCcccccch
Confidence 99999999998421100 0112234689999999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 667 GIILFELIV-GIPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 667 GvILyELLT-Gk~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
||++|||+| |.+||...+..+.+.+++..... +..+..+++++.+||.+||+.||.+|| |+.+|++
T Consensus 234 G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RP---s~~~il~ 300 (311)
T d1t46a_ 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRP---TFKQIVQ 300 (311)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCcccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999998 77778777776777676665543 345677999999999999999999999 8999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=375.25 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=204.4
Q ss_pred ccceEE-Eeecccceeecccc------------ceehhhhh-hchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEeCCeEE
Q 002953 460 SQIDLL-LAGKGALSEHDDFP------------QVLKKADM-IRKNAVESILAERDILISVRNPFVVRFFYSFTCRENLY 525 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~------------kvlKK~~i-~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ly 525 (863)
.++.+. .||+|+||+|+.+. +++|+... ........+.+|+.+|++++|||||++++++..+..+|
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 344444 89999999997542 24444332 23344567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc----------CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCC
Q 002953 526 LVMEYLNGGDLYSLLRNL----------GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGL 595 (863)
Q Consensus 526 LVmEy~~GGsL~dlLk~~----------g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGL 595 (863)
+|||||++|+|.+++... ..++...+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999999998643 2368889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh
Q 002953 596 SKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIV 675 (863)
Q Consensus 596 Ak~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLT 675 (863)
|+..... ..........||+.|+|||.+.+..++.++|||||||++|||+|
T Consensus 180 a~~~~~~-----------------------------~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t 230 (308)
T d1p4oa_ 180 TRDIYET-----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 230 (308)
T ss_dssp CCGGGGG-----------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH
T ss_pred ceeccCC-----------------------------cceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHh
Confidence 9842110 00122334579999999999999999999999999999999999
Q ss_pred C-CCCCCCCChHHHHHHHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHc
Q 002953 676 G-IPPFNAEHPQQIFDNILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQ 736 (863)
Q Consensus 676 G-k~PF~~~~~~el~~kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILq 736 (863)
| .+||.+.+..+++..+..+.. +..+..+++.+.+||.+||+.||.+|| |+++|++
T Consensus 231 ~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RP---s~~~il~ 287 (308)
T d1p4oa_ 231 LAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRP---SFLEIIS 287 (308)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 8 589999999999998877654 455778999999999999999999999 9999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=371.56 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=194.7
Q ss_pred EEeecccceeecccc----------ceehhhh-hhchhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe-CCeEEEEEeecC
Q 002953 465 LLAGKGALSEHDDFP----------QVLKKAD-MIRKNAVESILAERDILISVRNPFVVRFFYSFTC-RENLYLVMEYLN 532 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~----------kvlKK~~-i~~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~lyLVmEy~~ 532 (863)
.+||+|+||+|+.+. +++|+.. .......+.+.+|+++|++++|||||++++++.. ++.+|+|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 389999999997542 2344433 2355566889999999999999999999998765 568999999999
Q ss_pred CCChHHHHHhc-CCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccccccCCCCCCCCCC
Q 002953 533 GGDLYSLLRNL-GCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPA 611 (863)
Q Consensus 533 GGsL~dlLk~~-g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~dl~~p~ 611 (863)
+|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||+.++.+||+|||+++........
T Consensus 113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~------ 186 (311)
T d1r0pa_ 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD------ 186 (311)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC------
T ss_pred cCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc------
Confidence 99999998765 45778889999999999999999999999999999999999999999999999852111000
Q ss_pred ccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC-CCChHHHHH
Q 002953 612 VSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFN-AEHPQQIFD 690 (863)
Q Consensus 612 ~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~-~~~~~el~~ 690 (863)
.........||+.|+|||++.+..++.++||||||+++|||++|..||. ..+..++..
T Consensus 187 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 187 ---------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp ---------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred ---------------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 0011234579999999999999999999999999999999999766664 445555666
Q ss_pred HHhhcCCCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 691 NILNRKIPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 691 kIl~~~~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
.+..+.. +..|..+++++.+||.+||..||.+|| ++.||++|
T Consensus 246 ~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 246 YLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp HHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 6666543 345778999999999999999999999 99999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-42 Score=362.67 Aligned_cols=253 Identities=19% Similarity=0.233 Sum_probs=187.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCCCC-eeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRNPF-VVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~~lyLVmEy~ 531 (863)
+|.+. .||+|+||+|+.+. +++|... .......+..|+++|+.++|++ |+.+.+++.+.+..|+||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~--~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE--SCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEc--hhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 35554 89999999997652 3344222 1223345789999999998665 666677778888999999999
Q ss_pred CCCChHHHHHh-cCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC---CCcEEEeecCCccccccCCCCCC
Q 002953 532 NGGDLYSLLRN-LGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH---DGHIKLTDFGLSKVGLINSTDDL 607 (863)
Q Consensus 532 ~GGsL~dlLk~-~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~---~g~VKLiDFGLAk~~~~~s~~dl 607 (863)
+++|...+.. .+.+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+.........
T Consensus 86 -~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~- 163 (299)
T d1ckia_ 86 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ- 163 (299)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC-
T ss_pred -CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc-
Confidence 5577666654 467999999999999999999999999999999999999764 4579999999998532111100
Q ss_pred CCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002953 608 SGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEHPQQ 687 (863)
Q Consensus 608 ~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~~~e 687 (863)
........+.+||+.|||||++.+..++.++|||||||++|||++|.+||.......
T Consensus 164 -----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 164 -----------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp -----------------------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred -----------------------ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 000123346789999999999999999999999999999999999999998765443
Q ss_pred HHHHHh---hcC--CCCCCCCCCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCC
Q 002953 688 IFDNIL---NRK--IPWPRVPEEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFF 740 (863)
Q Consensus 688 l~~kIl---~~~--~~~p~~p~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFF 740 (863)
....+. ... .+.+.....+|+++.+||.+||..||.+||++..+.++|+|+|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 332221 111 12223346789999999999999999999944444566777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.9e-40 Score=350.86 Aligned_cols=240 Identities=19% Similarity=0.241 Sum_probs=188.4
Q ss_pred cceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcCC-CCeeEEEEEEEeCCeEEEEEeec
Q 002953 461 QIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVRN-PFVVRFFYSFTCRENLYLVMEYL 531 (863)
Q Consensus 461 ~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~~lyLVmEy~ 531 (863)
+|.+. .||+|+||+|+.+. +++|.. ........+.+|+++++.|.| +||+.+++++......|+||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE--ECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEE--ccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 45554 89999999997763 233321 122333457889999999976 89999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecC-----CCcEEEeecCCccccccCCCC
Q 002953 532 NGGDLYSLLRNLG-CLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAH-----DGHIKLTDFGLSKVGLINSTD 605 (863)
Q Consensus 532 ~GGsL~dlLk~~g-~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~-----~g~VKLiDFGLAk~~~~~s~~ 605 (863)
|++|.+++...+ .+++..+..++.|++.||+|||++|||||||||+|||++. .+.+||+|||+|+........
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence 779999987654 6999999999999999999999999999999999999974 578999999999853211110
Q ss_pred CCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-
Q 002953 606 DLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGIILFELIVGIPPFNAEH- 684 (863)
Q Consensus 606 dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGvILyELLTGk~PF~~~~- 684 (863)
. ........+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 163 ~------------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 163 Q------------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp C------------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred c------------------------ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 0 000122346789999999999999999999999999999999999999997543
Q ss_pred --hHHHHHHHhhcCC--CCCCCCCCCCHHHHHHHHhhccCCcCCcCC
Q 002953 685 --PQQIFDNILNRKI--PWPRVPEEMSPEAHDLIDRFLTEDPHQRLG 727 (863)
Q Consensus 685 --~~el~~kIl~~~~--~~p~~p~~iS~el~dLI~k~L~~DP~kRpg 727 (863)
....+.++..... +.+.+...+|+++.+++..|+..+|.+||.
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred hhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 3334444433221 122234678999999999999999999993
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=352.40 Aligned_cols=237 Identities=21% Similarity=0.293 Sum_probs=177.3
Q ss_pred Eeecccceeecccc-----ceehhhhhhchhHHHHHHHHHHHH--HhcCCCCeeEEEEEEEeCC----eEEEEEeecCCC
Q 002953 466 LAGKGALSEHDDFP-----QVLKKADMIRKNAVESILAERDIL--ISVRNPFVVRFFYSFTCRE----NLYLVMEYLNGG 534 (863)
Q Consensus 466 vLGkG~FG~V~~~~-----kvlKK~~i~~k~~~e~~l~Ei~IL--~~L~HPnIVkL~~~f~d~~----~lyLVmEy~~GG 534 (863)
.||+|+||.|+.+. +++|+. ..........|.+++ ..++|||||++++++.+++ .+|||||||++|
T Consensus 10 ~iG~G~fg~Vy~~~~~g~~vAvK~~---~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 10 SIGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEECCSSSEEEEEEETTEEEEEEEE---CGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCEEEEEEEE---CccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 79999999997653 344432 223334444555544 5789999999999998764 589999999999
Q ss_pred ChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh--------CCccccCCCCcceeecCCCcEEEeecCCccccccCCCCC
Q 002953 535 DLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS--------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDD 606 (863)
Q Consensus 535 sL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs--------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~~~~~s~~d 606 (863)
+|.++|++ ..+++..+..++.|++.||.|||+ +|||||||||+||||+.++++||+|||+++.......
T Consensus 87 ~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~-- 163 (303)
T d1vjya_ 87 SLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD-- 163 (303)
T ss_dssp BHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT--
T ss_pred CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc--
Confidence 99999987 468999999999999999999996 5999999999999999999999999999985211100
Q ss_pred CCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCC------CCccceeechhHHHHHHHhCCCCC
Q 002953 607 LSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTG------HGTTADWWSVGIILFELIVGIPPF 680 (863)
Q Consensus 607 l~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~------ys~ksDIWSLGvILyELLTGk~PF 680 (863)
.........+||+.|||||++.+.. ++.++|||||||+||||+||.+||
T Consensus 164 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~ 218 (303)
T d1vjya_ 164 -------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218 (303)
T ss_dssp -------------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred -------------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence 0001223568999999999997653 567899999999999999998877
Q ss_pred CCC---------------ChHHHHHHHhhcCCCCCCCCCC-----CCHHHHHHHHhhccCCcCCcCCCCCHHHHHcC
Q 002953 681 NAE---------------HPQQIFDNILNRKIPWPRVPEE-----MSPEAHDLIDRFLTEDPHQRLGSGGASEVKQH 737 (863)
Q Consensus 681 ~~~---------------~~~el~~kIl~~~~~~p~~p~~-----iS~el~dLI~k~L~~DP~kRpg~~SAeEILqH 737 (863)
... ........+..... .|.++.. .+..+.+|+.+||+.||.+|| |+.||+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~ei~~~ 291 (303)
T d1vjya_ 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARL---TALRIKKT 291 (303)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC---CHHHHHHH
T ss_pred CcccccccchhhcccccchHHHHHHHHhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 321 22233333333222 2333222 234588999999999999999 99999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-38 Score=342.84 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=188.2
Q ss_pred ccceEE-Eeecccceeecccc-------ceehhhhhhchhHHHHHHHHHHHHHhcC-----------CCCeeEEEEEEEe
Q 002953 460 SQIDLL-LAGKGALSEHDDFP-------QVLKKADMIRKNAVESILAERDILISVR-----------NPFVVRFFYSFTC 520 (863)
Q Consensus 460 ~~~~l~-vLGkG~FG~V~~~~-------kvlKK~~i~~k~~~e~~l~Ei~IL~~L~-----------HPnIVkL~~~f~d 520 (863)
.+|.+. +||+|+||+|+.+. +++|+.. ......+.+.+|+++|+.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~-~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEe-ccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 447655 99999999997652 3444322 22234467788999998875 5789999988765
Q ss_pred C--CeEEEEEeecCCCChHHHHH---hcCCCChhhHHHHHHHHHHHHHHHHh-CCccccCCCCcceeecCCC------cE
Q 002953 521 R--ENLYLVMEYLNGGDLYSLLR---NLGCLDEDVARVYIAEVVLALEYLHS-LRVVHRDLKPDNLLIAHDG------HI 588 (863)
Q Consensus 521 ~--~~lyLVmEy~~GGsL~dlLk---~~g~L~e~~i~~Ia~QIl~ALeyLHs-~GIIHRDLKPeNILLd~~g------~V 588 (863)
. ...+++|+++..+....... ....+++..++.++.||+.||+|||+ +||+||||||+||||+.++ .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 4 56777777776554433322 23568999999999999999999997 8999999999999998765 39
Q ss_pred EEeecCCccccccCCCCCCCCCCccCcccCCCCCccchhhhhhhhhhccccccCCCCCCChhhhcCCCCCccceeechhH
Q 002953 589 KLTDFGLSKVGLINSTDDLSGPAVSGTTLLGDEEPQLTASEHQQERRKKRSAVGTPDYLAPEILLGTGHGTTADWWSVGI 668 (863)
Q Consensus 589 KLiDFGLAk~~~~~s~~dl~~p~~~g~~l~g~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGv 668 (863)
+|+|||.|.... ......+||+.|+|||++.+..|+.++|||||||
T Consensus 172 kl~dfg~s~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 172 KIADLGNACWYD----------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217 (362)
T ss_dssp EECCCTTCEETT----------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred eEeecccccccc----------------------------------cccccccccccccChhhccccCCCccccccchHH
Confidence 999999987411 1223568999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH------HHHHHHhh--cC------------------C----CC---------------CCCC
Q 002953 669 ILFELIVGIPPFNAEHPQ------QIFDNILN--RK------------------I----PW---------------PRVP 703 (863)
Q Consensus 669 ILyELLTGk~PF~~~~~~------el~~kIl~--~~------------------~----~~---------------p~~p 703 (863)
++++|++|+.||...... .....+.. +. . .. ...+
T Consensus 218 il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (362)
T d1q8ya_ 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297 (362)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccC
Confidence 999999999999754321 11111110 00 0 00 0111
Q ss_pred CCCCHHHHHHHHhhccCCcCCcCCCCCHHHHHcCCCCCCCChhHHhhccCCccCCCCC
Q 002953 704 EEMSPEAHDLIDRFLTEDPHQRLGSGGASEVKQHVFFKDINWDTLARQKAAFVPTSES 761 (863)
Q Consensus 704 ~~iS~el~dLI~k~L~~DP~kRpg~~SAeEILqHPFFk~IdW~~l~~~~ppfvP~~~s 761 (863)
...++++.+||.+||+.||.+|| ||+|+|+||||+++.+. ...+.|..+...+
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~ 350 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLGM--EEIRVPDRELYGS 350 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTTC--TTCCCTTSCTTCB
T ss_pred cccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCCc--ccCCCCCcccCCC
Confidence 23467899999999999999999 99999999999976532 2233444444433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=4.3e-20 Score=182.44 Aligned_cols=122 Identities=20% Similarity=0.195 Sum_probs=93.7
Q ss_pred EEeecccceeecccc------ceehhhhh--------h----------chhHHHHHHHHHHHHHhcCCCCeeEEEEEEEe
Q 002953 465 LLAGKGALSEHDDFP------QVLKKADM--------I----------RKNAVESILAERDILISVRNPFVVRFFYSFTC 520 (863)
Q Consensus 465 ~vLGkG~FG~V~~~~------kvlKK~~i--------~----------~k~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 520 (863)
..||+|+||+|+.+. +++|.... . ..........|...|.++.|++++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-- 83 (191)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--
T ss_pred CEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--
Confidence 389999999997652 33332110 0 011223456789999999999999988653
Q ss_pred CCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHhCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 521 RENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 521 ~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..++||||++++.+. .++...+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+|+.
T Consensus 84 --~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 84 --GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp --TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEE
T ss_pred --CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCccc
Confidence 237999999886543 35667788999999999999999999999999999999865 589999999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.66 E-value=3.9e-05 Score=76.23 Aligned_cols=101 Identities=18% Similarity=0.155 Sum_probs=69.2
Q ss_pred HHHHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCChHHHHHhcCCCChhhHHHHHHHHHHHHHHHHh----
Q 002953 493 VESILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDVARVYIAEVVLALEYLHS---- 567 (863)
Q Consensus 493 ~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL~dlLk~~g~L~e~~i~~Ia~QIl~ALeyLHs---- 567 (863)
...+.+|..+|..|. +--+.+++.+...++..|+||++++|.++...... ......++.++...|..||+
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~ 127 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCT
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCcc
Confidence 334678999988774 33367888888889999999999999877544321 11122223333333333331
Q ss_pred -------------------------------------------------------CCccccCCCCcceeecCCCcEEEee
Q 002953 568 -------------------------------------------------------LRVVHRDLKPDNLLIAHDGHIKLTD 592 (863)
Q Consensus 568 -------------------------------------------------------~GIIHRDLKPeNILLd~~g~VKLiD 592 (863)
..++|+|+.|.|||++.++.+-|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lID 207 (263)
T d1j7la_ 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID 207 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEee
Confidence 1278999999999998766667999
Q ss_pred cCCccc
Q 002953 593 FGLSKV 598 (863)
Q Consensus 593 FGLAk~ 598 (863)
|+.+..
T Consensus 208 we~a~~ 213 (263)
T d1j7la_ 208 LGRSGR 213 (263)
T ss_dssp CTTCEE
T ss_pred chhccc
Confidence 998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.08 E-value=0.00058 Score=67.14 Aligned_cols=104 Identities=19% Similarity=0.168 Sum_probs=64.3
Q ss_pred HHHHHHHHHHhcCC--CCeeEEEEEEEeCCeEEEEEeecCCCChHH--------------HHHhcCC-------CChhhH
Q 002953 495 SILAERDILISVRN--PFVVRFFYSFTCRENLYLVMEYLNGGDLYS--------------LLRNLGC-------LDEDVA 551 (863)
Q Consensus 495 ~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~~lyLVmEy~~GGsL~d--------------lLk~~g~-------L~e~~i 551 (863)
.+..|...|+.|.. -.+.+++.+..+.+..|+||++++|.++.. .+.+... +.....
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~ 129 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAK 129 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHH
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccch
Confidence 46678888887743 336778888888889999999999876532 1111000 100000
Q ss_pred HHH----------------------HHHHHHHHHHHHh-------CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 552 RVY----------------------IAEVVLALEYLHS-------LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 552 ~~I----------------------a~QIl~ALeyLHs-------~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
..+ .......+..+.. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 130 HRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 000 0001122333332 2379999999999998776678999998874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.43 E-value=0.0022 Score=68.53 Aligned_cols=29 Identities=17% Similarity=0.335 Sum_probs=25.9
Q ss_pred CccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 569 RVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 569 GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++|+|+.|.|||++.+ .++|+||.+|..
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 58999999999999866 489999999885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.20 E-value=0.0095 Score=63.07 Aligned_cols=38 Identities=18% Similarity=0.251 Sum_probs=27.6
Q ss_pred HHHHHHHHHHhcC-CCCeeEEEEEEEeCCeEEEEEeecCCCCh
Q 002953 495 SILAERDILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDL 536 (863)
Q Consensus 495 ~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~lyLVmEy~~GGsL 536 (863)
...+|..+++.+. +.-..++++++.. .+||||++|..|
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3557999998874 5445678877653 689999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.43 E-value=0.049 Score=55.91 Aligned_cols=29 Identities=21% Similarity=0.303 Sum_probs=24.1
Q ss_pred CCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 568 LRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 568 ~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
.++||+|+.|.|||++. + ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 46899999999999974 3 45899998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.92 E-value=0.042 Score=55.52 Aligned_cols=47 Identities=28% Similarity=0.224 Sum_probs=34.9
Q ss_pred HHHHHHHHHHHHHHH----hCCccccCCCCcceeecCCCcEEEeecCCccc
Q 002953 552 RVYIAEVVLALEYLH----SLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKV 598 (863)
Q Consensus 552 ~~Ia~QIl~ALeyLH----s~GIIHRDLKPeNILLd~~g~VKLiDFGLAk~ 598 (863)
...+..+...+...+ ..|+||+|+.++||+++.+...-|+||+.|..
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333444444444444 35899999999999999887778999999874
|